1990 •½¬Œ³”N“x –k—¢‘åŠwˆãŠw•”E‘åŠw•a‰@Œ¤‹†‹ÆÑW
i’Fo”Å•¨‚ÅŒäŠm”F‰º‚³‚¢j

<<101 Á‰»Ší>>

1. mŒ´’˜n The Concepts, Procedures and Problems Related in Endoscopic Laser Therapy of Early Gastric Cancer. ”äŠé”\Ž÷C“ˆ”ömCŽR”ö“N•FC¬—ÑLsC‘ •ÀŸC‹e’rŽj˜YCˆ­”üƒ•vCŽOd–슰ŠìC‚‹´r‹BC匴÷iŠOj: Surg. Endosc., 3: 1`6, 1989.

2. mŒ´’˜n Arterial Infusion of Combination Therapy Using Dibutyryl Adenosine 3',5'-monophosphate and Mitomycin C for Hepatocellualr Carcinoma Occluding Main Portal Vein: Case studies. ΈäŒö“¹CŠ¡•”‚ЂƂÝCŽÄ“c‹v—YC‰ª•”Ž¡–íi“àjC‰œ•½‰ë•Fi•a—jCMasaharu TsuchiyaiŒc‘åj: Angiology, 40(12): 1072`1078, 1989.

3. mŒ´’˜n Roles of Microfilaments in Exocytosis: A New Hypothesis. £ì²‹vCŽR‰È³•½i‰ðj: Cell Structure and Function, 14(5): 531`544, 1989.

4. mŒ´’˜n Mouse Strain Variations in the Magnitude of Induction of Liver DT-Diaphorase and Hereditary Transmission of the Trait. –x]Ž •vC“n•Ó“”ü”Ti¶‰»jC‘]ª—R”üŽqC‚ŽR‹v”üŽqi¶‰»ŒnjC’r“c•ä‚i¶‰»jC‘ëàV’¼’èi¶—j: Comp. Biochem. Physiol., 93B(2): 493`498, 1989.

5. mŒ´’˜n Rat Strain Variations in Liver Cytosolic DT-Diaphorase Activity and Possible Significance of the Trait in Carcinogenesis by Azo Dyes. –x]Ž •vC’r“c•ä‚i¶‰»jC‹ÊˆäL–¾i“àjC‘¾“cŒ°¬i•új: Comp. Biochem. Physiol., 93B(4): 673`677, 1989.

6. mŒ´’˜n t•s‘S‚̈ݔS–ŒƒwƒLƒ\ƒTƒ~ƒ“‚É‹y‚Ú‚·‰e‹¿|—c‹ŒŒ‰t’ŠoÜ‚Ì—\–hŒø‰Ê‚ðŠÜ‚ß‚Ä|. ‹TŽRmˆêiŽRŒ`‘åjC‘¼4–¼CÎŒ´˜a•Fi‰»jC¼ŽRŒ›Žqi¶‰»ŒnjC–x“c‹±Žqi¶‰»j: Cyto-Protection and Biology, 7: 133`138, 1989.

7. mŒ´’˜n ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éˆÝŠà[’B“xf’f‚ÉŠÖ‚·‚é—Õ°•a—Šw“IŒ¤‹†|Š×‰šŒ^ˆÝŠà‚ð’†S‚É|. –Ø“cŒõLC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: Gastroenterological Endoscopy, 31(5): 1141`1155, 1989.

8. mŒ´’˜n ‹}«ˆÝ”S–Œ•a•Ï‚Ì—Õ°“I¥“àŽ‹‹¾“IŒŸ“¢|“Á‚É‘O’ë•”‹}«‘ÎÌ«’×ᇂɂ‚¢‚Ä|. ¼Œ³Ž›Ž—çCˆêŒ´—ºC“©ŽRaˆê˜NC‰ª•”Ž¡–íi“àjCˆ×‹ß‹`•viŽRŒû‘åj: Gastroenterological Endoscopy, 31(7): 1783`1793, 1989.

9. mŒ´’˜n ’¼’°ƒJƒ‹ƒ`ƒmƒCƒh12—á‚Ì—Õ°•a—Šw“IŒŸ“¢|“Á‚É“àŽ‹‹¾“Iƒ|ƒŠƒyƒNƒgƒ~[‚Ì—L—p«‚ɂ‚¢‚Ä|. ¬—Ñ´“TCŸ–””º‰hC‹e’n–FtCŽO•xO”VC—é–Ø—TCŽR–{‰À³CŒÜ\—’³LC¼Œ³Ž›Ž—çi“àjC‘å’J„³iŠOjC£ìŒªˆêC’†‰p’ji•a—j: Gastroenterological Endoscopy, 32(1): 67`73, 1990.

10. mŒ´’˜n ”|—{×–EŠ”‚ÌЉîiÁ‰»ŠíjKE-24. ŽR‰º˜a–çi“Œ•a‰@•a—jC’†‰p’ji•a—j: Human Cell, 2(3): 340, 1989.

11. mŒ´’˜n ”|—{×–EŠ”‚ÌЉîiÁ‰»ŠíjKE-43. “n•Óˆê]i“Œ•a‰@•a—jC’†‰p’ji•a—j: Human Cell, 2(4): 463, 1989.

12. mŒ´’˜n Genotypes of Alcohol Dehydrogenase and Aldehyde Dehydrogenase Loci in Japanese Alcohol Flushers and Nonflushers. a’J–¾—²i“àjCMichio YasunamiCAkira Yoshida (City of Hope): Human Genetics, 82: 14`16, 1989.

13. mŒ´’˜n Development of Cellular Polarity and Tight Junctions in Parotid Acinar Cells of Postnatal Rat. ‹Ê–؉p–¾i‰ðjC‹g”ö’miŽ¨jCŽR‰È³•½i‰ðj: J. Electron Microsc., 38(5):340`351, 1989.

14. mŒ´’˜n Intracellular Accumulation of Basement Membrane Components during Morphogenesis of Rat Submandibular Gland. –å’J—TˆêCŽR‰È³•½i‰ðj: J. Histochem. Cytochem., 37(9): 1387`1392, 1989.

15. mŒ´’˜n The Growth Promoting Effect of Transforming Growth Factor-ƒ¿ in Human Breast Cancer Cell Lines. ‘ •ÀŸiŠOjCYamaguchi, K.C Asanuma, F.C Suzuki, M.C Abe, K.: Jpn. J. Clin. Oncol., 19(4): 360`366, 1989.

16. mŒ´’˜n Microcirculatory Responses to Estradiol Benzoate in "Irreversible" Stage of Macronodular Liver Cirrhosis in the Rat. ΈäŒö“¹CŠ¡•”‚ЂƂÝC“¡“c–F–MCŽÄ“c‹v—Yi“àjC‹{‘òŽµ˜Yi“dŒ°ƒZƒ“ƒ^[jC‰œ•½‰ë•Fi•a—jCYasuo Fujishiroi“Œ“d•a‰@jCMasaharu TsuchiyaiŒc‘åj: Microcirculation Annual 1989: 123`124, 1989.

17. mŒ´’˜n Pathogenesis of Water-Immersion Stress-Induced Gastric Ulcers in Rats with Renal Failure. —é–Ø—SŽqC‹TŽRmˆêiŽRŒ`‘åjC‘¼2–¼C¼ŽRŒ›Žqi¶‰»ŒnjCÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»j: Scand. J. Gastroenterol., 24(Suppl. 162): 127`130, 1989.

18. mŒ´’˜n Effect of the Proton Pump Inhibitor, NC-1300, on Gastric Mucus Secretion in Rats. ¬Œ´iC‘å씎”Vi¶‰»jCÎŒ´˜a•Fi‰»jC–x“c‹±ŽqC¬Žº—Tˆêi¶‰»jC‰ª•”Ž¡–íi“àj: Scand. J. Gastroenterol., 24(Suppl. 162): 186`189, 1989.

19. mŒ´’˜n VƒsƒŠƒhƒ“ƒJƒ‹ƒ{ƒ“Ž_Œn‡¬R‹ÛÜT-3262 (Tosufloxacin tosilate)‚Ì’_`’†ˆÚs‹y‚Ñ’_”X‰Š‚ɑ΂·‚é—L—p«. ›“c•¶•vC‘åŒI–ΖFiº˜a‘åjC‚—W—T‘¾˜YC•x‰iÃ’ji‰¡•lŽs‘åjCŠâ‘ºŒ’ˆê˜YCŽR“c‘ñŽii“ŒŠC‘åjCŽÄ“c‹v—YCŽR“cL•vi“àjC‰ª•”˜a•FC‰Á“¡s—Yi¹ ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åj: The Japanese Journal of Antibiotics, 42(9): 1873`1881, 1989.

20. mŒ´’˜n H2Žó—e‘ÌhR–òŽ¡—ÃÁ‰»«’×ᇂ̓AÄ”­—vˆö‚ÌŒŸ“¢. ¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: Therapeutic Research, 10(2): 156`164, 1989.

21. mŒ´’˜n Ž_•ª”åŽhŒƒÜ‚̈ݔS‰t“œ’`”’Ž¿‚É‹y‚Ú‚·‰e‹¿i‘æ2•ñj. ¬Žº—TˆêC‘å씎”VC¬Œ´ii¶‰»jCÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»jC‰ª•”Ž¡–íi“àj: Therapeutic Research, 10(5): 1967`1971, 1989.

22. mŒ´’˜n Ž_‚ƈݔS‰t“œ’`”’Ž¿•Ï“®. –x“c‹±ŽqC¬Œ´ii¶‰»jCÎŒ´˜a•Fi‰»jC⨳—YCŒK“c”£C‘å씎”Vi“àjC¬Žº—TˆêCX‰ºŒOi¶‰»jC‰ª•”Ž¡–íi“àj: Therapeutic Research, 10(8): 3208`3215, 1989.

23. mŒ´’˜n ‚wüŽB‰e‚Ì—§ê‚©‚ç|ƒ|ƒŠ[ƒv‚¨‚æ‚Ñ‘å’°Šàf’f‚É‚¨‚¯‚é’’°‘¢‰e‚Ì–ðŠ„|. ŒÜ\—’³LCŸ–””º‰hCŽR–{‰À³C¬—Ñ´“TC‰ª•”Ž¡–íi“àjC‘å’J„³C‚‹´r‹BiŠOjCˆä“›–rC‘–쳈êi•újC£ìŒªˆêC’†‰p’ji•a—j: Therapeutic Research, 10(Suppl. 1): 36`42, 1989.

24. mŒ´’˜n Á‰»ŠíŠàŠ³ŽÒ––½ŒŒè÷—±‹…‚É”F‚ß‚ç‚ê‚éATPaseŠˆ«‚Ì•Ï“®. ’JŒû–ÒC‰ª“c–LŽŸC‘å–ì—²C‘OìŒö’jC¼Œ³Ž›Ž—çi“àj: Šà‚Ɖ»Šw—Ö@, 16(10): 3491`3493, 1989.

25. mŒ´’˜n ‘ŠúˆÝŠà‚ɑ΂·‚郌[ƒU[+OK-432‹Ç’•¹—p—Ö@. “ˆ”ömC”äŠé”\Ž÷C¬—ÑLsCŽR”ö“N•FCã–쑈ê˜YC“Œ”ŽC‰Á“¡NsCŽOd–슰ŠìC匴÷iŠOjC‰ªTˆê˜YC’†‰p’ji•a—j: Á‰»Ší“àŽ‹‹¾, 1(2): 191`196, 1989.

26. mŒ´’˜n ‘å’°Šà‚Ì’´‰¹”g‘œ‚ÉŠÖ‚·‚éŠî‘b“IŒ¤‹†. ‘å’J„³C–ÈŠÑ•¶•vCH“¡N¶C‹g“c@‹ICŽOd–슰ŠìCˆ­”üƒ•vC‘å‹{“Œ¶C‚‹´r‹BC匴÷C”äŠé”\Ž÷iŠOj: Á‰»Ší“àŽ‹‹¾, 1(4): 723`730, 1989.

27. mŒ´’˜n ¬ˆÝŠà‚Ì—Õ°•a—Šw“IŒŸ“¢. ŽR“cŽŠlC‰¡ŽR–õC¼Œ³Ž›Ž—çCˆÀ’BŒ£C“c•Ó‘CâŒû“NÍC–Ø“cŒõLC¬ò˜aŽO˜YC‰ª•”Ž¡–íi“àjCŽOd–슰ŠìC”äŠé”\Ž÷iŠOjC’†‰p’ji•a—j: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 34: 155`159, 1989.

28. mŒ´’˜n ‘½”­ˆÝŠà91—á‚ÌŒŸ“¢. ˆÉ“¡‹ÏC¬ò˜aŽO˜YC²–ìG–íCˆ°Œ´‹BCˆÀ’BŒ£C“c•Ó‘C“©ŽRaˆê˜NCâŒû“NÍCŽR“cŽŠlC–Ø“cŒõLC‰¡ŽR–õC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjCŽOd–슰ŠìC 匴÷C”äŠé”\Ž÷iŠOjC’†‰p’ji•a—j: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 34: 160`164, 1989.

29. mŒ´’˜n ‘å’°Villous tumor‚Ì—Õ°•a—Šw“IŒŸ“¢. ¬—Ñ´“TCŒÜ\—’³LC‹e’n–FtC—é–Ø—TCŽR–{‰À³CŸ–””º‰hC‰ª•”Ž¡–íi“àjCH“¡N¶iŠOjC£ìŒªˆêC’†‰p’ji•a—jC‚‹´r‹BiŠOj: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 34: 180`183, 1989.

30. mŒ´’˜n ’´‰¹”g“àŽ‹‹¾‚É‚æ‚é–«äX‰Š‚ÌŒŸ“¢. âŒû“NÍC–Ø“cŒõLCŽR“cŽŠlC–ì“o½Cˆ°Œ´‹BC¬ò˜aŽO˜YC‰¡ŽR–õC•›“‡TˆêCŽO‹´—˜‰·CˆÀŠC‹`—jC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 34: 197`201, 1989.

31. mŒ´’˜n ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éˆÝ’×ᇂ̌Ÿ“¢|“Á‚Ɉݒ×ᇂÌEUSŽž‘Š‚ÆŽ¡–ü”»’è‚ɂ‚¢‚Ä|. –Ø“cŒõLC¼Œ³Ž›Ž—çCŽR“cŽŠlCâŒû“NÍCˆ°Œ´‹BC–ì“o½C¬ò˜aŽO˜YC‰¡ŽR–õC•›“‡TˆêCˆÀŠC‹`—jC‰ª•”Ž¡–íi“àjCŽOd–슰ŠìC”äŠé”\Ž÷iŠOjC’† ‰p’ji•a—j: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 34: 45`50, 1989.

32. mŒ´’˜n oŒŒ«’×ᇂ̒·ŠúŒo‰ß‚ÌŒŸ“¢|“Á‚ÉÄoŒŒ‚ɂ‚¢‚Ä|. ²–ìG–íC‰¡ŽR–õC“c•Ó‘CˆÉ“¡‹ÏCˆ°Œ´‹BCŽR“cŽŠlCâŒû“NÍC–Ø“cŒõLC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC“ˆ”ömCŽOd–슰ŠìC”äŠé”\Ž÷ iŠOj: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 35: 120`124, 1989.

33. mŒ´’˜n ’_”X‘B‹ØŽîÇ‚Ìf’f‚É‚¨‚¯‚é’´‰¹”g“àŽ‹‹¾‚Ì—L—p«. âŒû“NÍC–Ø“cŒõLCŽR“cŽŠlC–ì“o½Cˆ°Œ´‹BC‰¡ŽR–õC•›“‡TˆêCŽR“cL•vC^‹ÊŽõ”ü¶CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC‹g“c@‹ICˆ­”üƒ•vC‘å‹{“Œ¶C ”äŠé”\Ž÷iŠOjCΈä‰pºC–{‹§C’†‰p’ji•a—j: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 35: 196`200, 1989.

34. mŒ´’˜n ICG•¹—p‘¢‰e‰º‚Ìd‰»ÜŒŒŠÇ“à’“ü–@‚ÌŒŸ“¢. “c•Ó‘C‘•ª–ΔŽCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC”äŠé”\Ž÷iŠOj: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 35: 72`76, 1989.

35. mŒ´’˜n •a—¶ŒŸ•W–{‚É‚¨‚¯‚鎉–bŠÌ‚ÌŒv‘ªŠw“IŒŸ“¢. Žs£‹I‘ã”üCˆÉ“¡—R”üŽqC“n•ÓiŽqi“Œ•a‰@•a—jCŽsì‚‚íi•a‰@•a—j: _“Þ쌧—Õ°‰q¶ŒŸ¸‹ZŽt‰ïŽGŽ, 22(1): 44`47, 1987.

36. mŒ´’˜n ŠeŽíõF–@‚ð—p‚¢‚½ˆÝ‰©FŽî‚Ì•a—‘gDŠw“IŒŸ“¢. ‰¡‘ò³ŽuCŽR‰º˜a–çC“n•Óˆê]CŽÂ“cGi“Œ•a‰@•a—jC’†‰p’ji•a—j: _“Þ쌧—Õ°‰q¶ŒŸ¸‹ZŽt‰ïŽGŽ, 23(3): 164`167, 1988.

37. mŒ´’˜n ‘å’°ƒƒ‰ƒm|ƒVƒX‚É‚¨‚¯‚éF‘f•Û—L×–E‚Ì•a—Šw“IŒŸ“¢. ŽR‰º˜a–çCŽÂ“cGC‰¡‘ò³ŽuC“n•Óˆê]C‘êì—T”üCŒÃ‘º‚¢‚³‚Ýi“Œ•a‰@•a—jC’†‰p’ji•a—j: _“Þ쌧—Õ°‰q¶ŒŸ¸‹ZŽt‰ïŽGŽ, 23(4): 210`215, 1988.

38. mŒ´’˜n ’_”XƒRƒŒƒXƒeƒ|ƒVƒX‚Ì•a—‘gDŠw“IŒŸ“¢. “n•Óˆê]C‰¡‘ò³ŽuCŽR‰º˜a–çCŽÂ“cGi“Œ•a‰@•a—jC’†‰p’ji•a—j: _“Þ쌧—Õ°‰q¶ŒŸ¸‹ZŽt‰ïŽGŽ, 24(1): 13`16, 1989.

39. mŒ´’˜n ‘ŠúˆÝŠà‚Ì“àŽ‹‹¾ƒŒ[ƒU[ÆŽË+OK432‹Ç’•¹—p—Ö@. “ˆ”ömC”äŠé”\Ž÷C¬—ÑLsCŽR”ö“N•FCã–쑈ê˜YC“Œ”ŽC‰Á“¡NsCŽOd–슰ŠìC匴÷iŠOj: “ú–{ƒŒ[ƒU[ˆãŠw‰ïŽ, 10(3): 151`154, 1989.

40. mŒ´’˜n Orthotopic Liver Transplantation with Use of Mizoribine, Cyclosporine and FK506 in Dogs. ²“¡ŒõŽjC‰¡“c˜a•FC‘듇í‰ëC’†ŽR‹`‰îCŒY•”P’jC“à“c‹v‘¥Cˆ¢‘]OˆêiŠOjC‘å•”½C‰œ•½‰ë•Fi•a—j: “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽ, 20: 56`59, 1989.

41. mŒ´’˜n ‘ŠúˆÝŠà‚É‚¨‚¯‚郌[ƒU[‚̉ž—p|Endoscopic Surgery‚ɂ‚¢‚Ä|. ”äŠé”\Ž÷C“ˆ”ömC¬—ÑLsiŠOj: “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽ, 21: 176`178, 1989.

42. mŒ´’˜n \“ñŽw’°’×ᇋً}Žèp—á‚Ì—Õ°“IŒŸ“¢. ’Ë–{GlC÷–{MˆêCˆ­”üƒ•vC‘ •ÀŸCŽOd–슰ŠìC‚‹´r‹BC匴÷C”äŠé”\Ž÷Cˆ¢‘]OˆêiŠOj: “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 22(8): 2004`2008, 1989.

43. mŒ´’˜n ”S–Œ‰º‘wZ‘å’°Šà‚¨‚æ‚ьŗL‹Ø‘wZ‘å’°Šà‚Ì—Õ°•a—Šw“IŒ¤‹†|‚Æ‚­‚Ép‘Op’†’´‰¹”gf’f‚Æ‚ÌŠÖ˜A‚É‚¨‚¢‚Ä|. ‘å’J„³iŠOj: “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 22(9): 2283`2291, 1989.

44. mŒ´’˜n ƒ‰ƒbƒgˆÝ”S‰t“œƒ^ƒ“ƒpƒNŽ¿‹y‚шݔS–Œ’ïR«‚ɑ΂·‚éŽ_•ª”åŽhŒƒ‚̉e‹¿. ¬Žº—TˆêC¬Œ´ii¶‰»jCÎŒ´˜a•Fi‰»jC‰ª•”Ž¡–íi“àjC–x“c‹±Žqi¶‰»j: “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(3): 11`17, 1990.

45. mŒ´’˜n ’°Œ^ƒx[ƒ`ƒFƒbƒg•a‚ɑ΂·‚é‰h—{—Ö@‚Ì—Õ°“IŒ¤‹†. ¬—Ñ´“TCŒÜ\—’³LC‹e’n–FtC—é–Ø—TCŽR–{‰À³CŸ–””º‰hC‰ª•”Ž¡–íi“àj: “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ, 42(7): 1265`1271, 1989.

46. mŒ´’˜n Á‰»ŠÇ‰^“®‚ÌV‚µ‚¢‰ðÍ•û–@|ƒ}ƒEƒX“Eo’°ŠÇ‰^“®‚É‚¨‚æ‚Ú‚·Scoporamine-N-butylbromide‚¨‚æ‚ÑMetoclopramide‚Ì Œø‰Ê. ‰Á“¡NsCã–쑈ê˜YC“Œ”ŽiŠOjC‘ëàV’¼’èC‘åŠÑMi¶—jC”äŠé”\Ž÷iŠOj: –k—¢ˆãŠw, 19(4): 440`444, 1989.

47. mŒ´’˜n –³ŠÌŠú‚ÉBio-pump‚É‚æ‚éƒoƒCƒpƒXŽè‹Z‚ð—p‚¢‚½ƒCƒk“¯Š«“¯ŽîŠÌˆÚA|ŽèpŽè‹Z‚ÌŠm—§‚ÆV–Ɖu—}§ÜFK506‚̖Ɖu—}§Œø‰Ê‚ɂ‚¢‚Ä|. ‰¡“c˜a•FC‘듇í‰ëC²“¡ŒõŽjC’†ŽR‹`‰îCŒY•”P’jC¡ˆäŒ‰C“à“c‹v‘¥Cˆ¢‘]OˆêiŠOjC‘å•”½C‰œ•½‰ë•Fi•a—jC^è‹`•FiŽÀ“®Œnj: –k—¢ˆãŠw, 19(5): 501`509, 1989.

48. mŒ´’˜n ’_”XŒ‹Î‚ɑ΂·‚é‘ÌŠOŽ®ÕŒ‚”g‚É‚æ‚é”jÓp‚ÌŠî‘b“I—Õ°“IŒ¤‹†. –å˜eŒ›iŠOj: –k—¢ˆãŠw, 19(5): 518`527, 1989.

49. mŒ´’˜n ƒ‰ƒbƒgŽ¨‰º‘B‘B–[×–E‚Ì”­¶‚ÉŠÖ‚·‚é“dŽqŒ°”÷‹¾“IŒ¤‹†. ‹g”ö’miŽ¨•@jC‹Ê–؉p–¾CŽR‰È³•½i‰ðj: –k—¢ˆãŠw, 19(6): 594`603, 1989.

50. mŒ´’˜n V‚µ‚¢ŒoŒû’°ŠÇôòÜ‚É‚æ‚é‘å’°“àŽ‹‹¾ŒŸ¸–@‚ÌŒŸ“¢|­—Ê“Š—^–@‚Æ‚Ì”äŠr‚àŠÜ‚ß‚Ä|. ŽO•xO”Vi“àjC‘åˆä“c³li‘åˆä“c•a‰@jCŸ–””º‰hC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: –k—¢ˆãŠw, l9(3): 317`320, 1989.

51. mŒ´’˜n –{‰@‚É‚¨‚¯‚é‘å’°ƒ|ƒŠ[ƒvÇ—á‚ÌŒŸ“¢. ŽO•xO”Vi“àjC‘åˆä“c³li‘åˆä“c•a‰@j: –k—¢ˆãŠw, l9(4): 421`425, 1989.

52. mŒ´’˜n Œ€ÇŠÌ•s‘SC—nŒŒ«•nŒŒ‚Å”­Ç‚µ‹~–½‚µ“¾‚½ Wilson •a‚Ì1—á. ‘å“c„•äC^“º‘¾˜YC¬“‡–M•FiŽ™j: –k—¢ˆãŠwC20(1): 26`30, 1990.

53. mŒ´’˜n ŽÀŒ±’×ᇂɑ΂·‚éŽ_•ª”å—}§Ü‚Æ–hŒäˆöŽq‘BÜ•¹—p“Š—^‚ÌŒø‰Ê|Cimetidine‚ÆCetraxate‚É‚æ‚錟“¢|. Žs쑸•¶i“àjCÎŒ´˜a•Fi‰»ŠwjC¬Žº—Tˆêi¶‰»jC¬“‡—m“ñi“àjC¬Œ´iC–x“c‹±Žqi¶‰»j: –ò—‚ÆŽ¡—Ã, 18(3): 1065`1070, 1990.

54. m’Z•ñn Microcirculatory Injury of Rat Gastric Mucosa by Ethanol and Its Prevention of Endogenous PGE2. Ž­ŽæMC¼ŽR˜a’jC¬“c—²Ž¡Cã–ìWŒ›i–ò—j: Microcirculation Annual 1989, p.105`106, 1989.

55. m’Z•ñn ‘ÌŽ¿«‰©átŠÌ‚É‚¨‚¯‚郊ƒKƒ“ƒfƒBƒ“‚ÌŒŒ‰t‘gDŠw“IŒŸ“¢. ˆÀ•”ˆä½lA¼è–õŽiC“c’†’¼Œ©C‘å›r–¾i’}”g‘åjC™–{Œ³Mi“Œ–M‘åjCŽÄ“c‹v—Yi“àj: ŠÌ‘Ÿ, : 1040, 1989.

56. m’Z•ñn 90”N‘ã‚Ì•a—‚Ö‚ÌŠú‘Ò. ”äŠé”\Ž÷iŠOj: •a—‚Æ—Õ°, 8(2): 181, 1990.

57. mŒ¤‹†•ñn ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“uŠÌ—\”õ”\v‚Í‚¶‚ß‚É. ŽÄ“c‹v—Yi“àj: “Œ•”ŠÌ‘ŸƒtƒH[ƒ‰ƒ€ '89‘æ2‰ñ‹L˜^W, 1990.

58. mŒ¤‹†•ñiŒú¶Èjn –å–¬ŒŒs“®‘ÔŒŸ“¢ˆÏˆõ‰ï•ñ. ‰œ•½‰ë•Fi•a—jC–Øt•vi•ÛŒ’‰q¶‘åjCrì³”Ži‹v—¯•Ä‘åjC“à“cr˜ai“ú‘åjC‘å•”½i•a—jC–Ø’JŒ’ˆêi“Œ‹ž“sjCŒKŒ´‹I”Vi‡‘åjC’†ÀˆÀ“ñ i‹à‘åjC“ñìr“ñi‡‘åjCXˆÀŽj“Ti‹ž‘åj: Œú¶È“Á’莾Š³–å–¬ŒŒsˆÙíÇ’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.16`18, 1989.

59. mŒ¤‹†•ñiŒú¶Èjn “Á”­«–å–¬ˆ³˜´iÇ‚É‚¨‚¯‚é—Þ“´•Ç×–E‚Ì“®‘Ô|‚Æ‚­‚ÉŠÌd•ÏÇ‚Æ‚Ì”äŠr‚ð’†S‚Æ‚µ‚Ä. ‰œ•½‰ë•FC‘å•”½i•a—j: Œú¶È“Á’莾Š³–å–¬ŒŒsˆÙíÇ’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.53`56, 1989.

60. mŒ¤‹†•ñiŒú¶Èjn ŠÌÖ¬‘ŠŒÝŠÔ•«‡‚Ì•a—Šw“IŒŸ“¢. ‰œ•½‰ë•FC‘å•”½C“n•Ó´Ž¡i•a—j: Œú¶È“Á’莾Š³–å–¬ŒŒsˆÙíÇ’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.57`59, 1989.

61. mÇ—á•ñn ’˜–¾‚È’á’`”’ŒŒÇ‚ð’悵‚½•³ü’ŽÇ‚Ì1—á. ŽO•xO”Vi“àjC쑺½C‘åˆä“c³lC¼–ì„C’|‘©³“ñ˜YC‘åˆä“c“ñ˜Yi‘åˆä“c•a‰@jC¬ò˜aŽO˜YCŒÜ\—’³LCŸ–””º‰hC‰ª•”Ž¡–íi“àj: Gastroenterological Endoscopy, 31(11): 3021`3031, 1989.

62. mÇ—á•ñn ‹}«ˆÝ”S–Œ•a•Ï‚ɑ΂·‚é”S–Œ•ÛŒìÜ‚¨‚æ‚ÑH2ƒuƒƒbƒJ[‚ÌŒø‰Ê‚Ì”äŠr. ¼Œ³Ž›Ž—çi“àj: Medical Tribune, 1989.

63. mÇ—á•ñn ΊD‰»’_”XŠà‚Ì1—á. ˆÉ“¡‹`–çC”ª\ì—v•½C¬”g‘qŽjŽqC’Ë–{GlC–¥‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ˆã—Ã, 43(11): 1186`1189, 1989.

64. mÇ—á•ñn ˆÀ‘§Ž_ƒGƒXƒgƒ‰ƒWƒI[ƒ‹‚ª‘tŒø‚µ‚½–³ÇŒó«Œ´”­«’_`«ŠÌd•Ï‚Ì1—á. ¼–Ø–ÎŽ÷CΈäŒö“¹C”’èŒh“ñC™–{­’¼CVˆäd‹ICŠ¡•”‚ЂƂÝC‘•ª–ΔŽCŽR“cL•vCŽÄ“c‹v—YC‰ª•”Ž¡–íi“àjC‘å•”½C‰œ•½‰ë•Fi•a—j: ŠÌ‘Ÿ, 29(12): 1638`1642, 1988.

65. mÇ—á•ñn ƒeƒKƒt[ƒ‹¥ƒEƒ‰ƒVƒ‹”z‡Ü(UFT)‚Ìp‘O“Š—^‚ª’˜Œø‚µ‚½Borrmann 2Œ^isˆÝŠà‚Ì1Žèp—á. ã™G‰iCˆÀŠC‹`—jC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjCŽOd–슰ŠìiŠOjC–{‹§i•a—j: Šà‚Ì—Õ°, 35(8): 963`969, 1989.

66. mÇ—á•ñn ‘å’°“àŽ‹‹¾ŒŸ¸’¼Œã‚É”­Ç‚µ‚½‹•ŒŒ«‘å’°‰Š‚Ì1—á. ŒÜ\—’³LCŸ–””º‰hCŽO‹´—˜‰·C¼ŽR˜a’jCŽO•xO”VC¬—Ñ´“TCŽR–{‰À³C¼Œ³Ž›Ž—çi“àjC£ìŒªˆêC’†‰p’ji•a—jC”äŠé”\Ž÷iŠOj: Á‰»Ší“àŽ‹‹¾, 1(5): 731`735, 1989.

67. mÇ—á•ñn H“¹ˆ««•FŽî. ŽOd–슰ŠìC”äŠé”\Ž÷iŠOjC‰¡ŽR–õC¬ò˜aŽO˜Yi“àj: Á‰»Ší“àŽ‹‹¾, 2(1): 94`95, 1990.

68. mÇ—á•ñn L”Í‚Èœ‘“]ˆÚ‚ð‚«‚½‚µ‚½H“¹¬×–EŠà‚Ì1—á. “c•Ó‘C¡‘º´ŽqC“c•Ó—R”üC‘“c‰p–¾CˆË“c•qC²“‡Œh´C’j‘S³ŽOC’†‘ºé¶C²–ìm—EC‰i‰ª’å’ji“àj: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 34: 232`235, 1989.

69. mÇ—á•ñn ”S–Œ‰ºŽîá‡ó‚ÌŒ`‘Ô‚ðŽ¦‚µRLH‚Æ‚µ‚ÄŒo‰ßŠÏŽ@‚³‚ꂽˆÝˆ««ƒŠƒ“ƒpŽî‚Ì1—á. ‰ª“c‘ìŽqC‰–’J—z‰îC’r“c“TŽŸC¡‘º´ŽqCˆË“c•qC‘“c‰p–¾C‹e’n–FtC²“‡Œh´C’j‘S³ŽOC–Ø“cŒõLi“àj: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 35: 256`259, 1989.

70. mÇ—á•ñn Šg‘å• o‹¾‚É‚æ‚èŠÌ•\–Ê‚Ì–Ñ׌ŒŠÇŠg’£‚ðØ–¾‚µ‚½Rendu-Osler-Weber•a‚Ì1—á. ŽOŽ}MC¼–Ø–ÎŽ÷C‘ºã‹§lCŽR“cŽŠlC™–{­’¼CŽR“cL•vCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 35: 370`372, 1989.

71. mÇ—á•ñn ŠÌ‹æˆæ‚ÉŒÀ‹Ç‚µ‚½‘±”­«’_`«ŠÌd•Ï‘œ‚ð’悵‚½ŠÌ–å•”’_ŠÇŠà‚Ì1—á. a’J–¾—²C™–{­’¼CâŒû“NÍC¼–{ˆÌ’jC‘ºã‹§lC‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—Yi“àj: ’_“¹, 4(1): 62`67, 1990.

72. mÇ—á•ñn ˆÝGlomusŽîᇂÌ1—á. –x]˜aLC‰¡“c˜a•FC¡ˆäŒ‰Cˆ¢‘]OˆêiŠOjCŒK”ö’èmi•a—j: “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 22(12): 2833`2836, 1989.

73. mÇ—á•ñn ‰¡sŒ‹’°‚É•Ç“àá‘‚ðŒ`¬‚µC•a—‘gDŠw“I‚ÉŠm”F‚µ“¾‚½Crohn•a‚Ì1—á. £ìŒªˆêC’†‰p’jC‰œ•½‰ë•Fi•a—jCŸ–””º‰hCŽR–{‰À³CŒÜ\—’³LC‰ª•”Ž¡–íi“àjCH“¡N¶iŠOj: “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(2): 243`247, 1990.

74. mÇ—á•ñn Œ´”­‘ƒ‚ª—Ç‚­ŠÇ—‚³‚ê”x“]ˆÚ‚Ì‚È‚©‚Á‚½ŠÌ×–EŠà‚Ì”]“]ˆÚ‚Ì1—á. Œ‹éL‘×i‰º“s‰ê‘‡•a‰@jC^‹ÊŽõ”ü¶C“¡ˆä•ÛŽ¡C‰J‹{Œ«ˆêC–Ø“c–FŽ÷C›’m–çC–ì“o½i“àjC—é–Ø‚—SCŒÜŒŽ—–Îi‰º“s‰ê‘‡•a‰@j: —Õ°‚ÆŒ¤‹†, 66(4): 1207`1212, 1989.

75. mÇ—á•ñn ˆÝ‘O’ë•”‘O•Ç‚̇UcŒ^‘ŠúˆÝŠà. ¬ò˜aŽO˜YC¼Œ³Ž›Ž—çi“àj: —Õ°ˆã, 15(11): 1902`1904, 1989.

76. m—Õ°Ž¡Œ±n ’_Ηn‰ð—Ö@‚Ì’·Šú—\Œã. ‘•ª–ΔŽi“àj: Medical Tribune, '89(11.2): 50`51, 1989.

77. m—Õ°Ž¡Œ±n Sucralfate‚É‚æ‚éˆÝ’×ᇂÌÄ”­‚Æ‚»‚̈öŽq‚ÌŒ¤‹†; •aˆã‰@¥f—Ê‚É‚æ‚鑽Ž{Ý“ˆêƒvƒƒgƒR[ƒ‹ŽŽŒ±. ‰ª•”Ž¡–íC¼Œ³Ž›Ž—çi“àjC¬ì’¨–çiˆ¤•Q‘åjCìãŸiO‘O‘åjCˆäãCˆêiH“c‘åjC‘ìŸäi“úÔ’·èŒ´”š•a‰@j: Therapeutic Research, 10(4): 1593`1606, 1989.

78. m—Õ°Ž¡Œ±n ƒtƒBƒ“ƒK[¥ƒs[ƒX–@‚É‚æ‚éICGŽŽŒ±‚Ì‘½Ž{Ý‚É‚¨‚¯‚錟“¢. ˜Q‹v—˜•FCˆ¾’ÖM’jC“ì•”ŸŽii‡“V“°‘åjCŽÄ“c‹v—Yi“àjC…–{—´“ñiŽOd‘åjC’Òˆä³i“ޗLjã‰È‘åjC‚“cºi‹à‘òˆã‰È‘åjCŽ…“‡’B–çi‰ª‘åjCìè Š°’†i’¹Žæ‘åjC‰v‘ò›{i‘—§‘åã•a‰@jC’Jì‹vˆêi‹v—¯•Ä‘åjC¼“ˆ‹ªi–k‘åjC•½–쳌›i“Œ‹žŒxŽ@•a‰@jC¼è¼•½i“ŒŠC‘åj: ŠÌ’_äX, 20(2): 347`351, 1990.

79. m—Õ°Ž¡Œ±n Œû‘¤ØœüŒˆ’è‚Ì‚½‚߂̈ݶŒŸ‚Æ“àŽ‹‹¾ƒNƒŠƒbƒsƒ“ƒO–@. ŽOd–슰ŠìC¬—ÑLsC“ˆ”ömC匴÷C”äŠé”\Ž÷iŠOjC¬ò˜aŽO˜YC‰¡ŽR–õC¼Œ³Ž›Ž—çi“àj: Á‰»Ší“àŽ‹‹¾, 2(2): 135`143, 1990.

80. m—Õ°Ž¡Œ±n ˆÝ’×ᇂɑ΂·‚éRioprostil‚Ì‘æ2‘Š—Õ°ŽŽŒ±|“ñd–ÓŒŸ–@‚É‚æ‚é—p–@—p—Ê‚ÌŒŸ“¢|. ŽODH”niɪŒ§—§‘‡•a‰@jC‰ª•”Ž¡–íC¼Œ³Ž›Ž—çi“àjC’J“àºiŽD–yˆã‰È‘åjCŒã“¡—R•vi“Œ–k‘åjC³@Œ¤iH“c‘åjC¼”ö—TCŠâè—L—Çi“ú‘åjC XŽ¡Ž÷i“Œ—ˆã‘åjC•Ÿ•x‹v”Vi’}”g‘åjC’j‘S³ŽOi‰¡•lŽs—§Žs–¯•a‰@jCŽO—Ö„CŒ´àV–Îi“ŒŠC‘åjC’†àVŽO˜Yi–¼ŒÃ‰®‘åjC’†“‡•q•viŽs—§–L’†•a‰@jC Š™“c•Miã‘åjCŠÝ´ˆê˜Yi“¿“‡‘åjC”ª”öP—Çi•Ÿ‰ª‘åjC‘ìŸäi“úÔ’·èŒ´”š•a‰@jC¬ì’¨–çiˆ¤•Q‘åj: “à‰È•ó”Ÿ, 36(4): 77`91, 1989.

81. m—Õ°Ž¡Œ±n \“ñŽw’°’×ᇂɑ΂·‚éRioprostil‚Ì‘æ2‘Š—Õ°ŽŽŒ±|“ñd–ÓŒŸ–@‚É‚æ‚é—p—Ê‚ÌŒŸ“¢|. ŽODH”niɪŒ§—§‘‡•a‰@jC‰ª•”Ž¡–íC¼Œ³Ž›Ž—çi“àjC’J“àºiŽD–yˆã‰È‘åjCŒã“¡—R•vi“Œ–k‘åjC³@Œ¤iH“c‘åjC¼”ö—TCŠâè—L—Çi“ú‘åjC XŽ¡Ž÷i“Œ—ˆã‘åjC•Ÿ•x‹v”Vi’}”g‘åjC’j‘S³ŽOi‰¡•lŽs—§Žs–¯•a‰@jCŽO—Ö„CŒ´àV–Îi“ŒŠC‘åjC’†àVŽO˜Yi–¼ŒÃ‰®‘åjC’†“‡•q•viŽs—§–L’†•a‰@jC Š™“c•Miã‘åjCŠÝ´ˆê˜Yi“¿“‡‘åjC”ª”öP—Çi•Ÿ‰ª‘åjC‘ìŸäi“úÔ’·èŒ´”š•a‰@jC¬ì’¨–çiˆ¤•Q‘åj: “à‰È•ó”Ÿ, 36(5): 161`176, 1989.

82. m—Õ°Ž¡Œ±n ˆÝ‰Š‚ɑ΂·‚éRioprostil‚Ì‘æ2‘Š—Õ°ŽŽŒ±|“ñd–ÓŒŸ–@‚É‚æ‚é—p—Ê‚ÌŒŸ“¢. ŽODH”niɪŒ§—§‘‡•a‰@jC‰ª•”Ž¡–íC¼Œ³Ž›Ž—çi“àjC’J“àºiŽD–yˆã‰È‘åjCŒã“¡—R•vi“Œ–k‘åjC³@Œ¤iH“c‘åjC¼”ö—TCŠâè—L—Çi“ú‘åjC XŽ¡Ž÷i“Œ—ˆã‘åjC•Ÿ•x‹v”Vi’}”g‘åjC’j‘S³ŽOi‰¡•lŽs—§Žs–¯•a‰@jCŽO—Ö„CŒ´àV–Îi“ŒŠC‘åjC’†àVŽO˜Yi–¼ŒÃ‰®‘åjC’†“‡•q•viŽs—§–L’†•a‰@jC Š™“c•Miã‘åjCŠÝ´ˆê˜Yi“¿“‡‘åjC”ª”öP—Çi•Ÿ‰ª‘åjC‘ìŸäi“úÔ’·èŒ´”š•a‰@jC¬ì’¨–çiˆ¤•Q‘åj: “à‰È•ó”Ÿ, 36(7): 255`270, 1989.

83. m‘àn “àŽ‹‹¾‚É‚æ‚éˆÝŠà‚Ì[’B“x‚ÆŽ¡—Ã. ”äŠé”\Ž÷iŠOj: Clinician, 90(387): 66`72, 1990.

84. m‘àn Ä”­–hŽ~–Ê‚©‚ç‚Ý‚½ˆÝ’×ᇂ̎¡—Ã. ¼Œ³Ž›Ž—çi“àj: Kyo, (84): 9`13, 1989.

85. m‘àn nj󂩂çf’f‚Öu“fŒŒv. ¼Œ³Ž›Ž—çi“àj: Medic, 24(9): 21`24, 1989.

86. m‘àn Á‰»«’×á‡. ˆÀŠC‹`—jC¼Œ³Ž›Ž—çi“àj: Medicament News, (1282): 19`23, 1990.

87. m‘àn ã•”Á‰»ŠÇoŒŒ. ‰¡ŽR–õC¼Œ³Ž›Ž—çi“àj: Medicina, 26(7): 1216`1217, 1989.

88. m‘àn ’·ŠúˆÛŽ—Ö@‚ňݥ\“ñŽw’°’×ᇂÌÄ”­—\–h‚͉”\‚©H ˆÀŠC‹`—jC¼Œ³Ž›Ž—çi“àj: Medicina, 27(2): 208`211, 1990.

89. m‘àn ‘ŠúˆÝŠà‚Í”ñŽèp“I‚ÉŽ¡—ɔ\‚©H ”äŠé”\Ž÷C“ˆ”ömiŠOj: Medicina, 27(2): 222`224, 1989.

90. m‘àn Á‰»«’×ᇂÌÄ”­‘Îô. ¼Œ³Ž›Ž—çi“àj: Modern Medicine, 88(8): 33`37, 1989.

91. m‘àn H2-blocker‚̓I[ƒ‹ƒ}ƒCƒeƒB‚©. ^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çi“àj: Modern Physician, 10(3): 311`314, 1990.

92. m‘àn ˆÝ‚ðl‚¦‚é|Á‰»«’×á‡. ¼Œ³Ž›Ž—çi“àj: ƒXƒYƒPƒ“PHC, (5): 37`46, 1989.

93. m‘àn ‹}«ˆÝ”S–Œ•a•Ï(AGML)‚̬ˆö|ŠO‰È‚Ì—§ê‚©‚ç|. ’Ë–{GlC”äŠé”\Ž÷CŽOd–슰ŠìiŠOjC“©ŽRaˆê˜NCˆêŒ´—ºC¼Œ³Ž›Ž—çi“àj: ˆÝ‚Æ’°, 24(6): 645`651, 1989.

94. m‘àn ’Ž‚‰Š‚ª‹^‚í‚ꂽ’Ž‚ŠàA‚±‚ÌÇ—á‚ÌŽ¡—Õûj. H“¡N¶C”äŠé”\Ž÷iŠOj: ŠO‰È, 51(8): 772`775, 1989.

95. m‘àn ŠÌ×–E•Ï«E‰óŽ€‚Ì•a—. ‰œ•½‰ë•FC‹àŽq‘C²“¡³Ž÷i•a—j: ŠÌ’_äX, 19(2): 173`177, 1989.

96. m‘àn –ò•¨«ŠÌáŠQ‚Ì•a—. ‘å•”½C‰œ•½‰ë•Fi•a—j: ŠÌ’_äX, 19(4): 767`774, 1989.

97. m‘àn ‹}«ˆÝ”S–Œ•a•Ï(AGML)‚Æ‚Í|ŠO‰È‚Ì—§ê‚©‚ç|. ’Ë–{GlC”äŠé”\Ž÷iŠOj: ÅVˆãŠw, 44(10): 2017`2021, 1989.

98. m‘àn ‹}«ˆÝ”S–Œ•a•Ï(AGML)‚Æ‚»‚ÌŽü•Ó|”S‰t‚ÆAGML. –x“c‹±Žqi¶‰»jCÎŒ´˜a•Fi‰»j: ÅVˆãŠw, 44(10): 2152`2156, 1989.

99. m‘àn “àŽ¤ŠjŽèp‚ÌŒŸ“¢. ’©’·“N–íC‘哇s•FC´…³•vCŒã“¡‹I•vC“n•Ó—´•FC‹g“cŸ–¾C’r‰i½C’†‘ºG•viã”ö’†‰›‘‡•a‰@j: é‹ÊŒ§ˆãŠw‰ïŽGŽ, 24(3): 713`715, 1989.

100. m‘àn ‘å’°ŠàŠÌ“]ˆÚ—á‚ÌŒŸ“¢. ’r‰i½iŠOjC‘哇s•FC´…³•vCŒã“¡‹I•vC“n•Ó—´•FC‹g“cŸ–¾C’©’·“N–íC’†‘ºG•viã”ö’†‰›‘‡•a‰@j: é‹ÊŒ§ˆãŠw‰ïŽGŽ, 24(3): 717`720, 1989.

101. m‘àn Á‰»«’×ᇂÌNatural History. ˆÀŠC‹`—jC¼Œ³Ž›Ž—çi“àj: Ž¡—Ã, 71(10): 2065`2070, 1989.

102. m‘àn ˆÝ”S–Œ–hŒä‚É‚¨‚¯‚é”S‰t¥d’YŽ_‚̈Ӌ`. –x“c‹±Žqi¶‰»j: Ž¡—Êw, 23(3): 264`268, 1989.

103. m‘àn “ÁW: ˜Vlf—Ã|f’fŠî€|m˜V”NŽÒ‚É‚¨‚¯‚éf’fŠî€nÁ‰»«’×á‡. ŽO‹´—˜‰·C¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: ŽÀŒ±Ž¡—Ã, (617): 176`178, 1989.

104. m‘àn ’_“¹•a•Ï‚Ì’´‰¹”gf’f. ‘•ª–ΔŽC™–{­’¼CâŒû“NÍCŽÄ“c‹v—Yi“àj: Á‰»Ší‰È, 11(6): 698`706, 1989.

105. m‘àn ‘å—Ê“fŒŒ‚ɑ΂·‚é”ñŽèp“I—Ö@‚Æ‚»‚ÌŒÀŠE. ’Ë–{GlC”äŠé”\Ž÷iŠOj: Á‰»ŠíŠO‰È, 13(2): 163`168, 1990.

106. m‘àn ã•”Á‰»ŠÇoŒŒ‚ɑ΂·‚é‹Ù‹}“àŽ‹‹¾Ž~ŒŒ. –Ø“cŒõLC¼Œ³Ž›Ž—çC“c•Ó‘C²–ìG–íC‘•ª–ΔŽC‰¡ŽR–õC‰ª•”Ž¡–íi“àj: Á‰»Ší“àŽ‹‹¾, 1(3): 278`284, 1989.

107. m‘àn Á‰»ŠÇoŒŒ‚ɑ΂·‚é“àŽ‹‹¾“IƒŒ[ƒU[Ž~ŒŒ–@|—ðŽj“I•Ï‘J‚©‚ç‚Ý‚½Ä•]‰¿|. ”äŠé”\Ž÷C“ˆ”ömC¬—ÑLsiŠOj: Á‰»Ší“àŽ‹‹¾, 1(3): 293`299, 1989.

108. m‘àn ‘å’°ƒ|ƒŠƒyƒNƒgƒ~[‚Ì•]‰¿‚ÆŽ¡–ü”»’è. Ÿ–””º‰hCŒÜ\—’³LCŽO•xO”VC¬—Ñ´“TCŽR–{‰À³C¼Œ³Ž›Ž—çi“àjC‚‹´r‹BC”äŠé”\Ž÷iŠOjC£ìŒªˆêC’†‰p’ji•a—j: Á‰»Ší“àŽ‹‹¾, 1(7): 937`946, 1989.

109. m‘àn Šà‚Ì“àŽ‹‹¾“IŽ¡—Â̕]‰¿. ”äŠé”\Ž÷C“ˆ”ömiŠOj: Á‰»Ší“àŽ‹‹¾, 1(7): 987`991, 1989.

110. m‘àn ˆÝ’×ᇂ̒´‰¹”g“àŽ‹‹¾f’f. –Ø“cŒõLC¼Œ³Ž›Ž—çCŽR“cŽŠlCâŒû“NÍC–ì“o½C‰¡ŽR–õC‰ª•”Ž¡–íi“àjCŽOd–슰ŠìC”äŠé”\Ž÷iŠOjC’†‰p’ji•a—j: Á‰»«’×á‡|—Õ°‚ÆŠî‘b, 8(2): 132`141, 1989.

111. m‘àn ŒŸ¸Œv‰æ–@|—Õ°ŒŸ¸‚ÌŒöŽ®W|‡X.Á‰»ŠÇŽ¾Š³; 9. ˆÝ¥\“ñŽw’°’×á‡. ˆÀŠC‹`—jC¼Œ³Ž›Ž—çi“àj: ‘‡—Õ°, 38(‘Š§): 1312`1316, 1989.

112. m‘àn Á‰»«’×á‡iˆÝ¥\“ñŽw’°’×á‡j. ‰¡ŽR–õC¼Œ³Ž›Ž—çi“àj: “ú–{ˆãŽt‰ïŽGŽ, 103(3): 351`355, 1990.

113. m‘àn ’_ÎESWL‚Ì•›ì—p¥‡•¹Ç. –å˜eŒ›C÷–{MˆêiŠOjCˆêŒ´—ºi“àjCã–ìˆê–çC•½“cMlC”äŠé”\Ž÷iŠOj: “ú–{—Õ°, 47(12): 2758`2761, 1989.

114. m‘àn 5'-ƒkƒNƒŒƒIƒ`ƒ_[ƒ[. ŽÄ“c‹v—Yi“àj: “ú–{—Õ°, 47(‘Š§): 313, 1989.

115. m‘àn ˆÝ‚É‚¨‚¯‚é“àˆö«ƒGƒCƒRƒTƒmƒCƒh‚Ìì—p‚ÆR‰ŠÇ–òCR’×ᇖò. Ž­ŽæMC¼ŽR˜a’ji–ò—jC—é–Ø—Ti“àjCã–ìWŒ›i–ò—j: •a‘Ô¶—, 8(8): 657`665, 1989.

116. m‘àn ŠÌŠà—ÞŽ—•a•Ï‚Ì•a—Šw“I‘¤–Ê. ‰œ•½‰ë•FC‘å•”½C‹àŽq‘C‚ˆä’qŽqC–{‹´ˆèŽqC–Ø“c–FŽ÷i•a—j: • •”‰æ‘œf’f, 10(1): 7`14, 1990.

117. m‘àn ‰º•”Á‰»ŠÇ“®Ã–¬ŠïŒ`|—Õ°•ª—Þ‚ÉŠÖ‚·‚élŽ@‚Æ–{–M•ñ—á‚ÌWŒv. ‘–쳈êCˆä“›–rC‰““¡‚i•új: • •”‹~‹}f—ÂÌi•à, 10(1): 134`139, 1990.

118. m‘àn ‹}«• Ç‚Ìf’f‚ÆŽèp“K‰ž. ”äŠé”\Ž÷C“ˆ”ömiŠOj: –ˆ“úƒ‰ƒCƒt, 90(3): 26`29, 1990.

119. m‘àn lHäX‘Ÿ‚Æ‚»‚Ì—˜—p. ‰¡“c˜a•FC²“¡ŒõŽjiŠOjC“¡“c–F–Mi“àj: –ò‹Ç, 40(3): 965`969, 1989.

120. m‘àn “f‰ºŒŒ‚Ì•aˆö. ^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: —Õ°‚ÆŒ¤‹†, 66(12): 3706`3711, 1990.

121. m‘àn ‘ÌŠOÕŒ‚”g—Ö@. ŽÄ“c‹v—YCˆêŒ´—ºi“àj: —Õ°‚ÆŒ¤‹†, 66(8): 110, 1989.

122. m‘àn i“ÁWj’_΂ƒ_ÎÇ:f’f–@A¸–§ŒŸ¸. ‹g“c@‹IC”äŠé”\Ž÷Cˆ­”üƒ•vC‘å‹{“Œ¶iŠOj: —Õ°‚ÆŒ¤‹†, 66(8): 2404`2411, 1989.

123. m‘àn R’×ᇖò. ¼Œ³Ž›Ž—çi“àj: —Õ°‚ÆŒ¤‹†, 67(1): 61`64, 1990.

124. m‘àn ˆÝŠà‚Ì“àŽ‹‹¾Ž¡—Ã. ”äŠé”\Ž÷C¬—ÑLsC“ˆ”ömiŠOj: —Õ°ˆã, 15(11): 1854`1858, 1989.

125. m‘àn ˆÝ’×ᇂÌÄ”­—vˆö. ŽO‹´—˜‰·C‰¡ŽR–õC¼Œ³Ž›Ž—çi“àj: —Õ°‰ÈŠw, 26(1): 43`49, 1990.

126. m‘àn ”S–Œ–hŒä‹@\‚ÌV‚µ‚¢“W–]|”S‰t‚Ì—§ê‚©‚ç|. ¬Žº—Tˆêi¶‰»jCÎŒ´˜a•Fi‰»jC‰ª•”Ž¡–íi“àj: —Õ°‰ÈŠw, 26(1): 61`65, 1990.

127. m‘àn H“¹“à‘}ŠÇ–@. “ˆ”ömC”äŠé”\Ž÷iŠOj: —Õ°ŠO‰È, 44(11): 1573`1575, 1989.

128. m‘àn H“¹Šg’£–@. “ˆ”ömC”äŠé”\Ž÷iŠOj: —Õ°ŠO‰È, 44(9): 1141`1143, 1989.

129. m‘àn ˆÝŠà¥oŒŒ«’×á‡. ”äŠé”\Ž÷C“ˆ”ömC¬—ÑLsC匴÷iŠOjC“c•Ó‘C‰¡ŽR–õi“àj: —Õ°ŠO‰È, 45(2): 177`186, 1990.

130. m‘àn –ò•¨«ŠÌáŠQ‚Ì•a—. ‘å•”½C‰œ•½‰ë•Fi•a—j: —Õ°Á‰»Ší“à‰È, 4(11): 1783`1791, 1989.

131. m‘àn ˆÝŽèpŒã‚Ì•a•Ï‚Æ‚»‚Ì‘Îô,@‡Z.•«‡•”’×á‡;(4)Ž¡—Õûj|–ò•¨—Ö@‚ÆŽèp“K‰ž‚ð‚ß‚®‚Á‚Ä. ŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àjC’Ë–{GliŠOj: —Õ°Á‰»Ší“à‰È, 5(1): 81`86, 1990.

132. m‘àn ‘Þ‰@Œã‚̶ŠˆŽw“±;Á‰»«’×á‡. ‰¡ŽR–õC‰ª•”Ž¡–íi“àj: —Õ°¬l•a, 19(9): 146`148, 1989.

133. muÀn “]“|‚É‚æ‚é‘Å–oÇ‚ÅNSAID•ž—pŒã‚Ì‹}«ˆÝ‰Š. ¼Œ³Ž›Ž—çi“àj: Clinician, 36: 20`21, 1989.

134. muÀn ˆÝ’°“§Ž‹‚Æ’ÁázÜ. ¼Œ³Ž›Ž—çi“àj: ƒhƒNƒ^[ƒTƒƒ“, 34(3): 195`198, 1990.

135. muÀn “ljeuÀ|‚±‚ê‚ð‚Ç‚¤‚æ‚Þ‚©H ¼Šª”ŽC›Mˆêi•újC–x’rdŽ¡i‹~–½jC“cŠŽŒÈC’r“crºC¬—Ñ–ÎŽ÷C’J“c—ˆê˜YC¼—Ñ—²i•új: ‰æ‘œf’f, 9(6): 731`737, 1989.

136. muÀn Œûo“à‰ŠÇ|‚Í‚¶‚ß‚É|. ÝŠy“N–çiŽ¨•@j: Ž¨•@ˆôA‰È—Õ°, 82(11): 1511, 1989.

137. muÀn Œûo“à‰ŠÇ; Š´õÇ 2.ƒEƒBƒ‹ƒXŠ´õ‚É‚æ‚éŒû“à‰Ši’Pƒáv]C…“—Cƒwƒ‹ƒpƒ“ƒM|ƒiC–ƒ]CŽè‘«Œû•aj|f’f‚ÆŽ¡—Ã|. ‚‹´œAbCÝŠy“N–çiŽ¨•@j: Ž¨•@ˆôA‰È—Õ°, 82(11): 1514`1517, 1989.

138. muÀn –«•Ö”éA–ƒáƒ«ƒCƒŒƒEƒX. ŒÜ\—’³LCŸ–””º‰hC‰ª•”Ž¡–íi“àj: Á‰»Ší‰È, 11(1): 90`98, 1989.

139. muÀn ŠÌ’_äX‚ÌCTf’f|CT“lje‚É•K—v‚ÈŠî‘b’mŽ¯|1990. ‘–쳈êi•új: Á‰»ŠíŠO‰È, 13(1): 83`93, 1990.

140. muÀn ŠÌ’_äX‚ÌCTf’f|ŠÌ‘Ÿ(1)ŠÌ×–EŠà. ‘–쳈êCˆä“›–rC’J“c—ˆê˜Yi•újC’†‰p’ji•a—jC”äŠé”\Ž÷iŠOj: Á‰»ŠíŠO‰È, 13(2): 201`210, 1990.

141. muÀn ŠÌ’_äX‚ÌCTf’f|ŠÌ‘Ÿ(2)“]ˆÚ«ŠÌŠà. ‘–쳈êCˆä“›–rC‰““¡‚i•újC’†‰p’ji•a—jC”äŠé”\Ž÷iŠOj: Á‰»ŠíŠO‰È, 13(3): 363`370, 1990.

142. muÀn ã•”Á‰»ŠÇ“àŽ‹‹¾‘}“ü–@;‚¿‚å‚Á‚Æ‚Ì‹C”z‚è‚Å”’iãŽè‚É‚È‚é–@. ‰¡ŽR–õi“àjC”äŠé”\Ž÷iŠOj: Á‰»Ší“àŽ‹‹¾, 1(3): 381`386, 1989.

143. muÀn äXŠO‚É‚¨‚¯‚é‹Ù‹}ERP. ‘•ª–ΔŽC‰¡ŽR–õi“àjC‘Oì˜a•Fi‹~–½j: Á‰»Ší“àŽ‹‹¾, 1(4): 553`561, 1989.

144. muÀn ˆÝ’×ᇂ̕aŠúf’f‚Æ—\Œã. ‰¡ŽR–õC¼Œ³Ž›Ž—çC²–ìG–íC“c•Ó‘i“àj: Á‰»Ší“àŽ‹‹¾, 1(9): 1191`1197, 1989.

145. muÀn —pŒê‰ðà. ”äŠé”\Ž÷iŠOj: Á‰»Ší“àŽ‹‹¾, 2(1): 89`91, 1990.

146. muÀn ‚Ñ–«ŠÌŽ¾Š³‚ÌCT. ‰““¡‚C‘–쳈êi•új: • •”‰æ‘œf’f, 9(10): 833`840, 1989.

147. muÀn ‘ŸŠíˆÚA‚͂ǂ̂悤‚Éi•à‚µ‚½‚©iŠÌ‘ŸAäX‘ŸˆÚAj. ²“¡ŒõŽjiŠOj: •½¬Œ³”N“x_“Þ쌧‘åŠwŒöŠJu‹`—vj, p.30`36, 1989.

148. muÀn Scope-–«ˆÝ‰Š. ¼Œ³Ž›Ž—çi“àj: —Õ°‚Ì‚ ‚ä‚Ý, 28: 16`17, 1989.

149. mÀ’k‰ïn Á‰»«’×ᇂɂ¨‚¯‚éÄ”­–hŽ~‚Ì–ò•¨—Ö@. ¼”ö—Ti“ú‘åjC¼Œ³Ž›Ž—çi“àjC•½’ËG—Yi•½’ˈݒ°•a‰@j: Clinic Magazine, (7): 81`94, 1989.

150. mÀ’k‰ïn Á‰»«’×á‡|Ä”­|. ¼Œ³Ž›Ž—çi“àjCŽO—Ö„i“ŒŠC‘åjC¼‘ºD—YiŒú–Ø’†‰›ˆã‰@jC“c’†é’ji‘‡‚’Ã’†‰›•a‰@j: Medical Partner, 1(2): 2`10, 1989.

151. mÀ’k‰ïn ˆÝ¥\“ñŽw’°oŒŒ‚ð‚ß‚®‚é”–â‘è|•û–@˜_‚ð’†S‚É|. ¼Œ³Ž›Ž—çi“àjC²“¡²i“Œ–k‘åjC’‡hŽkiŽD–y¼‹æ•a‰@jC²X•”³Fi“Œ‹žˆã‰ÈŽ•‰È‘åjCŒ´“cˆê“¹iˆ®ìˆã‰È‘åjC‰iˆä—SŒái˜a‰ÌŽRˆã‰È‘åjC—LŽR åõi‡“V“°‘åjC•À–س‹`iˆ®ìˆã‰È‘åjC¬‰z˜a‰hiŒ§—§‚ª‚ñƒZƒ“ƒ^[VŠƒ•a‰@j: ˆÝ‚Æ’°, 24(4): 396`411, 1989.

152. mÀ’k‰ïn ‹}«ˆÝ”S–Œ•a•Ï(AGML). ¼Œ³Ž›Ž—çi“àjC²“¡²i“Œ–k‘åjC–öˆäG—YiŽRŒû‘åjCó“cC“ñi‘åãˆã‰È‘åjCŒS‘å—Ti•Ÿˆäˆã‰È‘åjC¼‰º•¶—YiŽ­Ž™“‡Œ§–ì“c’¬—§•a‰@jC•À–س‹` iˆ®ìˆã‰È‘åj: ˆÝ‚Æ’°, 24(6): 674`686, 1989.

153. mÀ’k‰ïn Á‰»ŠíŽ¾Š³‚Ì–ò•¨—Ö@‚Æ‚»‚ÌŒÀŠE. ‰ª•”Ž¡–íi“àjCoŒŽN•vi“Œ‘åjC‘½‰ê{K’jiŠÖ“Œ’üM•a‰@jCŽO—Ö„i“ŒŠC‘åj: “ú–{ˆãŽt‰ïŽGŽ, 103(3): 315`328, 1990.

154. mŠwp‘n i•ÒWj ˆÝ”S‰t•ª”å‚Ì•ªÍ¥‘ª’è‚̈Ӌ`; •ÒW X‰ê–{Ki‹ž‘åjC–x“c‹±Žqi–k—¢‘åj•ÒC “ú–{ˆãŠwŠÙ, “Œ‹ž, 89.09.27”­s.

155. mŠwp‘n iŽ·•Mj ŽY‹Æ“à‰È‘S‘C_Œo¥‹ØŒn/Á‰»Ší¥‘ãŽÓŒn; ’†“Å«ŠÌáŠQ‚Ì•a—C2: 553`562, ‰œ•½‰ë•FC‘å•”½i•a—j. •ÒW ‘c•ƒ]ˆí˜Yi–¼‘åjC—é–ØŒp”üi“Œ‘åjC‘º“c—R”ViŽY‹Æˆã‘åjC’r“c³”Vi‹ž‘åjCŒ“‚’BæÆi“Œ‹ž’üMjC“¡‘òŸ®iŽœ‘åj•ÒC ˆãŽ•–òo”Å, “Œ‹ž, 89.05.25”­s.

156. mŠwp‘n iŽ·•Mj Gastrointestinal Function, Regulation and Disturbance, Vol.7; Relation between Gastric Acid Secretion and Gastric Mucous Glycoproteins, –x“c‹±ŽqC¬Œ´ii¶‰»jCÎŒ´˜a•Fi‰»jC⨳—YC‘å씎”VCŒK“c”£i“àjC¬Žº—TˆêCX‰ºŒOi¶‰»jC‰ª•”Ž¡–íi“àj. •ÒW Nagao, F.iŽœŒbˆã‘åjCMatsuo, Y.i“ú‘åjCKasuya, Y.i¯–ò‘åjCTsuchiya, M.iŒc‘åj•ÒC Excerpta Medica, “Œ‹ž, 89.00.00”­s.

157. mŠwp‘n iŽ·•Mj ˆÝ”S‰t•ª”å‚Ì•ªÍ¥‘ª’è‚̈Ӌ`; …ZS‘©ƒXƒgƒŒƒX’×ᇂɂ¨‚¯‚郉ƒbƒgˆÝ”S–Œ”S‰t“œ’`”’Ž¿‘ª’è‚̈Ӌ`, p.17`22, ‘å‹v•Û„C“n•Ó—mŽOC匴éi‡‘åjCÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»j. •ÒW X‰ê–{Ki‹ž‘åjC–x“c‹±Žqi–k—¢‘åj•ÒC “ú–{ˆãŠwŠÙ, “Œ‹ž, 89.09.27”­s.

158. mŠwp‘n iŽ·•Mj ˆÝ”S‰t•ª”å‚Ì•ªÍ¥‘ª’è‚̈Ӌ`; ˆÝ”S‰tŠÜ—Ê‘ª’è–@‚Æ‚µ‚ẴwƒLƒ\ƒTƒ~ƒ“’è—Ê|ƒqƒgˆÝ”S–Œ•W–{‚É‚æ‚éŠî‘b“IŒŸ“¢‚¨‚æ‚ÑHPLC‚ð—p‚¢‚½‚Š´“x’è—Ê–@‚ÌŠJ”­, p.11`16, ÎŒ´˜a•Fi‰»jCX‰ºŒOC¬Œ´iC‘å씎”VC–x“c‹±Žqi¶‰»jCˆÀŠC‹`—jC‰ª•”Ž¡–íi“àjCHŽRŒ›‹`iŠOj. •ÒW X‰ê–{Ki‹ž‘åjC–x“c‹±Žqi–k—¢‘åj•ÒC “ú–{ˆãŠwŠÙ, “Œ‹ž, 89.09.27”­s.

159. mŠwp‘n iŽ·•Mj ’_ÎÇ; ¶ŠˆŽw“±A–ò•¨—Ö@AHŽ–—Ö@, p.78, ŽÄ“c‹v—YC‘•ª–ΔŽi“àj. •ÒW ‘å“¡³—Yiç—t‘åj•Ò, “ì]“°, “Œ‹ž, 90.01.00 ”­s.

160. mŠwp‘n iŽ·•Mj ‘ÌŠOÕŒ‚”gF’_ΔjӗÖ@; ÕŒ‚”g”­¶‘•’u‚ƃƒJƒjƒYƒ€, p.42`46, ŽÄ“c‹v—Yi“àj. •ÒW ‘å“¡³—YC“y‰®K_iç—t‘åj•Ò, ˆãŠw}‘o”Å, “Œ‹ž, 89.00.00 ”­s.

161. mŠwp‘n iŽ·•Mj Á‰»ŠíŽ¾Š³ÅV‚ÌŽ¡—Ã; ˆÝ’×á‡|Ž¡–üŠú‚ÌŽ¡—Ã, p.117`120, ¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj. •ÒW ‰ª”Ži“Œ‹žŒxŽ@•a‰@j,‘¼•Ò, “ì]“°, “Œ‹ž, 89.05.15 ”­s.

162. mŠwp‘n iŽ·•Mj Á‰»Ší“àŽ‹‹¾‹ZŽtŽŽŒ±–â‘è‰ðà; ‘å’°, p.398`407, Ÿ–””º‰hi“àj. •ÒW è“c—²•viº˜a•a‰@j,‘¼•Ò, ˆãŠw}‘o”Å, “Œ‹ž, 89.11.18 ”­s.

163. mŠwp‘n iŽ·•Mj ˆÝ”S‰t•ª”å‚Ì•ªÍ¥‘ª’è‚̈Ӌ`; Á‰»«’×ᇂɂ¨‚¯‚éˆÝ‰t’†”S‰t“œ’`”’Ž¿‘ª’è‚̈Ӌ`, p.3`9, ˆÀŠC‹`—jC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjCÎŒ´˜a•Fi‰»ŠwjC–x“c‹±Žqi¶‰»j. •ÒW X‰ê–{Ki‹ž‘åjC–x“c‹±Žqi–k—¢‘åj•Ò, “ú–{ˆãŠwŠÙ, “Œ‹ž, 89.09.27 ”­s.

164. mŠwp‘n iŽ·•Mj ¡“ú‚ÌŠÌ‘Ÿ•aŠw '89; ƒAƒ‹ƒR[ƒ‹«ŠÌáŠQ‚Ì”­¶‚Æi“W‚É‹y‚Ú‚·”ˆöŽqi”­Ç‚É‹y‚Ú‚·ŒÂl·‚Ì–â‘è‚ɂ‚¢‚Äj, p.44`45; —«ƒAƒ‹ƒR[ƒ‹«ŠÌáŠQ‚ÌŽÀî p.56`57, Š¡•”‚ЂƂÝi“àj. •ÒW “¡‘òŸ®iŽœŒbˆã‘åj•Ò, “ú–{ˆãŠwŠÙ, “Œ‹ž, 89.10.14 ”­s.

165. mŠwp‘n iŽ·•Mj • o‹¾Peritoneoscopy No.10uŽ‰–bŠÌ‚Æ• o‹¾ŒŸ¸v; Ž‰–bŠÌ‚É‚¨‚¯‚éŠÌ•\–ʔ햌‰ºŒŒŠÇ\’z|ŽÀŒ±“IŽ‰–bŠÌ‚Ƃ̑Δ䌟“¢|, p.45`47; Š¡•”‚ЂƂÝi“àjCŒú“cKˆê˜Yi–òÜ•”jCŽR“cL•vCŽÄ“c‹v—Yi“àjC‰œ•½‰ë•Fi•a—j. •ÒW Šâ‘ºŒ’ˆê˜Yi“ŒŠC‘åj•Ò, “ú–{ˆãŠwŠÙ, “Œ‹ž, 89.11.18 ”­s.

166. mŠwp‘n iŽ·•Mj }à“à‰Èf’fŽ¡—ÃuÀ‚V; Á‰»«’×á‡; Ž©‘RŽj‚Æ’·Šú—\Œã, p.232`239; ¼Œ³Ž›Ž—çi“àj. •ÒW ŽO—Ö„i“ŒŠC‘åj•Ò, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 89.01.20 ”­s.

167. mŠwp‘n iŽ·•Mj ƒuƒbƒNƒKƒCƒh: “à‰Èˆã‚Ì‚½‚ß‚ÌÁ‰»Ší•aŠw 150û; The Crohn's Disease and Ulcerative Colitis Fact Book, ‘æ2”Å, p.119, Ÿ–””º‰hC‰ª•”Ž¡–íi“àj. •ÒW ŽODH”niL“‡‘åj•Ò, Excerpta Medica, “Œ‹ž, 89.08.00 ”­s.

168. mŠwp‘n iŽ·•Mj ‰h—{Ž¡—Êw; ˆÝ’°Ž¾Š³AÁ‰»‹zŽûáŠQ, ‘æ1ü, p.104`119, Ÿ–””º‰hC‰ª•”Ž¡–íi“àjC…“ˆ‹žŽqCéˆä”üŽqi‰h—{‰Èj. •ÒW ”ª–Øš •vi–¼ŒÃ‰®‘åjCŒÜ“‡—Yˆê˜Yi“ŒŠC‘åj•Ò, u’kŽÐƒTƒCƒGƒ“ƒeƒBƒtƒBƒbƒN, “Œ‹ž, 89.11.20 ”­s.

169. mŠwp‘n iŽ·•Mj —Õ°ŒŸ¸MOOK, No.31, ƒAƒCƒ\ƒUƒCƒ€; ƒRƒŠƒ“ƒGƒXƒeƒ‰[ƒ[(ChE), p.88, ŽÄ“c‹v—Yi“àj. •ÒW ŽR•”Šwi“Œ‘åj‘¼C•Ò, ‹àŒ´o”Å, “Œ‹ž, 88.12.20 ”­s.

170. mŠwp‘n iŽ·•Mj Selenium in Biology and Medicine; Ebselen, a Seleno-Organic Compound, Inhibits Leukocyte Aggregation and Reduced the Plasma Leukotriene B4 Level in Humans and Rats, ŽÄ“c‹v—Yi“àj. •ÒW A. Wendel (Fovulfot fur Biologie, Universitat Konstanz)•Ò, Springer, Berlin, 89.00.00 ”­s.

171. mŠwp‘n iŽ·•Mj ÅVÁ‰»ŠíŠO‰ÈƒVƒŠ[ƒY 2. ˆÝŠà(1); Ž¡—Õûj|”ñŠÏŒŒ“IŽ¡—Ã, p.99`106, “ˆ”ömC”äŠé”\Ž÷iŠOj. •ÒW ˆ¢•”—ß•FiŒc‘åjCoŒŽN•vi“Œ‘åjC¬‘ò˜aŒbi‹ž‘åjC匴éi‡“V‘åj•Ò, ‹àŒ´o”Å, “Œ‹ž, 89.09.25”­s.

172. mŠwp‘n iŽ·•Mj äX“ª\“ñŽw’°Øœp; äXŽüˆÍ‰Š‚𔺂Á‚ÄØœ‚É“ïa‚µ‚½“û“ª•”Šà‚Ì1—á, p.308`310;@¡‰iŽ®‚Æ‚Ìo‰ï‚¢, p.460`463, ‘å‹{“Œ¶iŠOj. •ÒW ‹{èˆí•vi‹à‘ò‘åjC‚“c’‰Œhi’é‹ž‘åj•Ò, ˆãŠw}‘o”Å, “Œ‹ž, 89.10.31”­s.

173. m‹³‰È‘n iŽ·•Mj f—Óà‰ÈŠw; ’_“¹Ž¾Š³, p.154`161, ŽÄ“c‹v—Yi“àj. •ÒW ˆ¢•”—Tiã‘åj•Ò, ‹àŒ´o”Å, “Œ‹ž, 89.01.00 ”­s.

174. m‹³‰È‘n iŽ·•Mj ÅVˆãŠw’mŽ¯‚Ì®—FˆãŠw¥ˆã—ј_ ‡Y.ŒŸ¸; “àŽ‹‹¾ŒŸ¸, p.192`209, ”äŠé”\Ž÷C“ˆ”ömiŠOj. •ÒW ‹´–{M–çiŽœŒbˆã‘åjCŠÛŽR—Y“ñi¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åj•Ò, ˆãŽ•–òo”Å, “Œ‹ž, 89.05.10”­s.

175. m‹³‰È‘n iŽ·•Mj ÅVˆãŠw’mŽ¯‚Ì®—FˆãŠw¥ˆã—ј_CÁ‰»ŠÇC• •ÇC• –ŒŽ¾Š³; H“¹•¬–å’oŠÉÇCMallory-WeissÇŒóŒQ, ‡W.43`45, ”äŠé”\Ž÷C“ˆ”ömiŠOj. •ÒW ŠÛŽR—Y“ñi¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åj•Ò, ˆãŽ•–òo”Å, “Œ‹ž, 89.10.10”­s.

176. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj Œo’°‰h—{ŽÀŽ{ƒ}ƒjƒ…ƒAƒ‹; ²“¡ŒõŽjC‹à鳉ÀC¡ˆäŒ‰iŠOjC‘Oì˜a•Fi‹~–½jC‘åê³–¤iŠÅŒìŠw•”j. •ÒW ‘åê³–¤i–k—¢‘åj•Ò, –k—¢‘åŠw•a‰@, 89.09.00”­s.

177. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj Á‰»Ší•aƒZƒ~ƒi|36CŠÌd•ÏÇ: •a‘Ô‚Æ‘Îô; ŠÌd•ÏÇ|•a—Šw“IŠT”O, p.1`12, ‰œ•½‰ë•Fi•a—j. •ÒW Œ´“c®i“Æ‹¦ˆã‘åj•ÒC ‚Ö‚é‚·o”Å, “Œ‹ž, 89.09.00”­s.

178. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj “Œ•”ŠÌ‘ŸƒtƒH|ƒ‰ƒ€E1989”N‘æ2‰ñ‹L˜^W; ŠÌ—\”õ”\|Œ`‘Ô‚Æ‹@”\‚̉ð—£, p.118`129, ‰œ•½‰ë•Fi•a—j. •ÒW Œ´“c®i“Æ‹¦ˆã‘åj•ÒC ˆãŽ–o”ÅŽÐ, “Œ‹ž, 90.03.15”­s.

179. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj Annual Review Á‰»Ší 1990; Á‰»Ší“àŽ‹‹¾Ž¡—Ã, p.63`66, “ˆ”ömC”äŠé”\Ž÷iŠOj. •ÒW ‰ª”Ži“Œ‘åjCŽO—Ö„i“ŒŠC‘åjCoŒŽN•vi“Œ‘åjC‘å“¡³—Yiç—t‘åjCŒË“c„‘¾˜Yi“Œ‘åj•ÒC ’†ŠOˆãŠwŽÐ, “Œ‹ž, 90.01.10”­s.

180. mŠwpÜn ƒEƒCƒ‹ƒXŠÌ‰ŠŒ¤‹†à’cCŒ¤‹†§—ãÜuƒAƒ‹ƒR[ƒ‹«ŠÌŽ¾Š³‚Ì‘fˆö‚ÉŠÖ‚·‚镪Žqˆâ“`Šw“IŒ¤‹†v. a’J–¾—²i“àj.

181. mŠw‰ïn ih‘è•ñj ˆÝ¥\“ñŽw’°oŒŒ‚Ì—Õ°. ”äŠé”\Ž÷iŠOj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i89.10.05), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 1870, 1989.

182. mŠw‰ïn i“Á•Êu‰‰j ˆÝ•a•Ï‚Ì’´‰¹”g“àŽ‹‹¾f’f. ¼Œ³Ž›Ž—çi“àj: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‹ãB’n•û‰ï (89.11.17), ²‰ê.

183. mŠw‰ïn i“Á•Êu‰‰j H“¹Ã–¬áŽ‚ɑ΂·‚é“àŽ‹‹¾“Id‰»—Ö@|Å‹ß‚ÌŠÌ¥’_“¹ŒnŽ¾Š³‚Ì’mŒ©‚ðŠÜ‚ß‚Ä|. ‘•ª–ΔŽi“àj: Î쌧—Õ°“à‰Èˆã‰ïŠwpu‰‰‰ï (90.03.22), ¬¼.

184. mŠw‰ïn i‹³ˆçu‰‰j Á‰»«’×ᇖò•¨—Ö@‚ÌŒ»ó. ¼Œ³Ž›Ž—çi“àj: ‘æ206‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•û‰ï (89.09.16), Š‘ò.

185. mŠw‰ïn i‹³ˆçu‰‰j Preoperative Staging of T by Endoscopy and Endoscopic Ultrasonography. “ˆ”ömC”äŠé”\Ž÷iŠOj: Staging and Treatment of Gastric Cancer: Postgraduate Course on Digestive Oncology i89.09.22), Verona, Italy.

186. mŠw‰ïn i‹³ˆçu‰‰j Endoscopic Treatment of Gastric Cancer. “ˆ”ömC”äŠé”\Ž÷iŠOj: Staging and Treatment of Gastric Cancer: Postgraduate Course on Digestive Oncology i89.09.23), Verona, Italy.

187. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ’_Ηn‰ð—Ö@‚Ì’·Šú—\Œã|’_ÎÇ‚ÌŽ¡—ƒ·Šú—\Œã|. ‘•ª–ΔŽCŽÄ“c‹v—Yi“àj: ‘æ75‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (89.03.28), ‰¡•l, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 427, 1989.

188. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Investigation of the Safety of Famoxidine. ¼Œ³Ž›Ž—çi“àj: 21st Congress of European Association for Gastroenterology (89.05.04).

189. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ˆÝ‰Š‚Í‚Ç‚¤‘¨‚¦‚ç‚ê‚Ä‚¢‚é‚©. ¼Œ³Ž›Ž—çi“àj: ‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.05.12), –¼ŒÃ‰®.

190. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éˆÝŠà[’B“xf’f. –Ø“cŒõLC¼Œ³Ž›Ž—çi“àj: ‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.05.13), –¼ŒÃ‰®, Gastroenterol. Endosc., 31(10): 2797`2799, 1989.

191. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ICG•¹—p‘¢‰e‰º‚Ìd‰»ÜŒŒŠÇ“à’“ü’“ü–@‚ÌŒŸ“¢. “c•Ó‘C‘•ª–ΔŽCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC”äŠé”\Ž÷iŠOj: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (89.06.03), ‘O‹´.

192. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ’´‰¹”g‚É‚æ‚é’_”XŒŸf‚ÌŒ»ó‚ÆŒo‰ßŠÏŽ@‚ÌŒŸ“¢. ”’èŒh“ñC‘•ª–ΔŽi“àj: ‘æ38‰ñ“ú–{Á‰»ŠíW’cŒŸfŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (89.09.17), b•{.

193. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Á‰»«’×ᇂ̒·Šú—\Œã‚ɂ‚¢‚Ä. ŽO‹´—˜‰·Cˆ°Œ´‹Bi“àj: ‘æ22‰ñ_“Þ쌧Á‰»Ší•aˆãŠw‰ï‘‰ï (89.11.04), ‰¡•l.

194. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ã•”Á‰»ŠÇ‘å—ÊoŒŒ—á‚Ì—Õ°“IŒŸ“¢. “c•Ó‘C–Ø“cŒõLC‘•ª–ΔŽi“àjC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.06), “Œ‹ž, ‹~‹}ˆãŠw, p.701, 1989.

195. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éäX’_“¹Žîá‡f’f. âŒû“NÍCŽR“cŽŠli“àj: ‘æ49‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (89.12.08), “Œ‹ž, —\•ñW, p.11, 1989.

196. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ŠÌŠà‚Ìinterventional radiology|zŠÂ‚Ì“Á«‚ƧŒä|:ŠÌd•Ï‡•¹ŠÌ×–EŠà‚ÌŒŒŠÇ\’z‘œ‚ÆŽ¡—Ã. ΈäŒö“¹CŽÄ“c‹v—Yi“àj: ‘æ9‰ñ“ú–{‰æ‘œˆãŠw‰ï (90.02.24), “Œ‹ž, “ú–{‰æ‘œˆãŠw‰ïŽGŽ, 8(5): 370, 1990.

197. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j H2Žó—e‘ÌhR܈ێ—Ö@‰ºˆÝ’×ᇂÌÄ”­ˆöŽq|“àŽ‹‹¾‘œ‚É‚æ‚錟“¢|. ¼Œ³Ž›Ž—çi“àj: ‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.30), “Œ‹ž, ´˜^W, p.97, l990.

198. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ˆÝ[’B“xf’f‚Ìi•à. ”äŠé”\Ž÷iŠOj: ‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i89.05.12), –¼ŒÃ‰®.

199. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ˆÝŠà‚Ì“àŽ‹‹¾Ž¡—Â̌»‹µ‚Æ«—ˆ. “ˆ”ömC”äŠé”\Ž÷iŠOj: ‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i89.05.12), –¼ŒÃ‰®.

200. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‘ŠúˆÝŠà‚É‚¨‚¯‚郌[ƒU[‚̉ž—p|Endoscopic Surgery‚ɂ‚¢‚Ä |. ”äŠé”\Ž÷C“ˆ”ömC¬—ÑLsiŠOj: “ú–{ŠO‰ÈŒn˜A‡Šw‰ï‘æ14‰ñŠwpW‰ï i89.06.21), ‘åã.

201. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j “àŽ‹‹¾Ž¡—Â̗§ê‚©‚ç|‚—îŽÒ‚É‚¨‚¯‚é‘ŠúˆÝŠàŽ¡—Â̖â‘è“_|. ˆÉ“¡Žºiˆ¤’mŒ§‚ª‚ñƒZƒ“ƒ^[jC”äŠé”\Ž÷iŠOj: ‘æ27‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i89.10.25), –¼ŒÃ‰®.

202. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ˆÝŠà‚Ì“àŽ‹‹¾“IƒŒ[ƒU[Ž¡—ÃÇ—á‚ÌŒŸ“¢. ¬—ÑLsC“ˆ”ömiŠOj: ‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i89.11.23), “Œ‹ž, ´˜^W, p.116, 1989.

203. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ˆÝŠà‚Ì“àŽ‹‹¾“IŽ¡—Â̕]‰¿. ¬•”ªŽµ˜Yi‘—§‚ª‚ñƒZƒ“ƒ^[jC”äŠé”\Ž÷iŠOj: ‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i89.11.23), “Œ‹ž, ´˜^W, p.16, 1989.

204. mŠw‰ïn iƒpƒlƒ‹j oŒŒ«’×ᇂ̒ZŠú‚¨‚æ‚Ñ’·Šú—\Œã‚ÌŒŸ“¢. “c•Ó‘C¼Œ³Ž›Ž—çi“àj: ‘æ75‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (89.03.28), ‰¡•l.

205. mŠw‰ïn iƒpƒlƒ‹j ¬Ž™‚ÌŒŒ’†ƒyƒvƒVƒm|ƒQƒ“’l‚ÌŒŸ“¢. ^“º‘¾˜YC‘å“c„•äC¬“‡–M•FiŽ™jCΈ䟌Èi•új: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.20), VŠƒ, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 93(3): 564, l989.

206. mŠw‰ïn iƒpƒlƒ‹j Usefulness of the Endoscopic Examination for Diagnosis of the Rare upper Gastrointestinal Tumor in Children. ^“º‘¾˜YCדc‚Ì‚¼‚ÝC‘å“c„•äC¬“‡–M•FiŽ™j: 19th International Congress of Pediatrics (89.07.26), Paris,

207. mŠw‰ïn iƒpƒlƒ‹j ŠÌd•Ïǂɑ΂·‚éŒoŒû‚¨‚æ‚Ñ”ñŒoŒû•ªŽ}½ƒAƒ~ƒmŽ_“Š—^‚Ì’·Šú—\Œã‚ɑ΂·‚éŒø‰Ê. ¼–Ø–ÎŽ÷i“àj: ‘æ24‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (89.10.20), ’·–ì, ŠÌ‘Ÿ, 30(Suppl. 2): 27, 1989.

208. mŠw‰ïn iƒpƒlƒ‹j Edmondson‡UŒ^ŠÌ×–EŠà‚ÌÄŒŸ“¢(2)ŒuŒõŒ°”÷‘ªŒõ‘•’u‚ð—p‚¢‚Ä. ‚ˆä’qŽqi•a—jCŒÃ’J–[Ž}i•a‰@•a—•”jC‰œ•½‰ë•Fi•a—j: ‘æ24‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (89.10.21), ’·–ì, ŠÌ‘Ÿ, 30(Suppl.2): 112, 1989.

209. mŠw‰ïn iƒpƒlƒ‹j Á‰»ŠíŠàŠ³ŽÒ––½ŒŒè÷—±‹…‚Ìcathepsin DŠˆ«. ’JŒû–ÒC‘OìŒö’jC‘å–ì—²C‹k“c‹P—YCŠô¢‹´“ÄC¼Œ³Ž›Ž—çi“àj: ‘æ27‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (89.10.25°27), –¼ŒÃ‰®.

210. mŠw‰ïn iƒpƒlƒ‹j ‘ŠúˆÝŠà‚Ìf’fŒÀŠE‚É’§‚Þ|Pharmacoendoscopy‚É‚æ‚é‘ŠúˆÝŠà‚Ìf’f|. ¬ò˜aŽO˜YC¼Œ³Ž›Ž—çi“àj: ‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.11.24), “Œ‹ž, —\•ñW, p.135, 1989.

211. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj ’×ᇫ‘å’°‰Š‚ÌŽ¡—Ã|“à‰È¥ŠO‰È‚ÌÚ“_. Ÿ–””º‰hC¬—Ñ´“TCŽO•xO”VCŽR–{‰À³CŒÜ\—’³Li“àjC‚‹´r‹BiŠOj: ‘æ44‰ñ“ú–{‘å’°ãè–å•aŠw‰ï‘‰ï (89.11.17), “Œ‹ž, ‘å’°ãè–åŽ, 42(5): 751, 1989.

212. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj ˆÝŽ¾Š³‚ɑ΂·‚é’´‰¹”g“àŽ‹‹¾‚ÌŽÀÛ. –Ø“cŒõLC¼Œ³Ž›Ž—çi“àj: ‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.11.22), “Œ‹ž.

213. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Total colonoscopy‚ÌŽè‹Z|‹Ù‹}ŒŸ¸‚Æ’Ê팟¸|. ŽR–{‰À³CŸ–””º‰hi“àj: ‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.11.22), “Œ‹ž, —\•ñW, p.144, 1989.

214. mŠw‰ïn iˆê”Êu‰‰j ’_ÎÇ‚É‚Ä“Eo‚³‚ꂽ’_”X“à’_`‚ٌ̈^×–E‚ÌŒŸ“¢. “cŠ‰xŽqi•a‰@•a—jC’†‰p’ji•a—j: ‘æ6‰ñ“ú–{—Õ°×–EŠw‰ï_“Þ쌧Žx•”’n•û‰ïŠwpu‰‰‰ï (87.08.29), ˆÉ¨Œ´, ´˜^W, p.24, 1987.

215. mŠw‰ïn iˆê”Êu‰‰j A Study on the Healing Process of Gastric Ulcer Using Endoscopic Ultrasonography (EUS). –Ø“cŒõLC¼Œ³Ž›Ž—çC•›“‡TˆêC‰¡ŽR–õC‰ª•”Ž¡–íi“àj: ‡Y European Congress of Digestive Endoscopy (88.09.08), Rome, Endoscopy, 20(Suppl.): 91, 1988.

216. mŠw‰ïn iˆê”Êu‰‰j ŠÌd•ÏÇ‚Ì—Õ°“IŒŸ“¢. ¼–Ø–ÎŽ÷C”’èŒh“ñC™–{­’¼CVˆäd‹ICŽR“cL•vCΈäŒö“¹CŽÄ“c‹v—YC‰ª•”Ž¡–íi“àj: ‘æ30‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (88.10.21), Ž­Ž™“‡.

217. mŠw‰ïn iˆê”Êu‰‰j ŠÌ“à’_ŠÇ‘BŽí(Intrahepatic Bile Duct Adenoma)‚Ì•a—‘gDŠw“IŒ¤‹†. ‹àŽq‘C‘å•”½CŠâŸºŒ[ˆêC‰œ•½‰ë•Fi•a—j: ‘æ78‰ñ“ú–{•a—Šw‰ï‘‰ï (89.03.30), ‹ž“s, “ú–{•a—Šw‰ï‰ïŽ, 78(‘‰ï†): 278, 1989.

218. mŠw‰ïn iˆê”Êu‰‰j ‰º•”Á‰»ŠÇ“®Ã–¬ŠïŒ`(AVM)‚Ìf’f‚ÆŽ¡—Ã. ‘–쳈êC‹àˆä¹ŒPC¼ŽR³ŒáC¬—ѬŽiC‹àˆä’Ë•¶–¾C–{‹´CC¼–{—æŽqCˆä“›–ri•új: ‘æ48‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï (89.04.05), _ŒËC “ú–{ˆãŠw•úŽËüŠw‰ïŽ¥‘æ48‰ñ´˜^WC49(—Õ‘): s72, l989.

219. mŠw‰ïn iˆê”Êu‰‰j Á‰»ŠíŒn‘ŸŠí‚É‚¨‚¯‚éEpithelial Membrane Antigen—z«×–E‚Ì•ª•z“Á«‚ɂ‚¢‚Ä. ‰¡‘ò³ŽuCŽÂ“cGCŽR‰º˜a–çC“n•Óˆê]C‘êì—T”üCŒÃ‘º‚¢‚³‚Ýi“Œ•a‰@•a—jC’†‰p’ji•a—j: ‘æ38‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï (89.04.30), •Ÿ“‡, ‰q¶ŒŸ¸, 38(3): 352, 1989.

220. mŠw‰ïn iˆê”Êu‰‰j äXŠà‚ɑ΂·‚é’´‰¹”g“àŽ‹‹¾‚ÌŒŸ“¢. âŒû“NÍC–Ø“cŒõLCŽR“cŽŠlCˆ°Œ´‹BC¬ò˜aŽO˜YC‰¡ŽR–õC•›“‡TˆêCŽO‹´—˜‰·C¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC‹g“c@‹ICˆ­”üƒ•vC‘å‹{“Œ¶C”äŠé”\Ž÷ iŠOjC–{‹§C’†‰p’ji•a—j: ‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.05.11), –¼ŒÃ‰®, —\eW, p.252, 1989.

221. mŠw‰ïn iˆê”Êu‰‰j oŒŒ«ˆÝA\“ñŽw’°’×ᇂ̒·Šú—\Œã‚ÌŒŸ“¢i“Á‚ÉÄoŒŒ—á‚ɂ‚¢‚Äj. ²–ìG–íC‰¡ŽR–õC“c•Ó‘Cˆ°Œ´‹BCŽR“cŽŠlC–Ø“cŒõLC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC“ˆ”ömCŽOd–슰ŠìC”äŠé”\Ž÷iŠOj: ‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.05.12), –¼ŒÃ‰®.

222. mŠw‰ïn iˆê”Êu‰‰j Á‰»«’×ᇂ̒·Šú—\Œã‚ɂ‚¢‚ÄiƒAƒ“ƒP[ƒg—á‚Ì—Õ°“IŒŸ“¢j. ˆ°Œ´‹BC–Ø“cŒõLC‰¡ŽR–õCˆÀŠC‹`—jCŽO‹´—˜‰·C¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: ‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.05.12), –¼ŒÃ‰®, —\eW, p.269, 1989.

223. mŠw‰ïn iˆê”Êu‰‰j “f‰ºŒŒ‚ð’悵‚½Schonlein-HenochŽ‡”Á•a‚Ì1—á. ŽOŽ}MCΈäŒ\‘¾Cã™G‰iC‘OìŒö’jC–Ø“cŒõLC‰¡ŽR–õCŸ–””º‰hC‰ª•”Ž¡–íi“àjC’†‰p’ji•a—j: ‘æ382‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.05.13), “Œ‹ž.

224. mŠw‰ïn iˆê”Êu‰‰j “àŽ‹‹¾‚ÅŠÏŽ@‚µ‚½’¼’°ƒJƒ‹ƒ`ƒmƒCƒh‚ÌŒŸ“¢. ¬—Ñ´“TCŒÜ\—’³LC‹e’n–FtC—é–Ø—TCŽR–{‰À³CŸ–””º‰hC‰ª•”Ž¡–íi“àjCH“¡N¶iŠOjC£ìŒªˆêC’†‰p’ji•a—j: ‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.05.13), –¼ŒÃ‰®, —\eW, p.207, 1989.

225. mŠw‰ïn iˆê”Êu‰‰j H2ƒuƒƒbƒJ[Ž¡—ɺˆÝ’×ᇂ̓¥Ä”­—vˆö‚ÉŠÖ‚·‚錟“¢. ¼Œ³Ž›Ž—çCŽO‹´—˜‰·Cˆ°Œ´‹BC‰¡ŽR–õC¬ò˜aŽO˜YCˆÀŠC‹`—jC‰ª•”Ž¡–íi“àj: ‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.05.13), –¼ŒÃ‰®, —\eW, p.214, 1989.

226. mŠw‰ïn iˆê”Êu‰‰j 123I-iodoamphetamine‚ð—p‚¢‚½Œo’¼’°–å–¬ƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚É‚æ‚é–å–¬ŒŒs“®‘Ô‚ÌŒŸ“¢|“Á‚ÉH“¹Ã–¬áŽ”j’]‚Æ‚ÌŠÖ˜A«‚ɂ‚¢‚Ä. ”’èŒh“ñCΈäŒö“¹C‘•ª–ΔŽC‘ºã‹§lC™–{­’¼C¼–Ø–ÎŽ÷CVˆäd‹ICŠ¡•”‚ЂƂÝCŽR“cL•vCŽÄ“c‹v—Yi“àjC‘º“cWˆê˜YCΈ䟌Èi•új: ‘æ25‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (89.06.01), ‹à‘ò.

227. mŠw‰ïn iˆê”Êu‰‰j ƒAƒ‹ƒR[ƒ‹’E…‘fy‘f‚ƃAƒ‹ƒfƒqƒh’E…‘fy‘f‚ÌGenotype‚ƃAƒ‹ƒR[ƒ‹«ŠÌŽ¾Š³‚̈â“`“I‘fˆö‚ɂ‚¢‚Ä. a’J–¾—²i“àjC‹g“cºiCity of HopejCŽÄ“c‹v—Yi“àj: ‘æ25‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (89.06.01), ‹à‘ò, ŠÌ‘Ÿ, 30(Suppl. 1): 118, 1989.

228. mŠw‰ïn iˆê”Êu‰‰j ֬ᎌŒ‰tƒKƒX•ªÍ‚É‚æ‚éH“¹Ã–¬áŽ‚Ì‚Ž_‘f•ªˆ³‚̬ˆö‚ÉŠÖ‚·‚錟“¢. ‘•ª–ΔŽC”’èŒh“ñCŽR“cL•vCΈäŒö“¹CŽÄ“c‹v—Yi“àjC‘Oì˜a•Fi‹~–½j: ‘æ25‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (89.06.01), ‹à‘ò, ŠÌ‘Ÿ, 30(Suppl. 1): 96, 1989.

229. mŠw‰ïn iˆê”Êu‰‰j oŒŒ«ˆÝA\“ñŽw’°’×ᇂ̒·Šú—\Œã‚ÌŒŸ“¢. ²–ìG–íC‰¡ŽR–õC“c•Ó‘Cˆ°Œ´‹BCˆÉ“¡‹ÏC“©ŽRaˆê˜NCŽR“cŽŠlCâŒû“NÍC–Ø“cŒõLC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC’Ë–{GlC“ˆ”ömCŽOd–슰ŠìC”ä Šé”\Ž÷iŠOj: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (89.06.02), ‘O‹´.

230. mŠw‰ïn iˆê”Êu‰‰j ŠÌd•Ï‚ÌŽ¡—Âɂæ‚éŒ`‘ÔŠw“I•Ï‰»|‰Â‹t«‰ß’ö‚ª”F‚ß‚ç‚ꂽ6—á‚ÌŒŸ“¢. ΈäŒö“¹CŽR“cL•vC”’èŒh“ñC™–{­’¼CVˆäd‹ICŠ¡•”‚ЂƂÝCŽÄ“c‹v—Yi“àjC‰œ•½‰ë•Fi•a—j: ‘æ25‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (89.06.02), ‹à‘ò, ŠÌ‘Ÿ, 30(Suppl. 1): 181, 1989.

231. mŠw‰ïn iˆê”Êu‰‰j “Á”­«–å–¬ˆ³˜´iÇ‚É‚¨‚¯‚é—Þ“´•Ç×–E‚Ì“®‘Ô|ŠÌd•ÏÇ‚Æ‚Ì”äŠr‚ð’†S‚Æ‚µ‚Ä|. ‘å•”½C“ñã—æŽqC‹àŽq‘C‚ˆä’qŽqC²“¡³Ž÷C“n•Ó´Ž¡CŠâŸºŒ[ˆêC‰œ•½‰ë•Fi•a—j: ‘æ25‰ñŠÌ‘ŸŠw‰ï (89.06.02), ‹à‘ò, ŠÌ‘Ÿ, 30(Suppl.): 172, 1989.

232. mŠw‰ïn iˆê”Êu‰‰j Šg‘å• o‹¾ŒŸ¸‚É‚æ‚èŠÌ•\–Ê‚Ì–Ñ׌ŒŠÇ‚ÌŠg’£‚ðØ–¾‚µ“¾‚½Rendu-Osler-Weber•a‚Ì1—á. ŽOŽ}MC¼–Ø–ÎŽ÷C‘ºã‹§lCŽR“cŽŠlC™–{­’¼CŽR“cL•vCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (89.06.03), ‘O‹´.

233. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚é’_”X‘B‹ØŽîÇ‚ÌŒŸ“¢. âŒû“NÍC–Ø“cŒõLCŽR“cŽŠlC–ì“o½Cˆ°Œ´‹BC‰¡ŽR–õC•›“‡TˆêCŽR“cL•vC¼Œ³Ž›Ž—çCŽÄ“c‹v—YC‰ª•”Ž¡–íi“àjC‹g“c@‹ICˆ­”üƒ•vC‘å‹{“Œ¶C”ä Šé”\Ž÷iŠOjC’†‰p’ji•a—j: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (89.06.03), ‘O‹´, Á‰»Ší“àŽ‹‹¾‚Ìi•à, 34: 197`201, 1989.

234. mŠw‰ïn iˆê”Êu‰‰j ’_“¹•Â½ÇpŒã‚ÌH“¹Ã–¬áŽ‚ɑ΂·‚é“àŽ‹‹¾ŒŸ¸‚ƃAƒCƒ\ƒg[ƒvŒŸ¸‚̈Ӌ`. Š™Œ`³ˆê˜YC‘¼i“s—§´£¬Ž™•a‰@jCΈ䟌Èi•új: ‘æ26‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï (89.06.07`09), ç—tC “ú–{¬Ž™ŠO‰ÈŠw‰ïŽC25(3): 499, l989.

235. mŠw‰ïn iˆê”Êu‰‰j •W€‹Èü–@‚ð—p‚¢‚½ˆöŽq•ªÍ‚É‚æ‚é’_“¹•Â½ÇpŒã‚Ì’_`—¬o󋵂̕]‰¿. ΓcŽ¡—YC‘¼i“s—§´£¬Ž™•a‰@jCΈ䟌Èi•új: ‘æ26‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï (89.06.07`09), ç—tC “ú–{¬Ž™ŠO‰ÈŠw‰ïŽC25(3): 539, l989.

236. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒgˆÝPGE2ŽY¶‚ɑ΂·‚éƒVƒƒ`ƒWƒ“‚Ìì—p. ¼ŽR˜a’jC쑺“¹Žqi–ò—jC—é–Ø—Ti“àjCã–ìWŒ›CŽ­ŽæMi–ò—j: ‘æ80‰ñ“ú–{–ò—Šw‰ïŠÖ“Œ•”‰ï (89.06.10), ç—tC —\eW, p.75, 1989.

237. mŠw‰ïn iˆê”Êu‰‰j Differential Diagnosis between Gastric Cancerous Invasion and Fibrosis of Co-existing Ulcer Using Endoscopic Ultrasonography. –Ø“cŒõLC¼Œ³Ž›Ž—çCŽR“cŽŠlCâŒû“NÍC‰ª•”Ž¡–íi“àj: 75th Holland Digestive Disease Week (89.06.22), Amsterdam.

238. mŠw‰ïn iˆê”Êu‰‰j A Study of Endoscopic Ultrasonography in the Diagnosis of Cancer the Pancreas. âŒû“NÍC–Ø“cŒõLCŽR“cŽŠlC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: 75th Holland Digestive Disease Week (89.06.23), Amsterdam, —\eW, p.132, 1989.

239. mŠw‰ïn iˆê”Êu‰‰j ’_“¹‹¾‚Åf’f‚µ“¾‚½’_ŠÇ“àZ‚ð‚Æ‚à‚È‚¤ŠÌ×–EŠà‚Ì1—á. “c’†”ŽŽuCŽOŽ}MCˆÉ“¡‹ÏC‘ºã‹§lC™–{­’¼CâŒû“NÍC–Ø“cŒõLC‘•ª–ΔŽC^‹ÊŽõ”ü¶CΈäŒö“¹CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: ‘æ205‰ñ“ú–{Á‰»ŠíŠw‰ïŠÖ“Œ’n•û‰ï (89.07.08), “Œ‹ž, —\eW, p.16, 1989.

240. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éäXŠà‚ÌŒŸ“¢. âŒû“NÍC–Ø“cŒõLCŽR“cŽŠlCˆ°Œ´‹BC¬ò˜aŽO˜YC‰¡ŽR–õC•›“‡TˆêCŽO‹´—˜‰·C¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC‹g“c@‹ICˆ­”üƒ•vC‘å‹{“Œ¶C”äŠé”\Ž÷ iŠOjC–{‹§C’†‰p’ji•a—j: ‘æ20‰ñ“ú–{äX‘ŸŠw‰ï (89.07.18), “Œ‹ž, äX‘Ÿ, 4(2): 300, 1989.

241. mŠw‰ïn iˆê”Êu‰‰j ƒGƒ^ƒm|ƒ‹ˆÝ”S–ŒáŠQ‹@˜‚Æ‚»‚ê‚ɑ΂·‚é“àˆö«ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“‚Ìì—p. ¼ŽR˜a’jCã–ìWŒ›C쑺“¹ŽqCŽ­ŽæMi–ò—j: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï (89.07.20-21), “Œ‹žC —\eW, p.176, 1989.

242. mŠw‰ïn iˆê”Êu‰‰j ’_”XŽûk“ú“à•Ï“®|“Á‚ÉŠÌd•ÏÇ‚É‚¨‚¯‚é’_”XŽûk“®‘Ԃɂ‚¢‚Ä. âŒû“NÍC–Ø“cŒõLCŽR“cŽŠlC‘•ª–ΔŽCŽR“cL•vCŽÄ“c‹v—Yi“àj: ‘æ25‰ñ“ú–{’_“¹Šw‰ï‘‰ï (89.08.24), ‹{è, ’_“¹, 3(3): 327, 1989.

243. mŠw‰ïn iˆê”Êu‰‰j ‹}‘¬“€Œ‹ƒf²|ƒvƒGƒ`ƒ“ƒO–@‚É‚æ‚é‘Á‰t‘B×–E‚Ì×–EœŠi‚ÌŠÏŽ@. £ì²‹vCŽR‰È³•½i‰ðj: ‘æ31‰ñŽ•‰ÈŠî‘bˆãŠw‰ï (89.09.01), “¿“‡, Ž•‰ÈŠî‘bˆãŠw‰ïŽGŽ, 31(•â): 39, l989.

244. mŠw‰ïn iˆê”Êu‰‰j ’˜–¾‚È’áƒJƒ‹ƒVƒEƒ€ŒŒÇ‚𗈂µ‚½‹}«äX‰Š‚Ì1—á. ’†ˆä‹v—YC‘•ª–ΔŽCâŒû“NÍC^‹ÊŽõ”ü¶CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: ‘æ44‰ñ_“Þ쌧“à‰ÈˆãŠw‰ïW’k‰ï (89.09.10), “¡‘ò.

245. mŠw‰ïn iˆê”Êu‰‰j ˆÝŠïŒ`Žî‚Ì‚P“ûŽ™—á. ^“º‘¾˜YC‘å“c„•äC¬“‡–M•FiŽ™j: ‘æ16‰ñ“ú–{¬Ž™‰h—{Á‰»Ší•aŠw‰ï (89.09.30), “Œ‹ž, —\eW, p.98, 1989.

246. mŠw‰ïn iˆê”Êu‰‰j oŒŒ«’×á‡A“Á‚É‘å—ÊoŒŒ—á‚ÌŒŸ“¢. “c•Ó‘C–Ø“cŒõLC‰¡ŽR–õC¼Œ³Ž›Ž—çi“àj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.05), ˆ®ì.

247. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éŠÌŠO’_ŠÇŠà‚ÌŒŸ“¢|‰º•”’_ŠÇŠà‚ÆäX“ª•”Šà‚ÌŠÓ•Ê‚ð’†S‚É|. ŽR“cŽŠlC–Ø“cŒõLCâŒû“NÍC–ì“o½C¬ò˜aŽO˜YC‰¡ŽR–õC^‹ÊŽõ”ü¶CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC”äŠé”\Ž÷iŠOjC’†‰p’ji•a—j: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.05), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 2076, 1989.

248. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚é–«äX‰Š‚ÌŒŸ“¢. âŒû“NÍC–Ø“cŒõLCŽR“cŽŠlCˆ°Œ´‹BC–ì“o½C¬ò˜aŽO˜YC‰¡ŽR–õC•›“‡TˆêCŽO‹´—˜‰·C^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çi“àj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.05), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 2090, 1989.

249. mŠw‰ïn iˆê”Êu‰‰j •ÖöŒŒ”½‰ž‚Ì—Õ°“I–â‘è“_. ”ª–؈ê•vC÷ˆäŒc‘¢C”·—EŽŠi—ÕŒŸjCät“n’‰’jC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—jCˆÀŠC‹`—jC¼Œ³Ž›Ž—çi“àj: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 59, 1989.

250. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒgˆÝPGŽY¶‚ɑ΂·‚éƒVƒƒ`ƒWƒ“‚Ìì—p. ¼ŽR˜a’jC쑺“¹Žqi–ò—jC—é–Ø—Ti“àjCã–ìWŒ›CŽ­ŽæMi–ò—j: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï (89.10.05°07), ˆ®ìC “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86: 337, 1989.

251. mŠw‰ïn iˆê”Êu‰‰j CCl4‹y‚ÑD-galactosamineŠÌáŠQ‚ɑ΂·‚édibutyryl cyclic AMP (DBcAMP)‚Ì—}§Œø‰Ê. ¼–Ø–ÎŽ÷i“àjC’|“à“ÖŽqi“Œ•a‰@Œ¤‹†ŒnjC™–{­’¼CŽR“cL•vCΈäŒö“¹CŽÄ“c‹v—Yi“àj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06), ˆ®ì.

252. mŠw‰ïn iˆê”Êu‰‰j Á‰»«’×ᇂ̒·Šú—\Œã‚ɂ‚¢‚Ä. ˆ°Œ´‹BCŽO‹´—˜‰·C‰¡ŽR–õC¬ò˜aŽO˜YCˆÀŠC‹`—jC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06), ˆ®ì.

253. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éˆÝŠà‚ÌŠÔŽ¿”½‰ž‚ÌŒŸ“¢|SSŠà‚ÆSŠà‚ÌŠÓ•Ê‚ðŠÜ‚ß‚Ä|.–Ø“cŒõLCŽR“cŽŠlCâŒû“NÍCˆ°Œ´‹BC–ì“o½C¬ò˜aŽO˜YC‰¡ŽR–õCŽO‹´—˜ ‰·C¼Œ³Ž›Ž—çi“àjCŽOd–슰ŠìC”äŠé”\Ž÷iŠOjC’†‰p’ji•a—j: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06), ˆ®ì.

254. mŠw‰ïn iˆê”Êu‰‰j •ÂÇ«‰©át‚É‚¨‚¯‚éPTCD‚ÌŒŸ“¢. ¡òOC–Ø“cŒõLCâŒû“NÍCŽR“cŽŠlC‘•ª–ΔŽC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çi“àjC‹g“c@‹ICˆ­”üƒ•vC‘å‹{“Œ¶iŠOjC’†‰p’ji•a—j: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06), ˆ®ì.

255. mŠw‰ïn iˆê”Êu‰‰j NSAID“Š—^‚É‚æ‚éˆÝ”S‰t—Ê‚Ì•Ï“®|Indomethacin“Š—^Œã‚̈ݔS–ŒŠe•”ƒwƒLƒ\ƒTƒ~ƒ“—Ê‚ÌŒŸ“¢. ÎŒ´˜a•Fi‰»jC¼ŽRŒ›ŽqC‰Y“c’ËMŽqi¶‰»ŒnjC¬Žº—TˆêC¬Œ´iC–x“c‹±Žqi¶‰»j: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(‘): 1994, 1989.

256. mŠw‰ïn iˆê”Êu‰‰j Mild Irritanti0.35N‰–Ž_jŒoŒû“Š—^Œã‚̃‰ƒbƒgˆÝ”S‰t“œ’`”’Ž¿‚Ì•Ï“®. D”¨“¹Gi‡‘åjC‘¼3–¼CÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»j: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(‘): 1995, 1989.

257. mŠw‰ïn iˆê”Êu‰‰j ’×ᇫ‘å’°‰Š‚Æ”DP‚ÉŠÖ‚·‚錟“¢. ¬—Ñ´“TCŸ–””º‰hCŽO•xO”VC—é–Ø—TCŽR–{‰À³CŒÜ\—’³LC¼Œ³Ž›Ž—çi“àjC‘å’J„³iŠOjC“‡“cMGiŽY•wj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 2124, 1989.

258. mŠw‰ïn iˆê”Êu‰‰j ŠÌŽ¾Š³‚É‚¨‚¯‚é”A’†ƒlƒIƒvƒeƒŠƒ“‚Ì“®‘Ô. ™–{­’¼C‘ºã‹§lC”’èŒh“ñC¼–Ø–ÎŽ÷CVˆäd‹ICŠ¡•”‚ЂƂÝC‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—Yi“àj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 2137, 1989.

259. mŠw‰ïn iˆê”Êu‰‰j Pirenzepine (Pz)‚ÌR’×á‡ì—p‚ɑ΂·‚éˆÝ”S‰t“œ’`”’Ž¿‚ÌŠÖ—^|Rat Aspirin’×ᇂÌê‡|. ¬“‡—m“ñi“àjC¬Žº—Tˆêi¶‰»jCÎŒ´˜a•Fi‰»ŠwjC¬Œ´ii¶‰»jC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC–x“c‹±Žqi¶‰»j: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 235, 1989.

260. mŠw‰ïn iˆê”Êu‰‰j Ž_•ª”åŽhŒƒ‚É”º‚¤ˆÝ”S–Œ’ïR«‚ÌŒŸ“¢i‘æ2•ñj. ¬Žº—TˆêC‘å씎”VC¬Œ´ii¶‰»jCÎŒ´˜a•Fi‰»jC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC–x“c‹±Žqi¶‰»j: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86i‘j: 2030, 1989.

261. mŠw‰ïn iˆê”Êu‰‰j •Ç“àá‘‚ðŒ`¬‚µ‚½Crohn•a3Ç—á‚ÌŒŸ“¢. £ìŒªˆêC’†‰p’jC›’m–çCΈä‰pºC–{‹§C‰œ•½‰ë•Fi•a—jC¬—Ñ´“TCŽO•xO”VCŽR–{‰À³CŒÜ\—’³LCŸ–””º‰hi“àjCH“¡N¶C‘å’J„³ iŠOj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽC86(—Õ‘): 2126, 1989.

262. mŠw‰ïn iˆê”Êu‰‰j äXŽ¾Š³‚É‚¨‚¯‚é–Ɖu‰»Šw“I‘ª’è–@‚̉ž—p‚ɂ‚¢‚Ä. ÷ˆäŒc‘¢CˆÀ“¡‹v”üŽqC”ª–؈ê•vC”·—EŽŠi—ÕŒŸjCät“n’‰’jC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.06), ‹ž“sC —Õ°•a—, 37(•â): 332, 1989.

263. mŠw‰ïn iˆê”Êu‰‰j ¬’°‹•ŒŒŽÀŒ±ƒ‚ƒfƒ‹‚Ì컂Ƃ»‚ê‚ç‚Ì–â‘è“_. ’†‰p’jC£ìŒªˆêC–{‹§C‰œ•½‰ë•Fi•a—j: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.07), ˆ®ì.

264. mŠw‰ïn iˆê”Êu‰‰j H“¹ŠÂó֬ᎂ̑¶Ý‚Æ‚»‚̈Ӌ`. ‘•ª–ΔŽC“c•Ó‘C‰¡ŽR–õC^‹ÊŽõ”ü¶CŽÄ“c‹v—YC¼Œ³Ž›Ž—çC‘åˆä“c³li“àj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.07), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 2070, 1989.

265. mŠw‰ïn iˆê”Êu‰‰j ˆÝ’×ᇂ̕¹—p—Ö@‚É‚¨‚¯‚éH2Žó—e‘ÌhRÜ‘ŠúŒ¸—Ê–@‚¨‚æ‚шێ—Ö@‚ÌŒŸ“¢. ˆÀŠC‹`—jC‰¡ŽR–õCŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.07), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 2161, 1989.

266. mŠw‰ïn iˆê”Êu‰‰j •Û‘¶“IŽ¡—ÂŌy‰õ‚µ‚½ƒCƒŒƒEƒXÇ—á‚Ì—Õ°“IŒŸ“¢. ŽO•xO”VCŸ–””º‰hC¬—Ñ´“TC¼ŽR˜a’jC—é–Ø—TCŽR–{‰À³C¼Œ³Ž›Ž—çi“àjC–ÈŠÑ•¶•vCH“¡N¶C‘å’J„³iŠOj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.07), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 404, 1989.

267. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éˆÝ•Ç‚ÌŒú‚³‚ÉŠÖ‚·‚錟“¢. ŽR“cŽŠlC‰ª•”Ž¡–íC–Ø“cŒõLCâŒû“NÍC–ì“o½C‰¡ŽR–õC¼Œ³Ž›Ž—çi“àj: ‘æ55‰ñ“ú–{’´‰¹”gˆãŠw‰ï (89.10.18), •Ÿ‰ª, “ú–{’´‰¹”gˆãŠw‰ïu‰‰˜_•¶W, 16(2): 153`154, 1989.

268. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚é–«äX‰Š‚ÌŒŸ“¢. âŒû“NÍC–Ø“cŒõLCŽR“cŽŠlC–ì“o½C¬ò˜aŽO˜YC‰¡ŽR–õC•›“‡TˆêC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çi“àj: ‘æ55‰ñ“ú–{’´‰¹”gˆãŠw‰ï (89.10.18), •Ÿ‰ª, “ú–{’´‰¹”gˆãŠw‰ïu‰‰˜_•¶W, 16(2): 481`482, 1989.

269. mŠw‰ïn iˆê”Êu‰‰j •W€‹Èü‚ð—p‚¢‚½Factor Analysis ‚É‚æ‚éTc-99m PMT‚̉ðÍ‚Æ’_“¹•Â½Ç‚ÌŒo‰ßŠÏŽ@. ΓcŽ¡—Yi“s—§´£¬Ž™•a‰@jC‘¼CΈ䟌ÈC–x’rdŽ¡i•új: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (89.10.19`21), ‘å’Ã, ŠjˆãŠw, 26(8): 1055, 1989.

270. mŠw‰ïn iˆê”Êu‰‰j “úíŠÌ¶ŒŸ‘gDŒŸõ‚É‚¨‚¯‚éHBeAg—z«Ç—á‚̖Ɖu‘gDŠw“I‚ÈŒŸ“¢. ’†‰p’jC£ìŒªˆêCΈä‰pºC–{‹§C‰œ•½‰ë•Fi•a—j: ‘æ24‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (89.10.20), ’·–ì.

271. mŠw‰ïn iˆê”Êu‰‰j ‘å’°ŠàŠÌ“]ˆÚ‚ɑ΂·‚éŒoƒJƒe[ƒeƒ‹“®–¬ÇðpŽ{s—á‚ÌŒŸ“¢. ‰““¡‚C‘–쳈êCˆä“›–rC¼–{—æŽqC‹àˆä’Ë•¶–¾C¬—ѬŽiC’J“c—ˆê˜Yi•új: “ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (89.10.20), ’·–ì, ŠÌ‘Ÿ, 30(Suppl. 2): 51, 1989.

272. mŠw‰ïn iˆê”Êu‰‰j –«ŠÌŽ¾Š³‚É‚¨‚¯‚éHbF‚̈Ӌ`. ™–{­’¼C‘ºã‹§lC”’èŒh“ñC¼–Ø–ÎŽ÷CVˆäd‹ICa’J–¾—²CŠ¡•”‚ЂƂÝC‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—Yi“àj: ‘æ24‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (89.10.20), ’·–ì, ŠÌ‘Ÿ, 30(Suppl. 2): 61, 1989.

273. mŠw‰ïn iˆê”Êu‰‰j DBcAMP, MMC“®’—Ö@‚ª‘tŒø‚µ‚½–å–¬Žîá‡Çð‡•¹ŠÌ×–EŠà‚Ì1—á. ”’Šñ‚ ‚©‚ËC¼–Ø–ÎŽ÷C‘ºã‹§lC™–{­’¼CVˆäd‹ICa’J–¾—²C‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—Yi“àjC‘–쳈êi•új: ‘æ24‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (89.10.21), ’·–ì, ŠÌ‘Ÿ, 30(Suppl. 2): 123, 1989.

274. mŠw‰ïn iˆê”Êu‰‰j Ž©ŒÈ–Ɖu«ŠÌ‰Š‚Ì‘gDŠw“IŒŸ“¢. ‘å•”½C‹àŽq‘C‚ˆä’qŽqC“n•Ó´Ž¡C‰œ•½‰ë•Fi•a—j: ‘æ24‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (89.10.21), ’·–ì, ŠÌ‘Ÿ, 30(Suppl.2): 100, 1989.

275. mŠw‰ïn iˆê”Êu‰‰j Œ‹ßŒ^ŠÌ×–EŠà‚É‚¨‚¯‚éŠÌ“àƒŠƒ“ƒpŠÇ\’z‰ü•Ï‘œ‚ÌŒŸ“¢(1). “n•Ó´Ž¡CŽOŽ}MC–Ø“c–FŽ÷C“ñã—æŽqC‚ˆä’qŽqC‹àŽq‘C²“¡³Ž÷CŠâŸºŒ[ˆêC‰œ•½‰ë•Fi•a—j: ‘æ24‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (89.10.21), ’·–ì, ŠÌ‘Ÿ, 30(Suppl.2): 112, 1989.

276. mŠw‰ïn iˆê”Êu‰‰j p‘O‚Éf’f‚µ“¾‚½‰ñ–Ó•”ˆ««ƒŠƒ“ƒpŽî‚É‚æ‚é’°dÏ‚Ì3Ç—á. ã™G‰iCŽR–{‰À³CΊ_“¿]CŽOŽ}MC¬—Ñ´“TCŽO•xO”VCŒÜ\—’³LCŸ–””º‰hC¼Œ³Ž›Ž—çi“àjCH“¡N¶C‘å’J„³C”äŠé”\Ž÷iŠOjC£ìŒªˆêC ’†‰p’ji•a—j: ‘æ22‰ñ_“Þ쌧Á‰»Ší•aˆãŠw‰ï‘‰ï (89.11.04), ‰¡•l.

277. mŠw‰ïn iˆê”Êu‰‰j H2ƒuƒƒbƒJ[Ž¡—ɺ‚É‚¨‚¯‚éˆÝ’×ᇂ̓‰»—vˆö‚ÌŒŸ“¢. ¼Œ³Ž›Ž—çCˆ°Œ´‹BC‰¡ŽR–õCŽO‹´—˜‰·CˆÀŠC‹`—ji“àj: ‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.11.22), “Œ‹ž.

278. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éˆÝ•Ç‚ÌŒú‚³‚ÉŠÖ‚·‚錟“¢. ŽR“cŽŠlC–Ø“cŒõLCâŒû“NÍC–ì“o½C¬ò˜aŽO˜YC‰¡ŽR–õC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjCŽOd–슰ŠìC”äŠé”\Ž÷iŠOjC–{‹§C’†‰p’ji•a—j: ‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.11.23), “Œ‹ž, —\•ñW, p.207, 1989.

279. mŠw‰ïn iˆê”Êu‰‰j Šg‘å• o‹¾‚É‚æ‚éŠÌ•\–ÊŠŒ©‚ÌŒŸ“¢. ”’èŒh“ñC‘ºã‹§lC™–{­’¼C¼–Ø–ÎŽ÷CVˆäd‹ICa’J–¾—²C‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—Yi“àj: ‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.11.24), “Œ‹ž.

280. mŠw‰ïn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@‚É‚¨‚¯‚é‘ŠúˆÝŠà‚ÌŽÀ‘Ô|ÇóA”­Œ©Œo˜H‚ð’†S‚Æ‚µ‚Ä|. ˆÀ’BŒ£C¬ò˜aŽO˜YCˆ°Œ´‹BC“c•Ó‘CâŒû“NÍC–Ø“cŒõLC‰¡ŽR–õCˆÀŠC‹`—jCŽO‹´—˜‰·C^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çi“àj: ‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.11.24), “Œ‹ž, —\•ñW, p.190, 1989.

281. mŠw‰ïn iˆê”Êu‰‰j ‘å’°G•½Žîᇂ̗հ•a—Šw“IŒŸ“¢. ¬—Ñ´“TCŸ–””º‰hCŽO•xO”VC—é–Ø—TCŽR–{‰À³CŒÜ\—’³LC¼Œ³Ž›Ž—çi“àjCH“¡N¶C‘å’J„³iŠOjC£ìŒªˆêC’†‰p’ji•a—j: ‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.11.24), “Œ‹ž, —\•ñW, p.241, 1989.

282. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éã•”Á‰»ŠÇ”S–Œ‰ºŽîᇂ̌Ÿ“¢. ŽR“cŽŠlC–Ø“cŒõLCâŒû“NÍCˆ°Œ´‹BC–ì“o½C¬ò˜aŽO˜YC‰¡ŽR–õC¼Œ³Ž›Ž—çi“àjCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOjC’†‰p’ji•a—j: ‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ïA‘æ1‰ñÁ‰»ŠíŽîᇂ̒´‰¹”g“àŽ‹‹¾f’f‚ÉŠÖ‚·‚錤‹†‰ï (89.11.24), “Œ‹ž, —\•ñW, p.377, 1989.

283. mŠw‰ïn iˆê”Êu‰‰j Angiographic Spectrum of Intrahepatic Bile Duct Stones. ‘–쳈êCˆä“›–rC¼–{—æŽqC‹àˆä’Ë•¶–¾C‰““¡‚i•újC’†‰p’ji•a—j: 75th Scientific Meeting of Radiological Society of North America (89.11.26), Chicago, Radiology, 173(Suppl.): 520, 1989.

284. mŠw‰ïn iˆê”Êu‰‰j H“¹Ã–¬áŽd‰»—Ö@‚ª‹Nˆö‚Æ‚È‚Á‚½‚ÆŽv‚í‚ê‚é”]”^ᇂÌ1—á. ‰¡ŽR‰xŽqC“c•Ó‘C–Ø“cŒõLC–kˆä‘¥•vi“àjC‰““¡¹FC‘Oì˜a•FC‘å˜a“c—²i‹~–½jC‘•ª–ΔŽC¼Œ³Ž›Ž—çC”¨—²ŽuC“cè‹`ºi“àj: ‘æ207‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•û‰ï (89.12.02), ‰¡•l.

285. mŠw‰ïn iˆê”Êu‰‰j ‰EŠá“à‰Š‚𕹔­‚µAŽ¸–¾‚ÉŽŠ‚Á‚½ŠÌ”^ᇂÌ1—á. Ä“¡rŽiC‘•ª–ΔŽC‹e’nVC‘ºã‹§lC“c’†”ŽŽuC¼–{ˆÌ’jC™–{­’¼Ca’J–¾—²C^‹ÊŽõ”ü¶CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: ‘æ207‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•û‰ï (89.12.02), ‰¡•l.

286. mŠw‰ïn iˆê”Êu‰‰j ã•”Á‰»ŠÇ–À“üäX‚Ì—Õ°‹y‚Ñ“àŽ‹‹¾“IŒŸ“¢|Doubling time‚Ì‘ª’è‚ðŠÜ‚ß‚Ä|. ã™G‰iC–Ø“cŒõLCˆ°Œ´‹BCŽR“cŽŠlCâŒû“NÍC¬ò˜aŽO˜YC‰¡ŽR–õC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çi“àjCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOjC–{‹§C’† ‰p’ji•a—j: ‘æ49‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (89.12.08), “Œ‹ž.

287. mŠw‰ïn iˆê”Êu‰‰j Lipiodol•¹—pd‰»—Ö@’†‚Ɉê‰ß«‚̈ӎ¯ÁŽ¸‚ð”F‚ß‚½ŠÌŠà‡•¹H“¹Ã–¬áŽ‚Ì1—á. ”\¨C‘•ª–ΔŽC‹{舤ŽqC“c•Ó‘C‘ºã‹§lCŽ™‹ÊW¹C^‹ÊŽõ”ü¶CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: ‘æ49‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (89.12.08), “Œ‹ž.

288. mŠw‰ïn iˆê”Êu‰‰j ’×ᇫ‘å’°‰Š‚ɇ•¹‚µ‚½‘Šú’¼’°Šà‚Ì1—á. rìä•vC¬—Ñ´“TCŸ–””º‰hCŽO•xO”VCâŒû“NÍC—é–Ø—TC–Ø“cŒõLCŽR–{‰À³CŒÜ\—’³LC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çi“àjC‘å’J„³iŠOjC£ìŒª ˆêC’†‰p’ji•a—j: ‘æ49‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (89.12.08), “Œ‹ž.

289. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚é‘å’°Šàf’f‚ÌŒŸ“¢. ¬—Ñ´“TCŸ–””º‰hCŽO•xO”VCâŒû“NÍCŽR“cŽŠlC—é–Ø—TC–Ø“cŒõLCŽR–{‰À³CŒÜ\—’³LC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çi“àjC‘å’J„³iŠOjC£ìŒª ˆêC’†‰p’ji•a—j: ‘æ49‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (89.12.09), “Œ‹ž.

290. mŠw‰ïn iˆê”Êu‰‰j ˆôA“ªˆÙ튴‚ðŽå‘i‚Æ‚µ‚½Plummer-VinsonÇŒóŒQ‚Ì1—á. ¼‰ª–¾—TC”óŒû²GCŒÃì_ŽOiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ70‰ñŽ¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŠwpu‰‰‰ï (89.12.16), ‰¡•l.

291. mŠw‰ïn iˆê”Êu‰‰j Á‰»«’×á‡úEÇ—á‚Ì•Û‘¶“IŽ¡—Ã. ¡ˆäPC“c’†•üŽqC¬–쎛½ŒåC“c•Ó‘C–Ø“cŒõLC™–{Ÿ•FC‘Oì˜a•Fi‹~–½j: ‘æ28‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (90.02.17), “Œ‹ž.

292. mŠw‰ïn iˆê”Êu‰‰j ‹}Œƒ‚ÈŒo‰ß‚ÅŽ€–S‚µ‚½dǃAƒ‹ƒR[ƒ‹«ŠÌd•Ï‚Ì1—á. —ÑO”üCa’J–¾—²C‘ºã‹§lC™–{­’¼C^‹ÊŽõ”ü¶CŽÄ“c‹v—YC¼Œ³Ž›Ž—çC¼–{ˆÌ’ji“àj: ‘æ208‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•û‰ï (90.02.17), “Œ‹ž, —\eW, p.54, 1990.

293. mŠw‰ïn iˆê”Êu‰‰j ƒ\ƒ}ƒgƒXƒ^ƒ`ƒ“‚É‚æ‚鎡—Ã‚ðŽŽ‚Ý‚½ƒ]ƒŠƒ“ƒWƒƒ[¥ƒGƒŠƒ\ƒ“ÇŒóŒQ‚Ì1—á. “c’†”ŽŽuC^‹ÊŽõ”ü¶C‘ºã‹§lC²–ìG–íCˆÉ“¡‹ÏCâŒû“NÍCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: ‘æ208‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•û‰ï (90.02.17), “Œ‹ž, —\•ñW, p.15, 1990.

294. mŠw‰ïn iˆê”Êu‰‰j ’˜–¾‚Ȉݓà“Ëo‚ð’悵‚½ˆÝŠà‚Ì1—á. ŽRãp‚³‚ä‚èCâŒû“NÍC¬ò˜aŽO˜YC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çCŽÄ“c‹v—Yi“àjC‰¡“c^“ñC“¡–ì’Wli”åjC‹àŽq‘C‹T’J“Oi•a—j: ‘æ9‰ñ“ú–{‰æ‘œˆãŠw‰ï (90.02.26), “Œ‹ž, “ú–{‰æ‘œˆãŠw‰ïŽGŽ, 8(5): 428, 1990.

295. mŠw‰ïn iˆê”Êu‰‰j Vasoconstrictive Effect of LTC4 on the Gastric Collecting Venules in Ethanol-Induced Gastric Mucosal Lesion. Ž­ŽæMC¼ŽR˜a’jCã–ìWŒ›i–ò—j: The 3rd Taisho International Symposium on Gastroenterology (90.03.15-16), “Œ‹žC —\eWCp.23, 1990.

296. mŠw‰ïn iˆê”Êu‰‰j ƒGƒ^ƒm|ƒ‹‚É‚æ‚郉ƒbƒgˆÝ”S–ŒáŠQ‚É‚¨‚¯‚郃CƒRƒgƒŠƒGƒ“C4‚ÌŠÖ—^. ¼ŽR˜a’jCã–ìWŒ›CŽ­ŽæMi–ò—j: ‘æ63‰ñ“ú–{–ò—Šw‰ï‘‰ï (90.03.25-28), “Œ‹žC Jpn. J. Pharmacol., 52(suppl.): 137, 1990.

297. mŠw‰ïn iˆê”Êu‰‰j ˆÝ”S‰tƒQƒ‹‰ñŽû‚¨‚æ‚Ñ”S‰t—Ê‘ª’è–@‚ÌŒŸ“¢. ¬Žº—Tˆêi¶‰»jCÎŒ´˜a•Fi‰»jC¬Œ´ii¶‰»jCŽs쑸•¶C¬“‡—m“ñC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC–x“c‹±Žqi¶‰»j: ‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.29), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(‘): 656, 1990.

298. mŠw‰ïn iˆê”Êu‰‰j ‰–Ž_‚ÌAdaptive Cytoprotection‚É‚¨‚¯‚éˆÝ”S‰t“œ’`”’Ž¿‚Ì•Ï“®‚ɂ‚¢‚Ä. D”¨“¹Gi‡‘åjC‘¼4–¼CÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»j: ‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.29), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(‘): 658, 1990.

299. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éˆÝ•Ç‚ÌŒú‚³‚ÉŠÖ‚·‚錟“¢. ŽR“cŽŠlC–Ø“cŒõLCâŒû“NÍC–ì“o½Cˆ°Œ´‹BC‰¡ŽR–õC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjCŽOd–슰ŠìC”äŠé”\Ž÷iŠOjC’†‰p’ji•a—j: ‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.30), “Œ‹ž, ´˜^W, p.625, 1990.

300. mŠw‰ïn iˆê”Êu‰‰j NSAID“Š—^‚É‚æ‚éˆÝ”S‰t—Ê‚Ì•Ï“®|Na Salicylate“Š—^Œã‚̈݊e•”ƒwƒLƒ\ƒTƒ~ƒ“—Ê‚ÌŒŸ“¢. ÎŒ´˜a•Fi‰»jC¼ŽRŒ›ŽqC‰Y“c’ËMŽqi¶‰»ŒnjC¬Žº—TˆêC¬Œ´ii¶‰»jCŽs쑸•¶C¬“‡—m“ñi“àjC–x“c‹±Žqi¶‰»j: ‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.30), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(‘): 576, 1990.

301. mŠw‰ïn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@‚É‚¨‚¯‚é‘ŠúˆÝŠàf’f‚ÌŽÀ‘Ô|‚wü‚Æ“àŽ‹‹¾‚̑Δä‚ð’†S‚É|. ˆÀ’BŒ£C¬ò˜aŽO˜YCˆÉ“¡‹ÏC²–ìG–íC‘åŒIŒ’•FCˆ°Œ´‹BC“c•Ó‘CŽR“cŽŠlCâŒû“NÍC–Ø“cŒõLC‰¡ŽR–õCˆÀŠC‹`—jCŽO‹´—˜‰·C^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—ç i“àj: ‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.30), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(—Õ‘): 206, l990.

302. mŠw‰ïn iˆê”Êu‰‰j Œ€ÇŠÌ‰Š‚ɑ΂·‚錌Ÿ÷ŒðŠ·‚ÌŠJŽnŽžŠú‚ÌŒŸ“¢. ‘ºã‹§lCa’J–¾—²C”’èŒh“ñC™–{­’¼C¼–Ø–ÎŽ÷CVˆäd‹IC‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—YC¼Œ³Ž›Ž—çC“c•Ó‘C–Ø“cŒõLi“àj: ‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.30), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(—Õ‘): 229, l990.

303. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒgˆÝ”S‰t“œ’`”’Ž¿¶‡¬Šˆ«‚É‹y‚Ú‚·ƒqƒXƒ^ƒ~ƒ“‚̉e‹¿. Žs쑸•¶i“àjCÎŒ´˜a•Fi‰»ŠwjC¬Žº—Tˆêi¶‰»jC¬“‡—m“ñi“àjC¬Œ´ii¶‰»jC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC–x“c‹±Žqi¶‰»j: ‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.30), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(—Õ‘): 575, l990.

304. mŠw‰ïn iˆê”Êu‰‰j Pirenzepine (Pz)‚ÌR’×á‡ì—p‚ɑ΂·‚éˆÝ”S‰t“œ’`”’Ž¿‚ÌŠÖ—^i‘æ2•ñj|Rat Ethanol’×ᇂÌê‡|. ¬“‡—m“ñi“àjCÎŒ´˜a•Fi‰»ŠwjC¬Žº—Tˆêi¶‰»jCŽs쑸•¶i“àjC¬Œ´ii¶‰»jC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC–x“c‹±Žqi¶‰»j: ‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.30), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(—Õ‘): 577, l990.

305. mŠw‰ïn iˆê”Êu‰‰j ŠÌ‘Ÿ•”•ªØœpŒã‚É‚¨‚¯‚éŠÌĶ‰ß’ö‚ÌŒŸ“¢|ŠÌ•”•ªØœpŒã24ŽžŠÔ‚܂ł̉Šú•Ï‰»|. “ñã—æŽqC‰œ•½‰ë•Fi•a—jC–kì’msiŠàŒ¤j: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.30), •Ÿ‰ª, “ú–{•a—Šw‰ï‰ïŽ, 79(1): 235, 1990.

306. mŠw‰ïn iˆê”Êu‰‰j ŠÌ×–EŠà‚ÌŠiŽqüˆÛ\’z‚Ì“Á«‚ɂ‚¢‚Ä. ‹àŽq‘C“n•Ó´Ž¡C²“¡³Ž÷C‚ˆä’qŽqCŠâŸºŒ[ˆêC‰œ•½‰ë•Fi•a—j: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.30), •Ÿ‰ª, “ú–{•a—Šw‰ï‰ïŽ, 79(1): 238, 1990.

307. mŠw‰ïn iˆê”Êu‰‰j ’°ŠÇ‚É”­¶‚µ‚½“®Ã–¬ŠïŒ`5Ç—á‚Ì•a—Šw“IŒŸ“¢. ’†‰p’jC£ìŒªˆêCΈä‰pºi•a—jC›’m–çi“àjC–{‹§C‰œ•½‰ë•Fi•a—j: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.31), •Ÿ‰ª.

308. mŠw‰ïn iˆê”Êu‰‰j ŒŒ´‹y‚у¿-L-Fucosidase‚ÉŠÖ‚·‚錟“¢. ™–{­’¼CVˆäd‹IC¼–{ˆÌ’jC‹àŽR“ñ˜YCa’J–¾—²C‘•ª–ΔŽCŽÄ“c‹v—Yi“àj: ‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.31), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(—Õ‘): 611, l990.

309. mŠw‰ïn iˆê”Êu‰‰j —Þ“VávጂɈ݊à‚ð‡•¹‚µ‚½1—á. X£¹Ž÷iŠOjCŒE’n~C—LX³Ž÷i‘—§“Œ‹ž‘æ2•a‰@j: “ú–{Á‰»Ší•aŠw‰ï’n•û‰ï i89.01.00), “Œ‹ž.

310. mŠw‰ïn iˆê”Êu‰‰j ‘å’°ŠàŠÌ“]ˆÚ—á‚ÌŒŸ“¢. ’r‰i½iŠOjC‘哇s•FC´…³•vCŒã“¡‹I•vC“n•Ó—´•FC‹g“cŸ–¾iã”ö’†‰›‘‡•a‰@jC’©’·“N–íC’†‘ºG•viŠOj: é‹ÊŒ§ŠO‰Èˆã‰ï i89.02.19), é‹Ê.

311. mŠw‰ïn iˆê”Êu‰‰j ×–E•ª—ô‰ß’ö‚ÌŽ¨‰º‘B‘B–[×–E‚É‚¨‚¯‚éƒSƒ‹ƒW‘•’u‚Ì“®‘Ô. ‹Ê–؉p–¾CŽR‰È³•½i‰ðj: ‘æ94‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i89.04.03), ‹{è, ‰ð–UŠwŽGŽ, 64(4): 427, l989.

312. mŠw‰ïn iˆê”Êu‰‰j ¶‚«‚½×–E‚ÌŠJŒû•ª”å‚ðŒ©‚é|ƒ‰ƒbƒg‘Á‰t‘B‚Å‚ÌŠÏŽ@|. £ì²‹vCŽR‰È³•½i‰ðj: ‘æ94‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i89.04.03), ‹{è, ‰ð–UŠwŽGŽ, 64(4): 433, l989.

313. mŠw‰ïn iˆê”Êu‰‰j •‚—VƒRƒ‰|ƒQƒ“ƒQƒ‹“à”|—{–@‚É‚æ‚é‘Á‰t‘B‘BŠÇ\‘¢Œ`¬ƒ‚ƒfƒ‹ƒVƒXƒeƒ€‚ÌŠJ”­. –å’J—TˆêCŽR‰È³•½i‰ðj: ‘æ94‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i89.04.03), ‹{è, ‰ð–UŠwŽGŽ, 64(4): 434, l989.

314. mŠw‰ïn iˆê”Êu‰‰j •ª—ôŠú‚Ì‘B×–E‚É‚¨‚¯‚é×–E‚Ì‹É«. ‹Ê–؉p–¾CŽR‰È³•½i‰ðj: ‘æ45‰ñ“ú–{“dŽqŒ°”÷‹¾Šw‰ïŠwpu‰‰‰ï i89.06.02), ‘åã, J. Electron Microsc., 38(4): 279, l989.

315. mŠw‰ïn iˆê”Êu‰‰j ƒ‚ƒmƒNƒ|ƒiƒ‹R‘Ì–@‚ð—p‚¢‚½ŠÌ‘Ÿ—R—ˆã”ç×–EŠ”‚Ì‘gD“à—R—ˆ‚Ì“¯’è. –å’J—TˆêCŽR‰È³•½i‰ðjC]ŒûŒá˜NiŠî¶Œ¤j: ‘æ22‰ñ“ú–{”­¶¶•¨Šw‰ï i89.06.23), ŽD–y, Development Growth and Differntiation, 31(4): 415, l989.

316. mŠw‰ïn iˆê”Êu‰‰j –³ŠÌŠú‚ÉBio-pump‚É‚æ‚éƒoƒCƒpƒXŽè‹Z‚ð—p‚¢‚½“¯Š«“¯ŽíŠÌˆÚAp. ‰¡“c˜a•FC‘듇í‰ëC²“¡ŒõŽjC’†ŽR‹`‰îCŒY•”P’jCˆ¢‘]OˆêC“à“c‹v‘¥iŠOj: ‘æ34‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i89.07.13), ‹v—¯•Ä, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 22(6): 1314, 1989.

317. mŠw‰ïn iˆê”Êu‰‰j CiclosporineAV–Ɖu—}§ÜFK506’P“Æ“Š—^‚È‚ç‚Ñ‚É‘½Ü•¹—p“Š—^‚É‚æ‚éƒCƒkäX\“ñŽw’°ˆÚA. ¡ˆäŒ‰C²“¡ŒõŽjC’†ŽR‹`‰îC‘듇í‰ëCŒY•”P’jC‰¡“c˜a•FCˆ¢‘]OˆêC“à“c‹v‘¥iŠOj: ‘æ34‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i89.07.13), ‹v—¯•Ä, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 22(6): 1448, 1989.

318. mŠw‰ïn iˆê”Êu‰‰j oŒŒ«‹}«ˆÝ’×ᇂɑ΂·‚鞶óØœp‚¨‚æ‚Ñ–D‡Ž~ŒŒp‚ÌŒŸ“¢. ’Ë–{GlCŽOd–슰ŠìC÷–{MˆêCã–쑈ê˜YC¬—ÑLsC‰Á“¡NsC“ˆ”ömC匴÷C”äŠé”\Ž÷iŠOj: ‘æ34‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i89.07.13), ‹v—¯•Ä, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 22(6): 1660, 1989.

319. mŠw‰ïn iˆê”Êu‰‰j ’×ᇫ‘å’°‰Š‚ÌpŽ®‚ÌŒŸ“¢|IRA‹y‚ÑIAA‚ð’†S‚Æ‚µ‚Ä|. ‘å’J„³C‚‹´r‹BC‘êK‹ÏCˆäŒ´ŒúC–ÈŠÑ•¶•vCÎì~CŒÃ”g‘qŽjŽqCH“¡N¶C‹g“c@‹ICˆ­”üƒ•vCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOj: ‘æ34‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i89.07.13), ‹v—¯•Ä, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 22(6): 1989.

320. mŠw‰ïn iˆê”Êu‰‰j ‘å’°úE—á‚ÌŒŸ“¢. ’r‰i½iŠOjC‘哇s•FC´…³•vCŒã“¡‹I•viã”ö’†‰›‘‡•a‰@jC“n•Ó—´•FC‹g“cŸ–¾C‹{“à–M_C’©’·“N–íC’†‘ºG•viŠOj: ‘æ34‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i89.07.13), ‹v—¯•Ä, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 22(6): 1989.

321. mŠw‰ïn iˆê”Êu‰‰j ’¼’°Šà‘¼‘ŸŠíZ—á‚ÌŒŸ“¢. H“¡N¶C‘å’J„³C–ÈŠÑ•¶•vCÎì~C–x]˜aLC“c’†~ŽiCŒÃ”g‘qŽjŽqC‚‹´r‹BC匴÷C”äŠé”\Ž÷iŠOj: ‘æ34‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i89.07.13), ‹v—¯•Ä, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 22(6): 243, 1989.

322. mŠw‰ïn iˆê”Êu‰‰j “¯• ŒZ’팢ŠÔ‚Å‚ÌäX\“ñŽw’°ˆÚA‚ÌŒ¤‹†. ’†ŽR‹`‰îC¡ˆäŒ‰C‘듇í‰ëCŒY•”P’jC‰¡“c˜a•FC²“¡ŒõŽjiŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i89.09.11), “Œ‹ž, ˆÚA, 24(—Õ‘): 171, 1989.

323. mŠw‰ïn iˆê”Êu‰‰j Œ¢ŠÌˆÚAŽèp–³ŠÌŠú’†‚Ì“ûŽ_¥ƒsƒ‹ƒrƒ“Ž_¥’_`Ž_‚Ì„ˆÚ‚ÉŠÖ‚·‚錟“¢. ‘듇í‰ëC‰¡“c˜a•FC²“¡ŒõŽjC’†ŽR‹`‰îCŒY•”P’jiŠOjC^è‹`•FiŽÀ“®ŒnjC“à“c‹v‘¥Cˆ¢‘]OˆêiŠOj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i89.09.12), “Œ‹ž, ˆÚA, 24(—Õ‘): 241, 1989.

324. mŠw‰ïn iˆê”Êu‰‰j CiclosporineAV–Ɖu—}§ÜFK506’P“Æ“Š—^‚È‚ç‚Ñ‚É‘½Ü•¹—p“Š—^‚É‚æ‚éƒCƒkäX\“ñŽw’°ˆÚA. ¡ˆäŒ‰C²“¡ŒõŽjC’†ŽR‹`‰îC‘듇í‰ëCŒY•”P’jC‰¡“c˜a•FiŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i89.09.12), “Œ‹ž, ˆÚA, 24(—Õ‘): 270, 1989.

325. mŠw‰ïn iˆê”Êu‰‰j CiclosporineAFK506“Š—^‚É‚æ‚éƒCƒkäX\“ñŽw’°“¯ŽíˆÚAiŽå‚ɈÚAäX‚Ì‘gD‘œ‚ð’†S‚Éj. ²“¡ŒõŽjC¡ˆäŒ‰C’†ŽR‹`‰îC‘듇í‰ëCŒY•”P’jC‰¡“c˜a•FiŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i89.09.12), “Œ‹ž, ˆÚA, 24(—Õ‘): 271, 1989.

326. mŠw‰ïn iˆê”Êu‰‰j oŒŒ«‚ˆÊˆÝ’×ᇎèp—á‚ÌŒŸ“¢. ’Ë–{GlCŽOd–슰ŠìC÷–{MˆêCã–쑈ê˜YC¬—ÑLsC‰Á“¡NsC“ˆ”ömC匴÷C”äŠé”\Ž÷iŠOj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i89.10.06), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 2157, 1989.

327. mŠw‰ïn iˆê”Êu‰‰j ‘ŠúˆÝŠà‚Ì“àŽ‹‹¾“IƒŒ[ƒU[ÆŽË+OK-432‹Ç’•¹—p—Ö@. “ˆ”ömC”äŠé”\Ž÷C¬—ÑLsCŽR”ö“N•FCã–쑈ê˜YC‰Á“¡NsCŽOd–슰ŠìC匴÷iŠOj: ‘æ10‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘å‰ï i89.10.13), ˆ®ì, ´˜^W, p.49, 1989.

328. mŠw‰ïn iˆê”Êu‰‰j Á‰»ŠÇ‰^“®‹Lq‚ׂ̈̊ȕւȑª’è–@‚ð—p‚¢‚½Metoclopramide‹y‚ÑCisapride‚Ì–ò•¨Œø‰Ê. ‰Á“¡NsCã–쑈ê˜YC”äŠé”\Ž÷iŠOj: ‘æ26‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï i89.10.13), “Œ‹ž, “ú–{—Õ°¶—Šw‰ïŽGŽ, 19(—Õ‘): 164`165, 1989.

329. mŠw‰ïn iˆê”Êu‰‰j ’·ŠúŒŒ‰t“§ÍŠ³ŽÒ‚Ì• •”Žèp. ‰¡“c˜a•FCŒY•”P’jC’†ŽR‹`‰îC²“¡ŒõŽjCŒY•”“ŒŽ¡CΓc˜a•vC’Ë–{GlC”äŠé”\Ž÷iŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ51‰ñ“ú–{—Õ°ŠO‰ÈˆãŠw‰ï‘‰ï i89.10.31), _ŒË, “ú–{—Õ°ŠO‰ÈˆãŠw‰ïŽ, 1989.

330. mŠw‰ïn iˆê”Êu‰‰j Pancreaticoduodenal Allotransplantation with Use of FK506, Ciclosporine and Triple Regimen Immunosuppression. ¡ˆäŒ‰C²“¡ŒõŽjC‘듇í‰ëC’†ŽR‹`‰îCŒY•”P’jC‰¡“c˜a•FC“à“c‹v‘¥C”äŠé”\Ž÷iŠOj: ‡W Congress of the European Society for Organ Transplantation i89.11.1`4), Barcelona, Spain, Abstract, p.256, 1989.

331. mŠw‰ïn iˆê”Êu‰‰j Gastrointestinal Complications Following Renal Transplantation. ‰¡“c˜a•FCOotsubo, O.C’†ŽR‹`‰îC²“¡ŒõŽjCŒY•”P’jC‘듇í‰ëC“à“c‹v‘¥iŠOjC‘å‹v•Û[li“àjC‰““¡’‰—Yi”åjC“n•”_“ñi‘ŸˆÚj: 1st Congress of the Asian Transplantation Society i89.11.22), ƒoƒŠ, ƒCƒ“ƒhƒlƒVƒA, ´˜^W, p.207, 1989.

332. mŠw‰ïn iˆê”Êu‰‰j ’°dÏ‚Å”­Ç‚µ‚½‚r󌋒°ŠàÇ—á‚ÌŒŸ“¢. “n•ÓˆêC‘å’J„³C²“¡KˆêC‰¡ŽR‹žŽqCŒ´‰pC‘êK‹ÏC²X–͖ؔ¾C÷–{MˆêCˆäŒ´ŒúC’r‰i½C–ÈŠÑ•¶•vCH“¡N¶C匴÷C”äŠé”\Ž÷iŠOj: ‘æ207‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•û‰ï i89.12.02), ‰¡•l.

333. mŠw‰ïn iˆê”Êu‰‰j ’_“¹‹·ó‚ɑ΂·‚é“àᑉ»ƒ`ƒ…[ƒu‚É‚æ‚Á‚ÄŠÌ“®–¬¥’_ŠÇᑂ𗈂µ‚½•ÂÇ«‰©át‚Ì1—á. ²“¡KˆêC‹g“c@‹IC’Ò—ºìC–ØìŽOŽl˜YC‰J‹{–¾•¶C¼ˆäŒ’Cˆ­”üƒ•vC‘å‹{“Œ¶C”äŠé”\Ž÷iŠOj: ‘æ207‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•û‰ï i89.12.02), ‰¡•l, —\eW, p.40, 1989.

334. mŠw‰ïn iˆê”Êu‰‰j \“ñŽw’°Á‰»«’×á‡úE‚Ì•Û‘¶“IŽ¡—ÃŒoŒ±. ‹{“à–M_C‘哇s•FC´…³•vCŒã“¡‹I•vC“n•Ó—´•FC¼ˆäŒ’C’r‰i½C‹g“cŸ–¾iŠOj: é‹ÊŒ§ˆãŠw‰ï‘‰ï i90.01.21), ‰Y˜a.

335. mŠw‰ïn iˆê”Êu‰‰j –«“Á”­«‹U«’°•ÂÇÇ‚Ì1—á‚Æ–{–M¬lÇ—á‚ÌŒŸ“¢. ‹{“à–M_C‘哇s•FC´…³•vCŒã“¡‹I•vC“n•Ó—´•FC¼ˆäŒ’C’©’·“N–íiŠOj: ‘æ208‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•ûŽx•”—á‰ï i90.02.17), “Œ‹ž.

336. mŠw‰ïn iˆê”Êu‰‰j —L‹@—nÜ‚É‚æ‚éˆÝ’×ᇂÌ1Žèp—á. ‰J‹{–¾•¶C“ˆ”ömC•Ð“c‰Ä–çC¼ŽR•Û”äŒÃCã–쑈ê˜YC‰Á“¡NsCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOjC’†‰p’ji•a—j: ‘æ208‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•ûŽx•”—á‰ï i90.02.17), “Œ‹ž, —\eW, p.5, 1990.

337. mŠw‰ïn iˆê”Êu‰‰j ‘å’°úEÇ—á‚ÌŒŸ“¢. ˆäŒ´ŒúC‘å’J„³C–ÈŠÑ•¶•vC¬—ÑLsCH“¡N¶C—é–س“¹C‘êK‹ÏC“n•ÓˆêC²“¡KˆêCŒ´‰pC‰¡ŽR‹žŽqC‹g“c@‹IC“ˆ”ömC‰Á“¡NsCˆ­”üƒ•vCŽOd –슰ŠìC‚‹´r‹BC匴÷C”äŠé”\Ž÷iŠOj: ‘æ35‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i90.02.23), ˆÉ¨.

338. mŠw‰ïn iˆê”Êu‰‰j Ciclosporine, FK‚È‚ç‚Ñ‚É‘½Ü‚ð—p‚¢‚½ƒCƒkäX\“ñŽw’°ˆÚA. ¡ˆäŒ‰C²“¡ŒõŽjC’†ŽR‹`‰îC‘듇í‰ëCŒY•”P’jC”äŠé”\Ž÷C‰¡“c˜a•FiŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ35‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i90.02.23), ˆÉ¨, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 23(2): 301, 1990.

339. mŠw‰ïn iˆê”Êu‰‰j Ciclosporine, FK506‚È‚ç‚Ñ‚É‘½Ü‚ð—p‚¢‚½ƒCƒkäX\“ñŽw’°ˆÚA‚É‚¨‚¯‚éˆÚAäX‚Ì•a—‘gDŠw“IŒŸ“¢. ²“¡ŒõŽjC¡ˆäŒ‰C’†ŽR‹`‰îC¼ŽR•Û”äŒÃC‘듇í‰ëCŒY•”P’jC”äŠé”\Ž÷C‰¡“c˜a•FiŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ35‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i90.02.23), ˆÉ¨, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 23(2): 302, 1990.

340. mŠw‰ïn iˆê”Êu‰‰j H“¹ŠàØœŒã‘ŠúŽ€–S—á‚ÌŒŸ“¢. ¬—ÑLsC–å˜eŒ›Cã–쑈ê˜YC‰Á“¡NsC“ˆ”ömCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOj: ‘æ35‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i90.02.23), ˆÉ¨, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 23(2): 447, 1990.

341. mŠw‰ïn iˆê”Êu‰‰j ˆÝŠà‚Ì\“ñŽw’°Z‚ɑ΂·‚é“àŽ‹‹¾“I‹…•””½“]–@‚Ì—L—p«‚ɂ‚¢‚Ä. ÷–{MˆêCŽOd–슰ŠìCã–쑈ê˜YC¬—ÑLsC’Ë–{GlC‰Á“¡NsC“ˆ”ömC匴÷C”äŠé”\Ž÷iŠOjC¬ò˜aŽO˜YC‰¡ŽR–õi“àjC–å˜eŒ›iŠOj: ‘æ35‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i90.02.24), ˆÉ¨, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 23(2): 413, 1990.

342. mŠw‰ïn iˆê”Êu‰‰j ˆ««•ÂÇ«‰©át‚ɑ΂·‚éŒo”çŒoŠÌ’_“¹ƒhƒŒƒi[ƒWp‚ÌŒŸ“¢. ‹g“c@‹ICˆ­”üƒ•vC—é–س“¹C‰¡“c“™C‘å‹{“Œ¶C匴÷C”äŠé”\Ž÷iŠOj: ‘æ35‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i90.02.24), ˆÉ¨, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 23(2): 569, 1990.

343. mŠw‰ïn iˆê”Êu‰‰j isŠàŠ³ŽÒ‚ɑ΂·‚éÝ‘îÖ¬‰h—{‚Ì—L—p«‚Æ“K‰ž‚ÉŠÖ‚·‚錟“¢. ã–쑈ê˜YC‘å’J„³C“Œ”ŽC’[ŽR䎟CˆÉ“¡‹`–çC—é–س“¹C²“¡–ÎC²X–͖ؔ¾C‰Á“¡NsC“ˆ”ömCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOj: ‘æ35‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i90.02.24), ˆÉ¨, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 23(2): 585, 1990.

344. mŠw‰ïn iˆê”Êu‰‰j Endoscopic Treatment of Early Gastric Cancer. ”äŠé”\Ž÷C¬—ÑLsC“ˆ”ömiŠOj: 2nd World Congress of Endoscopic Surgery i90.03.16), ƒAƒgƒ‰ƒ“ƒ^.

345. mŒ¤‹†‰ïn i“Á•Êu‰‰j –å–¬ˆ³˜´iÇ‚Ì•a—. ‰œ•½‰ë•Fi•a—j: ‘æ4‰ñ‹ß‹EŠÌ‘Ÿ•aŒ¤‹†‰ï, ‹ž“s, ‘æ4‰ñ‹ß‹EŠÌ‘Ÿ•aŒ¤‹†‰ï˜_•¶W,@p.7`11, 1989.

346. mŒ¤‹†‰ïn i“Á•Êu‰‰j Indocyanine green‚ɂ‚¢‚Ä. ŽÄ“c‹v—Yi“àj: ŠÌ‘ãŽÓŒ¤‹†‰ï (88.10.00), Ž­Ž™“‡.

347. mŒ¤‹†‰ïn i“Á•Êu‰‰j • •”‹~‹}Ž¾Š³‚ÆERCP|“Á‚ÉäXŠO‚É‚¨‚¯‚é‹Ù‹}ERP‚ð’†S‚Æ‚µ‚Ä. ‘•ª–ΔŽi“àj: ‘æ13‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï (89.09.09), ‹à‘ò.

348. mŒ¤‹†‰ïn i“Á•Êu‰‰j ˆÝŠà‚ɑ΂·‚郌[ƒU[Ž¡—Â̓K‰ž‚ÆŒÀŠE. ”äŠé”\Ž÷iŠOj: ‘æ9‰ñ“Œ‹ž’n‹æ‘—§•a‰@ŠO‰ÈŒ¤‹†‰ï i89.07.15), “Œ‹ž.

349. mŒ¤‹†‰ïn i“Á•Êu‰‰j ƒŒ[ƒU[‚É‚æ‚éŠà‚ÌŠO‰È“IŽ¡—Ã. ”äŠé”\Ž÷iŠOj: ‘æ17‰ñ_“Þ쌧‰›ŽOŽl‰ï‘‰ï i89.09.02), Œú–Ø.

350. mŒ¤‹†‰ïn i“Á•Êu‰‰j Endoscopic Surgery‚ÌŒ»‹µ|‘ŠúˆÝŠà‚Ì“àŽ‹‹¾‚ɂ‚¢‚Ä. ”äŠé”\Ž÷iŠOj: ‘æ4‰ñ•xŽRŽîᇖƉuŒ¤‹†‰ï i89.11.30), •xŽR.

351. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ã•”Á‰»ŠÇoŒŒ‚ɑ΂·‚éŒo“®–¬“IÇðp|Ç𕨎¿‚ÌŒŸ“¢FƒGƒ`ƒ‹°2°ƒVƒAƒmƒAƒNƒŠƒŒ[ƒg(ECA; ƒAƒƒ“ƒAƒ‹ƒtƒ@A)‚Ì—L—p«. ^‹ÊŽõ”ü¶i“àj: ‘æ13‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï (89.09.09), ‹à‘ò.

352. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ã”ç•t’…‚ɑ΂·‚é×–E¶•¨Šw“IƒAƒvƒ|ƒ`. £ì²‹vi‰ðj: ‘æ20‰ñŒä’ƒ‚Ì…Ž•ŠwŒ¤C‰ï i89.04.09), “Œ‹ž.

353. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ŠJ‹Æˆã‚É•K—v‚ÈÁ‰»ŠíŽ¾Š³‚Ì’mŽ¯|‰Ê‚µ‚Ĉ݊à‚ÍŽèp‚µ‚È‚¢‚ÅŽ¡‚¹‚é‚©. ”äŠé”\Ž÷iŠOj: ‘æ224‰ñ‘å˜a—Õ°ˆã’k˜b‰ïŒ¤C‰ï i89.11.15), ‘å˜a.

354. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Endoscopic SurgeryFÅ‹ß‚Ìi•à|‘ŠúˆÝŠà‚Ì“àŽ‹‹¾“IŽ¡—Ã|. ‰¡ŽR–õi“àjC“ˆ”ömiŠOj: ‘æ34‰ñ_“Þ쌧Á‰»Ší•aŒ¤‹†‰ï (89.06.10), ¬“cŒ´.

355. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j IVR‚̇•¹Ç|—\–h‚Æ‘Îô|Á‰»ŠÇoŒŒ. ˆä“›–ri•új: ‘æ1‰ñŠÖ“ŒInterventional RadiologyŒ¤‹†‰ï (89.08.05), “Œ‹ž, “ú–{ŒŒŠÇ‘¢‰eInterventional RadiologyŒ¤‹†‰ïŽGŽ, 4(2): 158, 1989.

356. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ICGÖ¬áŽ“à’“üŽž‚Ì“àŽ‹‹¾ŠŒ©‚ÌŒŸ“¢|‘¢‰eŠŒ©‚Ƃ̑Δ䂩‚ç|. ‘•ª–ΔŽC‘OìŒö’jC“c•Ó‘C‰¡ŽR–õC^‹ÊŽõ”ü¶CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC”äŠé”\Ž÷iŠOj: ‘æ9‰ñH“¹Ã–¬áŽd‰»—Ö@Œ¤‹†‰ï (90.01.13), “Œ‹ž.

357. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒƒbƒPƒ‹ŒeŽº12—á‚ÌŒŸ“¢. ‘å“c„•äC^“º‘¾˜YC¬“‡–M•FiŽ™jCΓc˜a•viŠOjC™–{Ÿ•FC–x’rdŽ¡C‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ14‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï (90.03.09), “Œ‹ž.

358. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Á‰»ŠíŠà‚Ì“àŽ‹‹¾“IŽ¡—ÃGƒŒ[ƒU[Ž¡—Ã. ”äŠé”\Ž÷iŠOjC¬àV—Ñ‘¾˜YiVŠƒ‘åj: ‘æ50‰ñVŠƒÁ‰»Ší•aŒ¤‹†‰ï i89.07.29), VŠƒ.

359. mŒ¤‹†‰ïn iƒpƒlƒ‹j Edmondson‡UŒ^ŠÌ×–EŠà‚ÌÄŒŸ“¢(1). ‚ˆä’qŽqi•a—jCŒÃ’J–[Ž}i•a‰@•a—•”jC‰œ•½‰ë•Fi•a—j: ‘æ25‰ñŠÌŠàŒ¤‹†‰ï (89.05.31), ‹à‘ò.

360. mŒ¤‹†‰ïn iƒpƒlƒ‹j H2Žó—e‘ÌhRÜ“Š—^‰º‚É‚¨‚¯‚éˆÕŽ¡«‹y‚ѓ«’×ᇂ̈ݕª”å‚ÌŒŸ“¢. ˆÀŠC‹`—jC¼Œ³Ž›Ž—çi“àj: ‘æ22‰ñˆÝ•ª”匤‹†‰ï (90.03.29), “Œ‹ž.

361. mŒ¤‹†‰ïn iˆê”Êu‰‰j •›tˆÚ“]‚ð‚Æ‚à‚È‚Á‚½ƒGƒ^ƒm[ƒ‹‹Ç’’·Šúi3”NˆÈãj¶‘¶’†‚ÌŠÌ×–EŠà‚Ì1—á. ‘•ª–ΔŽC™–{­’¼Ca’J–¾—²CŽR“cL•vCΈäŒö“¹CŽÄ“c‹v—Yi“àj: ‘æ26‰ñ‰ë–‰€ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (89.05.18), “Œ‹ž.

362. mŒ¤‹†‰ïn iˆê”Êu‰‰j ˆÙŽž•ûŒü‚ÌH“¹Ã–¬áŽ‚ª‚»‚ꂼ‚ꉓŠÌ«A‹ŠÌ«‚ÌŒŒ—¬•ûŒü‚ðŽ¦‚µ‚½IPH‚Ì1—á. ‘•ª–ΔŽCˆÉ“¡‹ÏC“c•Ó‘C‰¡ŽR–õC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çCŽÄ“c‹v—Yi“àj: ‘æ8‰ñH“¹Ã–¬áŽd‰»—Ö@Œ¤‹†‰ï (89.07.01), ˆ®ì.

363. mŒ¤‹†‰ïn iˆê”Êu‰‰j ˆÝŠïŒ`Žî‚Ì‚P“ûŽ™—á. ^“º‘¾˜YC¬“‡–M•FC‘å“c„•äiŽ™jC¼Œ³Ž›Ž—çi“àjCΓc˜a•vC”äŠé”\Ž÷iŠOj: ‘æ16‰ñ“ú–{¬Ž™“àŽ‹‹¾Œ¤‹†‰ï (89.07.01), ‹ž“s, —\eW, p.22, 1989.

364. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ž_•ª”åŽhŒƒÜ‚̈ݔS‰t“œ’`”’Ž¿‚É‹y‚Ú‚·‰e‹¿i‘æ3•ñj. ¬Žº—TˆêC‘å씎”VC¬Œ´ii¶‰»jCÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»jC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: ‘æ9‰ñƒqƒXƒ^ƒ~ƒ“ƒŒƒZƒvƒ^|Œ¤‹†‰ï (89.07.28), ‹ž“s, ´˜^W, p.11`12, 1989.

365. mŒ¤‹†‰ïn iˆê”Êu‰‰j ˆÝ”S‰tŠÜ—Ê‚©‚ç‚Ý‚½ƒ‰ƒbƒgƒGƒ^ƒm|ƒ‹’×ᇂɑ΂·‚éSucralfate‚ÌŒø‰Ê|ˆÝ”S–ŒƒwƒLƒ\ƒTƒ~ƒ“‘ª’è–@‚ð—p‚¢‚½ŒŸ“¢. ÎŒ´˜a•Fi‰»jC¬Žº—Tˆêi¶‰»jC¬“‡—m“ñi“àjC¬Œ´iC–x“c‹±Žqi¶‰»j: ‘æ40‰ñƒyƒvƒVƒ“Œ¤‹†‰ï (89.08.05), “Œ‹ž, ´˜^W, p.9, 1989.

366. mŒ¤‹†‰ïn iˆê”Êu‰‰j Metallic stent‚ÅŽ¡—µ‚½Budd-ChiariÇŒóŒQ‚Ì1—á. ‘–쳈êi•újCŒÃˆäŽ i–h‰qˆã‘åj: ‘æ1‰ñŠÖ“ŒInterventional RadiologyŒ¤‹†‰ï (89.08.05), “Œ‹ž, “ú–{ŒŒŠÇ‘¢‰eInterventional RadiologyŒ¤‹†‰ïŽGŽ, 4(2): 127, 1989.

367. mŒ¤‹†‰ïn iˆê”Êu‰‰j Á‰»ŠÇoŒŒ‚ÌIVR. ‘–쳈êi•új: ‘æ1‰ñŠÖ“ŒInterventional RadiologyŒ¤‹†‰ï (89.08.05), “Œ‹ž, “ú–{ŒŒŠÇ‘¢‰eInterventional RadiologyŒ¤‹†‰ïŽGŽ, 4(2): 136, 1989.

368. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒGƒ^ƒm|ƒ‹‚É‚æ‚éˆÝ”S–Œ”÷¬zŠÂáŠQ‚Æ“àˆö«ƒƒCƒRƒgƒŠƒGƒ“C4CƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“E2‚Ì–ðŠ„. Ž­ŽæMi–ò—j: ¶—ŠwŒ¤‹†ŠŒ¤‹†‰ï (89.08.24), ‰ªè.

369. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠÌd•Ï‚ɇ•¹‚·‚鉩át‚ɑ΂·‚éDOA‚ÌŽŽ‚Ý. ‘ºã‹§lC™–{­’¼C¼–Ø–ÎŽ÷Ca’J–¾—²C‘•ª–ΔŽCŽÄ“c‹v—Yi“àj: ‘æ6‰ñ_“ÞìŠÌ‰ŠƒZƒ~ƒi[ (89.09.02), ‰¡•l.

370. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”xŒ´”­‚Ì“]ˆÚ«¬’°Žîᇂɂæ‚é’°dÏ‚Ì1—á. Žðˆä’C•FC“c•Ó‘C–Ø“cŒõLi“àjC‘Oì˜a•FC–x’rdŽ¡i‹~–½jC‹àŽq‘i•a—j: ‘æ13‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï (89.09.08), ‹à‘ò.

371. mŒ¤‹†‰ïn iˆê”Êu‰‰j •ÂÇ«‰©át‚𗈂½‚µ‚½äX“à’_ŠÇ‘¹‚Ì1—á. Ί_“¿]C‘•ª–ΔŽCâŒû“NÍC^‹ÊŽõ”ü¶CŽOŽ}MC’†ˆä‹v—YCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC‘Oì˜a•Fi‹~–½j: ‘æ13‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï (89.09.08), ‹à‘ò.

372. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‰º•”Á‰»ŠÇ“®Ã–¬ŠïŒ`. ‰““¡‚C‘–쳈êCˆä“›–rC¼–{—æŽqC‹àˆä’Ë•¶–¾C¬—ѬŽiC‹àˆä¹ŒPi•új: ‘æ13‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï (89.09.08), ‹à‘ò, ‘æ13‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï´˜^W, p.97, 1989.

373. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œ€ÇŠÌ‰ŠFdNJ̉Š‚Ì• o‹¾‘œ‚Æ’·Šú—\Œã. ‘ºã‹§lC”’èŒh“ñC¼–Ø–ÎŽ÷CVˆäd‹ICa’J–¾—²C‘•ª–ΔŽCŽÄ“c‹v—Yi“àj: ‘æ26‰ñ• o‹¾§˜b‰ï (89.09.28), “Œ‹ž.

374. mŒ¤‹†‰ïn iˆê”Êu‰‰j H“¹Ã–¬áŽŒŒ‰tƒKƒX•ªÍ‚Ì—Õ°“IˆÓ‹`. ‘•ª–ΔŽC“c•Ó‘CΈäŒö“¹CŽÄ“c‹v—Yi“àjC”äŠé”\Ž÷iŠOjC‰œ•½‰ë•Fi•a—j: ‘æ22‰ñ“ú–{–å–¬ˆ³˜´iÇŒ¤‹†‰ï (89.09.30), “Œ‹ž.

375. mŒ¤‹†‰ïn iˆê”Êu‰‰j ICG‚ð—p‚¢‚½H“¹Ã–¬áŽ‚É‚¨‚¯‚錌s“®‘Ô‚ÌŒŸ“¢. ‘•ª–ΔŽC“c•Ó‘C”’èŒh“ñC™–{­’¼C¼–Ø–ÎŽ÷CŽÄ“c‹v—Yi“àj: ICGŒ¤‹†‰ï (89.10.04), ˆ®ì.

376. mŒ¤‹†‰ïn iˆê”Êu‰‰j “Á”­«–å–¬ˆ³˜´iÇ‚É‚¨‚¯‚é—Þ“´•ÇgŽqüˆÛ‚̕ω»‚ɂ‚¢‚Ä|ŠÌd•ÏÇ‚Æ‚Ì”äŠr‚ð’†S‚Æ‚µ‚Ä|. ‘å•”½C‰œ•½‰ë•Fi•a—j: Œú¶È“Á’莾Š³–å–¬ŒŒsˆÙíÇ’²¸Œ¤‹†”LJ“¯•ª‰È‰ï (89.10.11), ’·–ì.

377. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒoŒû’°ŠÇôò‰t‚É‚æ‚é‘å’°“àŽ‹‹¾‘Oˆ’u–@i2000 ml–@j‚ÌŒŸ“¢. ¬—Ñ´“TCŸ–””º‰hCŽO•xO”VC—é–Ø—TCŽR–{‰À³CŒÜ\—’³LC¼Œ³Ž›Ž—çi“àjC¬ìK—YC“‡“cŽœ•Fi–òÜj: ‘æ7‰ñ‘å’°ŒŸ¸–@Œ¤‹†‘‰ï (89.10.21), ‘å‹{.

378. mŒ¤‹†‰ïn iˆê”Êu‰‰j V‚µ‚¢Žîᇃ}[ƒJ[span-1a‚Ì—Õ°“IŒŸ“¢. ˆÉ“¡‹ÏC^‹ÊŽõ”ü¶CŸ–””º‰hC“©ŽRaˆê˜NCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjCΈ䟌Èi•új: ‘æ37‰ñ_“Þ쌧Á‰»Ší•aŒ¤‹†‰ï (89.11.04), ‰¡•l.

379. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒgEthanol’×ᇂɑ΂·‚éCimetidine, Cetraxate•¹—p“Š—^Œø‰ÊiˆÝ”S‰tŠÜ—ʕω»‚É‚æ‚錟“¢j. Žs쑸•¶i“àjCÎŒ´˜a•Fi‰»ŠwjC¬Žº—TˆêC¬“‡—m“ñi¶‰»jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: ‘æ17‰ñŽÀŒ±’×ᇌ¤‹†‰ï (89.12.01), “Œ‹ž, ´˜^W, p.54, 1989.

380. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éˆÝŠà‚Ì[’B“xf’fAStage f’f. –Ø“cŒõLCâŒû“NÍC–ì“o½C¬ò˜aŽO˜YC‰¡ŽR–õC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çi“àj: ‘æ54‰ñˆÝŠàŒ¤‹†‰ï (90.01.00), ‰¡•l.

381. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’_”XŒ‹Î‚ɑ΂·‚é‘ÌŠOÕŒ‚”g”jӗÖ@(ESWL)‚Ì—Õ°“IŒŸ“¢|”jÓŒã‚ÌŒo‰ß‚©‚ç‚Ý‚½“K‰ž|. ˆêŒ´—ºCã–ìˆê–çi“àjC–å˜eŒ›iŠOjCˆäŒ´ŒúC“c’†~ŽiCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC”äŠé”\Ž÷C•½“cMliŠOj: ‘æ20‰ñÁ‰»Ší‘ÌŠOÕŒ‚”g—Ö@Œ¤‹†‰ï (90.01.13), “Œ‹ž, ƒvƒƒOƒ‰ƒ€, p.3, 1990.

382. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’ÊíŒ^֬ᎈȊO‚ÌÁ‰»ŠÇ֬ᎂ̌Ÿ“¢. ^‹ÊŽõ”ü¶C‘•ª–ΔŽCŽRãp‚³‚ä‚èC–Ø“c–FŽ÷CŽÄ“c‹v—YC¼Œ³Ž›Ž—çC“c•Ó‘i“àj: ‘æ9‰ñH“¹Ã–¬áŽd‰»—Ö@Œ¤‹†‰ï (90.01.13), “Œ‹ž, ´˜^W, p.11, 1990.

383. mŒ¤‹†‰ïn iˆê”Êu‰‰j Šg‘å• o‹¾‚É‚æ‚éŠÌ•\–ÊŠŒ©‚ÌŒŸ“¢. ”’èŒh“ñC‘ºã‹§lC™–{­’¼C¼–Ø–ÎŽ÷CVˆäd‹ICa’J–¾—²C‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—Yi“àj: ‘æ27‰ñ• o‹¾§˜b‰ï (90.02.01), “Œ‹ž.

384. mŒ¤‹†‰ïn iˆê”Êu‰‰j “Á”­«–å–¬ˆ³˜´iÇ‚É‚¨‚¯‚é—Þ“´•ÇüˆÛ\’z‚ÌŒŸ“¢|ŠÌd•ÏÇ‚Æ‚Ì”äŠr‚ð’†S‚Æ‚µ‚Ä|i‘æ2•ñj. ‘å•”½C‰œ•½‰ë•Fi•a—j: Œú¶È“Á’莾Š³–å–¬ŒŒsˆÙíÇ’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘‰ï (90.02.07), “Œ‹ž.

385. mŒ¤‹†‰ïn iˆê”Êu‰‰j Aspirin\‘¢ŠÖ˜A•¨Ž¿“Š—^‚É‚æ‚郉ƒbƒgˆÝ”S‰t—Ê‚Ì•Ï“®|ƒwƒLƒ\ƒTƒ~ƒ“ŠÜ—Ê‘ª’è‚É‚æ‚錟“¢. ÎŒ´˜a•Fi‰»jC¼ŽRŒ›Žqi¶‰»ŒnjC¬Žº—TˆêC¬Œ´iC–x“c‹±Žqi¶‰»jCŽs쑸•¶C¬“‡—m“ñi“àj: ‘æ41‰ñƒyƒvƒVƒ“Œ¤‹†‰ï (90.02.17), ‹ž“s, ´˜^W, p.1, 1990.

386. mŒ¤‹†‰ïn iˆê”Êu‰‰j 0.35N‰–Ž_ŒoŒû“Š—^Œã‚̈ݔS–Œ‚̕ω»‚ɂ‚¢‚Ä. “c’†‰ë•FCD”¨“¹Gi‡‘åjC‘¼3–¼CÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»j: ‘æ8‰ñ Cytoprotecion Œ¤‹†‰ï (90.02.17), ‹ž“s, ´˜^W, p.18, 1990.

387. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹}«äX‰Š‚ÌPrimam/Care; —A‰t—Ö@‚Æt‹@”\. ¡ˆäPCó—˜–õC¬–쎛½ŒåC“c’†•üŽqCŽá—Ñ–õ‹vC™–{Ÿ•FCŒY•”P’jC‘Oì˜a•Fi‹~–½j: ‘æ28‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï (90.03.08), ‘åã.

388. mŒ¤‹†‰ïn iˆê”Êu‰‰j “àŽ‹‹¾“IäXŠÇƒhƒŒƒi[ƒW‹y‚ÑEST‚ª‘tŒø‚µ‚½äX”X–E‡•¹–«äX‰Š‚Ì1—á. ¡òOC‹{舤ŽqC‘•ª–ΔŽC^‹ÊŽõ”ü¶C”\¨CâŒû“NÍCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC¡ˆäPC‘Oì˜a•Fi‹~–½j: ‘æ14‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï (90.03.09), “Œ‹ž.

389. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‚­‚à–Œ‰ºoŒŒ‚É‚¨‚¯‚邃Aƒ~ƒ‰[ƒ[ŒŒÇ‚ÌŒŸ“¢. ¬–쎛½Œåi‹~–½jC–Ø“cŒõLC“c•Ó‘i“àjC–kˆä‘¥•vC“c’†ç•FC‰““¡¹FC–kŒ´F—YC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ14‰ñ“ú–{• •”f—ÃŒ¤‹†‰ï (90.03.09), “Œ‹ž.

390. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ž©—¥_Œo‚̈ݔS–Œ‚É‹y‚Ú‚·‰e‹¿|“Á‚ɈݓàpH,ˆÝ”S–ŒƒwƒLƒ\ƒTƒ~ƒ“‚ɂ‚¢‚Ä. —é–Ø—SŽqC‹TŽRmˆêiŽRŒ`‘åjC‘¼2–¼CÎŒ´˜a•Fi‰»jC¼ŽRŒ›Žqi¶‰»ŒnjC–x“c‹±Žqi¶‰»j: ‘æ22‰ñˆÝ•ª”匤‹†‰ï (90.03.29), “Œ‹ž, ˆÝ•ª”匤‹†‰ïŽ, 22: 81`84, 1990.

391. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’_“¹oŒŒ‚𗈂µ‚½•ÂÇ«‰©át‚Ì1—á. ‰J‹{–¾•¶C‹g“c@‹ICˆ­”üƒ•vC‘å‹{“Œ¶C”äŠé”\Ž÷iŠOj: ‘æ30‰ñ’_“¹‚ÌW‚¢ i89.06.30), “Œ‹ž.

392. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘å’°‘¼‘ŸŠíd•¡Šà‚ÌŒŸ“¢. ‘êK‹ÏC‘å’J„³CˆäŒ´ŒúC–ÈŠÑ•¶•vCÎì~CŒÃ”g‘qŽjŽqCH“¡N¶C‹g“c@‹ICˆ­”üƒ•vCŽOd–슰ŠìC‚‹´r‹BC匴÷C”äŠé”\Ž÷iŠOj: ‘æ31‰ñ‘å’°ŠàŒ¤‹†‰ï i89.07.00), ‘åã.

393. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’¼’°ŠàpŒã‹ÇŠÄ”­Ç—á‚ÌŒŸ“¢. ˆäŒ´ŒúC‘å’J„³C‘êK‹ÏC–ÈŠÑ•¶•vC¬—ÑLsCˆ¢‘]˜a“NCã–쑈ê˜YCH“¡N¶C“ˆ”ömC‚‹´r‹BC匴÷C”äŠé”\Ž÷iŠOj: ‘æ31‰ñ‘å’°ŠàŒ¤‹†‰ï i89.07.00), ‘åã.

394. mŒ¤‹†‰ïn iˆê”Êu‰‰j •ÂÇ«‰©át‚ɑ΂·‚éŒo”çŒoŠÌ’_“¹ƒhƒŒƒi[ƒWp‚ÌŒŸ“¢. ‹g“c@‹IC—é–س“¹C‰¡“c“™C‹à“cŒå˜YCˆ¢‘]˜a“NCˆ­”üƒ•vC‘å‹{“Œ¶C”äŠé”\Ž÷iŠOj: ‘æ11‰ñ_“ÞìŠÌ’k˜b‰ï i89.07.22), ‰¡•l.

395. mŒ¤‹†‰ïn iˆê”Êu‰‰j ––ŠúŠàŠ³ŽÒ‚ɑ΂·‚éÝ‘îÖ¬‰h—{‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢. ã–쑈ê˜YC‘å’J„³C“Œ”ŽC’[ŽR䎟CˆÉ“¡‹`–çC—é–س“¹C²“¡–ÎC‰Á“¡NsCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOjCŠp“c‡ŽqCŽRè—R‹IŽqiŠÅŒì•”j: ‘æ4‰ñÝ‘îÖ¬‰h—{Œ¤‹†‰ï i89.09.02), ‘åã.

396. mŒ¤‹†‰ïn iˆê”Êu‰‰j äX“ª\“ñŽw’°Øœp‚ðs‚Á‚½•¡ŽGäX’_ŠÇ‡—¬ˆÙí‚Ì1—á. ‹g“c@‹ICˆ­”üƒ•vC‘å‹{“Œ¶C”äŠé”\Ž÷iŠOj: ‘æ2‰ñ_“ÞìäX§˜b‰ï i89.11.28), ‰¡•l.

397. mŒ¤‹†‰ïn iˆê”Êu‰‰j “àŽ‹‹¾V•aŒ^iˆÄj‚É‚æ‚é‚O°‡UŒ^Ç—á|Ç—á‚U|. ¬—ÑLsiŠOj: ‘æ20‰ñH“¹•\ÝŠàǗጟ“¢‰ïiH“¹F‘fŒ¤‹†‰ïj i89.12.09), “Œ‹ž.

398. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘’_ŠÇŒ‹Î‚ɑ΂·‚éESWL‚ÌŒoŒ±. –å˜eŒ›CˆäŒ´ŒúC“c’†~ŽiiŠOjCˆêŒ´—ºCã–ìˆê–çCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC‘å‹{“Œ¶C”äŠé”\Ž÷C•½“cMliŠOj: ‘æ2‰ñÁ‰»ŠíŠO‰È‘ÌŠOÕŒ‚”g—Ö@Œ¤‹†‰ï i90.01.13), “Œ‹ž, ƒvƒƒOƒ‰ƒ€, p.4, 1989.

399. mŒ¤‹†‰ïn iˆê”Êu‰‰j ˆô“ªH“¹“EopŽ{sŠ³ŽÒ‚̉h—{ó‘Ô‚ÌŒŸ“¢. X“c‰À‘ãŽqC²“¡‘•cC–ؖí¶i‰h—{‰ÈjC²“¡ŒõŽjCŽOd–슰ŠìiŠOjC‘åê³–¤iŠÅŒìŠw•”jC–Ø‘º—˜”üCˆÉ“¡—msC²ìŒ«ˆêC‰Á‰ê’J”£i–òÜ•”jC–û ’J˜aŽqC¼èƒ^ƒcƒGiŠÅŒì•”j: ‘æ5‰ñ“ú–{Ö¬Œo’°‰h—{Œ¤‹†‰ï i90.01.26), “Œ‹ž, “ú–{Ö¬Œo’°‰h—{Œ¤‹†‰ïŽ, 5: 278, 1990.

400. mŒ¤‹†‰ïn iˆê”Êu‰‰j WŠw“IŽ¡—Âɂĉü‘P‚µ‚½”ñØœŠÌ’_ŠÇ”X–E‘BŠà‚Ì’·Šú¶‘¶—á. ‹g“c@‹ICˆ­”üƒ•vC‘å‹{“Œ¶C”äŠé”\Ž÷iŠOj: ‘æ31‰ñ’_“¹‚ÌW‚¢ i90.01.27), ˆÉ“Œ.

401. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”]Ž€ƒhƒi[‚ÌäX‘gD‚ÌŒŸ“¢. ’†ŽR‹`‰îC¡ˆäŒ‰CŒY•”P’jC²“¡ŒõŽjCE“cÍC‰¡“c˜a•FiŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ16‰ñäXˆÚA’k˜b‰ï i90.02.08), ‹à‘ò, —\eW, p.23, 1989.

402. mŒ¤‹†‰ïn iˆê”Êu‰‰j ciclosporine‚È‚ç‚Ñ‚ÉV–Ɖu—}§ÜFK506‚ð—p‚¢‚½ƒCƒkäX\“ñŽw’°ˆÚA. ²“¡ŒõŽjC¡ˆäŒ‰C’†ŽR‹`‰îC‘듇í‰ëCŒY•”P’jCE“cÍC‰¡“c˜a•FiŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ16‰ñäXˆÚA’k˜b‰ï i90.02.08), ‹à‘ò, —\eW, p.25, 1989.

403. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’¼’°pmŠàÇ—á‚Ì—Õ°•a—Šw“IŒŸ“¢. ‘å’J„³CˆäŒ´ŒúC‰ªTˆê˜YC‘êK‹ÏC’r‰i½CŒÃ”g‘qŽjŽqC–ÈŠÑ•¶•vCÎì~CH“¡N¶C‚‹´r‹BC匴÷C”äŠé”\Ž÷iŠOj: ‘æ32‰ñ‘å’°ŠàŒ¤‹†‰ï i90.02.17), ‘åã.

404. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’¼’°Šàp‘OpŒã‚É‚¨‚¯‚éƒ`[ƒ€ˆã—Âɂ‚¢‚Ä|“Á‚ɸ_“IƒPƒA[‚ɂ‚¢‚Ä|. •ÐŸºŒ[ŽqCŠp“c‡ŽqCŽRè—R‹IŽqC²•ª–õŽqC’†‘ºG‘ãiŠÅŒì•”jC–ÈŠÑ•¶•vCH“¡N¶C‘å’J„³iŠOjCŠ}Œ´—FKi¸j: ‘æ12‰ñ_“Þ쌧ƒXƒg[ƒ}Œ¤‹†‰ï i90.03.03), _“Þì.

405. mŒ¤‹†‰ïn iˆê”Êu‰‰j Á‰»ŠÇ‰^“®‹Lq‚Ì‚½‚ß‚ÌŠÈ•Ö‚È‘ª’è–@‚ð—p‚¢‚½ŠeŽí–òÜ‚Ì–ò•¨Œø‰Ê. ‰Á“¡NsCã–쑈ê˜YC÷–{MˆêiŠOjC‘ëàV’¼’èC‘åŠÑMi¶—jC”äŠé”\Ž÷iŠOj: ‚f‚h‚l‚cƒNƒ‰ƒu i90.03.03), ‰¡•l.

406. mŒ¤‹†‰ïn iˆê”Êu‰‰j p‘O‚ÉTcO4-ƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚ðs‚¢WÏ‚ðŽ¦‚µAØœp‚ðŽ{s‚µ‚½oŒŒ«¬’°•½ŠŠ‹ØŽî‚Ì1—á. X£¹Ž÷iŠOjC“c•Ó‘C¡ˆäPCˆäŒ…^—R”üC–Ø“cŒõLi“àjCŒY•”P’jiŠOjC‘Oì˜a•FC–x’rdŽ¡C‘å˜a“c—²i‹~–½j: ‘æ14‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï i90.03.08), “Œ‹ž.

407. mŒ¤‹†‰ïn iˆê”Êu‰‰j •…H«H“¹‰ŠpŒãiƒoƒCƒpƒXpj‚ÉŽc‘¶H“¹‚Ì”j—ô‚ð‹N‚±‚µ‚½‚ÆŽv‚í‚ê‚é1—á. X£¹Ž÷CŽOd–슰ŠìC“ˆ”ömC¬—ÑLsC”äŠé”\Ž÷iŠOj: ‘æ2‰ñ_“ÞìH“¹Ž¾Š³§˜b‰ï i90.03.15), _“Þì.

408. mŒ¤‹†‰ïn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚éoŒŒ«ˆÝ’×ᇎèpÇ—á‚ÌŒŸ“¢. ’Ë–{GlC÷–{MˆêCã–쑈ê˜YC¬—ÑLsC“ˆ”ömC‰Á“¡NsCˆ­”üƒ•vCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOj: ‘æ19‰ñˆÝŠO‰ÈŒ¤‹†‰ï i90.03.17), Ž­Ž™“‡.

409. mŒ¤‹†‰ïn iŒöŠJuÀj ‰ŠÇ«’°Ž¾Š³‚Ì“àŽ‹‹¾f’f. Ÿ–””º‰hi“àj: ‘æ14‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïƒZƒ~ƒi[ (89.07.23), “Œ‹ž, —\eW, p.91`94, 1989.

410. mŒ¤‹†‰ïn iŒöŠJuÀj ŠàŽ¡—ÂÌÅ‘OüiˆÝŠàA‘å’°Šà“™‚ɂ‚¢‚Äj. ”äŠé”\Ž÷iŠOj: _“Þ쌧‘åŠwŒöŠJuÀ i89.11.25), ‘Š–ÍŒ´.


<<102 SE–¬ŠÇ>>

411. mŒ´’˜n Responsiveness of the Ductus Arteriosus to Prostaglandin E1 Assessed by Combined Cross Sectional and Pulsed Doppler Echocardiography. •½Î‘C“¡–ì‹X”VCÄ“¡KˆêC¬ŒûO‹BC–åˆäL‹ÅCãp—z‘¾˜YC–xŒû‘דTiŽ™jC•äÏŒ³i—ÕŒŸjC”ª‘ãŒö•viŽ™j: Br. Heart J.,62: 140`147, 1989.

412. mŒ´’˜n The Role of Specific Granules in Ventricles on Atrial Natriuretic Peptide (ANP) Secretion in Acute Heart Failure. ²“¡´‹Mi“àjC‘“c‘ìi‹~–½jC^è‹`•FiŽÀ“®ŒnjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC’·’J쉄LC˜Iè‹P•vi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjC–Øì“c—²ˆê i“àj: Diuretics ‡V: Chemistry, Pharmacology, and Clinical Applications, p.615`617, 1990.

413. mŒ´’˜n ˜V”NŽÒ‚É‚¨‚¯‚éŽûkŠú‚ŒŒˆ³‚¨‚æ‚ÑŠg’£Šú‚ŒŒˆ³‚ÌŒŒs“®‘Ô‚ÆS‹@”\. ‘º¼€C™ŽRŠx•FC’ËŒ´Œª”VCˆÀ’B¥ºC¬—Ñ–¾–FC’·’J쉄LC–Øì“c—²ˆêi“àj: Geriatric Med., 27: 1494`1498, 1989.

414. mŒ´’˜n A Computer-Based Model of Parasystolic Activity Modulated by Ventricular Activation in the Open-Chest Dog. ¯–ìˆê–çC’r“cŒ›ºiˆã—pî•ñjC“c’†ŠÚ–¾”Ži¶•¨•¨—ŒnjC‹{Œ´‰p•viˆã—pî•ñj: J. Electrocardiol., 22(4): 277`283, 1989.

415. mŒ´’˜n No Specific Organ Removes Atrial Natriuretic Peptide from the Human Plasma. •‘ò—˜˜YC•½¼T‰EC‰Á“¡—zˆêC–Øì“c—²ˆêi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: Jpn. Circ. J., 53(7): 779`785, 1989.

416. mŒ´’˜n Reentrant Arrhythmias Generated by a Computer-Based Model of the Modulated Parasystole in an Open-Chest Dog. ¯–ìˆê–çC’r“cŒ›ºC‹{Œ´‰p•viˆã—pî•ñjC²“¡“oŽu˜Yi¶—j: Jpn. Heart J., 30(6): 885`894, 1989.

417. mŒ´’˜n Biphasic Accumulation of Leukocytes in Rat Cardiac Infarct Tissue Caused by Leukotriene B4 and Complement. Ž­ŽæMi–ò—jCT. KameyamaiŽO•H‰»¬jC²X–ØK“ñi“àjCã–ìWŒ›i–ò—jC‚–Ø”ü˜aŽqi¶‰»ŒnjCŽR‰È³•½i‰ðj: Jpn. J. Pharmacol., 50: 234`238, 1989.

418. mŒ´’˜n Hemodynamic and Neuroendocrine Adaptations of the Preterm Lamb Left Ventricle to Acutely Increased Afterload. Barry G. Baylen (Penn. State Univ.)Cãp—z‘¾˜Y(Ž™)CJames F. PadburyCMachiko IkegamiCAlan JobeCGeorge C. Emmanouilides (Penn. State Univ.): Pediatr. Res., 26(4): 336`342, 1989.

419. mŒ´’˜n ŠJSp‚É‚¨‚¯‚鶎ºŒ¸ˆ³venting‚Ì•K—v«‚ÌŒŸ“¢. •—ŠÔ”ÉC¼ŽR´ŒhC¡ˆäŠ°C’¬ˆä³lC‰€“c˜a•FCÎŒ´ºi‹¹ŠOj: ‹¹•”ŠO‰È, 42(7): 537`540, 1989.

420. mŒ´’˜n ‘ÏŒŒŠÇ•ÇCollapse«‚ðl—¶‚µ‚½”“®—¬ƒ|ƒ“ƒv‚ÌÖ¬ƒJƒjƒ…|ƒŒ“üŒûŒ`ó. ‹´–{¬Li¶‘ÌHjCˆÉ“¡’‰OCŽç‰®“llC–ö‘òG–¾CÎŒ´ºi‹¹ŠOjCX“c^ŽjC”nŸº´Ž‘i¶‘ÌHjCˆÀ‹vˆäLÍCù“c’¼i“ŒH‘åj: lH‘ŸŠí, 12(1): 245`248, 1983.

421. mŒ´’˜n ŒŒð‚̬’·‚ð—}‚¦‚鉓Sƒ|ƒ“ƒv—¬˜HŒ`óÝŒv. ‹´–{¬LC”nŸº´Ž‘i¶‘ÌHjCó—˜G’jCÎŒ´ºi”]ŠOjCù“c’¼C…–ìŸi“ŒH‘åj: lH‘ŸŠí, 17(3): 879`882, 1988.

422. mŒ´’˜n ”“®—¬ƒ|ƒ“ƒv‚ɑ΂·‚é‹à‘®ƒxƒ|ƒY‚̉ž—p. ‹´–{¬LC”nŸº´Ž‘i¶‘ÌHjCˆÉ“¡’‰OCÎŒ´ºi‹¹ŠOjCù“c’¼i¶‘ÌHj: ¶‘ÌÞ—¿, 1(1): 53`60, 1983.

423. mŒ´’˜n ŽíX‚Ìæ“V«SŽ¾Š³‚É‚¨‚¯‚é“®–¬ŠÇ‚ÌŒ`‘Ԃƕ½‰ß’ö‚ɂ‚¢‚Ä‚ÌSƒGƒR|}Cƒhƒvƒ‰–@‚ð—p‚¢‚½Œ¤‹†. •äÏŒ³i—ÕŒŸjC•½Î‘iŽ™jCŒÃ–ؗʈê˜YC’ß–ì˜a‘¥i—ÕŒŸj: “ú–{’´‰¹”gˆãŠw‰ïŽGŽ, 16(6): 538`545, 1989.

424. mŒ´’˜n ”]Ò‘‰t‚É‚¨‚¯‚éƒCƒkS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒzƒ‹ƒ‚ƒ“‚Ì‘¶Ý‚Æ‚»‚Ì—R—ˆ‚ÉŠÖ‚·‚錟“¢. ‘“c‘ìi‹~–½jC²“¡´‹Mi“àjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: “ú–{“à•ª”åŠw‰ïŽGŽ, 65(10): 1159`1170, 1989.

425. mŒ´’˜n ‰Â‹t“IS•s‘S‚É‚¨‚¯‚錌’†‚¨‚æ‚ÑS–[ANP“®‘Ô. ²“¡´‹MC’·’J쉄LC–Øì“c—²ˆêi“àjC‘“c‘ìi‹~–½jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: “ú–{“à•ª”åŠw‰ïŽGŽ, 65(8): 794`806, 1989.

426. mŒ´’˜n –k—¢Ž®ƒsƒXƒgƒ“¥ƒxƒ|ƒYŒ^lHS‘Ÿ|‚»‚ÌÝŒv‚ƃCƒk‚Ö‚Ì“K—p|. ‹´–{¬LC”nŸº´Ž‘i¶‘ÌHjCˆÉ“¡’‰OC¼ŽR´ŒhCŽç‰®“llCÎŒ´ºi‹¹ŠOjCX“c^ŽjCù“c’¼i¶‘ÌHj: –k—¢ˆãŠw, 12(3): 206`216, 1982.

427. mŒ´’˜n Ö¬ŒŒŽ_‘f•ªˆ³‚©‚ç‚Ý‚½‰ºŽˆÃ–¬áŽ‚É‚¨‚¯‚铮Ö¬•«‡‚Ì–ðŠ„‚Æ‚±‚ê‚É‹y‚Ú‚·d–ŒŠO–ƒŒ‚̉e‹¿‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢. ‹à鳉ÀiŠOj: –k—¢ˆãŠw, 20(1): 83`95, 1990.

428. mŒ´’˜n ‚¤‚ÁŒŒ«S•s‘S‚𔺂¤‚ŒŒˆ³Ç‚É‚¨‚¯‚é‹N—§ŽŽŒ±‚ƈÙí‚ÈzŠÂ—ÍŠw“I”½‰ž ¬‹Ê•q‰›C˜Iè‹P•vC”öŒ`’·—YCò–Ø‹|C–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, l9(5): 490`500, 1989.

429. mŒ´’˜n –{‘Ô«‚ŒŒˆ³Ç‚Éhydralazine‚ð—p‚¢‚½‚³‚¢‚É‚¨‚¯‚é‘Sg‚ÌzŠÂ“®‘Ô‚ÆtzŠÂ“®‘ÔA‚Æ‚­‚ÉRBF‚Æ‚ÌŠÖŒW. ò–Ø‹|CŠpN•vC˜Iè‹P•vC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, l9(6): 551`556, 1989.

430. mŒ´’˜n –{‘Ô«‚ŒŒˆ³Ç‚É‚¨‚¯‚é‘Sg‚ÌzŠÂ“®‘Ô‚ÆtzŠÂ‚Æ‚ÌŠÖŒW‚ɂ‚¢‚Ä. ò–Ø‹|CŠpN•vC˜Iè‹P•vC¬‹Ê•q‰›C–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, l9(6): 557`564, 1989.

431. mŒ´’˜n ‰EŽº‘¢‰e‚É‚¨‚¯‚é‰ES‹@”\‚Æ‚­‚ɉEŽº‹ìo•ª‰æ‚Ì•]‰¿‚¨‚æ‚Ѷ‰ESŽº‚Ì‘ŠŒÝŠÖŒW. ì–ì—´•FC–ì˜C’‰ŽœC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, l9(6): 565`574, 1989.

432. mŒ´’˜n ‰Æ‘°«‚ƒRƒŒƒXƒeƒ|ƒ‹ŒŒÇƒzƒ‚Ú‡‘̬Ž™‚ÌSŒŒŠÇ•a•Ï. –xŒû‘דTiŽ™jCŽR–{ÍC_’J“N˜Ni‘—§zŠÂŠí•aƒZƒ“ƒ^|j: –k—¢ˆãŠwC19(5): 483`489, 1989.

433. mŒ´’˜n “SŒ‡–R«•nŒŒ‚É‚¨‚¯‚éS‹@”\‚ÌŒŸ“¢. ‚‹´‚Ý‚Ç‚èC˜Iè‹P•vC–Øì“c—²ˆêi“àj: –¬ŠÇŠw, 29(11): 1199`1205, 1989.

434. mŒ´’˜n t“®–¬’¼‰º‚É‚¨‚¯‚é• •”‘å“®–¬ŽÕ’f‚Ìt“àŒŒ—¬•ª•zAt‹@”\‚É‹y‚Ú‚·‰e‹¿‚ÉŠÖ‚·‚錟“¢. ª–{EiŠOj: –¬ŠÇŠw, 29(4): 305`311, 1989.

435. mŒ´’˜n ASO‚ɑ΂·‚錌sÄŒšp‚Ì“K‰žŒˆ’èˆöŽq. ¡ˆäŒ‰C‹à鳉ÀCˆÉ“¡—ÇmCª–{ECˆ¢‘]OˆêiŠOj: –¬ŠÇŠw, 29(Suppl.): 25, 1989.

436. mŒ´’˜n rHUEPO‚ÌzŠÂ“®‘Ô‰ü‘PŒø‰Ê. ŠÛ–Ε¶ºC‚Œ³r•Fi“Œ‹žˆã‰ÈŽ•‰È‘åjC²“¡´‹Mi“àj: —Õ°“§Í, 5(6): 919`928, 1989.

437. mŒ´’˜n Extra Corporeal Circulation Influence on Plasma Atrial Natriuretic Peptide Concentration in Cardiac Surgery Patients. ó—˜G’jC‹ß“¡‡‹`CÎŒ´ºi‹¹ŠOjC‘¼: Chest, 96: 757`760, 1989.

438. m’Z•ñn ƒhƒvƒ‰|ƒJƒe|ƒeƒ‹(DC-101)‚É‚æ‚銥“®–¬ƒoƒCƒpƒXƒOƒ‰ƒtƒg“à‚ÌŒŒ—¬•ªÍ. ”¼’J×YC‰Í‡–õC‹ß“¡‡‹`C¼ŽR´ŒhCÎŒ´ºi‹¹ŠOj: ŠO‰ÈŽ¡—Ã, 60(5): 604`605, 1989.

439. mŒ¤‹†•ñn ‘å“®–¬‰ŠÇŒóŒQ‚ÉŠÖ‚·‚錤‹†•ñGŒz“®–¬ŒŒsÄŒšpŒã”]áŠQ‚ÌŒ´ˆö‚ÉŠÖ‚·‚éŽÀŒ±“IŒŸ“¢. ª–{EiŠOj: _“Þ쌧“Á’莾Š³Ž¡—ÃŒ¤‹†•ñ‘, 1990.

440. mŒ¤‹†•ñi•¶•”Èjn S‹Ø‘¹‚É‚¨‚¯‚鶑̖hŒäŒn‚Ì”½‰ž|S‹Ø[Ç‚Ö‚Ì‘½Œ`Šj”’ŒŒ‹…‚Ì—U“±‚·‚é‘–‰»ˆöŽq‚̘AŠÖ. Ž­ŽæMCŒ´“c–FÆCã–ìWŒ›C쑺“¹ŽqC”n“ˆ³—²C¬“c—²Ž¡i–ò—j: •¶•”ȉȊwŒ¤‹†”ïd“_—̈挤‹†i•½¬Œ³”N“xjS‹Ø×–EáŠQ‚̬ˆö‚Æ–hŒä‚ÉŠÖ‚·‚éŠî‘b“IŒ¤‹†iŒo‰ß•ñj.

441. mŒ¤‹†•ñi‘ãŽÓˆÙ펡—ÃŒ¤‹†Šî‹àjn LTB4‚É‚æ‚鑽Œ`Šj”’ŒŒ‹…ŒŒŠÇŠO—V‘–‚ÆS‹Ø[ÇŠg‘å‚É‚¨‚¯‚é–ðŠ„. Ž­ŽæMi–ò—j: ‘ãŽÓˆÙ펡—ÃŒ¤‹†Šî‹àŒ¤‹†‹ÆÑWCŒŒðÇ‚Ì•a‘Ô‚ÆŽ¡—ÂɊւ·‚鋤“¯Œ¤‹†i‘æ3•ñj, 16: 20`22, 1989.

442. mŒ¤‹†•ñi–k—¢‘åŠw‘‡Œ¤‹†jn S–[«Na—˜”Aƒzƒ‹ƒ‚ƒ“’è—Ê«‚̖ƉuŠw“IŒŸ“¢. ìã³–çi•ª¶j: ‘‡Œ¤‹†•ñ‘¥S–[«Na—˜”Aƒzƒ‹ƒ‚ƒ“‚ÌŠî‘b“IŒ¤‹†‚Æ‚»‚Ì—Õ°“I‰ž—p, p.5`7, 1990.

443. mÇ—á•ñn ’˜‚µ‚¢”x‚¤‚ÁŒŒ‚ð’悵‚½‹}«”xÇðÇ‚Ì2—á. –Øì“c—²ˆêC´…Š®‰xCìŒû’|’jCŠpN•vi“àj: zŠÂ‰ÈŠw, 9(5): 552`558, 1989.

444. mÇ—á•ñn ‚­‚à–Œ‰ºoŒŒ‚É‘±”­‚µ‚½‹}«”x…Žî‚Ì1—á||S‹@”\áŠQ‚ÌŠÖ—^‚ɂ‚¢‚Ä. ²“¡´‹MC‘“c‘ìC¬—Ñ–¾–FC’r“c‘׎qCV’Ã’J^li“àjC‚–ì½CÄ“¡Œ³—Çi”]ŠOjCŒK”ö’èmi•a—jC‘å˜a“c—²i‹~–½jC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, l9(3): 340`345, 1989.

445. mÇ—á•ñn S•s‘S‚𕹔­‚µ, ŽOë•Ù•Â½•s‘S‚ð‡•¹‚µ‚½S–[’†ŠuŒ‡‘¹Ç|S–[’†ŠuŒ‡‘¹‚Ì“ÁŽê•Â½–@‚Æ Polydioxanone ‹zŽû«–D‡Ž…‚É‚æ‚éŽOë•Ù—ÖŒ`¬p‚ðŽŽ‚Ý‚½1—cŽ™—á|. ‚ŽRr­i‹¹ŠOjCŽðˆäÍCŽè’ËŒõ—mC–k‘º¹–çC¬o¹HC‘å‘òŠ²•vi¹—ê•l¼•a‰@j: —Õ°‹¹•”ŠO‰È, 9(3): 301`304, 1989.

446. mÇ—á•ñn ŒŒŠÇ—Ö‚Æ”x‚ŒŒˆ³‚𔺂¤SŽº’†ŠuŒ‡‘¹Ç‚̈êŠú“IŽèpŽ¡Œ±—á. ‚—²½i‹¹ŠOjC‘å‘òŠ²•vC£”ö˜aGC쇖¾•FC¬o¹Hi¹—ê•l¼•a‰@j: —Õ°‹¹•”ŠO‰È, 9(4): 392`395, 1989.

447. m—Õ°Ž¡Œ±n –{‘Ô«‚ŒŒˆ³‚ɑ΂·‚éV‚µ‚¢ƒ¿1ƒuƒƒbƒJ[G‰–Ž_ƒuƒiƒ]ƒVƒ“iƒfƒ^ƒ“ƒg[ƒ‹Rj‚Ì—Õ°“IŒŸ“¢||‚Æ‚­‚É‚P“ú2‰ñ“Š—^‚Ì~ˆ³Œø‰Ê‚¨‚æ‚шÀ‘S«‚É‹y‚Ú‚·‰e‹¿ ||. ‘º¼€C㓈\˜YC씨˜alC’èG•vCˆßìGˆêC•‘ò—˜˜YC²“¡´‹MC‚‹´‚Ý‚Ç‚èC‰“ŽR”ŽC•½¼T‰ECŽO—Ö—SˆêC’†_Œ¹ˆêC¬ã”Ž•¶C”ª“‡—ǘaCŽá—Ñ–õ ‹vC–Øì“c—²ˆêi“àj: Progress in Medicine, 9(7): 2113`2126, 1989.

448. m—Õ°Ž¡Œ±n LC80‚Ì‹•ŒŒ«SŽ¾Š³‚ɑ΂·‚é—Õ°“IŒŸ“¢||‘½Ž{Ý‚É‚¨‚¯‚éƒI[ƒvƒ“ƒgƒ‰ƒCƒAƒ‹||. ‹g—˜˜ai“ú–{Ô\ŽšŽÐˆã—ÃZƒ“ƒ^[jC”Ñ‘ºUiŽD–yˆã‰È‘åjCV’J”Žˆêiº˜a‘åjC‘ –{’zi“Œ‹ž“s˜Vlˆã—ÃZƒ“ƒ^[jC’·“c—m•¶iº˜a‘åjCŽRè¸i•l¼ ˆã‰È‘åjC…–ìNi“¡“cŠw‰€jCŒË“ˆ—T“¿i‹v—¯•Ä‘åjCŽá—щ›iŽD–yzŠÂŠíƒNƒŠƒjƒbƒNjC‰¡ŽR–«iŽD–y‘æˆê•a‰@jCˆÀˆäº“ñiŽRŒ`‘åjC‘º“c˜a•FiŒQ”n ‘åjCדcºˆêiŽ©Ž¡ˆã‰È‘åjCŠÖŽ”üi²–ìŒú¶‘‡•a‰@jC‘ìOˆêi“ú–{ˆã‰È‘åjC”ª”¦_“ñi“ú–{ˆã‰È‘å•t‘®‘½–€‰iŽR•a‰@jC™–{P–¾C–îè‹`—Yi“Œ ‘åjC‰i–ìˆòiŽœŒbˆã‰È‘åjC‘ºŽR³”ŽiŠÖ“Œ’üM•a‰@jC¬oŒjŽOi‘—§‰¤Žq•a‰@jCÎìáÁˆê˜Yi‘—§“Œ‹ž‘æ“ñ•a‰@jC¬‘ò‹»i“Œ‹ž‘Dˆõ•ÛŒ¯•a‰@jCŠÖŒ° iŒÕ‚Ì–å•a‰@jC‘º¼€i–k—¢‘åE“àjC’zŽR‹vˆê˜Yi_“Þ쌧—§‚ª‚ñƒZƒ“ƒ^[jC—ѳ”ŽiŠÖ“Œ˜JЕa‰@jCŠO”¨ŠÞC¬ìGˆêi–¼ŒÃ‰®‘åjC“n•Ó–±iˆ¤’mˆã ‰È‘åjC“s’z‰ëliˆ¤’mŒ§Ï¶‰ï•a‰@jC“à“¡‰Ã”ViŠ ’J‘‡•a‰@jCŽá¼—Ç—²iŒö—§“©¶•a‰@jC‹g“c—íŒÈi’Ó‡Žs–¯•a‰@jC—é–Ø“¹¶i–L‹´Žs–¯•a‰@jC“n •Ó‰À•Fi–¼‰w‘Of—Ê•ÛŒ¯ˆã—ÃZƒ“ƒ^[jC…’JŒbŽŸi–¼é•a‰@jC²XŠ°ŒÈi‘åŠ_Žs–¯•a‰@jCˆÉ’n’mà_•vi‹ž“s•{—§ˆã‰È‘åjC“n•ÓrŒõi‹ž“s•{—§—^ŽÓ‚ÌŠC •a‰@jC—Ž‡³˜ai‹ž“s•{—§—Œ“Œ•a‰@jCŠÖˆê˜Yi‘åãˆã‰È‘åjC—ÑŸi“ú¶•a‰@jCà_“cˆÌ•¶i“ì‘åã•a‰@jCˆäã’Ê•qi‘åã‘åjCŽ™‹Ê˜a‹vi‘åãŒxŽ@•a ‰@jC‰º‘ºŽ˜Ni‘—§zŠÂŠí•aƒZƒ“ƒ^[jCÎŽR‘¾˜Ni‘—§ò–k•a‰@jC•ŸèPi_ŒË‘åjC‰ª–{—ÇŽOi•ºŒÉŒ§—§”Œ´•a‰@jCŒ´‰ªºˆêi‰ªŽR‘åjCŒËŽŸ‹v•q i‘å–´“cŽs—§•a‰@jC‚ŽRˆê¬i–k‹ãB’†‰›•a‰@jC‹´ê–M•i’·è‘åjC•ÐŽR’m”Vi’·èŽs—§Žs–¯•a‰@j: –ò—‚ÆŽ¡—Ã, 17(4): 1689`1711, 1989.

449. m—Õ°Ž¡Œ±n LC°80‚Ì‹·Sǂɑ΂·‚é—Õ°“IŒŸ“¢||‘½Ž{Ý‚É‚¨‚¯‚éƒI[ƒvƒ“ƒgƒ‰ƒCƒAƒ‹||. ‹g—˜˜ai“ú–{Ô\ŽšŽÐˆã—ÃZƒ“ƒ^[jC”Ñ‘ºUiŽD–yˆã‰È‘åjCV’J”Žˆêiº˜a‘åjC‘ –{’zi“Œ‹ž“sˆã—ÃZƒ“ƒ^[jC’·“c—m•¶iº˜a‘åjCŽRè¸i•l¼ˆã‰È ‘åjC…–ìNi“¡“cŠw‰€jCŒË“ˆ—T“¿i‹v—¯•Ä‘åjCŽá—щ›iŽD–yzŠÂŠíƒNƒŠƒjƒbƒNjC‰¡ŽR–«iŽD–y‘æˆê•a‰@jCˆÀˆäº“ñiŽRŒ`‘åjC‘º“c˜a•FiŒQ”n‘åjC דcºˆêiŽ©Ž¡ˆã‰È‘åjCŠÖŽ”üi²–ìŒú¶‘‡•a‰@jC‘ìOˆêi“ú–{ˆã‰È‘åjC”ª”¦_“ñi“ú–{ˆã‰È‘å•t‘®‘½–€‰iŽR•a‰@jC™–{P–¾C–îè‹`—Yi“Œ‘åjC ‰i–ìˆòiŽœŒbˆã‰È‘åjC‘ºŽR³”ŽiŠÖ“Œ’üM•a‰@jC¬oŒjŽOi‘—§‰¤Žq•a‰@jCÎìáÁˆê˜Yi‘—§“Œ‹ž‘æ“ñ•a‰@jC¬‘ò‹»i“Œ‹ž‘Dˆõ•ÛŒ¯•a‰@jCŠÖŒ°iŒÕ‚Ì –å•a‰@jC‘º¼€i–k—¢‘åE“àjC’zŽR‹vˆê˜Yi_“Þ쌧—§‚ª‚ñƒZƒ“ƒ^[jC—ѳ”ŽiŠÖ“Œ˜JЕa‰@jCŠO”¨ŠÞC¬ìGˆêi–¼ŒÃ‰®‘åjC“n•Ó–±iˆ¤’mˆã‰È ‘åjC“s’z‰ëliˆ¤’mŒ§Ï¶‰ï•a‰@jC“à“¡‰Ã”ViŠ ’J‘‡•a‰@jCŽá¼—Ç—²iŒö—§“©¶•a‰@jC‹g“c—íŒÈi’Ó‡Žs–¯•a‰@jC—é–Ø“¹¶i–L‹´Žs–¯•a‰@jC“n•Ó ‰À•Fi–¼‰w‘Of—Ê•ÛŒ¯ˆã—ÃZƒ“ƒ^[jC…’JŒbŽŸi–¼é•a‰@jC²XŠ°ŒÈi‘åŠ_Žs–¯•a‰@jCˆÉ’n’mà_•vi‹ž“s•{—§ˆã‰È‘åjC“n•ÓrŒõi‹ž“s•{—§—^ŽÓ‚ÌŠC•a ‰@jC—Ž‡³˜ai‹ž“s•{—§—Œ“Œ•a‰@jCŠÖˆê˜Yi‘åãˆã‰È‘åjC—ÑŸi“ú¶•a‰@jCà_“cˆÌ•¶i“ì‘åã•a‰@jCˆäã’Ê•qi‘åã‘åjCŽ™‹Ê˜a‹vi‘åãŒxŽ@•a ‰@jC‰º‘ºŽ˜Ni‘—§zŠÂŠí•aƒZƒ“ƒ^[jCÎŽR‘¾˜Ni‘—§ò–k•a‰@jC•ŸèPi_ŒË‘åjC‰ª–{—ÇŽOi•ºŒÉŒ§—§”Œ´•a‰@jCŒ´‰ªºˆêi‰ªŽR‘åjCŒËŽŸ‹v•q i‘å–´“cŽs—§•a‰@jC‚ŽRˆê¬i–k‹ãB’†‰›•a‰@jC‹´ê–M•i’·è‘åjC•ÐŽR’m”Vi’·èŽs—§Žs–¯•a‰@j: –ò—‚ÆŽ¡—Ã, 17(4): 1713`1730, 1989.

450. m‘àn S•s‘S‚Ì—\–hA¶ŠˆŽw“±‚Ì‚ ‚è‚©‚½. ‘º¼€C‰º—¢Œöºi“àj: Medical Practice, 6(6): 959`963, 1989.

451. m‘àn ‚¤‚ÁŒŒ«S•s‘S‚É‚¨‚¯‚é‰ES•s‘S‚̈Ӌ`. –Øì“c—²ˆêi“àj: Medical Practice, 6(7): 1164, 1989.

452. m‘àn SŽ¾Š³‚ÌŒo‰ß’†‚ɶ‚¸‚éˆÙí‚ȸ_”½‰ž. –Øì“c—²ˆêi“àj: Medical Practice, 6(8): 1362, 1989.

453. m‘àn ‹N—§«‚ŒŒˆ³Ç. –Øì“c—²ˆêi“àj: Medical Practice, 7(1): 131, 1990.

454. m‘àn ’ጌˆ³Ç‚ւ̃Aƒvƒ[ƒ`;@1.’ጌˆ³‚Æ‚Í|‚»‚̉uŠwA¬ˆöA•a‘ÔAf’fAŽ¡—Â̌»ó‚È‚Ç. –Øì“c—²ˆêC•½–콈ê˜YC”öŒ`’·—Yi“àj: Medicament News, (1283): 2`7, 1989.

455. m‘àn S•s‘SŽ¡—Öò‚Ì‘I‘ð. ‘º¼€i“àj: Medicina, 26(9): 1442`1443, 1989.

456. m‘àn zŠÂŠí–ò‚ÌŽg‚¢•û. ‘º¼€i“àjC“yŽtˆê•vi‘—§zŠÂŠí•aƒZƒ“ƒ^[jC”ÑÀG”ViS‘ŸŒŒŠÇŒ¤‹†ŠjCŽRŒû“OiŽOˆä‹L”O•a‰@j: Medicina, 26(9): 1561`1576, 1989.

457. m‘àn •Ù–ŒÇ; Ž¾Š³•ÊƒtƒHƒ[‚Ì‚½‚߂̃`ƒFƒbƒNƒŠƒXƒg‚ÆŠ³ŽÒŽw“±‚̃|ƒCƒ“ƒg. ‘º¼€C‘£’qLi“àj: Modern Physician, 9(5): 596`600, 1989.

458. m‘àn ’ጌˆ³. –Øì“c—²ˆêC–ì˜C’‰ŽœC•½–콈ê˜Yi“àj: Modern Physician, 9(5): 619`622, 1989.

459. m‘àn ‚ŒŒˆ³«SŽ¾Š³. –Øì“c—²ˆêC˜Iè‹P•vi“àj: Œ»‘ãˆã—Ã, 21(7): 1915`1920, 1989.

460. m‘àn Š´õ«ánæÒ. ‘º¼€C’·’J쉄LC’r“c‘׎qC¬‚L]i“àj: Œ»‘ãˆã—Ã, 21: 1856`1861, 1989.

461. m‘àn •sˆÀ’è‹·SÇ. ‘º¼€C¬—Ñ–¾–Fi“àj: Ž¡—Ã, 71(12): 2501`2508, 1989.

462. m‘àn –{‘Ô«‚ŒŒˆ³‚É‚¨‚¯‚錌s“®‘Ô‚Æ~ˆ³–ò‚Ì‘I‘ð. ‘º¼€i“àj: Ž¡—Êw, 22(6): 598, 1989.

463. m‘àn S‹Ø‰ŠAS“à–Œ‰ŠAS–Œ‰Š. ‘º¼€i“àj: ‘Ž‡—Õ°, 38(‘): 1197`1201, 1989.

464. m‘àn ‹}«S•s‘Si“ÁW:S‘Ÿ”­ì‚Ì—\–hj. ‘º¼€i“àj: —Õ°¬l•a, 20(1): 55`59, 1990.

465. muÀn “úŒoƒƒfƒBƒNƒCƒYi67Η«A‘O‹¹’É¥”w’Éj. ‘º¼€i“àj: Nikkei Medical, (1989.10.25): 1989.

466. muÀn ‘æˆêü‚̬Ž™zŠÂŠíŠwA‡U.f’fGSƒv[ƒ‹¥S‹ØƒXƒLƒƒƒ“. Έ䟌Èi•új: ¬Ž™‰Èf—Ã, 52(4): 700`710, 1989.

467. mŠwp‘n iŽ·•Mj Blood Flow in the Heart and Large Vessels; Application of Pressure-loss Coefficient, p.105`118, Aortic Stenosis|Blood Flow in the Aorta Measured with a Multisensor Catheter, p.119`123, Aortic Regurgitation| Measurement with a Multisensor Catheter, p.133`138, Pulmonary Regurgitation, p.138`142, The Multisensor Catheter, p.189`195, ”¼’J×Yi‹¹ŠOj. •ÒW Motoaki Sugawarai“Œ—ˆã‘åjCFumihiko Kajiyaiìèˆã‘åjCAkira Kitabatakeiã‘åjCHirohide Matsuoiìˆã‘åj•ÒC Springer-Verlag, 90.06.00”­s.

468. mŠwp‘n iŽ·•Mj Annual ReviewCzŠÂŠí 1990; V¶Ž™Šú‚Ì“®–¬ŠÇC •½Î‘iŽ™j. •ÒW ™–{P–¾C¼–{º•FC™‰º–õ˜YC–åŠÔ˜a•vC•ÒC ’†ŠOˆãŠwŽÐC90.01.10.”­s.

469. mŠwp‘n iŽ·•Mj –ƒŒ¥W’†Ž¡—ÂƃRƒ“ƒsƒ…|ƒ^; ‘̉t¥Ž_‰–Šî•½t‚̃Rƒ“ƒsƒ…|ƒ^ƒ‚ƒfƒ‹Cp.1`16C ’r“cŒ›ºiˆã—pî•ñj. •ÒW “c’†—ºi–ƒj•ÒC Ž½“°o”Å, “Œ‹ž, 89.07.20”­s.

470. mŠwp‘n iŽ·•Mj ŒðŠ´_Œo—}§–ò‚Æ‚ŒŒˆ³ƒnƒ“ƒhƒuƒbƒN; ŒŒs“®‘Ô‚Æ~ˆ³–ò, p.41`52, ˜Iè‹P•vi“àj. •ÒW ‘•{’B˜Yiˆ¤•Q‘åj•Ò, ƒƒfƒBƒJƒ‹ƒrƒ…[ŽÐ, ‘åã, 89.07.31 ”­s.

471. mŠwp‘n iŽ·•Mj Advances in Vascular Pathology 1989 Excepta Medica, International Congress Series 868; Change in Damping Factor of Windkessel System and Cardiovascular Dynamics by Aging in Essential Hypertension, p.913`917, ‘º¼€C’·’J쉄LC¬—Ñ–¾–FC’ËŒ´Œª”VC•½¼T‰EC•‘ò—˜˜YC–Øì“c—²ˆêi“àj. •ÒW Strano, A.CNovo, S.•Ò, Elsevier Science Publisher, B.V., Excerpta Medica, International Congress Series, 89.09.17 ”­s.

472. mŠwp‘n iŽ·•Mj VŽå—v’¥Œó‚©‚ç‚Ý‚½ŒŸ¸‚Ìi‚ß•û; zŠÂŠíŒn’¥Œó|’ጌˆ³, p.58`63, –Øì“c—²ˆêC–ì˜C’‰ŽœC•½–콈ê˜Yi“àj. •ÒW ¼“cdŽOi’é‹ž‘åj•Ò, V‹»ˆãŠwo”Å, “Œ‹ž, 90.01.10 ”­s.

473. mŠwp‘n iŽ·•Mj zŠÂŠí‰Èf’fŽ¡—ÑåŒn; ƒ`ƒAƒm[ƒ[, 3Šª: p.58`60, ˜Iè‹P•vi“àj. •ÒW ŠŒ´’·—Yi“ú‘åjCˆîŠ_‹`–¾iç—t‘åjC™–{P–¾i“Œ‘åjC“¡“‡³•qi‹ã‘åj•Ò, u’kŽÐ, “Œ‹žC89.11.20 ”­s.

474. mŠwp‘n iŽ·•Mj zŠÂŠí‰Èf’fŽ¡—ÑåŒn; ŒÄ‹z¢“ï, 3Šª: p.61`63, ˜Iè‹P•vC¬‚L]i“àj. •ÒW ŠŒ´’·—Yi“ú‘åjCˆîŠ_‹`–¾iç—t‘åjC™–{P–¾i“Œ‘åjC“¡“‡³•qi‹ã‘åj, u’kŽÐ, “Œ‹žC89.11.20 ”­s.

475. mŠwp‘n iŽ·•Mj zŠÂŠí‰Èf’fŽ¡—ÑåŒn; –¬”ˆÙí, 3Šª: p.68`69, ˆÓŽ¯áŠQ, p.70`71, ‘º¼€i“àj. •ÒW ŠŒ´’·—Yi“ú‘åjCˆîŠ_‹`–¾iç—t‘åjC™–{P–¾i“Œ‘åjC“¡“‡³•qi‹ã‘åj•Ò, u’kŽÐ, “Œ‹žC89.11.20 ”­s.

476. mŠwp‘n iŽ·•Mj zŠÂŠí‰Èf’fŽ¡—ÑåŒn; –{‘Ô«’ጌˆ³Ç, 2Šª: p.106`107; ‹N—§«’ጌˆ³ÇCp.108`109,@’˜ŽÒiŠ‘®j–Øì“c—²ˆêi“àj. •ÒW ŠŒ´’·—Yi“ú‘åjCˆîŠ_‹`–¾iç—t‘åjC™–{P–¾i“Œ‘åjC“¡“‡³•qi‹ã‘åj•Ò, u’kŽÐ, “Œ‹žC89.11.20 ”­s.

477. mŠwp‘n iŽ·•Mj ’ጌˆ³Ç‚Ìf’f‚ÆŽ¡—Ã; ’ጌˆ³Ç‚Æ‚»‚Ì–â‘è“_, p.12`37,@ –Øì“c—²ˆêi“àj. ƒƒfƒBƒJƒ‹ƒgƒŠƒrƒ…[ƒ“ŽÐ, “Œ‹žC90.02.28”­s.

478. mŠwp‘n iŽ·•Mj ’ጌˆ³Ç‚Ìf’f‚ÆŽ¡—Ã; ŒŒs—ÍŠw“IˆöŽq‚©‚ç‚Ý‚½’ጌˆ³Ç, p.38`47,@ –ì˜C’‰Žœi“àj. ƒƒfƒBƒJƒ‹ƒgƒŠƒrƒ…[ƒ“ŽÐ, “Œ‹žC90.02.28”­s.

479. mŠwp‘n iŽ·•Mj Progress in Atrial Peptide Research (ASH Symposium Series Vol. 3); Molecular Forms of Immunoreactive ANP in Human Plasma and Urine, p.223`225, ˆÀ“¡Œ¤ŽiCKihira, K.i–k—¢ƒ‰ƒ{jC‰Á“¡—zˆêi“àjC‘“c‘ìi‹~–½jC•‘ò—˜˜Yi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj. •ÒW Barry M. Brenner•Ò, Raven Press, New York, 89.00.00”­s.

480. mŠwp‘n iŽ·•Mj Progress in Atrial Peptide Research (ASH Symposium Series Vol. 3); Plasma Atrial Natriuretic Peptide Level and Molecular Forms in Dogs with Acute Heart Failure Induced by Experimenatal Aortic Regurgitation, p.445`447, ‘“c‘ìi‹~–½jC²“¡´‹Mi“àjC^è‹`•FiŽÀ“®ŒnjCAndo, K.i–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj. •ÒW Barry M. Brenner•Ò, Raven Press, New York, 89.00.00”­s.

481. mŠwp‘n iŽ·•Mj Progress in Atrial Peptide Research (ASH Symposium Series Vol. 3); Plasma Atrial Natriuretic Peptide Level and Molecular Forms in Dogs with Acute Heart Failure Produced by Experimenatal Mitral Regargitation, p.447`449, ²“¡´‹Mi“àjC‘“c‘ìi‹~–½jC^è‹`•FiŽÀ“®ŒnjCAndo, K.i–k—¢ƒ‰ƒ{jC’·’J쉄LC–Øì“c—²ˆêi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj. •ÒW Barry M. Brenner•Ò, Raven Press, New York, 89.00.00”­s.

482. mŠwp‘n iŽ·•Mj Progress in Atrial Peptide Research (ASH Symposium Series Vol. 3); Change of Molecular Forms of Atrial Natriuretic Peptide in Treated Congestive Heart Failure, p.501`503,@ •‘ò—˜˜YC’|“c’è¶C’·’J쉄Li“àjCAndo, K.i–k—¢ƒ‰ƒ{jC–Øì“c—²ˆêi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj. •ÒW Barry M. Brenner•Ò, Raven Press, New York, 89.00.00”­s.

483. mŠwp‘n iŽ·•Mj ¡“ú‚ÌŽ¡—âS‘Ÿ¥ŒŒŠÇ‚Ì‹~‹}£; ŒŒˆ³ˆÙí, p.115`132, –Øì“c—²ˆêC˜Iè‹P•vi“àj. •ÒW ðSˆêi“Œ—ˆã‘åj, ‰iˆä‘“X, “Œ‹ž, 88.04.15”­s.

484. mŠwp‘n iŽ·•Mj ¡“ú‚ÌŽY•wl‰ÈŽ¡—ÃŽwj; ƒmƒ“ƒXƒgƒŒƒXƒeƒXƒg (NST), p.251`252, ¼“‡³”ŽiŽY•wj. •ÒW ¬–쳕Fi“Œ‘åjC•“c‰À•Fi“Œ—ˆã‘åj•Ò, ˆãŠw‘‰@, “Œ‹ž, 89.06.01 ”­s.

485. mŠwp‘n iŽ·•Mj VŠO‰ÈŠw‘åŒnA‘æ13Šªi‹~‹}ŠO‰Èj; ––½ŒŒŠÇŠO‰È—̈æ, 13: 271`283, ª–{EiŠOj. •ÒW oŒŽN•vi“Œ‘åjC‘¼•ÒC ’†ŽR‘“X, “Œ‹ž, 89.12.28”­s.

486. m‹³‰È‘n iŽ·•Mj V—Õ°ŠO‰ÈŠw; ¬Ž™ŠO‰ÈA• •Ç|‘lŒaƒwƒ‹ƒjƒAA’â—¯áΊÛAÒ‘‘–ŒáŽAPilonidal SinusAŒ‹‡‘ÌAŽvtŠú‘O•Ð‘¤«“û‘B”ì‘å, p.790`798, Γc˜a•viŠOj. •ÒW X‰ª‹±•Fi“Œ‘åjC‘¼•ÒC ˆãŠw‘‰@, “Œ‹ž, 90.02.00”­s.

487. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj ƒTƒNƒZƒX¥ˆãŽt‘‰ÆŽŽŒ±—Õ°ŽÀ’n–â‘èW; ¬—Ñ–¾–Fi“àj. •ÒW ²“¡“oŽu˜Yi–k—¢‘åj•ÒC “ú–{ˆãŽ–V•ñŽÐ,@“Œ‹ž,@89.11.15 ”­s.

488. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj 1990; æ“V«SŽ¾Š³, p.322`324, ‘º¼€i“àj. •ÒW ˆîŠ_‹`–¾iç—t‘åj‘¼•Ò, ˆãŠw‘‰@,@“Œ‹ž,@90.02.15 ”­s.

489. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj }‚Å‚Ý‚ézŠÂ“®‘Ô; ‘̈ÊC‰^“®‚Ì‚à‚½‚ç‚·zŠÂ“®‘Ô, p.26`29, ‘º¼€i“àj. ƒƒWƒJƒ‹ƒrƒ…[ŽÐ,@“Œ‹ž,@90.03.20 ”­s.

490. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn iŠÄCj V‰SŽÒ‚Ì‚½‚ß‚ÌS“d}‚Ì‚æ‚Ý‚©‚½; ‘º¼€C’·’J쉄Li“àj. V‹»ˆãŠwo”Å,@“Œ‹ž,@89.10.20 ”­s.

491. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn iŽ·•Mj S“d}ƒ}ƒjƒ…ƒAƒ‹; S“d}”gŒ`‚©‚ç‚Ìf’f, p.42`80, ‘º¼€C’ËŒ´Œª”VCˆÀ’B¥ºi“àj. •ÒW ‘ìOˆêi“úˆã‘åj•Ò, Æ—ÑŽÐ,@“Œ‹ž,@89.12.20 ”­s.

492. m–|–ón iŽ·•Mj zŠÂ‚̶—; p.1`362, ‘º¼€C–ÎÝȈêC‰Á“¡—zˆêCX‹vPC‚’¹°sC㓈\˜YC’·’J쉄LCdL¢‹IŽqC•ìMŒåC¬—Ñ–¾–FC–î’[K•vC씨˜alC‹g“càˆi“àj. ŠÄC ‘º¼€i–k—¢‘åE“àj, ˆãŠw‘‰@,“Œ‹ž, 89.04.01 ”­s.

493. mŠw‰ïn i“Á•Êu‰‰j S‘Ÿ“Ë‘RŽ€‚Æ‘Îô. ‘º¼€i“àj: ‘æ31‰ñ_“Þ쌧ˆãŠw‰ï‘‰ïŠwp‘å‰ï (89.11.23), ‰¡•l.

494. mŠw‰ïn i‹³ˆçu‰‰j S””‚Ì’²ß. ¼“‡³”ŽiŽY•wj: ‘æ25‰ñV¶Ž™Šw‰ï (89.07.02), “Œ‹ž.

495. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j SŽ¾Š³‚ðl‚¦‚é; ‹~–½‹~‹}‚Ì—§ê‚Å. ¬—Ñ–¾–Fi“àj: ‘æ5‰ñ_“Þì•úŽËüŠwp‘å‰ï (89.06.11), ‰¡•l.

496. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Fluid Dynamical Mechanism of Anacrotic Notch in Great Arteries. ‹ß“¡‡‹`C”¼’J×YCÎŒ´ºi‹¹ŠOjC‘¼: 2nd International Symposium on Biofluid Mechanics and Biorheology (89.06.27), Munich.

497. mŠw‰ïn iƒVƒ“ƒzƒWƒEƒ€j Transitional circulation in newborn infant. •½Î‘iŽ™j: ‘æ25‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï (89.07.07), ‹v—¯•Ä, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 5: 39, l989.

498. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j dǃNƒ‚–Œ‰ºoŒŒ‚É•¹”­‚·‚éSzŠÂ‡•¹Ç‚Ì‹}«ŠúŠÇ—‚Ìd—v«. ¬—Ñ–¾–Fi“àjC–kŒ´F—YC‰““¡¹FC‘å˜a“c—²i‹~–½j: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.29), ·‰ª.

499. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j DOCA°H‰–‚ŒŒˆ³ƒ‰ƒbƒg‚̉ŠúŒŒˆ³‘‰Á‚ɑ΂·‚é“àˆö«ƒJƒŠƒNƒŒƒCƒ“°ƒLƒjƒ“Œn‚ÌŠÖ—^. ”n“ˆ³—²i–ò—jC‰Ô’ËŒõ’jCaãiCŽ­ŽæMi–ò—jC‘åÎKŽqi–òŠw•”j: ‘æ63‰ñ“ú–{–ò—Šw‰ï‘‰ï (90.03.25-28), “Œ‹žC Jpn. J. Pharmacol., 52(suppl.): 138, 1990.

500. mŠw‰ïn iƒpƒlƒ‹j ’PSŽºC¶‘¤–[Žº•Ù•Â½C“®–¬ŠÇŠJ‘¶C—LˆÓ‚ÈS–[ŠÔŒð’Ê‚ð”F‚ß‚È‚¢•¡‡SŠïŒ`2Ç—á‚ÌSŒŒs“®‘Ô‚Ì•]‰¿‚É‚¨‚¯‚éƒhƒvƒ‰SƒGƒR|–@‚̈Ӌ`. ‰Í‘º½ŽŸC•½Î‘C–xŒû‘דTC“¡–ìé”VC¬ŒûO‹BCˆäŒ…^—R”üC”ª‘ãŒö•viŽ™jC’†]¢–¾C¡ˆäŠ°C“c’†Ž•FC•x‰i½ˆêi‹¹ŠOj: ‘æ25‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï (89.07.06), ‹v—¯•Ä, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 5(1): 94, l989.

501. mŠw‰ïn iƒpƒlƒ‹j Pulmonary Edema Following Subarachnoid Hemorrhage|Evidence for a Cardiogenic Factor|. ¬—Ñ–¾–FC’r“c‘׎qC‰¬Œ´“ÄC–Øì“c—²ˆêi“àjC™–{Ÿ•FC–kŒ´F—YC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: 5th World Congress on Intensive and Critical Care Medicine (89.09.07), ‹ž“s, WCICCM Abstracts, p.269, 1989.

502. mŠw‰ïn iƒpƒlƒ‹j Change of Molecular Form of Atrial Natriuretic Peptide (ANP). •‘ò—˜˜YC’·’J쉄LC’|“c’è¶C•½¼T‰EC²“¡´‹MC‘º¼€C–Øì“c—²ˆêi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: 15th World CongressCInternational Union of Angiology (89.09.17), ƒ[ƒ}, Abstracts, p.256, 1989.

503. mŠw‰ïn iƒpƒlƒ‹j Vasodilator Therapy for Right Ventricular Failure of Acute Myocardial Infarction. •½¼T‰EC¬—Ñ–¾–FC’·’J쉄LC‘º¼€C–Øì“c—²ˆêi“àj: 15th World CongressCInternational Union of Angiology (89.09.17), ƒ[ƒ}, Abstracts, p.287, 1989.

504. mŠw‰ïn iƒpƒlƒ‹j “™—e«SŽûkŠú‚É‚¨‚¯‚é‘m–X•Ù‹t—¬‚Ìf’fŠw“I“ÁˆÙ«‚ɂ‚¢‚Ä. ’ËŒ´Œª”VC‘º¼€C‘£’qLC™ŽRŠx•FC¬—Ñ–¾–FC’·’J쉄LC–Øì“c—²ˆêi“àj: ‘æ37‰ñ“ú–{S‘Ÿ•aŠw‰ï (89.10.30), ‹ž“s, ‘æ37‰ñ“ú–{S‘Ÿ•aŠw‰ï—\eW, p.57, 1989.

505. mŠw‰ïn iƒpƒlƒ‹j ‰EŽº[Ç‚ÉŠÖ‚·‚é•a—Šw“IŒ¤‹†. ŒK”ö’èmi•a—jC²“¡giŒ`‘ÔŒnjC‹T’J“Oi•a—jCV’Ã’J^li“àj: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.29), •Ÿ‰ª, “ú–{•a—Šw‰ï‰ïŽ, 79(1): 360, 1990.

506. mŠw‰ïn iˆê”Êu‰‰j 4‰ñ‚ÌlH•Ù’uŠ·p‚ðs‚Á‚½1Ç—áD ‚—²½C•—ŠÔ”ÉC¼ŒûŽ•FC‰€“c˜a•FC“‡“cŒúCÎŒ´ºCi‹¹ŠOj: ‘æ70‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ïC “Œ‹ž.

507. mŠw‰ïn iˆê”Êu‰‰j A Study on Flow Control in a Piston-Bellows Type of Artificial Heart Pump. ‹´–{¬Li¶‘ÌHjCù“c’¼i“ŒH‘åjC”nŸº´Ž‘i¶‘ÌHjCˆÉ“¡’‰OCÎŒ´ºi‹¹ŠOj: 27th Annual Meeting of the American Society for Artificial Internal Organs (81.05.06`08), AnaheimC Abstracts, 10: 5, 1981.

508. mŠw‰ïn iˆê”Êu‰‰j Œ¢‚É‚¨‚¯‚élHS‘Ÿ‚Ì—¬—Ê”gŒ`‚Æ—¬—ʧŒä. ˆÉ“¡’‰Oi‹¹ŠOjC‹´–{¬LC”nŸº´Ž‘CX“c^Žji¶‘ÌHjC¡•ª–ÎCÎŒ´ºi‹¹ŠOjCˆÀ‹vˆäLÍCù“c’¼i“ŒH‘åj: ‘æ19‰ñ“ú–{lH‘ŸŠíŠw‰ï‘å‰ï (81.11.18), ‹à‘ò, —\eW, p.159, 1981.

509. mŠw‰ïn iˆê”Êu‰‰j ƒsƒXƒgƒ“¥ƒxƒ|ƒYŒ^lHS‘Ÿ‚Ì—¬—Ê”gŒ`. ‹´–{¬LC”nŸº´Ž‘i¶‘ÌHjCˆÉ“¡’‰Oi‹¹ŠOjCX“c^Žji¶‘ÌHjC¡•ª–ÎCÎŒ´ºi‹¹ŠOjCˆÀ‹vˆäLÍCù“c’¼i“ŒH‘åj: ‘æ19‰ñ“ú–{lH‘ŸŠíŠw‰ï‘å‰ï (81.11.18), ‹à‘òC —\eW, p.160, 1981.

510. mŠw‰ïn iˆê”Êu‰‰j Practical Application of the Welded Metal Bellows to a Pulsatile Pump. ‹´–{¬LC”nŸº´Ž‘i¶‘ÌHjCˆÉ“¡’‰OCÎŒ´ºi‹¹ŠOjCù“c’¼i“ŒH‘åj: 28th Meeting of the American Society for Artificial Internal Organs (82.04.14`15), ChicagoC Abstracts, 11: 4, 1982.

511. mŠw‰ïn iˆê”Êu‰‰j ‘ÏŒŒŠÇ•ÇCollapse«‚ðl—¶‚µ‚½”“®—¬ƒ|ƒ“ƒv‚ÌÖ¬ƒJƒjƒ…|ƒŒ“üŒûŒ`ó. ‹´–{¬Li¶‘ÌHjCˆÉ“¡’‰OCŽç‰®“llC–ö‘òG–¾CÎŒ´ºi‹¹ŠOjCX“c^ŽjC”nŸº´Ž‘i¶‘ÌHjCˆÀ‹vˆäLÍCù“c’¼i“ŒH‘åj: ‘æ20‰ñ“ú–{lH‘ŸŠíŠw‰ï‘å‰ï (82.09.14), “Œ‹žC —\eW, p.100, 1982.

512. mŠw‰ïn iˆê”Êu‰‰j A Newly Designed Cannula Entrance in Pulsatile Pump|With Special Consideration about Venous Wall Collapse. ‹´–{¬Li¶‘ÌHjCˆÉ“¡’‰OCÎŒ´ºi‹¹ŠOjCˆÀ‹vˆäLÍCù“c’¼i“ŒH‘åj: 29th Annual Meeting of the American Society for Artificial Internal Organs (83.04.28`30), Toronto, Abstracts, 12: 5, 1983.

513. mŠw‰ïn iˆê”Êu‰‰j ‰ESƒoƒCƒpƒXŽž‚Ì—¬—Ê”gŒ`‚Ì”x‚ւ̉e‹¿. Žç‰®“llCˆÉ“¡’‰OCÎŒ´ºi‹¹ŠOjC‹´–{¬LC”nŸº´Ž‘Ci¶‘ÌHjCù“c’¼C‘O“c_‹`i“ŒH‘åj: ‘æ21‰ñ“ú–{lH‘ŸŠíŠw‰ï‘å‰ï (83.09.14), ŽD–y, —\eW, p.26, 1983.

514. mŠw‰ïn iˆê”Êu‰‰j lHS‘Ÿ‚ÌŒŒðŒ`¬‚ɑ΂·‚邹‚ñ’f‘¬“x‚̉e‹¿. ‹´–{¬Li¶‘ÌHjCŽç‰®“llCÎŒ´ºi‹¹ŠOjCù“c’¼i“ŒH‘åj: ‘æ36‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ï‘‰ï (83.11.12), ‹ž“sC “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ, 31(—Õ‘): 1852, 1983.

515. mŠw‰ïn iˆê”Êu‰‰j The Effect of Right Ventricular Bypass on the Intrapulmonary shunt: A Comparison of Pulsetile and Nonpulsatile Flows. ‹´–{¬Li¶‘ÌHjCŽç‰®“llCÎŒ´ºi‹¹ŠOjC”nŸº´Ž‘i¶‘ÌHjC—é–Ø”ŽŽqiˆãŠw‰ÈjC•½ˆä–@”Ži“àjC‘O“c_‹`Cù“c’¼i“ŒH‘åj: 4th Congress of the International Society for Artificial Organs (83.11.16), ‹ž“sC Artificial Oragans, 7(Abstracts): 7, 1983.

516. mŠw‰ïn iˆê”Êu‰‰j ‰“Sƒ|ƒ“ƒv‚É‚¨‚¯‚é—nŒŒ. ‹´–{¬Li¶‘ÌHjCó—˜G’jC¼ŽR“¿‘åCÎŒ´ºi‹¹ŠOjC”nŸº´Ž‘i¶‘ÌHjC—é–Ø”ŽŽqiˆãŠw‰ÈjC•½ˆä–@”Ži“àjC•ŽR½Ž÷C™‰Y—f‰îCù“c’¼i“ŒH ‘åj: ‘æ22‰ñ“ú–{lH‘ŸŠíŠw‰ï‘å‰ï (84.11.09), ‘åãC —\eW, p.36, 1984.

517. mŠw‰ïn iˆê”Êu‰‰j Plasma Atrial Natriuretic Peptide (ANP) Level and Molecular Forms in Canines with Heart Failure Induced by Experimental Aortic Regurgitation (AR). ‘“c‘ìi‹~–½jC²“¡´—²i“àjC^è‹`•FiŽÀ“®ŒnjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: 3rd American Society of Hypertension (88.00.00), New York, Am. J. Hypertension, 1(3): 131`132, 1988.

518. mŠw‰ïn iˆê”Êu‰‰j ‰Â‹t“I‘å“®–¬•Ù‹t—¬‚É‚¨‚¯‚錌’†ANP“®‘Ô‚Æ‘¶Ý—lŽ®. ‘“c‘ìi‹~–½jC²“¡´‹Mi“àjC^è‹`•FiŽÀ“®ŒnjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{j: ‘æ65‰ñ“ú–{¶—Šw‰ï‘å‰ï (88.04.04), ˜a‰ÌŽR.

519. mŠw‰ïn iˆê”Êu‰‰j CARDIOLOGIST; A CAI System for Heart Failure Based on Simulation of Cardiovascular System. ’ß“c—z˜aC’|“ດŽC’r“cŒ›ºiˆã—pî•ñjC²“¡“oŽu˜Yi¶—j: 6th World Congress of Medical Informatics (89.02.11), Singapore.

520. mŠw‰ïn iˆê”Êu‰‰j –«t•s‘S‚Ì‚ŒŒˆ³‡•¹—á‚Æ”ñ‡•¹—á‚É‚¨‚¯‚铧͑OŒã‚Ì“™ŽÚ«•‰‰×‚É‚æ‚锽‰ž«‚Ì·ˆÙ‚ɂ‚¢‚Ä. ”ª“‡—ǘaC’ËŒ´Œª”VC‘£’qLC–ÎÝȈêC‘º¼€C–Øì“c—²ˆêi“àj: ‘æ86‰ñ“ú–{“à‰ÈŠw‰ï (89.04.01), ‹ž“s, “ú–{“à‰ÈŠw‰ïŽGŽ, 78(2): 232, 1989.

521. mŠw‰ïn iˆê”Êu‰‰j ŠeŽíSŽ¾Š³‚ÆS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh(ANP)‚ÌŠÖŒW‚ɂ‚¢‚Ä. ’·’J쉄LC•‘ò—˜˜YC²“¡´‹MC™ŽRŠx•FC‘º¼€C–Øì“c—²ˆêi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: ‘æ86‰ñ“ú–{“à‰ÈŠw‰ï (89.04.02), ‹ž“s, “ú–{“à‰ÈŠw‰ïŽGŽ, 78(2): 263, 1989.

522. mŠw‰ïn iˆê”Êu‰‰j The Role of Specific Granules in Ventricles on Atrial Natriuretic Peptide (ANP) Secretion in Acute Heart Failure. ²“¡´‹Mi“àjC‘“c‘ìi‹~–½jCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC’·’J쉄LC˜Iè‹P•vi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjC–Øì“c—²ˆêi“àj: 3rd International Conference on Diuretics (89.04.04), Mexico, —\eW, p.615`617, 1989.

523. mŠw‰ïn iˆê”Êu‰‰j RISƒv[ƒ‹ƒf[ƒ^‚̈ʑŠ‰ðÍ‚É‚æ‚éŠO«S‹ØÁ‚ÌŒŸ“¢. ¼Šª”ŽC’r“crºC“cŠŽŒÈC–x’rdŽ¡C’†‘òŒ\Ž¡CΈ䟌ÈC¼—Ñ—²i•újC¬—Ñ–¾–Fi“àj: ‘æ48‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï (89.04.05), _ŒËC “ú–{ˆãŠw•úŽËüŠw‰ïŽ¥‘æ48‰ñ´˜^WC49(—Õ‘): 595, l989.

524. mŠw‰ïn iˆê”Êu‰‰j Beta-atrial Natriuretic Polypeptide (Beta-ANP) Like Immunoreactivity in Canine Plasma. ²“¡´‹Mi“àjC‘“c‘ìi‹~–½jC^è‹`•FiŽÀ“®ŒnjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC’·’J쉄LC–Øì“c—²ˆêi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: ‘æ66‰ñ“ú–{¶—Šw‰ï (89.04.06), ‰ªŽRC Jpn. J. Physiol., 39(Suppl.): s218, 1989.

525. mŠw‰ïn iˆê”Êu‰‰j Hemodynamic Alteration by Recombinant Human Erythropoietin Administration in Hemodialyzed Patient with Normal Cardiac Function. ‚Œ³r•FCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjC²“¡´‹Mi“àjC‘“c‘ìi‹~–½j: 4th American Society of Hypertension (89.05.10), New York, Am. J. Hypertension, 2(5): 79A, 1989.

526. mŠw‰ïn iˆê”Êu‰‰j Beta-human Atrial Natriuretic Peptide (ANP) in Congestive Heart Failure (CHP). ˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC²“¡´‹Mi“àjCMasayoshi ShichiriCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: 4th American Society of Hypertension (89.05.11), New York, Am. J. Hyopertension, 2(5): 98A, 1989.

527. mŠw‰ïn iˆê”Êu‰‰j The Role of Specific Granules in Ventriculus on Atrial Natriuretic Peptide (ANP) Secretion in Acute Heart Failure. ²“¡´‹Mi“àjC‘“c‘ìi‹~–½jCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC’·’J쉄Li“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjC–Øì“c—²ˆêi“àj: 4th American Society of Hypertension (89.05.11), New York, Am. J. Hypertension, 2(5): 79A, 1989.

528. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g’f‘w–@‚É‚æ‚éŽíX‚Ìæ“V«SŽ¾Š³‚ɇ•¹‚·‚é“®–¬ŠÇ‚Ì•`o–@|’f–ʂ̊»‚Æ‚»‚̑Ó–«|. •½Î‘C–xŒû‘דTC“¡–ìé”VCãp—z‘¾˜YCÄ“¡KˆêC¬ŒûO‹BC”ª‘ãŒö•viŽ™j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.19), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(3): 534Cl989.

529. mŠw‰ïn iˆê”Êu‰‰j ŽhŒƒ“`“±˜H‚Ì•Ï’²‚ÉŠî‚­–[ŽºƒuƒƒbƒN‚Ì”Šwƒ‚ƒfƒ‹. ’r“cŒ›ºC’ß“c—z˜aC‹{Œ´‰p•vC’|“ດŽiˆã—pî•ñjC—ŠZF“ñi“àjC”’‘é‘’jiˆã—pî•ñjC²“¡“oŽu˜Yi¶—j: ‘æ28‰ñ“ú–{MEŠw‰ï‘å‰ï (89.05.24), ‘åãC ˆã—p“dŽq‚ƶ‘ÌHŠwC27(“Á•Ê): 334, 1989.

530. mŠw‰ïn iˆê”Êu‰‰j ‰Â‹t“I‘å“®–¬•Ù‹t—¬‚ÌANP•ª”å‚É‚¨‚¯‚éSŽº‚ÌŠÖ—^. ²“¡´‹MC¬‚L]C•‘ò—˜˜YC’·’J쉄LC–Øì“c—²ˆêi“àjC‘“c‘ìi‹~–½jCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ï (89.06.01), “Œ‹žC “ú–{“à•ª”åŠw‰ïŠwp‘‰ï´˜^W, 65(4): 254, 1989.

531. mŠw‰ïn iˆê”Êu‰‰j ‰^“®•‰‰×‚É‚¨‚¯‚éS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh(ANP)‚ÌŒŒ’†“®‘Ô. ¬‚L]C²“¡´‹MC•‘ò—˜˜YCˆ¢•”éC’|“c’è¶C•ìMŒåC’·’J쉄LC–Øì“c—²ˆêi“àjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ï (89.06.01), “Œ‹žC “ú–{“à•ª”åŠw‰ïŠwp‘‰ï´˜^W, 65(4): 255, 1989.

532. mŠw‰ïn iˆê”Êu‰‰j –UŒŸS‚É‚¨‚¯‚éS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh‚Ì‹ÇÝ‚Æ•Ï“®. V’Ã’J^li“àjCŒK”ö’èmC‹T’J“Oi•a—jC‘“c‘ìi‹~–½jC’J²]Žqi“àjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{j: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ï (89.06.03), “Œ‹ž, “ú–{“à•ª”åŠw‰ïŠwp‘‰ï´˜^W, 65(4): 411, 1989.

533. mŠw‰ïn iˆê”Êu‰‰j S‘Ÿ•Ù–ŒÇ‚¨‚æ‚ÑŠg’£Œ^S‹ØÇ‚ÌTreadmill‰^“®ŽŽŒ±‚ɑ΂·‚éST’ቺ‚Ì‹•ŒŒ«SŽ¾Š³‚Æ‚Ì·ˆÙ. –kŠp”Ž“¹C´…Š®‰xCìŒû’|’jCVȈê•vC‰Í–쓹¢Cì–ì—´•FC–ì˜C’‰ŽœC˜Iè‹P•vC–Øì“c—²ˆêi“àj: ‘æ132‰ñ“ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (89.06.04), ‰¡•l.

534. mŠw‰ïn iˆê”Êu‰‰j ‹}«S‹Ø[ǂɇ•¹‚µ‚½¶ŽºŽ©—R•Ç”j—ô‚ÌŒŸ“¢. Îì’¼Ž÷C¬—Ñ–¾–FC‰¬Œ´“ÄC¬‚L]C‰º—¢ŒöºCV’Ã’J^lC’r“c‘׎qC–Øì“c—²ˆêi“àjC¼ŽR´Œhi‹¹ŠOjCŒK”ö’èmi•a—j: ‘æ16‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï (89.06.08), ˆ®ì, ICU‚ÆCCU, 13(—Õ‘): 125, 1989.

535. mŠw‰ïn iˆê”Êu‰‰j ‹}«S‹Ø[ǂɇ•¹‚µ‚½SŽº’†ŠuúE‚ÌŒŸ“¢. ‰¬Œ´“ÄC¬—Ñ–¾–FCÎì’¼Ž÷C‰º—¢ŒöºC¬‚L]C’r“c‘׎qCV’Ã’J^lC–Øì“c—²ˆêi“àjC¼ŽR´Œhi‹¹ŠOjCŒK”ö’èmi•a—j: ‘æ16‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï (89.06.08), ˆ®ì, ICU‚ÆCCU, 13(—Õ‘): 81, 1989.

536. mŠw‰ïn iˆê”Êu‰‰j FontanŒ^ŽèppŒã‚Ì”x“®–¬‹t—¬(PR)‚Ì•ªÍ. ‰Í‡–õCéŠÔŒ«“ñC{–K‘ i“Œ—ˆã‘åjC”¼’J×Yi‹¹ŠOj: ‘æ19‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwpW‰ï (89.06.08), ŽD–y, ´˜^W, p.98, 1989.

537. mŠw‰ïn iˆê”Êu‰‰j Vitamin E ‚ÌS‹Ø•ÛŒìŒø‰Ê‚ÌŒŸ“¢. •—ŠÔ”ÉC¼ŽR´ŒhC“ü‘ò²mC¼ŒûŽ•FC‚ŽR­rCˆ¢•””\–¾C’¬“c³lC‹ß“¡‡‹`C‚—²½CÎŒ´ºi‹¹ŠOj: ‘æ19‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwpW‰ï (89.06.08), ŽD–y, “ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŽGŽ, 19(3): 536`538, 1989.

538. mŠw‰ïn iˆê”Êu‰‰j ‘å“®–¬•Ù’uŠ·Ç—á‚É‚¨‚¯‚銥“®–¬ŒŒ—¬•ªÍ. ”¼’J×Yi‹¹ŠOjC‘¼: ‘æ19‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwpW‰ï (89.06.08), ŽD–y, “ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŽGŽ, 19(4): 765`767, 1989.

539. mŠw‰ïn iˆê”Êu‰‰j ‚­‚à–Œ‰ºoŒŒ‹}«Šú‚É‚¨‚¯‚éSzŠÂ“®‘Ô‚Æ_ŒoŒ´«”x…Žî‚ÌŒŸ“¢. ²“¡´‹MC¬—Ñ–¾–FC¬‚L]C’r“c‘׎qC’·’J쉄LC‘º¼€C–Øì“c—²ˆêi“àjC‘å˜a“c—²i‹~–½j: ‘æ16‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï (89.06.09), ˆ®ì, ICU‚ÆCCU, 13(—Õ‘): 243, 1989.

540. mŠw‰ïn iˆê”Êu‰‰j dÇ‚ŒŒˆ³‚É‚¨‚¯‚éƒJƒvƒgƒvƒŠƒ‹––㉺“Š—^‚É‚æ‚錌s—ÍŠw“I•Ï‰»‚Æ—Õ°“I—L—p«‚ɂ‚¢‚Ä. ‘£’qLC’ËŒ´Œª”VC¬ã”Ž•¶C”ª“‡—ǘaCŽá—Ñ–õ‹vCˆÀ’B¥ºC‘º¼€C–Øì“c—²ˆêi“àj: ‘æ16‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï (89.06.09), ˆ®ì, ICU‚ÆCCU, 13(—Õ‘): 248, 1989.

541. mŠw‰ïn iˆê”Êu‰‰j ƒhƒbƒvƒ‰ƒJƒe|ƒeƒ‹‚É‚æ‚銥“®–¬ƒoƒCƒpƒXƒOƒ‰ƒtƒg“àŒŒ—¬•ªÍ|“Á‚ÉSVG‚ÆIMAG‚Æ‚Ì”äŠrŒŸ“¢|. Žç‰®“llCˆ¢•”–«—Yi–¼ŒÃ‰®‘åjC”¼’J×Yi‹¹ŠOjC‘¼: ‘æ19‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwpW‰ï (89.06.09), ŽD–y, ´˜^W, p.230, 1989.

542. mŠw‰ïn iˆê”Êu‰‰j “ñ‘w‚Ì‹Uo‚𶂶‚½‰ð—£«‘å“®–¬áŽ‚Ì1—á. Žl‹{—R”üŽqCÎì’¼Ž÷C’r“c‘׎qCìŒû’|’jC’·’J쉄LCV’Ã’J^lC‘º¼€C–Øì“c—²ˆêi“àjCŒK”ö’èmi•a—j: ‘æ383‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.06.10), “Œ‹ž.

543. mŠw‰ïn iˆê”Êu‰‰j Œü¸_–ò‚ÌSzŠÂŒn‚É‹y‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä. Ί_“¿]i“àjC’ç–M•FC“c’†•üŽqC™ŽRŒ’–çCŠp“c’厡C™ŽRˆêCŽO‰Y’å‘¥i¸jC¬—Ñ–¾–FCL£—²ˆêC“¡–ìé”VC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ16‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï (89.06.10), ˆ®ì, ICU‚ÆCCU, 13(—Õ‘): 276, 1989.

544. mŠw‰ïn iˆê”Êu‰‰j S‘Ÿ•Ù–ŒÇ‚¨‚æ‚ÑŠg’£Œ^S‹ØÇ‚ÌTreadmill‰^“®ŽŽŒ±‚ɑ΂·‚éST’ቺ‚Ì‹•ŒŒ«SŽ¾Š³‚Æ‚Ì·ˆÙ. –kŠp”Ž“¹C´…Š®‰xCìŒû’|’jCVȈê•vC‰Í–쓹¢Cì–ì—´•FC–ì˜C’‰ŽœC˜Iè‹P•vC–Øì“c—²ˆêi“àj: “ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï‘æ132‰ñ—á‰ï (89.06.17), _“Þì.

545. mŠw‰ïn iˆê”Êu‰‰j Fontani‰E–[°”x“®–¬’¼Ú•«‡jpŒã”x“®–¬“àŒŒ—¬•ªÍ. ‰Í‡–õC—ÑF“ñCéŠÔŒ«“ñC{–K‘ i“Œ—ˆã‘åjC”¼’J×Yi‹¹ŠOj: ‘æ25‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï (89.07.06), ‹v—¯•Ä, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 5(1): 65, 1989.

546. mŠw‰ïn iˆê”Êu‰‰j ¶Œã6ƒJŒŽˆÈ“à‚ɉ‰ñ‚ÌŒo”ç“Iƒoƒ‹|ƒ“‚É‚æ‚é‹·ó‚ÌŠg‘åp‚ªŽ{s‚³‚ꂽ‘å“®–¬k󂨂æ‚Ñ‘å“®–¬•Ù‹·ó|6Ç—á‚̃tƒHƒ|ƒAƒbƒv. “¡–ìé”VC•½Î‘C–xŒû‘דTCãp—z‘¾˜YC”ª‘ãŒö•viŽ™j: “ú–{¬Ž™zŠÂŠíŠw‰ï (89.07.07) ‹v—¯•Ä, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 5(1): 143, 1989.

547. mŠw‰ïn iˆê”Êu‰‰j Žå”x“®–¬‚É‚¨‚¯‚éŠg’£Šú‡—¬”gŒ`‚̉ðÍ. ‹ß“¡‡‹`C”¼’J×YCÎŒ´ºi‹¹ŠOj: ‘æ25‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï (89.07.07), ‹v—¯•Ä, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 5(1): 137, 1989.

548. mŠw‰ïn iˆê”Êu‰‰j ‹·ó‚Ì‚È‚¢Ç—á‚É‚Ý‚ç‚ê‚éanacrotic notch—lˆ³•Ï‰»‚̬ˆö‚ɂ‚¢‚Ä. ¡ˆäŠ°C”¼’J×Yi‹¹ŠOjC‘¼: ‘æ25‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï (89.07.07), ‹v—¯•Ä, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 5(1): 137, 1989.

549. mŠw‰ïn iˆê”Êu‰‰j Š¥ŒŒ—¬Œv‘ª—pƒhƒvƒ‰ƒJƒe|ƒeƒ‹‚Ì“Á«‚Æ‚»‚Ì—Õ°‰ž—p. ”¼’J×Yi‹¹ŠOjC‘¼: ‘æ25‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï (89.07.07), ‹v—¯•Ä, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 5(1): 138, 1989.

550. mŠw‰ïn iˆê”Êu‰‰j Standardization of Two-dimensional Echocardiographic Planes for a Imaging of the Ductus Arteriosus Associated with Various Congenital Heart Disease. •½Î‘C“¡–ìé”VC–xŒû‘דTC”ª‘ãŒö•viŽ™j: 19th International Congress of Pediatrics (89.07.25), Paris.

551. mŠw‰ïn iˆê”Êu‰‰j Doppler Echocardiographic Indices for Evaluation of Pulmonary Hypertension. —Ñ‘‘‘¾˜YC˜Iè‹P•vC¬‹Ê•q‰›C‚‹´‚Ý‚Ç‚èC•zìTˆê˜YC´…Š®‰xC–Øì“c—²ˆêi“àj: XIth Congress of the European Society of Cardiology (89.09.10`14), ƒtƒ‰ƒ“ƒX, Eur. Heart J., Suppl., p.20, 1989.

552. mŠw‰ïn iˆê”Êu‰‰j Change in Damping Factor of Windkessel System and Cardiovascular Dynamics by Aging in Essential Hypertension. ‘º¼€C’·’J쉄LC¬—Ñ–¾–FC’ËŒ´Œª”VC•½¼T‰EC•‘ò—˜˜YC–Øì“c—²ˆêi“àj: 15th World CongressCInternational Union of Angiology (89.09.17), ƒ[ƒ}.

553. mŠw‰ïn iˆê”Êu‰‰j ‹}«S‹Ø[Ç‚É‚¨‚¯‚é123I-MIBG‚¨‚æ‚Ñ201TlS‹ØƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚ÌŒŸ“¢. ì–ì—´•FC–ì˜C’‰ŽœC´…Š®‰xC•½–콈ê˜YC–]ŒŽr’¼C”öŒ`’·—YC‰Í–쓹¢C–kŠp”Ž“¹CìŒû’|’jCVȈê•vC–Øì“c—²ˆêi“àjCΈ䟌ÈC’†‘òŒ\Ž¡ i•új: “ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï‘æ133‰ñ—á‰ï (89.09.30), VŠƒ.

554. mŠw‰ïn iˆê”Êu‰‰j S”X‰t‚Ì×–E•a—Šw“I‰ðÍ. ‰¡ŽR‘åC‘å–ì‰pŽ¡i•a‰@•a—•”jC‘ –{”ŽsiŽY•wj: ‘æ8‰ñ“ú–{—Õ°×–EŠw‰ï_“Þ쌧Žx•”’n•û‰ï (89.09.30), ‰¡•lC ´˜^WCp.14, 1989.

555. mŠw‰ïn iˆê”Êu‰‰j ³íŒŒˆ³‚¨‚æ‚Ñ‚ŒŒˆ³ƒ‰ƒbƒg‚É‚¨‚¯‚éANP. –ö–Εvi‘‡—Õ°ŒnjC´…Š®‰xC–ì˜C’‰Žœi“àj: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), “Œ‹ž, —Õ°•a—, 37(•âû): 109, 1989.

556. mŠw‰ïn iˆê”Êu‰‰j Hemodynamic Analysis of a New Angiotensin Converting Enzyme Inhibitor Delapril Hydrochloride in Essential Hypertension. ˜Iè‹P•vC•zìTˆê˜YC¬‹Ê•q‰›C²“¡´‹MC—Ñ‘‘‘¾˜YC´…Š®‰xC–Øì“c—²ˆêi“àj: The Second Saratoga International Conference on Atherosclerosis in Towada (89.10.12), \˜a“c, Abstracts, p.56, 1989.

557. mŠw‰ïn iˆê”Êu‰‰j –{‘Ô«‚ŒŒˆ³Ç‚ÌzŠÂ“®‘Ô‚É‹y‚Ú‚·‰–Ž_Delapril‚̉e‹¿. •zìTˆê˜YC˜Iè‹P•vC¬‚L]C‚‹´‚Ý‚Ç‚èC–kŠp”Ž“¹C¬‹Ê•q‰›C—Ñ‘‘‘¾˜YC´…Š®‰xC–Øì“c—²ˆêi“àj: ‘æ26‰ñ“ú–{—Õ°¶—Šw‰ï (89.10.13), “Œ‹ž, “ú–{—Õ°¶—Šw‰ïŽGŽ, 19(Suppl.): 156, 1989.

558. mŠw‰ïn iˆê”Êu‰‰j ‚ŒŒˆ³‚É‚¨‚¯‚錌ˆ³‚ÌdÇ“x•ª—Þ‚ÆŒŒs—ÍŠw“I“Á’¥Œ^‚ÌŠÖ˜A‚ɂ‚¢‚Ä. ‘£’qLC’ËŒ´Œª”VC’r“c‘׎qC¬‚L]C²“¡´‹MC¬—Ñ–¾–FC’·’J쉄LC‘º¼€C–Øì“c—²ˆêi“àj: ‘æ26‰ñ“ú–{—Õ°¶—Šw‰ï (89.10.13), “Œ‹ž, “ú–{—Õ°¶—Šw‰ïŽGŽ, 19(Suppl.): 156, 1989.

559. mŠw‰ïn iˆê”Êu‰‰j ”x‚ŒŒˆ³Ç—á‚É‚¨‚¯‚é”x“®–¬“à2•ô«‡—¬”gŒ`‚Ì•ªÍ. ”¼’J×Yi‹¹ŠOjC‘¼: ‘æ26‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï (89.10.13), “Œ‹ž, “ú–{—Õ°¶—Šw‰ïŽGŽ, 19(—Õ‘): 147, 1989.

560. mŠw‰ïn iˆê”Êu‰‰j ŽhŒƒ“`“±˜H‚Ì•Ï’²‚ÉŠî‚­–[ŽºƒuƒƒbƒN‚Ì”Šwƒ‚ƒfƒ‹. ’r“cŒ›ºC‹{Œ´‰p•vC’|“ດŽC¯–ìˆê–çiˆã—pî•ñjC“yˆä˜a”üi¶•¨•¨—ŒnjC²“¡“oŽu˜Yi¶—j: ‘æ6‰ñ“ú–{S“dŠw‰ïŠwpW‰ï (89.10.14), ŽRŒ`.

561. mŠw‰ïn iˆê”Êu‰‰j •s®–¬S“d}M†”­¶‘•’u‚Æ‚»‚ê‚É‚æ‚éf’f«”\•]‰¿. ‹{Œ´‰p•viˆã—pî•ñj: ‘æ6‰ñ“ú–{S“dŠw‰ïŠwpW‰ï (89.10.14), ŽRŒ`C S“d}C9(5): 658, 1989.

562. mŠw‰ïn iˆê”Êu‰‰j ’Pˆê–[ŽºŒ‹ß×–E‚ÅŠÏŽ@‚³‚ꂽWenckebachŽüŠú‚ÉŠÖ‚·‚錟“¢. ¯–ìˆê–çiˆã—pî•ñjCJustus AnumonwoCMario DelmorCJose Jalifeiƒjƒ…|ƒˆ|ƒNB—§‘åj: ‘æ6‰ñ“ú–{S“dŠw‰ïŠwpW‰ï (89.10.14), ŽRŒ`C S“d}C9(5): 674, 1989.

563. mŠw‰ïn iˆê”Êu‰‰j S‹Ø[ÇŒãÄŠÁ—¬ƒ‚ƒfƒ‹‚ÌŠJ”­,ƒr|ƒY–@‚ƃoƒ‹|ƒ“–@‚Ì”äŠr‚ɂ‚¢‚Ä. ”¯N—YiŽÀ“®jC’†ŽR–ÎMCŠÛŽR–ΑPiŽÀ“®ŒnjC“ޗljÀ—mi¶•¨•¨—ŒnjCˆ°Œ´‹v‘ãC˜kì_ŽiiŽÀ“®ŒnjC—ŠZF“ñC‹{Œ´‰p•vC’r“cŒ›ºiˆã—pî•ñjC ²“¡“oŽu˜Yi¶—j: “ú–{S“dŠw‰ï (89.10.14), ŽRŒ`, “ú–{S“dŠw‰ïŽ, 9(5): 580, l989.

564. mŠw‰ïn iˆê”Êu‰‰j ‰EŽº‘¢‰e‚É‚æ‚é‰ES‹@”\‚Ì•]‰¿‹y‚Ѷ‰ES‹@”\‚Ì”äŠrŒŸ“¢. ì–ì—´•FC–ì˜C’‰ŽœC´…Š®‰xC’·’J쉄LC•½–콈ê˜YC–]ŒŽr’¼C”öŒ`’·—YC‰Í–쓹¢C–kŠp”Ž“¹CìŒû’|’jCVȈê•vC–Øì“c—²ˆêi“àjCΈ䟌ÈC’† ‘òŒ\Ž¡i•új: ‘æ26‰ñ“ú–{—Õ°¶—Šw‰ï (89.10.14), “Œ‹ž, “ú–{—Õ°¶—Šw‰ïŽGŽ, 19(Suppl.): 186`187, 1989.

565. mŠw‰ïn iˆê”Êu‰‰j S•s‘S‚É‚¨‚¯‚é‘m–X•Ù‹t—¬“®‘Ԃɂ‚¢‚Ä. ’ËŒ´Œª”VC‘º¼€C‘£’qLC’r“c‘׎qC¬‚L]C²“¡´‹MC¬—Ñ–¾–FC’·’J쉄LC–Øì“c—²ˆêi“àj: ‘æ26‰ñ“ú–{—Õ°¶—Šw‰ï (89.10.14), “Œ‹ž, “ú–{—Õ°¶—Šw‰ïŽGŽ, 19(Suppl.): 197`198, 1989.

566. mŠw‰ïn iˆê”Êu‰‰j ŠúŠOŽûkŽž‚ÌŠ¥“®–¬“àŒŒ—¬”gŒ`‚Ì•ªÍ. æѳŠîC”¼’J×Yi‹¹ŠOjC‘¼: ‘æ26‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï (89.10.14), “Œ‹ž, “ú–{—Õ°¶—Šw‰ïŽGŽ, 19(—Õ‘): 182, 1989.

567. mŠw‰ïn iˆê”Êu‰‰j ’PŠ¥ó“®–¬“à‚ÌŠ¥ŒŒ—¬•ªÍ. ¼ŽR´ŒhC”¼’J×Yi‹¹ŠOjC‘¼: ‘æ26‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï (89.10.14), “Œ‹ž, “ú–{—Õ°¶—Šw‰ïŽGŽ, 19(—Õ‘): 182, 1989.

568. mŠw‰ïn iˆê”Êu‰‰j BentallpŒãÇ—á‚É‚¨‚¯‚銥“®–¬“àŒŒ—¬•ªÍ|“Á‚Éwater hammerˆ³—Í”g‚Æ‚ÌŠÖ˜A‚ɂ‚¢‚Ä|. ‹ß“¡‡‹`C”¼’J×Yi‹¹ŠOjC•OŽR‹P’ji“ŒŽæŽè•a‰@j: ‘æ26‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï (89.10.14), “Œ‹ž, “ú–{—Õ°¶—Šw‰ïŽGŽ, 19(—Õ‘): 185, 1989.

569. mŠw‰ïn iˆê”Êu‰‰j Œã•‰‰×‘‘å‚ɑ΂·‚é‘m–X•Ù‹t—¬“®‘Ԃ‚¢‚Ä|“™ŽÚ«•‰‰×–@‚É‚æ‚錟“¢|. ’ËŒ´Œª”VC‘º¼€C‘£’qLC‰º—¢ŒöºC™ŽRŠx•FC”ª“‡—ǘaC¬—Ñ–¾–FC’·’J쉄LC–Øì“c—²ˆêi“àj: “ú–{’´‰¹”gˆãŠw‰ï‘æ55‰ñŒ¤‹†”­•\‰ï (89.10.17`19), •Ÿ‰ª.

570. mŠw‰ïn iˆê”Êu‰‰j 81mKr‚É‚æ‚é‰EŽºŽûk‹y‚ÑŠg’£‹@”\‚ÌŒŸ“¢. ì–ì—´•FC–ì˜C’‰ŽœC´…Š®‰xC•½–콈ê˜YC–]ŒŽr’¼C”öŒ`’·—YCì–쓹¢C–kŠp”Ž“¹CìŒû’|’jCVȈê•vC–Øì“c—²ˆêi“àjCΈ䟌ÈC’†‘òŒ\Ž¡ i•új: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (89.10.19), ‘å’Ã, ŠjˆãŠw, 26(8): 989, 1989.

571. mŠw‰ïn iˆê”Êu‰‰j ‹}«S‹Ø[Ç‚¨‚æ‚Ñ”ì‘åŒ^S‹ØÇ‚É‚¨‚¯‚é123I-MIBG‚¨‚æ‚Ñ201TlƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚ÌŒŸ“¢. ´…Š®‰xCì–ì—´•FC–ì˜C’‰ŽœC•½–콈ê˜YC–]ŒŽr’¼C”öŒ`’·—YCì–쓹¢C–kŠp”Ž“¹CìŒû’|’jCVȈê•vC–Øì“c—²ˆêi“àjCΈ䟌ÈC’†‘òŒ\Ž¡ i•új: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (89.10.21), ‘å’Ã, “ú–{ŠjˆãŠw‰ïŽGŽ´˜^W, p.1063, 1990.

572. mŠw‰ïn iˆê”Êu‰‰j ƒCƒkS•s‘S‚É‚¨‚¯‚éƒÀ-ANP‚ɂ‚¢‚Ä. ²“¡´‹MC¬‚L]C•‘ò—˜˜YC’·’J쉄LC–Øì“c—²ˆêi“àjC^è‹`•FiŽÀ“®ŒnjC‘“c‘ìi‹~–½jCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È ‘åj: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ï (89.10.21), ŽD–y, “ú–{“à•ª”åŠw‰ïŽGŽ´˜^W, 65(9): 905, 1989.

573. mŠw‰ïn iˆê”Êu‰‰j –{‘Ô«‚ŒŒˆ³Ç‚É‚¨‚¯‚é“™ŽÚ«•‰‰×‚É‚æ‚éS—\”õ”\‚Ì•]‰¿‚ɂ‚¢‚Ä|S”ì‘å‚Ì—L–³‚É‚æ‚錟“¢|. ™ŽRŠx•FC•‘ò—˜˜YC’ËŒ´Œª”VC‰º—¢ŒöºC‘£’qLC¬—Ñ–¾–FC’·’J쉄LC‘º¼€C–Øì“c—²ˆêi“àj: ‘æ37‰ñ“ú–{S‘Ÿ•aŠw‰ï (89.10.30), ‹ž“s, ‘æ37‰ñ“ú–{S‘Ÿ•aŠw‰ï—\eW, p.60, 1989.

574. mŠw‰ïn iˆê”Êu‰‰j –«•nŒŒÇ‚É‚¨‚¯‚é“™ŽÚ«•‰‰×‚ɑ΂·‚锽‰ž. ‚‹´‚Ý‚Ç‚èC•ìMŒåC˜Iè‹P•vC–Øì“c—²ˆêi“àj: ‘æ37‰ñ“ú–{S‘Ÿ•aŠw‰ï (89.10.31), ‹ž“s, ‘æ37‰ñ“ú–{S‘Ÿ•aŠw‰ï—\eW, p.150, 1989.

575. mŠw‰ïn iˆê”Êu‰‰j ACƒoƒCƒpƒXpŒã‚̃Oƒ‰ƒtƒg“àŒŒ—¬•ªÍ. ‰Í‡–õCˆä㌒Ž¡CéŠÔŒ«“ñC{–K‘ i“Œ—ˆã‘åjCÎŒ´ºC‹ß“¡‡‹`C¼ŽR´ŒhC”¼’J×Yi‹¹ŠOjC‘¼: ‘æ51‰ñ“ú–{—Õ°ŠO‰ÈˆãŠw‰ï‘‰ï (89.10.31), _ŒË, “ú–{—Õ°ŠO‰ÈˆãŠw‰ïŽGŽ, 50(9): 1870, 1989.

576. mŠw‰ïn iˆê”Êu‰‰j ‘å“®–¬•Ç‚̉𗣌»Û‚ÉŠÖ‚·‚é•a—‘gDŠw“IŒŸ“¢. V’Ã’J^lC–Øì“c—²ˆêi“àjCŒK”ö’èmi•a—jC²“¡giŒ`‘ÔŒnjC‹T’J“Oi•a—j: ‘æ37‰ñ“ú–{S‘Ÿ•aŠw‰ï (89.11.01), ‹ž“s, ‘æ37‰ñ“ú–{S‘Ÿ•aŠw‰ï—\eW, p.218, 1989.

577. mŠw‰ïn iˆê”Êu‰‰j ‹Ù‹}‚ÉŒo”ç“Iƒoƒ‹[ƒ“ƒJƒe[ƒeƒ‹‚É‚æ‚é‹·ó‚ÌŠg‘åp‚ðŽ{s‚µ‚½‘å“®–¬k󂨂æ‚Ñ‘å“®–¬•Ù‹·ó‚Ì“ûŽ™—á‚ÌŒŸ“¢. “¡–ìé”ViŽ™jC¼ŽR´Œhi‹¹ŠOjC¡ˆäPC”~Œ´ŽÀC™–{Ÿ•FCV“¡³‹PC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.08), “Œ‹ž, ´˜^W, s-826, 1989.

578. mŠw‰ïn iˆê”Êu‰‰j “àˆö«DOAÇ—á‚ÌŒŸ“¢. ¬—Ñ–¾–FCŠpN•vC’r“c‘׎qCV’Ã’J^lC‰¬Œ´“ÄC’†_Œ¹ˆêC’·’J쉄LC‘º¼€C–Øì“c—²ˆêi“àjC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.09), ‹~‹}ˆãŠw,i—Õ‘j: S853, 1989.

579. mŠw‰ïn iˆê”Êu‰‰j S‹Ø‰Š‚ðŒJ‚è•Ô‚µ‹}Œƒ‚ÈŒo‰ß‚ð‚Æ‚Á‚½1—á. ŠpN•vC’·’J쉄LCV’Ã’J^lCŠ“c”ü—æ”TC‰Í–쓹¢C‘º¼€C–Øì“c—²ˆêi“àjCŒK”ö’èmi•a—j: ‘æ387‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.11.11), “Œ‹ž.

580. mŠw‰ïn iˆê”Êu‰‰j Postrepolarization Refractoriness and Wenckebach Periodicity Occur in Single Atrioventricular Nodal Cells. ¯–ìˆê–çiˆã—pî•ñjCJustus AnumonwoCMario DelmorCJose Jalifeiƒjƒ…|ƒˆ|ƒNB—§‘åj: American Heart Association 62nd Scientific Sessions (89.11.13), New Orleans, Circulation, 80(4): ‡U-133, 1989.

581. mŠw‰ïn iˆê”Êu‰‰j –{‘Ô«‚ŒŒˆ³‚ɑ΂·‚éCaptopril‚ƃÀŽÕ’f–ò‚Ì•¹—pŽ¡—Ã||Propranolol‚Æpindolol‚̑Δ䌟“¢. ‘º¼€i“àjC’zŽR‹vˆê˜YiŒ§—§ŠàƒZƒ“ƒ^[jCŒ“–{¬•ki“ŒŠC‘åj: ‘æ10‰ñ“ú–{—Õ°–ò—Šw‰ï (89.11.14), “Œ‹ž.

582. mŠw‰ïn iˆê”Êu‰‰j ˜V”NŽÒ‚ŒŒˆ³‚É‚¨‚¯‚錌ˆ³‚ÌŒ^‚¨‚æ‚ÑdÇ“x‚É‚æ‚錌s“®‘Ԃ̕ω»‚ɂ‚¢‚Ä. ‘º¼€C’ËŒ´Œª”VC™ŽRŠx•FC‘£’qLC‰º—¢ŒöºC¬—Ñ–¾–FC’·’J쉄LC–Øì“c—²ˆêi“àj: ‘æ31‰ñ“ú–{˜V”NˆãŠw‰ï‘‰ï (89.11.14), –¼ŒÃ‰®, “ú–{˜V”NˆãŠw‰ïŽ, 26: 97, 1989.

583. mŠw‰ïn iˆê”Êu‰‰j dÇ‚ŒŒˆ³‚É‚¨‚¯‚éƒJƒvƒgƒvƒŠƒ‹––㉺“Š—^‚Ì—Õ°“I—L—p«‚ɂ‚¢‚Ä. ”ª“‡—ǘaC‘£’qLC‘º¼€C–Øì“c—²ˆêi“àj: ‘æ10‰ñ“ú–{—Õ°–ò—Šw‰ï (89.11.14), “Œ‹ž, —vŽ|W, p.89, 1989.

584. mŠw‰ïn iˆê”Êu‰‰j Šg’£Šú‚ŒŒˆ³1480—á‚É‚¨‚¯‚錌s“®‘Ô‚¨‚æ‚ÑS‹@”\‚ɂ‚¢‚Ä. ’ËŒ´Œª”VC‘º¼€C‘£’qLC¬‚L]C’r“c‘׎qC¬—Ñ–¾–FC’·’J쉄LC–Øì“c—²ˆêi“àj: ‘æ30‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï (89.11.20), ‹ž“s, ‘æ30‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï—\eW, p.967, 1989.

585. mŠw‰ïn iˆê”Êu‰‰j PGE1“®’‚É‚æ‚é–å–¬ŒŒ—¬‚̕ω»|Œ´”­«ŠÌŠà‚Æ“]ˆÚ«ŠÌŠà‚Ì”äŠr. ¼ŽR³ŒáC‘–쳈êC‹àˆä¹ŒPC‰““¡‚C‹àˆä’Ë•¶–¾C¬—ѬŽiC¼–{—æŽqCˆä“›–ri•új: “ú–{–¬ŠÇŠw‰ï (89.11.20), ‹ž“s, –¬ŠÇŠw, 29(10): 1989.

586. mŠw‰ïn iˆê”Êu‰‰j ‚ŒŒˆ³‚É‚¨‚¯‚é‰Á—î‚É‚æ‚éWindkessel Œn‚ÌDamping factor‚̕ω»‚ÆSzŠÂ“®‘Ô‚ÌŠÖŒWA‚Æ‚­‚É«•Ê“ÁˆÙ«‚ɂ‚¢‚Ä. ‘º¼€C’·’J쉄LC¬—Ñ–¾–FC•ìMŒåC’ËŒ´Œª”VC’r“c‘׎qC¬‚L]C‘£’qLC–Øì“c—²ˆêi“àj: ‘æ30‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï (89.11.22), ‹ž“s.

587. mŠw‰ïn iˆê”Êu‰‰j ‚¤‚ÁŒŒ«S•s‘S‚ð‡•¹‚µ‚½‚ŒŒˆ³Ç‚ɑ΂·‚é‹N—§•‰‰×‚̉e‹¿. ŠpN•vC¬‹Ê•q‰›C˜Iè‹P•vC”öŒ`’·—YCò–Ø‹|C•zìTˆê˜YC´…Š®‰xC–Øì“c—²ˆêi“àj: “ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï‘æ134‰ñ—á‰ï (89.12.02), “Œ‹ž.

588. mŠw‰ïn iˆê”Êu‰‰j V¶Ž™Šú‚Éf’f‚µ‚½‹Ø«•”SŽº’†ŠuŒ‡‘¹‚Ì—Õ°‘œ. –ì“n³•FC•½Î‘CŠ—Œ´FC¬ŒûO‹BC”ª‘ãŒö•viŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï (89.l0.28), ‘å‹{.

589. mŠw‰ïn iˆê”Êu‰‰j ‰EŽº“à‚Ì‹‘å‚È vegetative mass ‚𕹔­‚µ‚½V¶Ž™S“à–Œ‰Š‚Ì1—á. •—’£KŽiCˆäŒ…^—R”üC‘åι–çC–ì“n³•FCŠÖª“OiŽ™jC¼“c—zi—Õ•a—jCŠ—Œ´FC”ª‘ãŒö•vC¬ŒûO‹BiŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï (89.l0.28), ‘å‹{.

590. mŠw‰ïn iˆê”Êu‰‰j V¶Ž™Ž‘±«”x‚ŒŒˆ³Ç(PPHN)‚É‚¨‚¯‚éƒhƒvƒ‰ƒGƒR|–@‚É‚æ‚ézŠÂ“®‘Ô‚Ì•ªÍ. Š`À—R•FC¬ŒûO‹BC–ì“n³•FCŠ—Œ´FC•½Î‘C”ª‘ãŒö•viŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï (89.l0.28), ‘å‹{.

591. mŠw‰ïn iˆê”Êu‰‰j ‹}«S‹Ø[ÇÇ‚É‚¨‚¯‚é123I-MIBG‹y‚Ñ201TlS‹ØƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚ÌŒŸ“¢. ¼Šª”ŽCΈ䟌ÈC’†‘òŒ\ŽiC“cŠŽŒÈC¬—Ñ–ÎŽ÷C¼ŽR³ŒáCˆË“cˆêdC‹e’rŒhi•újC´…Š®‰xCì–ì—´•FC–ì˜C’‰Žœi“àj: ‘æ9‰ñ“ú–{‰æ‘œˆãŠw‰ï (90.02.00), “Œ‹ž, “ú–{‰æ‘œˆãŠwŽGŽ, 8(5): 415, 1990.

592. mŠw‰ïn iˆê”Êu‰‰j –{‘Ô«‚ŒŒˆ³Ç‚É‚¨‚¯‚é‘Sg‚ÌzŠÂ“®‘Ô‚ÆtzŠÂ‚Æ‚ÌŠÖ˜A«‚ɂ‚¢‚Ä. ¬‚L]Cò–Ø‹|CŠpN•vC•zìTˆê˜YC´…Š®‰xC˜Iè‹P•vC–Øì“c—²ˆêi“àj: “ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï‘æ135‰ñ—á‰ï (90.02.17), “Œ‹ž.

593. mŠw‰ïn iˆê”Êu‰‰j IABP‚ª—L—p‚Å‚ ‚Á‚½PTCA’†‹}«Š¥•ÂÇ‚Ì2—á. •½¼T‰ECÎì’¼Ž÷i“àjC‰iˆä‡CŽR–{_–¤iÀ’ÃŽs—§•a‰@j: ‘æ81‰ñ“ú–{zŠÂŠíŠw‰ï“ŒŠC’n•û‰ï (90.02.17), –¼ŒÃ‰®.

594. mŠw‰ïn iˆê”Êu‰‰j ƒhƒvƒ‰ƒJƒe|ƒeƒ‹‚Ì“Á«‚Æ‚»‚Ì—Õ°‰ž—p|CFR‚É‚æ‚éA-CƒoƒCƒpƒXp‚Ì•]‰¿|. ”¼’J×Yi‹¹ŠOjC‘¼: ‘æ20‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ï‘‰ï (90.02.22), ‰ªŽR, ´˜^W, p.122, 1990.

595. mŠw‰ïn iˆê”Êu‰‰j Annulo-Aortic-EctasiaÇ—á‚ɑ΂·‚éBentallp‘OŒã‚̶Š¥“®–¬“àŒŒ—¬•ªÍ. ‹ß“¡‡‹`C”¼’J×Yi‹¹ŠOjC•OŽR‹P’ji“ŒŽæŽè•a‰@jCÎŒ´ºi‹¹ŠOj: ‘æ20‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ï‘‰ï (90.02.24), ‰ªŽR, ´˜^W, p.295, 1990.

596. mŠw‰ïn iˆê”Êu‰‰j VSD‚Ì•”ˆÊ•Êf’f‚É‚¨‚¯‚éƒhƒvƒ‰ƒGƒR|‚Ì–ðŠ„. ‘å]‰ëGCìˆä°”üC“•ûLˆêCŒÃ–ؗʈê˜Yi—ÕŒŸjC•½Î‘iŽ™j: ‘æ15‰ñ“ú–{’´‰¹”gˆãŠwŒŸ¸Œ¤‹†‰ïŒ¤‹†”­•\‰ï (90.02.25), “Œ‹žC ’´‰¹”gŒŸ¸‹Zp, l5(1): 35`36, l990.

597. mŠw‰ïn iˆê”Êu‰‰j VSDi‡TŒ^j‚ÌŒo‰ßŠÏŽ@’†‚Ƀoƒ‹ƒTƒ‹ƒo“´“®–¬áŽ”j—ô‚ð”F‚ß‚½‚P’jŽ™—á‚̃hƒvƒ‰SƒGƒR|}ŠŒ©. “•ûLˆêCìˆä°”üC‘å]‰ëGCŒÃ–ؗʈê˜Yi—ÕŒŸjC•½Î‘iŽ™j: ‘æ15‰ñ“ú–{’´‰¹”gˆãŠwŒŸ¸Œ¤‹†‰ïŒ¤‹†”­•\‰ï (90.02.25), “Œ‹žC ’´‰¹”gŒŸ¸‹Zp, l5(1): 37`38, l990.

598. mŠw‰ïn iˆê”Êu‰‰j Effect of Protocol and Disease on the Kinetics of Oxygen during Exercise Testing. Myers, J.CWalsh, D.CBuchanan, N.CMcCauley, P.CKraemer, M.(Long Beach VA Medical Center)C´…Š®‰xi“àjCFroelicher, V.F.(Long Beach VA Medical Center): 39th Annual Scientific Session of American College of Cardiology (90.03.22), New Orleans, USA, JACC, 15(2): 237A, 1990.

599. mŠw‰ïn iˆê”Êu‰‰j ”x‚ŒŒˆ³Ç(PH)‚É‚Ý‚ç‚ê‚é2•ô«”x“®–¬‹ìo—¬‘¬”gŒ`‚̬ˆö‚ÉŠÖ‚·‚錤‹†. ”¼’J×Yi‹¹ŠOjC‘¼: ‘æ54‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (90.03.27), •Ÿ‰ª, Abstracts‡U, p.97, 1990.

600. mŠw‰ïn iˆê”Êu‰‰j S‹@”\’ቺ—á‚É‚¨‚¯‚é‰^“®•‰‰×Žž‚ÌS–[«Na—˜”Aƒyƒvƒ`ƒh(ANP)‚ƶŽº‹ìo—¦(EF)‚Æ‚ÌŠÖŒW. ‰Í–쓹¢C–ì˜C’‰ŽœC´…Š®‰xCì–ì—´•FC–]ŒŽr’¼C•½–콈ê˜YC”öŒ`’·—YC–kŠp”Ž“¹CìŒû’|’jCVȈê•vC¼ŽRŒcŽqCC–Øì“c—²ˆêi“àjCΈ䟌ÈC’† ‘òŒ\Ž¡i•új: ‘æ54‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (90.03.27), ”Ž‘½, Jpn. Circ. J., 54(´): 34, 1990.

601. mŠw‰ïn iˆê”Êu‰‰j S‹Ø[Ç‚É”º‚¤‹@ŠB“I‡•¹Ç‚Ì—Õ°•a—Šw“IŒŸ“¢. ¬—Ñ–¾–FC‰¬Œ´“ÄCÎì’¼Ž÷C’r“c‘׎qCV’Ã’J^lC’ËŒ´Œª”VC’·’J쉄LC‘º¼€C–Øì“c—²ˆêi“àj: ‘æ54‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (90.03.27), ”Ž‘½, Jpn. Circ. J., 54(´): 40, 1990.

602. mŠw‰ïn iˆê”Êu‰‰j L”͈ÍS‹Ø[Ç‚Å‚ÌPulsed Doppler–@¶ŽºŠg’£“®‘ÔŽw•W‚̈ꌩ³í‰»pattern‚ð‚«‚½‚·‹@˜‚ɂ‚¢‚Ä. ìŒû’|’jC´…Š®‰xC–kŠp”Ž“¹CVȈê•vC‰Í–쓹¢C¼ŽRŒcŽqC–ì˜C’‰ŽœC˜Iè‹P•vC–Øì“c—²ˆêi“àj: ‘æ54‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (90.03.28), ”Ž‘½, Jpn. Circ. J., 54(´): 159, 1990.

603. mŠw‰ïn iˆê”Êu‰‰j ”|—{ŒŒŠÇ•½ŠŠ‹Ø×–E‚É‚¨‚¯‚éƒGƒ“ƒhƒZƒŠƒ“‚É‚æ‚éPI‘ãŽÓ‰ñ“]‚¨‚æ‚уAƒ‰ƒLƒhƒ“Ž_‚Ì—V—£‚ɑ΂·‚éì—p. •ìMŒåi“àj: ‘æ54‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (90.03.28), ”Ž‘½, Jpn. Circ. J., 54(´): 266, 1990.

604. mŠw‰ïn iˆê”Êu‰‰j Ventricular Gradient‚ÌŒoŽž“I•Ï“®‚ÆSŽº×“®è‡’l. ¯–ìˆê–çC’r“cŒ›ºC‹{Œ´‰p•viˆã—pî•ñjC—ŠZF“ñi“àjC²“¡“oŽu˜Yi¶—j: ‘æ54‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (90.03.28), •Ÿ‰ª, Jpn. Circ. J., 54(‘): 123, 1990.

605. mŠw‰ïn iˆê”Êu‰‰j ”ñ•ÂÇ«”ì‘åŒ^S‹ØÇ‚ÌŒŒŸ÷S–[«—˜”Aƒyƒvƒ`ƒh‚Ɖ^“®•‰‰×Žž‚ÌS‹@”\‚Æ‚ÌŠÖŒW. –kŠp”Ž“¹CìŒû’|’jCVȈê•vC¼ŽRŒcŽqCì–ì—´•FC‰Í–쓹¢CŠpN•vC•zìTˆê˜YC”öŒ`’·—YC–ì˜C’‰ŽœC˜Iè‹P•vC–Øì“c—²ˆêi“àjCΈ䟌ÈC’†‘òŒ\ Ž¡i•új: ‘æ54‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (90.03.29), ”Ž‘½, Jpn. Circ. J., 54(´): 239, 1990.

606. mŠw‰ïn iˆê”Êu‰‰j ANP•ª”å‚É‚¨‚¯‚éƒSƒ‹ƒW‘•’u‚̕ω». ²“¡´‹Mi“àjC‘“c‘ìi‹~–½jC’·’J쉄LC–Øì“c—²ˆêi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{j: ‘æ54‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (90.03.29), ”Ž‘½, Jpn. Circ. J., 54(´): 292, 1990.

607. mŠw‰ïn iˆê”Êu‰‰j DiscreteŒ^‘å“®–¬•Ù‰º‹·óÇiKelly ‡UŒ^j‚Ì1¬l—á. ‚ŽRr­i‹¹ŠOjC‘å‘òŠ²•vCŽè’ËŒõ—mC–k‘º¹–çC¬o¹Hi¹—ê•l¼•a‰@j: ‘æ67‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i88.09.10j, “Œ‹ž, “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ, 37(12): 2612, 1989.

608. mŠw‰ïn iˆê”Êu‰‰j ”x‚ŒŒˆ³‚ÆS•s‘S‚𕹔­‚µ,ŽOë•Ù•Â½•s‘SÇ‚ð‡•¹‚µ‚½S–[’†ŠuŒ‡‘¹Ç. ‚ŽRr­i‹¹ŠOjCŽðˆäÍCŽè’ËŒõ—mC–k‘º¹–çC¬o¹HC‘å‘òŠ²•vi¹—ê•l¼•a‰@j: ‘æ68‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i88.12.10j, “Œ‹ž, “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ, 37(12): 2622, 1989.

609. mŠw‰ïn iˆê”Êu‰‰j t“®–¬ãA• •”‘å“®–¬ŽÕ’f‚É‚æ‚é‹•ŒŒŒãÄŠÁ—¬‚Ìt‚É—^‚¦‚é‰e‹¿. “y‰®“ÖC–쌩ŽREC’|’†’qºC•lè‚—TC“c’†—ºi–ƒŒj: ‘æ4‰ñ“ú–{ShockŠw‰ï‘‰ï i89.04.22j, ‘åã.

610. mŠw‰ïn iˆê”Êu‰‰j ƒhƒvƒ‰SƒGƒR|–@‚É‚æ‚éV¶Ž™—‘‰~E•”ŒŒ—¬‚ÌŒŸ“¢. •½Î‘C¬ŒûO‹BCÄ“¡KˆêC–åˆäL‹ÅCŠ—Œ´FC–xŒû‘דTC”ª‘ãŒö•viŽ™j: ‘æ25‰ñ“ú–{V¶Ž™Šw‰ï‘‰ï‘‰ï i89.07.04j, “Œ‹ž.

611. mŠw‰ïn iˆê”Êu‰‰j æ“V«SŽ¾Š³‚𔺂¤‹É¬–¢nŽ™l3—á‚ÌŒŸ“¢. –ì“n³•FC¬ŒûO‹BCŠ—Œ´FC”ª‘ãŒö•viŽ™jCG.C. Emanuilides (UCLA): ‘æ25‰ñ“ú–{V¶Ž™Šw‰ï‘‰ï i89.07.04j, “Œ‹ž.

612. mŠw‰ïn iˆê”Êu‰‰j ƒhƒbƒvƒ‰|SƒGƒR|–@‚É‚æ‚é”xŒŒ—¬Œ¸­Œ^SŽ¾Š³‚É‚¨‚¯‚é’Z—pŒã‚̃Vƒƒƒ“ƒgŒŒŠÇ‚Ì•`o‹y‚ÑŠÇ“àŒŒ—¬‚Ì•]‰¿. –xŒû‘דTC•½Î‘C“¡–ìé”VCãp—z‘¾˜YC”ª‘ãŒö•viŽ™jC’†]¢–¾C¡ˆäŠ°C“c’†Ž•Fi‹¹ŠOj: ‘æ25‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï i89.07.06j, ‹v—¯•Ä, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 5: 89, l989.

613. mŠw‰ïn iˆê”Êu‰‰j —¼‘¤‹}«Žw“®–¬•ÂÇ‚ð‚«‚½‚µ‚½Œ´”­«ŒŒ¬”ÂŒŒÇ‚Ì1—á. ŒÃì—T‰îC‹à鳉ÀCª–{EC—§ÎWC’©’·“N–íC“‡“cŒªC“n•ÓŒ’Ž™C¼ŽR•Û”äŒÃCX£¹Ž÷C‰J‹{–¾•¶C¼ˆäŒ’C¡ˆäŒ‰iŠOjCŽR‰º‚¦‚èŽqC“¡–ì—R”ü i“àj: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï i89.09.30), ‘Š–ÍŒ´, –k—¢ˆãŠw, 19(6): 644, 1989.

614. mŠw‰ïn iˆê”Êu‰‰j ƒAƒ‹ƒuƒ~ƒ“preclotting‚µ‚½DacronlHŒŒŠÇ‚É‚æ‚ébypassp‚Ì—Õ°“IŒŸ“¢. ¡ˆäŒ‰C‹à鳉ÀCˆÉ“¡—ÇmCª–{EiŠOj: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï i89.09.30), ‘Š–ÍŒ´, –k—¢ˆãŠw, 19(6): 646, 1989.

615. mŠw‰ïn iˆê”Êu‰‰j p‘O”畆Á“Å‚ÌlHŒŒŠÇŠ´õ—\–hŒø‰Ê‚ÉŠÖ‚·‚錟“¢. ª–{EC¡ˆäŒ‰C‹à鳉ÀCˆÉ“¡—ÇmiŠOj: ‘æ51‰ñ“ú–{—Õ°ŠO‰ÈˆãŠw‰ï‘‰ï i89.11.02), _ŒË, “ú–{—Õ°ŠO‰ÈˆãŠw‰ïŽGŽ, 50(9): 374, 1989.

616. mŠw‰ïn iˆê”Êu‰‰j ŒŒ‰tƒKƒX•ªÍ‚É‚æ‚鉺ŽˆÃ–¬”÷¬zŠÂ‚ÌŒŸ“¢. ‹à鳉ÀCª–{EC¡ˆäŒ‰CˆÉ“¡—ÇmiŠOj: ‘æ51‰ñ“ú–{—Õ°ŠO‰ÈˆãŠw‰ï‘‰ï i89.11.02), _ŒË, “ú–{—Õ°ŠO‰ÈˆãŠw‰ïŽGŽ, 50(9): 375, 1989.

617. mŠw‰ïn iˆê”Êu‰‰j • •”‘å“®–¬áŽ”j—ô—á‚̉摜‚É‚æ‚錟“¢|ᎂɋy‚Ú‚·˜’Åœž™‚̉e‹¿|. ‹à鳉ÀCª–{EC¡ˆäŒ‰CˆÉ“¡—ÇmiŠOjC¡ˆäPC™–{Ÿ•FC“‡’÷ˆêC‘Oì˜a•Fi‹~–½j: ‘æ30‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï i89.11.20), ‹ž“s, –¬ŠÇŠw, 29(10): 906, 1989.

618. mŠw‰ïn iˆê”Êu‰‰j Myonephropathic-metabolic syndrome‚ÉŠÖ‚·‚錟“¢|‚Æ‚­‚É‹•ŒŒ‹Ø‚Ìreperfusion injury‚ɂ‚¢‚Äi‘æ3•ñj|. ª–{EC¡ˆäŒ‰C‹à鳉ÀCˆÉ“¡—ÇmiŠOj: ‘æ30‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï i89.11.20), ‹ž“s, –¬ŠÇŠw, 29(10): 927, 1989.

619. mŠw‰ïn iˆê”Êu‰‰j •«‡•”“à–Œ”ìŒú‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢. ª–{EiŠOj: ‘æ2‰ñŒŒŠÇáŠQŒ¤‹†‰ï i89.11.25), “Œ‹ž.

620. mŠw‰ïn iˆê”Êu‰‰j “®–¬d‰»«‹}«‰ºŽˆ“®–¬•ÂÇ‚É‚æ‚émyonephropathic-metabolic syndrome‚ÉŠÖ‚·‚錟“¢. ª–{EC¡ˆäŒ‰C‹à鳉ÀCˆÉ“¡—ÇmiŠOj: ‘æ24‰ñ“ú–{¬l•aŠw‰ï i90.01.15), “Œ‹ž, “ú–{¬l•aŠw‰ï‰ïŽ, 16: 75, 1990.

621. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ˜V”NŽÒ‚ŒŒˆ³‚ÌŠÇ—‚Ì‚µ‚©‚½. ‘º¼€i“àj: Chronic Disease Œ¤‹†‰ï (89.09.09), “Œ‹ž.

622. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ŒŒŠÇŠO‰È‚ÆŠ´õ. ª–{EiŠOj: ‘æ4‰ñ_“Þ쌧ŒŒŠÇŠO‰ÈŒ¤‹†‰ï i89.09.22), ‰¡•l.

623. mŒ¤‹†‰ïn iƒpƒlƒ‹j Œo”ç‹zŽûŒ^»Ü‚Ì•]‰¿•û–@;@‘æ“ñ•”—Õ°ŽŽŒ±. ‘º¼€i“àj: Œo”ç‹zŽûŒ^»ÜƒVƒ“ƒ|ƒWƒEƒ€ (89.10.05), “Œ‹ž.

624. mŒ¤‹†‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj V¶Ž™C“ûŽ™‚Ì‘å“®–¬•Ù‹·ó‚ɑ΂µ‚ÄŒo”ç“Iƒoƒ‹|ƒ“Šg‘åp‚ðŽ{s‚µ‚½3ǗႨ‚æ‚ѬŽ™Šú‚ÉŽ{s‚µ‚½l—á‚ÌŒŸ“¢. –xŒû‘דTC•½Î‘C“¡–ìé”VC–î‘òŒ’ŽiCŽO‘òmŽiCãp—z‘¾˜YC”ª‘ãŒö•viŽ™j: ‘æ1‰ñPediatric Interventional Cardiology Œ¤‹†‰ï (90.01.13), “c.

625. mŒ¤‹†‰ïn iˆê”Êu‰‰j –k—¢Ž®lHS‘Ÿ‚Ì“Á’¥‚Æ–â‘è“_. ‹´–{¬LC”nŸº´Ž‘i¶‘ÌHjCˆÉ“¡’‰OC¡•ª–ÎC“c’†”Ž”VCÎŒ´ºi‹¹ŠOjCX“c^Žji¶‘ÌHjCù“c’¼i“ŒH‘åj: ‘æ7‰ñ‘ã—p‘ŸŠíŒ¤‹†‘‰ï (82.02.05), ‘Š–ÍŒ´C –k—¢ˆãŠw, 12(2): 180, 1982.

626. mŒ¤‹†‰ïn iˆê”Êu‰‰j lHS‘Ÿ‚Ì—¬—Ê”gŒ`|”x“àƒVƒƒƒ“ƒg‚Æ‚ÌŠÖŒW‚ɂ‚¢‚Ä|. ‹´–{¬Li¶‘ÌHjCŽç‰®“llCˆÉ“¡’‰OCÎŒ´ºi‹¹ŠOjC”nŸº´Ž‘i¶‘ÌHjC—é–Ø”ŽŽqiˆãŠw‰ÈjC•½ˆä–@”Ži“àjC‘O“c_‹`Cù“c’¼i“ŒH‘åj: ‘æ8‰ñ‘ã—p‘ŸŠíŒ¤‹†‘‰ï (83.02.04), ‘Š–ÍŒ´C –k—¢ˆãŠw, 13(2): 152, 1983.

627. mŒ¤‹†‰ïn iˆê”Êu‰‰j lHS‘Ÿ‚É‚¨‚¯‚錌ðŒ`¬‚Æ‘¬“xŒù”z. ‹´–{¬Li¶‘ÌHjCŽç‰®“llCó—˜G’jCÎŒ´ºi‹¹ŠOjC”nŸº´Ž‘i¶‘ÌHjC•½ˆä–@”Ži“àjC—é–Ø”ŽŽqiˆãŠw‰ÈjC‘O“c_‹`Cù“c’¼i“ŒH‘åj: ‘æ9‰ñ‘ã—p‘ŸŠíŒ¤‹†‘‰ï (84.02.01), ‘Š–ÍŒ´C –k—¢ˆãŠw, 14(2): 120, 1984.

628. mŒ¤‹†‰ïn iˆê”Êu‰‰j lHS‘Ÿ‚É‚¨‚¯‚錌‹…”j‰ó‚Æ‘¬“xŒù”z. ‹´–{¬LC”nŸº´Ž‘i¶‘ÌHjCó—˜G’jCÎŒ´ºi‹¹ŠOjC—é–Ø”ŽŽqiˆãŠw‰ÈjC™‰Y—f‰îCù“c’¼i“ŒH‘åj: ‘æ10‰ñ‘ã—p‘ŸŠíŒ¤‹†‘‰ï (85.01.28), ‘Š–ÍŒ´C –k—¢ˆãŠw, 15(2): 138, 1985.

629. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹}«S‹Ø[Ç‚É‚¨‚¯‚é¶S•s‘S‚ƉES•s‘S•a‘Ô‚ÌŠÖ˜A‚¨‚æ‚ÑŒŒŠÇŠg’£Ü—Ö@‚É‚æ‚é•Ï‰». •½¼T‰EC¬—Ñ–¾–FC‘º¼€C–Øì“c—²ˆêi“àj: ‘æ9‰ñ—Õ°S‘Ÿ•aŒ¤‹†‰ï (88.04.23), ‘åã.

630. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒhƒvƒ‰SƒGƒR|–@‚É‚æ‚鶖[“à–Œ—l\‘¢•¨‚ÌŠÓ•Ê. ìˆä°”üC‘å]‰ëGC•äÏŒ³CŒÃ–ؗʈê˜Yi—ÕŒŸjC•½Î‘iŽ™j: “ú–{’´‰¹”gˆãŠwŒŸ¸Œ¤‹†‰ï (89.02.26), –¼ŒÃ‰®C ’´‰¹”gŒŸ¸‹Zp, l4(2): 80`81, 1989.

631. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹}Œƒ‚ÈSŠg‘å‚ÆS•s‘S‚ðŽå‘i‚É”­Ç‚µ‚½ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á. ‰¬Œ´“ÄC¬—Ñ–¾–FC’·’J쉄LC´…Š®‰xC‘º¼€C–Øì“c—²ˆêi“àjCŒÃì—FC‘D”ö’‰Fi–@ˆãjCV’Ã’J^li“àjCŒK”ö’èmi•a—j: —Õ°S‘Ÿ•aŒ¤‹†‰ï (89.04.10), ‘åã.

632. mŒ¤‹†‰ïn iˆê”Êu‰‰j DŽ_‹…‘‘½‚𔺂¤S‹Ø‰Š‚Ì1—á. ¬‚L]C’·’J쉄LC‘º¼€C–Øì“c—²ˆêi“àj: —Õ°S‘Ÿ•aŒ¤‹†‰ï (89.04.10), ‘åã.

633. mŒ¤‹†‰ïn iˆê”Êu‰‰j S‹ØÁ‚É‚¨‚¯‚éSƒv[ƒ‹ˆÊ‘Š‰ðÍ‚Ì—L—p«. ¼Šª”ŽCΈ䟌ÈC’†‘òŒ\Ž¡C¼—Ñ—²i•újC¬—Ñ–¾–Fi“àj: ‘æ593‰ñ•úŽËüf—ÃŒ¤‹†‰ï (89.05.00), “Œ‹žC —Õ°ŠjˆãŠwC22(4): 52, l989.

634. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘å“®–¬‚É‚¨‚¯‚éŽ_«ƒ€ƒR‘½“œ‚ÌõF–@‚ÌŒŸ“¢. ‘å‹´‚ä‚©‚èCˆÉ“¡®ŽqC‹ß–ì´”üCŽsì‚‚íi•a‰@•a—jCV’Ã’J^li“àjCŒK”ö’èmC‰œ•½‰ë•Fi•a—j: ‘æ40‰ñ•a—‹ZpŒ¤‹†‰ï (89.08.06), “Œ‹ž, •a—‹Zp,(40): 12`13,1990.

635. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒhƒvƒ‰ƒJƒe|ƒeƒ‹‚É‚æ‚ésingle coronary artery“à‚ÌŒŒ—¬•ªÍ. ”¼’J×Yi‹¹ŠOjC‘¼: ‘æ9‰ñ¬Ž™S‹@”\ŒŒs“®‘Ô’k˜b‰ï (89.10.14), “Œ‹ž.

636. mŒ¤‹†‰ïn iˆê”Êu‰‰j SzŠÂƒ‚ƒfƒ‹‚ÉŠî‚­S•s‘Sf’fŽ¡—ÃŽx‰‡ƒVƒXƒeƒ€CARDIOLOGIST. ’ß“c—z˜aC’|“ດŽiˆã—pî•ñjC²“¡“oŽu˜Yi¶—jC“c’†—ºi–ƒj: ‘æ7‰ñ–ƒŒ¥W’†Ž¡—ÃRƒ“ƒsƒ…|ƒ^Œ¤‹†‰ï (89.11.18), •xŽR, ´˜^W, p.16, 1989.

637. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’´‰¹”gƒhƒvƒ‰ƒJƒe|ƒeƒ‹‚É‚æ‚éŠeŽíSŽ¾Š³‚ÌŠ¥“®–¬“àŒŒ—¬•ªÍ. ”¼’J×Yi‹¹ŠOjC‘¼: ‘æ3‰ñ’´‰¹”gŠ¥ŒŒ—¬Œv‘ªŒ¤‹†‰ï (89.12.02), ‘åã.

638. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‰^“®•‰‰×Žž‚É‚¨‚¯‚ézŠÂ“®‘ÔA‚Æ‚­‚ɶŽº‹ìo—¦(EF)‚ÆS–[«Na—˜”Aƒyƒvƒ`ƒh(ANP)‚Æ‚ÌŠÖŒW. ‰Í–쓹¢Cì–ì—´•FC–]ŒŽr’¼C–kŠp”Ž“¹CìŒû’|’jC´…Š®‰xC–ì˜C’‰ŽœC–Øì“c—²ˆêi“àj: ‘æ30‰ñzŠÂŠí•‰‰×Œ¤‹†‰ï (90.02.03), “Œ‹ž.

639. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹}«ŒŒˆ³ã¸‚ÌS‘Ÿ‘gDS–[«—˜”Aƒyƒvƒ`ƒh”Z“x‚É‚¨‚æ‚Ú‚·‰e‹¿FWKY ‚ÆSHR‚Å‚ÌŒŸ“¢. ´…Š®‰xC–kŠp”Ž“¹CìŒû’|’jCVȈê•vC¼ŽRŒcŽqCì–ì—´•FC‰Í–쓹¢C–ì˜C’‰ŽœC–Øì“c—²ˆêi“àjC–ö–Εvi‘‡—Õ°Œnj: ‘æ3‰ñANPŒ¤‹†‰ï (90.02.23), ‘Š–ÍŒ´.

640. mŒ¤‹†‰ïn iˆê”Êu‰‰j ANP•ª”å‚É‚¨‚¯‚éƒRƒ‹ƒW‘•’u‚̕ω». ²“¡´‹MC’·’J쉄LC¬‚L]C•‘ò—˜˜YC–Øì“c—²ˆêi“àjCŽðˆäNOCŽR‰È³•½i‰ðjC‘“c‘ìi‹~–½jCŸ–”CiŒ`‘ÔŒnjC^è‹`•FiŽÀ“®ŒnjCŠÛ–Î •¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{j: ‘æ3‰ñANPŒ¤‹†‰ï (90.02.23), ‘Š–ÍŒ´.

641. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‰^“®•‰‰×Žž‚É‚¨‚¯‚ézŠÂ“®‘ÔA‚Æ‚­‚ɶŽº‹ìo—¦‚ÆS–[«Na—˜”Aƒyƒvƒ`ƒh‚Æ‚ÌŠÖŒW. ‰Í–쓹¢Cì–ì—´•FC–kŠp”Ž“¹C´…Š®‰xC–ì˜C’‰ŽœC–Øì“c—²ˆêi“àjC–ö–Εvi‘‡—Õ°Œnj: ‘æ3‰ñANPŒ¤‹†‰ï (90.02.23), ‘Š–ÍŒ´.

642. mŒ¤‹†‰ïn iˆê”Êu‰‰j • •”‘å“®–¬‹Ù‹}ŽèpŽž‚Ì–ƒŒŠÇ—. –쌩ŽREC‘ºã‰ëŽqCŒÜ\”¨mC•lè‚—TC¬‘òÍŽqC–î“c_C“¡Œ´ŒjŽqCóˆäŽõŽqi–ƒj: ‘æ12‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï i89.03.08`10j, –kŠC“¹.

643. mŒ¤‹†‰ïn iˆê”Êu‰‰j Paget-SchroetterÇŒóŒQ‚Ì2—á. “‡“cŒªC¡ˆäŒ‰C¼ˆäŒ’CŒÃ“cˆê“¿C‹à鳉ÀCª–{EiŠOj: ‘æ59‰ñŒŒŠÇŠO‰ÈǗጟ“¢‰ï i89.04.22), “Œ‹žC ŒŒŠÇŠO‰ÈCl990.

644. mŒ¤‹†‰ïn iˆê”Êu‰‰j • •”‘å“®–¬¥‰º‘åÖ¬ŠÔ‚ÉÄ”­‚µ‚½ˆ««Œã• –ŒŽîᇂÌ1Žèp—á. ¡ˆäŒ‰Cã–쑈ê˜YC‹à鳉ÀCˆÉ“¡—ÇmCΓc˜a•vCª–{EiŠOj: ‘æ9‰ñŒŒŠÇŠO‰È‡“¯Œ¤‹†‰ï i89.05.20), ‘q•~.

645. mŒ¤‹†‰ïn iˆê”Êu‰‰j Š´õ‚𔺂Á‚½¶ãüâ|“®–¬”j—ô‚Ì1Žèp—á. X£¹Ž÷C¡ˆäŒ‰C‹à鳉ÀCª–{EiŠOj: ‘æ60‰ñŒŒŠÇŠO‰ÈǗጟ“¢‰ï i89.07.01), ç—t.

646. mŒ¤‹†‰ïn iˆê”Êu‰‰j “ûŠàpŒã‚Ìãüâ|“®–¬”j—ô‚Ì1—á. X£¹Ž÷C‹à鳉ÀC²“¡KˆêC¡ˆäŒ‰Cª–{EiŠOj: ‘æ60‰ñŒŒŠÇŠO‰ÈǗጟ“¢‰ï i89.07.01), ç—t, ŒŒŠÇŠO‰È, 9(1): 1990.

647. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠO«ŽlŽˆŒŒŠÇ‘¹7—á‚ÌŒŸ“¢. ‹à鳉ÀCª–{EC¡ˆäŒ‰CˆÉ“¡—ÇmiŠOjCV“¡³‹PC™–{Ÿ•FC‘Oì˜a•Fi‹~–½j: ‘æ3‰ñLimb SalvageŒ¤‹†‰ï i89.07.07), ˆ®ì, ´˜^W, 3: 10, 1989.

648. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”j—ô«• •”‘å“®–¬áŽpŒã‚É”­¶‚µ‚½¶“à’°œ“®–¬áŽ‚Ì1Žèp—á. ’©’·“N–íC¡ˆäŒ‰C’|“cC¼ŽR•Û”äŒÃC¼ˆäŒ’C‹à鳉ÀCª–{EiŠOjC‘Oì˜a•Fi‹~–½j: ‘æ61‰ñŒŒŠÇŠO‰ÈǗጟ“¢‰ï i89.09.09), “Œ‹ž.

649. mŒ¤‹†‰ïn iˆê”Êu‰‰j lHŒŒŠÇ¥hŽå“®–¬•«‡•”‚Ì’·Šú—\Œã‚ÉŠÖ‚·‚錟“¢. ª–{EiŠOj: ‘æ1‰ñŒŒŠÇáŠQŒ¤‹†‰ï i89.09.12), “Œ‹ž.

650. mŒ¤‹†‰ïn iˆê”Êu‰‰j ASO‚ɑ΂·‚éRŒŒ¬”–ò‚ÌŒø‰Ê‚ÉŠÖ‚·‚錟“¢. ª–{EiŠOj: ‘æ4‰ñ_“Þ쌧ŒŒŠÇŠO‰ÈŒ¤‹†‰ï i89.09.22), ‰¡•l.

651. mŒ¤‹†‰ïn iˆê”Êu‰‰j ¶‘’°œ“®–¬‹}«•ÂÇŒãA5ŽžŠÔ‚ÅŽ€–S‚µ‚½1—á. ™–ìŽOç’jCª–{EC‹à鳉ÀC¡ˆäŒ‰iŠOj: ‘æ63‰ñŒŒŠÇŠO‰ÈǗጟ“¢‰ï i90.01.20), “Œ‹ž, ŒŒŠÇŠO‰È, 1990.

652. mŒ¤‹†‰ïn iˆê”Êu‰‰j Paget-SchroetterÇŒóŒQ‚Ì3—á. “‡“cŒªC¡ˆäŒ‰CŒÃ“cˆê“¿C¼ˆäŒ’C™–ìŽOç’jC‹à鳉ÀC‘å‹{“Œ¶Cª–{ECE“cÍiŠOj: ‘æ736‰ñŠO‰ÈW’k‰ï i90.03.10), “Œ‹ž, ´˜^W, p.24, 1990.


<<103 ŒÄ‹zŠí>>

653. mŒ´’˜n ‹C“¹‰ß•q«ŒŸ¸’†‚ÌŒz•”ŒÄ‹z‰¹‚̕ω». “팴”Í”VC‰ØŽ÷¬CÎì—ºCˆäŒË“cÆ‹`C²“¡“ú²ŽqC‘q“c¬CŽR–{”Ž”VC•Ð‹Ë^lC–{‘½ƒC–î“ߣM—YCˆ¢•”’¼C•y“c—FKi“àj: Therapeutic Research, 10(10): 429`433, 1989.

654. mŒ´’˜n Mouth Occlusion Pressure as a Useful Indicator for Wearing from Mechanical Ventilation. ‘Š”nˆêˆåi‹~–½jC‘å’Ë—m‹vC•y“c—FKi“àj: Tohoku J. Exp. Med., 156(Suppl.): 181`187, 1988.

655. mŒ´’˜n Œ´”­«”xŠàØœ—á‚É‚¨‚¯‚é—\Œã‚ÌŒŸ“¢. ˆ¢•””\–¾C‹g‘º”Ž–MC•½ˆäŽO˜YC•i“cƒCÎŒ´ºi‹¹ŠOjC‹T’J“Oi•a—jCž`ŒE–LC–î“ߣM—Yi“àj: ŒÄ‹zŠíŠO‰È, 3(4): 396`401, 1989.

656. mŒ´’˜n ¬Ž™‚̉ߕq«”x‘Ÿ‰Š. –¥‰YŽ‘¥C’†“ˆ‰p•FiŽ™j: ¬Ž™‰ÈC30(9): 991`998Cl989.

657. mŒ´’˜n ‰ESƒoƒCƒpƒXŽž‚Ì—¬—Ê”gŒ`‚Ì”x‚ւ̉e‹¿. Žç‰®“llCˆÉ“¡’‰OCÎŒ´ºi‹¹ŠOjC‹´–{¬LC”nŸº´Ž‘i¶‘ÌHjCù“c’¼C‘O“c_‹`i“ŒH‘åj: lH‘ŸŠí, 13(1): 100`103, 1984.

658. mŒ´’˜n ‹C“¹”M‚É‚¨‚¯‚é‹CŠÇŽx‹¾ŠŒ©‚ÉŠÖ‚·‚錤‹†|“Á‚É”ŠŒ©‚Ì—L–³‚Æ‹¹•”‚wüˆÙí¥•K—v—A‰t—Ê‚¨‚æ‚Ñ—\Œã‚Æ‚ÌŠÖŒW. •Ð‹Ë^li“àjC‰©‹àˆäN–¤C‘Š”nˆêˆåi‹~–½jC•y“c—FKi“àj: ”Mi“ú–{”MŠw‰ï‰ïŽj, 15(1): 8`14, 1989.

659. mŒ´’˜n Až‚ÝŒ^lHS‘Ÿ‚ÌŒ¤‹†. ˆÉ“¡’‰OCŽç‰®“llC–ö‘òG–¾CÎŒ´ºi‹¹ŠOjC‹´–{¬LC”nŸº´Ž‘i¶‘ÌHjCù“c’¼i“ŒH‘åj: –k—¢ˆãŠw, 12(‘): 108`109, 1982.

660. mŒ´’˜n ‚•p“x—zˆ³ŒÄ‹z‚Ì’áŽ_‘f«”xŒŒŠÇŽûk‚ɑ΂·‚é‰e‹¿. ›’J˜a]C“n•Ó•qC‚•¶‰Øi–ƒj: –ƒŒ, 38(11): 1492`497, 1989.

661. mŒ´’˜n ‹C“¹”MŽž‚Ì”xŒŒŠÇ“§‰ß«‚ÉŠÖ‚·‚錤‹†. •Ð‹Ë^lC–î“ߣM—YC•y“c—FKi“àjC‰FˆäŒª“ñC‰F’Öؗ´ˆêC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC‚èŒõ‹Ii—Õ•a—j: —Õ°ŒÄ‹z¶—, 21(2): 133`138, 1989.

662. mŒ´’˜n Ž‰–bÇðÇŒóŒQ‚ÌBALFŠŒ©. ‚èŒõ‹Ii—Õ•a—jCV“¡³‹PC–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC•Ð‹Ë^li“àj: —Õ°ŒÄ‹z¶—, 21(2): 141`144, 1989.

663. mŒ´’˜n ‹CŠÇŽx”x–Eôò‰t‚É‚¨‚¯‚郿2|Macroglobulin”÷—Ê‘ª’è‚ÌŠî‘b“I‹y‚Ñ—Õ°“IŒŸ“¢. ‚èŒõ‹ICâ“Œ—R‹IC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—jC”~Œ´ŽÀiŽ™jC‘Š”nˆêˆåi‹~–½jCÎ삈êC•Ð‹Ë^lC–î“ߣM—YC•y“c—FKi“àj: —Õ°•a—, 37(7): 825`829, 1989.

664. m’Z•ñn Vanishing Tumor. ‘Š”nˆêˆåi‹~–½j: “úŒoƒƒfƒBƒJƒ‹, 18(14): 15`16, 1989.

665. mÇ—á•ñn TSS—ÞŽ—‚Ì•a‘Ô‚ð’悵‚½”x‰Š‹…‹Û”sŒŒÇ‚Ì1—á. ”Š_mCL£—²ˆêC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽ, 10(1): 380`381, 1989.

666. mÇ—á•ñn ‹}«ƒŠƒ“ƒp«”’ŒŒ•a‚ɇ•¹‚µ‚½”xƒ€ƒR[ƒ‹Ç‚Ì1Øœ—á. ‹ß“¡‡‹`C•i“cƒC•½ˆäŽO˜YCŽR–{‹LŒ°C‹g‘º”Ž–MCÎŒ´ºi‹¹ŠOj: “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ, 37: 734`737, 1989.

667. mÇ—á•ñn “Á”­«“ûâô‹¹‚Ì1—á. ‚“cM˜aC‹{–{–”‹gi“àjC’†Œ´Ž•FC•ž•”¬•FC‘å–ØŽõ—²C‰¡ŽR„C¬‘òŠÞC‹e’rŒ÷ŽŸiŒx—F•a‰@j: “ú–{‹¹•”—Õ°, 49(1): 64`69, 1990.

668. mÇ—á•ñn ’˜‚µ‚¢‚CO2ŒŒÇA–³ŒÄ‹z‚ð’悵‚½’x”­«ƒWƒXƒLƒlƒWƒA‚Ì1—á. ²“¡“ú²ŽqCŽR–{”Ž”VCÎì—ºC“팴”Í”VC•Ð‹Ë^lC–î“ߣM—YCˆ¢•”’¼C‘å’Ë—m‹vC•y“c—FKi“àjC’ç–M•FCL£—²ˆêC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: —Õ°ŒÄ‹z¶—, 21(1): 23`32, 1989.

669. m‘àn ¬Ž™‹CŠÇŽxƒtƒ@ƒCƒo|ƒXƒRƒs|‚Ì“K‰ž‚Æ–â‘è“_. ”~Œ´ŽÀC–¥‰YŽ‘¥iŽ™j: ¬Ž™‰ÈC30(6): 611`620Cl989.

670. m‘àn Ž¾Š³‚É‚æ‚é‰æ‘œf’f‚ÌŽí—Þ‚Æ“K‰ž: ŒÄ‹zŠí. ”~Œ´ŽÀiŽ™j: ¬Ž™‰Èf—Ã,@53(4): 1039`1048, 1990.

671. m‘àn ‹z“ü—Ö@. ”~Œ´ŽÀiŽ™j: ¬Ž™‰Èf—ÃC52(‘): 103`106Cl989.

672. m‘àn V‚µ‚¢¶—‹@”\ŒŸ¸i”x‹@”\j|ŠjˆãŠwŒŸ¸‚ð’†S‚Æ‚µ‚Ä|. ”~Œ´ŽÀC–¥‰YŽ‘¥C’†“ˆ‰p•FiŽ™j: ¬Ž™‰Èf—ÃC53(1): 100`106Cl989.

673. m‘àn ŒÄ‹z•s‘S. •½Î‘iŽ™j: ¬Ž™“à‰ÈC21: 352`356Cl989.

674. m‘àn lHŒÄ‹z‚Ì“K‰ž. –쌩ŽREi–ƒj: —Õ°ŠÅŒìCl5(7): 970`974Cl989.

675. muÀn ‹}«ŒÄ‹z•s‘S‚Ì•a‘Ô¶—. ‘Š”nˆêˆåi‹~–½j: Modern Physician, 9(3): 297`299, 1989.

676. muÀn ”ñ׋۫”x‰Ši1j. ‰œ•½‰ë•Fi•a—j: ŒÄ‹z, 9(3): 293`298, 1990.

677. muÀn ICU‚É‚¨‚¯‚錟¸‚ƃ‚ƒjƒ^ƒŠƒ“ƒO|‹¹•”‚̉摜f’f|. ‘Š”nˆêˆåi‹~–½j: W’†Ž¡—Ã, 1(3): 295`302, 1989.

678. muÀn ¬Ž™¶—Šw“I”x‹@”\ŒŸ¸‡T. –¥‰YŽ‘¥C”~Œ´ŽÀC’†“ˆ‰p•FiŽ™j: ¬Ž™‰Èf—ÃC52(12): 2717`2722Cl989.

679. mŠwp‘n iŽ·•Mj ‡–°Žž–³ŒÄ‹zÇŒóŒQ; ¬Ž™Ž¾Š³Cp.120`131, “n•Ó“oiŽ™j. •ÒW ‘꓇”Ci“Œ–k‘åj•ÒC ˆã–òƒWƒƒ|ƒiƒ‹ŽÐC‘åãC89.11.l0.”­s.

680. m‹³‰È‘n iŽ·•Mj ÅVˆãŠw’mŽ¯‚Ì®—;ˆãŠwŠe˜_ ‡U.ŒÄ‹zŠí¥‹¹•Ç¥cŠuŽ¾Š³; cŠuŽ¾Š³, p.149`156, •Ð‹Ë^lC•y“c—FKi“àj. •ÒW ‹à–ìŒö˜Yi“Œ—ˆã‘åj•Ò, ˆãŽ•–òo”Å, “Œ‹ž, 90.01.10”­s.

681. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj ¡“ú‚̬Ž™Ž¡—ÃŽwj@‘æ8”Å; ”x•ª‰æÇCp.382, “n•Ó“oiŽ™j. •ÒW ”·‰Ã”Vi“Œ–M‘åjCŽO‰ÍtŽ÷i‹ž‘åjCd“c­Mi¬òd“c¬Ž™‰Èj•Ò, ˆãŠw‘‰@C“Œ‹žC89.09.l5”­s.

682. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Critical Care, Emergencies‚É‚¨‚¯‚é‹CŠÇŽx‹¾‚̉ž—p|—L“Å•¨Ž¿•ž—p‚É”º‚¤‹}«Šú‹C“¹•a•Ï‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢|. ‘Š”nˆêˆåCL£—²ˆêC’ç–M•Fi‹~–½jC¬—Ñ–¾–Fi“àjC‘å˜a“c—²i‹~–½jC•Ð‹Ë^lC–î“ߣM—Yi“àj: ‘æ12‰ñ“ú–{‹CŠÇŽxŠw‰ï‘‰ï (89.07.08), “Œ‹ž.

683. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‹CŠÇŽxŠg’£Ü‹z“üŽž‚ÌŠ·‹C‹@”\‚Æ“®–¬ŒŒ‚̕ω». ”~Œ´ŽÀiŽ™j: ‘æ22‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï (89.11.29), •Ÿ‰ª.

684. mŠw‰ïn iˆê”Êu‰‰j ”x¬×–EŠà‚É‚¨‚¯‚éŽîᇊ֘A“œ½RŒ´”­Œ»‚ÌŒŸ“¢. Š}ˆäŒ‰C‹T’J“Oi•a—jCät“n’‰’ji—Õ•a—j: ‘æ78‰ñ“ú–{•a—Šw‰ï‘‰ï (89.03.30), ‹ž“s, “ú–{•a—Šw‰ï‰ïŽ, 78: 139, 1989.

685. mŠw‰ïn iˆê”Êu‰‰j ‹¹‘BŽîᇂÌMRI. “cŠŽŒÈC’J“c—ˆê˜YC¬—Ñ–ÎŽ÷C¼Šª”ŽC’r“crºC‘º“cWˆê˜YC÷ˆä´ŽqC–x’rdŽ¡C›MˆêC¼—Ñ—²i•új: ‘æ48‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï (89.04.05), _ŒËC “ú–{ˆãŠw•úŽËüŠw‰ïŽ¥‘æ48‰ñ´˜^WC49(—Õ‘): s57, l989.

686. mŠw‰ïn iˆê”Êu‰‰j ”xRadionuclide Angiography ‚ÌFactor Analysis‚É‚æ‚é”xŽ¾Š³Š³ŽÒ‚Ì”xŒŒ—¬“®‘Ô‚ÌŒŸ“¢. ’†‘òŒ\Ž¡CΈ䟌ÈC¼Šª”ŽC–x’rdŽ¡C’r“crºC“cŠŽŒÈC¼—Ñ—²i•új: ‘æ48‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï (89.04.05), _ŒËC “ú–{ˆãŠw•úŽËüŠw‰ïŽ¥‘æ48‰ñ´˜^WC49(—Õ‘): s65, l989.

687. mŠw‰ïn iˆê”Êu‰‰j ŠO«‰¡Šu–Œƒwƒ‹ƒjƒA‚Ì1Ž¡Œ±—á. “V–ì—²bC‹ß“¡‡‹`i‹¹ŠOjC‘¼: ‘æ144‰ñˆïéŠO‰ÈˆãŠw‰ï (89.05.00), …ŒË.

688. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™ŒÄ‹zŠíŽ¾Š³‚É‚¨‚¯‚é123I|IMP”xƒVƒ“ƒ`ƒOƒ‰ƒ€‚ÌŒŸ“¢. ”~Œ´ŽÀC–¥‰YŽ‘¥C²“¡—Y“ñCŽR“¿‚Ý‚ïC“n•Ó“oCΓc®”VC’†“ˆ‰p•FiŽ™jC–x’rdŽ¡CΈ䟌Èi•új: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.20), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 93(3): 768, l989.

689. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™‚É‚¨‚¯‚釖°Žž–³ŒÄ‹zƒ‚ƒjƒ^|‘•’uiƒAƒvƒmƒ‚ƒjƒ^| MAY-715j‚ÌŽg—p‚ÉŠÖ‚·‚錟“¢. –¥‰YŽ‘¥C”~Œ´ŽÀC²“¡—Y“ñCŽR“¿‚Ý‚ïC“n•Ó“oCΓc®”VC’†“ˆ‰p•FiŽ™j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (89.05.20), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 93(3): 768, l989.

690. mŠw‰ïn iˆê”Êu‰‰j Ž‰–bÇðÇŒóŒQ‚ÌBALFŠŒ©. ‚èŒõ‹Ii—Õ•a—jC•Ð‹Ë^li“àjCV“¡³‹PC–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ62‰ñ—Õ°ŒÄ‹z¶—Œ¤‹†‰ï (89.06.17), “Œ‹ž.

691. mŠw‰ïn iˆê”Êu‰‰j ƒƒCƒRƒgƒŠƒGƒ“C4‚É‚æ‚é‹C“¹ôò‰t’†‚Ì‘B«ƒJƒŠƒNƒŒƒCƒ“Šˆ«‚Ì‘‘å‹@˜. ”n“ˆ³—²CHong Yong Jin CŽ­ŽæMi–ò—j: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï (89.07.20-21), “Œ‹žC —\eW, p.177, 1989.

692. mŠw‰ïn iˆê”Êu‰‰j Effects of Latex and Different Doses of Silica on Behavior of Iron Particles in Rabbit Lungs. ‘ŠàVDŽ¡C‚“c™¦C‹´–{‹Nˆê˜YC•x‰i‰qC’F—mi‰qjC¬’J½i“Œ‹ž“d‹@‘åjCK. ChiyotaniiŒ]”x˜JЕa‰@j: 7th International Conference on Biomagnetism (89.08.17), New York.

693. mŠw‰ïn iˆê”Êu‰‰j Accessory Muscle Activity in Patients with Cervical Spinal Cord Injury. ‘Š”nˆêˆåCó—˜–õC‘å‚O–«C‘å˜a“c—²i‹~–½j: The 5th World Congress on Intensive & Critical Care Medicine (89.09.06), ‹ž“s.

694. mŠw‰ïn iˆê”Êu‰‰j ƒƒCƒRƒgƒŠƒGƒ“C4Ö¬“à“Š—^‚É‚æ‚é‹C“¹“à‘B«ƒJƒŠƒNƒŒƒCƒ“Šˆ«—V—£‚Ì‘‘å. ”n“ˆ³—²CHong Yong JinCŽ­ŽæMi–ò—j: ‘æ39‰ñ“ú–{ƒAƒŒƒ‹ƒM|Šw‰ï‘‰ï (89.09.28°30), “Œ‹žC ƒAƒŒƒ‹ƒM|, 38: 1989.

695. mŠw‰ïn iˆê”Êu‰‰j A Newly Designed Pneumatic-Pulse-Pump-Membrane Oxygenator. ‹´–{¬Li¶‘ÌHjC•x‰i½ˆêi‹¹ŠOjCMinoru YoshidaCYasunori Sasaki (NDK): 7th World Congress of the International Society for Artificial Organs (89.10.04), ŽD–yC Artificial Organs, 13(4): 305, 1989.

696. mŠw‰ïn iˆê”Êu‰‰j Tracheotomies: A 15-Year Experience. ¼‰ª–¾—TC‚‹´œAbCŒÃì_ŽOCŒ´“cGˆêC‹àŽqŒ÷iŽ¨•@j: ‘æ6‰ñ¢ŠE‹CŠÇH“¹‰ÈŠw‰ï (89.10.17), “Œ‹žC ‘æ6‰ñ¢ŠE‹CŠÇH“¹‰ÈŠw‰ï—\eW, p.78.

697. mŠw‰ïn iˆê”Êu‰‰j Radionuclide Angiocardiography‚Ì Factor Analysis‚É‚æ‚éæ“V«SŽ¾Š³Š³ŽÒ‚Ì”xŒŒ—¬“®‘Ô‚ÌŒŸ“¢. ’†‘òŒ\Ž¡CΈ䟌ÈC¼Šª”ŽC’J“c—ˆê˜YC‹e’rŒhCˆË“cˆêdC¼—Ñ—²i•új: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (89.10.21), ‘å’Ã, ŠjˆãŠw, 26(8): 1073, 1989.

698. mŠw‰ïn iˆê”Êu‰‰j Œz‘‘¹Š³ŽÒ‚̌ċzŠÇ—‚ÉŠÖ‚·‚錟“¢. ‘Š”nˆêˆåC‹e–ì—²–¾Có—˜–õC“c’†–ö…C‰““¡¹FC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.08), “Œ‹ž.

699. mŠw‰ïn iˆê”Êu‰‰j ‡TŠú‘BŠàÄ”­—á‚Ì—Õ°•a—Šw“IŒŸ“¢. •i“cƒC‹g‘º”Ž–MC•½ˆäŽO˜YCì~C•ŽR’¼Ž÷CÎŒ´ºi‹¹ŠOjCŠ}ˆäŒ‰C‹T’J“Oi•a—j: ‘æ30‰ñ“ú–{”xŠàŠw‰ï‘‰ï (89.11.10), ‰ªŽR, ”xŠà, 29(5): 461, 1989.

700. mŠw‰ïn iˆê”Êu‰‰j –³ŒŒ´”|’n‚É‚æ‚éhCGƒ¿-subunitŽY¶”xŠà×–EŠ”‚ÌŽ÷—§‚Æ‚»‚Ì«ó. Š}ˆäŒ‰C‹T’J“Oi•a—j: ‘æ30‰ñ“ú–{”xŠàŠw‰ï‘‰ï (89.11.10), ‰ªŽR, ”xŠà, 29(5): 517, 1989.

701. mŠw‰ïn iˆê”Êu‰‰j dÇ‹Ø–³—Íǂ̉摜f’f|MRI‚ÍCT‚É‘ã‚í‚éf’f–@‚©|. “cŠŽŒÈC’J“c—ˆê˜YC¬—Ñ–ÎŽ÷C¼ŽR³ŒáC¼Šª”ŽC’r“crºC›MˆêC¼—Ñ—²i•újC•½ˆäŽO˜YC‹g‘º”Ž–Mi‹¹ŠOjC“팴”Í”Vi“àj: ‘æ30‰ñ“ú–{”xŠàŠw‰ï (89.11.11), ‰ªŽR, ”xŠài‘æ30‰ñ“ú–{”xŠàŠw‰ï‘‰ï†j, 29(5): 566, 1989.

702. mŠw‰ïn iˆê”Êu‰‰j ‹CŠÇŽxšb‘§Š³Ž™‚ɑ΂·‚é‰^“®•‰‰×ƒeƒXƒg‚ÌÄ•]‰¿. “n•Ó“oC’†“ˆ‰p•FC”~Œ´ŽÀC²“¡—Y“ñC–¥‰YŽ‘¥CŽl‘q³”ŽiŽ™j: ‘æ26‰ñ“ú–{¬Ž™ƒAƒŒƒ‹ƒM|Šw‰ï (89.11.17), ‘åã, ´˜^W, P.130, l989.

703. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™Šú‹C“¹‰ß•q«ŒŸ¸‚Ì•]‰¿–@‚ɂ‚¢‚Ä‚ÌŒŸ“¢. –¥‰YŽ‘¥C’†“ˆ‰p•FC“n•Ó“oC”~Œ´ŽÀC²“¡—Y“ñCŽl‘q³”ŽCiŽ™j: ‘æ26‰ñ“ú–{¬Ž™ƒAƒŒƒ‹ƒM|Šw‰ï (89.11.17), ‘åãC “ú–{¬Ž™ƒAƒŒƒ‹ƒM|Šw‰ïŽGŽ, 3(2): 67, l989.

704. mŠw‰ïn iˆê”Êu‰‰j –UŒŸ‚Å–¾‚ç‚©‚É‚È‚Á‚½‹¹–Œˆ««’†”çŽî‚Ì1—á. “cŠ‰xŽqi“Œ•a‰@•a—jC–{‹§C’†‰p’ji•a—jC‘å–ì‰pŽ¡i•a‰@•a—j: ‘æ28‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïŠwpu‰‰‰ï (89.11.17), ‰¡•l, “ú–{—Õ°×–EŠw‰ïŽGŽ, 28(5): 695, 1989.

705. mŠw‰ïn iˆê”Êu‰‰j ƒAƒfƒmƒEƒCƒ‹ƒX”x‰ŠŒã‚É–«ŒÄ‹zŠíÇó‚ð’悵‚½3Ç—á‚Ì—Õ°“IŒŸ“¢. Žl‘q³”ŽC’†“ˆ‰p•FC“n•Ó“oCŽR“¿‚Ý‚ïC”~Œ´ŽÀC–¥‰YŽ‘¥C²“¡—Y“ñiŽ™jC–x’rdŽ¡i•új: ‘æ22‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï (89.11.30), •Ÿ‰ª.

706. mŠw‰ïn iˆê”Êu‰‰j ‹C“¹‰ß•q«ŽŽŒ±‚Ì standardization; ŠeŽí‹C“¹‰ß•q«•]‰¿•û–@‚É‚¨‚¯‚é‘ŠŒÝŠÖŒW. –¥‰YŽ‘¥iŽ™j: ‘æ22‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï (89.12.01), •Ÿ‰ª.

707. mŠw‰ïn iˆê”Êu‰‰j ¶”x‘S“Eop‚ðŽ{s‚µ‚½dÇ‹CŠÇŽxŠg’£Ç‚Ì‚P’jŽ™—á. ŠÖª“OCˆäŒ…^—R”üCŽR“cr•FCŽl‘q³”ŽC–¥‰YŽ‘¥C”~Œ´ŽÀC“n•Ó“oC’†“ˆ‰p•FiŽ™jC•½ˆäŽO˜YC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ22‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï (89.12.01), •Ÿ‰ª.

708. mŠw‰ïn iˆê”Êu‰‰j ‹CŠÇŽxšb‘§Š³Ž™‚̉^“®‘Ï—e”\‚ɂ‚¢‚Ä‚ÌŒŸ“¢. “n•Ó“oC’†“ˆ‰p•FC”~Œ´ŽÀC²“¡—Y“ñC–¥‰YŽ‘¥CŽl‘q³”ŽiŽ™j: ‘æ22‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï (89.12.01), •Ÿ‰ª, ´˜^WCp.91C1989.

709. mŠw‰ïn iˆê”Êu‰‰j ‹CŠÇˆÙ•¨‚Ì1—á. ’†‘º—vC‹àŽqŒ÷CŒÃ‘òTˆêCŒÃì_ŽOiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ70‰ñŽ¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŠwpu‰‰‰ï (89.12.16), ‰¡•l.

710. mŠw‰ïn iˆê”Êu‰‰j Paraneoplastic Syndrome, ‹}«ŒÄ‹z•s‘S‚ðŽå’¥‚Æ‚µ‚½”xŠà‚Ì1—á. V“cŒ’‘¾˜YiŽ¨jC“c’†•üŽqC¬–쎛½ŒåC–kˆä‘¥•vC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ28‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (90.02.17), “Œ‹ž.

711. mŠw‰ïn iˆê”Êu‰‰j ‘O—§‘BŠà‚ð‡•¹C‰¡Šu–Œ‚ðŠÑ’Ê‚µ• o“ài“W‚𗈂½‚µ‚½¶‹¹–Œˆ««’†”çŽî‚Ì1–UŒŸ—á. –{‹§C’†‰p’jCΈä‰pºC£ìŒªˆêi•a—jCA‘—˜Œöi‡“V‘åjC‰œ•½‰ë•Fi•a—j: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.30), •Ÿ‰ª, “ú–{•a—Šw‰ï‰ïŽ, 79(1): 231, 1990.

712. mŠw‰ïn iˆê”Êu‰‰j ‹C“¹‰ß•q«ŒŸ¸’†‚̘A‘±«ƒ‰‰¹‚ÌŒŸ“¢. “팴”Í”VC‰Ô“cL‰pC‹v•Û“cŸCˆäŒË“cÆ‹`C²“¡“ú²ŽqC‘q“c¬C•Ð‹Ë^lCž`ŒE–LC–î“ߣM—YCˆ¢•”’¼C‘å’Ë—m‹vC•y“c—FKi“àj: ‘æ29‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ï‘‰ï i89.04.05), ‹ž“s, “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 27(‘): 268, 1989.

713. mŠw‰ïn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@ŒÄ‹zŠí“à‰È‚É‚¨‚¯‚é”xŠàÇ—á‚ÉŠÖ‚·‚錟“¢iŠJ‰@Œã13”NŠÔ‚ÌÇ—á‚ɂ‚¢‚Äj. –î“ߣM—YC²“¡“ú²ŽqCŽR–{”Ž”VCŽ›ˆä”ÉŸCÎ삈êC“팴”Í”VCŒ´•ŽjC•Ð‹Ë^lCž`ŒE–LCˆ¢•”’¼C‘å’Ë—m‹vC•y“c—FKi“àj: ‘æ29‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ï‘‰ï i89.04.05), ‹ž“s, “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 27(‘): 279, 1989.

714. mŠw‰ïn iˆê”Êu‰‰j Œ´ˆö•s–¾‚Ì‚Ñ‚Ü‚ñ«”xŽ¾Š³‚É‚¨‚¯‚é‹CŠÇŽx”x–Eôò‰t•ªÍ‚ÌŽ¡—Âɑ΂·‚é—Õ°“IŒŸ“¢. •Ð‹Ë^li“àjC‘Š”nˆêˆåi‹~–½jC‚èŒõ‹Ii—Õ•a—jCÎ삈êC²“¡“ú²ŽqCÎì—ºCŽR–{”Ž”VCž`ŒE–LC–î“ߣM—YCˆ¢•”’¼C‘å’Ë—m‹vC•y“c—FK i“àj: ‘æ29‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ï‘‰ï i89.04.06), ‹ž“s, “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 27(‘): 386, 1989.

715. mŠw‰ïn iˆê”Êu‰‰j 111In-•WŽ¯”’ŒŒ‹…‚Ì”xŽ¾Š³‚É‚¨‚¯‚éf’f“IˆÓ‹`. ŽR–{”Ž”VC“팴”Í”Vi“àjCΈ䟌Èi•újC—é–Ø“¹OC‹ß“¡‚¦‚èCÎì—ºC•Ð‹Ë^lCž`ŒE–LC–î“ߣM—YCˆ¢•”’¼C‘å’Ë—m‹vC•y“c—FKi“àj: ‘æ29‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ï‘‰ï i89.04.07), ‹ž“s, “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 27(‘): 481, 1989.

716. mŠw‰ïn iˆê”Êu‰‰j ”x¬×–EŠà‚Æ‚ÌŠÓ•Ê‚ª¢“ï‚Å‚ ‚Á‚½Pseudolymphoma‚Ì1—á. ²“¡“ú²ŽqCˆäŒË“cÆ‹`C‘q“c¬CÎì—ºC“팴”Í”VC•Ð‹Ë^lC–î“ߣM—YC–{‘½ƒCˆ¢•”’¼C•y“c—FKi“àj: ‘æ84‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ïŠÖ“Œ’n•û‰ï i89.05.13), “Œ‹ž.

717. mŠw‰ïn iˆê”Êu‰‰j ‹C“¹”M‚É‚¨‚¯‚é‹CŠÇŽx”x–Eôò‰tŠŒ©‚ɂ‚¢‚Ä‚ÌŒŸ“¢. •Ð‹Ë^li“àjC‚èŒõ‹Ii—Õ•a—jC–î“ߣM—Yi“àjC‰©‹àˆäN–¤C‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ15‰ñ“ú–{”MŠw‰ï‘‰ï i89.05.20), O‘O, “ú–{”MŠw‰ï‰ïŽ, 15(3): 191, 1989.

718. mŠw‰ïn iˆê”Êu‰‰j ŠJ‹¹”x¶ŒŸÇ—á‚Ì—\Œã‹K’èˆöŽq‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢. ²“¡“ú²ŽqC•Ð‹Ë^lCŽR–{”Ž”VCÎì—ºC–î“ߣM—YC•y“c—FKi“àjC•i“cƒC•½ˆäŽO˜YC‹g‘º”Ž–Mi‹¹ŠOjC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ16‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï i89.06.08), ˆ®ì, ICU‚ÆCCU, 13(‘): 109, 1989.

719. mŠw‰ïn iˆê”Êu‰‰j Œ´”­«½œ‰ºÃ–¬ŒŒðÇ‚ªŒ´ˆö‚Æ‚È‚Á‚½”x[Ç‚Ì1—á. ˆäŒË“cÆ‹`C“팴”Í”VCÎì—ºC–î“ߣM—YCˆ¢•”’¼C•y“c—FKC“cè‹`ºi“àjC“‡“cŒªC¡ˆäŒ‰Cª–{EiŠOj: ‘æ384‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i89.07.08), “Œ‹ž.

720. mŠw‰ïn iˆê”Êu‰‰j Œ´ˆö•s–¾‚Ì‚Ñ‚Ü‚ñ«”xŽ¾Š³‚É‚¨‚¯‚é‹CŠÇŽx”x–Eôò‰t•ªÍ‚ƃXƒeƒƒCƒhŽ¡—Â̗LŒø«‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢. •Ð‹Ë^lC²“¡“ú²ŽqC“팴”Í”VC–î“ߣM—YC–{‘½ƒCˆ¢•”’¼C•y“c—FKi“àjC‘Š”nˆêˆåi‹~–½jC‚èŒõ‹Ii—Õ•a—j: ‘æ12‰ñ“ú–{‹CŠÇŽxŠw‰ï‘‰ï i89.07.08), “Œ‹ž, ‹CŠÇŽxŠw, 11(‘): 109, 1989.

721. mŠw‰ïn iˆê”Êu‰‰j Auscultation over the Neck during Bronchial Provocation Test in Asthmatics. “팴”Í”VC•Ð‹Ë^lC–î“ߣM—YC–{‘½ƒCˆ¢•”’¼C•y“c—FKi“àj: 14th International Congress on Lung Sounds i89.08.14), Winnipeg, Canada.

722. mŠw‰ïn iˆê”Êu‰‰j Šm’èf’f‚É‹ê—¶‚µ‚½ˆ¾—±Œ‹Šj‚Ì2Ç—á. ‚“cM˜aC²“¡“ú²ŽqCÎì—ºC•Ð‹Ë^lC“팴”Í”VC–î“ߣM—YC–{‘½ƒCˆ¢•”’¼C•y“c—FKi“àj: ‘æ86‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ïŠÖ“Œ’n•û‰ï i89.09.09), “Œ‹ž.

723. mŠw‰ïn iˆê”Êu‰‰j Combined Oat Cell Carcinoma‚Ì‘gDŒ^‚ð‚Æ‚Á‚½”x–å•”‘Šú”xŠà‚Ì1—á. ‘q“c¬CˆäŒË“cÆ‹`CÎì—ºC²“¡“ú²ŽqC“팴”Í”VC•Ð‹Ë^lC–î“ߣM—YC–{‘½ƒCˆ¢•”’¼C•y“c—FKi“àjC•½ˆäŽO˜YC‹g‘º”Ž–Mi‹¹ŠOjCŠ}ˆäŒ‰C‹T’J “Oi•a—j: ‘æ85‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ïŠÖ“Œ’n•û‰ï i89.09.09), “Œ‹ž.

724. mŠw‰ïn iˆê”Êu‰‰j šq“f‚É‚¨‚¯‚鉡Šu–Œ‚Ì“­‚«|Š·‹C‰^“®‚Æ‚Ì”äŠr|. ²“¡“ú²ŽqC‰ØŽ÷¬i“àjC“c’†^Ÿi‘‡—Õ°ŒnjCÎì—ºC“팴”Í”VC•Ð‹Ë^lC–î“ߣM—YC–{‘½ƒCˆ¢•”’¼C•y“c—FKC“cè‹`ºi“àj: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï i89.09.30), ‘Š–ÍŒ´, –k—¢ˆãŠw, 19(6): 644, 1989.

725. mŠw‰ïn iˆê”Êu‰‰j Diaphragmatic Shortening during Vomiting. ˆ¢•”’¼C‰ØŽ÷¬C²“¡“ú²ŽqC“팴”Í”VC“c’†‚lC•y“c—FKi“àj: International Symposium on Control of Breathing and Dyspnea i89.10.28), å‘ä, Abstracts, p.53, 1989.

726. mŠw‰ïn iˆê”Êu‰‰j ‹¹•”‚wüŽÊ^㶉E·‚ð”F‚ß‚½‰ÄŒ^‰ß•q«”x‰Š‚Ì1—á. —é–Ø“¹OC²“¡“ú²ŽqC‘q“c¬C“팴”Í”VC•Ð‹Ë^lC–î“ߣM—YC–{‘½ƒCˆ¢•”’¼C•y“c—FKC“cè‹`ºi“àj: ‘æ387‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i89.11.11), “Œ‹ž.

727. mŠw‰ïn iˆê”Êu‰‰j Acute Eosinophilic Pneumonia‚Ì1—á. ²“¡“ú²ŽqC‚“cM˜aC‘q“c¬CÎì—ºC“팴”Í”VC•Ð‹Ë^lC–î“ߣM—YCˆ¢•”’¼C•y“c—FKi“àjC‘Š”nˆêˆåi‹~–½j: ‘æ88‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ïŠÖ“Œ’n•û‰ï i90.02.17), “Œ‹ž.

728. mŠw‰ïn iˆê”Êu‰‰j Dermadrome‚ª‘Šú”­Œ©‚ÌŒ_‹@‚Æ‚È‚Á‚½”xŠà‚Ì1—á. ‚“cM˜aC‘q“c¬C“팴”Í”VCˆ¢•”’¼C•y“c—FKi“àjC’ËŒ´“NÆCŠâè‰ëi”çjC•½ˆäŽO˜YC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ390‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i90.03.10), b•{.

729. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ¬Ž™”x‹@”\ŒŸ¸–@‚ÌŠî‘bCV¶Ž™‚æ‚èŽvtŠú‚Ü‚Å‚Ì”x‹@”\‚Ì•]‰¿G“ûŽ™ŠúŒÄ‹zƒpƒ^|ƒ“‚̉ðÍ. –¥‰YŽ‘¥iŽ™j: “ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï¬Ž™”x‹@”\ŒŸ¸uK‰ï (89.05.l8), VŠƒC ¬Ž™”x‹@”\ŒŸ¸uK‰ïƒeƒLƒXƒgCp.21`27, l989.

730. mŒ¤‹†‰ïn iˆê”Êu‰‰j ARDS‚Ì•a‘ԉ𖾂Ɋւ·‚錤‹†. ‘Š”nˆêˆåi‹~–½j: ‘æ5‰ñŽ_‘f—R—ˆƒ‰ƒWƒJƒ‹Œ¤‹†‰ï (89.05.17), ‘Š–ÍŒ´.

731. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒŒðœ‹Žp’†‚É Massive Air Leak ‚ð’悵‚½‰E”x“®–¬’P“ÆŒ‡‘¹Ç‚Ì1’jŽ™—á. ã–ìM–íC’†“ˆ‰p•FC“n•Ó“oC”~Œ´ŽÀC–¥‰YŽ‘¥C“‡–{—R‹IŽqCŽl‘q³”ŽiŽ™jCó—˜G’ji‹¹ŠOj: ‘æ3‰ñ“ú–{¬Ž™‹~‹}ˆãŠwŒ¤‹†‰ï (89.06.17), “Œ‹žC ¬Ž™‰È—Õ°, 43(2): 410, l990.

732. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹}«ŒÄ‹z¢“ï‚ð’悵‚½ Bronchial cast ‚Ì3—á. Žl‘q³”ŽC”~Œ´ŽÀC–¥‰YŽ‘¥C“n•Ó“oC’†“ˆ‰p•FiŽ™jC–x’rdŽ¡i•új: ‘æ3‰ñ“ú–{¬Ž™‹~‹}ˆãŠwŒ¤‹†‰ï (89.06.17), “Œ‹žC ¬Ž™‰È—Õ°, 43(2): 411, l990.

733. mŒ¤‹†‰ïn iˆê”Êu‰‰j •ÂÇ«ŒÄ‹zŠíŽ¾Š³Š³Ž™‚̉^“®•‰‰×ƒeƒXƒg‚É‚¨‚¯‚éƒpƒ‹ƒXƒIƒLƒVƒ|ƒ^|‚Ì—L—p«‚ɂ‚¢‚Ä‚ÌŒŸ“¢. Žl‘q³”ŽC’†“ˆ‰p•FC“n•Ó“oC”~Œ´ŽÀC–¥‰YŽ‘¥iŽ™j: ‘æ4‰ñƒpƒ‹ƒXƒIƒLƒVƒƒgƒŠ|Œ¤‹†‰ï (89.06.24), “Œ‹žC ƒpƒ‹ƒXƒIƒLƒVƒƒgƒŠ|, 3: 95`97, l989.

734. mŒ¤‹†‰ïn iˆê”Êu‰‰j ¬Ž™ŒÄ‹zŠíŽ¾Š³‚É‚¨‚¯‚é123I-IMP”xƒVƒ“ƒ`ƒOƒ‰ƒ€‚ÌŒŸ“¢. ”~Œ´ŽÀCŽl‘q³”ŽC–¥‰YŽ‘¥C“n•Ó“oC’†“ˆ‰p•FiŽ™jC–x’rdŽ¡CΈ䟌Èi•új: ‘æ5‰ñŠÖ“Œ’n‹æŒÄ‹zŠíŠjˆãŠwŒ¤‹†‰ï (89.09.09), “Œ‹ž.

735. mŒ¤‹†‰ïn iˆê”Êu‰‰j ¸_‰È—̈抳ŽÒ‚É‚Ý‚ç‚ꂽdÇ”x‰Š‚ÉŠÖ‚·‚錟“¢. “c’†•üŽqC¼ŽR’¼‹vC•½“cŒõ”ŽC’ç–M•FC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ26‰ñ_“Þ쌧Š´õÇŒ¤‹†‰ï (89.09.09), ‰¡•l.

736. mŒ¤‹†‰ïn iˆê”Êu‰‰j PDA‚É‹Nˆö‚µ‚½”xoŒŒ‚É‚¨‚¯‚éHFO‚ÌŽg—pŒoŒ±. –ì“n³•FC¬ŒûO‹BCŠp“cV•½iŽ™j: ‘æ3‰ñHFOŒ¤‹†‰ï (90.02.25), “Œ‹ž.

737. mŒ¤‹†‰ïn iˆê”Êu‰‰j šq“fŽž‚ÌŒ¢‰¡Šu–Œ‚Ì“®‚«|’´‰¹”g‚ð—p‚¢‚½‹Ø“÷‚Ì’·‚³‚ÌŒŸ“¢|. ‰ØŽ÷¬i“àjC“c’†^Ÿi‘‡—Õ°ŒnjC²“¡“ú²ŽqC“팴”Í”VCˆ¢•”’¼C•y“c—FKi“àj: ‘æ9‰ñ_“ÞìŒÄ‹zƒJƒ“ƒtƒ@ƒŒƒ“ƒX i89.05.20), Œú–Ø.

738. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹C“¹‰ß•q«ŒŸ¸’†‚ÌŒz•”ŒÄ‹z‰¹‚̕ω». “팴”Í”VC‰ØŽ÷¬CÎì—ºCˆäŒË“cÆ‹`C²“¡“ú²ŽqC‘q“c¬CŽR–{”Ž”VC•Ð‹Ë^lC–{‘½ƒC–î“ߣM—YCˆ¢•”’¼C•y“c—FKi“àj: ‘æ13‰ñ”x‰¹iŒÄ‹z‰¹jŒ¤‹†‰ï i89.06.10), “Œ‹ž, Ther. Res., 10(10): 429`433, 1989.

739. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œ¢‰¡Šu–Œ‚Ì”ñŠ·‹C‹@”\|šq“fŽž‚Ì“­‚«|. ²“¡“ú²Žqi“àjC“c’†^Ÿi‘‡—Õ°ŒnjC‰ØŽ÷¬C“팴”Í”VCˆ¢•”’¼C•y“c—FKi“àj: “ú–{MEŠw‰ïê–å•ÊŒ¤‹†‰ï‘æ5‰ñuŒÄ‹z‚Ì—Õ°MEvŒ¤‹†‰ï i89.06.16), “Œ‹ž.

740. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹C“¹”MŽž‚Ì”xŒŒŠÇ“§‰ß«‚ÉŠÖ‚·‚錤‹†. •Ð‹Ë^lC–î“ߣM—YC•y“c—FKi“àjC‰FˆäŒª“ñC‰F’Öؗ´ˆêC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC‚èŒõ‹Ii—Õ•a—j: ‘æ62‰ñ—Õ°ŒÄ‹z¶—Œ¤‹†‰ï i89.06.17), “Œ‹ž.

741. mŒ¤‹†‰ïn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@‚É‚¨‚¯‚éÝ‘îŽ_‘f—Ö@‚ÌŒ»ó‚Æ‚»‚Ì–â‘è“_. Î삈êC‚“cM˜aC‘q“c¬C²“¡“ú²ŽqCÎì—ºC“팴”Í”VC•Ð‹Ë^lC–î“ߣM—YC–{‘½ƒCˆ¢•”’¼C•y“c—FKi“àjC‘Š”nˆêˆåi‹~–½j: ‘æ10‰ñ_“ÞìŒÄ‹zƒJƒ“ƒtƒ@ƒŒƒ“ƒX i89.11.25), ‰¡•l.

742. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒÄ‹z¢“ïAšb–‚ðŽå’¥‚Æ‚µ•›t”玿ƒzƒ‹ƒ‚ƒ“Ü’ZŠúŽ¡—Ã’†‚É”­Ç‚µ‚½P. Carinii”x‰Š‚Ì1—á. ‚“cM˜aC“팴”Í”VCˆ¢•”’¼C•y“c—FKi“àjC¬—Ñ–¾–FC–kŒ´F—YC‘Š”nˆêˆåi‹~–½j: ‘æ27‰ñ_“Þ쌧Š´õÇŒ¤‹†‰ï i90.02.03), ‰¡•l.

743. mŒ¤‹†‰ïn iˆê”Êu‰‰j –òÜ—U‹N«”x‰Š‚Ì‹CŠÇŽx”x–Eôò‰t‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢. ‘q“c¬C—é–Ø“¹OC‰Ô“cL‰pi“àjC‚èŒõ‹Ii—Õ•a—jCÎì—ºC•Ð‹Ë^lC–î“ߣM—YCˆ¢•”’¼C•y“c—FKi“àjC‘Š”nˆêˆåi‹~–½j: ‘æ35‰ñFLDƒVƒ“ƒ|ƒWƒEƒ€ i90.03.10), “Œ‹ž.


<<104 _Œoi¸_‰ÈŠw‚ðŠÜ‚Þj>>

744. mŒ´’˜n Cerebral Blood Flow and Cerebral Hematocrit in Patients with Cerebral Ischemia Measured by Single-photon Emission Computed Tomography. âˆä•¶•FCŒÜ\—’‹v‰ÀC—é–ØGˆêC“cè‹`ºi“àj: Acta Neurol. Scand., 127(Suppl.): 9`13, 1989.

745. mŒ´’˜n A Newly Designed Flow-Regulating Device in Shunt Therapy of Hydrocephalus. ‹´–{¬Li¶‘ÌHjCì–ìM”Vi”]ŠOj: Artificial Organs, 13(5): 483`485, 1989.

746. mŒ´’˜n Properties of Single Chloride Channels in Primary Neuronal Cultures of Drosophila. Daisuke YamamotoiŽO•H‰»¬¶–½Œ¤jC—é–ØM”Vi¶—j: Biochimica et Biophysica Acta, 986: 187`190, 1989.

747. mŒ´’˜n Two Components of Calcium Channel Current in Embryonic Chick Skeletal Muscle Cells Developing in Culture. ‰Á”Z³–¾i¶—jC—N“c–MŽqi¶•¨•¨—jC²“¡—º•½i¶—j: Develop. Brain Res., 47(1): 101`112, 1989.

748. mŒ´’˜n Cranial Burr Hole for Revascularization in Moyamoya Disease. ‰““¡¹FCì–ìM”VC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOj: J. Neurosurg., 71: 180`185, 1989.

749. mŒ´’˜n Faster Firing Neurons of the Superior Central Raphe and Ongoing Behaviors in Freely Moving Rats. ŽRèŽÌ•vi¶—j: Jpn. J. Physiol. Psychol. Psychophysiol., 7(1): 27`38, 1989.

750. mŒ´’˜n The in Vivo Effects of Indomethacin on Reactivity of the Rat Pial Arterioles. ‰¤”C’¼CXˆä½“ñC‘å‚O–«i”]ŠOj: Kitasato Med., 19(4): 426`435, 1989.

751. mŒ´’˜n ƒtƒ‹ƒ‰ƒ[ƒpƒ€AƒgƒŠƒAƒ]ƒ‰ƒ€Aƒ]ƒsƒNƒƒ“‚Ì‹L‰¯‚ɑ΂·‚éì—p. ‘ºèŒõ–Mi¸j: Medical Tribune, 22: 32, 1989.

752. mŒ´’˜n Responses of the Pial Arterioles to Hemorrhagic Hypotension in Rat; A Possible Role of Adenosine. Xˆä½“ñC‰¤”C’¼C‘å‚O–«C–î“cŒ«ŽOi”]ŠOjCŽ­ŽæMi–ò—j: Microcircul. Annual.(Proceeding), p.47`48, 1989.

753. mŒ´’˜n Sodium valproate ‚Ì•¹—p‚ªcarbamazepine ‚¨‚æ‚Ñcarbamazepine-10,11-epoxide ‚Ì—V—£Œ^ŒŒ’†”Z“x‚É‚¨‚æ‚Ú‚·‰e‹¿‚È‚ç‚Ñ‚É‚»‚Ì—Õ°“IˆÓ‹`. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂiŽ™j: TDM Œ¤‹†, 6(1): 93`95, 1989.

754. mŒ´’˜n Radioreceptor Assay of Clonazepam and Diazepam in Blood for Therapeutic Drug Monitoring. ¼ì—²C¼“c—zC‘å’J‰pŽ÷i—Õ•a—jC»‰ŸÂCŽO‰YŽõ’jiŽ™jC{“¡–F³i–k—¢ƒ‰ƒ{jC‹v•Û”Žºi–òŠw•”j: Therapeutic Drug Monitoring, 11(4): 483`486, 1989.

755. mŒ´’˜n Clear Cell Ependymoma, A Histological Variant with Diagnostic Implications. ì–ìM”VC–î“cŒ«ŽOi”]ŠOjC–ö‰ºŽO˜Yi•a—j: Virchows Archiv. A Pathol Anat., 415: 467`472, 1989.

756. mŒ´’˜n “ª•”ŠO‚𔺂¤‘½”­ŠO—á‚É‚¨‚¯‚铪ŠW“àˆ³ƒ‚ƒjƒ^[‚Ìd—v«. ‰““¡¹FC‚–ì½C“c’†ç•FC‹´–{—²i‹~–½jC¼X–Mºi‘—§‘Š–ÍŒ´•a‰@j: ˆã—Ã, 43(10): 1010`1013, 1989.

757. mŒ´’˜n Ž©ŽEŠé}Œë—p‚É‚æ‚é‹}«ƒjƒgƒ‰ƒ[ƒpƒ€’†“Å‚Ì—Õ°|68Ç—á‚ɂ‚¢‚Ä‚ÌŒŸ“¢Œ‹‰Ê‚©‚ç|. “‡“c‰hŽqCŽO‰Y’å‘¥i¸j: ÅVˆãŠw, 44(11): 2349`2359, 1989.

758. mŒ´’˜n Diazepam ¿Ü‚Ì”­”MŽžŠÔŸ[“Š—^–@‚É‚æ‚é”M«‚¯‚¢‚ê‚ñ‚ÌÄ”­—\–hŠúŠÔ’†‚É‚Ä‚ñ‚©‚ñ‚ÖˆÚs‚µ‚½Ç—á‚̊댯ˆöŽq‚ÉŠÖ‚·‚錟“¢. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂiŽ™j: ¬Ž™‰È—Õ°, 42(11): 2419`2426, 1989.

759. mŒ´’˜n ‚¤‚Á•aŽ¡—Âɂ¨‚¯‚éMAD‘jŠQ–ò•œŠˆ‚̉”\«. ‘ºèŒõ–Mi¸j: _Œo¸_–ò—, 11: 763`779, 1989.

760. mŒ´’˜n •Ð“ª’É‚Ì—\–h“IŽ¡—ÂɊւ·‚錤‹†. ŒÜ\—’‹v‰ÀCâˆä•¶•FC“cè‹`ºi“àj: _Œo“à‰ÈŽ¡—Ã, 6(6): 555`560, 1989.

761. mŒ´’˜n “«‚¤‚•a‚ÌŽ¡—Ã|bó‘Bƒzƒ‹ƒ‚ƒ“—Ö@‚Æ“dŒ‚—Ö@‚ÌŒŸ“¢|. Žá“c•””Ž•¶CŽRéˆê˜YCŠ}Œ´—FKC΋½‰ªƒC‘å’J‹`•vCŽO‰Y’å‘¥i¸j: _“Þì¸_–ò—, (2): 19`22, 1988.

762. mŒ´’˜n ƒjƒgƒ‰ƒ[ƒpƒ€‚Ì‹}«’†“ÅÇó‚ɂ‚¢‚Ä. “‡“c‰hŽqCŽá“c•””Ž•¶C‘å’J‹`•vCŽO‰Y’å‘¥i¸j: _“Þì¸_–ò—, (3): 37`44, 1989.

763. mŒ´’˜n V‚½‚ÉlˆÄ‚µ‚½…“ªÇƒVƒƒƒ“ƒgƒVƒXƒeƒ€—pƒAƒ“ƒ`¥ƒwƒbƒh•Ù. ‹´–{¬Li¶‘ÌHjCì–ìM”Vi”]ŠOj: lH‘ŸŠí, 17(2): 787`790, 1988.

764. mŒ´’˜n ”ñƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“ŒnR•sˆÀ–ò. ‘ºèŒõ–Mi¸j: ¸_‰ÈŽ¡—Êw, 5: 25`43, 1990.

765. mŒ´’˜n OverstretchÇ—á‚ÌŽ¡—Ã. ŽOˆäŒö•FC”Ñ“cG•vC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOjC‘å˜a“c—²i‹~–½j: Ò‘ŠO‰È, 3: 137`141, 1989.

766. mŒ´’˜n Ò‘ƒ‚ƒjƒ^ƒŠƒ“ƒO‚Ì—L—p«‚ɂ‚¢‚Ä. ‹kŽ ‘i”]ŠOj: Ò‘ŠO‰È, 3: 15`19, 1989.

767. mŒ´’˜n Ò‘‹ó“´Ç‚Ì”­¶ƒƒJƒjƒYƒ€‚ɑ΂·‚él‚¦•û. ‹kŽ ‘C”Ñ“cG•vi”]ŠOj: Ò’ÅÒ‘ƒWƒƒ[ƒiƒ‹, 3(2): 113`118, 1990.

768. mŒ´’˜n ”X–EŒ`¬«”]ŽºŽüˆÍ«”’Ž¿“icystic PVLj‚Ì”­’B—\Œã. –åˆäL‹ÅC–쑺ƒŽqCŒ´^lCŠ—Œ´FC»‰ŸÂC’†‘ºP•äCÄ“¡KˆêC¬ŒûO‹BC”ª‘ãŒö•viŽ™j: “ú–{¬Ž™‰ÈŠw‰ïŽGŽC 94(1): 91`96, 1990.

769. mŒ´’˜n •”•ª”­ì‚ɑ΂·‚é carbamazepine ’PÜŽ¡—Â̌ø‰Ê|carbamazepine ‚È‚ç‚Ñ‚É carbamazepine-10,11-epoxide ŒŒ’†”Z“xƒ‚ƒjƒ^ƒŠƒ“ƒO‚̈Ӌ`|. ŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂiŽ™j: “ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(6): 1365`1373, l989.

770. mŒ´’˜n ”]ŽºŽüˆÍ«”’Ž¿“iPVLj‚ÌŽ¥‹C‹¤–‰摜ŠŒ©|‘æ‚PŽ™‚ªŒ’í‚Å‘æ‚QŽ™‚ªPVL‚Å‚ ‚Á‚½‘o‘Ù—á‚É‚¨‚¯‚é”äŠr|. –åˆäL‹ÅCŠ—Œ´FCÄ“¡KˆêC•½Î‘C”ª‘ãŒö•viŽ™jC›Mˆêi•új: “ú–{V¶Ž™Šw‰ïŽGŽC25(3): 581`589, 1989.

771. mŒ´’˜n dÇ‚ŒŒˆ³«”]“àŒŒŽîpŒã‚Ì“ªŠW“àˆ³. ’†ŽRŒ«ŽiC‹{â‰À’jC²“¡Œ’CŽs앶•FC‰ªGGCŽRŒû»Žqi”]ŠOjC‘å˜a“c—²i‹~–½jC–î“cŒ«ŽOi”]ŠOj: ”]‚Æ_Œo, 41(11): 1149`1154, 1989.

772. mŒ´’˜n ”]‘²’†‹}«Šú‚Ì‚¨‚¯‚錌Ÿ÷MHPG‚Ì•Ï“®. “Œ–M•FC”¨—²ŽuCâˆä•¶•FC_“c’¼C“cè‹`ºi“àj: ”]‘²’†, 11(4): 366`372, 1989.

773. mŒ´’˜n ‰„‘ŠO‘¤ÇŒóŒQ‚ð’悵‚½‰ð—£«’Åœ“®–¬áŽ‚Ì1—á|Ž¡—Ãã‚Ì–â‘è“_‚ɂ‚¢‚Ä. “ü‘qŽŒÈC‹{â‰À’jC‘å‚O–«C–î“cŒ«ŽOi”]ŠOjCL£—²ˆêi“àj: ”]‘²’†, 11: 133`139, 1989.

774. mŒ´’˜n ”]“®–¬áŽªŽ¡Žèp‚ÉŽŠ‚炸Ž€–S‚µ‚½ƒNƒ‚–Œ‰ºoŒŒ—á‚ÌŒŸ“¢. –kŒ´F—YCÄ“¡Œ³—ÇC‘å˜a“c—²i‹~–½jC“ü‘qŽŒÈC–kŒ´s—YC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOj: ”]‘²’†‚ÌŠO‰È, 17: 128`131, 1989.

775. mŒ´’˜n ƒ‰ƒbƒg”]‹•ŒŒŽž‚̃‚ƒmƒAƒ~ƒ“•úo‚ɂ‚¢‚Ä‚ÌŒ¤‹†. –약CC_“c’¼i“àj: –k—¢ˆãŠw, 19(6): 587`593, 1989.

776. mŒ´’˜n ¸_•ª—ô•aŠ³ŽÒ‚É‚¨‚¯‚éYM-09151‚Ì—Õ°–ò—Šw“IŒŸ“¢. Έä‘P‹PC‘ºèŒõ–Mi¸j: –ò—‚ÆŽ¡—Ã, 17(9): 153`167, 1989.

777. mŒ´’˜n ”]ŒŒŠÇ‰Š‚Ì‚P¬l—á|Ž©Œ±—á‚Ì•ñ‚Æ”]ŒŒŠÇ‰Š‚ɂ‚¢‚Ä|. Ä“¡–L˜aC‹{“c‰Ã¢ŽqCŒÃ˜a‹vKC“cè‹`ºi“àj: —Õ°_Œo, 29(4): 456`463, 1989.

778. mŒ´’˜n ˆê‰ß«‘SŒ’–Y”­ì‚Ì2Ç—á|PETŠŒ©‚ð’†S‚Æ‚µ‚Ä|. ‰¬–ì—Ti“àjC‰¡ˆä•—Ž™C¼”öŒ’Ž‘CtŒ´Œo•FC—¢‹g‰c“ñ˜Yi‘—§¸__ŒoƒZƒ“ƒ^[j: —Õ°_Œo, 29(5): 599`605, 1989.

779. mŒ´’˜n ¬l”­Ç‚Ì–«Š´Šo«ƒjƒ…[ƒƒpƒ`[‚Ì—Õ°“IŒŸ“¢. Ä“¡–L˜aC‹{“c‰Ã¢ŽqCדc–«C’¹‹‡ŽOCŒÃ˜a‹vKi“àj: —Õ°_Œo, 29(7): 859`865, 1989.

780. mŒ´’˜n HAMŠ³ŽÒ‚É‚¨‚¯‚鑉toligoclonal bands‚ÌŒŸ“¢. Ä“¡–L˜ai“àjC”[ŒõOC‰FhŒ÷Žs˜YC¼–{ŽÀCˆäŒ`ºOiŽ­Ž™“‡‘åj: —Õ°_Œo, 29(8): 976`981, 1989.

781. mŒ´’˜n Šá‹ØŒ^dÇ‹Ø–³—ÍÇ‚Æ‚µ‚ÄŠÏŽ@‚³‚ê‚Ä‚¢‚½mitochondria myopathy (cytochrome C oxidase•”•ªŒ‡‘¹j‚Ì2—á. ¼“cs³i“àjCâ“cçŽíCtŒ´Œo•FC”W’†ªÆC—¢‹g‰c“ñ˜Yi‘—§¸__ŒoƒZƒ“ƒ^[j: —Õ°_Œo, 29(9): 1180`1182, 1989.

782. mŒ´’˜n ”]Š²[Ç‚Ì”]”gŠŒ©|MRIŠŒ©‚Æ‚Ì‘Ì”ä|. ”¨—²Žui“àjC™ŽRˆêi¸jC‹g–{gŽqi—ÕŒŸj: —Õ°”]”g, 32(1): 5`13, 1990.

783. m’Z•ñn Effectiveness and Plasma Levels of Sodium Valproate Monotherapy in the Treatment of Epilepsies in Children: A Further Study. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂiŽ™j: Jpn. J. Psychiatr. Neurol., 43(3): 517`518, 1989.

784. m’Z•ñn Ò‘‘“àŽîá‡. ›Mˆêi•új: “ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ïŽGŽ, 2(1): 39`39, 1989.

785. m’Z•ñn H‹G—Õ°‘å‰ï‹LŽ–;Ò‘Ò’Å. ›Mˆêi•új: “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 49(4): 496, 1989.

786. m’Z•ñn ’s•ð|‹ÇŠ”]zŠÂ‚©‚ç‚̃Aƒvƒ[ƒ`. âˆä•¶•Fi“àj: ˜V”NŠú’s•ðŒ¤‹†‰ïŽ, 2: 18`20, 1989.

787. mŒ¤‹†•ñn •p‰ñ‚ÌŽîᇓàoŒŒ‚ð‚«‚½‚µ‚½’®_ŒoâŽî‚Ì1—á. ‘q“c²i”]ŠOjCÄ“¡•ŽuCԒ˽Æiˆä“c•a‰@jC›Mˆêi•újC‚–ØGi‘å˜aŽs—§•a‰@j: _ŒoŠO‰È, 29: 328`332, 1989.

788. mŒ¤‹†•ñi•¶•”Èjn ŠÌˆÚA‚̃VƒXƒeƒ€‰»‚Æ„i‚ÉŠÖ‚·‚錤‹†|”íŠkoŒŒ‚Ì“à‰ÈŽ¡—Âɂæ‚é—\Œã|. “cè‹`ºC_“c’¼C–kˆä‘¥•vi“àj: º˜a62°63”N“x‰ÈŠwŒ¤‹†”ï•â•‹àˆê”ÊŒ¤‹†(A)Œ¤‹†¬‰Ê•ñ‘, p.60`68, 1989.

789. mŒ¤‹†•ñi•¶•”Èjn ƒ‰ƒWƒIƒŒƒZƒvƒ^|ƒAƒbƒZƒC‚É‚æ‚éƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“ŒnR‚Ä‚ñ‚©‚ñ–ò‚Ì—LŒø”Z“xˆæ‚ÌŒŸ“¢. »‰ŸÂiŽ™j: º˜a63”N“x•¶•”ȉȊwŒ¤‹†”ï•â•‹ài§—㌤‹† AjŒ¤‹†¬‰Ê•ñ‘C1989.

790. mŒ¤‹†•ñiŒú¶Èjn ’s•ðŽ¾Š³‚Ì—\–h¥Ž¡—ÃA•û–@‚ÉŠÖ‚·‚錤‹†; Œü¸_•a–ò‚â”]zŠÂ‘ãŽÓ‰ü‘PÜ“™‚É‚æ‚鎡—ÃA’s•ð‚É“Á—L‚ȸ_Çó‚â–â‘ès“®‚Ì—\–h¥Ž¡—Ó™‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²¸. ’·’JìP—YiˆÉ“¤”BŽR‰·ò•a‰@jC“cè‹`ºC‹àŽq®“ñi“àjCŠ‹’J•¶’jC‰““¡‰pri–¼ŒÃ‰®‘åjCA‘ºŒ¤ˆêC‘ë_Žui•l¼ˆã‘åjC’·’Jì˜a•vC¡ˆäK[i¹ ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åj: Œ¤‹†•ñ‘, p.100`108, 1989.

791. mŒ¤‹†•ñiŒú¶Èjn _Œo×–E‚̈Þk‚ª’˜–¾‚Å‚ ‚Á‚½’s•ðÇ—á. ’·’JìˆêŽqC¼“cs³CŒÃ˜a‹vKi“àjC–ö‰ºŽO˜YC–{‹§i•a—j: Œú¶ÈƒVƒ‹ƒo[ƒTƒCƒGƒ“ƒXŒ¤‹†•ñ‘, p.64`66, 1989.

792. mŒ¤‹†•ñiŒú¶Èjn ”]ŽåŠ²“®–¬•ÂÇǂɉ—‚¯‚é‹ÇŠ”]ŒŒ—¬‚Ì’·Šú—\Œã. âˆä•¶•Fi“àj: Œú¶ÈzŠÂŠí•aŒ¤‹†ˆÏ‘õ”ï‚É‚æ‚錤‹†•ñW, p.215, 1989.

793. mŒ¤‹†•ñiŒú¶Èjn Onion bulb\‘¢‚ð—L‚·‚é’E‘«ƒjƒ…[ƒƒpƒ`[‚Ì”­Ç‹@˜‚ÉŠÖ‚·‚錤‹†|—Õ°“I–ƉuŠw“I‚¨‚æ‚ѶŒŸäC• _Œo‘gD‘œ‚ÌŒŸ“¢|. ŒÃ˜a‹vKCÄ“¡–L˜aCˆÉ“¡”Ž–¾C¼“cs³Ca’JŒb”üŽqi“àj: Œú¶È¸__ŒoŽ¾Š³Œ¤‹†ˆÏ‘õ”ïuƒjƒ…[ƒƒpƒ`[‚̬ˆö‹y‚ÑŽ¡—ÂɊւ·‚錤‹†, p.133, 1989.

794. mŒ¤‹†•ñiŒú¶Èjn CJD”D•wŠ³ŽÒ‚Ì–UŒŸ”]‚©‚çƒ}ƒEƒX‚Ö‚ÌTransmission¬Œ÷—á. ‹Êˆä—mˆêC¬“ˆ‹vŽqi¶‰»jC–k“‡—Œbi¶‰»ŒnjCìŒû‹BC‘å’J‹`•vCŽO‰Y’å‘¥i¸jC²“¡³Ž÷i•a—jC‘êŒûG–çC“cŒû•¶Íi‰q¶Šw•”jCÎŒ´DOi“s —§_ŒoŒ¤j: Œú¶È“Á’莾Š³u’x”­«ƒEƒCƒ‹ƒXŠ´õvŒ¤‹†”Ç•½¬Œ³”N“xŒ¤‹†•ñ‘, p.133`137, 1990.

795. mŒ¤‹†•ñiŒú¶Èjn ”ñ“TŒ^“I‚È•a—ŠŒ©‚ð”F‚ß‚½‰^“®ƒjƒ…[ƒƒ“•a—á. ŒÃ˜a‹vKC’·’JìˆêŽqC¼“cs³i“àjC–ö‰ºŽO˜Yi•a—j: Œú¶È“Á’莾Š³_Œo•Ï«Ž¾Š³’²¸Œ¤‹†”Ç1988”N“xŒ¤‹†•ñ‘, p.67, 1989.

796. mŒ¤‹†•ñiŒú¶Èjn ˜V”NŠú’s•ð‚Ì–ò•¨Ž¡—ÂɊւ·‚錤‹†. ’·’JìP—YiˆÉ“¤”BŽR‰·ò•a‰@jC“cè‹`ºC‹àŽq®“ñi“àjCŠq²˜YCŽ‰Æ—²i“ú–{ˆã‰È‘åjC•Ÿ“à–õ’jiŒc‰ž‘åjCr–،ܘYi“ŒŠC‘åjC‘å—F‰pˆêi—•—‰ï •a‰@jCŠ‹’J•¶’jC‰““¡‰pri–¼ŒÃ‰®‘åj: Œú¶È“Á’莾Š³’s•ðŽ¾Š³‘Îô’²¸Œ¤‹†•ñ‘, 1989.

797. mŒ¤‹†•ñiŒú¶Èjn ’E‘«ƒjƒ…[ƒƒpƒ`[‚É‚¨‚¯‚éRganglideR‘Ì|ELISA‚É‚¨‚¯‚錟“¢|. Ä“¡–L˜aCa’J”üŒbŽqCˆÉ“¡”Ž–¾CŒÃ˜a‹vKi“àj: Œú¶È“Á’莾Š³–Ɖu«_ŒoŽ¾Š³’²¸Œ¤‹†•ñ‘, p.192`196, 1989.

798. mŒ¤‹†•ñiŒú¶Èjn ‰^“®ƒjƒ…[ƒƒ“•aŠ³ŽÒŒŒ´’†‚ÌIgMƒNƒ[ƒ“R‘Ì‚ª”FŽ¯‚·‚é“œ½. Ä“¡–L˜aCˆÉ“¡”Ž–¾Ca’J”üŒbŽqCŒÃ˜a‹vKi“àj: Œú¶È“Á’莾Š³–Ɖu«_ŒoŽ¾Š³’²¸Œ¤‹†•ñ‘, p.197`200, 1989.

799. mŒ¤‹†•ñiŒú¶Èjn zŠÂŠíê–å•a‰@‚É‚¨‚¯‚ézŠÂŠíŽ¾Š³“o˜^•[‚É‚æ‚éƒpƒCƒƒbƒgƒXƒ^ƒfƒB‚ÌŽŽs. _“c’¼C–약Ci“àj: º˜a63”N“xŒú¶ÈzŠÂŠí•aŒ¤‹†ˆÏ‘õ”ï‚É‚æ‚錤‹†•ñW, p.372`373, 1989.

800. mŒ¤‹†•ñi‰ÈŠw‹Zp’¡jn CJD ”­ÇˆöŽq‚Ì”Zk‚Æ”|—{×–EŒn‚Å‚Ì‘B‚ÌŽŽ‚Ý. ‹Êˆä—mˆêC¬“ˆ‹vŽqi¶‰»j: •½¬Œ³”N“x‰ÈŠw‹Zp’¡uƒvƒŠƒIƒ“ŠÖ˜AŽ¾Š³iƒNƒƒCƒcƒtƒFƒ‹ƒg¥ƒ„ƒRƒu•aj”­Œ»‹@\‰ðÍ‹Zp‚ÌŠJ”­vŒ¤‹†¬‰Ê•ñ‘, p.5`15, 1990.

801. mÇ—á•ñn —¼‘¤–¬—‘pŽ‰–bŽî‚𔺂Á‚½”]—ÀŽ‰–bŽî‚Ì1Ç—á|MRI‚Ì—L—p«‚ɂ‚¢‚Ä|. ‚‹´½C“¡–{ŽiCóˆäˆê˜YC•Ÿ“‡‹`Ž¡iº˜a‘åjC›Mˆêi•új: CTŒ¤‹†, 11(3): 341`345, 1989.

802. mÇ—á•ñn ƒNƒŠƒbƒsƒ“ƒO’¼Œã‘Α¤‚É”j—ô‚ð‚«‚½‚µ‚½—¼‘¤“àŒz“®–¬áŽ‚Ì1Žèp—á. “ü‘qŽŒÈC‚–ì½C“c’†ç•FCÄ“¡Œ³—ÇC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‹~‹}ˆãŠw, 13: 905`908, 1989.

803. mÇ—á•ñn ‘å–ƒ¸_•a‚Ì6—á. “¿ˆä’BŽiC•ÄŒ³—˜²CŠâ‰ºŠoC”óŽRŒõ‹³Cˆî“cr–çCŽO‘º«C—é–Ø‹`“¿i÷¹‹u•Û—{‰@jCìŒû‹Bi¸jCìˆä®CŒIŒ´˜a•Fi÷¹‹u•Û—{‰@j: ¸_ˆãŠw, 31(9): 919`929, 1989.

804. mÇ—á•ñn Ò‘ŽîᇂƂ̊ӕʂª¢“ï‚Å‚ ‚Á‚½Œz‘ŒŒŠÇŽî‚Ì1—á. “c’†–ö…C”Ñ“cG•vCŽOˆäŒö•FC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOj: “ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ïŽGŽ, 2: 174`175, 1989.

805. mÇ—á•ñn ‘“à”­ˆç‚ðŽ¦‚µ‚½Œz‘_ŒoüˆÛŽî‚Ì1—á. ‰ªGGCz–K’m–çC”Ñ“cG•vCŽOˆäŒö•FC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOj: “ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ïŽGŽ, 2: 180`181, 1989.

806. mÇ—á•ñn ‹}«d–Œ‰º”^ᇂÌ1Ž¡Œ±—á. ŽR“cŸCó—˜–õC™–{Ÿ•FC‘å‚O–«C–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽ, 10(1): 236`238, 1989.

807. mÇ—á•ñn “Ý“IŠO‚É‚æ‚é’Åœ“®–¬‘¹‚ÌŒoŒ±. ”Ñ“cG•vCì–ìM”VC‰““¡¹FCÄ“¡Œ³—Çi”]ŠOjCL£—²ˆêi“àjC‘å˜a“c—²i‹~–½jC–î“cŒ«ŽOi”]ŠOj: ”]_ŒoŠO‰È, 17: 1051`1060, 1989.

808. mÇ—á•ñn ‹»–¡‚ ‚éCTŠŒ©‚ð’悵‚½‹}«”]Ç‚Ì‚P“ûŽ™—á. ŽO‰YŽõ’jC”~Œ´ŽÀiŽ™jC‘å•”½i•a—j: –k—¢ˆãŠwC19(4): 460`462, 1989.

809. m—Õ°Ž¡Œ±n ’·Šú“Š—^‚É‚¨‚¯‚éYM-09151‚̸_•ª—ô•a‚ɑ΂·‚éŒø‰Ê‹y‚шÀ‘S«‚ÌŒŸ“¢. ‘ºèŒõ–Mi¸j: ˆãŠw‚Æ–òŠw, 22: 733`746, 1989.

810. m—Õ°Ž¡Œ±n V‚µ‚¢ƒxƒ“ƒYƒAƒ~ƒhŒnR¸_•a–òYM-09151‚̉Šú‘æ‡U‘ŠŽŽŒ±. ‘ºèŒõ–MCŽRŠpxCZ‹gHŽŸC΋½‰ªƒi¸jC‘¼11–¼: V–ò‚Æ—Õ°, 38: 1385`1398, 1989.

811. m—Õ°Ž¡Œ±n V‚½‚ÈIminodibenzylŒn‰»‡•¨(Y-516)‚̸_•ª—ô•a‚ɑ΂·‚é—Õ°Œø‰Ê. ‹à–쎠C‚‹´—ÇiˆÇ—Ñ‘åjC‘ºèŒõ–Mi¸jC‘¼10–¼: –ò—‚ÆŽ¡—Ã, 17(6): 2657`2671, 1989.

812. m—Õ°Ž¡Œ±n KB-831i‰–Ž_ƒgƒ‰ƒ]ƒhƒ“j‚ÌR‚¤‚ÂŒø‰Ê|‘½Ž{Ý‹¤“¯Œ¤‹†‚É‚æ‚éƒI[ƒvƒ“ŽŽŒ±|. 㓇‘—˜CŒIŒ´‰ë’¼C‚‹´—ÇCX‰·—C’·’Jì˜a•vC‰““¡r‹giˆÇ—Ñ‘åjC‘ºèŒõ–Mi¸jC”óŒû‹P•FiˆÇ—Ñ‘åj: –ò—‚ÆŽ¡—Ã, 17(Suppl. 5): 1451`1463, 1989.

813. m—Õ°Ž¡Œ±n V‚µ‚¢R‚¤‚–òKB-831i‰–Ž_ƒgƒ‰ƒUƒhƒ“j‚Ì‚—îŽÒ‚¤‚•a‚ɑ΂·‚é—Õ°ŽŽŒ±. ΋½‰ªƒC‘ºèŒõ–Mi¸jC㓇‘—˜iˆÇ—Ñ‘åj: –ò—‚ÆŽ¡—Ã, 17(Suppl. 5): 1519`1527, 1989.

814. m—Õ°Ž¡Œ±n V‚µ‚¢BenzamideŒnR¸_•a–òYM-09151‚̸_•ª—ô•a‚ɑ΂·‚é‘æ‡U‘ŠŽŽŒ±. ‘ºèŒõ–Mi¸jCX‰·—C‚‹´—ÇC‰¼‰®“N•FC•—ÕŒ³iˆÇ—Ñ‘åjC”ª–Ø„•½iŒc‘åjC㓇‘—˜iˆÇ—Ñ‘åj: –ò—‚ÆŽ¡—Ã, 17: 4347`4365, 1989.

815. m—Õ°Ž¡Œ±n ¸_•ª—ô•a‚ɑ΂·‚éƒCƒ~ƒmƒWƒxƒ“ƒW[ƒ‹—U“±‘ÌY-516‚̃NƒƒJƒvƒ‰ƒ~ƒ“‘ÎÆ“ñd–ÓŒŸ”äŠrŽŽŒ±. ‰Á“¡LŸC‚‹´—ÇiˆÇ—Ñ‘åjC”ª–Ø„•½iŒc‘åjC•—ÕŒ³CX‰·—iˆÇ—Ñ‘åjC‘ºèŒõ–Mi¸j: —Õ°•]‰¿, 17: 177`196, 1989.

816. m—Õ°Ž¡Œ±n ¸_•ª—ô•a‚ɑ΂·‚éV‚µ‚¢BenzamideŒnR¸_•a–òYM-09151‚ƃnƒƒyƒŠƒh[ƒ‹‚Ì“ñd–ÓŒŸ”äŠrŽŽŒ±. X‰·—C•—ÕŒ³C‹à–쎠C㓇‘—˜C‰¼”ö“N•FiˆÇ—Ñ‘åjC‘ºèŒõ–Mi¸jC”ª–Ø„•½iˆÇ—Ñ‘åj: —Õ°•]‰¿, 17: 349`377, 1989.

817. m‘àn ‚µ‚­‚Ý‚Æ“­‚«: “®Šá_Œo¥ŠŠŽÔ_Œo. _“c’¼i“àj: Clinical Neuroscience, 8(2): 18`21, 1990.

818. m‘àn áŠQ‚Æ‚»‚Ìf‚©‚½: “®Šá_Œo¥ŠŠŽÔ_Œo. _“c’¼i“àj: Clinical Neuroscience, 8(2): 31`34, 1990.

819. m‘àn ”][Ç‚ÌŽ¡—ÂÆÄ”­—\–h. _“c’¼i“àj: Medical Digest, 38(3): 7`12, 1989.

820. m‘àn ˆê‰ß«”]‹•ŒŒ”­ì. _“c’¼i“àj: Medical Practice, 6(‘): 23`26, 1989.

821. m‘àn ”]oŒŒ. _“c’¼i“àj: Modern Physician, 9(5): 561`563, 1989.

822. m‘àn ƒ]ƒsƒNƒƒ“. ‘ºèŒõ–Mi¸j: ƒJƒŒƒ“ƒgƒeƒ‰ƒs[, 7: 1893`1895, 1989.

823. m‘àn ˜’ŒŊԔƒwƒ‹ƒjƒA. ›Mˆêi•új: ‰æ‘œf’f, 9(6): 678`685, 1989.

824. m‘àn ‰–Ž_ƒXƒ‹ƒgƒvƒŠƒh. ‘ºèŒõ–Mi¸j: Œ»‘ãˆã—Ã, 22: 9`11, 1990.

825. m‘àn ƒƒCƒ‰ƒbƒNƒX. ‘ºèŒõ–Mi¸j: Žž‚ÌV–ò, 10: 37`38, 1989.

826. m‘àn ƒoƒ‹ƒlƒ`[ƒ‹. ‘ºèŒõ–Mi¸j: Žž‚ÌV–ò, 10: 41`42, 1989.

827. m‘àn ƒeƒgƒ‰ƒ“ƒhù 90 mg. ‘ºèŒõ–Mi¸j: Žž‚ÌV–ò, 11: 38`42, 1989.

828. m‘àn ‚—îŽÒ‚̉ŠúÇŒóA‰ŠúŽ¡—Ãmf—ẪRƒcn‚ß‚Ü‚¢. ŒÃ˜a‹vKi“àj: ŽÀŒ±Ž¡—Ã, 616: 6`7, 1989.

829. m‘àn ”][Ç‚ÌÄ”­—\–h|“à‰È‚Ì—§ê‚©‚ç|. _“c’¼i“àj: zŠÂ‰ÈŠw, 9(7): 736`740, 1989.

830. m‘àn R‚Ä‚ñ‚©‚ñ–ò’PÜŽ¡—Ã. ŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂiŽ™j: ¬Ž™‰Èf—Ã, 52(11): 2521`2530, 1989.

831. m‘àn R‚Ä‚ñ‚©‚ñ–ò‚ÌŽ¡—ÓI–ò•¨ƒ‚ƒjƒ^ƒŠƒ“ƒO. ŽO‰YŽõ’jiŽ™j: ¬Ž™“à‰ÈC22(1): 85`93, 1990.

832. m‘àn Guillain-Barre ÇŒóŒQ. Ä“¡–L˜aC‰¬–ì—Ti“àj: _Œo¸_–ò—, 12(2): 95`104, 1990.

833. m‘àn ‚ˆÀ•a‚Ì_ŒoÇó. ”¨—²Žui“àj: _Œo“à‰È, 31(4): 343`352, 1989.

834. m‘àn Cimetidine‚É‚æ‚é’†•_ŒoáŠQ. ΋½‰ªƒi¸j: _Œo“à‰ÈŽ¡—Ã, 6(4): 337`339, 1989.

835. m‘àn Vincristine‚É‚æ‚é”]ÇAŽ©—¥_ŒoáŠQ. ŒÃ˜a‹vKi“àj: _Œo“à‰ÈŽ¡—Ã, 7(1): 3`6, 1990.

836. m‘àn R•sˆÀ–ò‚Ìì—p‹@˜‚ð‚ß‚®‚Á‚Ä. ‘ºèŒõ–Mi¸j: _“Þ쌧¸_ˆãŠw‰ïŽ, 38: 3`16, 1989.

837. m‘àn ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ò•¨‚É‚æ‚éˆË‘¶‚Æ‹L‰¯áŠQ. ΋½‰ªƒi¸j: ¸_ˆãŠw, 32(3): 267`274, 1990.

838. m‘àn Ò’ÅAÒ‘ŠO‰È‚É‚¨‚¯‚éƒXƒeƒƒCƒh—Ö@. ŽOˆäŒö•Fi”]ŠOj: Ò’Å¥Ò‘ƒWƒƒ[ƒiƒ‹, 1: 417`419, 1989.

839. m‘àn Ò‘‘“àŽîᇂ̎èp. ŽOˆäŒö•FC¼X–Mºi‘—§‘Š–ÍŒ´•a‰@jC”Ñ“cG•vC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOjC‘å˜a“c—²i‹~–½j: Ò’Å¥Ò‘ƒWƒƒ[ƒiƒ‹, 2(12): 885`892, 1989.

840. m‘àn ”]ŒŒŠÇáŠQ‚Ì•a‘Ôf’f‚Æ•”ˆÊf’f. ”¨—²ŽuC“cè‹`ºi“àj: ‘‡—Õ°, 38(11): 2783`2794, 1989.

841. m‘àn ƒp[ƒLƒ“ƒ\ƒ“•a‚ÌŠm’èf’f‚ÆŽ¡—Ã. ŒÃ˜a‹vKC’·’JìˆêŽqCדc–«i“àj: ‘‡—Õ°, 38(5): 947`948, 1989.

842. m‘àn “ª’É‚ÌŠÓ•Êf’f‚ÆŽ¡—Ã. âˆä•¶•Fi“àj: “à‰È, 64(2): 229`233, 1989.

843. m‘àn ‹}«ŠúŒz‘i’Åj‘¹‚Ö‚Ì‘Îô. ‘å˜a“c—²i‹~–½j: “ú–{ˆãŽ–V•ñ, (3407): 13`14, 1989.

844. m‘àn Ò‘Žîá‡. ›Mˆêi•új: “úàÕˆã•ñ, 34(1): 35`45, 1989.

845. m‘àn ¬Ž™‚É‚¨‚¯‚éR‚Ä‚ñ‚©‚ñ–ò•¨—Ö@‚Ì“ÁˆÙ«. ŽO‰YŽõ’jiŽ™j: ”]‚Æ”­’BC22(2): 154`159, 1990.

846. m‘àn R‚Ä‚ñ‚©‚ñ–ò•¨—Ö@|’PÜŽ¡—ÂƌŒ’†”Z“xƒ‚ƒjƒ^ƒŠƒ“ƒO‚̈Ӌ`|. ŽO‰YŽõ’jiŽ™j: ”­’B–ò—¥–ò•¨Ž¡—ÃŒ¤‹†‰ïŽGŽC2(1): 55`63, 1989.

847. m‘àn ƒNƒƒCƒcƒtƒFƒ‹ƒg¥ƒ„ƒRƒu•a‚Ì•aŒ´‘Ì‚Æ”­Ç‹@˜. ‹Êˆä—mˆêC¬“ˆ‹vŽqi¶‰»j: •a‘Ô¶—, 9(10): 858`862, 1989.

848. m‘àn MRI —LŠŒ©Ç—á‚©‚ç‚Ý‚½‰fŽžŽå‘i‚Ì•ªÍ|Ò‘AÒ’ÅŽ¾Š³‚ɂ‚¢‚Ä|. ‘º“cWˆê˜Yi•új: –k‘«—§ŒSŽsˆãŽt‰ï‰ï•ñ, (129): 10`17, 1990.

849. m‘àn ’¹‚Ì”­º|’®Šoi‡UjšFŠwK‚̌‘̔­’B‹y‚Ñ”]‚ÌšF§Œä. ŽRèŽÌ•vi¶—j: –k—¢ˆãŠw, 19(1): 6`11, 1989.

850. m‘àn ”]ŒŒŠÇáŠQ–«Šú‚ÌŽ¡—Ã. ”¨—²ŽuC“cè‹`ºi“àj: —Õ°‚ÆŒ¤‹†, 66(6): 1900`1906, 1989.

851. m‘àn ŽŒøŒ^¸__Œo—pÜ. ŽO‰Y’å‘¥i¸j: —Õ°‚Æ–ò•¨Ž¡—Ã, 8(4): 484`487, 1989.

852. m‘àn ”]Žîá‡. ›Mˆêi•új: —Õ°‰æ‘œ, 5(12): 34`42, 1989.

853. m‘àn ˜’ɂ̉摜f’f; CT. ›Mˆêi•új: —Õ°‰æ‘œ, 5(9): 30`39, 1989.

854. m‘àn ‘‡•a‰@¸_‰È‚ÌŒ»ó‚Æ–â‘èi‡Tj|‘åŠwˆãŠw•”•t‘®•a‰@‚Ì—§ê‚©‚ç|. ’†“‡ß•vCŽO‰Y’å‘¥i¸j: —Õ°¸_ˆãŠw, 18(5): 589`596, 1989.

855. m‘àn Sˆö«‘½ˆù. ’†“‡ß•vi¸j: —Õ°¸_ˆãŠw, 18(9): 1379`1384, 1989.

856. m‘àn “ÁW:˜V”NŠú’s•ð‚̊댯ˆöŽqAlzheimer•a‚̊댯ˆöŽqg“ª•”ŠOh. ‹{â‰À’ji”]ŠOj: ˜V”NŠú’s•ð, 4: 75`78, 1989.

857. muÀn ”]ŒŒŠÇáŠQ–«Šú‚ÌŽ¡—ÂÌi‚ß•û. ‹àŽq®“ñC_“c’¼i“àj: Medicament News, (1286): 1`4, 1989.

858. muÀn ˆÓŽ¯áŠQ|¨‡|. ”¨—²Žui“àj: Medicina, 26(7): 1110`1114, 1989.

859. muÀn ‰æ‘œf’f‚Ì‚½‚߂̳í‰ð–U}•ˆ;“ªŠWҒňÚs•”¥Ò’Å¥Ò‘. ›Mˆêi•új: Modern Physician, 9: 797`802, 1989.

860. muÀn ”M«‚¯‚¢‚ê‚ñ‚Æ‚Ä‚ñ‚©‚ñ. ŽO‰YŽõ’jiŽ™j: Petit enfant, 9(12): 145`147, 1989.

861. muÀn ÉŽ_–ò‚Å“ª’É‚ª‚È‚º‹N‚±‚é. âˆä•¶•Fi“àj: ƒNƒŠƒjƒVƒAƒ“, 36(385): 49`52, 1989.

862. muÀn ƒp[ƒLƒ“ƒ\ƒ“•a‚ÌV‚µ‚¢Ž¡—Â̎Ž‚Ý¥’·ŠúƒŒƒ{ƒhƒpÇŒóŒQ‚ɑ΂µ‚Ä. ’·’JìˆêŽqi“àj: ˆãŠw‚Ì‚ ‚ä‚Ý, 150(13): 829, 1989.

863. muÀn ‚¤‚•a. ˆîŒ©ˆòºCŽO‰Y’å‘¥i¸j: ŒŽŠ§–òŽ–, 32(1): 77`82, 1990.

864. muÀn Ž©—¥ŒP—û–@. ’†“‡ß•vi¸j: Ž¡—Ã, 71(4): 941`946, 1989.

865. muÀn ‚Ä‚ñ‚©‚ñ|’PÜŽ¡—ÂƖò•¨ŒŒ’†”Z“xƒ‚ƒjƒ^ƒŠƒ“ƒO‚ð’†S‚É|. ŽO‰YŽõ’jiŽ™j: ¬Ž™‰È—Õ°C42(4): 707`717, 1989.

866. muÀn ‹¹˜’ňÚs•”‚ÌÒ‘ŽîᇂÆÒ‘ŒŒŠÇáŠQ. ”Ñ“cG•vi”]ŠOjC‘å˜a“c—²i‹~–½j: Ò’ÅAÒ‘, 3: 421`427, 1990.

867. muÀn ’É‚Ý‚Ì—Õ°. âˆä•¶•Fi“àj: “à‰È, 64(2): 277`289, 1989.

868. muÀn ¬Ž™‚Ì”M«‚¯‚¢‚ê‚ñ|‚»‚ÌŠÇ—‚Æ—\Œã‚ð’†S‚É|. ŽO‰YŽõ’jiŽ™j: •ÛŒ¯ˆã‚Ì—Õ°C(294): 2`11, 1989.

869. muÀn Sˆö«•p”Ç. ’†“‡ß•vi¸j: —Õ°–ƒŒ, 13(11): 1539`1541, 1989.

870. mÀ’k‰ïn ƒp[ƒLƒ“ƒ\ƒ“•a‚ÌŽ¡—Ã. –ö‘òM•viMB‘åjCŒÃ˜a‹vKi“àj: “à‰È, 63(5): 903`922, 1989.

871. mŠwp‘n iŽ·•Mj Brain Hypoxia; ‰–Ž_ƒtƒ‹ƒiƒŠƒWƒ“‚É‚æ‚é•Ð“ª’É‚Ì—\–h“IŽ¡—Ã, 3: 3`8, ŒÜ\—’‹v‰ÀCâˆä•¶•FC“cè‹`ºi“àj. •ÒW Œã“¡•¶’jC‘¼•Ò, ‚É‚ã[‚ë‚ñŽÐ, “Œ‹ž, 89.07.31”­s.

872. mŠwp‘n iŽ·•Mj }à:“à‰Èf’fŽ¡—ÃuÀ 15. ƒp[ƒLƒ“ƒ\ƒ“ÇŒóŒQ‚Æ—Þ‰Ž¾Š³; –ò•¨«ƒp[ƒLƒ“ƒ\ƒ“•a, p.210`215, ŒÃ˜a‹vKC’·’JìˆêŽqi“àj. •ÒW äÝ”N“Oi“Œ‘åj•Ò, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 89.11.01”­s.

873. mŠwp‘n iŽ·•Mj Annual Review _Œo 1990; “ª’É‚ÌV‚µ‚¢‘Û•ª—Þ, p.372`377, âˆä•¶•Fi“àj. •ÒW Œã“¡•¶’jC‘¼•Ò, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 90.01.10”­s.

874. mŠwp‘n iŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj; ”]‘h¶–@, p.42`43, ‘å˜a“c—²i‹~–½j. ŠÄC “ú–쌴d–¾Cˆ¢•”³˜aŠÄC, ˆãŠw‘‰@, “Œ‹ž, 90.02.15”­s.

875. mŠwp‘n iŽ·•Mj ––½_Œo‘¹‚É‚¨‚¯‚é“d‹Cf’fŠw; ‰^“®_Œo“`“±‘¬“x•ª•z‚Ì‘ª’è, p.1`9, ‹kŽ ‘i”]ŠOj. ƒG[ƒUƒC, “Œ‹ž, 88.04.10”­s.

876. mŠwp‘n iŽ·•Mj ŠÌáŠQŠ³ŽÒ‚Ö‚Ì“Š–ò; Ö°’ÁÃÜEŒü¸_–ò, p.55`64, ΋½‰ªƒi¸j. ƒ~ƒNƒX, “Œ‹ž, 89.04.01”­s.

877. mŠwp‘n iŽ·•Mj ¸_‰È Mook, ¸_‰È—̈æ‚É‚¨‚¯‚é–ò•¨—Ö@; _ŒoÇ, ‘Š§ 1: 303`314, ΋½‰ªƒi¸j. •ÒW ”ª–Ø„•½iŒc‰ž‘åj•Ò, ‹àŒ´o”Å, “Œ‹ž, 89.12.20”­s.

878. mŠwp‘n iŽ·•Mj ÅVMRIî•ñ; ”]¥_Œo;‰ŠÇ, p.82`91, ›Mˆêi•új. •ÒW ‰Í–ì“Öi“Œ‹ž—Žqˆã‘åjC¼ìˆêi“Œ‘åjC¬–ì—RŽqi“Œ‹ž—Žqˆã‘åjCŒ´“c‘¾iŽœŒbˆã‘åj•Ò, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 89.08.01 ”­s.

879. m‹³‰È‘n iŽ·•Mj —Õ°•a‘ÔŠw; ¸_¥_ŒoŽ¾Š³, p.272`286, ’¹‹‡ŽOi“àj. •ÒW ²“¡—Ç’¨i_ŒËí”Õ’Z‘åjC¼Œ´‚Œ«i‹âˆÇ’Z‘åj•Ò, “ì]“°, “Œ‹ž, 89.04.10”­s.

880. m‹³‰È‘n iŽ·•Mj _Œo•aŠw; ––½_ŒoáŠQ, p.427`441, ’¹‹‡ŽOi“àj. •ÒW “cè‹`ºi“àjC‹g“c[’jiŽ©Ž¡ˆã‰È‘åj•Ò, ˆãŠw‘‰@, “Œ‹ž, 89.11.01”­s.

881. m‹³‰È‘n iŽ·•Mj VŽå—v’¥Œó‚©‚ç‚Ý‚½ŒŸ¸‚Ìi‚ß•û; “ª’É, p.157`160, ŒÃ˜a‹vKi“àj. •ÒW ¼“cdŽOC•Ò, V‹»ˆãŠwo”Å, “Œ‹ž, 90.01.10”­s.

882. m‹³‰È‘n iŽ·•Mj _Œo“à‰È Quick Reference; Ò‘Žîá‡, p.568`584; Ò‘ŠO, p.597`617, ‘å˜a“c—²i‹~–½j. •ÒW …–ì”ü–Mi‡“V“°‘åj•Ò, •¶Œõ“°, “Œ‹ž, 89.09.27”­s.

883. m‹³‰È‘n iŽ·•Mj ”]_ŒoŠO‰È Quick Reference|‡—“I‚Èf’f‚ÆŽ¡—Ã|; Ò‘ŠO|‹}«Šú|, p.546`556, –î“cŒ«ŽOi”]ŠOj. •ÒW ŽR‰Y»iç—t‘åj•ÒC •¶Œõ“°, “Œ‹ž, 89.06.16”­s.

884. m‹³‰È‘n iŽ·•Mj ŒûoSgˆãŠw—Õ°uÀC‘æ‡UŠª:f’f¥Ž¡—ÕÒ; ƒZƒlƒXƒgƒpƒ`[C¸_•ª—ô•aC‚»‚Ì‘¼, ‡U: 109`128, ’†“‡ß•vi¸j. •ÒW “à“cˆÀMi“Œ‹žˆã‰È‘åj•ÒC ‘—Ñ, “Œ‹ž, 89.11.10”­s.

885. m‹³‰È‘n iŽ·•Mj ¸_•ÛŒ’iŒn“ŠÅŒìŠwuÀAê–åŠî‘b 11j; “ü‰@¶Šˆ‚̸_•ÛŒ’, 11: 167`195, ²“¡Šìˆê˜Yi¸j. •ÒW ‘â‘׎Ÿ˜Yi“Œ‹ž‘Û‘åjC‘¼•ÒC ˆãŠw‘‰@, “Œ‹ž, 90.01.06”­s.

886. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ƒTƒNƒZƒXˆãŽt‘‰ÆŽŽŒ±—Õ°ŽÀ’n–â‘èW;@ •S“úŠPCWerdnig-Hoffmann •a ‘¼,@p.154, 240, 320, 387, 393`394, ŽO‰YŽõ’jiŽ™j. ŠÄC ²“¡“oŽu˜Yi–k—¢‘åjŠÄC, “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 89.11.15 ”­s.

887. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj V–ò•¨—Ö@; •Ð“ª’É, p.674`675; ŒQ”­“ª’É, p.676`677, âˆä•¶•Fi“àj. •ÒW ã“c‘×C‘¼•Ò, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 89.12.25”­s.

888. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj; “ª’É, 31: 190`191, âˆä•¶•Fi“àj. •ÒW ˆîŠ_‹`–¾C‘¼•Ò, ˆãŠw‘‰@, “Œ‹ž, 89.02.15”­s.

889. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ‰^“®¥HŽ–¥‹x—{‚̃ŠƒYƒ€‚ƃ^ƒCƒ~ƒ“ƒO; ãŽè‚ȇ–°‚Ì‚Æ‚è•û, p.25`40, ‘ºèŒõ–Mi¸j. –¾Ž¡¶–½Œú¶Ž–‹Æ’c, “Œ‹ž, 89.00.00”­s.

890. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj —D‚ꂽ”­ì—}§Œø‰Ê‚Ƹ_Çó‰ü‘PŒø‰Ê|ƒfƒOƒŒƒg|ƒ‹Ç—áW|; ‘½“®CŠwKáŠQ‚ðŽ¦‚µ‚½9΂̒jŽq|•”•ª‚Ä‚ñ‚©‚ñ|, p.14`15, ŽO‰YŽõ’jiŽ™j. •ÒW ‘åÀ’îˆêi‘—§¸_¥_ŒoƒZƒ“ƒ^|j•ÒC “ú–{ƒ`ƒoƒKƒCƒM|, •ó’Ë, 89.06.00”­s.

891. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj e‚¤‚Âf‚ª‚í‚©‚é–{; ‘ºèŒõ–Mi¸j. ‚²‚Ü‘–[, “Œ‹ž, 90.01.31”­s.

892. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj ‚æ‚­‚í‚©‚铧͗Ö@Aƒnƒ“ƒhƒuƒbƒN; ƒ‰ƒCƒtƒTƒCƒNƒ‹•Ê‚É‚Ý‚½“§ÍŠ³ŽÒ‚Ì‹ê”Yi‘æ8Í:¸_ˆãŠw‚Ì—§ê‚©‚ç‚Ý‚½“§ÍŠ³ŽÒj, p.230`263, ²“¡Šìˆê˜Yi¸j. •ÒW ‘¾“c˜a•vi“Œ—ˆã‘åj•ÒC ƒƒfƒBƒJo”Å, ‘åã, 89.06.30”­s.

893. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj “§ÍŠ³ŽÒ‚̸_ˆãŠw‚ÆS——Ö@; “§ÍŠ³ŽÒ‚̃\[ƒVƒƒƒ‹¥ƒCƒ[ƒW‚ÌŒŸ“¢|self-other orientation method ‚É‚æ‚é|, p.152`162, ²“¡Šìˆê˜Yi¸jC•ŸŽR‰Ãji‘‡ˆã—ÑŠ’k•”jC÷ˆäŒšŽ¡i‹´–{ƒNƒŠƒjƒbƒNjCRobert C. ZillerC‘å‘q–LiƒtƒƒŠƒ_‘åj. •ÒW ÔŠÔ—§Ž}iŒÕ‚Ì–å•a‰@j•ÒC “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 89.07.05”­s.

894. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj “§ÍŠ³ŽÒ‚̸_ˆãŠw‚ÆS——Ö@; ‰Æ‘°“à‚Ì–â‘è‚ÌŒ°Ý‰»‚É‚æ‚蓱“üŠú‚¤‚‚Ƒމ@Œã‚ɃqƒXƒeƒŠ[‚ð’悵‚½Ç—á, p.213`218, ²“¡Šìˆê˜Yi¸j. •ÒW ÔŠÔ—§Ž}iŒÕ‚Ì–å•a‰@j•ÒC “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 89.07.05”­s.

895. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn iŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj 1990”N”Å; ¬Ž™‚Ì‹}«”]‰Š¥”]Ç, p.734`735, ŽO‰YŽõ’jiŽ™j. •ÒW ˆîŠ_‹`–¾iç—t‘åjC‘½‰ê{K’jiŠÖ“Œ’üM•a‰@jC”öŒ`‰x˜Yi“Œ‘åj•Ò, ˆãŠw‘‰@, “Œ‹ž, 90.02.15 ”­s.

896. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn iŽ·•Mj ¸_‰È Mook, No.24, SgÇ; SgÇ‚ÆÖ°—Ö@, p.125`132, ’†“‡ß•vi¸j. •ÒW •³ŒšˆêiˆÇ—Ñ‘åj•Ò, ‹àŒ´o”Å, “Œ‹ž, 89.10.20”­s.

897. mŠwpÜn ‘æ1‰ñ“ú–{Ž©—¥ŒP—ûŠw‰ïJMI‹L”OÜiŽ©—¥ŒP—û–@‚ÌŒ¤‹†‚Æ•‹y‚ÉvŒ£‚µ‚½jC ’†“‡ß•vi¸j.

898. mŠw‰ïn i“Á•Êu‰‰j Žq‚Ç‚à‚½‚¿‚ÌS‚É”—‚é|”Y‚ß‚éŽq‚Ç‚à‚½‚¿‚Ì—Õ°—á‚ð’Ê‚µ‚Ä|. ²“¡Šìˆê˜Yi¸j: ‘æ21‰ñŠwZ•ÛŒ’Šw‰ï‘‰ï (90.02.09), ‰¡•l.

899. mŠw‰ïn i“Á•Êu‰‰j Brain 89•ñ. âˆä•¶•Fi“àj: ‘æ1‰ñ“ú–{”]zŠÂ‘ãŽÓŠw‰ï i89.11.18), “Œ‹ž.

900. mŠw‰ïn i‹³ˆçu‰‰j Žîᇫ•a•ÏINƒZƒ~ƒi[e‹¹˜’ňÚs•”•a•Ï‚É‚æ‚é_Œo•a•Ïf. ‹kŽ ‘i”]ŠOj: ‘æ24‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï‘‰ï (89.09.08), ŽD–y.

901. mŠw‰ïn i‹³ˆçu‰‰j Ò‘Ž¾Š³‚̃‚ƒjƒ^ƒŠƒ“ƒO. ‹kŽ ‘i”]ŠOj: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.27), ·‰ª.

902. mŠw‰ïn i‹³ˆçu‰‰j OPLL‚É‚æ‚éMyelopathy‚Ì•a‘Ô¶—. ‹kŽ ‘i”]ŠOj: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.29), ·‰ª.

903. mŠw‰ïn i‹³ˆçu‰‰j Œã“ª—tŽ‹’†•‚¨‚æ‚ÑŠá‹…‰^“®i”]Š²j‚ÉŠÖŒW‚µ‚½MRI. ›Mˆêi•új: ‘æ12‰ñ_ŒoŠá‰ÈuK‰ï (89.10.21), “Œ‹ž, _ŒoŠá‰È, 6(•â): 129, 1989.

904. mŠw‰ïn i‹³ˆçu‰‰j Arnold-Chiari ŠïŒ`‚É‚Æ‚à‚È‚¤Ò‘‹ó“´Ç. ‹kŽ ‘i”]ŠOj: ‘æ10‰ñ“ú–{”]_ŒoŠO‰ÈƒRƒ“ƒOƒŒƒX (90.03.30), “Œ‹ž.

905. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j The Effects of Triazolam, Flurazepam and Zopiclone on Human Memory. ‘ºèŒõ–MC΋½‰ªƒi¸j: International Joint Meeting on Sleep Research (89.05.00), Honolulu.

906. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j The Search for the Creutzfeldt-Jakob Disease Agent: Subcellular Distribution of the Transmissible Agent in CJD Mouse Brain, and Re-Examination of PrP Requirement for the CJD Infectivity. ‹Êˆä—mˆêC¬“ˆ‹vŽqi¶‰»jC–k“‡—Œbi¶•¨‰»ŠwŒnjC“cŒû•¶Íi‰q¶Šw•”jC‘å’J‹`•vCŽO‰Y’å‘¥i¸j: Canadian International Neuroscience Symposium (89.06.05), Guelph (Canada), Proceedings, p.18, 1989.

907. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ¬Ž™‚É‚¨‚¯‚é‚Ä‚ñ‚©‚ñ–ò•¨—Ö@‚Ì“ÁˆÙ«iŽå‘è:‚Ä‚ñ‚©‚ñf—ÂÌÅ‹ß‚Ìi•àj. ŽO‰YŽõ’jiŽ™j: ‘æ31‰ñ“ú–{¬Ž™_ŒoŠw‰ï‘‰ï (89.07.08), ŽD–yC ”]‚Æ”­’B, 21(‘‰ï†): s98, 1989.

908. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ¸_•ÛŒ’–@Ž{sŒã‚ð‚ß‚®‚Á‚Ä|‘‡•a‰@‚Ì—§ê‚©‚ç|. ˆîŒ©ˆòºi¸j: _“Þ쌧¸_ˆãŠw‰ï (89.07.15), ‰¡•l.

909. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j The Newest Psychotropic Molecules under Development in Japan. ‘ºèŒõ–Mi¸j: 6th Conference of Bio-Clinical Interface (89.09.00), Rouffach, France.

910. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Ö°—Ö@‚Ƃ͉½‚©|Ž„‚ÌÖ°—Ö@|. ’†“‡ß•vi¸j: ‘æ35‰ñ“ú–{Ö°ˆãŠwS—Šw‰ï (89.09.16), “Œ‹ž.

911. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‰^“®_Œo“`“±‘¬“x‚Ì‘ª’è|‚Æ‚­‚ÉSlow Component‚ɂ‚¢‚Ä. ‹kŽ ‘i”]ŠOj: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.07), ‹ž“s.

912. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ”]oŒŒ‚Ì“à‰È‹~‹}ˆã—ÂƗ\Œã. –kˆä‘¥•vC”’J‹`GC‹e–ì—²–¾C–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC_“c’¼C“cè‹`ºi“àj: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.06), “Œ‹ž, ´˜^W, s-698, 1989.

913. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ’Pƒƒwƒ‹ƒyƒX”]‰Š‚Ì”]”g. ™ŽRˆêi¸jC”¨—²Žui“àjCŽí“c^»—Yi¸j: ‘æ19‰ñ“ú–{”]”gE‹Ø“d}Šw‰ï (89.11.11), ‰ªŽR.

914. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ¸_‰È‹~‹}‚ɂ‚¢‚Ä; ‘åŠw•a‰@‚É‚¨‚¯‚é¸_‰È‹~‹}|–k—¢‘åŠw‚ÌŒoŒ±‚©‚ç|. ’†“‡ß•vCΈä‘P‹PCŠ}Œ´—FKC’ç–M•FCˆîŒ©ˆòºCŽO‰Y’å‘¥i¸j: ‘æ2‰ñ“ú–{‘‡•a‰@¸_ˆãŠw‰ï (89.11.11), ‹ž“s.

915. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒŠƒ‰ƒNƒZ[ƒVƒ‡ƒ“|ˆÙ‚È‚é‹Z–@‚Æ‚»‚ÌŒø‰Ê‚Ì“ÁF|Ž©—¥ŒP—û–@‚É‚¨‚¯‚郊ƒ‰ƒNƒZ[ƒVƒ‡ƒ“. ’†“‡ß•vi¸j: ‘æ2‰ñ“ú–{S—ˆã—ÔŠw‰ï˜A‡‘å‰ï (89.11.19), “Œ‹ž.

916. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Žó“®“I’ˆÓW’†|‚»‚Ì‹³Ž¦‚ÌŽÀۂƈӋ`|. ’†“‡ß•vi¸j: ‘æ12‰ñ“ú–{Ž©—¥ŒP—ûŠw‰ï (89.11.26), L“‡.

917. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒ^[ƒ~ƒiƒ‹¥ƒPƒA‚ɂ‚¢‚Ä|‘åŠw•a‰@‚Ì—§ê‚©‚ç;ƒ^[ƒ~ƒiƒXƒPƒA[‚ÌŒ»ó‚Æ–â‘è“_|. ²“¡Šìˆê˜Yi¸j: ‘æ22‰ñ“ú–{ƒvƒ‰ƒCƒ}ƒŠ[ƒPƒAŠw‰ï_“ÞìŽx•”ŠwpW‰ï (90.03.24), ‘Š–ÍŒ´.

918. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ŒŒŠÇ«’s•ð‚Ì”]zŠÂ|ŒŒŠÇ”½‰ž«‚ÌŒŸ“¢|. ”¨—²Žui“àj: ‘æ14‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï i89.03.03), “Œ‹ž.

919. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj ‘SgŠÇ—‚ð—v‚·‚é¸_Ž¾Š³Š³ŽÒ‚Ì•a‘Ô‚Æ‚»‚Ì”FŽ¯. “c’†•üŽqC’ç–M•FCL£—²ˆêC‹e–ì—²–¾C‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jCΊ_“¿]C‰iŽR’¼“¹CŽRéˆê˜YCŽO‰Y’å‘¥i¸j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.06), “Œ‹ž.

920. mŠw‰ïn iˆê”Êu‰‰j ƒjƒgƒ‰ƒ[ƒpƒ€‚Ì‹}«’†“ÅÇó‚ɂ‚¢‚Ä. “‡“c‰hŽqCŽá“c•””Ž•¶C‘å’J‹`•vCŽO‰Y’å‘¥i¸j: ‘æ26‰ñ_“Þ쌧¸_–ò—§˜b‰ï (89.00.00), ‰¡•l.

921. mŠw‰ïn iˆê”Êu‰‰j An Activation Map of Dendrites in a Cochlear Nucleus of Frog. ‘åŠÑMi¶—j: ‘æ66‰ñ“ú–{¶—Šw‰ï (89.04.05`07), ‰ªŽRC Jpn. J. Physiol., 39(Suppl.): S173, 1989.

922. mŠw‰ïn iˆê”Êu‰‰j Two Distinct Mechanisms are Responsible for single Potassium Channel Block by Internal Tetraethylammonium Ions. Daisuke YamamotoiŽO•H‰»¬¶–½Œ¤jC—é–ØM”Vi¶—j: ‘æ66‰ñ“ú–{¶—Šw‰ï (89.04.05`07), ‰ªŽRC Jpn. J. Physiol., 39(Suppl.): S59, 1989.

923. mŠw‰ïn iˆê”Êu‰‰j Allopurinol‚ª’˜Œø‚ðŽ¦‚µ‚½Œ´ˆö•s–¾‚̕Б¤«”]‰ŠŒã‚Ä‚ñ‚©‚ñ‚Ì1—á. ˆÀ•ÛŒ«ˆêCãp—z‘¾˜YC”’ˆäGKiŽ™jC“cì•s’m•viŠƒ–è“¿B‰ï‘‡•a‰@jC‘å–î’B’ji¹˜H‰Á‘Û•a‰@j: ‘æ182‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þì’n•û‰ï (89.04.15), ‰¡•l, _“ÞìˆãŠw‰ïŽGŽ, l989.

924. mŠw‰ïn iˆê”Êu‰‰j Ò‘Œã³’†’†ŠuØŠJ–@‚ÌŒŸ“¢. ŽOˆäŒö•Fi”]ŠOjC‘å˜a“c—²i‹~–½j: ‘æ60‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ï (89.04.17), VŠƒ.

925. mŠw‰ïn iˆê”Êu‰‰j Sodium valproate ‚Ì•¹—p‚ªcarbamazepine‚¨‚æ‚Ñcarbamazepine-10,11-epoxide‚Ì—V—£Œ^ŒŒ’†”Z“x‚É‚¨‚æ‚Ú‚·‰e‹¿‚È‚ç‚Ñ‚É‚»‚Ì—Õ°“IˆÓ ‹`. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂiŽ™j: ‘æ4‰ñ–ò•¨ƒ‚ƒjƒ^ƒŠƒ“ƒO‘S‘Œð—¬‰ï¥‘æ6‰ñ“ú–{TDMŠw‰ïŠwpW‰ï‡“¯ŠwpW‰ï (89.05.13), “Œ‹ž, u‰‰—vŽ|WCp.23, 1989.

926. mŠw‰ïn iˆê”Êu‰‰j Œü¸_–ò’·Šú•ž—pŠ³ŽÒ‚É‚Ý‚ç‚ꂽ’áNaŒŒÇ‚ÌŒŸ“¢. Ί_“¿]C’ç–M•FC™ŽRˆêCŽRéˆê˜YCŠp“c’厡C™ŽRŒ’ŽuC‰iŽR’¼Ž÷CŽO‰Y’å‘¥CŽOˆä—ÇŽ÷i¸jCL£—²ˆêi‹~–½j: ‘æ85‰ñ“ú–{¸__ŒoŠw‰ï (89.05.18), ‹à‘ò, ´˜^W, p.143, 1989.

927. mŠw‰ïn iˆê”Êu‰‰j “úíƒXƒgƒŒƒX‚Æ‚¤‚•aE‚¤‚Âó‘ÔE_ŒoÇ‹y‚Ñ“à‰ÈE”畆‰ÈŠO—ˆŠ³ŽÒ. —Ñsˆê˜YC¡ˆä–¾—Yi‰q¶Šw•”jC’†“‡ß•vi¸jC•ŸŽR‰Ãji‘‡‘Š’k•”jCŽO‰Y’å‘¥i¸j: ‘æ85‰ñ“ú–{¸__ŒoŠw‰ï (89.05.18), ‹à‘ò, ¸__ŒoŠwŽGŽ, 91(9): 665, 1989.

928. mŠw‰ïn iˆê”Êu‰‰j _Œo«HŽv•sUǂɑ΂·‚és“®—Ö@|Ž©Œ±—á‚ÌŒŸ“¢|. ŒÃ’m‹MŒbŽqC‘å’J‹`•vC‚‹´–¾”äŒÃCŽO‰Y’å‘¥i¸j: ‘æ85‰ñ“ú–{¸__ŒoŠw‰ï (89.05.19), ‹à‘ò.

929. mŠw‰ïn iˆê”Êu‰‰j ‘åŠw•a‰@‚É‚¨‚¯‚é¸_‰ÈƒfƒCƒPƒA‚ÌŽŽ‚Ý. ’†“‡ß•vCŠ}Œ´—FKCŽO‰Y’å‘¥i¸jC—é–؃ŒbiŠÅŒì•”jC”’–ØŒ´—tŽqiƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“jC¬–Ø‘]‰ÀŽqi‘‡‘Š’k•”jC”’–ØŒ´ŽsŽŸCŽR–{–¾”üiƒŠƒnƒr ƒŠƒe[ƒVƒ‡ƒ“jC‘ê‘ò‚é‚ÝŽqi‘‡‘Š’k•”j: ‘æ85‰ñ“ú–{¸__ŒoŠw‰ï (89.05.19), ‹à‘ò, ¸__ŒoŠwŽGŽ, 91(11): 1989.

930. mŠw‰ïn iˆê”Êu‰‰j Œ‡_”­ì‚Æ•¡ŽG•”•ª”­ì‚ª‘OŒã‚µ‚Ä”F‚ß‚ç‚ꂽǗá‚ÌŒŸ“¢. »‰ŸÂCŽO‰YŽõ’jC”’ˆäGKiŽ™j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.19), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 93(3): 474, 1989.

931. mŠw‰ïn iˆê”Êu‰‰j ™•ú«ƒoƒ‹ƒvƒŽ_»Ü(KW-6066N)‚ÌŒø‰Ê|ŒŒ’†”Z“x‚È‚ç‚Ñ‚É—Õ°–Ê‚©‚ç‚̈êlŽ@|. ŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂiŽ™j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.19), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(3): 478, 1989.

932. mŠw‰ïn iˆê”Êu‰‰j ”]Ž¿ŽüˆÍ«”’Ž¿“(PVL)‚É‚¨‚¯‚鎥‹C‹¤–‰摜f’f‚Ì—L—p«‚ÌŒŸ“¢. –쑺ƒŽqCŠ—Œ´FC’†‘ºP•äC¬ŒûO‹BCÄ“¡KˆêC–åˆäL‹ÅC”ª‘ãŒö•viŽ™j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.19), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(3): 629, 1989.

933. mŠw‰ïn iˆê”Êu‰‰j _Œo«HŽv•sUÇŒóŒQ‚ð’悵‚½ãó‰èŽî‚Ì1—á|Šù•ñ—á‚Æ‚Ì”äŠr|. ‰iŽR’¼“¹CâE–{–¾•FC²“¡Šìˆê˜Yi¸j: ‘æ85‰ñ“ú–{¸_ˆãŠw‰ï (89.05.20), ‹à‘ò.

934. mŠw‰ïn iˆê”Êu‰‰j Arnold-ChiariŠïŒ`‚ɇ•¹‚·‚éÒ‘‹ó“´Ç‚̬ˆö‚É‚¨‚¯‚鑉t“®‘Ô‚ÌŠÖ—^. ‹kŽ ‘CŽs앶•FC”Ñ“cG•vCŽOˆäŒö•FC–î“cŒ«ŽOi”]ŠOj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï (89.05.25), …ŒË.

935. mŠw‰ïn iˆê”Êu‰‰j OverstretchÇ—á‚ÌŽèpŽ¡—Ã. ŽOˆäŒö•FC”Ñ“cG•vC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï (89.05.25), …ŒË.

936. mŠw‰ïn iˆê”Êu‰‰j ‰„‘‚æ‚苹‘‚ɂ킽‚é‹‘åÒ‘Ž‰–bŽî‚Ì‚P—á. í”ՉÈêC‰ªGGCŽR“cŸCz–K’m–çC‹kŽ ‘i”]ŠOj: ‘æ34‰ñ“ú–{”]_ŒoŠw‰ïŠÖ“Œ’n•û‰ï (89.05.27), “Œ‹ž.

937. mŠw‰ïn iˆê”Êu‰‰j Possible Involvement of Adenosine in Vasodilatory Response of the Rat Pial Arterioles to Hypotension. Xˆä½“ñC‰¤”C’¼C‘å‚O–«C–î“cŒ«ŽOi”]ŠOjCŽ­ŽæMi–ò—j: The 14th International Symposium on Cerebral Blood Flow and Metabolism (89.05.28`06.01), ƒ{ƒ[ƒjƒACƒCƒ^ƒŠƒA, Journal of Cerebral Blood Flow and Metabolism, 9(Suppl.): S487, 1989.

938. mŠw‰ïn iˆê”Êu‰‰j The in Vivo Effect of Iloprost, a Stable Prostacyclin Analogue, on the Caliber of the Cerebral Microvessels. Xˆä½“ñC‰¤”C’¼C‘å‚O–«C–î“cŒ«ŽOi”]ŠOj: The 14th International Symposium on Cerebral Blood Flow and Metabolism (89.05.28`06.01), ƒ{ƒ[ƒjƒACƒCƒ^ƒŠƒA, Journal of Cerebral Blood Flow and Metabolism, 9(Suppl.): S666, 1989.

939. mŠw‰ïn iˆê”Êu‰‰j ˆã—Ãî•ñƒVƒXƒeƒ€‚ƈãŽt‚̃XƒgƒŒƒX. ’†“‡ß•vC’ç–M•FCŽRéˆê˜YC”’싳li¸jC•ŸŽR‰Ãji‘‡‘Š’k•”jCŽO‰Y’å‘¥i¸jC‹v•Û“c_–çC¡ˆä•ÛŽŸi“ú–{¶ŽY«–{•”j: ‘æ30‰ñ“ú–{SgˆãŠw‰ï (89.06.10), –¼ŒÃ‰®.

940. mŠw‰ïn iˆê”Êu‰‰j Œz’ÅAŒz‘‘¹‚É”º‚¤ŠO«’Åœ“®–¬áŽ‚Ì1—á. ŽR“cŸCŽs앶•FC‰““¡¹Fi”]ŠOjCó—˜–õCV“¡³‹PC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ27‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (89.06.24), Š‘ò.

941. mŠw‰ïn iˆê”Êu‰‰j ‹­—̓lƒIƒ~ƒmƒtƒ@[ƒQƒ“‚b‚É‚æ‚éƒAƒiƒtƒBƒ‰ƒLƒV[ƒVƒ‡ƒbƒN‚Ì1—á. ”’싳li¸jC“c•Ó‘C‘Š”nˆêˆåC–Ø“cŒõLC“¡–ìé”VC¡ˆäPC¼ŽR´ŒhC–kˆä‘¥•vC‘å˜a“c—²i‹~–½j: ‘æ27‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (89.06.24), Š‘ò.

942. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g’f‘w–@‚Åf’f‚µ‚½”]ŽºŽüˆÍ«”’Ž¿“(PVL)‚Ì”­’B—\Œã. –åˆäL‹ÅC–ì“n³•FCŠ—Œ´FC’†‘ºP•äCÄ“¡KˆêC¬ŒûO‹BiŽ™j: ‘æ25‰ñ“ú–{V¶Ž™Šw‰ï‘‰ï (89.07.03), “Œ‹žC ´˜^WCp.188, 1989.

943. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™‚̓«‚Ä‚ñ‚©‚ñ‚ɑ΂·‚éƒAƒƒvƒŠƒm|ƒ‹‚ÌŽg—pŒoŒ±. ˆ¤b_ŽuC¼‰ª½Ž¡CX–{ŽCÎì”üC^•”~C‘å–î’B’jC¼‘ºVŽOi¹˜H‰Á‘Û•a‰@jC”’ˆäGKCãp—z‘¾˜YiŽ™j: ‘æ31‰ñ“ú–{¬Ž™_ŒoŠw‰ï‘‰ï (89.07.06), ŽD–yC ”]‚Æ”­’B, 21(‘‰ï†): s113, 1989.

944. mŠw‰ïn iˆê”Êu‰‰j Carbamazepine ‚È‚ç‚Ñ‚É Carbamazepine-10,11-epoxide ‚Ì—V—£Œ^ŒŒ’†”Z“x‚ÉŠÖ‚·‚錟“¢|ŒŒ´ƒ¿1-acid glycoprotein ”Z“x‚Æ‚ÌŠÖ˜A|. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂiŽ™j: ‘æ31‰ñ“ú–{¬Ž™_ŒoŠw‰ï‘‰ï (89.07.08), ŽD–yC ”]‚Æ”­’B, 21(‘‰ï†): s129, 1989.

945. mŠw‰ïn iˆê”Êu‰‰j Treatment of West Syndrome with Gamma Globulin: A Multicenter Study. Hashimoto, K.i“ú–{ˆã‰È‘åjCAriizumi, M.i“Æ‹¦ˆã‘åjCŽO‰YŽõ’jiŽ™jC‘¼: 19th International Congress of Pediatrics (89.07.24), Paris, Abstracts, p.190, 1989.

946. mŠw‰ïn iˆê”Êu‰‰j Effectiveness and Plasma Levels of Valproic Acid with Use of a Slow-Release Preparation. ŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂiŽ™j: 19th International Congress of Pediatrics (89.07.24), Paris, Abstracts, p.309, 1989.

947. mŠw‰ïn iˆê”Êu‰‰j Combination Therapy of Sodium Valproate and Clonazepam in Patients with Intractable Epilepsy. »‰ŸÂCŽO‰YŽõ’jC”’ˆäGKiŽ™j: 19th International Congress of Pediatrics (89.07.24), Paris, Abstracts, p.457, 1989.

948. mŠw‰ïn iˆê”Êu‰‰j Periventricular Leukomalacia: Magnetic Resonance Evaluation. –åˆäL‹ÅCŠ—Œ´FCÄ“¡KˆêC”ª‘ãŒö•viŽ™j: 19th International Congress of Pediatrics (89.07.26), Paris, Abstracts, p.220, 1989.

949. mŠw‰ïn iˆê”Êu‰‰j Prevention of Recurrent Febrile Convulsions with Rectal Diazepam and Development of Epilepsy. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂiŽ™j: 19th International Congress of Pediatrics (89.07.26), Paris, Abstracts, p.439, 1989.

950. mŠw‰ïn iˆê”Êu‰‰j Ò‘‰ßL’£áŠQ‚É‚¨‚¯‚éÒ‘“àˆ³‚̕ω». ”Ñ“cG•vC‹kŽ ‘CŽs앶•FC“c’†–ö…CŽOˆäŒö•FC–î“cŒ«ŽOi”]ŠOj: ‘æ24‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï‘‰ï (89.09.07), ŽD–y.

951. mŠw‰ïn iˆê”Êu‰‰j ‰fŽžŠŒ©‚Å‹}«Œz‘‘¹Š³ŽÒ‚Ì—\Œã‚Í—\‘ª‚Å‚«‚é‚©H. ŽRè‹`‹éi”]ŠOjC‘å˜a“c—²C–kŒ´F—YC‰““¡¹Fi‹~–½jC‹kŽ ‘C”Ñ“cG•vC–î“cŒ«ŽOi”]ŠOj: ‘æ24‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï‘‰ï (89.09.07), ŽD–y.

952. mŠw‰ïn iˆê”Êu‰‰j ‰„‘‚æ‚苹‘‚ɂ킽‚鋑厉–bŽî‚Ì1—á. í”ՉÈêi”]ŠOjC‚–ØGi‘å˜aŽs—§•a‰@jCŽR“cŸC”Ñ“cG•vC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOj: ‘æ24‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï‘‰ï (89.09.07), ŽD–y.

953. mŠw‰ïn iˆê”Êu‰‰j Ò‘Œã³’†Šui“ü–@‚ÌŽÀÛ. ŽOˆäŒö•FC–kŒ´s—YC”Ñ“cG•vC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOjCóˆä²‹vC¼X–Mºi‘—§‘Š–ÍŒ´•a‰@j: ‘æ24‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï‘‰ï (89.09.08), ŽD–y.

954. mŠw‰ïn iˆê”Êu‰‰j 10”N‚ÌŒo‰ß‚Å‚­‚à–Œ‰ºoŒŒ‚É‚ÄÄ”­‚µA”]“®–¬áŽ‚ÌV‚½‚È”­¶‚ð‚Ý‚½‘½”­«”X–Et‚Ì1—á. ‘ˆä³„C“c’†ç•FC‹{â‰À’ji”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ35‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.09.09), “Œ‹ž.

955. mŠw‰ïn iˆê”Êu‰‰j ˆê‘¤«Šá‹…“Ëo‚Å”­Ç‚µ‚½Žá”N«“ªŠWŠOi“W‘–ŒŽî‚Ì1—á. óˆä²‹vi‘—§‘Š–ÍŒ´•a‰@jCŽOˆäŒö•Fi”]ŠOjC¼X–MºC퉪Š°i‘—§‘Š–ÍŒ´•a‰@jC‹v•Û’·¶i—Žqˆãj: ‘æ35‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.09.09), “Œ‹ž.

956. mŠw‰ïn iˆê”Êu‰‰j ’ˆÓáŠQ¥‘½“®Ž™‚ɇ•¹‚·‚é_ŒoÇASgÇÇó‚Ì’²¸•ñ. Vˆä‘ìCˆÉ“¡ˆèŽqCX“c¶‹IŽqC—é–ؑבãC²“¡ç•äŽqCâE–{–¾•FC²“¡Šìˆê˜Yi¸j: ‘æ7‰ñ“ú–{¬Ž™SgˆãŠw‰ï (89.09.09), ‘åã.

957. mŠw‰ïn iˆê”Êu‰‰j uƒˆƒgƒ‰ƒ“ƒXv‚ÆuF‚¯‚ç‚ꂽƒgƒ‰ƒ“ƒXv‚̶—Šw“IŒŸ“¢|ƒT[ƒ‚EƒOƒ‰ƒtƒB[‚É‚æ‚é––½”畆‰·‚ðŽw•W‚Æ‚µ‚Ä|. ”’싳lC’†“‡ß•vi¸j: ‘æ35‰ñ“ú–{Ö°ˆãŠwS—Šw‰ï (89.09.15), “Œ‹ž.

958. mŠw‰ïn iˆê”Êu‰‰j The Role of Adenosine in Autoregulation of the Cerebral Blood Flow; Effects of Caffeine on Vasodilatory Response of the Rat Pial Arterioles to Hypotension. Xˆä½“ñC‰¤”C’¼C‘å‚O–«C–î“cŒ«ŽOi”]ŠOjCŽ­ŽæMi–ò—j: The Symposium on Purine Nucleosides and Mucleotides in Cell Signalling (89.09.17`20), Rockville,•Ä‘.

959. mŠw‰ïn iˆê”Êu‰‰j ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚Ì“ª•”MRŠŒ©. ¬—Ñ–ÎŽ÷C›MˆêC’r“crºC“cŠŽŒÈC¼Šª”ŽC¼ŽR³ŒáC’J“c—ˆê˜YC‰¡ŽR‹v˜NC¼—Ñ—²i•új: “ú–{Ž¥‹C‹¤–ˆãŠw‰ï (89.09.18), “Œ‹ž, “ú–{Ž¥‹C‹¤–ˆãŠw‰ïŽGŽ, 9(2): 251, 1989.

960. mŠw‰ïn iˆê”Êu‰‰j ÛHáŠQ‚𔺂¤’j«‚̃Aƒ‹ƒR[ƒ‹ˆË‘¶Ç‚Ì5—á. ŽR“ckˆêC—é–ØŒ’“ñi‘—§—×{Š‹v—¢•l•a‰@jCX“c¶‹IŽqi¸jC”óŒûiC…’J—R”üŽqCˆî•x³Ž¡C¼â—˜”VC‰G–XŽq“c²C‰Í–ì—T–¾i‘—§—×{Š‹v—¢•l•a ‰@j: ‘æ24‰ñ“ú–{ƒAƒ‹ƒR[ƒ‹ˆãŠw‰ï‘‰ï (89.09.23), “Œ‹ž, ƒAƒ‹ƒR[ƒ‹Œ¤‹†‚Æ–ò•¨ˆË‘¶, 24: 350, 1989.

961. mŠw‰ïn iˆê”Êu‰‰j —«ƒAƒ‹ƒR[ƒ‹ˆË‘¶ÇŽÒ‚ÆŽq‹Ÿ’B(1). X“c¶‹IŽqi¸jC‘º‰ª‰p—YC—é–ØŒ’“ñC‰Í–ì—T–¾CV”ü—mˆêi‘—§—×{Š‹v—¢•l•a‰@j: ‘æ24‰ñ“ú–{ƒAƒ‹ƒR[ƒ‹ˆãŠw‰ï‘‰ï (89.09.23), “Œ‹ž, ƒAƒ‹ƒR[ƒ‹Œ¤‹†‚Æ–ò•¨ˆË‘¶, 24: 373, 1989.

962. mŠw‰ïn iˆê”Êu‰‰j Žá‚¢—«‚̃Aƒ‹ƒR[ƒ‹ˆË‘¶Ç|ÛHáŠQ‡•¹ŒQ‚ƃAƒ‹ƒR[ƒ‹ˆË‘¶Ç’P“ÆŒQ‚Ì”äŠr|. …’J—R”üŽqC—é–ØŒ’“ñCŽR“ck“ñCˆî•x³Ž¡C¼â—˜”VC‰Í–ì—T–¾C”óŒûii‘—§—×{Š‹v—¢•l•a‰@jCX“c¶‹IŽqi¸j: ‘æ24‰ñ“ú–{ƒAƒ‹ƒR[ƒ‹ˆãŠw‰ï‘‰ï (89.09.23), “Œ‹ž, ƒAƒ‹ƒR[ƒ‹Œ¤‹†‚Æ–ò•¨ˆË‘¶, 24: 375, 1989.

963. mŠw‰ïn iˆê”Êu‰‰j Arnold-ChiariŠïŒ`‚É”º‚¤Ò‘‹ó“´Ç‚ÌŽèp. ‹kŽ ‘C‚–ì½C‰iˆä–ÎŽ÷Cz–K’m–çC”Ñ“cG•vC–î“cŒ«ŽOi”]ŠOj: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.27), ·‰ª.

964. mŠw‰ïn iˆê”Êu‰‰j ”]“®Ã–¬ŠïŒ`“Eop’†‚Ì”]”玿ŒŒ—¬—Ê‘ª’è. “c’†–ö…CŽRè‹`‹éC‰iˆä–ÎŽ÷C“c’†ç•FC“ü‘qŽŒÈC‹´–{—²C‚–쮎¡C‘q“c²C‰““¡¹FC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.27), ·‰ª.

965. mŠw‰ïn iˆê”Êu‰‰j ‘åŒ^AVM‚ɑ΂·‚é“Eop‚̉”\«. ‹{â‰À’jC‰ªGGCŽR“cŸC“c’†–ö…C–kŒ´s—YC‘q“c²C‘å‚O–«C‰““¡¹FCÄ“¡Œ³—ÇC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.27), ·‰ª.

966. mŠw‰ïn iˆê”Êu‰‰j ˆ««¯äPŽîiGrade ‡V,‡Wj‚É‚¨‚¯‚é’·Šú¶‘¶—á‚Ì—Õ°‹y‚Ñ•a—Šw“IŒŸ“¢. ì–ìM”VCˆÉ“¡”ä˜CŽuCŽR“cŸCŽs앶•FC–î“cŒ«ŽOi”]ŠOjC–ö‰ºŽO˜Yi•a—j: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.27), ·‰ª.

967. mŠw‰ïn iˆê”Êu‰‰j –«d–Œ‰ºŒŒŽî‚Ì”­¶¥‘ˆ«‚Í—\Œ©‚Å‚«‚é‚©. ¼X–MºCŽOˆäŒö•FC–kŒ´s—YCóˆä²‹vC‚–ì½i”]ŠOj: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.27), ·‰ª.

968. mŠw‰ïn iˆê”Êu‰‰j ”]ŠÁ—¬ˆ³‚̕ω»‚ɑ΂·‚郉ƒbƒg”]“î–Œ”÷¬ŒŒŠÇ‚Ì”½‰ž«. Xˆä½“ñC‰¤”C’¼C‘å‚O–«C“c’†ç•FC‹´–{—²C–î“cŒ«ŽOi”]ŠOjC²“¡Œ’i‘‡‘å“c•a‰@j: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.27`29), ·‰ª.

969. mŠw‰ïn iˆê”Êu‰‰j “ªŠW’ê“‚æ‚ѓ÷Žî‚ÌŒoŒ±. Žs앶•FCŽR“cŸCˆÉ“¡”ä˜CŽuCì–ìM”VC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½jC›Mˆêi•új: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.29), ·‰ª.

970. mŠw‰ïn iˆê”Êu‰‰j ”]”^ᇂƔ]ŽîᇂÌMRI. í”ՉÈêi”]ŠOjC‚–ØGi‘å˜aŽs—§•a‰@jC‘å“ä’mC‘ˆä³„CŽRè‹`‹éCŽR“cŸCz–K’m–çC‹´–{—²CŽs앶•FC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC›Mˆê i•új: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.29), ·‰ª.

971. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™‚Ì•”•ª”­ì‚ɑ΂·‚éCarbamazepine ’PÜŽ¡—Â̒·Šú—\Œã. »‰ŸÂCŽO‰YŽõ’jC”’ˆäGKiŽ™j: ‘æ23‰ñ“ú–{‚Ä‚ñ‚©‚ñŠw‰ï (89.10.06), “Œ‹ž, ´˜^W, p.69, 1989.

972. mŠw‰ïn iˆê”Êu‰‰j GH3×–E‚ɑ΂·‚é×–E“àî•ñ“`’B•ªŽq‚ÌŠÖ—^. —é–ØM”Vi¶—jC‚–Ø”ŽC‹g‰ª‹i‘‘åjCH“¡‰À‹viŽO•H‰»¬¶–½Œ¤j: ‘æ27‰ñ“ú–{¶•¨•¨—Šw‰ï (89.10.06`08), “Œ‹žC ¶•¨•¨—, 29: S296, 1989.

973. mŠw‰ïn iˆê”Êu‰‰j Clonazepam‚Ì—V—£Œ^ŒŒ’†”Z“x‚ÉŠÖ‚·‚錟“¢|ŒŒ´ƒ¿1-acid glycoprotein”Z“x‚Æ‚ÌŠÖ˜A. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂiŽ™j: ‘æ23‰ñ“ú–{‚Ä‚ñ‚©‚ñŠw‰ï (89.10.07), “Œ‹ž, ´˜^W, p.153, 1989.

974. mŠw‰ïn iˆê”Êu‰‰j Transient Type Calcium Channel in the Regulation of Intracellular Calcium Level of GH3 Cells. —é–ØM”Vi¶—jCH“¡‰À‹viŽO•H‰»¬¶–½Œ¤jC‚–Ø”ŽC‹g‰ª‹i‘‘åjC“c’†ŠÚ–¾”Ži¶•¨•¨—ŒnjC‰Á”Z³–¾i¶—j: 7th International Conference on Cyclic Nucleotides, Calcium, and Protein Phosphorylation. (89.10.08`13), _ŒËC Abstract, p. 172, 1989.

975. mŠw‰ïn iˆê”Êu‰‰j Trans-sulcal Approach into the Spinal Cord. ŽOˆäŒö•FC”Ñ“cG•vC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOj: ‘æ9‰ñ‘Û”]_ŒoŠO‰ÈŠw‰ï (89.10.09), ƒjƒ…[ƒfƒŠ[.

976. mŠw‰ïn iˆê”Êu‰‰j Changes in Brain Lipid Composition of an Adult Type SSPE. ‘å’J‹`•vi¸jC‚ŽR‹v”üŽqi¶‰»ŒnjC‹Êˆä—mˆêC¬“ˆ‹vŽqi¶‰»jC¬Œû“OCΈä‘P‹PC–]ŒŽ•Û‘¥C›Œ´“¹ÆCŽO‰Y’å‘¥i¸j: 8th World Congress of Psychiatry (89.10.13), Athens, Greece, Proceedings, p.125, 1989.

977. mŠw‰ïn iˆê”Êu‰‰j The in Vivo Effects of Indomethacin on Reactivity of the Rat Pial Arterioles. ‰¤”C’¼CXˆä½“ñC‘å‚O–«C–î“cŒ«ŽOi”]ŠOj: The lst International Stroke Congress (89.10.15`19), ‹ž“s.

978. mŠw‰ïn iˆê”Êu‰‰j Retrograde Thrombosis of Feeding Arteries after Removal of Arteriovenous Malformations. ‹{â‰À’jC‘q“c²C‘å‚O–«C‰““¡¹FCÄ“¡Œ³—ÇC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: The lst International Stroke Congress (89.10.15`19), ‹ž“s.

979. mŠw‰ïn iˆê”Êu‰‰j Logoclonic Seizure Caused by Tumor Confined in the SMA. –kŒ´s—YC“c’†–ö…i”]ŠOjC‘ºèŒõ–Mi¸j: 18th International Epilepsy Congress (89.10.18), New Delhi, India.

980. mŠw‰ïn iˆê”Êu‰‰j Plasma Level to Dose Ratio and Protein Binding of Clonazepam in Epileptic Children. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂiŽ™j: 18th International Epilepsy Congress (89.10.19), New Delhi, Abstracts, p.72, 1989.

981. mŠw‰ïn iˆê”Êu‰‰j 123I-IMP”]ŒŒ—¬ƒVƒ“ƒ`ƒOƒ‰ƒtƒB[ƒOƒ‹[ƒvƒXƒ^ƒfƒB‚ÌŒŸ“¢i‹U—z«A‹U‰A«—á‚ɂ‚¢‚Äj. ’†“c“T¶Cì㌛ŽiiŽœŒbˆã‘åjC‘¼CΈ䟌Èi•új: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (89.10.19`21), ‘å’Ã, ŠjˆãŠw, 26(8): 1026, 1989.

982. mŠw‰ïn iˆê”Êu‰‰j ”]oŒŒŠ³ŽÒ‚Ì123I-IMP SPECT‚ÆXüCT‚Ì”äŠrŒŸ“¢. Έ䟌ÈC¼Šª”ŽC¼ŽR³ŒáC¬—Ñ–ÎŽ÷C’†‘òŒ\Ž¡CΈä‰s®CˆË“cˆêdC¼—Ñ—²i•újC—é–ØGˆêCâˆä•¶•Fi“àj: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (89.10.19`21), ‘å’Ã, ŠjˆãŠw, 26(8): 996, 1989.

983. mŠw‰ïn iˆê”Êu‰‰j Influence of Concurrent Administration of Sodium Valproate on the Plasma Concentrations of Carbamazepine and its Epoxide. ŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂiŽ™j: 18th International Epilepsy Congress (89.10.20), New Delhi, Abstracts, p.83, 1989.

984. mŠw‰ïn iˆê”Êu‰‰j R¸_•a–ò‚Ì’ZŠú‹L‰¯‚É‹y‚Ú‚·‰e‹¿. ΋½‰ªƒCìŒû‹BC‚‹´–¾”äŒÃCZ‹gHŽŸC—é–Ø–q•FC‘ºèŒõ–MCŽO‰Y’å‘¥i¸j: ‘æ19‰ñ“ú–{_Œo¸_–ò—Šw‰ï (89.10.25), •Ÿ‰ª.

985. mŠw‰ïn iˆê”Êu‰‰j ENG Study of Abnormal Eye Movement. Two Cases Report of Opsoclonus in Acute Encephalitis. ‹g”ö’mC“¿‘Œú“ñiŽ¨•@j: ‡W. Symposium fur Neuro-Otologie. (89.10.26), Berlin, ‡W. Symposium fur Neuro-Otologie Abstracts, p.13, 1989.

986. mŠw‰ïn iˆê”Êu‰‰j Šà––Šúáu’ɂɑ΂·‚éŒo”ç“IƒRƒ‹ƒhƒgƒ~[‚ÌŒoŒ±. ¼X–MºCŽOˆäŒö•FC–kŒ´s—YCóˆä²‹vi”]ŠOjC‰Í‘ºONC’Jì’B–çi—Žqˆã‘åj: ‘æ44‰ñ‘—§•a‰@—×{Š‘‡ˆãŠw‰ï (89.10.27), å‘ä.

987. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g’f‘w–@‚ňÙí‚ðŽw“E‚³‚ꂽ‚É‚à‚©‚©‚í‚炸áz«ƒ}ƒq‚ð’悵‚½’áo¶‘ÌdŽ™‚É‚¨‚¯‚鎥‹C‹¤–‰摜ŠŒ©. –åˆäL‹ÅC–ì“n³•FCŠ—Œ´FC’†‘ºP•äCÄ“¡KˆêC¬ŒûO‹BiŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï (89.10.27), ‘å‹{, ´˜^W, p.59, 1989.

988. mŠw‰ïn iˆê”Êu‰‰j V¶Ž™‘ƒó‹•ŒŒ«”]áŠQ‚É‚¨‚¯‚鎥‹C‹¤–‰摜ŠŒ©. –åˆäL‹ÅC–ì“n³•FCŠ—Œ´FC’†‘ºP•äCÄ“¡KˆêC¬ŒûO‹BC”ª‘ãŒö•viŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï (89.10.27), ‘å‹{, ´˜^W, p.93, 1989.

989. mŠw‰ïn iˆê”Êu‰‰j ƒˆ[ƒhƒzƒ‹ƒ€ƒK[ƒ[‚É‚æ‚é‚ÆŽv‚í‚ê‚é¸_Çó‚ð’悵‚½2Ç—á. Š}Œ´—FKCìŒû‹BCŽá“c•””Ž•¶C΋½‰ªƒCŽO‰Y’å‘¥i¸j: ‘æ27‰ñ“Œ‹ž¸_ˆãŠw‰ï (89.10.28), “Œ‹ž.

990. mŠw‰ïn iˆê”Êu‰‰j ”]“®Ã–¬ŠïŒ`dÇ—á‚ɑ΂·‚é‹~‹}ˆã—Ã. ‰iˆä–ÎŽ÷C‘ˆä³„C‚–ì½C‹{â‰À’jCŽRè‹`‹éCŽR“cŸC“c’†ç•FC“c’†–ö…C‹´–{—²C‰““¡¹FC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.06), “Œ‹ž.

991. mŠw‰ïn iˆê”Êu‰‰j ƒNƒ‚–Œ‰ºoŒŒ‹}«ŠúŽ¡—Â̌Ÿ“¢. ‚–ì½i”]ŠOjC¼ŽR’¼‹vi‹~–½jC•½“cŒõ”ŽC“c’†–ö…C‰iˆä–ÎŽ÷i”]ŠOjC–kŒ´F—Yi‹~–½j‰““¡¹Fi”]ŠOjC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.06), “Œ‹ž.

992. mŠw‰ïn iˆê”Êu‰‰j “ª•”ŠO‚ɇ•¹‚·‚éƒVƒ‡ƒbƒN‚ÌŒŸ“¢. ‰““¡¹FC‰iˆä¬Ž÷C“c’†–ö…i”]ŠOjC–kŒ´F—YC‘Oì˜a•FC‘å˜a“c—²i‹~–½jC‹´–{—²C‹{â‰À’ji”]ŠOj: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.07), “Œ‹ž.

993. mŠw‰ïn iˆê”Êu‰‰j ”]“®Ã–¬ŠïŒ^dÇ—á‚ɑ΂·‚é‹~‹}ˆã—Ã. ‰iˆä¬Ž÷C”’ˆä³‘¥C‚–ì½C‹{â‰À’jCŽRè‹`‹éCŽR“cŸC“c’†ç•FC“c’†–ö…C‹´–{—²C‰““¡¹FC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.08), “Œ‹ž.

994. mŠw‰ïn iˆê”Êu‰‰j ƒNƒ‚–Œ‰ºoŒŒ‚É‚æ‚éDOAÇ—á‚ÌŒŸ“¢. –kŒ´F—Yi‹~–½jC‰““¡¹Fi”]ŠOjC•½“cŒõ”ŽC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.08), “Œ‹ž.

995. mŠw‰ïn iˆê”Êu‰‰j Ò‘¬”]•Ï«Ç‚É‚¨‚¯‚é‰^“®_Œo“`“±‘¬“x•ª•z‚ÌŒŸ“¢. •x‰p–¾CtŒ´ŒoFi‘—§¸_¥_ŒoƒZƒ“ƒ^[jC‹kŽ ‘i”]ŠOj: ‘æ19‰ñ“ú–{”]”g¥‹Ø“d}Šw‰ïŠwp‘å‰ï (89.11.10), ‰ªŽR.

996. mŠw‰ïn iˆê”Êu‰‰j ³’†¥ŽÚœ_ŒoŽhŒƒ‚É‚¨‚¯‚éSSEP”gŒ`‚Ì”äŠrŒŸ“¢. ŠŽi–r•¶C²‹´–M•FC‹gÜ‹vmŽqCŒ´“cGŽ÷C”·—EŽŠC‰LŽ”~Žqi—ÕŒŸjC‹kŽ ‘i”]ŠOj: ‘æ19‰ñ“ú–{”]”g¥‹Ø“d}Šw‰ïŠwp‘å‰ï (89.11.10), ‰ªŽR.

997. mŠw‰ïn iˆê”Êu‰‰j “úíƒXƒgƒŒƒX‚̃pƒ^[ƒ“(1)’ÇŽŽ‚É‚¨‚¯‚éŠî–{ƒpƒ^[ƒ“. ¡ˆä–¾—YC²“¡_MC—Ñsˆê˜Yi‰q¶Šw•”jC•ŸŽR‰Ãji‘‡‘Š’k•”jC’†“‡ß•vi¸j: ‘æ5‰ñ“ú–{ƒXƒgƒŒƒXŠw‰ï (89.11.10), “Œ‹ž.

998. mŠw‰ïn iˆê”Êu‰‰j S—ƒXƒgƒŒƒX‘Έ‚ÌŒø‰Ê•ÊAŒ´ˆö•Ê’²¸. ²“¡_MC¡ˆä–¾—YC—Ñsˆê˜Yi‰q¶Šw•”jC•ŸŽR‰Ãji‘‡‘Š’k•”jC’†“‡ß•vi¸j: ‘æ5‰ñ“ú–{ƒXƒgƒŒƒXŠw‰ï (89.11.10), “Œ‹ž.

999. mŠw‰ïn iˆê”Êu‰‰j “úíƒXƒgƒŒƒX‚̃pƒ^[ƒ“(2)’Êí¶Šˆ‚Æ”ñ’Êí¶Šˆ‚Å‚ÌŽx”z“IŒXŒü. —Ñsˆê˜YC²“¡_MC¡ˆä–¾—Yi‰q¶Šw•”jC•ŸŽR‰Ãji‘‡‘Š’k•”jC’†“‡ß•vi¸j: ‘æ5‰ñ“ú–{ƒXƒgƒŒƒXŠw‰ï (89.11.10), “Œ‹ž.

1000. mŠw‰ïn iˆê”Êu‰‰j ”ü—eŠO‰È‚ɑ΂·‚é¸_‰ÈƒRƒ“ƒTƒ‹ƒe[ƒVƒ‡ƒ“. ΋½‰ªƒCŽRéˆê˜YCŽá“c•””Ž•¶CìŒû‹BCâE–{–¾•FCŽO‰Y’å‘¥i¸j: ‘æ2‰ñ“ú–{‘‡•a‰@¸_ˆãŠw‰ï (89.11.11), ‹ž“s.

1001. mŠw‰ïn iˆê”Êu‰‰j ƒ‹[ƒ`ƒ“”]”gŒŸ¸’†‚É”F‚ß‚ç‚ꂽ—Õ°”­ì‚Æ”­ìŽž”]”g‚ɂ‚¢‚Ä. ‹g‘º‹vmŽqi“Œ•a‰@Œ¤‹†ŒnjC‰LŽ”~ŽqC²‹´–M•FCŠŽi–r•¶i—ÕŒŸjCΈä‘P‹PC΋½‰ªƒCˆîŒ©ˆòºC‘ºèŒõ–Mi¸j: ‘æ19‰ñ“ú–{”]”gE‹Ø“d}Šw‰ï (89.11.11), ‰ªŽR, ´˜^W, p.342, 1989.

1002. mŠw‰ïn iˆê”Êu‰‰j ”]zŠÂŽ©“®’²ß”\‚É‚¨‚¯‚éƒAƒfƒmƒVƒ“‚Ì–ðŠ„;ƒ‰ƒbƒg”]“ד®–¬‚̒ጌˆ³‚ɑ΂·‚锽‰ž«‚ƃJƒtƒFƒmƒ“‚̉e‹¿. Xˆä½“ñC‰¤”C’¼C‘å‚O–«C‘q“c²C‹{â‰À’jC–î“cŒ«ŽOi”]ŠOj: ‘æ1‰ñ“ú–{”]zŠÂ‘ãŽÓŠw‰ï (89.11.16`17), “Œ‹ž.

1003. mŠw‰ïn iˆê”Êu‰‰j ¶‘ÌtˆÚA‚̬Ž™¥Â”NŠú—á‚æ‚è‚Ý‚½‰Æ‘°. ²“¡Šìˆê˜YC—é–ؑבãi¸jC•ŸŽR‰Ãji‘‡ˆã—ÑŠ’k•”jCâE–{–¾•FCÔ¯ŒbŽqi¸j: ‘æ30‰ñ“ú–{Ž™“¶¥Â”N¸_ˆãŠw‰ï (89.11.17), •l¼, ´˜^W, p.11, 1989.

1004. mŠw‰ïn iˆê”Êu‰‰j ˆË‘¶“I‚Ђ«‚±‚à‚èó‘Ô‚Æ‚¤‚Âó‘Ô|¶‘ÌtˆÚA¬Ž™¥Â”NŠú—á‚ÌŠÏŽ@‚©‚ç|. ²“¡Šìˆê˜YC—é–ؑבãCÔ¯ŒbŽqi¸j: ‘æ30‰ñ“ú–{Ž™“¶¥Â”N¸_ˆãŠw‰ï (89.11.18), •l¼Žs, ´˜^W, p.51, 1989.

1005. mŠw‰ïn iˆê”Êu‰‰j ’¼’°Šà‚ÌŽèpŒã‚ÉoŒ»‚·‚é¸_áŠQ‚ɂ‚¢‚Ä. Š}Œ´—FKCìŒû‹BCŽá“c•””Ž•¶C΋½‰ªƒCŽO‰Y’å‘¥i¸jC‘å’J„³C‚‹´r‹BC”äŠé”\Ž÷iŠOj: ‘æ44‰ñ“ú–{‘å’°ãè–å•aŠw‰ï (89.11.18), “Œ‹ž, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ, 42(5): 884, 1989.

1006. mŠw‰ïn iˆê”Êu‰‰j ‘O“ª—t—Þã”çŽî‚Ì1—á. ‰ªGGC²“¡Œ’C’†ŽRŒ«Žii”]ŠOj: ‘æ36‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.11.25), “Œ‹ž.

1007. mŠw‰ïn iˆê”Êu‰‰j ŠÌd•Ï‚ɇ•¹‚µ‚½”]”^ᇂÌ1—á. ‚–ì½C‹´–{—²Cì–ìM”Vi”]ŠOjC–쑺ƒŽqCדc‚Ì‚¼‚ÝiŽ™j: ‘æ36‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.11.25), “Œ‹ž.

1008. mŠw‰ïn iˆê”Êu‰‰j Žl‹u‘Ì‘…‚­‚à–Œ”X–E‚Ì3¬l—á. ‹g“cF—FC–kŒ´s—YCŽOˆäŒö•FC¼X–Mºi‘—§‘Š–ÍŒ´•a‰@jC‹´–{—²i”]ŠOj: ‘æ36‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.11.26), “Œ‹ž.

1009. mŠw‰ïn iˆê”Êu‰‰j Psychiatric Problems of Abusers of Bron, an OTC Cough Cure Solution Containing Methylephedrine, Codein and Caffeine. ΋½‰ªƒC‹g“c–FŽqCΈä‘P‹PC‘ºèŒõ–MCŽO‰Y’å‘¥i¸j: 28th ACNP (89.12.11), Hawaii.

1010. mŠw‰ïn iˆê”Êu‰‰j Adversive Seizure Status: Case Reports. ‚‹´–¾”äŒÃC‘ºèŒõ–MCˆîŒ©ˆòºCZ‹gHŽŸCŽRŠpxi¸j: 12th International Congress of EEG and Clinical Neurophysiology (90.01.19), Rio de Janeiro.

1011. mŠw‰ïn iˆê”Êu‰‰j The Role of the Substantia Nigra on Amygdaloid Kindling. ‘ºèŒõ–MC‚‹´–¾”äŒÃC—é–Ø–q•Fi¸jC“n•ÓŽ i“Œ•a‰@Œ¤‹†Œnj: 12th International Congress of EEG and Clinical Neurophysiology (90.01.19), Rio de Janeiro, EEG Clin. Neurophysiol., 75: S148, 1990.

1012. mŠw‰ïn iˆê”Êu‰‰j Œo’±Œ`œ“´”]‰º‚‘Ì“EoŒã‚ÌMRIŠŒ©. ¼Šª”ŽC›MˆêC‰¡ŽR‹v˜NC¬—Ñ–ÎŽ÷C¼ŽR³ŒáC“cŠŽŒÈC¼—Ñ—²i•új: “ú–{Ž¥‹C‹¤–ˆãŠw‰ï (90.02.00), Šò•Œ, “ú–{Ž¥‹C‹¤–ˆãŠw‰ïŽGŽ, 10(Suppl. 1): 90, 1990.

1013. mŠw‰ïn iˆê”Êu‰‰j Žs”̉tó’ÁŠP–ò‚Ì——pEˆË‘¶‚ÉŠÖ‚·‚é—Õ°¸_ˆãŠw“IŒ¤‹†. ‹g“c–FŽqC΋½‰ªƒC‘ºèŒõ–Mi¸j: Œú¶È¸__ŒoŽ¾Š³Œ¤‹†ˆÏ‘õ”¬Œ³”N“xŒ¤‹†•ñ‰ï (90.02.01), “Œ‹ž.

1014. mŠw‰ïn iˆê”Êu‰‰j ¸_•a—lÇó‚ɂĉf‚µ‚½‚Ä‚ñ‚©‚ñ‚Ì3—á. Šâ”öŒõ_i¸j: _“Þì‚Ä‚ñ‚©‚ñ (90.02.03), ‰¡•l.

1015. mŠw‰ïn iˆê”Êu‰‰j ƒrƒ^ƒ~ƒ“B6‘å—ʗÖ@‚ª‘tŒ÷‚µ‚½EIEE‚Ì1—á. ²“¡‰ë•FCŽO‘òmŽiC”’ˆäGKC–xŒû‘דTiŽ™jC‘å–î’B’ji¹˜H‰Á‘Û•a‰@j: ‘æ182‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þì’n•û‰ï (90.02.17), ‰¡•l.

1016. mŠw‰ïn iˆê”Êu‰‰j ‘½”­ŠOŽ¡—Ã’†‚ÉŒoŒ±‚µ‚½Wernicke”]Ç‚Ì1—á. •“cŒ[iŒ`ŠOjC–kŒ´F—Yi‹~–½jC–،Ҋ®miŒ`ŠOjC‰FˆäŒª“ñC’ç–M•FCŽá—Ñ–õ‹vC‘Š”nˆêˆåC‰F’Öؗ´ˆêC‘å˜a“c—²i‹~–½j: ‘æ28‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (90.02.17), “Œ‹ž.

1017. mŠw‰ïn iˆê”Êu‰‰j ŠO4”NŒã‚É”­Ç‚µ‚½‹C”]Ç‚Ì1—á. ‘ˆä³„C‰iˆä–ÎŽ÷C“c’†–ö…C‹´–{—²C‹{â‰À’ji”]ŠOj: ‘æ37‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (90.03.03), “Œ‹ž.

1018. mŠw‰ïn iˆê”Êu‰‰j Ò‘‘“à germ cell tumor ‚Ì1—á. óˆä²‹vC‹g“cF—Fi‘—§‘Š–ÍŒ´•a‰@jC–kŒ´s—YCŽOˆäŒö•Fi”]ŠOjC¼X–Mºi‘—§‘Š–ÍŒ´•a‰@j: ‘æ37‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (90.03.03), “Œ‹ž.

1019. mŠw‰ïn iˆê”Êu‰‰j ‘åŠw•a‰@ƒfƒCƒPƒA‚É‚¨‚¯‚é‰Æ‘°‰ïŠˆ“®. Š}Œ´—FKi¸jC—é–؃ŒbiŠÅŒì•”jCŽR–{–¾”üiƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•”jC¼˜e~i¸jC¬–Ø‘]‰ÀŽqi‘‡‘Š’k•”jC”’–ØŒ´ŽsŽŸC”’–ØŒ´—tŽqiƒŠƒnƒrƒŠ ƒe[ƒVƒ‡ƒ“•”jC‘ê‘ò‚é‚ÝŽqi‘‡‘Š’k•”jC’†“‡ß•vCŽO‰Y’å‘¥i¸j: ‘æ10‰ñ“ú–{ŽÐ‰ï¸_ˆãŠw‰ï (90.03.10), ‹à‘ò.

1020. mŠw‰ïn iˆê”Êu‰‰j ƒfƒCƒPƒA’ÊŠŠ³ŽÒ‚Ì‘Ì—Í•]‰¿|‚Æ‚­‚ɸ_•ª—ô•a‚ɂ‚¢‚Ä|. ”’–ØŒ´ŽsŽŸiƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•”jC—é–؃ŒbiŠÅŒì•”jCŽR–{–¾”üiƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•”jC¬–Ø‘]‰ÀŽqi‘‡‘Š’k•”jC¼˜e~i¸jC”’–ØŒ´—tŽqiƒŠ ƒnƒrƒŠƒe[ƒVƒ‡ƒ“•”jC‘ê‘ò‚é‚ÝŽqi‘‡‘Š’k•”jCŠ}Œ´—FKC’†“‡ß•vCŽO‰Y’å‘¥i¸j: ‘æ10‰ñ“ú–{ŽÐ‰ï¸_ˆãŠw‰ï (90.03.10), ‹à‘ò.

1021. mŠw‰ïn iˆê”Êu‰‰j Œã“ªŠWâ|”]ŒŒŠÇáŠQ‚É‚¨‚¯‚éŠáÇói‘æ1•ñj|”]Š²¬”][Ç‚ÆSkew deviation|. “Œ–M•FC—é–ØGˆêCŒÜ\—’‹v‰ÀC–kˆä‘¥•vC‹àŽq®“ñC”¨—²ŽuCâˆä•¶•FC_“c’¼C“cè‹`ºi“àj: ‘æ85‰ñ“ú–{“à‰ÈŠw‰ï‘‰ï i89.04.03), ‹ž“s.

1022. mŠw‰ïn iˆê”Êu‰‰j Familial Juvenile Neuronal Disease; A New Disease? ’·’JìˆêŽqCŒÃ˜a‹vKi“àj: 12th ISN Meeting i89.04.27), Algarve.

1023. mŠw‰ïn iˆê”Êu‰‰j ‘½”­«“ªŠW“àΊD‰»‚𔺂¢f’f‚É‹ê—¶‚µ‚½‘O‰º¬”]“®–¬—̈æ[Ç‚Ì1—á. f‘ò’BŽuC²ŽRߎqCŽO•x“N˜YC‰¬–ì—TC’·’JìˆêŽqCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ382‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i89.05.13), “Œ‹ž.

1024. mŠw‰ïn iˆê”Êu‰‰j ”]ŒŒŠÇŽB‰eŠŒ©‚©‚ç‚Ý‚½”]Š²¥¬”][Ç‚Ì—Õ°“IŒŸ“¢. ˆ¢‹v’Óñ•vi“àjC’|“àˆè’jC¯–ì–õ•FC‚–ؽC‚–ØNsi϶‰ï’†‰›•a‰@jCŠC˜VŒ´iˆê˜Yi϶‰ïŒü“‡•a‰@j: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.24), …ŒË.

1025. mŠw‰ïn iˆê”Êu‰‰j ㎈—DˆÊ‚Ì[•”Š´ŠoáŠQ‚ð’悵‚½ƒ~ƒGƒƒpƒ`[‚Ì—Õ°“IŒŸ“¢. ‰““¡ˆêÆC¼“cs³C’·’JìˆêŽqC‰¬–ì—TC¼‰ª¹‹ICÄ“¡–L˜aCŒÃ˜a‹vKi“àjC‹kŽ ‘i”]ŠOj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.24), …ŒË.

1026. mŠw‰ïn iˆê”Êu‰‰j One-and-a-halfÇŒóŒQ‚ÌŒoŽž“IŠÏŽ@ . ŠÛŽR”ŽŽuC“Œ–M•FC—é–ØGˆêC”¨—²ŽuC_“c’¼C“cè‹`ºi“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.25), …ŒË.

1027. mŠw‰ïn iˆê”Êu‰‰j ƒgƒƒ|ƒjƒ“°‡TR‘Ì‚É‚æ‚é‹ØüˆÛ‚̃^ƒCƒv•ª‚¯|ƒqƒg•a‘Ô‹Ø‚É‚¨‚¯‚錟“¢|. ¼–{MŽqC’¹‹‡ŽOC“cè‹`ºi“àjC’†‘ºŒ’iŠñjCˆÀˆä”ü]i‘‡—Õ°Œnj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.25), …ŒË.

1028. mŠw‰ïn iˆê”Êu‰‰j RMAGR‘Ì—z«IgM M’`”’ŒŒÇ‚É”º‚¤’E‘«‘½”­_Œo‰Š‚ɑ΂·‚錌Ÿ÷ŒðŠ·—Ö@‚ÌŽ¡—ÃŒø‰Ê. ¼–{ŠÂCŽR‰º‡Íi¼ŽR“úÔjC‘å¼W¶iŽY‹Æˆã‘åjCÄ“¡–L˜ai“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.25), …ŒË.

1029. mŠw‰ïn iˆê”Êu‰‰j Four Cases of Myelopathy with Disturbed Deep Sensation Dominantly in Upper Limb|Neurophysiological Consideration|. ¼“cs³C’·’JìˆêŽqC‰““¡ˆêÆC¼‰ª¹‹ICŒÃ˜a‹vKi“àj: International Symposium on Advanced Evoked Potentials and Related Techniques in Clinical Neurophysiology i89.05.25), Roma.

1030. mŠw‰ïn iˆê”Êu‰‰j Recurrent Neuropathy ‚Ì6—á|Š´ŠoáŠQ‚©‚ç‚Ý‚½ŒŸ“¢. ‘D–{‚ЂƂÝCÄ“¡–L˜aC¼‰ª¹‹IC¼“cs³Cדc–«CŒÃ˜a‹vKi“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.25), …ŒË.

1031. mŠw‰ïn iˆê”Êu‰‰j ”]ŒŒŠÇáŠQ‚É‚Ý‚ç‚ê‚é‘ÌŽ²‚Ì‚Ë‚¶‚ê. ‘O“c^Ž¡C—ŠZF“ñCŒÃ‹´‹I‹vCŒÃ˜a‹vKi“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.25), …ŒË.

1032. mŠw‰ïn iˆê”Êu‰‰j Onion bulb\‘¢‚ð—L‚·‚é’E‘«ƒjƒ…[ƒƒpƒ`[‚Ì”­¶‹@˜‚ÉŠÖ‚·‚錤‹†|‘æ1•ñ. —Õ°“IA—Õ°–ƉuŠw“I‚¨‚æ‚ѶŒŸäC• _Œo‘gDŠw“IŒŸ“¢. a’J”üŒbŽqCÄ“¡–L˜aC’¹‹‡ŽOCˆÉ“¡”Ž–¾Cדc–«C¼“cs³CŒÃ˜a‹vKi“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.25), …ŒË.

1033. mŠw‰ïn iˆê”Êu‰‰j ‰^“®ƒjƒ…[ƒƒ“•aŠ³ŽÒŒŒ´’†‚ÌIgM’PƒNƒ[ƒ“R‘Ì‚ª”FŽ¯‚·‚é“œ½RŒ´. ˆÉ“¡”Ž–¾Ca’J”üŒbŽqCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.25), …ŒË.

1034. mŠw‰ïn iˆê”Êu‰‰j ”ñ“TŒ^“I‚È•a—ŠŒ©‚ð”F‚ß‚½‰^“®ƒjƒ…[ƒƒ“•a‚Ì3—á. ’·’JìˆêŽqi“àjC–ö‰ºŽO˜Yi•a—jC‹{“c‰Ã¢ŽqCa’J”üŒbŽqCŽO•x“N˜YCf‘ò’BŽuC¼“cs³CÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.25), …ŒË.

1035. mŠw‰ïn iˆê”Êu‰‰j HTCV-1 associated uveitis. “ú–ì‰p’‰C¼‰ª³ŒhCˆî‘ºŠ²•vC²”ŒGŽOCÂŽR—FŽOi¬“cŒ´Žs—§•a‰@jCÄ“¡–L˜ai“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.26), …ŒË.

1036. mŠw‰ïn iˆê”Êu‰‰j ‰ºŽˆ‰“ˆÊ‚É‹­‚¢•Ð–ƒáƒ‚ð’悵‚½Ž‹°oŒŒ‚ɂ‚¢‚Ä‚ÌŒŸ“¢. –kˆä‘¥•vC–약CC”¨—²ŽuCâˆä•¶•FC_“c’¼C“cè‹`ºi“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.26), …ŒË, ´˜^W, p.320, 1989.

1037. mŠw‰ïn iˆê”Êu‰‰j ”íŠkoŒŒ’´‹}«Šú‚É‚¨‚¯‚錌ŽîŠg‘åˆöŽq‚ɂ‚¢‚Ä|ŒŒs—ÍŠw“IˆöŽq‚ð’†S‚Æ‚µ‚Ä|. ‹àŽq®“ñC–kˆä‘¥•vC”¨—²ŽuC—é–ØGˆêC“Œ–M•FCâˆä•¶•FC_“c’¼C“cè‹`ºi“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.26), …ŒË, ´˜^W, p.321, 1989.

1038. mŠw‰ïn iˆê”Êu‰‰j Ž‹°•a•Ï‚É”º‚¤‚ŽŸ_Œo‹@”\áŠQ‚Ì‹ÇŠ”]ŒŒ—¬. —é–ØGˆêCâˆä•¶•FCŒÜ\—’‹v‰ÀC_“c’¼C“cè‹`ºi“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.26), …ŒË, —Õ°_ŒoŠw, 29(12): 1582, 1989.

1039. mŠw‰ïn iˆê”Êu‰‰j ”]ŒŒŠÇáŠQŒã‚̉¼«‹…–ƒáƒ‚É‚æ‚鉉ºáŠQ‚̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. ‘O“c^Ž¡C—ŠZF“ñCŒÃ‹´‹I‹vCŒÃ˜a‹vKi“àj: ‘æ26‰ñ“ú–{ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ˆãŠw‰ï‘‰ï i89.06.02), å‘ä.

1040. mŠw‰ïn iˆê”Êu‰‰j ‘å”]”玿‚É‘½”‚̃Aƒ‹ƒcƒnƒCƒ}[Œ´üˆÛ•Ï‰»‚ð‚Ý‚éis«Šjã«–ƒáƒ‚ɂ‚¢‚Ä. “V–ì’¼“ñCŠâ•£Œ‰C‰¡ˆäWi_“Þ샊ƒnƒrƒŠjC–ö‰ºŽO˜Yi•a—jCˆäŠÖ‰hŽOC’·—FGŽ÷C¼‰º³–¾i‰¡•lŽs‘åjC’·’JìˆêŽqCŒÃ˜a‹vKi“àj: ‘æ30‰ñ“ú–{_Œo•a—Šw‰ï‘‰ï i89.06.21), “Œ‹ž.

1041. mŠw‰ïn iˆê”Êu‰‰j ¬lHistiocytosis X—á. ’·’JìˆêŽqCŒÃ˜a‹vKC¼“cs³i“àjC’†‰p’jC–ö‰ºŽO˜Yi•a—j: ‘æ30‰ñ“ú–{_Œo•a—Šw‰ï‘‰ï i89.06.21), “Œ‹ž.

1042. mŠw‰ïn iˆê”Êu‰‰j Disconnection syndrome‚𗈂µ‚½‘O‘å”]“®–¬[Ç‚Ì1—á. ²ŽRߎqC’·’JìˆêŽqCÄ“¡–L˜aCŒÃ‹´‹I‹vi“àjCd–ìKŽŸiˆÉ“¤”BŽR‰·ò•a‰@j: ‘æ109‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i89.07.01), “Œ‹ž.

1043. mŠw‰ïn iˆê”Êu‰‰j ‘Sg‚±‚Þ‚ç•Ô‚è•a—lÇó‚ð’悵ŒŒ´ˆŸ‰”’á’lA«‘B‹@”\’ቺ‚ð”F‚ß‚½’¼’°Šà‚Ì1—á. ¼‰ª³ŒhC“ú–ì’‰‰pC㓈\˜Yi¬“cŒ´Žs—§•a‰@jCŒÃ˜a‹vKi“àj: ‘æ109‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i89.07.01), “Œ‹ž.

1044. mŠw‰ïn iˆê”Êu‰‰j ‘OÒ‘“®–¬ÇŒóŒQ‚Ì1Ç—á. ŽO•x“N˜YC‰¬–ì—TC’·’JìˆêŽqCÄ“¡–L˜aC¬ŽR“àŠ²_CŒÃ˜a‹vKi“àjCŽOˆäŒö•Fi”]ŠOjC›Mˆêi•újCŒK”ö’èmi•a—j: ‘æ24‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï i89.09.07), ŽD–y.

1045. mŠw‰ïn iˆê”Êu‰‰j Ò‘ƒ~ƒIƒNƒ[ƒkƒX‚Ì–ò•¨Ž¡—Âɂ‚¢‚Ă̈êlŽ@iŽ©Œ±2—á‚Æ•¶Œ£“IlŽ@j. ‰““¡ˆêÆC‹{“c‰Ã¢ŽqCדc–«C’·’JìˆêŽqCŒÃ˜a‹vKi“àjC–kŒ´s—Yi”]ŠOj: ‘æ24‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï i89.09.07), ŽD–y.

1046. mŠw‰ïn iˆê”Êu‰‰j •‘“¥•a—l•sˆÓ‰^“®‚ð’悵‚½Willis“®–¬—Ö•ÂÇÇ‚Ì1—á. Œ˘aŽqC’·’JìˆêŽqCÄ“¡–L˜aCŒÃ‹´‹I‹vCŒÃ˜a‹vKi“àj: ‘æ385‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i89.09.09), “Œ‹ž.

1047. mŠw‰ïn iˆê”Êu‰‰j ”]ŒŒŠÇ•a•Ï‚ð—L‚·‚éÇ—á‚É‚¨‚¯‚é~ˆ³ŒÀŠE|”]zŠÂ“®‘Ô–Ê‚æ‚è‚ÌŒŸ“¢. ‹àŽq®“ñi“àjCàV“c“OCŒIŽR—ÇãEC¬•x”ŽÍi‘—§zŠÂŠí•aƒZƒ“ƒ^[jC“‚‘ò~i‘åã”]_ŒoŠO‰È•a‰@j: ‘æ12‰ñ“ú–{‚ŒŒˆ³Šw‰ï‘‰ï i89.09.14), ŽD–y.

1048. mŠw‰ïn iˆê”Êu‰‰j ¶‘O‘å”]“®–¬—̈æ‚Ì[Ç‚É‚æ‚éu“¹‹ï‚Ì‹­”—“IŽg—pv. ‘O“c^Ž¡C²ŽRߎqC‰¬–ì—TCŒÃ‹´‹I‹vi“àjC¬’r‘׎qCΖєü‘ãŽqiƒŠƒnƒrƒŠjCŽí“c^»—Yi¸j: ‘æ13‰ñ“ú–{_ŒoS—Šw‰ï i89.09.29), “Œ‹ž.

1049. mŠw‰ïn iˆê”Êu‰‰j ƒgƒƒ|ƒjƒ“°I R‘Ì‚ð—p‚¢‚½¶ŒŸ‹Ø‚̃^ƒCƒv•ª‚¯|‰æ‘œ‰ðÍ‚É‚æ‚錟“¢|. ¼–{MŽqC’¹‹‡ŽOi“àjCˆÀˆä”ü]i‘‡—Õ°ŒnjC’†‘ºŒ’iŠñjC“c’†ŠÚ–¾”Ži¶•¨•¨—ŒnjC¬¼”Ž‹`i‰q¶Šw•”j: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï i89.09.30), ‘Š–ÍŒ´, –k—¢ˆãŠw, 19(6): 644, 1989.

1050. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒg‚É‚¨‚¯‚é”]‹•ŒŒŽž‚̃‚ƒmƒAƒ~ƒ“•úo‚ɂ‚¢‚Ä‚ÌŒ¤‹†. –약CC_“c’¼C“cè‹`ºi“àj: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï i89.09.30), ‘Š–ÍŒ´, –k—¢ˆãŠw, 19(6): 645, 1989.

1051. mŠw‰ïn iˆê”Êu‰‰j ƒgƒƒ|ƒjƒ“°I R‘Ì‚É‚æ‚霊i‹ØüˆÛ‚̃^ƒCƒv•ª‚¯|ATPaseõF‚ƈقȂé‘Ô“x‚ðŽ¦‚µ‚½Ç—á‚ÌŒŸ“¢|. ¼–{MŽqC’¹‹‡ŽOi“àjCˆÀˆä”ü]i‘‡—Õ°ŒnjC’†‘ºŒ’iŠñjC“c’†ŠÚ–¾”Ži¶•¨•¨—ŒnjC¬¼”Ž‹`i‰q¶Šw•”j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i89.10.06), ‹ž“s.

1052. mŠw‰ïn iˆê”Êu‰‰j MRI‚Åf’f‚µ“¾‚½”]’ê“®–¬ŒŒðÇ‚Ì1—á. ¡ˆä¸Cˆ¢‹v’Óñ•vC‹àŽq®“ñC_“c’¼C“cè‹`ºi“àj: ‘æ110‰ñ_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i89.10.07), “Œ‹ž.

1053. mŠw‰ïn iˆê”Êu‰‰j Ž‹_ŒoˆÞkA_Œo«“ï’®A‘̘H’¥ŒóA’s•ð‚ð’悵‚½HMSN type ‡T’jŽq—á. ¼‰ª¹‹IC’––“‹vŠxC’·’JìˆêŽqCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ110‰ñ_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i89.10.07), “Œ‹ž.

1054. mŠw‰ïn iˆê”Êu‰‰j ”]oŒŒ‚ðŒJ‚è•Ô‚µ‚½œŒ`¬•s‘SÇ‚Ì1—á. ŠÛŽR”ŽŽuCˆ¢‹v’Óñ•vC”¨—²ŽuC_“c’¼C“cè‹`ºi“àj: ‘æ386‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i89.10.14). “Œ‹ž.

1055. mŠw‰ïn iˆê”Êu‰‰j Cerebrospinal Fluid Levels of Noradrenaline Metabolite in Acute Cerebral Infarction. “Œ–M•FC”¨—²ŽuCâˆä•¶•FC_“c’¼C“cè‹`ºi“àj: The 1st International Stroke Congress i89.10.16), ‹ž“s.

1056. mŠw‰ïn iˆê”Êu‰‰j Magnetic Resonance Brain Imaging of Migraine. ŒÜ\—’‹v‰ÀCâˆä•¶•FC“cè‹`ºi“àjC›Mˆêi•új: ‡W International Headache Congress i89.10.16), Sydney, Cephalolgia, 9(Suppl. 10): 189-190, 1989.

1057. mŠw‰ïn iˆê”Êu‰‰j Neurotransmitter Substances in Extrapyramidal Disorder. ’·’JìˆêŽqCŒÃ˜a‹vKi“àj: International Conference in Alzheimer's Parkinson's Disease i89.11.08), ‹ž“s.

1058. mŠw‰ïn iˆê”Êu‰‰j Flicker VECP‚É‚¨‚¯‚éU•Žü”g”“Á«. ‹g–{gŽqi—ÕŒŸjC”¨—²Žui“àjCŽRéˆê˜YCŽí“c^»—Yi¸j: ‘æ19‰ñ“ú–{”]”g¥‹Ø“d}Šw‰ï i89.11.10), ‰ªŽR.

1059. mŠw‰ïn iˆê”Êu‰‰j ‰·“x•Ï‰»‚Ì’mŠo_ŒoŠˆ“®“dˆÊ (SNAP) ‚É‹y‚Ú‚·‰e‹¿. Ä“¡]”üŽqCr”¦“Äi—ÕŒŸjC’¹‹‡ŽOi“àjC‹kŽ ‘i”]ŠOjC‰ª“‡dFiìèˆä“c•a‰@j: ‘æ19‰ñ“ú–{”]”g¥‹Ø“d}Šw‰ïŠwp‘å‰ï i89.11.10), ‰ªŽR.

1060. mŠw‰ïn iˆê”Êu‰‰j ‰¹Šy‚É‚æ‚é”]”g•Ï‰»‚Ì’è—Ê“IŒŸ“¢i‘æ2•ñj|Ž¸ŒêÇŠ³ŽÒ‚Å‚ÌŒŸ“¢|. ŠC˜VŒ´iˆê˜YC¬ì’ÃŽqC‚–ØNsC¯–ì°•FC‹îƒP—䳃i϶‰ï’†‰›•a‰@jC”¨—²Žui“àj: ‘æ19‰ñ“ú–{”]”g¥‹Ø“d}Šw‰ïŠwp‘å‰ï i89.11.10), ‰ªŽR.

1061. mŠw‰ïn iˆê”Êu‰‰j ƒp[ƒLƒ“ƒ\ƒ“•a”­Ç‚ɉ—‚¯‚é˜V‰»‚̉e‹¿i‘æ2•ñj. ’·’JìˆêŽqC’–ŒÒ‹vŠxC³–Ø‚©‚‚çCŒÃ‹´‹I‹vCŒÃ˜a‹vKi“àj: ‘æ31‰ñ“ú–{˜V”NˆãŠw‰ï‘‰ï i89.11.14), –¼ŒÃ‰®.

1062. mŠw‰ïn iˆê”Êu‰‰j ‚—î”­Ç‚Ì–«is«‘½”­ªƒjƒ…[ƒƒpƒ`[‚Ì2–UŒŸ—á. f‘ò’BŽuCÄ“¡–L˜aC‰¬–ì—TC³–Ø‚©‚‚çCדc–«CŒÃ‹´‹I‹vCŒÃ˜a‹vKi“àj: ‘æ31‰ñ“ú–{˜V”NˆãŠw‰ï‘‰ï i89.11.14), –¼ŒÃ‰®.

1063. mŠw‰ïn iˆê”Êu‰‰j ”][ÇŠ³ŽÒ‚É‚¨‚¯‚錌ˆ³“ú“à•Ï“®‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ’–ŒÒ‹vŠxCŠÛŽR”ŽŽuC‹àŽq®“ñC_“c’¼C“cè‹`ºi“àj: ‘æ31‰ñ“ú–{˜V”NˆãŠw‰ï‘‰ï i89.11.14), –¼ŒÃ‰®, ´˜^W, p.85, 1989.

1064. mŠw‰ïn iˆê”Êu‰‰j ƒmƒ‹ƒAƒhƒŒƒiƒŠƒ“‘ãŽÓŽY•¨‚ƉÁ—î‚Æ‚ÌŠÖŒW. “Œ–M•FCŒÜ\—’‹v‰ÀC”¨—²ŽuCâˆä•¶•FC_“c’¼C“cè‹`ºi“àj: ‘æ31‰ñ“ú–{˜V”NˆãŠw‰ï‘‰ï i89.11.15), –¼ŒÃ‰®.

1065. mŠw‰ïn iˆê”Êu‰‰j “ú–{•a—–UŒŸS•ñ‚©‚猩‚½”]ŒŒŠÇŽ¾Š³Ž€‚Ì„ˆÚ. –약CC_“c’¼C“cè‹`ºi“àj: ‘æ31‰ñ“ú–{˜V”NˆãŠw‰ï‘‰ï i89.11.16), –¼ŒÃ‰®.

1066. mŠw‰ïn iˆê”Êu‰‰j NaHCO3•‰‰×‚É‚æ‚é”]ŒŒŠÇ”½‰ž«‚ÌŒŸ“¢. ˆ¢‹v’Óñ•vCâˆä•¶•FC—é–ØGˆêC“cè‹`ºi“àj: ‘æ1‰ñ“ú–{”]zŠÂ‘ãŽÓŠw‰ï‘‰ï i89.11.16), “Œ‹ž.

1067. mŠw‰ïn iˆê”Êu‰‰j ”]ÇðÇ‚Ì123I-IMP SPECT. ’|“àˆè’jC”Š_mC¯–ì°•FC‚–ؽC‹îƒP—䳃C‚–ØNsCŠC˜VŒ´iˆê˜Yi϶‰ï’†‰›•a‰@jC”¨—²Žui“àj: ‘æ1‰ñ“ú–{”]zŠÂ‘ãŽÓŠw‰ï‘‰ï i89.11.17), “Œ‹ž.

1068. mŠw‰ïn iˆê”Êu‰‰j ”]ŒŒ—¬‚̉»Šw“I’²ß‚ɑ΂·‚éƒJƒ‹ƒ‚ƒWƒ…ƒŠƒ“‘jŠQ܂̉e‹¿. “Œ–M•FC”¨—²ŽuCŠÛŽR”ŽŽuC–k‘ººC˜°‰i”­Câˆä•¶•FC_“c’¼C“cè‹`ºi“àj: ‘æ30‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï i89.11.22), ‹ž“s.

1069. mŠw‰ïn iˆê”Êu‰‰j ’˜–¾‚È‚ƒ~ƒIƒOƒƒrƒ“ŒŒÇ‚𔺂Á‚½’Pƒƒwƒ‹ƒyƒX”]‰Š‚Ì1—á. ¡ˆä¸Cˆ¢‹v’Óñ•vC‹àŽq®“ñC_“c’¼C“cè‹`ºi“àj: ‘æ111‰ñ_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i89.12.02), “Œ‹ž.

1070. mŠw‰ïn iˆê”Êu‰‰j 15”NŠÔfollow‚µ“¾‚½Shy-DragerÇŒóŒQ‚Ì1–UŒŸ—á. ¼“cs³C’·’JìˆêŽqCÄ“¡–L˜aCŒÃ˜a‹vKi“àjC–ö‰ºŽO˜Yi•a—j: ‘æ111‰ñ_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i89.12.02), “Œ‹ž.

1071. mŠw‰ïn iˆê”Êu‰‰j Downbeat nystagmus‚Ébaclofen‚ª—LŒø‚Å‚ ‚Á‚½1—á. ŽO•x“N˜YC’·’JìˆêŽqCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ112‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i90.03.03), “Œ‹ž.

1072. mŒ¤‹†‰ïn i“Á•Êu‰‰j R•sˆÀ–ò‚Æ‹L‰¯áŠQ. ‘ºèŒõ–Mi¸j: ‘æ26‰ñ_“Þ쌧¸_–ò—§˜b‰ï (89.00.00), ‰¡•l.

1073. mŒ¤‹†‰ïn i“Á•Êu‰‰j Å‹ß‚Ì”­’BáŠQ‚Ìl‚¦•û‚ÆáŠQŽ™‹³ˆç‚É–]‚Þ‚±‚Æ. ²“¡Šìˆê˜Yi¸j: ‘Š–ÍŒ´Žs“ÁŽê‹³ˆçŒ¤‹†‰ï‘‰ï (89.05.16), ‘Š–ÍŒ´.

1074. mŒ¤‹†‰ïn i“Á•Êu‰‰j ‚Ä‚ñ‚©‚ñŽ¡—Âɂ¨‚¯‚éR‚Ä‚ñ‚©‚ñ–òŒŒ’†”Z“x‘ª’è‚Ì—Õ°“IˆÓ‹`. ŽO‰YŽõ’jiŽ™j: ‘æ11‰ñˆïé‚Ä‚ñ‚©‚ñ§˜b‰ï (89.05.27), “y‰Y.

1075. mŒ¤‹†‰ïn i“Á•Êu‰‰j ¬Ž™‚Ì”M«‚¯‚¢‚ê‚ñ|‚»‚ÌŠÇ—‚Æ—\Œã‚ð’†S‚É|. ŽO‰YŽõ’jiŽ™j: ‘æ271‰ñ_“Þ쌧•ÛŒ¯ˆã‹¦‰ïŒŽ—ጤ‹†‰ï (89.09.17), •ÛŒ¯ˆã‚Ì—Õ°, (294): 2`11, 1989.

1076. mŒ¤‹†‰ïn i“Á•Êu‰‰j Å‹ß‚ÌŒü¸_–ò‚ɂ‚¢‚Ä. ŽO‰Y’å‘¥i¸j: ‹à‘ò¸_‰Èˆã‰ï (89.11.04), ‹à‘ò.

1077. mŒ¤‹†‰ïn i“Á•Êu‰‰j ƒgƒ‰ƒ“ƒLƒ‰ƒCƒU[‚Ì’mŽ¯‚Æ‚»‚ÌŽg‚¢•û. ŽO‰Y’å‘¥i¸j: _“Þ쌧¸_•a‰@‹¦‰ï¥“à‰ÈˆãŠw‰ï‡“¯u‰‰‰ï (90.02.10), ‰¡•l.

1078. mŒ¤‹†‰ïn i“Á•Êu‰‰j ’·Šú“§ÍŠ³ŽÒ‚̸_‰q¶. ²“¡Šìˆê˜Yi¸j: ‘æ17‰ñŽR—œ“§ÍŒ¤‹†‰ï (90.03.04), •xŽm‹g“c, ŽR—œ“§ÍŒ¤‹†‰ï‰ï•ñ, 9: 1990.

1079. mŒ¤‹†‰ïn i‹³ˆçu‰‰j Å‹ß‚Ì“oZ‹‘”Û‚Ìl‚¦•û‚Ɖ‡•‚ɂ‚¢‚Ä. ²“¡Šìˆê˜Yi¸j: •½’ËŽs“oZ‹‘”ÛŒ¤‹†‰ïi•½’ËŽs‹³ˆçˆÏˆõ‰ïj (89.08.28), •½’Ë.

1080. mŒ¤‹†‰ïn i‹³ˆçu‰‰j R‚Ä‚ñ‚©‚ñ–ò‚ÌTDM|Clinical Pharmacokinetics‚Ì—˜_‚ÆŽÀÛ|. ŽO‰YŽõ’jiŽ™j: ‘æ7‰ñ–ò•¨Ž¡—ƒjƒ^ƒŠƒ“ƒOŒ¤‹†‰ï“Á•Êƒ[ƒ~ƒi|ƒ‹ (89.09.03), “Œ‹ž, u‰‰W, p.41`52, 1989.

1081. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ”]Žîá‡. ›Mˆêi•új: ‘æ4‰ñMR—Õ°uÀ (89.09.16), “Œ‹ž.

1082. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ‚Ä‚ñ‚©‚ñ‚Ì–ò•¨—Ö@. ŽO‰YŽõ’jiŽ™j: ‘æ19‰ñ¬Ž™_ŒoŠwƒZƒ~ƒi|i“ú–{¬Ž™_ŒoŠw‰ïj (89.11.04), _ŒË, u‹`—pƒeƒLƒXƒg, p.51`57, 1989.

1083. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ¸_”–ŽãŽÒ‚̸_áŠQ‚Ì—\–h‚Æ‘Îô|¸_”–ŽãŽÒ‚Ƃ̃Rƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚ÌáŠQ|. ²“¡Šìˆê˜Yi¸j: •½¬Œ³”N“x_“Þ쌧¸_”–ŽãŽÒˆ¤Œì‹¦‰ïŒ¤C‰ï (89.12.06), ‰¡•l.

1084. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ˆê”Ê—Õ°‚ɉ—‚¯‚éŒü¸_–òŽ¡—Â̔–â‘è. ŽO‰Y’å‘¥i¸j: “ú–{ˆãŠw‹¦‰ï‘æ147‰ñf—ç˜b‰ï (90.01.08), “Œ‹ž.

1085. mŒ¤‹†‰ïn i‹³ˆçu‰‰j áŠQŽ™‚Ì”­’B‚Æ•Ûˆç‚ɂ‚¢‚Ä. ²“¡Šìˆê˜Yi¸j: ‘æ1‰ñ’¬“cŽsáŠQŽ™•Ûˆç˜A—‹¦‹c‰ï (90.01.17), ’¬“c.

1086. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‘åŒ^AVM‚ÌŽèp¬Ñ‚ÉŠÖ˜A‚·‚锈öŽq‚Æ‘Îô. ‹{â‰À’jC“c’†–ö…C“ü‘qŽŒÈCz–K’m–çC‘q“c²CÄ“¡Œ³—ÇC‰““¡¹FC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½jC’†ŽRŒ«“ñi‘å“c•a‰@j: ‘æ18‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŒ¤‹†‰ï (89.05.22), “Œ‹ž.

1087. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j “ª•”ŠO‚É‚¨‚¯‚é”]zŠÂ‘ãŽÓáŠQ|Diffuse Brain Injury‚Ì”]zŠÂ“®‘ÔG123I-IMP SPECT‚ɑ΂·‚錟“¢. ‰““¡¹FC“c’†ç•FC‚–ì½C‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ13‰ñ“ú–{_ŒoŠOŒ¤‹†‰ï (90.03.28), “Œ‹ž.

1088. mŒ¤‹†‰ïn iƒpƒlƒ‹j Strio-capsulo-thalamic AVMs‚ɑ΂·‚é“Eop‚ÌŒoŒ±. “c’†–ö…C‰ªGGCŽRè‹`‹éCŽs앶•FC–kŒ´s—YC‘q“c²CÄ“¡Œ³—ÇC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ18‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŒ¤‹†‰ï (89.05.22), “Œ‹ž.

1089. mŒ¤‹†‰ïn iƒpƒlƒ‹j Œ¤C‚Ì•]‰¿‚Æ‚»‚ÌŠˆ—p:Žw“±ˆã‚Ì•]‰¿‚ƈç¬. ŒÃ˜a‹vKi“àj: ‘æ7‰ñ—Õ°Œ¤CŒ¤‹†‰ï i89.04.22), “Œ‹ž.

1090. mŒ¤‹†‰ïn iˆê”Êu‰‰j Lithium Baby ‚Ì2—á|5΂܂ł̌o‰ßŠÏŽ@. ŽRéˆê˜YC’ç–M•FC’†“‡ß•vCŽO‰Y’å‘¥i¸j: ‘æ9‰ñƒŠƒEƒ}ƒ`Œ¤‹†‰ï (89.04.22), “Œ‹ž, —\eW, p.32, 1989.

1091. mŒ¤‹†‰ïn iˆê”Êu‰‰j ¬Ž™‚Ì•ú’u‚Æ‹s‘Ò. Šâ”öŒõ_i¸j: –k—¢‘åŠw¸__Œo‰ÈŒ¤‹†‰ï (89.05.15), ‘Š–ÍŒ´.

1092. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”]“®Ã–¬ŠïŒ`“EoŒã‚Ì“ªŠW“àˆ³‘ª’è‚̈Ӌ`‚Æ“ªŠW“àˆ³˜´i‚ÌŒ´ˆö. “ü‘qŽŒÈi”]ŠOjCÄ“¡•Žuiˆä“c•a‰@jC“c’†ç•FC‹´–{—²C‘q“c²C‘å‚O–«C‰““¡¹FC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ18‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŒ¤‹†‰ï (89.05.21), “Œ‹ž.

1093. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒŒŠÇŽÊã•`o•s”\‚È”]ŒŒŠÇŠïŒ`21—á‚ÌŒŸ“¢|“Á‚ÉA‚»‚Ìf’f•û–@A—Õ°“IˆÓ‹`AŽ¡—Âɂ‚¢‚Ä. ‘q“c²C“c’†–ö…C–kŒ´s—YCí”ՉÈêCŽs앶•FC‚–쮎¡CÄ“¡Œ³—ÇC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC‘å˜a“c—²i‹~–½jC›Mˆêi•új: ‘æ18‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŒ¤‹†‰ï (89.05.21), “Œ‹ž.

1094. mŒ¤‹†‰ïn iˆê”Êu‰‰j _ŒoÇ‚Í•Ï‚í‚Á‚½. Ží“c^»—Yi¸j: –k—¢‘åŠwˆãŠw•”¸_‰ÈŒ¤‹†‰ï (89.06.05), ‘Š–ÍŒ´.

1095. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”]Ž€”»’è‚ÌŽÀó. L£—²ˆêC–kˆä‘¥•vC‘å˜a“c—²i‹~–½j: ‘æ2‰ñ”]Ž€¥”]‘h¶Œ¤‹†‰ï (89.06.16), “Œ‹ž.

1096. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹­”—ÇóC•s“oZ‚ð’悵‚½7ΗŽ™‚ÌÇ—á. ˆÉ“¡ˆèŽqi¸j: ‘æ7‰ñŽ™“¶¸_‰È—Õ°Œ¤‹†‰ï (89.06.23`24), –¼ŒÃ‰®.

1097. mŒ¤‹†‰ïn iˆê”Êu‰‰j Anterior Sacral Meningocele‚Ì2Ç—á|“Á‚ÉMRI‚Ìf’fã‚Ìd—v«‚ɂ‚¢‚Ä|. ‘å‚O–«CŽs앶•FCz–K’m–çC‹{â‰À’jC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½jC›Mˆêi•új: ‘æ6‰ñ“ñ•ªÒ’ÅŒ¤‹†‰ï (89.07.01), “Œ‹ž.

1098. mŒ¤‹†‰ïn iˆê”Êu‰‰j Sodium valproate ‚Ì•¹—p‚ª carbamazepine ‚¨‚æ‚Ñ carbamazepine-10,11-epoxide ‚Ì—V—£Œ^ŒŒ’†”Z“x‚É‚¨‚æ‚Ú‚·‰e‹¿‚È‚ç‚Ñ‚É‚»‚Ì—Õ°“IˆÓ‹`i•â“Uj. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂiŽ™j: ‘æ24‰ñ_“Þì‚Ä‚ñ‚©‚ñ§˜b‰ï (89.07.15), ‰¡•l.

1099. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œz’Å‘¹‚ɇ•¹‚µ‚½ŠO«’Åœ“®–¬áŽ‚Ì1—á. ŽR“cŸi”]ŠOjC–kŒ´F—Yi‹~–½jCz–K’m–çCŽRè‹`‹éC–î“cŒ«ŽOi”]ŠOjC‘å˜a“c—²i‹~–½j: ‘æ15‰ñ“ú–{Ò‘ŠO‰ÈŒ¤‹†‰ï (89.07.15), ‹{è.

1100. mŒ¤‹†‰ïn iˆê”Êu‰‰j Arnold-ChiariŠïŒ`‚ɇ•¹‚·‚éÒ‘‹ó“´Ç‚̬ˆö‚É‚¨‚¯‚鑉t“®‘Ô‚ÌŠÖ—^. ‹kŽ ‘CŽs앶•FC”Ñ“cG•vCŽOˆäŒö•FC–î“cŒ«ŽOi”]ŠOj: ‘æ4‰ñ“ú–{Ò‘ŠO‰ÈŒ¤‹†‰ï (89.07.15), ‹{è.

1101. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ò‘Œã³’†Šui“ü–@‚É•K—v‚ÈÒ‘”÷¬ŠO‰È‰ð–U. ŽOˆäŒö•FC”Ñ“cG•vC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOj: ‘æ4‰ñ“ú–{Ò‘ŠO‰ÈŒ¤‹†‰ï (89.07.15), ‹{è.

1102. mŒ¤‹†‰ïn iˆê”Êu‰‰j 5ÎŽž‚É‹­”—Çó‚Å”­•a‚µA‘½Ê‚ȃqƒXƒeƒŠ[Çó‚È‚Ç‚ð’悵‚½Ç—ái7ΗŽ™j. ˆÉ“¡ˆèŽqi¸j: ‘æ12‰ñ_“Þ쎙“¶¸_‰Èˆã§˜b‰ï (89.07.15), ‰¡•l.

1103. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠC–ÈÖ¬“´•”‘–ŒŽî‚ɑ΂·‚é“Eop‚̉”\«. ‹{â‰À’jC‰ªGGC‰iˆä–ÎŽ÷CŽRè‹`‹éCŽR“cŸC“c’†ç•FC“c’†–ö…C–kŒ´s—YCŽs앶•FCˆÉ“¡”ä˜CŽuC–î“cŒ«ŽOi”]ŠOj: ‘æ1‰ñ“ú–{“ªŠW’êŠO‰ÈŒ¤‹†‰ï (89.07.24), “Œ‹ž.

1104. mŒ¤‹†‰ïn iˆê”Êu‰‰j I-123-IMP SPECTŒŸ¸‚É‚ÄŽw“E‚µ“¾‚½’ጌˆ³‚É”º‚¤”]ŒŒ—¬ˆÙí‚Ì1—á. ¼Šª”ŽCΈ䟌ÈC“cŠŽŒÈC›MˆêC¼ŽR³ŒáC¬—Ñ–ÎŽ÷C‰¡ŽR‹v˜NC’†‘òŒ\Ž¡C‹e’nŒhCˆË“cˆêdC¼—Ñ—²i•új: ‘æ31‰ñ“ú–{ŠjˆãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (89.08.00), “Œ‹ž, ŠjˆãŠw, 26(11): 1462, 1989.

1105. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒEƒƒLƒi[ƒ[”]‘…ŠÁ—¬–@‚ÌŒø‰Ê‚ÆŒÀŠE. ‰““¡¹FC‰iˆä¬Ž÷C“c’†–ö…C‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½jCÄ“¡Œ³—Çi”]ŠOj: ‘æ5‰ñƒXƒpƒYƒ€ƒVƒ“ƒ|ƒWƒEƒ€ (89.08.06), ‹ž“s.

1106. mŒ¤‹†‰ïn iˆê”Êu‰‰j Carbamazepine ‚Ì‘Ì“à“®‘Ô‚Æ 10,11-dihydroxycarbamazepine ŒŒ’†”Z“x‘ª’èi—\•ñj. »‰ŸÂCŽO‰YŽõ’jC”’ˆäGKCדc‚Ì‚¼‚ÝiŽ™jC‘ˆä‹vKC‹v¼”üC{“¡–F³i–k—¢ƒ‰ƒ{j: ‘æ16‰ñ”­’B–ò—¥–ò•¨Ž¡—ÃŒ¤‹†‰ï (89.08.19), ˆ®ì, ´˜^W, p.2, 1989.

1107. mŒ¤‹†‰ïn iˆê”Êu‰‰j ™•ú«ƒoƒ‹ƒvƒŽ_»Ü (KW-6066N) ‚ÌŒø‰Ê|ŒŒ’†”Z“x‚È‚ç‚Ñ‚É—Õ°–Ê‚©‚ç‚̈êlŽ@i•â“U|j. ŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂiŽ™j: ‘æ4‰ñ_“Þ쬎™_Œo§˜b‰ï (89.09.02), ‰¡•l, ´˜^W, p.7, 1989.

1108. mŒ¤‹†‰ïn iˆê”Êu‰‰j ÛHáŠQ‚Ì–â‘è“_. Ží“c^»—Yi¸j: –k—¢‘åŠwˆãŠw•”¸_‰ÈŒ¤‹†‰ï (89.10.02), ‘Š–ÍŒ´.

1109. mŒ¤‹†‰ïn iˆê”Êu‰‰j SgÇŽ¡—Éߒö‚É‚¨‚¯‚é––½‰·‚̕ω». ’†“‡ß•vCŽRéˆê˜YC”’싳li¸j: Œú¶È: ¸_¥_ŒoŽ¾Š³Œ¤‹†ˆÏ‘õ”ïuSgÇ‚Ìf’f‹y‚ÑŽ¡—×\Œã‚ÉŠÖ‚·‚錤‹†v•½¬Œ³”N“x”ljï‹c (89.11.25), “Œ‹ž.

1110. mŒ¤‹†‰ïn iˆê”Êu‰‰j Š³ŽÒŽ©‚炪ƒ`[ƒ€ˆã—Ņ̃‚ð‚‚­‚è‚ ‚°‚½ƒ^[ƒ~ƒiƒ‹ƒP[ƒX. –@—R”üŽqCŽæo—ÁŽqC‰Á“‡–¾iˆã—ÑŠ’kŽºjC–û’J˜aŽqC–kŽR—æŽqC“àŽRŒúŽqC¬‘ò”ü˜aiŠÅŒì•”jCŽRéˆê˜YC²“¡Šìˆê˜Yi¸j: ‘æ13‰ñŽ€‚Ì—Õ°Œ¤‹†‰ï (89.11.25), “Œ‹ž, Ž€‚Ì—Õ°, 12(2):34`35, 1989.

1111. mŒ¤‹†‰ïn iˆê”Êu‰‰j Diazepam ¿Ü”­”MŽžŠÔŸ[“Š—^–@‚É‚æ‚é”M«‚¯‚¢‚ê‚ñ‚ÌÄ”­—\–hŒø‰Ê‚ÌWŒv‚Æ“¯–@Ž{s‚ÌŽÀÛ. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂCדc‚Ì‚¼‚ÝiŽ™j: ‘æ12‰ñ”M«‚¯‚¢‚ê‚ñ§˜b‰ï (89.12.16), “Œ‹ž.

1112. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”]“®–¬áŽ‚Ì‘‘å‚Æ‚»‚Ì‹@˜. ‘ˆä³‘¥C“c’†–ö…C‹{â‰À’jC–î“cŒ«ŽOC‰““¡¹FC‰iˆä–ÎŽ÷i”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ3‰ñ”]_Œo CT Œ¤‹†‰ï (90.01.26), ‰ªŽR.

1113. mŒ¤‹†‰ïn iˆê”Êu‰‰j “ªŠW’ê“‚æ‚ѓ÷Žî7—á‚ÌŒoŒ±. Žs앶•FCì–ìM”VCŽR“cŸC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—Yi‹~–½jC›Mˆêi•újCˆÉ“¡”ä˜CŽui”]ŠOj: ‘æ13‰ñ”]_ŒoCTŒ¤‹†‰ï (90.01.27), ‰ªŽR.

1114. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒrƒ^ƒ~ƒ“B6‚ª’˜Œø‚µ‚½”N—îˆË‘¶«‚Ä‚ñ‚©‚ñ«”]Ç‚Ì3—á. דc‚Ì‚¼‚ÝCŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂC²“¡‰ë•FiŽ™jC‘å–î’B’ji¹˜H‰Á‘Û•a‰@j: ‘æ5‰ñ_“Þ쬎™_Œo§˜b‰ï (90.01.27), ‰¡•l, ´˜^W, p.7, 1990.

1115. mŒ¤‹†‰ïn iˆê”Êu‰‰j ¬Ž™‚Ì•”•ª”­ì‚ɑ΂·‚éCarbamazepine’PÜŽ¡—Â̒·Šú—\Œãi•â“Uj. »‰ŸÂCŽO‰YŽõ’jC”’ˆäGKCדc‚Ì‚¼‚ÝiŽ™j: ‘æ25‰ñ_“Þì‚Ä‚ñ‚©‚ñ§˜b‰ï (90.02.03), ‰¡•l.

1116. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œã“ªœŠÂ’Å’E‰P‚Ì•úŽËüŠw“IŒŸ“¢. ”Ñ“cG•vC‹kŽ ‘CŽR“cŸC“c’†ç•Fi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½jC›Mˆêi•újCˆÉ“¡”ä˜CŽui”]ŠOj: ‘æ19‰ñ“ú–{_Œo•úŽËüŒ¤‹†‰ï (90.02.22), “Œ‹ž.

1117. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”]”^ᇂƔ]ŽîᇂÌMRIã‚ÌŠÓ•Ê“_|Low Intensity Rim‚Ìd—v«|. í”ՉÈêC‚–ØGC‘å“ä’mC‘ˆä³„CŽRè‹`‹éCŽR“cŸCz–K’m–çCŽs앶•FC‹´–{—²C‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC›Mˆêi•új: ‘æ19‰ñ“ú–{_Œo•úŽËüŒ¤‹†‰ï (90.02.22), “Œ‹ž.

1118. mŒ¤‹†‰ïn iˆê”Êu‰‰j ÛHáŠQ‚ÆP300. ŒÃ’m‹MŒbŽqCŒÃ‰ê—Ç•FC’|“à”ŽlC‘ºèŒõ–Mi¸j: ERPƒA[ƒxƒ“ƒg (90.03.00), “Œ‹ž.

1119. mŒ¤‹†‰ïn iˆê”Êu‰‰j Sodium Valproate•¹—pŽž‚ÌCarbamazepine‚È‚ç‚Ñ‚ÉCarbamazepine-10,11-epoxide‚Ì—V—£Œ^ŒŒ’†”Z“x‘ª’è‚Ì—Õ°“IˆÓ ‹`. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂCדc‚Ì‚¼‚ÝiŽ™j: ‘æ17‰ñŠÖ“Œ¬Ž™_ŒoŠwŒ¤‹†‰ï (90.03.24), “Œ‹ž.

1120. mŒ¤‹†‰ïn iˆê”Êu‰‰j _ŒoŽ¾Š³‚É‚¨‚¯‚éŒo“àŽ‹‹¾“Iˆãá‘‘Ýp18—á‚ÌŒŸ“¢. ‰¬–ì—TC’·’JìˆêŽqCÄ“¡–L˜aCדc–«CŒÃ˜a‹vKi“àj: ‘æ7‰ñ_Œo“à‰ÈŽ¡—ÃŒ¤‹†‰ï i89.06.24), “Œ‹ž.

1121. mŒ¤‹†‰ïn iˆê”Êu‰‰j _Œo‹ØŽ¾Š³‚É‚¨‚¯‚élHŒÄ‹z—Ö@‚̃VƒXƒeƒ€‰». דc–«CˆÉ“¡”Ž–¾C¼‰ª¹‹IC‰¬–ì—TCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ7‰ñ_Œo“à‰ÈŽ¡—ÃŒ¤‹†‰ï i89.06.24), “Œ‹ž.

1122. mŒ¤‹†‰ïn iˆê”Êu‰‰j Migrainous infarction‚Ì4—á. “Œ–M•FCâˆä•¶•FCŒÜ\—’‹v‰ÀC“cè‹`ºi“àj: ‘æ17‰ñ“ª’ÉŒ¤‹†‰ï i89.10.08), “Œ‹ž.

1123. mŒ¤‹†‰ïn iˆê”Êu‰‰j 6”NŠÔ‚É“n‚èg‘ÌáŠQŽÒ‚Æ‚µ‚ÄŽÔˆÖŽq¶Šˆ‚ð‘—‚Á‚½‹•‹U«áŠQ‚Ì1—á. ŠÛŽR”ŽŽuCˆ¢‹v’Óñ•vC“Œ–M•FC”¨—²ŽuC_“c’¼C“cè‹`ºi“àjC’ç–M•Fi¸j: _“Þ쌧“à‰ÈW’k‰ï i89.11.25), ‰¡•l.

1124. mŒ¤‹†‰ïn iˆê”Êu‰‰j Hereditary Motor and Sensory Neuropathy‚Ì—Õ°‘œ|Dyck, Lambert‚Ì—Õ°Œ^•ª—Þ‚Ì–â‘è“_‚ɂ‚¢‚Ä. Ä“¡–L˜aC‰““¡ˆêÆC¼‰ª¹‹IC’–ŒÒ‹vŠxC‰¬–ì—TC¼“cs³Cדc–«CˆÉ“¡”Ž–¾C’·’JìˆêŽqCŒÃ˜a‹vKi“àj: Œú¶È¸_¥_ŒoŽ¾Š³Œ¤‹†ˆÏ‘õ”ïƒjƒ…[ƒƒpƒ`[‚̬ˆö‚¨‚æ‚ÑŽ¡—ÂɊւ·‚錤‹†”Ç•½¬Œ³”N“x‘‰ï i90.01.13), “Œ‹ž.

1125. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‰^“®ƒjƒ…[ƒƒ“•aŠ³ŽÒŒŒ´’†‚É‚Ý‚ç‚ê‚éGal(ƒÀ1-3)GalNAc‚ÆGal(ƒÀ1-3)GalNAc‚ð”FŽ¯‚·‚éR‘Ì|––½_Œo“œ’`”’‚Æ‚Ì”½‰ž|. Ä“¡–L˜aCˆÉ“¡”Ž–¾C‰¬–ì”üŒbŽqC‰¬–ì—TCŒÃ˜a‹vKi“àj: Œú¶È“Á’莾Š³A–Ɖu«_ŒoŽ¾Š³’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘‰ï i90.01.19), “Œ‹ž.

1126. mŒ¤‹†‰ïn iˆê”Êu‰‰j Acute Axonal Form of Guillain-Barre Syndrome. Ä“¡–L˜aC‰¬–ì—TC‰¬–ì”üŒbŽqCˆÉ“¡”Ž–¾CŒÃ˜a‹vKi“àj: Œú¶È“Á’莾Š³A–Ɖu«_ŒoŽ¾Š³’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘‰ï i90.01.19), “Œ‹ž.

1127. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒp[ƒLƒ“ƒ\ƒ“•a”­Ç‚É‚¨‚¯‚é‰Á—î‚̉e‹¿. ‰““¡ˆêÆC’–ŒÒŠxC’·’JìˆêŽqCŒÃ‹´‹I‹vCŒÃ˜a‹vKi“àj: •½¬Œ³”N“xŒú¶ÈƒVƒ‹ƒo[ƒTƒCƒGƒ“ƒXŒ¤‹†u˜V‰»‚É”º‚¤“ÁˆÙ•a‘Ԃ̉ð–¾vu‚—îŽÒ‚Ì_Œo¥‹Ø‹@”\‚Æ‚»‚ÌáŠQ‚ÉŠÖ‚·‚錤‹†v(I-1) i90.02.02). –¼ŒÃ‰®,

1128. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‚’¼Ž‹‰^“®ŠáUŒŸ¸‚Å‚Ý‚é‰Á—î‚̉e‹¿. ²‹´–M•FCˆ¢•”—EŸi—ÕŒŸjC’·’JìˆêŽqCŒÃ˜a‹vKi“àj: •½¬Œ³”N“xŒú¶ÈƒVƒ‹ƒo[ƒTƒCƒGƒ“ƒXŒ¤‹†u˜V‰»‚É”º‚¤“ÁˆÙ•a‘Ԃ̉ð–¾vu‚—îŽÒ‚Ì_Œo¥‹Ø‹@”\‚Æ‚»‚ÌáŠQ‚ÉŠÖ‚·‚錤‹†v(I-1) i90.02.02), –¼ŒÃ‰®.

1129. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒp[ƒLƒ“ƒ\ƒ“•a‚É‚¨‚¯‚é‰Ò“®«Šá‹…‰^“®Œn‚̉ðÍ. ŒÃ˜a‹vKCŽO•x“N˜YC’·’JìˆêŽqCÄ“¡–L˜ai“àj: Œú¶È“Á’莾Š³_Œo•Ï«Ž¾Š³’²¸Œ¤‹†”Ç1989”N“x”ljï‹c i90.02.23), “Œ‹ž.

1130. mŒ¤‹†‰ïn iŒöŠJuÀj ”N‚ð‚Æ‚é‚ƃ{ƒP‚é‚©H Ží“c^»—Yi¸j: ¸_•ÛŒ’ŒöŠJuÀ (89.07.07), ˆéŽq.

1131. mŒ¤‹†‰ïn iŒöŠJuÀj ¬Ž™‚̸_“I–â‘è|’ˆÓŒ‡Š×áŠQiŠwKáŠQj‚ÆÛHáŠQ|. ²“¡Šìˆê˜Yi¸j: _“Þ쌧ŒöŠJ‘åŠwuÀ (89.10.07), ‘Š–ÍŒ´.

1132. mŒ¤‹†‰ïn iŒöŠJuÀj S‚Ì•a‚Æ‚ÍH Ží“c^»—Yi¸j: ¸_•ÛŒ’ŒöŠJuÀ (89.11.20), ˆéŽq.


<<105 “à•ª”åŠí>>

1133. mŒ´’˜n ƒJƒ‹ƒ`ƒgƒjƒ“ŽY¶‚•ª‰»bó‘B‚b×–EŽîᇊ”‚Ì“Á«‚ƃzƒ‹ƒ‚ƒ“•ª”å“®‘Ô. ‹T’J“Oi•a—jC–å’J‹vmŽqiŒ`‘ÔŒnjCˆäŒû“Œ˜Yi‘—§•a‰@‹ãB‚ª‚ñƒZƒ“ƒ^|j: Human CellC2(3): 231`237, 1989.

1134. mŒ´’˜n Electron Microscopic and Immunoelectron Microscopic Demonstration of Pancreatic Polypeptide Cells in Glucagonoma: Colocalization of Pancreatic Peptide and Glucagon in Single Secretory Granules. Akishi OoiCShogo KatsudaCIsao Nakanishi i‹à‘ò‘åjC‹T’J“Oi•a—jCKen Yamaguchii‘—§‚ª‚ñƒZƒ“ƒ^|jCHideo Kitamura i•Ÿˆä•a‰@jCYukinori Hayakawa i“¡“c•a‰@j: Ultrastructural Pathology, 13: 15`22, 1989.

1135. mÇ—á•ñn Primary Osteogenic Sarcoma of the Thyroid Gland: A Case Report. ‘å•”½C‹T’J“OC˜a“c’m‰vC‰œ•½‰ë•Fi•a—jCŒÃ‘òTˆêCŒÃì_ŽOC‚‹´Lbi“àj: Surg. Pathol., 2(1): 67`72, 1989.

1136. muÀn ƒhƒNƒ^[ƒYƒCƒ“ƒ^ƒrƒ…[:“ûŠà‚ƃzƒ‹ƒ‚ƒ“|“ûŠà‚Ì‘B§Œä|. ‘ –{”ŽsiŽY•wjCƒƒo[ƒg‚a.ƒfƒBƒNƒ\ƒ“iƒWƒ‡[ƒWƒ^ƒEƒ“‘åj: Medical English, 6(10): 6`14; 49`51, 1989.

1137. mŠwp‘n i•ÒWj Endocrine Pathology Update vol. 1. •ÒW Juan LechagoiƒeƒLƒTƒX‘åjC‹T’J“Oi–k—¢‘åj•ÒC Field & Wood, Philadelphia,U.S.A., 90.00.00”­s.

1138. mŠwp‘n iŽ·•Mj “à•ª”åŠw‚Ìi•ài‘æ7‰ñ•xŽmƒzƒ‹ƒ‚ƒ“ƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX‹L˜^j; “à•ª”åŽîᇂƉߌ`¬‚Ì•a—, 7: 80`91, ‹T’J“Oi•a—j. •ÒW ´…’¼—e•Ò, iŠ”jƒgƒvƒRo”Å•”, “Œ‹ž, 89.00.00”­s.

1139. mŠwp‘n iŽ·•Mj Endocrine Pathology Update ; Spectrum of Neuroendocrine Marker Substance Production in Carcinoid Tumors Revealed by Immunohistochemistry, 1: 151`169, ‹T’J“Oi•a—j. Field & Wood, Philadelphia, U.S.A., 90.00.00”­s.

1140. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒqƒgbó‘B‰‘ã”|—{Œn‚É‚æ‚é×–E–Œî•ñ“`’B‹@\‚ÌŒ¤‹†. ˆ¢•”D•¶C‹àXWC–‹`’‰i“àjC‹T’J“Oi•a—j: “ú–{‘gD”|—{Šw‰ï‘æ62‰ñ‘å‰ï (89.06.29), ‰¡•l, ‘gD”|—{Œ¤‹†, 8(1): 51, 1989.

1141. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒJƒ‹ƒ`ƒgƒjƒ“ŽY¶‚•ª‰»bó‘BC×–EŽîᇊ”‚Ì“Á«‚ƃzƒ‹ƒ‚ƒ“•ª”å“®‘Ô. ‹T’J“Oi•a—jC–å’J‹vmŽqiŒ`‘ÔŒnjCˆäŒû“Œ˜Yi‘—§•a‰@‹ãB‚ª‚ñƒZƒ“ƒ^|j: ‘æ62‰ñ“ú–{‘gD”|—{Šw‰ï‘å‰ï (89.06.29), ‰¡•l, ‘gD”|—{Œ¤‹†, 8(1): 52, 1989.

1142. mŠw‰ïn iƒpƒlƒ‹j bó‘Bàh–EŠà‚Ì×–EŠw“IŒŸ“¢. ‰¡ŽR‘åC‘å–ì‰pŽ¡i•a‰@•a—•”jCŒY•”“ŒŽ¡iŠOjC‘ –{”ŽsiŽY•wj: ‘æ28‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïŠwpu‰‰‰ï i89.11.17), ‰¡•l, “ú–{—Õ°×–EŠw‰ïŽGŽ, 28(5): 680, 1989.

1143. mŠw‰ïn iˆê”Êu‰‰j Transient Type of Ca2+ Current is Responsiple for the Ca2+ Influx Induced by Thyrotropin-Releasing Hormone Stimulation. —é–ØM”Vi¶—jCHiroshi TakagiCTohru Yoshiokai‘‘åjCYoshihisa KudoiŽO•H‰»¬¶–½Œ¤j: ‘æ12‰ñ_Œo‰ÈŠwŠwpW‰ï (88.12.07`09), –¼ŒÃ‰®C Neurosci. Res., 9(Suppl.): S119, 1989.

1144. mŠw‰ïn iˆê”Êu‰‰j Different Type of Ca2+ Currents are Responsible for the Ca2+ Influx Induced by High K+ and Thyrotropin-Releasing Hormone-Stimulation. —é–ØM”Vi¶—jCTohru YoshiokaCHiroshi Takagii‘‘åjCYoshihisa KudoiŽO•H‰»¬¶–½Œ¤jC‰Á”Z³–¾i¶—j: ‘æ66‰ñ“ú–{¶—Šw‰ï (89.04.05`07), ‰ªŽRC Jpn. J. Physiol., 39(Suppl.): S64, 1989.

1145. mŠw‰ïn iˆê”Êu‰‰j ƒqƒg‚Ì‚•ª‰»Œ^C×–EŽîá‡×–EŠ”(TT-cell)‚É‚¨‚¯‚镪”å“®‘Ô‚Æ×–E“à‚ÌŒ`‘Ô. ‹T’J“Oi•a—jC–å’J‹vmŽqiŒ`‘ÔŒnjCˆäŒû“Œ˜Yi‹ãBƒKƒ“ƒZƒ“ƒ^|jC“ˆ‰ªŸ‘¾˜Yi•ú‰eŒ¤j: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ïHŠúŠwp‘å‰ï (89.10.21), ŽD–y, “ú–{“à•ª”åŠw‰ïŽGŽ, 65(9): 33, 1989.

1146. mŠw‰ïn iˆê”Êu‰‰j ƒJƒ‹ƒ`ƒgƒjƒ“ŽY¶‚•ª‰»Œ^bó‘BC×–EŽîᇊ”‚É‚¨‚¯‚éexocytosis. –å’J‹vmŽqiŒ`‘ÔŒnjC‹T’J“Oi•a—jCˆäŒû“Œ˜Yi‹ãBƒKƒ“ƒZƒ“ƒ^|jC“ˆ‰ªŸ‘¾˜Yi•ú‰eŒ¤j: ‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï (89.10.23), –¼ŒÃ‰®, “ú–{ŠàŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€, p.49, 1989.

1147. mŠw‰ïn iˆê”Êu‰‰j Œ´”­«ã”笑̋@”\˜´iÇ12—á‚ÌŒŸ“¢. ŒY•”“ŒŽ¡C‰¡“c˜a•FC‰ª‘º—¥ŽqC“n•ÓŒ’Ž™CX£¹Ž÷C’Ë–{GlC’†ŽR‹`‰îCŒY•”P’jCΓc˜a•vC²“¡ŒõŽjC”äŠé”\Ž÷C¬—Ñ–ÎŽ÷iŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ51‰ñ“ú–{—Õ°ŠO‰ÈˆãŠw‰ï‘‰ï i89.10.31), _ŒË, “ú–{—Õ°ŠO‰ÈˆãŠw‰ïŽ, 1989.

1148. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠeŽíbó‘BŽ¾Š³‚É‚¨‚¯‚éThyroxin, Thyrogloblin ras oncogene p21‚Ì‘gD“à•ª•z. ŒY•”“ŒŽ¡C”äŠé”\Ž÷C“à“c‹v‘¥iŠOjCˆ¢•”D•¶i“àjC‹T’J“Oi•a—j: ‘æ22‰ñbó‘BŠO‰ÈŒŸ“¢‰ï i89.11.12), “Œ‹ž, —\eW, p.113. 1989.


<<106 ŒŒ‰tE‘¢ŒŒŠíEƒŠƒ“ƒp>>

1149. mŒ´’˜n Destruction of Erythrocytes under a Sinusoidally Fluctuating Shear Rate. ‹´–{¬Li¶‘ÌHjCÎŒ´ºi‹¹ŠOjCù“c’¼i“ŒH‘åj: Advences in Biomaterials, 8: 291`296, 1988.

1150. mŒ´’˜n Erythrocyte Destruction under Periodically Fluctuating Shear Rate; Comparative Study with Constant Shear Rate. ‹´–{¬Li¶‘ÌHj: Artificial Organs, 13(5): 458`463, 1989.

1151. mŒ´’˜n Mutual Interaction of Eicosapentaenoic Acid and Arachidonic Acid and Inhibition of the Formation of Lipoxygenase Products by Indomethacin in Washed Human Platelets. 쑺“¹ŽqCŒ´“c–FÆC“c’†–M’jCŽ­ŽæMi–ò—j: Asia Pacific Journal of Pharmacology, 4(3): 189`196, 1989.

1152. mŒ´’˜n Common Fragile Sites in Chromosomes of Bone Marrow Cells and Peripheral Blood Lymphocytes from Healthy Persons and Leukemia Patients. ŒÃ’J—²i“àjCOchi, H.CWatanabe, S.i‘—§ŠàƒZƒ“ƒ^[j: Cancer Genet. Cytogenet., 43: 131`138, 1989.

1153. mŒ´’˜n A Monoclonal Antibody 1A6 to T-cell Recognizes a Common Antigen Expressed on Lymphocytes from Normal and Leukemic Patients, and Inhibits NK Cell activity. Togashi, H.CGhoneum, M.CTakasugi, M.CŠ}ˆäŒ‰i•a—jCet al.: Hemotological Oncology, 7: 233`242, 1989.

1154. mŒ´’˜n ŒŒðŒ`¬¥ŒŒ‹…”j‰ó‚ɑ΂·‚邹‚ñ’f‘¬“x‚̉e‹¿. ‹´–{¬Li¶‘ÌHj: ˆã—p“dŽq‚ƶ‘ÌHŠw, 27(Suppl.): 145, 1989.

1155. mŒ´’˜n ˆâ“`«‹…óÔŒŒ‹…ǂɑ΂·‚éŽèp—á‚ÌŒŸ“¢. ’Ë–{GlC”ª\ì—v•½C–ΖØ_ŽqCˆÉ“¡‹`–çCŒÃ”g‘qŽjŽqC–¥‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjC¼–{‰x—YCŽO“‡Œ’C“n•”K•vCˆÀ”{–¾˜Yi‘—§‘Š–ÍŒ´•a ‰@j: ˆã—Ã, 43(11): 1124`1128, 1989.

1156. mŒ´’˜n lHÞ—¿•\–Ê‚É‚¨‚¯‚錌ðŒ`¬‚Æ‘¬“x“õ”z. ‹´–{¬Li¶‘ÌHjC‘O“c_‹`Cù“c’¼i“ŒH‘åj: ¶‘ÌÞ—¿, 2(4): 229`234, 1984.

1157. mŒ´’˜n ŒŒðŒ`¬‚ɑ΂·‚邹‚ñ’f‘¬“x‚̉e‹¿G‰š“ʉ~Œ^ŽŽŒ±‹@‚ð—p‚¢‚½ŒŒðŒ`¬“x•]‰¿. ‹´–{¬Li¶‘ÌHjCŽR–{^i®ŠOjCŽR“àŒ’Cù“c’¼i“ŒH‘åj: “ú–{‹@ŠBŠw‰ïu‰‰˜_•¶WC890(38): 22`24, 1989.

1158. mŒ´’˜n lãG“‚Ì•a—‘gDŠw“IŒŸ“¢. Š™“c—˜•FCŒ´“cGˆêC”ª”ö˜a—YC‚‹´œAbCÝŠy“N–çiŽ¨•@j: “ú–{G“Œ¤‹†‰ï‰ïŽC28: 34`38, 1989.

1159. mŒ´’˜n “–‰@‚É‚¨‚¯‚鬎™“Á”­«Ä¶•s—Ç«•nŒŒ‚Ì—\ŒãˆöŽq‚ÉŠÖ‚·‚錟“¢. ŽR–{OŽqC“‡–{—R‹IŽqC¡ˆäƒDC‰““¡‹I—YiŽ™j: –k—¢ˆãŠw, l9(2): 258`263, 1989.

1160. mŒ´’˜n ‘¢ŒŒŠíŽîᇂɂ¨‚¯‚éP“œ’`”’i‘½Ü‘Ï«ˆâ“`ŽqŽY•¨j”­Œ»‚Ì—Õ°“IˆÓ‹`. ät“n’‰’jCâ“Œ—R‹IC‘å’J‰pŽ÷i—Õ•a—j: —Õ°•a—, 37(7): 779`783, 1989.

1161. mŒ´’˜n Flow Cytometry‚É‚æ‚é‹}«”’ŒŒ•a‚É‚¨‚¯‚éP“œ’`”’‚Ì•ªÍ. ät“n’‰’jCâ“Œ—R‹IC‘å’J‰pŽ÷i—Õ•a—jC“¿O‰p¶i“àj: —Õ°•a—, 37(8): 899`904, 1989.

1162. m’Z•ñn Rapid Increase in the Intracellular Calcium Concentration by Endogenous Thromboxane A2 in Aggregation Induced by Threshold Doses of Thrombin. Ž­ŽæMCA. HuangCŒ´“c–FÆC쑺“¹Žqi–ò—j: Physiology and Pharmacology of Transmembrane Signalling, p.289`295, 1989.

1163. mŒ¤‹†•ñi‘ãŽÓˆÙ펡—ÃŒ¤‹†Šî‹àjn ŒŒ¬”ÂŒŒð‚ƃvƒƒXƒ^ƒmƒCƒh. Ž­ŽæMi–ò—j: ‘ãŽÓˆÙ펡—ÃŒ¤‹†Šî‹àŒ¤‹†‹ÆÑWCŒŒðÇ‚Ì•a‘Ô‚ÆŽ¡—ÂɊւ·‚鋤“¯Œ¤‹†i‘æ3•ñj, 16: 13`15, 1989.

1164. mÇ—á•ñn ”ñ•ª”åŒ^‘½”­«Žîᎌ`¬«Œ`Ž¿×–EŽî‚Ì2—á. —«éDCŽR‰º‚¦‚èŽqC‰Á“¡Ž¡ŽqC“¡–ì—R”üC‰–’J–ÎC“¿O‰p¶i“àjC‹T’J“Oi•a—j: –k—¢ˆãŠw, l9(5): 532`536, 1989.

1165. mŠw‰ïn iƒpƒlƒ‹j ’˜–¾‚È’á’`”’ŒŒ•a‚ÆäB‘Ÿ‚Ì‘½”­«Œ‹ß«•a•Ï‚𔺂Á‚½‘gD‹…Ç‚Ì1–UŒŸ—á. ŽOŽ}Mi“àjCŠâŸºŒ[ˆêC‰œ•½‰ë•Fi•a—j: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.3l), •Ÿ‰ª.

1166. mŠw‰ïn iˆê”Êu‰‰j lHÞ—¿•\–Ê‚É‚¨‚¯‚錌ðŒ`¬‚Æ‘¬“xŒù”z. ‘O“c_‹`Cù“c’¼i“ŒH‘åjC‹´–{¬Li¶‘ÌHj: ‘æ5‰ñ“ú–{ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ï‘å‰ï (83.11.20), ‘åãC ˜_•¶W, p.67`68, 1983.

1167. mŠw‰ïn iˆê”Êu‰‰j —nŒŒ‚ð‚à‚½‚ç‚·‘¬“xŒù”z‚͈̔͂ɂ‚¢‚Ä. ‹´–{¬Li¶‘ÌHjC—é–Ø”ŽŽqiˆãŠw‰ÈjC”nŸº´Ž‘i¶‘ÌHjC•ŽR½Ž÷C™‰Y—f‰îCù“c’¼i“ŒH‘åj: ‘æ6‰ñ“ú–{ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ï‘å‰ï (84.11.22), “Œ‹žC ´˜^W, p.69`70, 1984.

1168. mŠw‰ïn iˆê”Êu‰‰j ’PˆêŒŒ¬”‚Ì×–EŽ¿“àƒJƒ‹ƒVƒEƒ€”Z“x‚̃gƒƒ“ƒrƒ“ŽhŒƒŽž‚̕ω»|ƒfƒCƒWƒ^ƒ‹‰æ‘œŒ°”÷‹¾‚É‚æ‚é‰ðÍ|. ”n“ˆ³—²C‰©ˆ¤—æCŽ­ŽæMi–ò—j: ‘æ4‰ñ“ú–{ƒVƒ‡ƒbƒNŠw‰ï‘‰ï (89.04.22), ‘åãC “ú–{ƒVƒ‡ƒbƒNŠw‰ïŽGŽC4(1): 65`66, 1989.

1169. mŠw‰ïn iˆê”Êu‰‰j “–‰@‚Ì”pŠüŒŒ‰t‚ÌŒ»‹µ. ˆ¾–앶„i—ÕŒŸjC•x‰i½ˆêi‹¹ŠOj: ‘æ37‰ñ“ú–{—AŒŒŠw‰ï‘‰ï (89.05.00), _ŒË, “ú–{—AŒŒŠw‰ïŽGŽ, 35(2): 252, 1989.

1170. mŠw‰ïn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é–«ƒŠƒ“ƒp«”’ŒŒ•a‚ÉŠÖ‚·‚錟“¢. ŽR‰º‚¦‚èŽqC“¡–ì—R”üC‰–’J–ÎC“¿O‰p¶C–Øì“c—²ˆêi“àj: ‘æ382‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.05.13), “Œ‹ž.

1171. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™‹}«ƒŠƒ“ƒp«”’ŒŒ•a‚É‚¨‚¯‚铪ŠW•úŽËüÆŽË‚Æ High-dose MTX —Ö@‚Ì”äŠrŒŸ“¢‹y‚Ñ’·ŠúƒtƒHƒ|ƒAƒbƒvŠ³Ž™‚̸_”­’B‚É‹y‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä. “‡–{—R‹IŽqC¡ˆäƒDCŽR–{OŽqC‰““¡‹I—YiŽ™j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.20), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 93(3): 744, l989.

1172. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™”’ŒŒ•aŠ³ŽÒ‚É‚¨‚¯‚鈟‹}«”’Ž¿”]Ç‹y‚ÑΊD‰»–Ñ׌ŒŠÇÇ‚Æ’†•_Œo”’ŒŒ•a‚Æ‚ÌŠÖ˜A‚ɂ‚¢‚Ä. ¡ˆäƒDC“‡–{—R‹IŽqCŽR–{OŽqC‰““¡‹I—YiŽ™j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.20), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 93(3): 744, l989.

1173. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™‹}«ƒŠƒ“ƒp«”’ŒŒ•a‚É‚¨‚¯‚é”]‘¹‚Ì•]‰¿‚ɂ‚¢‚Ä. ŽR–{OŽqC“‡–{—R‹IŽqC¡ˆäƒDC‰““¡‹I—YiŽ™j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.20), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 93(3): 745, l989.

1174. mŠw‰ïn iˆê”Êu‰‰j ˆ««ƒŠƒ“ƒpŽî‚É‚¨‚¯‚éT×–ERŒ´Žó—e‘Ì”­Œ»‚̖Ɖu‘gD‰»Šw“IŒŸ“¢. Š}ˆäŒ‰CŒK”ö’èmC–{‹§CŠâŸºŒ[ˆêC‹T’J“Oi•a—j: ‘æ29‰ñ“ú–{–Ô“àŒnŠw‰ï‘‰ï (89.06.09), ‰ªŽR, “ú–{–Ô“àŒnŠw‰ï‰ïŽ, 29(•â): 92, 1989.

1175. mŠw‰ïn iˆê”Êu‰‰j ’˜–¾‚ÈŒŒ¬”ÂŒ¸­‚Æt•s‘S‚𔺂Á‚½Multicentric Angiofollicular Lymph Node Hyperplasia‚Ì1—á. ŠâŸºŒ[ˆêC“n•Ó´Ž¡CŠ}ˆäŒ‰CŒK”ö’èmi•a—j: ‘æ29‰ñ“ú–{–Ô“àŒnŠw‰ï‘‰ï (89.06.10), ‰ªŽR, “ú–{–Ô“àŒnŠw‰ï‰ïŽ, 29(•â): 80, 1989.

1176. mŠw‰ïn iˆê”Êu‰‰j Role of Thromboxane A2 in the Rate of Rise in Intracellular Calcium Concentration in Thrombin-Induced Aggregation of Rabbit Platelets. Ž­ŽæMCA. HuangC쑺“¹Žq CŒ´“c–FÆi–ò—j: ‡]‡Uth Congress of the International Society on Thrombosis and Haemostasis (89.08.19-25), “Œ‹žC Thrombosis and Haemostasis , 62(1): 102, 1989.

1177. mŠw‰ïn iˆê”Êu‰‰j Individuality of Platelets in Elevation of Cytoplasmic Free Calcium Level by Thrombin; An Analysis by Digital Imaging Microscopy. ”n“ˆ³—²CŽ­ŽæMi–ò—j: ‡]‡Uth Congress of the International Society on Thrombosis and Haemostasis (89.08.19-25), “Œ‹žC Thrombosis and Haemostasis , 62(1): 103, 1989.

1178. mŠw‰ïn iˆê”Êu‰‰j Relationship of Phospholipase A2 to Phospholipase C for Intracellular Calcium Mobilization in Aggregation of Rabbit Platelets. 쑺“¹ŽqCA. HuangCŽ­ŽæMi–ò—j: ‡]‡Uth Congress of the International Society on Thrombosis and Haemostasis (89.08.19-25), “Œ‹žC Thrombosis and Haemostasis , 62(1): 105, 1989.

1179. mŠw‰ïn iˆê”Êu‰‰j ƒƒCƒRƒgƒŠƒGƒ“B4‚É‚æ‚é”’ŒŒ‹…ŒŒŠÇŠO—V‘–‚ƃfƒLƒTƒƒTƒ]ƒ“‚É‚æ‚é‚»‚Ì—}§‹@˜. Ž­ŽæMC¬“c—²Ž¡i–ò—jC‰iˆäˆê¬i–ƒj: ‘æ39‰ñ“ú–{ƒAƒŒƒ‹ƒM|Šw‰ï‘‰ï (89.09.28°30), “Œ‹žC ƒAƒŒƒ‹ƒM|, 38: 1989.

1180. mŠw‰ïn iˆê”Êu‰‰j AMLŠ°‰ð“±“ü—Ö@’†‚É‚Ý‚ç‚ꂽARDS‚ɑ΂µ‚Ämethylprednisolone‘å—ʗÖ@‚ª‘tŒø‚µ‚½1—á. ŽR‰º‚¦‚èŽqCŒÃ’J—²C“¡–ì—R”üC‰–’J–ÎC“¿O‰p¶i“àj: “ú–{—Õ°ŒŒ‰tŠw‰ï‘æ106‰ñ—á‰ï (89.09.30), ‰¡•l.

1181. mŠw‰ïn iˆê”Êu‰‰j ”“®—¬‰º‚É‚¨‚¯‚錌ðŒ`¬|ŽüŠú“I‚É•Ï“®‚·‚邹‚ñ’f‘¬“x‚̉e‹¿|. ‹´–{¬Li¶‘ÌHjC¼ŒûŽ•FC‚—²½C¡ˆäŠ°Cˆ¢•””\–¾C“c’†Ž•FC“V–ì—²bC‘å“àŠîŽjC–쑺—F´CX“c—TlCæѳŠîCì~C“‡“cŒúC•i“cƒC‚ŽRr ­C¼ŽR“¿‘åC“ü‘ò²mCó—˜G’jC•—ŠÔ”ÉCÎŒ´ºi‹¹ŠOjCŽR“àŒ’Cù“c’¼i“ŒH‘åj: ‘æ27‰ñ“ú–{lH‘ŸŠíŠw‰ï‘å‰ï (89.09.30), ˆ®ìC —\eW, p.140, 1989.

1182. mŠw‰ïn iˆê”Êu‰‰j Effect of Sinusoidally Fluctuating Shear Rate on Clot Growth. ‹´–{¬Li¶‘ÌHjCŽR“àŒ’Cù“c’¼i“ŒH‘åj: 7th World Congress of the International Society for Artificial Organs (89.10.04), ŽD–yC Artificial Organs, 13(4): 305, 1989.

1183. mŠw‰ïn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é“Á”­«ŒŒ¬”ÂŒ¸­«Ž‡”Á•ai–«Œ^j‚ÌŽ¡—ìтȂç‚Ñ‚É—\Œã. “¿O‰p¶C‰–’J–ÎC“¡–ì—R”üCŒÃ’J—²CŽR‰º‚¦‚èŽqC–Øì“c—²ˆêi“àj: ‘æ386‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.10.14), “Œ‹ž.

1184. mŠw‰ïn iˆê”Êu‰‰j ”][Ç‚Ü‚½‚ÍTIA ‚ÌIn-111-•WŽ¯ŒŒ¬”ƒVƒ“ƒ`ƒOƒ‰ƒtƒB[|Œz•”Wςɂ‚¢‚Ä|. ¼Šª”ŽC’r“crºC“cŠŽŒÈCãˆä˜aŽqCˆË“cˆêdC’†‘òŒ\Ž¡C¼—Ñ—²i•új: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (89.10.21), ‘å’Ã, ŠjˆãŠw, 26(8): 1071, 1989.

1185. mŠw‰ïn iˆê”Êu‰‰j œ‘ˆÚAŒã‚Ìrecipient‚Ì––½ŒŒƒŠƒ“ƒp‹…‚É‚¨‚¯‚éõF‘Ìfragile sites‚̕ω». ŒÃ’J—²i“àjC“n•Ó¹C‚ŽR‡C‘啽–r˜Yi‘—§‚ª‚ñƒZƒ“j: ‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï (89.10.24), –¼ŒÃ‰®, ‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï‹LŽ–, p.114, 1989.

1186. mŠw‰ïn iˆê”Êu‰‰j VP-16‚É‚æ‚éK562×–E‚Ì‘B—}§‚ƃAƒ~ƒmŽ_×–E“à—A‘—’ቺ‚Æ‚ÌŠÖ˜A. ‰–’J–ÎCŽR‰º‚¦‚èŽqCŒÃ’J—²C“¡–ì—R”üC“¿O‰p¶C–Øì“c—²ˆêi“àj: ‘æ31‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï‘‰ï (89.11.09), –¼ŒÃ‰®, —Õ°ŒŒ‰t, 30(9): 1620, 1989.

1187. mŠw‰ïn iˆê”Êu‰‰j V‚µ‚­Ž÷—§‚µ‚½è÷—±‹…Œn×–EŠ”‚Æ‚»‚Ì«ó. ‰Á“¡Ž¡ŽqC–{‘º–ÎŽ÷C‘å‹v•Û—²’ji‰¡•lŽs‘åjCŽR‰º‚¦‚èŽqC‰–’J–ÎC“¿O‰p¶i“àjCät“n’‰’ji—Õ•a—j: ‘æ31‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï‘‰ï (89.11.10), –¼ŒÃ‰®, —Õ°ŒŒ‰t, 30(9): 1653, 1989.

1188. mŠw‰ïn iˆê”Êu‰‰j ƒEƒTƒMŒŒ¬”‹ÃW‚É‚¨‚¯‚éPhospholipase C Šˆ«‰»‚ɑ΂·‚éThromboxane A2 ‚Ì–ðŠ„. 쑺“¹ŽqCŽ­ŽæMi–ò—j: ‘æ12‰ñ“ú–{ŒŒðŽ~ŒŒŠw‰ï (89.12.01°02), ‘åãC ŒŒ‰t‚Æ–¬ŠÇ, 20(5): 387, 1989.

1189. mŠw‰ïn iˆê”Êu‰‰j ”x¶ŒŸ‚ÅŠm’èf’f‚µ‚½ATL‚Ì1Ç—á. ’†”öCˆêCŽR‰º‚¦‚èŽqCŒÃ’J—²C“¡–ì—R”üC‰–’J–ÎC“¿O‰p¶i“àj: “ú–{—Õ°ŒŒ‰tŠw‰ï‘æ107‰ñ—á‰ï (89.12.02), “Œ‹ž.

1190. mŠw‰ïn iˆê”Êu‰‰j ƒEƒTƒMŒŒ¬”‹ÃWŽž‚É‚¨‚¯‚é×–E“àƒJƒ‹ƒVƒEƒ€“®ˆõ‚̃zƒXƒzƒŠƒp|ƒ[A2‚É‚æ‚é’²ß. 쑺“¹ŽqC‰©ˆ¤—æCŒ´“c–FÆCŽ­ŽæMi–ò—j: ‘æ63‰ñ“ú–{–ò—Šw‰ï‘‰ï (90.03.25-28), “Œ‹žC Jpn. J. Pharmacol., 52(suppl.): 300, 1990.

1191. mŠw‰ïn iˆê”Êu‰‰j K562×–E‚̃Aƒ~ƒmŽ_×–E“à—A‘—‚ɑ΂·‚écycloheximide‚Ì—}§ì—p. ‰–’J–ÎCŽR‰º‚¦‚èŽqC“¿O‰p¶i“àj: ‘æ52‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ï (90.03.29), “Œ‹ž, “ú–{ŒŒ‰tŠw‰ïŽGŽ, 53(2): 245, 1990.

1192. mŠw‰ïn iˆê”Êu‰‰j ƒgƒƒ“ƒrƒ“ŽhŒƒŽž‚Ì’PˆêŒŒ¬”Â×–EŽ¿“àƒJƒ‹ƒVƒEƒ€”Z“x‚Ì‘‘å|ƒfƒWƒ^ƒ‹‰æ‘œŒ°”÷‹¾‚É‚æ‚é‰ðÍ. ”n“ˆ³—²CŽ­ŽæMi–ò—j: ‘æ52‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ï (90.03.29-31), “Œ‹žC “ú–{ŒŒ‰tŠw‰ïŽGŽ, 53(2): 423, 1990.

1193. mŠw‰ïn iˆê”Êu‰‰j HTL-V1R‘̉¿‚ª‚’l‚ðŽ¦‚µ‘½”­Œ‹ß«‰A‰e‚ª”F‚ß‚ç‚ꂽT×–E«ƒŠƒ“ƒpŽî‚Ì1—á. ‰Ô“cL‰pCŽR‰º‚¦‚èŽqC•Ð‹Ë^lC‰–’J–ÎC–î“ߣM—YCˆ¢•”’¼C•y“c—FKi“àjC•½ˆäŽO˜YC‹g‘º”Ž–Mi‹¹ŠOjCŠ}ˆäŒ‰i•a—j: ‘æ87‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ïŠÖ“Œ’n•û‰ï i89.11.18), “È–Ø.

1194. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒŒðŒ`¬‚ɑ΂·‚鑬“xŒù”z‚̉e‹¿. ‘O“c_‹`Cù“c’¼i“ŒH‘åjC‹´–{¬Li¶‘ÌHj: “ú–{‹@ŠBŠw‰ïŠÖ“ŒŠw¶‰ï‘æ22‰ñŠw¶ˆõ‘²‹ÆŒ¤‹†”­•\u‰‰‰ï (83.03.10), ‰Y˜aC u‰‰‘OüW, p.91`92, 1983.

1195. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ž©Œ±ITPi–«Œ^j‚Ì—\Œã‚ÌŒŸ“¢. “¿O‰p¶C‰–’J–ÎC“¡–ì—R”üCŒÃ’J—²CŽR‰º‚¦‚èŽqCŽl‹{—R”üŽqC²“¡ƒŽqi“àj: _“Þ쌌‰tŒ¤‹†‰ï‘æ21‰ñ—á‰ï (90.02.03), ‰¡•l.


<<107 t‘ŸE”A˜H>>

1196. mŒ´’˜n Comparative Analysis of DST Alone and DST with Intermittent Coverage by Cyclophosphamide. Š‹¼ŒMCŒF–ì˜a—YCŠâ‘º³ŽkC‹g“cˆê¬C^‰ºß•vC‰““¡’‰—YCŽðˆä‹ŠC¬ŽÄŒ’i”åjC”Ñ‚Šì‹v—YiŽ™jC“à“c‹v‘¥iŠOjC“n•”_“ñi‘ŸˆÚj: Trans. Proc., 21(1): 1837`1838, l989.

1197. mŒ´’˜n The Role for Reactive Oxygen Species in Cyclosporin A Induced Nephrotoxicity in Rats. ŒF–ì˜a—YC‹g“cˆê¬CŠâ‘º³ŽkC‰““¡’‰—YCŽðˆä‹Ši”åjC’†‘º‘‰qi•ª¶jCŒK”ö’èmi•a—j: Trans. Proc., 21(1): 941`942, l989.

1198. mŒ´’˜n t•s‘Sƒ‚ƒfƒ‹‚ɑ΂·‚éŒoŒû‹z’…ÜAST-120‚̉e‹¿‚ÉŠÖ‚·‚錟“¢. Žðˆä‹ŠCŒF–ì˜a—Yi”åjC‹g“c‹`Ki϶‰ï‰¡•l“ì•”•a‰@j: ¬Ž™t•s‘SŒ¤‹†‰ïŽC9: 149`155, 1989.

1199. mŒ´’˜n ŒoŒû‹z’…ÜAST-120‚Ìt•s‘Sƒ‚ƒfƒ‹‚É‚¨‚¯‚éŒø‰Ê|tŽ…‹…‘Ì‘gD‹y‚Ñglomerular hypertrophy‚ɑ΂·‚é‰e‹¿|. ‹g“c‹`Ki϶‰ï‰¡•l“ì•”•a‰@jCŽðˆä‹Ši”åjCŒK”ö’èmi•a—j: ¬Ž™t•s‘SŒ¤‹†‰ïŽC9: 156`158, 1989.

1200. mŒ´’˜n ƒLƒ…ƒvƒ‰ƒAƒ“ƒ‚ƒjƒEƒ€ƒŒ[ƒˆƒ“–Œ\‘¢‚̈Ⴂ‚É‚æ‚éƒÀ2-microglobulinœ‹Ž“Á«‚Ì”äŠrŒŸ“¢. ŒF–ì˜a—Yi”åjC“ì•”³lC¬ŽR½C‘Š CˆêitƒZƒ“jC‹g“cˆê¬CŽðˆä‹Ši”åj: lH‘ŸŠíC18(3): 1133`1136, 1989.

1201. mŒ´’˜n t•s‘Sƒ‚ƒfƒ‹‚É‚¨‚¯‚éŒoŒû‹z’…ÜAST-120‚Ì•a‘Ô‚Æt‘gD‘œ‚É‹y‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä. Žðˆä‹ŠCŒF–ì˜a—Yi”åjC‹g“c‹`KiÏ¢‰ï‰¡•l“ì•”•a‰@j: t•s‘SC1(1): 135`140, 1989.

1202. mŒ´’˜n –«ˆÛŽ“§ÍŠ³ŽÒ‚ÌŒŒ´Ž_‰»”\. ŒF–ì˜a—Yi”åjC“ì•”³lC¬ŽR½C‘Š CˆêitƒZƒ“jCŽðˆä‹Ši”åjC’†‘º‘‰qi•ª¶j’|“ೋCi–]¯“¡‘òƒNƒŠƒjƒbƒNj: t•s‘SC1(1): 57`62, 1989.

1203. mŒ´’˜n ‘‡‰ï’Ã’†‰›•a‰@”å”AŠí‰È‚É‚¨‚¯‚é1986”N|1987”N‚Ì2”NŠÔ‚Ì“ü‰@Š³ŽÒ‚ÆŽèp‚Ì“Œv“IŒŸ“¢. ‹PºC“ü]Œ[CŠâ‘º³ŽkCò”ŽˆêC‹v•Û¯ˆêC¬ŽÄŒ’i”åj: ¼“ú”å”A, 51(3): 1029`1033, l989.

1204. mŒ´’˜n ¬Ž™tŽ¾Š³‚É‚¨‚¯‚é‰^“®ˆ•û‚Ì‚½‚ß‚ÌŠeŽí‰^“®•‰‰×ŽŽŒ±‚ÌŒŸ“¢. ŒÃ£º•vi‘—§—×{Š¼•Ê•{•a‰@jCŽðˆä‹Ši”åj: “ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(4): 884`889, 1989.

1205. mŒ´’˜n t•s‘Sƒ‚ƒfƒ‹‚ɑ΂·‚éŒoŒû‹z’…ÜAST-120‚̉e‹¿‚ÉŠÖ‚·‚錤‹†|ƒƒTƒ“ƒWƒEƒ€‹@”\AŽ…‹…‘Ì”ì‘å‚ÉŠÖ‚·‚錟“¢|. ‹g“c‹`KiÏ¢‰ï‰¡•l“ì•”•a‰@jCŽðˆä‹Ši”åj: “ú–{¬Ž™t‘Ÿ•aŠw‰ïŽGŽC2(2): 39, 1989.

1206. mŒ´’˜n ƒ‰ƒbƒgt•s‘Sƒ‚ƒfƒ‹‚ɑ΂·‚éŒoŒû‹z’…ÜAST-120‚̉e‹¿‚ÉŠÖ‚·‚錟“¢. Žðˆä‹ŠCŒF–ì˜a—Yi”åjC‹g“c‹`Ki϶‰ï‰¡•l“ì•”•a‰@j: “ú–{¬Ž™t‘Ÿ•aŠw‰ïŽGŽC2(2): 40, 1989.

1207. mŒ´’˜n t•s‘Sƒ‰ƒbƒg‚É‚¨‚¯‚éŒoŒû‹z’…ÜAST-120‚ÌŒø‰Ê|t•s‘Si“W‘jŽ~‚ÉŠÖ‚·‚élŽ@|. Žðˆä‹ŠCŒF–ì˜a—YC‚—Ç‘Žqi”åjCŒK”ö’èmi•a—j: “ú–{t‘ŸŠw‰ïŽCXXXI(4): 39`45, 1989.

1208. mŒ´’˜n MTT-assay‚ð—p‚¢‚½ƒqƒgäNã÷Šà×–EŠ”‚̧ŠàÜŠ´Žó«ŽŽŒ±. ‘ò‘º³”VC¬“c“‡–M’ji”åjC’·‘q˜a•FC’†‘ºGi–h‰q‘åj: “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 80(8): 1195`1202, l989.

1209. mŒ´’˜n 50ΈÈã‚Ì’jŽq‚É‚¨‚¯‚é‘O—§‘BÇ‚ÌŒŸ“¢|‘æ2‰ñ’[–ì’¬‘O—§‘BŒŸf‚ÌŒ‹‰Ê‚ÌŒŸ“¢. ’Ë–{‘׎iCŒF–{‰x–¾C‚–Ø—Ç’jCŽRŒûNGC‹g‰ª‘ôiŽD–yˆã‘åjC‰¡ŽR‰p“ñi”åjC—ÑŒªŽ¡i–kŒ©Ô\Žš•a‰@jCŒÃ‰®¹Ž™C¬–¸Œ[iŒÃ‰®•a‰@j: ”å”A‹I—v, 35: 1701`1708, l989.

1210. mŒ´’˜n Kidney Transplant Nephrotic Syndrome with Minimal Histologic Change in Focal Segmental Glomerulosclerosis: Clinical Recurrence? Jon-De LeeCŽðˆä‹Ši”åjC”Ñ‚Šì‹v—YiŽ™jCŒF–ì˜a—YCŠâ‘º³Žki”åjC‰Í¼‹IºC–kžŠ‚Ý‚Ç‚èiŽ™jCŒK”ö’èmi•a—j: –k—¢ˆãŠwC19(6): 619`623, 1989.

1211. mŒ´’˜n Characterization of a Polyreactive Monoclonal Antibody to ds DNA, Fx1A, and Heparan Sulfate Generated from BALB/c Mice Immunized with Rat Renal Homogenates. Chen, X-M.i“àjCAozuka, S.i‘—§ˆã—ÃZƒ“ƒ^[jCŠ™“cvŽõi“àjCOkamura, K.i‡“V“°‘åjC¬—Ñ–Li“àj: Clin. Immunol. Immunopathol., 51: 326`337, 1989.

1212. mŒ´’˜n Tubulointerstitial Nephritis Induced by Monoclonal Antiproximal Tubular Basement Membrane Antibodies in Mice. Chen, X-M.i“àjCTanaka, T.i‡“V“°‘åjC¬—Ñ–Li“àjCShigematsu, H.iMB‘åjCOkamura, K.i‡“V“°‘åj: Clin. Immunol. Immunopathol., 54: 40`52, 1990.

1213. mŒ´’˜n Abnormal Lipid Profiles at Various Stages of Uraemia. ’Ë–{—Y‰îCŽá—Ñ–õ‹vC‘å‹v•Û[li“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: Nephrol. Dial. Transplant., 4(Suppl.): 142`145, 1989.

1214. mŒ´’˜n Moderately Proteinuric IgA Nephropathy: Prognostic Prediction of Individual Clinical Courses and Steroid Therapy in Progressive Cases. ¬—Ñ–LC”äŠé”\”VC“¡ˆäˆêŽjC•ìºCŠÚ–샶i“àj: Nephron, 53: 250`256, 1989.

1215. mŒ´’˜n The Role of HLA-DR4 in the Long-term Prognosis of IgA Nephropathy. ”äŠé”\”VC¬—Ñ–LC‘å‹v•Û[li“àjC”–Ø“oiˆÚ–Æj: Nephron, 54: 264`265, 1990.

1216. mŒ´’˜n New Zealand F1 ƒ}ƒEƒXtǂɑ΂·‚é15-deoxyspergualin ‚ÌŽ¡—ÃŒø‰Ê‚Æì—p‹@˜. ‘å‹v•Û[lCˆäãŒcˆêC”~’J’¼Ž÷CŠ™“cvŽõi“àj: ¡“ú‚̈ÚA, 2(6): 451`455, 1989.

1217. mŒ´’˜n tˆÚAŒã‚̃TƒCƒgƒƒKƒƒEƒCƒ‹ƒXŠ´õÇ. ã‘C”~’J’¼Ž÷CŠ™“cvŽõC‘å‹v•Û[li“àjC‚‹{t’ji—ÕŒŸj: ¡“ú‚̈ÚA, 2: 310`315, 1989.

1218. mŒ´’˜n ¬Ž™CAPDŠ³ŽÒ‚̬’·‚Ƈ•¹Ç. ”Ñ‚Šì‹v—YCˆÉ“¡–¯ŒbC–kžŠ‚Ý‚Ç‚èiŽ™jCŒF–ì˜a—YCŽðˆä‹Ši”åj: ¬Ž™t•s‘SŒ¤‹†‰ïŽC9: 38`41, 1989.

1219. mŒ´’˜n ŒoŒû“I1,25(OH)2D3ƒpƒ‹ƒX—Ö@’·ŠúŽ{s—á‚ÌŒŸ“¢. ’Ë–{—Y‰îC–쑺K”Íi“àjC•xŠ~˜a”üi–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: t‚Æœ‘ãŽÓ, 3(1): 35`40, 1990.

1220. mŒ´’˜n ’·Šú“§Í—á‚É‚¨‚¯‚éƒAƒ~ƒƒCƒhœŠÖßÇ. ’†‘ò—¹ˆêC¬ìˆ¤ˆê˜YCŽO‰Y–õ•Fi‘—§²‘q•a‰@jCŠÚ–샶i“àjC“y“cOŠîC•lŒû‹ÓˆêC—é–Ø—mˆêC•Ûâ‰lˆêi‘—§²‘q•a‰@jCˆÀ“¡Œ¤C•ž•”‹`”ŽC‹g“c–L •Fi‹ž—t”å”AŠíƒNƒŠƒjƒbƒNj: t‚Æœ‘ãŽÓ, 3(1): 91`100, 1990.

1221. mŒ´’˜n ’·Šú“§ÍŠ³ŽÒ‚Ì‚“x“ñŽŸ«•›bó‘B‹@”\˜´iǂɑ΂·‚éŒoŒû“I1,25(OH)2D3ƒpƒ‹ƒX—Ö@. –쑺K”ÍC’Ë–{—Y‰îC‹g“càˆC‰i‰ª—²C–Øì“c—²ˆêi“àjC•xŠ~˜a”üi–k—¢ƒ‰ƒ{jC‚–Ø—TC‚‹´—Tˆê˜Yi‘Š–Í‘ä•a‰@jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: t‚Æ“§Í, 27(5): 955`960, 1989.

1222. mŒ´’˜n 123I-orthoiodohippurate (OIH)‚É‚æ‚ét“®‘Ô‹@”\ŒŸ¸‚Ì—Õ°“I•]‰¿|131I-OIH‚Æ‚Ì”äŠr‚¨‚æ‚Ñ—LŒøtŒŒ—¬—Ê‚Ì‘ª’è|. Έ䟌ÈC“cŠŽŒÈC¼™É”ŽC’†‘òŒ\Ž¡C¼—Ñ—²i•újC΋´Wi”åjCΓcŽ¡—Yi“s—§´£¬Ž™•a‰@j: “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 50(1): 68`75, 1990.

1223. mŒ´’˜n ¬Ž™tŽ¾Š³‚É‚¨‚¯‚é–Ɖu—}§Ü‘½Ü­—Ê•¹—p—Ö@. ‰Í¼‹IºC–kžŠ‚Ý‚Ç‚èCŠ—Œ´FC…–ì—@iŽ™jCŽðˆä‹Ši”åj: “ú–{¬Ž™t‘Ÿ•aŠw‰ïŽGŽC2(2): 139, 1989.

1224. mŒ´’˜n Å‹ß5”NŠÔ‚É”­Ç‚µ‚½¬Ž™SLE13—á‚Ì”­Œ©“®‹@‚©‚ç‚Ý‚½—Õ°•a—Šw“IŒŸ“¢. –kžŠ‚Ý‚Ç‚èC‰Í¼‹IºC”Ñ‚Šì‹v—YiŽ™jCŽðˆä‹Ši”åj: “ú–{¬Ž™t‘Ÿ•aŠw‰ïŽGŽC2(2): 25, 1989.

1225. mŒ´’˜n ‹}«ŠÔŽ¿«t‰Š‚É”º‚¤‹}«”ñ–R”A«t•s‘SŠ³Ž™‚Ì”A’†“d‰ðŽ¿‚̕ω». ‰Í¼‹IºC‘åι–çiŽ™j: •‘ –ì—Žq‘åŠw‹I—vC25: 143`146, 1990.

1226. mŒ´’˜n tˆÚA—Õ°‚É‚¨‚¯‚éciclosporine, mizoribine, steroid, ALG 4܇•¹“Š—^–@. ŒY•”P’jCŒY•”“ŒŽ¡C‰¡“c˜a•FC‘듇í‰ëC’†ŽR‹`‰îC²“¡ŒõŽjiŠOjCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—Yi”åjCŠ™“cvŽõC‘å‹v•Û[li“àjC“n•”_“ñC”–Ø “oi‘ŸˆÚjC“à“c‹v‘¥i“Œ‘åˆã‰ÈŒ¤j: —Õ°ˆÚA–ƉuŒ¤‹†‰ïŽ, 12: 55`63, 1990.

1227. m’Z•ñn Œ§ˆãŽt‰ïŽ–‹ÆAtŽ¾Š³‘Îô‚Ì3”NŠÔ‚Ì‚Ü‚Æ‚ß. Žðˆä‹Ši”åj: _“Þ쌧“§ÍŽ{ݘA—‹¦‹c‰ï•ñ, (4): 11`12Cl989.

1228. m’Z•ñn 1988”N“xŽÀŽ{ƒAƒ“ƒP[ƒgu“§ÍŽ{Ý‚Å‚ÌЊQ‚É‚æ‚é‹Ù‹}Ž–‘Ԃւ̑Ήžv‚Ì•ªÍŒ‹‰Ê‚ɂ‚¢‚Ä. “ú‘ä‰p—Yi‰¡•l‘æˆê•a‰@jCŽðˆä‹Ši”åjC“¿“c”Ž³i‹î‰ª“¿“cƒNƒŠƒjƒbƒNj: _“Þ쌧“§ÍŽ{ݘA—‹¦‹c‰ï•ñ, (4): 5`10Cl989.

1229. mŒ¤‹†•ñiŒú¶Èjn ¬Ž™CAPDŠ³ŽÒ‚̎Љ‹A. Žðˆä‹Ši”åjCˆÉ“¡–¯ŒbC”Ñ‚Šì‹v—YC–kžŠ‚Ý‚Ç‚èiŽ™jCŒF–ì˜a—Yi”åjC‰Í¼‹IºiŽ™j: Œú¶ÈuSgáŠQŒ¤‹†v¬Ž™tŽ¾Š³‚Ìis‘jŽ~‚Æ’·ŠúŠÔŠÇ—‚̃VƒXƒeƒ€‰»‚ÉŠÖ‚·‚錤‹†º˜a63”N“xŒ¤‹†•ñ‘, p. 211`214, 1989.

1230. mŒ¤‹†•ñiŒú¶Èjn IgAt‰Š‚Æ‚»‚ÌŠÔŽ¿•a•Ï‚Ì•]‰¿. ‰Í¼‹IºC–kžŠ‚Ý‚Ç‚èiŽ™jCŽðˆä‹Ši”åj: Œú¶ÈSgáŠQŒ¤‹†C¬Ž™tŽ¾Š³‚Ìis‘jŽ~‚Æ’·ŠúŠÇ—‚̃VƒXƒeƒ€‰»‚ÉŠÖ‚·‚錤‹†Cº˜a63”N“xŒ¤‹†•ñ‘, p.77`81, 1989.

1231. mŒ¤‹†•ñiŒú¶Èjn ”÷¶•¨“ñŽŸ‘ãŽÓŽY•¨‚̖Ɖu—}§ì—pA“Á‚ÉtÇ”­Ç‚¨‚æ‚Ñi“W‚Ì—}§‚ɂ‚¢‚Ä||‚·‚Å‚É”­Ç‚µ‚½New Zealand Black/White F1 (NZB/W F1)ƒ}ƒEƒXSLEtǂɑ΂·‚é15-deoxyspergualin‚ÌŽ¡—ÃŒø‰Ê[[. ‘å‹v•Û[lC”~’J’¼Ž÷CˆäãŒcˆêCŠ™“cvŽõi“àj: Œú¶ÈV–òŠJ”­Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.117`124, 1989.

1232. mŒ¤‹†•ñiŒú¶Èjn Œy“x‚Ì’`”’”A‚ð’æ‚·‚éIgAtÇ‚Ì—\Œã. ¬—Ñ–LC”äŠé”\”VC•ìºCãŽRŽO‘ãŽqC“¡ˆäˆêŽji“àj: Œú¶È“Á’莾Š³uis«táŠQv’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñW, p.7`16, 1989.

1233. mŒ¤‹†•ñiŒú¶Èjn ‚Z¶ŒŸ”A‚ÌŽÀ‘Ô. Žðˆä‹Ši”åj: Œú¶È“Á’莾Š³uis«táŠQ’²¸Œ¤‹†vº˜a63”N“xŒ¤‹†•ñ‘ Cp.102`104, 1989.

1234. mŒ¤‹†•ñiŒú¶Èjn _“Þ쌧‚Ìt‘Ÿ•aŒŸfƒVƒXƒeƒ€. Žðˆä‹Ši”åj: Œú¶È“Á’莾Š³uis«táŠQ’²¸Œ¤‹†vº˜a63”N“xŒ¤‹†•ñ‘ Cp.357`358, 1989.

1235. mŒ¤‹†•ñiŒú¶Èjn Œú¶ÈSgáŠQŒ¤‹†; ¬Ž™tŽ¾Š³‚Ìis‘jŽ~‚Æ’·ŠúŠÇ—‚̃VƒXƒeƒ€‚ÉŠÖ‚·‚錤‹†u¬Ž™CAPDŠ³ŽÒ‚̬’·‚Æ…—n«ƒrƒ^ƒ~ƒ“‚ɂ‚¢‚Äv. ”Ñ‚Šì‹v—YC–kžŠ‚Ý‚Ç‚èCˆÉ“¡–¯ŒbiŽ™jCŽðˆä‹Ši”åj: º˜a63”N“xŒ¤‹†•ñ, p.200`201, 1988.

1236. mŒ¤‹†•ñiŒú¶Èjn Œú¶ÈSgáŠQŒ¤‹†; ¬Ž™tŽ¾Š³‚Ìis‘jŽ~‚Æ’·ŠúŠÇ—‚̃VƒXƒeƒ€‚ÉŠÖ‚·‚錤‹† ¢¬Ž™CAPDŠ³ŽÒ‚̬’·‚Æ…—n«ƒrƒ^ƒ~ƒ“‚ɂ‚¢‚Ä£. ”Ñ‚Šì‹v—YC–kžŠ‚Ý‚Ç‚èCˆÉ“¡–¯ŒbiŽ™jCŽðˆä‹Ši”åj: º˜a63”N“xŒ¤‹†•ñ,@p.200`201, 1988.

1237. mÇ—á•ñn JRA ‚ð‹­‚­‹^‚킹‚銳Ž™‚ɇ•¹‚µ‚½‘ƒóŽ…‹…‘Ìd‰»Ç‚Ì1—á. ŽR–{OŽqC–kžŠ‚Ý‚Ç‚èC¯–ì—¤•vC‰Í¼‹IºiŽ™j: ŠÖ“Œ¬Ž™t‘ŸŒ¤‹†‰ïŽ,@5(1): 17`18, 1989.

1238. mÇ—á•ñn ƒlƒtƒ|ƒ[ÇŒóŒQ‚Å”­Ç‚µ‚½IgAtÇ‚Ì1—á|IgA Nephropathy with Nephrotic Syndrome or Idiopathic Nephrotic Syndrome with IgA Mesangial Deposits ?|. –kžŠ‚Ý‚Ç‚èC“à“¡„•FC‰Í¼‹IºiŽ™j: ŠÖ“Œ¬Ž™t‘ŸŒ¤‹†‰ïŽ,@5(1): 22`23, 1989.

1239. mÇ—á•ñn “ÁˆÙ‚ÈŽ…‹…‘Ì•a•Ï‚ð’悵‚½–Œ«‘B«Ž…‹…‘Ìt‰Š‚Ì1—á. “c‘º_ŽOC•ìºCãŽRŽO‘ãŽqC¬—Ñ–Li“àj: t‰ŠÇ—ጤ‹†, 5: 92`95, 1989.

1240. mÇ—á•ñn ‚“x‚ÌŽ…‹…‘Ìt‰ŠA”A׊ÇEŠÔŽ¿«t‰Š‚𔺂Á‚½ Castleman •a‚Ì1—á. ”äŠé”\”VC‰Ô“cL‰pC–쑺K”ÍC’Ë–{—Y‰îC•ìºCŠ™“cvŽõCŠÚ–샶C¬—Ñ–Li“àjCŠ}ˆäŒ‰i•a—j: t‰ŠÇ—ጤ‹†, 6: 120`124, 1990.

1241. mÇ—á•ñn Ä”R‚ðŒJ‚è•Ô‚µ‚½ƒ‹[ƒvƒXt‰Š‚Ì1—á. ãŽRŽO‘ãŽqC•ìºCŠ™“cvŽõC”äŠé”\”VC¬—Ñ–Li“àj: t‰ŠÇ—ጤ‹†, 6: 16`22, 1990.

1242. mÇ—á•ñn Ž‘±«—²‹N«g”ÁAŽá”N«ŠÖ߃ŠƒEƒ}ƒ`—l‚ÌŠÖ߉Š‚É‘ƒóŽ…‹…‘Ìd‰»Ç‚𔺂Á‚½1’jŽ™—á. V‘º•¶’jC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: t‰ŠÇ—ጤ‹†,@6: 115`119, 1990.

1243. mÇ—á•ñn ‰E‘å‘Úœ“ª‰óŽ€‚ð’悵‚½¬Ž™t•s‘SÇ—á. ‰Í¼‹IºC–kžŠ‚Ý‚Ç‚èCˆÉ“¡–¯ŒbCƒŒƒCƒ‚ƒ“ƒh¥ƒtƒ‰ƒ“ƒVƒAC”Ñ‚Šì‹v—YiŽ™jCŽðˆä‹Ši”åj: ‘æ10‰ñ_“ÞìCa¥œ‘ãŽÓŒ¤‹†‰ï•ñW,@10: 25`29, 1989.

1244. mÇ—á•ñn •úŽËü«ˆÞkäNã÷‚É‹Nˆö‚µ‚½äNã÷Ž©‘R”j—ô‚Ì1—á. ‹PºC“ü]Œ[C‘ê–{‰ë•¶CŠâ‘º³Žki”åj: ”å”AŠíŠO‰È, 2(4): 409`412, 1989.

1245. m—Õ°Ž¡Œ±n ¬Ž™tˆÚAŒã‚Ì‹}«‹‘┽‰ž‚ɑ΂·‚émuromonab CD3‚ÌŽ¡—ÃŒø‰Ê. ˆÉ“¡ŽŒÈi“Œ—‘åjCŽðˆä‹Ši”åj: ¬Ž™‰È—Õ°C42(7): 1551`1560, 1989.

1246. m—Õ°Ž¡Œ±n ¬Ž™t«•nŒŒ‚ɑ΂·‚érecombinant human erythropoietin (EPOCH)‚Ì—Õ°•]‰¿|•Û‘¶Šú–«t•s‘SŠ³ŽÒ‚ɑ΂·‚é‰e‹¿‚ɂ‚¢‚Ä. ˆÉ“¡ŽŒÈi“Œ—‘åjCŽðˆä‹Ši”åj: ¬Ž™‰È—Õ°C43(3): 85`96, 1990.

1247. m—Õ°Ž¡Œ±n AN69HF‚ð—p‚¢‚½ŒŒ‰tàh‰ß“§Í‚ł̒ᕪŽq’`”’‚Ìœ‹Ž‚Æ‚»‚Ì‹@˜. ‚–Ø—Ti”åjC¬ŽR½C“ì•”³lCéˆä°”üC—Ñ‹v”üŽqC‘Š CˆêitƒZƒ“jC‹g“cˆê¬CŒF–ì˜a—YCŽðˆä‹Ši”åj: t‚Æ“§Íi•ÊûjƒnƒCƒpƒtƒH[ƒ}ƒ“ƒXƒƒ“ƒuƒŒƒ“'89, 27: 100`103, 1989.

1248. m—Õ°Ž¡Œ±n –«ˆÛŽ“§ÍŠ³ŽÒ‚Ì•Ö”é‚ɑ΂·‚éH•¨‘@ˆÛŠÜ—LƒEƒGƒn[ƒX‚ÌŽg—pŒoŒ±. ŒF–ì˜a—YC“ü]Œ[CŽðˆä‹Ši”åjCHŽRŒbŽqC÷ˆäŒ’Ž¡i‹´–{ƒNƒŠƒjƒbƒNj: —Õ°“§ÍC5(8): 111`114, 1989.

1249. m—Õ°Ž¡Œ±n t«•nŒŒŠ³ŽÒ‚ɑ΂·‚é recombinant human ergthropoietin (EPOCH)‚Ì—Õ°“IŒ¤‹†||“ñd–ÓŒŸ–@‚É‚æ‚é‚R—p—Ê”äŠrŽŽŒ±||. •½‘ò—R•½iMŠy‰€•a‰@jC•½“ˆ–M–Òié‹Êˆã‰È‘åjCr쳺iVŠƒ‘åjC¬‚’Ê•viç—t‘åjC¬–¸—z‰îiŒÕ‚Ì–å•a‰@jC‹gìNsié‹Êˆã‰È‘åjC²’†Žy i“Œ‹ž—Žqˆã‘åjCŽÂ“cëi‹à‘òˆã‰È‘åjCXˆä_¢i‘åãŽs—§‘åjC—é–سŽiiMŠy‰€•a‰@jCç—t‰hŽsiŽOŠ}Žs—§ŽOŠ}‘‡•a‰@jC‚‹´Žõiå‘äŽÐ‰ï•ÛŒ¯•a ‰@jC‹à“c_C‘O‘½—²‹gi‚¢‚í‚«Žs—§‘‡”Ö鋤—§•a‰@jC“à“cMˆêi϶‰ï‘O‹´•a‰@jCŽRŒ`—zi“ú—§‘‡•a‰@jCó–ì‘×C•“¡d–¾iŽ©Ž¡ˆã‰È‘åjC‰œ“cŒ’ “ñi‰œ“cƒNƒŠƒjƒbƒNjC”‘qsGié‹Êˆã‰È‘åjC“ˆ“crPiç—tŽÐ‰ï•ÛŒ¯•a‰@jC’†àV—¹ˆêi‘—§²‘q•a‰@jCŒIŒ´—åit“ú•”G˜a•a‰@jC¬o‹PCŒE“cŽÀ i‡“V“°‘åjC•ì´i“Œ‘åjC¯–ì³Mi¹‹´ƒNƒŠƒjƒbƒNjC‰Ž“c‹’jC—é–Ø—m’ÊiŒc‘åjC¬˜H—Çi“ì‘åˆäƒNƒŠƒjƒbƒNjC™–ìM”ŽC”g‘½–쓹NCŒE“cŒ¤ “ñC²“¡FŽqi“Œ—Žqˆã‘åjCΓc®ŽuC‘å˜a“cŽ i¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åjC‰z캎OC‚‹´Œ’iº˜a‘åjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjCŠ™“cvŽõi–k—¢‘åE “à‰ÈjCâ–{M•vC“n•Ó—LŽOi–¼ŒÃ‰®‘åjCŽRèe—YiOωq•a‰@jCàV¼ŒªŽŸi‹ž‘åjC¬–ì—˜•Fi‹ž“s‘æˆêÔ\Žš•a‰@jCÜ“c‹`³iã‘åjC–k‰ª—˜ —YC‰ª‘ºŽÍC‰¡ì•üŽqiŠÖ¼˜JЕa‰@jCˆäã—²C“ú–ì‰ë”Vi‘“—´‰ïˆäã•a‰@jC‘Oì³MC“c’†Š°i‘åãŽs—§‘åjC”Ñ“cŠìri‘åã•{—§•a‰@jCÔŠ_—m“ñ i‘å–ì•a‰@jC“¡“c‰ÃˆêCˆä㹎mCâˆä—ÚŽÀi•ºŒÉˆã‰È‘åjC¬–ìŽRŒOi‹ã‘åjC’†‘º’è•qi¬‘q‘æˆê•a‰@jC“¡Œ©œ·C•Û—˜Œhi•Ÿ‰ªÔ\Žš•a‰@jC¬ì’¨–ç iˆ¤•Q‘åj: t‚Æ“§Í, 27(1): 157`177, 1989.

1250. m—Õ°Ž¡Œ±n AMSƒyƒj[ƒ‹ƒCƒ“ƒvƒ‰ƒ“ƒgAƒCƒ“ƒtƒŒ[ƒ^ƒuƒ‹Œ^ƒ‚ƒfƒ‹700‚Ì—Õ°ŽŽŒ±¬Ñ. ”’ˆä«•¶C‚”g^²Ž¡i“Œ–M‘åjC‹àŽq–Î’jiˆ®ìˆã‰È‘åjC“¡‰ª’mºC–،õiŠâŽèˆã‰È‘åjC‰ª–{dâXCŠÑˆä•¶•Fi¹˜H‰Á‘Û•a‰@jC“¡–ì’Wli”åjC–Ø Œ´—T“ñiŒö—§–L‰ª•a‰@jC’†–씎iƒ}ƒcƒ_•a‰@jC–œ”g½C‘å¼—msiŽs—§‰F˜a“‡•a‰@jCã—ä—ŠŒ[C•½”ö”ŽC‰Á“¡‰ë‹vC“ú“cŠ¯CŽR“c—zŽii϶‰ï‰ºŠÖ‘‡•a ‰@j: ”å”A‹I—v, 35: 913`920, 1990.

1251. m—Õ°Ž¡Œ±n Ö¬«”A˜H‘¢‰e‚É‚¨‚¯‚é”ñƒCƒIƒ“«ƒˆ[ƒh‘¢‰eÜIohexol‚Ì—L—p«‚ÌŒŸ“¢|“_“HÃ’‚É‚æ‚é”A˜H‘¢‰e(DIP). ’¬“c–L•½iŽœŒb‘åjC¬–ö’m•Fi–k‘åjCŒF–{‰x–¾iŽD–yˆã‰È‘åjCÜŠ}¸ˆêi“Œ–k‘åjC¬ìHŽÀiMB‘åjCˆ¢‘]‰À˜Yi“Œ‘åjC“‡è~iç—t‘åjCŠÝ–{F i“ú‘åjCHŒ³¬‘¾i“ú–{ˆã‰È‘åjCŽO–ؽi“Œ‹žˆã‰È‘åjC¬ŽÄŒ’i”åjC‘å“c•˜a¶i–¼ŒÃ‰®Žs—§‘åjC‹g“cCi‹ž‘åjC“n粌ˆi‹ž“s•{—§ˆã‰È‘åjC‹{ì ª’ji’¹Žæ‘åjC‘åXO”Vi‰ª‘åjC“¡“cK—˜i‚’mˆã‰È‘åjC]“¡kìi‹v—¯•Ä‘åjC‘åˆäD’‰iŽ­Ž™“‡‘åjC‘åÎK•FiŽœŒb‘åj: —Õ°ˆã–ò, 5(8): 1703`1716, 1989.

1252. m‘àn “ú–{‚É‚¨‚¯‚étˆÚA‚ÌŒ»‹µ. Žðˆä‹Ši”åjCV‘º•¶’jiŽ™j: ˆãŠw‚Ì‚ ‚ä‚ÝC150(9): 609`612, 1989.

1253. m‘àn —˜”A–ò. Žðˆä‹Ši”åj: ŠO‰ÈC51(5): 481`486, 1989.

1254. m‘àn “ÁŽêƒPƒA‚ðŽó‚¯‚Ä‚¢‚銳ŽÒ‚Ì"ˆÀ‘S«‚ƈÀŠy«"|CAPDŽ{sŠ³ŽÒ|. ‹{“‡•Ÿ]itƒZƒ“j: ŒŽŠ§ƒi[ƒVƒ“ƒOC9(10): 76`77, 1989.

1255. m‘àn “ÁŽêƒPƒA‚ðŽó‚¯‚Ä‚¢‚銳ŽÒ‚Ì"ˆÀ‘S«‚ƈÀŠy«"|ŒŒ‰t“§ÍŽ{sŠ³ŽÒ|. ‹{“‡•Ÿ]itƒZƒ“j: ŒŽŠ§ƒi[ƒVƒ“ƒOC9(11): 78`81, 1989.

1256. m‘àn tŽ¾Š³¶ŠUŠÇ—‚̃|ƒCƒ“ƒg|Šw“¶Šú|. Žðˆä‹Ši”åj: ŒöO‰q¶C53(5): 301`304, 1989.

1257. m‘àn –«t‰ŠEt•s‘SŠ³ŽÒ‚̶ŠˆŽw“±|ŠwZŒŸf‚æ‚è|. Žðˆä‹Ši”åjCV‘º•¶’jiŽ™j: Ž¡—ÃC72(3): 119`126, 1990.

1258. m‘àn ‰æ‘œf’fut‘Ÿv. Žðˆä‹Ši”åjCV‘º•¶’jiŽ™j: ¬Ž™‰Èf—ÃC53(4): 1024`1030, 1990.

1259. m‘àn ¬Ž™t•s‘S‚ÌŽ¡—ÂÌi•à‚Æ”½È. Žðˆä‹Ši”åj: ¬Ž™‰Èf—ÃC53(6): 1368`1373, 1989.

1260. m‘àn ¬Ž™‚Ì“§Í‚Æ–â‘è“_. Žðˆä‹Ši”åjC”Ñ‚Šì‹v—YiŽ™jCŒF–ì˜a—Yi”åjCV‘º•¶’jC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™j: t‚Æ“§ÍC27(1): 33`40, 1989.

1261. m‘àn Ž‡”Á•a«t‰Š|¬Ž™|. Žðˆä‹Ši”åjCV‘º•¶’jC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™j: t‚Æ“§ÍC27(‘): 163`165, 1989.

1262. m‘àn • –Œ‰ŠEƒCƒŒƒEƒX. ŒF–ì˜a—Yi”åj: t‚Æ“§ÍitŽ¾Š³‚Ì–ò•¨—Ö@jC27: 457, 1989.

1263. m‘àn ”xŠà. ŒF–ì˜a—Yi”åj: t‚Æ“§ÍitŽ¾Š³‚Ì–ò•¨—Ö@jC27: 521`522, 1989.

1264. m‘àn ŽíX‚ÌŒŒ‰tò‰»—Ö@:@tˆÚA‚Æ“§ÍƒAƒ~ƒƒCƒh[ƒVƒX. ŒF–ì˜a—YC‚–Ø—Ti”åjC“ì•”³lC¬ŽR½C‘Š CˆêitƒZƒ“jCŽðˆä‹ŠC‰““¡’‰—Yi”åjCŒüˆäLÆC‚‹´—Tˆê˜Yi‘Š–Í‘ä•a‰@jC÷ˆäŒ’Ž¡i‹´–{ƒNƒŠƒjƒb ƒNjC‰¡“c^“ñi”åjC¬‘q—TKiŒú–؃NƒŠƒjƒbƒNj: t‚Æ“§Íi•ÊûjƒnƒCƒpƒtƒH[ƒ}ƒ“ƒXƒƒ“ƒuƒŒƒ“'89, 27: 39`43, 1989.

1265. m‘àn ”A˜HŒn‚ƶBŠíŽ¾Š³. Žðˆä‹Ši”åj: “ú–{ˆãŽt‰ïŽGŽi—Õ‘jC102(10): 180`193, 1989.

1266. m‘àn “ú–{‚É‚¨‚¯‚étˆÚA‚ÌŒ»ó. Žðˆä‹Ši”åj: “ú–{ˆãŽ–V•ñC(3415): 134`135, 1989.

1267. m‘àn t•s‘S•a‘ԂƬ’·áŠQ. Žðˆä‹Ši”åj: “ú–{¬Ž™i‰h—{Á‰»Ší•aŠw‰ïŽGŽjC3(1): 51`61, 1989.

1268. m‘àn tˆÚA‚É”º‚¤ŽÐ‰ï“I”–â‘è. Žðˆä‹Ši”åj: —Õ°“§ÍC5(11): 83`87, 1989.

1269. m‘àn S–[«Na—˜”Aƒzƒ‹ƒ‚ƒ“. ’Ë–{—Y‰îi“àj: Current Review “§Í—Ö@EtˆÚA, p.72`83, 1989.

1270. m‘àn ‘ƒóŽ…‹…‘Ìd‰»Ç‚̬ˆö‚Æ—Õ°‘œ. ¬—Ñ–LCŠÚ–샶C”äŠé”\”Vi“àj: Medical Practice, 6(10): 1637`1643, 1989.

1271. m‘àn IgA tÇ. ¬—Ñ–Li“àj: Medical Practice, 6(—Õ‘): 555`556, 1989.

1272. m‘àn ”D•w‚Ì…‘ãŽÓ‚Æt‹@”\. ‰¡“c^“ñCŒF–ì˜a—YCŽðˆä‹Ši”åj: ƒyƒŠƒlƒCƒ^ƒ‹ƒPƒA, 2ŒŽ†, 1990.

1273. m‘àn ’áNaE‚NaŒŒÇ. ’Ë–{—Y‰îi“àj: ˆãŠw‚Æ–òŠw, 22(2): 301`307, 1989.

1274. m‘àn —nŒŒ«”A“ÅÇÇŒóŒQ. ”Ñ‚Šì‹v—YiŽ™j: ¬Ž™‰Èf—Ã,@52(6): 1347`1352, 1989.

1275. m‘àn tŽ¾Š³‚Ì–ò•¨—Ö@: tˆÚA‚ÉŽg—p‚³‚ê‚é–òÜ||–R”A. ‘å‹v•Û[li“àj: t‚Æ“§Í, 27: 566`567, 1989.

1276. m‘àn i“ÁWj‘ÌŠOÕŒ‚”gŒ‹Î”jӗÖ@ESWL;”A˜HŒ‹ÎESWL‚̇•¹Ç. ^‰ºß•vCrìFC‹v•Û¯ˆêi”åj: “ú–{—Õ°C47(12): 40`44, 1989.

1277. m‘àn i“ÁWj‘ÌŠOÕŒ‚”gŒ‹Î”jӗÖ@ESWL;‘匋ÎESWL‚Æstone street‚ÌŠÇ—|tƒTƒ“ƒSóŒ‹Î‚ð’†S‚É|. rìFC‹v•Û¯ˆêC^‰ºß•vi”åj: “ú–{—Õ°C47(12): 60`64, 1989.

1278. m‘àn ŒŒ”A‚̉摜f’fGŠjˆãŠwŒŸ¸‚Ì–ðŠ„. ΋´Wi”åj: —Õ°‰æ‘œ, 5(8): 62`76, 1989.

1279. m‘àn ƒoƒiƒWƒEƒ€Aƒtƒb‘f‚È‚Ç‚Ì‘¼Œ³‘f. ’Ë–{—Y‰îi“àj: —Õ°“§Í, 5(11): 1743`1747, 1989.

1280. m‘àn ”]Ž€‚Ì¥”F‚Æ‘ŸŠíˆÚA‚̈ì˜H. ¬ŽÄŒ’i”åj: —Õ°“§ÍC5(3): 335`336, 1989.

1281. muÀn ”A’`”’. Žðˆä‹Ši”åj: Medicina, ‘Š§†C26(10): 1634Cl989.

1282. muÀn ”A“œ. Žðˆä‹Ši”åj: Medicina, ‘Š§†C26(10): 1635Cl989.

1283. muÀn »“œ‚Ɖ–‚ÌÛ‚è‰ß‚¬‚É‚æ‚éŠQ. Žðˆä‹Ši”åj: ­”NŽÊ^V•·i¬Šw•ÛŒ’ƒjƒ…[ƒXjC(254): 1, 1989.

1284. muÀn ‘æ15‰ñˆãH§’k‰ï‚ÉoÈ‚µ‚Ä. Žðˆä‹Ši”åj: lH‘ŸŠíC18(4): 1518, 1989.

1285. muÀn Chance Proteinuria. Žðˆä‹Ši”åj: “à‰È, 63(6): 1070, 1989.

1286. muÀn ŠwZ‘̈ç‚É‚¨‚¯‚éê–åˆã‚̃AƒhƒoƒCƒX. ’·â—T”Ži‰¡•lŽs¬Ž™ƒAƒŒƒ‹ƒM[ƒZƒ“ƒ^[jCŽðˆä‹Ši”åj: —Õ°ƒXƒ|[ƒcˆãŠwC6(4): 413`417, 1989.

1287. muÀn ”r”AáŠQ‚ÌŽ¡—Â̎ÀÛ|–ò•¨—Ö@‚ÆŽèp“K‰ž|. ‰¡ŽR‰p“ñi”åjC¼‘ò—iH“c‘åjC“‡è~iç—t‘åj: Medic, 24(12): 1`9, 1989.

1288. muÀn ŒŸ¸‚ÌŽÀۂƃPƒA‚̃|ƒCƒ“ƒg|t¶ŒŸ|. ΋´Wi”åj: —Õ°ŠÅŒì, 16(3): 366`369, 1990.

1289. muÀn ƒCƒ“ƒXƒ^ƒ“ƒgƒJƒƒ‰‚ð—p‚¢‚½p’†“§Ž‹ƒ‚ƒjƒ^[‘œ‚Ì‹L˜^•û–@. ‹g“cˆê¬CŽu‘º“NC–å˜e˜abi”åj: —Õ°”å”AŠí‰È, 43(9): 821, 1989.

1290. mÀ’k‰ïn –«t‰Š‚Æt•s‘S‚Ìf—Âð‚ß‚®‚Á‚Ä. äGli“ŒŠC‘åjC‹g‘òMsi–h‰qˆã‘åjCŽðˆä‹Ši”åjC‚‹´ii“ú‘åj: Ž¡—ÃC72(3): 173`196, 1990.

1291. mŠwp‘n iŽ·•Mj ¡“ú‚̬Ž™Ž¡—ÃŽwj@‘æ8”Å; ŒŒŸ÷ŒðŠ·–@Cp.478`479, ”Ñ‚Šì‹v—YiŽ™j. •ÒW ”·‰Ã”Vi“Œ–M‘åjCŽO‰ÍtŽ÷i‹ž‘åjCd“c­M•ÒC ˆãŠw‘‰@, “Œ‹ž, 89.09.15”­s.

1292. mŠwp‘n iŽ·•Mj Recent Studies of IgA Nephropathy in Japan; Therapeutic Approach in IgA Nephropathy, p.187`209, ¬—Ñ–LC”äŠé”\”Vi“àj. •ÒW Arakawa, M.CGejyo, F.•Ò, Nishimura/Smith-Gordon, 89.10.00 ”­s.

1293. mŠwp‘n iŽ·•Mj tŽ¾Š³‚Ì–ò•¨—Ö@; ‡Z. tˆÚA (3)‘ÎǗÖ@¥•nŒŒ, p.555`556, Š™“cvŽõi“àj. “Œ‹žˆãŠwŽÐ, “Œ‹žC89.11.30 ”­s.

1294. mŠwp‘n iŽ·•Mj ¡“ú‚̬Ž™Ž¡—ÃŽwj;@@ ‹}«Ž…‹…‘Ìt‰Š, 8: 484`485, Žðˆä‹Ši”åj. •ÒW ”·‰Ã”Vi“Œ–M‘åjC‘¼, ˆãŠw‘‰@, “Œ‹ž, 89.09.15”­s.

1295. mŠwp‘n iŽ·•Mj t‰Š¥ƒlƒtƒ[ƒ[;@@ ¬Ž™‚É‘½‚¢t‰Š¥ƒlƒtƒ[ƒ[, 5: 55`65, Žðˆä‹Ši”åjC”Ñ‚Šì‹v—YiŽ™j. •ÒW ’·‘òr•FiˆÇ—Ñ‘åj, “ì]“°, 89.12.01”­s.

1296. mŠwp‘n iŽ·•Mj Annual Review t‘Ÿ 1990;@@ CAPD‚ÆtˆÚA, p.215`221, ŒF–ì˜a—YC¬ŽÄŒ’i”åj. •ÒW ‰z캎Oiº˜a‘åj,‘¼C ’†ŠOˆãŠwŽÐ, 90.01.10”­s.

1297. m‹³‰È‘n iŽ·•Mj ƒvƒ‹ƒ~ƒGˆãŠwŠe˜_i“à‰ÈCŠO‰ÈC¬Ž™‰Èj¬’·¥”­’B‚ÌáŠQCo¶‚É”º‚¤áŠQ; ‹}«t•s‘SCŒ´”­«Ž…‹…‘ÌŽ¾Š³Cæ“V«ƒlƒtƒ|ƒ[Ct‚Ìæ“VˆÙíCp.137`140, ”Ñ‚Šì‹v—YiŽ™j. •ÒW –،p–«i“Œ–M‘åj•ÒC ˆãŽ•–òo”Å, “Œ‹ž, 89.11.10”­s.

1298. m‹³‰È‘n iŽ·•Mj Še‰È‚Ì‚½‚ß‚Ì’´‰¹”gŒŸ¸|(2)¬Ž™‰È¥ŠO‰È¥”å”AŠí‰È¥ŽY‰È¥•wl‰È|—Õ°ŒŸ¸Mook; …tÇ‚Æt”X–EÇ, p.73`77, “¡–ì’WlC΋´Wi”åj. •ÒW “n•ÓŸ–i‹ž“s•{—§ˆã‘åj‘¼•Ò, ‹àŒ´o”Å, “Œ‹žC89.11.30”­s.

1299. m‹³‰È‘n iŽ·•Mj ÅVˆãŠw’mŽ¯‚Ì®—|”å”AŠí‰ÈŠe˜_; t•s‘S;t«‚ŒŒˆ³Ç;tŒŒŠÇ«•a•Ï;‚»‚Ì‘¼‚ÌtŽ¾Š³, p.204`217, ¬ŽÄŒ’i”åj. •ÒW ¡‘ºˆê’j •Ò ˆãŽ•–òo”Å, “Œ‹žC90.01.30”­s.

1300. m‹³‰È‘n iŽ·•Mj “§ÍiXIXj;@@ ŒŒ‰t“§Í’†‚ÌŽ–ŒÌ‚Æ‘Îô, p.66`75, Žðˆä‹Ši”åj. •ÒW ¬‚’Ê•viç—t‘åj, ˆãŠw}‘, 89.07.08”­s.

1301. m‹³‰È‘n iŽ·•Mj “§Í—Ö@ƒnƒ“ƒhƒuƒbƒN;@@ ¬Ž™‚Ì“§Í,@‰ü’ù‘æ5”Å, p.376`388, Žðˆä‹Ši”åj. •ÒW ‰z캎Oiº˜a‘åj,‘¼C ‹¤“¯ˆã‘o”ÅŽÐ, 90.01.15”­s.

1302. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj TURP|”å”AŠí‰ÈŽ¡—Ãnƒ“ƒhƒuƒbƒN; p.296`300, ¬ŽÄŒ’i”åj. •ÒW “n•ÓŸ–@•Ò “ìŽR“°, “Œ‹žC89.06.00”­s.

1303. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj V–ò•¨—Ö@ '90”N”Å; ‹}«ŠÔŽ¿«t‰Š, ¬—Ñ–Li“àj. •ÒW ã“c‘×C´…Šì”ª˜YCtŒ©Œ’ˆê•Ò, ƒƒWƒJƒ‹Eƒrƒ…[ŽÐ,@“Œ‹ž,@89.12.00 ”­s.

1304. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj “à‰Èf—à Q & A; t¶ŒŸ‚Ì“K”Û|ˆ««‚ŒŒˆ³Ç|, 23: p.26`29, ŠÚ–샶i“àjC“y“cOŠîi‘—§²‘q•a‰@j. ˜Z–@o”Å, –¼ŒÃ‰®, 89.00.00 ”­s.

1305. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ¬Ž™ƒƒfƒBƒJƒ‹ƒ`ƒFƒbƒN‚Ɖ^“®Žw“±‚ÌŽÀÛ;@@ ‡Y.t‘Ÿ‚̃ƒfƒBƒJƒ‹ƒ`ƒFƒbƒN‚Ɖ^“®Žw“±, p.115`121, Žðˆä‹Ši”åjC’·â—T”Ži‰¡•lŽs¬Ž™ƒAƒŒƒ‹ƒM[ƒZƒ“ƒ^[j. •ÒW ‘å‘^•Fi“ú‘åj•Ò, •¶Œõ“°, 89.06.01”­s.

1306. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ÒWj iŽ·•Mj‚±‚Ç‚à‚Ìt‘Ÿ•aƒKƒCƒh,‡T;@@ ŠwZŒŸ”A‚Ìi‚ß•û‚ÆŠÇ—¥Ž¡—Ã, p.23`37, Žðˆä‹Ši”åj. •ÒW –kìÆ’ji“ú‘åjCŽðˆä‹Ši–k—¢‘åj, “ú–{ŒöO‰q¶‹¦‰ï, “Œ‹žC89.08.30”­s.

1307. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ÒWEŽ·•Mj ‚±‚Ç‚à‚Ìt‘Ÿ•aƒKƒCƒh,‡U;@@ ŠwZŒŸ”A‚Ì•û–@‚ÆŽ–Œã‘[’u, p.68`91, Žðˆä‹Ši”åj. •ÒW –kìÆ’ji“ú‘åjCŽðˆä‹Ši–k—¢‘åj, “ú–{ŒöO‰q¶‹¦‰ï,“Œ‹žC89.08.30”­s.

1308. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj Œ’Nf’f‚É‚¨‚¯‚é”AŒŸ¸|”»’è‚©‚玖ŒãŠÇ—‚Ü‚Å|;@@ ’nˆæ‚É‚¨‚¯‚鑇“ItŽ¾Š³E—\–hŠÇ—‘Îô, p.47`50, Žðˆä‹Ši”åj. •ÒW ´…–}¶iL“‡‘åj, “ú–{¬Ž™•ÛŒ’Šw‰ï, “Œ‹ž, 89.11.03”­s.

1309. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj ŠwZŒŸ”A‚Ì‚·‚ׂÄ;@@ ŠÇ—‚ÆŽ¡—Ã, p.91`120, Žðˆä‹Ši”åj. •ÒW “ú–{ŠwZ•ÛŒ’‰ïC —\–hˆãŠwŽ–‹Æ’†‰›‰ï, 90.01.30”­s.

1310. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn iŽ·•Mj ƒi[ƒX‚Ì‚½‚ß‚ÌŠíŠBŠí‹ï; ŒŸ¸, p.54`59, ”å”AŠí, p.236`260, ΋´Wi”åj. •ÒW ÷ˆäŒ’ŽiiŽœŒbˆã‘åj•Ò, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹žC89.06.10”­s.

1311. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j DNA Fingerprints Detect Somatic DNA Changes in Transitional Carcinoma of the Bladder (TCC). “à“c–LºCH. NeuwirthC N.C. Cadavid: AACR (American Association Cancer Research) (89.05.00), San Francisco.

1312. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j “«t‰Š¥ƒlƒtƒ[ƒ[–ò•¨—Ö@‚̎肪‚©‚è; IgAtǂɑ΂·‚é•›t”玿ƒXƒeƒƒCƒh—Ö@. ¬—Ñ–Li“àj: ‘æ24‰ñ“ú–{¬Ž™¥t‘Ÿ•aŠw‰ï (89.06.00), –¼ŒÃ‰®.

1313. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‘ÌŠOÕŒ‚”g”A˜HŒ‹Î”jÓp(ESWL)‚ÌŒoŒ±. ^‰ºß•vi”åj: “ú–{ŠO‰ÈŒn˜A‡Šw‰ï (89.06.21), ‘åã.

1314. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Epidemiology and Treatments of Renal Diseases in Asian Countries; Management of Congenital Hydronephrosis. ”Ñ‚Šì‹v—YCΊٕ•viŽ™jCŽðˆä‹Ši”åj: ‘æ24‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ï 2th Asian Symposium of Pediatric Nephrology (ASPN) (89.06.28), –¼ŒÃ‰®.

1315. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Mizoribine‚ÌŽg—pŒoŒ±. Žðˆä‹Ši”åjCˆÉ“¡–¯ŒbC”Ñ‚Šì‹v—YiŽ™jCŒF–ì˜a—Yi”åjC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™j: ‘æ24‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ï (89.06.30), –¼ŒÃ‰®.

1316. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Search for the Unknown Trace Element Abnormalities in Uremia. ’Ë–{—Y‰îi“àj: 2nd Meeting of the International Society for Trace Element Research in Humans (89.09.28), “Œ‹ž.

1317. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j —cŽ™EŠw“¶ŒŸ”A‚Ì‚½‚ß‚Ì‘gD‚­‚è. Žðˆä‹Ši”åj: ‘æ36‰ñ“ú–{¬Ž™•ÛŒ’Šw‰ï (89.11.05), L“‡.

1318. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Carcinoma of the Prostate Endocrine Therapy. ¬ŽÄŒ’C“¡–ì’Wli”åj: Pan-Pacific Surgical Association 20th Congress (90.02.13), Hawaii.

1319. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Carcinoma of the Bladder: Staging Classification and Patient Evaluation. ¬ŽÄŒ’C“¡–ì’Wli”åj: Pan-Pacific Surgical Association 20th Congress (90.02.14), Hawaii.

1320. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ŒŒs“®‘Ô‚É—^‚¦‚éƒGƒŠƒXƒƒ|ƒGƒ`ƒ“‚ÌŒø‰Ê. Š™“cvŽõi“àj: ‘æ8‰ñ“ú–{MEŠw‰ïlH‘ŸŠí•”‰ï (90.02.17), ‘åã.

1321. mŠw‰ïn iƒpƒlƒ‹j CAPD and the Pediatric Patient. Žðˆä‹Ši”åj: Hakone CAPD Expert Meeting (89.09.03), ” ª.

1322. mŠw‰ïn iƒpƒlƒ‹j ”A˜HŒ‹Î‚ÌŽ¡—Õûj. ¬ŽÄŒ’i”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06), “Œ‹ž, —\eW, p.69, 1989.

1323. mŠw‰ïn iƒpƒlƒ‹j ESWLiÕŒ‚”gŒ‹Î”jӗÖ@j‚Ì“K‰ž‚ÆŒÀŠE|Ž„‚Í‚±‚¤‚µ‚Ä‚¢‚é|. rìFi”åj: ‘æ37‰ñ_“Þ쌧”å”AŠí‰Èˆã‰ï (89.11.18), _“Þì.

1324. mŠw‰ïn iƒpƒlƒ‹j ESWL, New Type. C. Chaussy (FRG)C¬ŽÄŒ’i”åj: 7th World Congress on Endourology and ESWL (89.11.28), ‹ž“s.

1325. mŠw‰ïn iƒpƒlƒ‹j Treatment of Upper Urinary Tract Caliculi by ESWL with Therasonic Lithotripsy Treatment System. •ìƒCò”ŽˆêC¬ŽÄŒ’C^‰ºß•vCŠÑˆä•¶•Fi”åjC‰ª–{dâXC‰i“cŠ²’jC“¡–{‹±Žmi¹˜H‰Á‘Û•a‰@jC{ŽRˆê•äi”åj: 7th World Congress on Endourology and ESWL (89.11.28), ‹ž“s.

1326. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj t•s‘S‚Ö‚Ìis‚Æ–hŽ~;H‰a—Ö@‚ð’†S‚Æ‚µ‚Ä. ’Ë–{—Y‰îi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: ‘æ18‰ñ“ú–{t‘ŸŠw‰ï“Œ•”•”‰ï (88.05.06`07), “Œ‹ž.

1327. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj ¬Ž™‚¨‚æ‚Ѭl”­Ç‚ÌIgAtÇ‚Ì•a—. d¼GˆêiMB‘åjC¬—Ñ–LC”äŠé”\”Vi“àj: ‘æ19‰ñ“ú–{t‘Ÿ•aŠw‰ï“Œ•”•”‰ï (89.06.10), “Œ‹ž.

1328. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj t•s‘SE“§Í—Ö@‚ÆŠˆ«Ž_‘f|–«t•s‘SŠ³ŽÒ‚ÌŒŒ´Ž_‰»”\(SOA)‚ÆŒŒ‰t“§Í‚ÌSOA‚ւ̉e‹¿‚ɂ‚¢‚Ä|. ŒF–ì˜a—YC‚–Ø—TC“ü]Œ[i”åjC“ì•”³lC¬ŽR½C‘Š CˆêitƒZƒ“jCŽðˆä‹Ši”åjC’†‘º‘‰qi•ª¶jC–쌳‚¯‚¢Žqi¶‰»Œnj: ‘æ34‰ñ“ú–{“§Í—Ö@Šw‰ï (89.07.09), “Œ‹ž.

1329. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj PTH‚ÆCaƒ|ƒ“ƒv. ’Ë–{—Y‰îi“àj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï (89.11.09), •l¼.

1330. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Management of Staghorn Calculi. ¬ŽÄŒ’i”åj: 7th World Congress on Endourology and ESWL (89.11.30), ‹ž“s.

1331. mŠw‰ïn iˆê”Êu‰‰j FUT(nafamostat mesilate)‚ð—p‚¢‚½–³ƒwƒpƒŠƒ“‰»“§Í‚Ì2Ç—á. –쑺ƒŽqiŽ™j: ‘æ172‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þì’n•û‰ï (88.04.16), ‰¡•l, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 92(8): 149, 1988.

1332. mŠw‰ïn iˆê”Êu‰‰j • ˆ³«”AŽ¸‹Ö‚ɑ΂·‚éStamyŽèp‚ÌŒoŒ±. ìã’B‰›C‰F“s‹{‘ñŽ¡C_è­—TC–å˜e˜abi”åj: ‘æ129‰ñ“ú–{”å”AŠí‰ÈŠw‰ïŒF–{’n•û‰ï (89.00.00), ŒF–{.

1333. mŠw‰ïn iˆê”Êu‰‰j Œ´”­«Ž…‹…‘ÌŽ¾Š³‚̖Ɖuˆâ“`Šw“IŒŸ“¢. ¬—Ñ–LC”äŠé”\”VC•ìºCŠ™“cvŽõC’Ë–{—Y‰îC‘å‹v•Û[lC–Øì“c—²ˆêi“àj: ‘æ86‰ñ“ú–{“à‰ÈŠw‰ï (89.04.02), ‹ž“s, “ú–{“à‰ÈŠw‰ïŽGŽ, 78(2): 287, 1989.

1334. mŠw‰ïn iˆê”Êu‰‰j ƒCƒk’Pƒ—â‹p•Û‘¶t‚̈ÚA¶’…ŠúŠÔ‚ÌANP‚É‚æ‚鉄’·Œø‰Ê. ^è‹`•FiŽÀ“®ŒnjC²“¡´‹MC’·’J쉄Li“àjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: ‘æ66‰ñ“ú–{¶—Šw‰ï (89.04.06), ‰ªŽRC Jpn. J. Physiol., 39(Suppl.): s249, 1989.

1335. mŠw‰ïn iˆê”Êu‰‰j ‰·‘jŒŒ«‹y‚Ñ—â‘jŒŒ«‹}«t•s‘S‚É‚¨‚¯‚銈«Ž_‘f‚ÌŠÖ—^. Šâ‘º³ŽkCŒF–ì˜a—YC‚–Ø—TC‹g“cˆê¬C^‰ºß•vC‰““¡’‰—YCŽðˆä‹ŠC¬ŽÄŒ’i”åjC^è‹`•FiŽÀ“®Œnj: ‘æ77‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (89.04.19), ‘åã.

1336. mŠw‰ïn iˆê”Êu‰‰j RƒÁ-seminoproteinƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì‚É‚æ‚é‘O—§‘B‚̖Ɖu‘gD‰»Šw“IŒŸ“¢i‘æ2•ñj. “¡–ì’WlC‘ºŽR‰ëˆêC¼‘º´ŽuCŒàŠ²ƒC‰¡ŽR‰p“ñC^‰ºß•vC‰““¡’‰—YC΋´WC¬ŽÄŒ’i”åjCŒK”ö’èmi•a—j: ‘æ77‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (89.04.19), ‘åã.

1337. mŠw‰ïn iˆê”Êu‰‰j RƒÁ-seminoprotein‚ÆProstatic specific antigen‚Ì‘ŠŠÖ«‚ɂ‚¢‚Äi‘æ1•ñj. ‘å–x—C“¡–ì’WlC{ŽRˆê•äCŠâ‘º³ŽkCŠ‹¼ŒMC‰¡ŽR‰p“ñC΋´WC¬ŽÄŒ’i”åjC–ؖF˜aCˆÉ“¡Œ[i‰q¶Šw•”j: ‘æ77‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (89.04.20), ‘åã.

1338. mŠw‰ïn iˆê”Êu‰‰j tá±”AŠÇˆÚs•”Œ‹ÎÇ‚ÉŠÖ‚·‚éESWL‚ÌŽ¡—ÃŒoŒ±|pŒã”AŠÇƒXƒeƒ“ƒg—¯’u‚ð’†S‚É|. rìFC‹g‘òˆê•FC‹v•Û¯ˆêCΓc—T‘¥C¬ŽÄŒ’C^‰ºß•vi”åj: ‘æ77‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (89.04.21), ‘åã.

1339. mŠw‰ïn iˆê”Êu‰‰j äNã÷Šà×–E‚ɑ΂·‚éVR¶•¨Ž¿Kazusamycin A‚Ì‘B—}§Œø‰Ê. ‘ò‘º³”VC¬“c“‡–M’ji”åjC’·‘q˜a•FC‰Æ“c˜a•vC’†‘ºGi–h‰qˆã‘åj: ‘æ77‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (89.04.21), ‘åã.

1340. mŠw‰ïn iˆê”Êu‰‰j Œo”A“¹“I’´‰¹”g’f‘w–@‚É‚æ‚éäNã÷Žîá‡[’B“x‚Ìf’f. “ü]Œ[C’†žŠO—²Cìã’B‰›C¬—ÑŒ’ˆêC–{“c’¼NC‰¡“c^“ñC“à“c–LºC‰¡ŽR‰p“ñC΋´WC¬ŽÄŒ’i”åj: ‘æ77‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (89.04.21), ‘åã.

1341. mŠw‰ïn iˆê”Êu‰‰j Allelic Deletion in Transitional Cell Carcinoma of the Bladder (TCCB). Harry NaurithCBradiay FrasiorC“à“c–Lºi”åjCJohn White: AUA Eighty Fourth Annual Meeting (89.05.07`11), ƒ_ƒ‰ƒX.

1342. mŠw‰ïn iˆê”Êu‰‰j ‚ƒJƒŠƒEƒ€ŒŒÇ‚Æ‘ãŽÓ«ƒAƒVƒh|ƒVƒX‚ð‚«‚½‚µ‚½3Ç—á‚ÌŒŸ“¢. –kžŠ‚Ý‚Ç‚èC”Ñ‚Šì‹v—YCˆÉ“¡–¯ŒbCΊٕ•vC“n•Ó“oC›šà†‹ÊiŽ™jCŽðˆä‹Ši”åj: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.19), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(3): 587, 1989.

1343. mŠw‰ïn iˆê”Êu‰‰j ƒƒTƒ“ƒMƒEƒ€‘B«t‰Š‚Ì—Õ°Œo‰ß‚ÆŽ¡—Ã|¬l‚ɃLƒƒƒŠ|ƒI|ƒo|‚µ‚½Ç—á‚ÌŒŸ“¢|. ‰Í¼‹IºC–kžŠ‚Ý‚Ç‚èC”Ñ‚Šì‹v—YCƒŒƒCƒ‚ƒ“ƒh¥ƒtƒ‰ƒ“ƒVƒAiŽ™jCŽðˆä‹Ši”åj: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (89.05.19), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(3): 647, 1989.

1344. mŠw‰ïn iˆê”Êu‰‰j ‹ßˆÊ”A׊Ǒ¤’ê×–E–Œ‚É‚¨‚¯‚éCa2+/H+ pump‚Ì’²ß‹@˜. ’Ë–{—Y‰îi“àj: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ï (89.06.01), “Œ‹ž, “ú–{“à•ª”åŠw‰ïŠwp‘‰ï´˜^W, 65(4): 259, 1989.

1345. mŠw‰ïn iˆê”Êu‰‰j tˆÚA‚É‚¨‚¯‚ét•Û‘¶‚É‹y‚Ú‚·ANP‚ÌŒø‰Ê. ˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC^è‹`•FiŽÀ“®ŒnjC²“¡´‹MC’·’J쉄Li“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ï (89.06.02), “Œ‹žC “ú–{“à•ª”åŠw‰ïŠwpW‰ï´˜^W, 65(4): 353, 1989.

1346. mŠw‰ïn iˆê”Êu‰‰j ƒƒTƒ“ƒMƒEƒ€‘B«•Ï‰»‚ð‚Æ‚à‚È‚Á‚½‘ƒóŽ…‹…‘Ìd‰»Ç‚Ì1—á. ¬‹v•Û“§CŽá—Ñ–õ‹vC”äŠé”\”VC¬—Ñ–Li“àj: ‘æ19‰ñ“ú–{t‘Ÿ•aŠw‰ï“Œ•”•”‰ï (89.06.09), “Œ‹ž.

1347. mŠw‰ïn iˆê”Êu‰‰j ‚”N—î”­Ç‚Ì‹}«Ž…‹…‘Ìt‰Š‚Ì4—á. •ìºCãŽRŽO‘ãŽqC“c‘º_ŽOCŠÔ’†‹v”üC‘ˆäL—mC²“¡’¼”VCŠ™“cvŽõC¬—Ñ–Li“àj: ‘æ19‰ñ“ú–{t‘Ÿ•aŠw‰ï“Œ•”•”‰ï (89.06.09), “Œ‹ž.

1348. mŠw‰ïn iˆê”Êu‰‰j ”DP’†Šú‚É“ž‚è‚Í‚¶‚ß‚Ä”DP‚É‹C•t‚­‚Æ‹¤‚É“§Í“±“ü‚³‚êA•p‰ñ‚ÌŒŒ‰t“§Í(HD)‹y‚ÑŒŒ‰tàh‰ß“§Í(HDF)‚Ì‹–‚Å‹“Ž™‚µ“¾‚½‘½”­«”X–Et(PCK)‚É‚æ ‚é–«t•s‘S(CRF)‚Ì1—á. •ìºCãŽRŽO‘ãŽqC“c‘º_ŽOCŠ™“cvŽõC–xˆäºC‘å‹v•Û[lC–Øì“c—²ˆêC‹g“càˆC“‡“c”£i“àj: ‘æ19‰ñ“ú–{t‘Ÿ•aŠw‰ï“Œ•”•”‰ï (89.06.09), “Œ‹ž.

1349. mŠw‰ïn iˆê”Êu‰‰j S󌋒°Šà‚ð‡•¹‚µ‚½‘ƒóŽ…‹…‘Ìd‰»Ç(FGS)‚Ì1—á. Š™“cvŽõC’Å–¼³_CŽR“c³•vC•ìºCãŽRŽO‘ãŽqC¬—Ñ–Li“àj: ‘æ19‰ñ“ú–{t‘Ÿ•aŠw‰ï“Œ•”•”‰ï (89.06.09), “Œ‹ž.

1350. mŠw‰ïn iˆê”Êu‰‰j ƒAƒ~ƒƒCƒhtÇ‚É‹}«Ž…‹…‘Ìt‰Š‚𕹔­‚µ‚½1—á. ãŽRŽO‘ãŽqCŠÔ’†‹v”üC•ìºCŠ™“cvŽõC¬—Ñ–LC”äŠé”\”Vi“àj: ‘æ19‰ñ“ú–{t‘Ÿ•aŠw‰ï“Œ•”•”‰ï (89.06.09), “Œ‹ž.

1351. mŠw‰ïn iˆê”Êu‰‰j IgAtÇŒo‰ß’†‚É‹}«Ž…‹…‘Ìt‰Š‚ð‡•¹‚µ‚½1Ç—á. ”äŠé”\”VC“c‘º_ŽOC•ìºCãŽRŽO‘ãŽqCã‘C¬—Ñ–Li“àj: ‘æ19‰ñ“ú–{t‘Ÿ•aŠw‰ï“Œ•”•”‰ï (89.06.09), “Œ‹ž.

1352. mŠw‰ïn iˆê”Êu‰‰j Ž…‹…‘Ì‚Ì”¼ŒŽ‘ÌŒ`¬‚È‚ç‚Ñ‚ÉC3’¾’…‚ð”F‚ß‚½ŠÔŽ¿«t‰Š‚É‚æ‚é‹}«t•s‘S‚Ì1—á. ‘åι–çC“L–ØGC•½Î‘C–kžŠ‚Ý‚Ç‚èC”Ñ‚Šì‹v—YC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: ‘æ19‰ñ“ú–{t‘ŸŠw‰ï“Œ•”•”‰ï (89.06.10), “Œ‹ž.

1353. mŠw‰ïn iˆê”Êu‰‰j Subclinical‚ÉSjogrenÇŒóŒQ‚̇•¹‚ð‹^‚킹‚½Lupust‰Š‚Ì1¬Ž™—á. –kžŠ‚Ý‚Ç‚èC”Ñ‚Šì‹v—YC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: ‘æ19‰ñ“ú–{t‘ŸŠw‰ï“Œ•”•”‰ï (89.06.10), “Œ‹žC —\eWCp.122, 1989.

1354. mŠw‰ïn iˆê”Êu‰‰j —Õ°“I‚ÉŠÔŽ¿áŠQ‚ð‚«‚½‚µ‚½Ž‡”Á•a«t‰Š2—á‚Ì—Õ°•a—Šw“IŒŸ“¢. ˆäŒ…^—R”üC¬àV”ü˜aC‰©‹àˆä‚³‚‚«CŠÖª“OC^“º‘¾˜YC”~Œ´ŽÀC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™j: ‘æ179‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þì’n•û‰ï (89.06.17), ‰¡•l.

1355. mŠw‰ïn iˆê”Êu‰‰j äNã÷‚ð‰·‘¶‚µ“¾‚½‹‘åäNã÷ŽîᇂÌ1—á. ‰¡“c^“ñCŠâ‘º³ŽkC“ü]Œ[C‘ˆä‘¥ºC–{“c’¼NC‰¡ŽR‰p“ñC΋´WC¬ŽÄŒ’i”åj: ‘æ32‰ñ_“Þì”å”AŠí‰Èˆã‰ï (89.06.19), ˆÉ¨Œ´.

1356. mŠw‰ïn iˆê”Êu‰‰j t•s‘Sƒ‚ƒfƒ‹‚ɑ΂·‚éŒoŒû‹z’…ÜAST-120‚̉e‹¿‚ÉŠÖ‚·‚錤‹†. ‹g“c‹`Ki϶‰ï‰¡•lŽs“ì•”•a‰@jAŽðˆä‹Ši”åj: ‘æ24‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ï (89.06.29), –¼ŒÃ‰®.

1357. mŠw‰ïn iˆê”Êu‰‰j Å‹ß5”NŠÔ‚É”­Ç‚µ‚½¬Ž™SLE13—á‚Ì”­Œ©“®‹@‚©‚ç‚Ý‚½—Õ°•a—Šw“IŒŸ“¢. –kžŠ‚Ý‚Ç‚èC‰Í¼‹IºC”Ñ‚Šì‹v—YiŽ™jCŽðˆä‹Ši”åj: ‘æ24‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ï (89.06.29), –¼ŒÃ‰®, “ú–{¬Ž™t‘Ÿ•aŠw‰ïŽGŽC2(2): 147, 1989.

1358. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™tŽ¾Š³‚É‚¨‚¯‚é–Ɖu—}»Ü‘½Ü­—Ê•¹—p—Ö@. ‰Í¼‹IºC–kžŠ‚Ý‚Ç‚èCŠ—Œ´FC…–ì—@iŽ™jCŽðˆä‹Ši”åj: ‘æ24‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ï (89.07.01), –¼ŒÃ‰®C —\eW, p.235, l989.

1359. mŠw‰ïn iˆê”Êu‰‰j ŒŒ‰t“§ÍŠ³ŽÒ‚ɑ΂·‚é1,25(OH)2D3ƒpƒ‹ƒX—Ö@‚ÌPTH•ª”å—}§Œø‰Ê‚Ì‹@˜‚ÉŠÖ‚·‚錟“¢. ’Ë–{—Y‰îC–쑺K”Íi“àjC•xŠ~˜a”üi–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: ‘æ7‰ñ“ú–{œ‘ãŽÓŠw‰ï (89.07.08`09), “Œ‹ž.

1360. mŠw‰ïn iˆê”Êu‰‰j 1ƒ¿(OH)D3/CaCO3ŒðŒÝ“Š—^–@‚É‚æ‚ét«œˆÙ‰h—{Ç‚ÌŽ¡—Ã. ’Ë–{—Y‰îC–쑺K”ÍCã‘C‘å‹v•Û[li“àj: ‘æ34‰ñ“ú–{“§Í—Ö@Šw‰ï (89.07.10), “Œ‹ž.

1361. mŠw‰ïn iˆê”Êu‰‰j “§ÍŠ³ŽÒ‚É‚¨‚¯‚é’YŽ_ƒJƒ‹ƒVƒEƒ€(CaCO3)“Š—^‚ªŒ´ˆö‚ÆŽv‚í‚ꂽ“§ÍŠ³ŽÒ‚ÌtŒ‹ÎÇ—á. ã‘C‹g“càˆC–쑺K”ÍC‰i‰ª—²C’Ë–{—Y‰îC‘å‹v•Û[lC–Øì“c—²ˆêi“àj: ‘æ34‰ñ“ú–{“§Í—Ö@Šw‰ï (89.07.10), “Œ‹ž.

1362. mŠw‰ïn iˆê”Êu‰‰j ƒGƒŠƒXƒƒ|ƒGƒ`ƒ“(EPO)“Š—^‚É‚æ‚èAS¥zŠÂŠíŒn‡•¹Ç‚Ì’˜–¾‚ȉü‘P‚ª‚¦‚ç‚ꂽˆÛŽ“§ÍÇ—á. ‹g“càˆC•ìºCãŽRŽO‘ãŽqCŠ™“cvŽõC‘å‹v•Û[lC–Øì“c—²ˆêi“àj: ‘æ34‰ñ“ú–{“§Í—Ö@Šw‰ï (89.07.10), “Œ‹ž.

1363. mŠw‰ïn iˆê”Êu‰‰j CAPDŠ³ŽÒ‚Ì––½_Œo“`’B‘¬“x‚ɂ‚¢‚Ä. ‚–Ø—TCŒF–ì˜a—YCŽðˆä‹ŠC‚‹´—Tˆê˜Yi”åj: ‘æ34‰ñ“ú–{“§Í—Ö@Šw‰ï (89.07.10), “Œ‹ž.

1364. mŠw‰ïn iˆê”Êu‰‰j t”X–E‚𔺂Á‚½‹¹•”t‚Ì1—á. Žu‘º“NC‹g“cˆê¬C–å˜e˜abC¬—ÑŒ’ˆêC΋´Wi”åj: ‘æ464‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï (89.07.13), “Œ‹ž, “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 81(1): 144, 1990.

1365. mŠw‰ïn iˆê”Êu‰‰j Early Detection of Renal Disease by Urinary NAG Index. Igarashi SumikoCKaneko HarujiCYagisawa KatsumiCNagasaka YasuhiroCTaguchi HirokazuCFujiwara YoshitoiŒ§—\–h‹¦‰ïC‰¡•lŽs‘åjCΊٕ•viŽ™jCŽðˆä‹Ši”åj: 8th Congress of the International Pediatric Nephrology Association (89.08.27), Toronto, ´˜^†, 2020, 1989.

1366. mŠw‰ïn iˆê”Êu‰‰j Two Cases of Congenital Nephrotic Syndrome in 2 Days of Life. ”Ñ‚Šì‹v’jC–kžŠ‚Ý‚Ç‚èCˆÉ“¡–¯ŒbiŽ™jCŽðˆä‹Ši”åj: 8th Congress of the International Pediatric Nephrology Association (89.08.28), Toronto.

1367. mŠw‰ïn iˆê”Êu‰‰j Oral Adsorbent (AST-120) Reduces Mesangial Trappment of Macromolecules, Glomerular Hypertrophy and Improves Renal Morphology in the Rat Model of Subtotal Nephrectomy. Yoshida, Y.i ϶‰ï‰¡•lŽs“ì•”•a‰@jCŽðˆä‹Ši”åjCŒK”ö’èmi•a—j: ‘æ8‰ñ‘Û¬Ž™t‘Ÿ•aŠw‰ï (89.08.28), ƒgƒƒ“ƒg.

1368. mŠw‰ïn iˆê”Êu‰‰j Antiplatelet Agents and Fresh Frozen Plasma in Hemolytic Uremic Syndrome(HUS)-Serum Creatinine Elevation Rate Per Hour as an Indicator. –kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™j: 8th Congress of the International Pediatric Nephrology Association (89.08.28), Toronto, Pediatric Nephrology, 3(4): c185, 1989.

1369. mŠw‰ïn iˆê”Êu‰‰j Clinico-Histopathological Correlation in 50 Cases of Henoch-Schoenlein Purpura Nephritis. ‰Í¼‹IºC–kžŠ‚Ý‚Ç‚èiŽ™j: 8th Congress of the International Pediatric Nephrology Association (89.08.28), Toronto, —\eWC9-084, 1989.

1370. mŠw‰ïn iˆê”Êu‰‰j Effect of Oral-adsorbent (AST-120) in Uremic Rats: A Break in the Vicious Cycle. Žðˆä‹Ši”åjCŒK”ö’èmi•a—jCYoshida, Y.i ϶‰ï‰¡•lŽs“ì•”•a‰@j: ‘æ8‰ñ‘Û¬Ž™t‘Ÿ•aŠw‰ï (89.08.31), ƒgƒƒ“ƒg.

1371. mŠw‰ïn iˆê”Êu‰‰j Proteinuria Starts from Deep Nephrons in Experimental Model of Focal Glomerulosclerosis. Ίٕ•viŽ™j: 8th Congress of the International Pediatric Nephrology Association (89.08.31), Toronto, ´˜^†C9045.@l989.

1372. mŠw‰ïn iˆê”Êu‰‰j Castleman•a‚É‚æ‚è‹}«t•s‘S‚ð’悵ƒXƒeƒƒCƒh—Ö@‚ðŽ{s‚µ‚½1—á. ‰Ô“cL‰pC–쑺K”ÍC’Ë–{—Y‰îCŠÚ–샶C”äŠé”\”VC•ìºC“¡–ì—R”üC¬—Ñ–LC–Øì“c—²ˆêi“àjCŠ}ˆäŒ‰C‰œ•½‰ë•Fi•a—j: ‘æ385‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.09.09), “Œ‹ž.

1373. mŠw‰ïn iˆê”Êu‰‰j ƒ‹[ƒvƒXƒ‚ƒfƒ‹ƒ}ƒEƒX‚É‚¨‚¯‚é15-deoxyspergualin (DSP)‚Ìì—p‹@˜‚ÉŠÖ‚·‚錟“¢. ‘å‹v•Û[lCŠ™“cvŽõi“àjC^è‹`•FiŽÀ“®ŒnjC“àŽR’|•F: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (89.09.11), “Œ‹ž.

1374. mŠw‰ïn iˆê”Êu‰‰j tˆÚAŒãŽ€–S—á‚É‚¨‚¯‚鎀–S—vˆö‚ÌŒŸ“¢. “c‘º_ŽOCŽá—Ñ–õ‹vC’Ë–{—Y‰îCŠ™“cvŽõC‘å‹v•Û[lC–Øì“c—²ˆêi“àjC’†ŽR‹`‰îCŒY•”P’jC‰¡“c˜a•FC²“¡ŒõŽjiŠOjCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰ —YCŽðˆä‹Ši”åj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (89.09.11), “Œ‹ž, ˆÚA, 24(—Õ): 187, 1989.

1375. mŠw‰ïn iˆê”Êu‰‰j tˆÚA‚É‚¨‚¯‚é”A’†ƒCƒ“ƒ^[ƒƒCƒLƒ“2”Z“x‚Ì‘ª’èˆÓ‹`‚ɂ‚¢‚Ä. “ü]Œ[CŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—YCŽðˆä‹ŠC¬ŽÄŒ’i”åjC‘å‹v•Û[li“àj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (89.09.11), “Œ‹ž, ˆÚA, 24: 179, 1989.

1376. mŠw‰ïn iˆê”Êu‰‰j ‰·‘jŒŒt‚Ì’Pƒ•\–Ê—â‹p•Û‘¶‚ÉŠÖ‚·‚錤‹†. ŒF–ì˜a—YC‰““¡’‰—YCŽðˆä‹ŠC¬ŽÄŒ’i”åj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (89.09.11), “Œ‹ž, ˆÚA, 24: 223, 1989.

1377. mŠw‰ïn iˆê”Êu‰‰j tˆÚA‚ª“§ÍƒAƒ~ƒƒCƒh[ƒVƒX‚É‹y‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä. ŒF–ì˜a—YC“ü]Œ[C^‰ºß•vC‰““¡’‰—YCŽðˆä‹ŠC¬ŽÄŒ’i”åjC‰¡“c˜a•FiŠOjC‘å‹v•Û[li“àj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (89.09.12), “Œ‹ž, ˆÚA, 24: 234, 1989.

1378. mŠw‰ïn iˆê”Êu‰‰j High Flux Membrane‚ð—p‚¢‚½ŒŒ‰tàh‰ß“§Í‚É‚¨‚¯‚é’ᕪŽq—Ê’`”’œ‹Ž”\‚ÌŒoŽž“I•Ï‰». ¬ŽR½itƒZƒ“ƒ^[jCŒF–ì˜a—Yi”åjC“ì•”³lC‘Š CˆêitƒZƒ“ƒ^[jCŽðˆä‹Ši”åj: ‘æ27‰ñ“ú–{lH‘ŸŠíŠw‰ï‘å‰ï (89.09.29), ˆ®ì.

1379. mŠw‰ïn iˆê”Êu‰‰j Thromboxane-A2-Induced Calcium Mobilization and Phosphoinositide Turnover in Cultured Rat Aorta Vascular Smooth Muscle Cells. ‰¡“c^“ñCŒF–ì˜a—YCŽðˆä‹Ši”åjCElwood E. Reynolds (Cleveland Clinic Foundation): ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï (89.09.30), ‘Š–ÍŒ´, –k—¢ˆãŠw, 19(6): 643, 1989.

1380. mŠw‰ïn iˆê”Êu‰‰j t”í–Œ‰ºt“Eop:‹‘┽‰ž‚ð‹N‚±‚µ‚½ˆÚAt‚Ì“Eo. ‰““¡’‰—YCŒF–ì˜a—YC“ü]Œ[C‹g“cˆê¬C‰¡“c^“ñC^‰ºß•vC¬ŽÄŒ’i”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06), “Œ‹ž.

1381. mŠw‰ïn iˆê”Êu‰‰j ‰Šúf’f‚ª¢“ï‚Å‚ ‚Á‚½¸‘ƒŽîᇂ̌Ÿ“¢. ¬“c“‡–M’jC‘ò‘º³”VCó–ì—F•FC’·‘q˜a•FC’†‘ºGi”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06), “Œ‹ž, —\eW, p.222, 1989.

1382. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™‚É‚¨‚¯‚éI-123 Hippuran‚ð—p‚¢‚½tŒŒ—¬—Ê‘ª’è‚ɂ‚¢‚Ä. “c‘ºˆè•vi“s—§–L“‡•a‰@jC‘¼CΈ䟌Èi•új: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (89.10.21), ‘å’Ã, ŠjˆãŠw, 26(8): 1087, 1989.

1383. mŠw‰ïn iˆê”Êu‰‰j p’†‚wüŽB‰e‚É‚¨‚¯‚éƒCƒ“ƒXƒ^ƒ“ƒgƒtƒBƒ‹ƒ€‚̉ž—p. ¬“c“‡–M’jC‘ò‘º³”VC’†‘ºGi”åj: ‘æ39‰ñ“ú–{”å”AŠí‰ÈŠw‰ï’†•”‘‰ï (89.11.04`05), •xŽR.

1384. mŠw‰ïn iˆê”Êu‰‰j Œy“x’`”’”AIgAtÇ‚Ì—Õ°Œo‰ß. ¬—Ñ–LC”äŠé”\”VC•ìºCŠÚ–샶i“àj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï (89.11.09), •l¼.

1385. mŠw‰ïn iˆê”Êu‰‰j IgAtÇ‚É‚¨‚¯‚éIgARƒqƒgIgAR‘Ì‚Ì‘¶Ý. ”äŠé”\”VC¬—Ñ–Li“àj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï (89.11.09), •l¼.

1386. mŠw‰ïn iˆê”Êu‰‰j ’·ŠúCAPDŠ³ŽÒ‚É‚¨‚¯‚é• –Œ‹@”\‚ÌŒoŽž•Ï‰». ‚–Ø—TCŒF–ì˜a—YCŽðˆä‹Ši”åj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï‘‰ï (89.11.09), •l¼.

1387. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒgt•s‘Sƒ‚ƒfƒ‹‚ɑ΂·‚éŒoŒû‹z’…ÜAST-120‚̉e‹¿‚ÉŠÖ‚·‚錟“¢. Žðˆä‹ŠCŒF–ì˜a—Yi”åjCV‘º•¶’jiŽ™jCŒK”ö’èmi•a—jC‹g“c‹`Ki϶‰ï‰¡•lŽs“ì•”•a‰@j: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï‘‰ï (89.11.09), •l¼.

1388. mŠw‰ïn iˆê”Êu‰‰j ƒAƒ“ƒWƒIƒeƒ“ƒVƒ“ŒðŠ·y‘f‘jŠQÜ(ACE1)‚Ì–«t•s‘S(CRF)is‘jŽ~‚Ö‚ÌŒø‰Ê. ŒF–ì˜a—YC“ü]Œ[C‰¡“c^“ñCŽðˆä‹Ši”åj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï‘‰ï (89.11.09), •l¼, —\eW, p.173, 1989.

1389. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™IgAtÇ‚Ì—Õ°•a—Šw“IŒŸ“¢. –kžŠ‚Ý‚Ç‚èCV‘º•¶’jC”Ñ‚Šì‹v—YC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: ‘æ32‰ñ“ú–{t‘Ÿ•aŠw‰ï‘‰ï (89.11.09), •l¼, —\eWCp.129, 1989.

1390. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™tˆÚAŠ³ŽÒ‚É‚¨‚¯‚éNa, K”rŸ•‚ÌŒŸ“¢. V‘º•¶’jiŽ™jCŒF–ì˜a—Yi”åjC–kžŠ‚Ý‚Ç‚èC”Ñ‚Šì‹v—YC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: ‘æ32‰ñ“ú–{t‘Ÿ•aŠw‰ï‘‰ï (89.11.09), •l¼, —\eWCp.171, 1989.

1391. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒgt•s‘Sƒ‚ƒfƒ‹‚ɑ΂·‚éŒoŒû‹z’…ÜAST-120‚̉e‹¿‚ÉŠÖ‚·‚錟“¢. V‘º•¶’jiŽ™jCŒF–ì˜a—YCŽðˆä‹Ši”åjCŒK”ö’èmi•a—jC‹g“c‹`Ki϶‰ï‰¡•lŽs“ì•”•a‰@jCˆÉ¨“¹mC›–ìŽOŠì’jC㌴N•viŒà‰H‰»Šwj: ‘æ32‰ñ“ú–{t‘Ÿ•aŠw‰ï‘‰ï (89.11.09), •l¼, —\eWCp.173, 1989.

1392. mŠw‰ïn iˆê”Êu‰‰j ‚·‚Å‚É”­Ç‚µ‚½ŽÀŒ±ƒ‹[ƒvƒXtǂɑ΂·‚é15-deoxyspergualin (DSP)‚ÌŽ¡—ÃŒø‰Êi‡Uj‘gDŠw“IŠm”F. Š™“cvŽõCˆäãŒcˆêC‘å‹v•Û[li“àjC^è‹`•FiŽÀ“®Œnj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï (89.11.10), •l¼.

1393. mŠw‰ïn iˆê”Êu‰‰j SLEtÇ‚É‚æ‚铧ÍÇ—á‚Ì—Õ°“I“Á’¥‚Æt•s‘S”­Çi“W—vˆö‚ÌŒŸ“¢. “c‘º_ŽOi“àj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï (89.11.10), •l¼.

1394. mŠw‰ïn iˆê”Êu‰‰j 15-deoxyspergualin (DSP)‚É‚æ‚éNew Zealandƒ}ƒEƒXiB/Wƒ}ƒEƒXjtÇ‚ÌŽ¡—ÃG‘æ2•ñ.@Œø‰Ê‚Ì—e—ʈˑ¶«‚ÉŠÖ‚·‚錟“¢. ‘å‹v•Û[lC‰J‹{Œ«ˆêCŠ™“cvŽõi“àjC^è‹`•FiŽÀ“®Œnj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï (89.11.10), •l¼.

1395. mŠw‰ïn iˆê”Êu‰‰j ’j«ƒ‹[ƒvƒXt‰Š‚Ì—Õ°•a—Šw“IŒ¤‹†. ŠÚ–샶C¬—Ñ–LC”äŠé”\”Vi“àjC“y“cOŠîC•lŒû‹Óˆêi‘—§²‘q•a‰@j: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï (89.11.10), •l¼.

1396. mŠw‰ïn iˆê”Êu‰‰j ‘ƒóŽ…‹…‘Ìd‰»Ç‚ɑ΂·‚éƒXƒeƒƒCƒh”½‰ž«‚ɂ‚¢‚Ä. •ìºC”äŠé”\”VCŠ™“cvŽõCŠÚ–샶C¬—Ñ–Li“àj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï (89.11.11), •l¼.

1397. mŠw‰ïn iˆê”Êu‰‰j Changes in Serum Albumin in Renal Transplant Recipients. ŒF–ì˜a—YC“ü]Œ[C^‰ºß•vC‰““¡’‰—Yi”åjCEra, S.CSogami, M.iŠò•Œ‘åj: The lst Congress of the Asian Transplantation Scciety (89.11.23), ƒCƒ“ƒhƒlƒVƒAEƒoƒŠ“‡.

1398. mŠw‰ïn iˆê”Êu‰‰j Kidney Transplantation, Nephrotic Syndrome with Minimal Histologic Change in Focal Segmental Glomerulosclerosis: Clinical Recurrence? Žðˆä‹ŠCŒF–ì˜a—Yi”åjC‰Í¼‹IºC”Ñ‚Šì‹v—YiŽ™jCLee, J.D.C‰““¡’‰—Yi”åjCŒK”ö’èmi•a—j: The lst Congress of the Asian Transplantation Scciety (89.11.24), ƒCƒ“ƒhƒlƒVƒAEƒoƒŠ“‡.

1399. mŠw‰ïn iˆê”Êu‰‰j Extracorporeal Shockwave Lithotripsy of Ureteropelvic Junction Stones. ^‰ºß•vCrìFC‹v•Û¯ˆêC¬ŽÄŒ’i”åj: 7th World Congress on Endourology and ESWL (89.11.28), ‹ž“s.

1400. mŠw‰ïn iˆê”Êu‰‰j –k—¢‘åŠw‚É‚¨‚¯‚étˆÚA‚ÌŒ»‹µi‡]‡Xj. “n•”_“ñC”–Ø“oiˆÚA–Ɖuj: ‘æ808‰ñç—tˆãŠw‰ï—á‰ïC‘æ5‰ñ‘æ2ŠO‰È—á‰ï (89.12.00), ç—t.

1401. mŠw‰ïn iˆê”Êu‰‰j Heterogeneity of Calcium Pump Activity in Proximal and Distal Tubules of Rat Kidney. ’Ë–{—Y‰îCã‘i“àj, Saitoh, M.CSugimura, K.: 22nd Ann. Meet. Am. Soc. Nephrol. (89.12.03`06), Washington, D.C.

1402. mŠw‰ïn iˆê”Êu‰‰j Arrest in Progression of Advanced Glomerular Disease in New Zealand Mice (B/W Mice) by 15-deoxyspergualin (DSP). ˆäãŒcˆêC‘å‹v•Û[lCŠ™“cvŽõCŽá—Ñ–õ‹vi“àj: 22nd Ann. Meet. Am. Soc. Nephrol. (89.12.03`06), Washington, D.C., Kidney Int., 37(1): 417, 1990.

1403. mŠw‰ïn iˆê”Êu‰‰j Treatment of Heymann Nephritis (HN) by Bactobolin (BN). Š™“cvŽõC’|“àN—YC“à“c–ž”üŽqC²“¡’¼”VC•ìºC¬—Ñ–LC‘å‹v•Û[li“àj: 22nd Ann. Meet. Am. Soc. Nephrol. (89.12.03`06), Washington, D.C., Kidney Int., 37(1): 418, 1990.

1404. mŠw‰ïn iˆê”Êu‰‰j Oxidative Stress in Maintenance Dialysis Patients. ŒF–ì˜a—Yi”åjC’†‘º‘‰qi•ª¶jC‘Š CˆêC“ì•”³litƒZƒ“jCŽðˆä‹Ši”åj: 22nd the American Society of Nephrology (89.12.04), ƒƒVƒ“ƒgƒ“.

1405. mŠw‰ïn iˆê”Êu‰‰j Vo2 max‘ª’莞‚É‚¨‚¯‚é”A’†“d‰ðŽ¿‚ÌŒŸ“¢. V‘º•¶’jC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºC–åˆäL‹ÅC–¥‰YŽ‘¥C“n•Ó“oC’†“ˆ‰p•FiŽ™j: “ú–{‘̗͈ãŠw‰ïŠÖ“Œ’n•û‰ï (89.12.09), “Œ‹ž.

1406. mŠw‰ïn iˆê”Êu‰‰j ‘ÌŠOÕŒ‚”gŒ‹Î”jÓ‘•’u(Therasonics)Žg—p‚É‚æ‚éã•””A˜HŒ‹ÎŽ¡—ÃŒoŒ±. •ìƒCò”ŽˆêC¬ŽÄŒ’C^‰ºß•vCŠÑˆä•¶•FC‰ª–{dâXi”åj: ‘æ27‰ñé‹ÊŒ§ˆãŠw‰ï‘‰ï (90.01.21), é‹Ê.

1407. mŠw‰ïn iˆê”Êu‰‰j Once-A-Week Self Administered Subcutaneous (sc) Erythropoietin (EPO): The Optimal Route of EPO for CAPD Patients. ‰¡“c^“ñCŒF–ì˜a—YC“ü]Œ[CŽðˆä‹Ši”åj: 10th Annual Conference on: Peritoneal Dialysis (90.02.08), Dallas.

1408. mŠw‰ïn iˆê”Êu‰‰j Oxidative Stress in Patients with CAPD. ŒF–ì˜a—YC‰¡“c^“ñi”åjC’†‘º‘‰qi•ª¶jC“ü]Œ[CŽðˆä‹Ši”åj: 10th Annual Conference on: Peritoneal Dialysis (90.02.08), Dallas.

1409. mŠw‰ïn iˆê”Êu‰‰j Once-a-Week Self Administrated Subcutaneous Erythropoietin: The Optimal Route of EPO for CAPD Patients. ‰¡“c^“ñC“ü]Œ[CŒF–ì˜a—YCŽðˆä‹Ši”åj: 10th Annual Conference on : Peritoneal Dialysis (90.02.08`10), Texas.

1410. mŠw‰ïn iˆê”Êu‰‰j ŒŒŸ÷ŒðŠ·—Ö@‚ƃpƒ‹ƒX—Ö@‚É‚æ‚è‰ü‘P‚ª‚Ý‚ç‚ꂽRŽ…‹…‘ÌŠî’ê–ŒR‘Ì‚É‚æ‚é‹}‘¬is«Ž…‹…‘Ìt‰Š‚Ì1—á. ‰J‹{Œ«ˆêC’Ë–{—Y‰îC”äŠé”\”VCŠÚ–샶C¬—Ñ–LC–Øì“c—²ˆêi“àj: ‘æ389‰ñ“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (90.02.10), “Œ‹ž.

1411. mŠw‰ïn iˆê”Êu‰‰j ”A“¹ˆÙ•¨‚Ì1—á. {ŽRo•äC“à“c–LºCŒàŠ²ƒC“ü]Œ[CŒÃ”¨½”VC‘å–x—C^‰ºß•vC‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ1‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï (90.02.17), ‰¡•l.

1412. mŠw‰ïn iˆê”Êu‰‰j Œã• –ŒŽ‰–bŽî‚Ì1—á. Œ´–ì—TŽiC¯Ži´Žui”åjC¼èÍ“ñiŽ©‰q‘à‰¡{‰ê•a‰@j: ‘æ1‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï (90.02.17), ‰¡•l.

1413. mŠw‰ïn iˆê”Êu‰‰j ƒ~ƒ…[ƒ‰[ŠÇ”X–E‚Ì1—á|Œo’¼’°“I’´‰¹”g’f‘w‘œ(TRUS), CT, MRIŠe‰æ‘œ‚̑Δ䌟“¢. {ŽRo•äCŒüˆäLÆCŒàŠ²ƒC“¡–ì’WlC΋´Wi”åj: ‘æ9‰ñ“ú–{‰æ‘œˆãŠw‰ï (90.02.26), “Œ‹ž.

1414. mŠw‰ïn iˆê”Êu‰‰j t«ã”笑̋@”\˜´iÇ‚É‚¨‚¯‚éCa•‰‰×ŽŽŒ±Ap‘O¶‰»ŠwŒŸ¸’l‚Æ“Eoã”笑Ìd—Ê‚Æ‚Ì‘ŠŒÝŠÖŒW. “à“c‹v‘¥C¼‘º—mŽ¡CHŽRŽµç’jC™–{‹v”VC‰¡“c˜a•FCŒY•”“ŒŽ¡iŠOjCŠ™“cvŽõC‘å‹v•Û[li“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjC‹T’J“Oi•a—j: ‘æ1‰ñ“ú–{“à•ª”åŠO‰ÈŠw‰ï i89.00.00), “Œ‹ž.

1415. mŠw‰ïn iˆê”Êu‰‰j tˆÚA—Õ°‚É‚¨‚¯‚éciclosporine, mizoribine, steroid, ALG 4܇•¹“Š—^–@. ŒY•”P’jCŒY•”“ŒŽ¡C‰¡“c˜a•FC‘듇í‰ëC’†ŽR‹`‰îC²“¡ŒõŽjiŠOjCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—Yi”åjCŠ™“cvŽõC‘å‹v•Û[li“àjC“n•”_“ñC”–Ø “oi‘ŸˆÚjC“à“c‹v‘¥i“Œ‘åj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i89.09.11), “Œ‹ž, ˆÚA, 24(—Õ‘): 149, 1989.

1416. mŠw‰ïn iˆê”Êu‰‰j tˆÚAŠ³ŽÒŠJ• ŽèpÇ—á‚Ì—Õ°“IŒŸ“¢. ‰¡“c˜a•FC’†ŽR‹`‰îCŒY•”P’jC²“¡ŒõŽjC¡ˆäŒ‰C‘듇í‰ëiŠOjCŠ™“cvŽõC‘å‹v•Û[li“àjCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—Yi”åjC“n•”_“ñi‘Ÿ ˆÚjC“à“c‹v‘¥i“Œ‘åj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i89.09.12), “Œ‹ž, ˆÚA, 24(—Õ‘): 302, 1989.

1417. mŠw‰ïn iˆê”Êu‰‰j Advantages of Mizoribine over Azathioprine in Combination Therapy with Cyclosporine for Renal Transplantation. Mita, K.CŒY•”P’jC’†ŽR‹`‰îC‰¡“c˜a•FC²“¡ŒõŽjC“à“c‹v‘¥iŠOj: ‡W Congress of the European Society for Organ Transplantation i89.11.1`4), Barcelona, Spain, Abstract, p.198, 1989.

1418. mŠw‰ïn iˆê”Êu‰‰j Preservation of Canine Kidneys with Simple Surface Cooling Using Eurocollins Solution Added with a High Concentration of Urokinase. ^è‹`•FiŽÀ“®ŒnjC‰¡“c˜a•FC²“¡ŒõŽjCŒY•”P’jC’†ŽR‹`‰îC‘듇í‰ëiŠOjC‰œ•½‰ë•Fi•a—jC‹{‘òŽµ˜Yi“dŒ°ƒZƒ“ƒ^[jC“à“c‹v‘¥iŠOj: 1st Congress of the Asian Transplantation Society i89.11.22), ƒoƒŠ, ƒCƒ“ƒhƒlƒVƒA.

1419. mŠw‰ïn iˆê”Êu‰‰j Advantage of Triple Therapy with Mizoribine, Ciclosporine and Prednisolone over Other Types Triple and/or Double Therapy Including Ciclosporine for Renal Transplantation. “à“c‹v‘¥i“Œ‘åjCNishimura, Y.CMita, K.CŒY•”P’jC’†ŽR‹`‰îC‰¡“c˜a•FC²“¡ŒõŽjiŠOjC‰““¡’‰—Yi”åjC‘å‹v•Û[li“àj: 1st Congress of the Asian Transplantation Society i89.11.22), ƒoƒŠ, ƒCƒ“ƒhƒlƒVƒA, ´˜^W, p.180, 1989.

1420. mŒ¤‹†‰ïn i‹L”Ou‰‰j –«tŽ¾Š³‚Æ“§Í‚̇•¹Ç. Žðˆä‹Ši”åj: “Œt‹¦‘æ17‰ñ‘‰ï (89.04.02), “Œ‹ž.

1421. mŒ¤‹†‰ïn i“Á•Êu‰‰j –«t•s‘S‚Ì•Û‘¶Šú—Ö@‚ÆtˆÚA. ŒF–ì˜a—Yi”åj: ŒF’JŽsˆãŽt‰ïu‰‰‰ï (88.12.21), ŒF’JŽs.

1422. mŒ¤‹†‰ïn i“Á•Êu‰‰j Å‹ß‚Ìt•s‘SŽ¡—Âɂ‚¢‚Ä. ŒF–ì˜a—Yi”åj: ¼ŽRŽsˆãŽt‰ïu‰‰‰ï (89.03.20), ¼ŽRŽs.

1423. mŒ¤‹†‰ïn i“Á•Êu‰‰j t•s‘Sˆã—Âɂ¨‚¯‚éCAPDŽ¡—Ẩʂ½‚·–ðŠ„|ƒPƒAƒVƒXƒeƒ€‚ɂ‚¢‚Ä|. Žðˆä‹Ši”åj: H“cŒ§CAPD§’k‰ï (89.04.0l), H“c.

1424. mŒ¤‹†‰ïn i“Á•Êu‰‰j ’·Šú“§ÍŠ³ŽÒ‚Ìœ‡•¹Ç‚ɂ‚¢‚Ä. ŒF–ì˜a—Yi”åj: ‘æ1‰ñ‰ºŠÖ“§Íˆã—ÃŽ{ÝŠwpu‰‰‰ï (89.05.13), ‰ºŠÖ.

1425. mŒ¤‹†‰ïn i“Á•Êu‰‰j tŽ¾Š³ care system |t•s‘SŠÇ—‚É‚¨‚¯‚éCAPD‚̈ʒu‚¯|. Žðˆä‹Ši”åj: ‘æ1‰ñ‰ºŠÖ“§Íˆã—ÃŽ{ÝŠwpu‰‰‰ï (89.05.13), ‰ºŠÖ.

1426. mŒ¤‹†‰ïn i“Á•Êu‰‰j CAPD‚ÌŒ»ó. Žðˆä‹Ši”åj: ‘æ12‰ñ_“Þ쌧CAPDŠÅŒìŒ¤C‰ï (89.05.28), _“Þì.

1427. mŒ¤‹†‰ïn i“Á•Êu‰‰j ”ñƒlƒtƒ[ƒ[Œ^Ž…‹…‘Ìt‰Š‚̃XƒeƒƒCƒh—Ö@. ¬—Ñ–Li“àj: ‘æ2‰ñç—tŒ§tƒZƒ~ƒi[ (89.06.00), ç—t.

1428. mŒ¤‹†‰ïn i“Á•Êu‰‰j CAPDŠ³ŽÒ‚Ì• –Œ‰Š‚Ƹ_“IŽx‰‡‚ɂ‚¢‚Ä. ŒF–ì˜a—Yi”åj: ‘æ11‰ñŒQ”nŒ§CAPDŠÅŒìƒZƒ~ƒi[ (89.06.03), ŒQ”n.

1429. mŒ¤‹†‰ïn i“Á•Êu‰‰j t•s‘S‚̃g[ƒ^ƒ‹ƒPƒA[. Žðˆä‹Ši”åj: ‘æ3‰ñ‹ãB¬Ž™ƒlƒtƒƒƒW[Œ¤‹†‰ï (89.06.10), •Ÿ‰ª.

1430. mŒ¤‹†‰ïn i“Á•Êu‰‰j tŽ¾Š³Š³Ž™‚̶—¥•a—. Žðˆä‹Ši”åj: ‘æ5‰ñ—{ŒìŠwZ•ÛŒ’ŠÇ—uK‰ï (89.08.03), ‰¡{‰ê.

1431. mŒ¤‹†‰ïn i“Á•Êu‰‰j u‚¢‚܈ã—Â̢ŠE‚Å‚Ív|ˆã—Ãl‚Æ‚µ‚Ä‚Ì–ðŠ„‚ðl‚¦‚é|. Žðˆä‹Ši”åj: ƒ‚ƒ_ƒ“ƒ†ƒŠƒiƒŠƒVƒXu‰‰‰ï (89.10.22), H“cŽs.

1432. mŒ¤‹†‰ïn i“Á•Êu‰‰j ˆã—ÃVŽž‘ã‚̃jƒ…[ƒRƒ“ƒZƒvƒg‚ÍŠwZ•ÛŒ’‚É”@‰½‚È‚é‰e‹¿‚ð‹y‚Ú‚µ‚Ä‚¢‚é‚©. Žðˆä‹Ši”åj: ‘æ37‰ñ–k—¤ŽOŒ§ŠwZ•ÛŒ’Œ¤‹†‹¦‹c‰ï (89.10.28), ¬¼Žs.

1433. mŒ¤‹†‰ïn i“Á•Êu‰‰j “§ÍŠ³ŽÒ‚ւ̃GƒŠƒXƒƒ|ƒGƒ`ƒ“‚Ì“Š—^‚Æ•›ì—p‚ɂ‚¢‚Ä. Š™“cvŽõi“àj: •Ÿ“‡t«•nŒŒŒ¤‹†‰ï (89.11.18), •Ÿ“‡.

1434. mŒ¤‹†‰ïn i“Á•Êu‰‰j CAPD—Ö@. Žðˆä‹Ši”åj: ƒTƒeƒ‰ƒCƒgƒZƒ~ƒi[iŒŒ‰tò‰»‹ZpƒZƒ~ƒij (89.12.03), “Œ‹ž.

1435. mŒ¤‹†‰ïn i“Á•Êu‰‰j ƒGƒŠƒXƒƒ|ƒGƒ`ƒ“‚Ìt•s‘S¥“§ÍŠ³ŽÒ‚Å‚ÌŽg—p¬Ñ‚Æ¡Œã‚Ì“W–]. Žðˆä‹Ši”åj: ‘æ2‰ñŠâŽèƒGƒŠƒXƒƒ|ƒGƒ`ƒ“Œ¤‹†‰ï (90.02.13), ·‰ª.

1436. mŒ¤‹†‰ïn i“Á•Êu‰‰j “§ÍƒAƒ~ƒƒCƒh[ƒVƒX. ŒF–ì˜a—Yi”åj: ŒF–{Œ§“§ÍŒ¤‹†‰ï (90.02.23), ŒF–{.

1437. mŒ¤‹†‰ïn i“Á•Êu‰‰j ˆã—ÃVŽž‘ã‚ÌCAPD—Ö@‚Ì‚ ‚è‚©‚½. Žðˆä‹Ši”åj: ‘æ5‰ñŠÖ¼¥’†¥Žl‘CAPDƒi[ƒXƒZƒ~ƒi[ (90.02.25), ‘åã.

1438. mŒ¤‹†‰ïn i“Á•Êu‰‰j ˆã—ÃVŽž‘ã‚̃jƒ…[ƒRƒ“ƒZƒvƒg|ˆã—Ãl‚µ‚Ä‚Ì–ðŠ„|. Žðˆä‹Ši”åj: ‘æ14‰ñ_“Þ쌧CAPDŠÅŒìŒ¤‹†‰ï (90.03.18), ‰¡•l.

1439. mŒ¤‹†‰ïn i“Á•Êu‰‰j ¬Ž™‚Ìt‘Ÿ•a|ŠÇ—‚ÆŽ¡—ÃAŋ߂̘b‘è|. Žðˆä‹Ši”åj: ¬“cŒ´ŽsˆãŽt‰ïŠwpu‰‰‰ï (90.03.29), ¬“cŒ´.

1440. mŒ¤‹†‰ïn i“Á•Êu‰‰j ¬Ž™t•s‘S‚É‚¨‚¯‚éƒGƒŠƒXƒƒ|ƒGƒ`ƒ““Š—^‚ÌŽÀÛ. Žðˆä‹Ši”åj: ‹ž“st•s‘SŽ¡—ç’k‰ï (90.03.31), ‹ž“s.

1441. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ŒŒ‰t“§Í’†‚ÌŽ–ŒÌ‚Æ‘Îô. Žðˆä‹Ši”åj: ‘æ18‰ñ“§Í—Ö@]Ž–EˆõŒ¤C‰ï (89.07.21), “Œ‹ž.

1442. mŒ¤‹†‰ïn i‹³ˆçu‰‰j RODŽ¡—ÂÌV‚µ‚¢“WŠJ. ’Ë–{—Y‰îi“àj: ‘æ2‰ñ•ºŒÉŒ§ROD§˜b‰ï (89.09.09), _ŒË, t‚Æœ‘ãŽÓ, 3(1): 146, 1990.

1443. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ¬Ž™ŠútŽ¾Š³‚ÌŠÇ—‚ÆŽw“±. Žðˆä‹Ši”åj: ‘æ39‰ñ‘S‘ŠwZ•ÛŒ’Œ¤‹†‘å‰ï (89.11.17), …ŒËŽs.

1444. mŒ¤‹†‰ïn i‹³ˆçu‰‰j “§ÍƒAƒ~ƒƒCƒh[ƒVƒX‚Ì—Õ°. Žðˆä‹Ši”åj: ‘æ35‰ñé‹ÊŒ§t•s‘S§’k‰ïŒ¤‹†”­•\‰ï (89.12.01), ‘å‹{.

1445. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ¬Ž™‚Å‚ÌCAPD—Ö@‚ÌŒ»‹µ‚Æ“W–]. Žðˆä‹Ši”åj: Ý‘îˆã—ÃŒ¤‹†‰ï (90.02.27), “Œ‹ž.

1446. mŒ¤‹†‰ïn i‹³ˆçu‰‰j Žq‹Ÿ‚Ìt‘Ÿ•a‚ÌŠÇ—‚ÆŽ¡—Ã. Žðˆä‹Ši”åj: t‘ŸŽ¾Š³u‰‰‰ï (90.02.28), ¬“cŒ´.

1447. mŒ¤‹†‰ïn i‹³ˆçu‰‰j tˆÚA|—Õ°ˆã‚Í‚Ç‚¤‚©‚©‚í‚é‚Ì‚©|. Žðˆä‹Ši”åj: _“Þ쌧•ÛŒ’ˆã‹¦‰ï’nˆæˆã—ÊwK‰ï (90.03.09), ‰¡•l.

1448. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ŒoŒû1,25(OH)2D3ƒpƒ‹ƒX—Ö@‚É‚æ‚é‚“x“ñŽŸ«•›bó‘B‹@”\˜´iÇ‚ÌŽ¡—Ã. ’Ë–{—Y‰îC–쑺K”Íi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: ‘æ8‰ñt‚Æœ‘ãŽÓŒ¤‹†‰ï (89.10.07), ‘åã.

1449. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j • ˆ³«”AŽ¸‹Ö‚ÌŽÀ‘Ô’²¸‚ÆäNã÷Œz•”‚‚肠‚°p‚ÌŒoŒ±. ‰¡ŽR‰p“ñi”åj: _“Þì•p”A¥”AŽ¸‹ÖƒVƒ“ƒ|ƒWƒEƒ€ (89.11.11), ‰¡•l.

1450. mŒ¤‹†‰ïn iƒpƒlƒ‹j ¬Ž™‚ÌtˆÚA. ‰““¡’‰—Yi”åj: ‘æ11‰ñ¬Ž™t•s‘SŒ¤‹†‰ï (89.09.21`22), VŠƒ.

1451. mŒ¤‹†‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj CAPD’·ŠúŽ{s—á‚Ì–â‘è“_;‚Æ‚­‚Ét«œˆÙ‰h—{ǂƬ’·”­ˆç‚ɂ‚¢‚Ä. ˆÉ“¡–¯ŒbiŽ™j: ‘æ3‰ñ¬Ž™CAPD•×‹­‰ï (89.09.21), VŠƒ.

1452. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠwZŒŸ”AAŒp‘±ŠÇ—‚̈Ӌ`. Žðˆä‹Ši”åj: Œú¶È“Á’莾Š³’²¸Œ¤‹†”Çuis«táŠQv•½¬Œ³”N“xŒ¤‹†‹ÆÑ”­•\‰ï”­•\”NŒŽ“ú(90.02.09), “Œ‹ž.

1453. mŒ¤‹†‰ïn iˆê”Êu‰‰j IgAtÇ‚É‚Äfollow’†‚ÉScholein-HenochŽ‡”Á•a‚ð‡•¹‚µAƒlƒtƒ[ƒ[ÇŒóŒQ‚ð’悵‚½1—á. •x‰i‹B•FC“c”¨ˆÉ“sŽqC•Ÿ“c‰xŽqC‘å’ˉpŽiC‘å‹v•Û[li“àjC‹Ê’uŒ›ˆê: ‘æ43‰ñ_“Þ쌧“à‰ÈˆãŠw‰ïW’k‰ï (89.00.00), —tŽR.

1454. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”å”AŠí‰È—̈æ‚Å‚ÌŽÄ—è“’‚ÌŽg—pŒoŒ±. ΋´WCŽO–ØM’ji”åj: ‘æ5‰ñ—Õ°“Œ—mˆãŠwŒ¤‹†‰ï (89.05.26), “Œ‹ž.

1455. mŒ¤‹†‰ïn iˆê”Êu‰‰j ˆÚAt“®–¬‹·ó‚ɑ΂·‚éPTA. ‰““¡‚C‘–쳈êCˆä“›–rC¼–{—æŽqC‹àˆä’Ë•¶–¾C¬—ѬŽiC’J“c—ˆê˜Yi•új: ‘æ1‰ñŠÖ“ŒInterventional RadiologyŒ¤‹†‰ï (89.08.05), “Œ‹ž, “ú–{ŒŒŠÇ‘¢‰eInterventional RadiologyŒ¤‹†‰ïŽGŽ, 4(2): 128, 1989.

1456. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‚“x‚ÌŽ…‹…‘Ìt‰ŠA”A׊ÇEŠÔŽ¿«t‰Š‚𔺂Á‚½Castleman•a‚Ì1—á. ”äŠé”\”VC–쑺K”ÍC’Ë–{—Y‰îC•ìºCŠ™“cvŽõCŠÚ–샶C¬—Ñ–Li“àj: ‘æ12‰ñ_“Þìt‰ŠŒ¤‹†‰ï (89.09.00), ‰¡•l.

1457. mŒ¤‹†‰ïn iˆê”Êu‰‰j t“à“®–¬•ÂÇ‚É‚æ‚鬎™ŒŒŠÇ«‚ŒŒˆ³Ç‚Ì1—á|•”•ª“It“®–¬Çðp‚Ì—L—p«. ¼Šª”ŽC–x’rdŽ¡C’J“c—ˆê˜YC¬—Ñ–ÎŽ÷C¼ŽR³ŒáC’r“crºC“cŠŽŒÈi•újCãŽR‘×~C’·’Jì—CˆÉ“¡‘ñi´£¬Ž™•a‰@j: ‘æ15‰ñ“ú–{ŒŒŠÇ‘¢‰e Interventional Radiology Œ¤‹†‰ï (89.09.00), –¼ŒÃ‰®, “ú–{ŒŒŠÇ‘¢‰e Interventional Radiology Œ¤‹†‰ïŽGŽ, 4(2): 80, 1989.

1458. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‰ºŠ{œ”XŽî‚Ì“Eo‚É‚æ‚èƒGƒŠƒXƒƒ|ƒGƒ`ƒ“‚ÌŒø‰Ê‚ð”F‚ß‚½¬Ž™CAPDÇ—á. –kžŠ‚Ý‚Ç‚èiŽ™j: ‘æ4‰ñ_“ÞìCAPDŒ¤‹†‰ï (89.09.09), ‰¡•l, —\eW, p.102, 1989.

1459. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ž‘±«—²‹N«g”ÁCŽá”N«ŠÖ߃ŠƒEƒ}ƒ`—l‚ÌŠÖ߉Š‚É‘ƒóŽ…‹…‘Ìd‰»Ç‚𔺂Á‚½1’jŽ™—á. V‘º•¶’jC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: ‘æ12‰ñ_“Þìt‰ŠŒ¤‹†‰ï (89.09.16), ‰¡•l, t‰ŠÇ—ጤ‹†, 6: 115`119, 1990.

1460. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’ZŠúŠÔ‚É3‰ñ‚Ì‹}«t•s‘S”­ì‚ð‹N‚±‚µ‚½ŠÔŽ¿«t‰Š‚Ì‚P’jŽ™—á. V‘º•¶’jC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: ‘æ11‰ñ¬Ž™t•s‘SŒ¤‹†‰ï (89.09.21), VŠƒ.

1461. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒVƒNƒƒXƒ|ƒŠƒ“‚ð“Š—^‚µ‚½¬Ž™tˆÚAŠ³ŽÒ10—á‚Ì—Õ°“IŒŸ“¢. V‘º•¶’jiŽ™jCŒF–ì˜a—Yi”åjC–kžŠ‚Ý‚Ç‚èC”Ñ‚Šì‹v—YC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: ‘æ11‰ñ¬Ž™t•s‘SŒ¤‹†‰ï (89.09.22), VŠƒ.

1462. mŒ¤‹†‰ïn iˆê”Êu‰‰j —cŽá‹y‚Ñ‚T—ƒbƒg‚É‚¨‚¯‚ét•s‘S‚Ìis‚ɂ‚¢‚Ä|tˆŸ‘S“Eƒ‚ƒfƒ‹‚ð—p‚¢‚Ä‚ÌŒŸ“¢|. V‘º•¶’jiŽ™jCŽðˆä‹Ši”åjCˆÉ¨“¹mC㌴N•viŒà‰H‰»Šw¶•¨ˆãŠwŒ¤‹†Šj: ‘æ11‰ñ¬Ž™t•s‘SŒ¤‹†‰ï (89.09.22), VŠƒ.

1463. mŒ¤‹†‰ïn iˆê”Êu‰‰j t•s‘Sƒ‚ƒfƒ‹‚ɑ΂·‚éŒoŒû‹z’…ÜAST-120“Š—^‚̉e‹¿‚ÉŠÖ‚·‚錤‹†|Ž…‹…‘ÌŒŒs“®‘Ô‚ÉŠÖ‚·‚錟“¢|. ‹g“c‹`Ki ϶‰ï‰¡•lŽs“ì•”•a‰@jCŽðˆä‹Ši”åj: ‘æ11‰ñ¬Ž™t•s‘SŒ¤‹†‰ï (89.09.22), VŠƒ.

1464. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‰ºŠ{”XŽî‚Ì“Eo‚Å•nŒŒ‚̉ü‘P‚ð‚Ý‚½‚PÇ—á|Recombinant Erythropoietin(r-EPO)‚Ì”½‰ž«‚̉ü‘P|. –kžŠ‚Ý‚Ç‚èCV‘º•¶’jCˆÉ“¡–¯ŒbC”Ñ‚Šì‹v—YC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: ‘æ11‰ñ¬Ž™t•s‘SŒ¤‹†‰ï (89.09.22), VŠƒ, —\eWCp.102, 1989.

1465. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”DPoŽY‚É‚æ‚è’˜‚µ‚­Œy‰õ‚µ‚½“Á”­«•‚Žî‚Ì1—á. Žç‰®—˜‰ÀC–쑺K”ÍC’Ë–{—Y‰îC‘å‹v•Û[li“àj: ‘æ21‰ñ“Œ‹ž—Õ°‘̉tŒ¤‹†‰ï (89.10.14), “Œ‹ž.

1466. mŒ¤‹†‰ïn iˆê”Êu‰‰j tˆÚAlHŒŒŠÇ•«‡p‚É‚¨‚¯‚鶗“I‘gDÚ’…Ü‚Ì—L—p«‚ɂ‚¢‚Ä. “ü]Œ[C‰¡“c^“ñCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—Yi”åj: ‘æ4‰ñtˆÚAŒŒŠÇŠO‰ÈŒ¤‹†‰ï (89.11.03), •xŽR.

1467. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’á‘Ìd¬Ž™‚ÌtˆÚA‚ÌŽèpŽè‹ZiƒrƒfƒIj. ‰““¡’‰—Yi”åj: ‘æ4‰ñtˆÚAŒŒŠÇŠO‰ÈŒ¤‹†‰ï (89.11.03), •xŽR.

1468. mŒ¤‹†‰ïn iˆê”Êu‰‰j ¶‘Ìdonor‚Ìt“EœpiƒrƒfƒIj. ‰““¡’‰—Yi”åj: ‘æ4‰ñtˆÚAŒŒŠÇŠO‰ÈŒ¤‹†‰ï (89.11.03), •xŽR.

1469. mŒ¤‹†‰ïn iˆê”Êu‰‰j –h‰qˆã‘å”å”AŠí‰È‚Ås‚Á‚Ä‚¢‚鶑ÌtˆÚA‚ÌŽèpŽè‹Z‚ɂ‚¢‚Ä. ‘ò‘º³”VC´…rŽŸC씨KŽkC‚”ö‰ë–çCó–ì—F•FC’·‘q˜a•FC‰Æ“c˜a•vC‘ºˆäŸC’†‘ºGi”åj: ‘æ4‰ñtˆÚAŒŒŠÇŠO‰ÈŒ¤‹†‰ï (89.11.03), •xŽR.

1470. mŒ¤‹†‰ïn iˆê”Êu‰‰j “àƒVƒƒƒ“ƒg•”lHŒŒŠÇ‚É‹U“®–¬áŽ‚ª‘½”­‚µ‚½1—á. ‹g“cˆê¬C•ìƒC–å˜e˜abCŒF–ì˜a—YC‰““¡’‰—YCŽðˆä‹Ši”åj: ‘æ4‰ñtˆÚAŒŒŠÇŠO‰ÈŒ¤‹†‰ï (89.11.03), •xŽR.

1471. mŒ¤‹†‰ïn iˆê”Êu‰‰j tƒTƒ“ƒSóŒ‹Îǂɑ΂·‚éESWL‚ÌŽ¡—ÃŒoŒ±. rìFCΓc—T‘¥C‹v•Û¯ˆêC^‰ºß•vC¬ŽÄŒ’i”åj: ‘æ3‰ñ“ú–{Endourology ESWLŒ¤‹†‰ï (89.11.27), ‹ž“s.

1472. mŒ¤‹†‰ïn iˆê”Êu‰‰j AST-120‚ª”A׊ǂɋy‚Ú‚·‰e‹¿‚ÌŒŸ“¢. V‘º•¶’jiŽ™jCŽðˆä‹Ši”åjCˆÉ¨“¹mC㌴N•viŒà‰H‰»Šwj: ”A“ÅÇ•a‘ÔŒ¤‹†‰ï (89.12.02), Šò•Œ.

1473. mŒ¤‹†‰ïn iˆê”Êu‰‰j CAPDŠ³Ž™‚É‚¨‚¯‚ét«œˆÙ‰h—{ǂɂ‚¢‚Ä‚ÌŒŸ“¢. ˆÉ“¡–¯ŒbC–kžŠ‚Ý‚Ç‚èCV‘º•¶’jCΊٕ•vC”Ñ‚Šì‹v—YC‰Í¼‹IºiŽ™jC–x’rdŽ¡i•újCŽðˆä‹Ši”åj: ¬Ž™CAPDŒ¤‹†‰ï (90.01.13), ‰¡•l, —\eWCp.10, 1990.

1474. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒŒ‰t“§Í“±“üŽžA‹¹•”‚wüŠŒ©‚ɂ‚¢‚Ä. ˜a“cŒ¹ŽiC–¾Î•q•FCŠ¡•”‚ЂƂÝC÷ˆä–¾”üCŒBŠ|L“ñC“y‰®ÍC‘å‹v•Û[li“àj: ‘æ822‰ñç—tˆãŠw—á‰ïA‘æ23‰ñ”xŠàŒ¤‹†Ž{Ý—á‰ï (90.01.15), ç—t.

1475. mŒ¤‹†‰ïn iˆê”Êu‰‰j pŒã‘Šú‚Ét‹@”\’ቺCŒŒ¬”ÂŒ¸­C•nŒŒ‚ð‚«‚½‚µCOKT3‚ª’˜Œø‚ð’悵‚½¬Ž™¶‘ÌtˆÚA‚Ì‚P—á. V‘º•¶’jCŽR“cr•FCŠÖª“OC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™jC“ü]Œ[C‰¡“c^“ñCŒF–ì˜a’jC^‰ºß•vC‰““¡’‰—YCŽðˆä‹ŠC¬ŽÄŒ’i”åj: ‘æ23‰ñtˆÚA—Õ°ŒŸ“¢‰ï (90.01.26), ‘å’Ã, —\eWCp.69, 1990.

1476. mŒ¤‹†‰ïn iˆê”Êu‰‰j tˆÚAŒã‚ÉCMVŠ´õÇ‚ð’悵‚½2—á. Žç‰®—˜‰ÀC‰J‹{Œ«ˆêC“´“c‰fŽqC“c‘º_ŽOCŠ™“cvŽõC‘å‹v•Û[lC–Øì“c—²ˆêi“àjCŒY•”P’jC’†ŽR‹`‰îC²“¡ŒõŽjiŠOjC“ü]Œ[CŒF–ì˜a—YC^‰ºß•vC ‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ23‰ñtˆÚA—Õ°ŒŸ“¢‰ï (90.01.27), ‘å’Ã, —\eW, p.110, 1990.

1477. mŒ¤‹†‰ïn iˆê”Êu‰‰j IgAtÇ‚É‚¨‚¯‚éŠÔŽ¿•a•Ï‚Ì•]‰¿. ‰Í¼‹IºC–kžŠ‚Ý‚Ç‚èiŽ™jCŽðˆä‹Ši”åj: Œú¶ÈSgáŠQŒ¤‹†•½¬Œ³”N“xu¬Ž™tŽ¾Š³‚Ìis‘jŽ~‚Æ’·ŠúŠÇ—‚̃VƒXƒeƒ€‰»‚ÉŠÖ‚·‚錤‹†v (90.01.31), “Œ‹ž.

1478. mŒ¤‹†‰ïn iˆê”Êu‰‰j CAPDŠ³ŽÒ‚É‚¨‚¯‚郊ƒ“‹z’…Ü‚Æ‚µ‚Ä‚ÌCaCO3‚ÌŒø‰Ê‚¨‚æ‚Ñ•›ì—p‚ɂ‚¢‚Ä. ˆÉ“¡–¯ŒbC”Ñ‚Šì‹v—YiŽ™jCŽðˆä‹Ši”åj: Œú¶ÈSgáŠQŒ¤‹†•½¬Œ³”N“xu¬Ž™tŽ¾Š³‚Ìis‘jŽ~‚Æ’·ŠúŠÇ—‚̃VƒXƒeƒ€‰»‚ÉŠÖ‚·‚錤‹†v (90.01.31), “Œ‹ž.

1479. mŒ¤‹†‰ïn iˆê”Êu‰‰j ¬Ž™CAPDŠ³ŽÒ‚̎Љ‹A. Žðˆä‹Ši”åjC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºCV‘º•¶’jC”Ñ‚Šì‹v—YCˆÉ“¡–¯ŒbiŽ™jCŒF–ì˜a—Yi”åj: Œú¶ÈSgáŠQŒ¤‹†•½¬Œ³”N“xu¬Ž™tŽ¾Š³‚Ìis‘jŽ~‚µ’·ŠúŠÇ—‚̃VƒXƒeƒ€‚ÉŠÖ‚·‚錤‹†v (90.01.31), “Œ‹ž.

1480. mŒ¤‹†‰ïn iˆê”Êu‰‰j IgAtÇ‚Ìis«‚ÌŒ©‹É‚ß|’†“™“xˆÈã‚Ì’`”’”AÇ—á‚ɂ‚¢‚Ä. ¬—Ñ–LC”äŠé”\”VCŠÚ–샶C•ìºi“àj: Œú¶È“Á’莾Š³’²¸Œ¤‹†”Çuis«táŠQv•½¬Œ³”N“xŒ¤‹†”­•\‰ï (90.02.00), “Œ‹ž.

1481. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘ŠúŽ¡—Ãi—\–h‘Îô’†Sj‚ÉŠÖ‚·‚錤‹†. Žðˆä‹Ši”åjC‰Í¼‹IºiŽ™j: ut•s‘Sˆã—ÃŒ¤‹†Ž–‹Æv•½¬Œ³”N“xŒ¤‹†‹ÆÑ”­•\‰ï (90.02.02), “Œ‹ž.

1482. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”DP‘O”¼Šú‚É”A’`”’‚ªoŒ»‚µƒlƒtƒ[ƒ[ÇŒóŒQ‚Ö‚Æi“W‚µ‚½2Ç—á. Š™“cvŽõC¬àVŒ°ˆêC“c‘º_ŽOC•ìºC”äŠé”\”VCŠÚ–샶C¬—Ñ–Li“àj: ‘æ13‰ñ_“Þìt‰ŠŒ¤‹†‰ï (90.02.03), ‰¡•l.

1483. mŒ¤‹†‰ïn iˆê”Êu‰‰j IgAtÇ‚Ì”­Ç‚©‚çˆÚA‚Ü‚Å. V‘º•¶’jC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: ‘æ13‰ñ_“Þìt‰ŠŒ¤‹†‰ï (90.02.03), ‰¡•lC —\eWCp.6, 1990.

1484. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ä”R‚ðŒJ‚è•Ô‚µ‚½ƒ‹[ƒvƒXt‰Š‚Ì1—á. ãŽRŽO‘ãŽqC•ìºCŠ™“cvŽõC¬—Ñ–LC”äŠé”\”Vi“àj: ‘æ11‰ñ_“Þìt‰ŠŒ¤‹†‰ï (90.03.04), ‰¡•l,

1485. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”÷¶•¨“ñŽŸ‘ãŽÓŽY•¨‚̖Ɖu—}§ì—pA“Á‚Ét‰Š”­Ç‚¨‚æ‚Ñi“W‚Ì—}§‚ɂ‚¢‚Ä. ‘å‹v•Û[lCŠ™“cvŽõi“àjC^è‹`•FiŽÀ“®Œnj: Œú¶ÈŽ©ŒÈ–ƉuŽ¾Š³Ž¡—Öò‚ÌŠJ”­Œ¤‹†”Ç‘æ6‰ñ‘‰ï (90.03.16), “Œ‹ž.

1486. mŒ¤‹†‰ïn iˆê”Êu‰‰j PAN17DX‚ł̒ᕪŽq—Ê’`”’‚Ìœ‹Ž”\‚ÌŒŸ“¢. ¬ŽR½itƒZƒ“ƒ^[jCŒF–ì˜a—Yi”åjC“ì•”³lC—Ñ‹v”üŽqCéˆä°”üC´…”ÍŽqC‘Š CˆêitƒZƒ“ƒ^[jCŽðˆä‹Ši”åj: ‘æ5‰ñƒnƒCƒpƒtƒH[ƒ}ƒ“ƒX¥ƒƒ“ƒuƒŒƒ“Œ¤‹†‰ï (90.03.17), “Œ‹ž.

1487. mŒ¤‹†‰ïn iˆê”Êu‰‰j t«ã”笑̋@”\˜´iÇ‚É‚¨‚¯‚é“Eoã”笑̂̕a—‘gDŠw“IŒŸ“¢. ™–{‹v”VCHŽR’¨•vC“à“c‹v‘¥CŒY•”“ŒŽ¡C‰¡“c˜a•FC²“¡ŒõŽjiŠOjCŠ™“cvŽõC’Ë–{—Y‰îC‘å‹v•Û[li“àj: ‘æ37‰ñ_“ÞìtŒ¤‹†‰ï i89.00.00), _“Þì.

1488. mŒ¤‹†‰ïn iˆê”Êu‰‰j tĈÚAÇ—á‚ÌŒŸ“¢. ²“¡ŒõŽjC‰¡“c˜a•FC‘듇í‰ëC’†ŽR‹`‰îCŒY•”P’jCˆ¢‘]OˆêiŠOjCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—Yi”åjCŠ™“cvŽõC‘å‹v•Û[li“àjC“n•”_“ñC”–Ø “oi‘ŸˆÚjC“à“c‹v‘¥i“Œ‘åj: ‘æ22‰ñtˆÚA—Õ°ŒŸ“¢‰ï i89.02.17), ˆÉ•Û, ˆÚA, 24(6): 664, 1989.

1489. mŒ¤‹†‰ïn iˆê”Êu‰‰j tˆÚ—Õ°‚É‚¨‚¯‚éciclosporine, mizoribine, steroid, ALG 4܇•¹“Š—^–@. ŒY•”P’jCŒY•”“ŒŽ¡C‰¡“c˜a•FC‘듇í‰ëC’†ŽR‹`‰îC²“¡ŒõŽjiŠOjCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—Yi”åjCŠ™“cvŽõC‘å‹v•Û[li“àjC“n•”_“ñC”–Ø “oi‘ŸˆÚjC“à“c‹v‘¥i“Œ‘åj: ‘æ12‰ñ—Õ°ˆÚA–ƉuŒ¤‹†‰ï i89.06.10), “Œ‹ž.

1490. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”]Ž€Š³ŽÒ‚©‚ç‚Ìt“Eo‚ÌH•v. ’†ŽR‹`‰îC¡ˆäŒ‰C‘듇í‰ëCŒY•”P’jC‰¡“c˜a•FC²“¡ŒõŽjiŠOjC“à“c‹v‘¥i“Œ‘åjCE“cÍiŠOjCŒF–ì˜a—YC‰““¡’‰—Yi”åjC‘å‹v•Û[li“àj: ‘æ23‰ñtˆÚA—Õ°ŒŸ“¢‰ï i90.01.26), ‘å’Ã, tˆÚA—Õ°ŒŸ“¢‰ïŽ, 23: 22, 1990.

1491. mŒ¤‹†‰ïn iˆê”Êu‰‰j Žr‘ÌtˆÚA‚É‚¨‚¯‚éciclosporine, mizoribine, steroid, ALG 4܇•¹“Š—^–@. ŒY•”P’jC’†ŽR‹`‰îC¡ˆäŒ‰C‰¡“c˜a•FC²“¡ŒõŽjCE“cÍiŠOjCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—Yi”åjC‘å‹v•Û[li“àjC“n•”_“ñC”–Ø“oi‘ŸˆÚjC“à “c‹v‘¥i“Œ‘åj: ‘æ23‰ñtˆÚA—Õ°ŒŸ“¢‰ï i90.01.26), ‘å’Ã, tˆÚA—Õ°ŒŸ“¢‰ïŽ, 23: 58, 1990.

1492. mŒ¤‹†‰ïn iˆê”Êu‰‰j tĈÚAÇ—á‚ÌŒŸ“¢. ²“¡ŒõŽjC¡ˆäŒ‰C‘듇í‰ëC’†ŽR‹`‰îCŒY•”P’jCE“cÍiŠOjCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—Yi”åjCŠ™“cvŽõC‘å‹v•Û[li“àjC“n•”_“ñC”–Ø“o i‘ŸˆÚjC‰¡“c˜a•FiŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ23‰ñtˆÚA—Õ°ŒŸ“¢‰ï i90.01.26), ‘å’Ã, tˆÚA—Õ°ŒŸ“¢‰ïŽ, 23: 60, 1990.


<<108 ¶BŠí>>

1493. mŒ´’˜n T-3262 (tosafloxacin tosilate)‚Ì‘O—§‘B‘gD“à•ª•z‚ÌŒŸ“¢. ’r“cŽ C¼‘º´ŽuC΋´Wi”åj: Chemotherapy, 37(9): 1149`1153, l989.

1494. mŒ´’˜n ƒÁ-Seminoprotein‚ɑ΂·‚郂ƒmƒNƒ[ƒiƒ‹R‘Ì‚ÌŒ¤‹†. “¡–ì’WlC΋´WC¬ŽÄŒ’i”åjC¯‡Ž¡C‘Šˆé’å˜aCˆÀ“cŒ’ŽŸ˜YiŒc‘åjC\‰ÍFiƒRƒXƒ‚‘Œ¤j: “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 81(1): 37`44, l990.

1495. mŒ´’˜n Mechanism for the Removal of Residual Cytoplasm from Spermatids during Mouse Spermiogenesis. ŽðˆäNOCŽR‰È³•½i‰ðj: Anat. Rec., 223(1): 43`48, 1989.

1496. mŒ´’˜n Analgesia and Anesthesia during Labor in Japan and Developed Countries. Vˆä³•vC¼“‡³”ŽC’F‰pŽ÷iŽY•wj: Asia-Oceania J. Obstet. Gynecol., 15(3): 213`221, 1989.

1497. mŒ´’˜n Proliferation and Responsiveness to Estrogen of Human Endometrial Cancer Cells under Serum-free Culture Conditions. Holinka, C.F.(Mount Sinai Univ.)CˆÀ¼Œ·C`GŽ÷iŽY•wjCKimmel, N.(Mount Sinai Univ)C‘ –{”ŽsiŽY•wjCGurpide, E.(Mount Sinai Univ.): Cancer Research, 49(12): 3297`3301, 1989.

1498. mŒ´’˜n Stimulatory Effects of 4-hydroxytamoxifen on Proliferation of Human Endometrial Adenocarcinoma Cells (Ishikawa Line). ˆÀ¼Œ·iŽY•wjCHolinka, C.F.(Mount Sinai Univ.)C‘ –{”ŽsiŽY•wjCGurpide, E.(Mount Sinai Univ.): Cancer Research, 49(9): 2362`2365, 1989.

1499. mŒ´’˜n Changes in Endoplasmic Reticulum during Spermiogenesis in the Mouse. ’†–{’¼CŽðˆäNOi‰ðj: Cell Tissue Res., 257: 279`284, 1989.

1500. mŒ´’˜n Quantitative Estimation of an ƒ¿2 Pregnancy-associated Protein in Normal Pregnancy by Electroimmunoassay. ’†‹Œõ¶iŽY•wjCˆ­”ü³“Ti•l¼ˆã‰È‘åjC‘]ª—R”üŽqi¶‰»ŠwŒnjCVˆä³•viŽY•wj: Clin. Chim. Acta, 182: 103`108, 1989.

1501. mŒ´’˜n Žq‹{“à–ŒŠà‚̃XƒeƒƒCƒhƒzƒ‹ƒ‚ƒ“Š´Žó«‚Æ‚»‚Ìì—p‹@˜. `GŽ÷C`˜aŽqiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC‰º“c—²•vC‘ –{”ŽsiŽY•wj: Human Cell, 2(3): 265`271, 1989.

1502. mŒ´’˜n Effects of Serine and Glycine on Proliferation of an Ishikawa Cell Veriant. “n•ÓƒiŽY•wjCHolinka, C.F.CˆÀ¼Œ·C‘ –{”ŽsiŽY•wjCGurpide, E.: J. Steroid Biochem., 34(1-6): 165`168, 1989.

1503. mŒ´’˜n ’鉤؊JpŒã‚ÌŠÇ—;–k—¢‘åŠw•a‰@‚ÌŽÀÛ. ¼“‡³”ŽCª–{‘‘ˆêCVˆä³•viŽY•wj: ƒyƒŠƒlƒCƒ^ƒ‹ƒPƒA, 8(6): 513`519, 1989.

1504. mŒ´’˜n Žq‹{Œz•”ˆÙŒ`¬‚Ìf’f‚ÆŽ¡—Ã. ã–V•qŽqC˜e“c–M•vC²X–Ø‹I[C—Ñ—æŽqCX‘òFsCŠp“cV•½C‘ –{”ŽsCVˆä³•viŽY•wj: Šà‚Ɖ»Šw—Ö@, 16(4): 1592`1597, 1989.

1505. mŒ´’˜n Žq‹{‘ÌŠàƒzƒ‹ƒ‚ƒ“—Ö@‚Ìì—p‹@˜. ‘ –{”ŽsC`GŽ÷C‰Á“¡—ÇŽ÷C`˜aŽqiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jCˆÀ¼Œ·C“n•ÓƒiŽY•wjCHolinka, C.F., Gurpide, E.: Šà‚Ɖ»Šw—Ö@, 16(4): 1851`1857, 1989.

1506. mŒ´’˜n NSTiCST‚ðŠÜ‚Þj. ¼“‡³”ŽiŽY•wj: ŽY‰È‚Æ•wl‰È, 56(‘): 413`419, 1989.

1507. mŒ´’˜n Œv‰æ•ª•Ø‚É‚æ‚霔ՈʬÑ|“Á‚É•ª•ØŒo‰ß‚ɂ‚¢‚Ä|. ¼“‡³”ŽC–ì“c–FlC’F‰pŽ÷C“‡“cMGiŽY•wj: ŽY•wl‰È‚ÌŽÀÛ, 39(2): 273`279, 1990.

1508. mŒ´’˜n ”ŠO‘‚Ì•êŽq‹~‹}‘̧. ¼“‡³”ŽiŽY•wj: ŽüŽYŠúˆãŠw, (—Õ‘): 333`336, 1989.

1509. mŒ´’˜n Žá”NŽq‹{‘ÌŠà‚Ì—Õ°•a—Šw“IŒŸ“¢. ã–V•qŽqC‘å‰ÍŒ´‘C“y‰®Œ³ˆêC‘ –{”ŽsCVˆä³•viŽY•wj: “ú–{ŠàŽ¡—Êw‰ïŽ, 24(10): 2362`2368, 1989.

1510. mŒ´’˜n Žq‹{“à–ŒÇ‚É‚¨‚¯‚錌’†CA19-9‘ª’è‚Ì—Õ°“IˆÓ‹`. “n•ÓƒCã–V•qŽqC`GŽ÷C‘ –{”ŽsiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ, 42(2): 155`161, 1990.

1511. mŒ´’˜n Žq‹{‘ÌŠà‚É”º‚·‚é“à–Œ‘BÇ|‘ÌŠà‚Ì”­¶‚Æ—\Œã”»’è‚ÌŽw•W‚Æ‚µ‚Ă̈Ӌ`‚ɂ‚¢‚Ä|. ‘ –{”ŽsCã–V•qŽqC`GŽ÷C‘å‰ÍŒ´‘iŽY•wj: “ú–{•wl‰È•a—EƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ïŽGŽ, 7(2): 179`184, 1989.

1512. mŒ´’˜n • •ÇŒ¸ˆ³‘•’u‚ÌŽg—pŒoŒ±‚Æ‚»‚ÌŒø‰Ê. ‹ªˆüC—âˆÛtC‘·ˆÔC¼“‡³”ŽCVˆä³•viŽY•wj: •ª•Ø‚Æ–ƒŒ, (65°66): 18`22, 1989.

1513. mŒ´’˜n ³í”D•w‚ÌŒŒ’†•›bó‘Bƒzƒ‹ƒ‚ƒ““®‘Ô. •xŠ~˜a”üCΓc—™CŽRèŒõOi–k—¢ƒ‰ƒ{jCã–V•qŽqC“‡“cMGiŽY•wj: —Õ°•a—, 37(11): 1269`1273, 1989.

1514. mŒ¤‹†•ñi•¶•”Èjn RƒKƒ“ƒ}[ƒZƒ~ƒmƒvƒƒeƒCƒ“ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì‚É‚æ‚é‘O—§‘B–ƉuƒVƒ“ƒ`ƒOƒ‰ƒtƒB[. “¡–ì’WlC–{“c’¼NC‘ºŽR‰ëˆêi”åj: •½¬Œ³”N“x‰ÈŠwŒ¤‹†”ï•â•‹àŽÀÑ•ñ‘Cl989.

1515. m‚»‚Ì‘¼‚Ì•ñn ŽY•wl‰È—̈æ‚É‚¨‚¯‚郌[ƒU[ˆãŠw‹y‚Ñ’†‘‚̈óÛ‹L. ‘ –{”ŽsiŽY•wj: “ú–{ƒŒ[ƒU[ˆãŽ, 9(4): 40`42, 1989.

1516. mÇ—á•ñn Œo’¼’°“I’´‰¹”g’f‘w–@‚ª—L—p‚Å‚ ‚Á‚½ƒ~ƒ…[ƒ‰[ŠÇ”X–E‚Ì1—á. ŒüˆäLÆC‘å–x—CŒàŠ²ƒC“¡–ì’WlC΋´Wi”åj: JSUM Proceedings, (10): 783`784, 1989.

1517. mÇ—á•ñn Ä”­Žq‹{ŒzŠà‚ɑ΂µ‚ÄCDDP-Peplomysin•¹—p‰»Šw—Ö@‚ª—LŒø‚Å‚ ‚Á‚½1—á. Šp“cV•½Cã–V•qŽqC‘ –{”ŽsCVˆä³•viŽY•wj: Oncology & Chemotherapy, 5(3): 288`292, 1989.

1518. mÇ—á•ñn “Á”­«”DP‰©át‚Ì1Ç—á. —§‰ª˜aOCA–ìM…C–ì“c–FlC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGCVˆä³•viŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 26(1): 73`77, 1989.

1519. mÇ—á•ñn ’˜–¾‚ÈŠO‰A•”•‚ŽîAt‹@”\áŠQ‚𔺂Á‚½dÇ”DP’†“ÅÇ‚Ì1—á. Šâ’JO–¾C–ì“c–FlC—§‰ª˜aOC¯“c—²CA–ìM…C‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wjC‰Á“¡–FŽi‰Á“¡ƒ}ƒ^ƒjƒeƒBƒNƒŠƒjƒbƒNj: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 26(2): 47`51, 1990.

1520. mÇ—á•ñn Žq‹{ŒzŠà‚ÌS”X“]ˆÚ‚Ì3—á‚ÌS”X‰t×–EŠŒ©. â–{ˆÉ“¤”üCã–V•qŽqC‘ –{”ŽsiŽY•wjC‘å–ì‰pŽ¡i—ÕŒŸj: “ú–{—Õ°×–EŠw‰ïŽGŽ, 28(6): 885`889, 1989.

1521. mÇ—á•ñn –k—¢‘åŠw•a‰@CPC,@‘æ147‰ñ: Žq‹{ŒzŠà‚ɑ΂·‚骎¡ŽèpŒã‹}Œƒ‚È“]‹A‚ð‚½‚Ç‚Á‚½1—á. ‘ –{”ŽsCŽÂŒ´—m‰îiŽY•wjC‹àŽq‘i•a—j: –k—¢ˆãŠw, 19(2): 281`283, 1989.

1522. mÇ—á•ñn Primary Transitional Cell Carcinoma of the Prostate. A Case Report; Imaging and Histologic Considerations. “¡–ì’WlC‰F“s‹{‘ñŽ¡C‘ˆä‘¥ºC“ü]Œ[Cò”ŽˆêC‰¡ŽR‰p“ñC΋´WC¬ŽÄŒ’i”åjC‘å•”½i•a—j: –k—¢ˆãŠw, 19(4): 452`456, 1989.

1523. m‘àn ‘O—§‘BƒVƒ“ƒ`ƒOƒ‰ƒtƒB[. “¡–ì’Wli”åj: Medical English, 6(10): 4`5, 1989.

1524. m‘àn ‘O—§‘B”ì‘åÇ‚Ì—Õ°|Šú‘Ò‚³‚ê‚é•Û‘¶“IŽ¡—Ö@. ΋´Wi”åj: ƒ‚ƒ_ƒ“ƒƒfƒBƒVƒ“, 18(8): 47`50, 1989.

1525. m‘àn i“ÁWj•aŠú•a‘Ô‚©‚ç‚Ý‚½–òÜ‚Ì‘I‘ð‚Æ“Š—^–@|‘O—§‘B‰Š|. ’r“cŽ C¬ŽÄŒ’i”åj: ˆãŠw‚Æ–òŠw, 21(4): 633`638, 1989.

1526. m‘àn Žq‹{‘ÌŠà‚Ìf’f–@|×–Ef‚Æhysteroscopy|. ã–V•qŽqC‘å‰ÍŒ´‘C‘ –{”ŽsC“‡“cMGiŽY•wj: ŽY‰È‚Æ•wl‰È, 56(4): 972`977, 1989.

1527. m‘àn Žq‹{‘ÌŠàŒŸf‚ÌŽÀÛ. Vˆä³•vC‘ –{”ŽsiŽY•wj: ŽY‰È‚Æ•wl‰È, 56(4): 978`984, 1989.

1528. m‘àn Hysterofiberscopy. ã–V•qŽqC‘ –{”ŽsiŽY•wj: ŽY‰È‚Æ•wl‰È, 56(‘): 215`218, 1989.

1529. m‘àn dÇ”DP’†“ÅÇ‚É‚¨‚¯‚é’鉤؊J–ƒŒ. Vˆä³•vC’F‰pŽ÷C’Jº”ŽC¼“‡³”ŽiŽY•wj: ŽY•wl‰È‚ÌŽÀÛ, 38(9): 1341`1348, 1989.

1530. m‘àn ‹~‹}ˆ’u|‘ÙŽ™;œ”Ոʕª•Ø|. ’F‰pŽ÷C“‡“cMGiŽY•wj: ŽüŽYŠúˆãŠw, 19(—Õ‘): 162`166, 1989.

1531. m‘àn •wl‰ÈŠàf—Âɂ¨‚¯‚é in vitro Œ¤‹†‚̉ž—p. ‘ –{”ŽsC`GŽ÷iŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC`˜aŽqiŽY•wjC”Ñ“c’q”ŽC—јa•Fi¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åj: ‘gD”|—{, 16(3): 98`104, 1990.

1532. m‘àn Žq‹{‘Ì•”‘BŠà‚Ì×–Ef‚É‚æ‚é‘gD•ª‰»“x”»’è. ‘ –{”ŽsiŽY•wjC‘å–ì‰pŽ¡C¡ˆä’‰˜Ni—ÕŒŸj: “ú–{—Õ°×–EŠw‰ïé‹ÊŽx•”‰ïŽ, (6°7): 4`7, 1989.

1533. m‘àn •wl‰ÈŠà”­Ç‚ÌNatural history; Žq‹{‘ÌŠà. ‘ –{”ŽsCã–V•qŽqC`GŽ÷C‘å‰ÍŒ´‘iŽY•wj: —Õ°•wl‰ÈŽY‰È, 44(3): 209`213, 1990.

1534. muÀn ”å”AŠí‰È—̈æ‚̉摜f’f|‘O—§‘BŠà(2). “¡–ì’WlC΋´Wi”åj: —Õ°‰æ‘œ, 5(6): 94`99, 1989.

1535. muÀn ˜V”NŽÒ‚̉摜f’f|˜V”NŽÒ‚Ì”å”AŠíŽ¾Š³‚̉摜f’f. “¡–ì’WlC¬ŽÄŒ’i”åj: ˜V‰»‚ÆŽ¾Š³, 2(12): 2499`2505, 1989.

1536. mŠwp‘n iŽ·•Mj Diagnostic Ultrasound of the Prostate; Transrectal Ultrasonography in the Diagnosis of Primary Transitional Cell Carcinoma of the Prostate: A Case Report, p.157`161, “¡–ì’WlC΋´WC¬ŽÄŒ’i”åj. •ÒW Martin Resnick (Case Western Univ.)•Ò, Elsevier, New York, 89.10.00”­s.

1537. mŠwp‘n iŽ·•Mj ŽY•wl‰Èf—à Q & A; ‰–Ž_ƒŠƒgƒhƒŠƒ“‚ÌŽg‚¢•û, p.106`107, ¼“‡³”ŽiŽY•wj. •ÒW Šâ“c³°iŽœŒbˆã‘åj‘¼•Ò, ˜Z–@o”ÅŽÐ, “Œ‹ž, 89.00.00 ”­s.

1538. mŠwp‘n iŽ·•Mj ŽY•wl‰Èf—à Q & A; ’ǘ^‘æ16†;Žq‹{‘ÌŠàŒŸf, p.1444`1445‚Ì3, ‘ –{”ŽsiŽY•wj. •ÒW Šâ“c³°iŽœŒbˆã‘åj‘¼•Ò, ˜Z–@o”ÅŽÐ, “Œ‹ž, 89.00.00 ”­s.

1539. mŠwp‘n iŽ·•Mj ‚ª‚ñf—à Q & A; ‘æ12†, Žq‹{‘Ì‚ª‚ñ‚Ìf’f•û–@, p.952`955, ‘ –{”ŽsiŽY•wj. •ÒW ”Ñ’Ë‹I•¶C‘¼•Ò, ˜Z–@o”ÅŽÐ, “Œ‹ž, 89.00.00 ”­s.

1540. mŠwp‘n iŽ·•Mj ¡“ú‚ÌŽY•wl‰ÈŽ¡—ÃŽwj; ƒŒ[ƒU[Ž¡—Ë@Ší, p.23`24, ‘ –{”ŽsiŽY•wj. •ÒW ¬–쳕Fi“Œ‘åjC•“c‰À•Fi“Œ—ˆã‘åj•Ò, ˆãŠw‘‰@, “Œ‹ž, 89.06.01 ”­s.

1541. mŠwp‘n iŽ·•Mj Drug TherapyƒRƒ“ƒpƒNƒgƒVƒŠ[ƒY(8)”D•w‚Ö‚Ì“Š–ò; oŽYŽž–ƒŒ‚Ì–â‘è“_, p.237`243, ¼“‡³”ŽiŽY•wj. ƒ~ƒNƒX, “Œ‹ž, 89.12.15 ”­s.

1542. mŠw‰ïn i“Á•Êu‰‰j Žq‹{“à–Œ×–Ef‚ÌÅ‹ß‚Ì“®Œü. ‘ –{”ŽsiŽY•wj: ‘æ7‰ñ“ú–{—Õ°×–EŠw‰ï•ŸˆäŒ§Žx•”ŠwpW‰ï (90.03.17), •Ÿˆä.

1543. mŠw‰ïn i‹³ˆçu‰‰j Žq‹{‘Ì•”×–Ef‚ð‚ß‚®‚Á‚Ä. ã–V•qŽqiŽY•wj: ‘æ8‰ñ“ú–{—Õ°×–EŠw‰ï_“Þ쌧Žx•”’n•û‰ï (89.09.30), ‰¡•l.

1544. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Žq‹{“à–Œ×–Ef‚É‚¨‚¯‚é–Ɖu×–E‰»Šw‚̉ž—p|“Á‚Ƀzƒ‹ƒ‚ƒ“Žó—e‘̂ɂ‚¢‚Ä|. ‘å–ì‰pŽ¡i•a‰@•a—•”jC`GŽ÷C‘ –{”ŽsiŽY•wj: ‘æ30‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï (89.06.15), “Œ‹žC “ú–{—Õ°×–EŠw‰ïŽGŽC28(2): 177, l989.

1545. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Žq‹{‘ÌŠà‚É”º‚·‚é“à–Œ‘BÇ|Žq‹{‘ÌŠà‚ÆŽq‹{“à–Œ‘BÇ‚Ì‘gDŠw“I–â‘è“_|. ‘ –{”ŽsCã–V•qŽqC`GŽ÷C‘å‰ÍŒ´‘iŽY•wj: ‘æ18‰ñ“ú–{•wl‰È¥•a—¥ƒRƒ‹ƒ|Šw‰ï (89.07.28), “Œ‹žC ´˜^WCp.22, 1989.

1546. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Žq‹{‘Ì•”‰ŠúŠà‚Ì×–Ef|Žq‹{Œz•”¥‘Ì•”‘BŠàA‚»‚̉Šú•a•Ï‚ð‚ß‚®‚Á‚Ä|. ‘ –{”ŽsiŽY•wj: ‘æ3‰ñ“ú–{—Õ°×–EŠw‰ïŠÖ“Œ˜A‡‰ïŠwpW‰ï (89.09.09), ¼–{C ƒvƒƒOƒ‰ƒ€Cp.17, 1989.

1547. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Œv‰æ–ƒŒ•ª•Ø‚̃ƒŠƒbƒg¥ƒfƒƒŠƒbƒg. ¼“‡³”ŽiŽY•wj: ‘æ30‰ñ“ú–{•ê«‰q¶Šw‰ï (89.10.27), “Œ‹ž, •ê«‰q¶, 30(4): 560, 1989.

1548. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Žq‹{‘ÌŠàŒŸf‚ÌŽÀÛ‚Æ“W–]G‹³ˆçƒVƒ“ƒ|ƒWƒEƒ€uŠàŒŸf‚ÌŽÀÛ‚Æ“W–]v. ‘ –{”ŽsiŽY•wj: ‘æ78‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.10.29), ‘å‹{C ƒvƒƒOƒ‰ƒ€C1989.

1549. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Žq‹{“à–Œ‘BÇ‚Ì”»’èŠî€i‹³ˆçƒVƒ“ƒ|ƒWƒEƒ€j. ‘å–ì‰pŽ¡i•a‰@•a—•”jC‘ –{”ŽsiŽY•wj: ‘æ28‰ñ“ú–{—Õ°×–EŠw‰ïH‹G‘å‰ï (89.11.16), ‰¡•l, “ú–{—Õ°×–EŽ, 28(5): 606, 1989.

1550. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ŒzŠÇ–DkpŽ{s—á‚Ì—¬‘ŽY‚ÉŠÖ‚·‚錟“¢. –ì“c–FlC’F‰pŽ÷CA–ìM…C’Jº”ŽCª–{‘‘ˆêC‹gŒ´ˆêC¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ266‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï (90.02.17), ‰¡•l.

1551. mŠw‰ïn iƒpƒlƒ‹j ƒGƒXƒgƒƒQƒ“ŽY¶‚ðŽ¦‚µ‚½—‘‘ƒ—Þ“à–ŒŠà‚Ì1—á. ŽRŒû“T—˜C‰º“c—²•vCã–V•qŽqC‘å‰ÍŒ´‘C²“¡—Ï–çC‘ –{”ŽsiŽY•wjCŠâŸºŒ[ˆêi•a—j: ‘æ28‰ñ“ú–{—Õ°×–EŠw‰ïH‹G‘å‰ï (89.11.16), ‰¡•l, “ú–{—Õ°×–EŽ, 28(5): 636, 1989.

1552. mŠw‰ïn iƒpƒlƒ‹j ‘O—§‘BŽîᇃ}|ƒJ|‚Ì”­Œ»‚ÉŠÖ‚·‚é•a—Šw“IŒ¤‹†. ²“¡giŒ`‘ÔŒnjCŒK”ö’èmC‹T’J“Oi•a—j: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.31), •Ÿ‰ª, “ú–{•a—Šw‰ï‰ïŽ, 79(1): 144, 1990.

1553. mŠw‰ïn iƒpƒlƒ‹j ‘O—§‘BŒ´”­¬×–EŠà‚Ì1–UŒŸ—á. ²“¡³Ž÷i“àjC‹àŽq‘C‚ˆä’qŽqCŒÃ’J–[Ž}CŠâŸºŒ[ˆêC‹T’J“OC‰œ•½‰ë•Fi•a—j: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.3l), •Ÿ‰ª.

1554. mŠw‰ïn iƒpƒlƒ‹j ”ñZ«“ûŠÇŠà‚ÆZ«“ûŠÇŠà‚Ì×–EŠw“I”äŠrŒŸ“¢. ‘å–ì‚ß‚®‚ÝC‘å–ì‰pŽ¡i•a‰@•a—•”jC’|’†°KiŠOjC‘ –{”ŽsiŽY•wj: ‘æ28‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïŠwpu‰‰‰ï i89.11.17), ‰¡•l, “ú–{—Õ°×–EŠw‰ïŽGŽ, 28(5): 665, 1989.

1555. mŠw‰ïn iƒpƒlƒ‹j “û‘B‚̃Aƒ|ƒNƒŠƒ“Šà‚Ì1Ç—á. ˆäìˆç‘ãC‘å–ì‰pŽ¡i•a‰@•a—•”jC’|’†°KiŠOjC‘ –{”ŽsiŽY•wj: ‘æ28‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïŠwpu‰‰‰ï i89.11.17), ‰¡•l, “ú–{—Õ°×–EŠw‰ïŽGŽ, 28(5): 672, 1989.

1556. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Žq‹{“à–Œ×–Ef‚É‚æ‚é‘ÌŠà—\Œã”»’è|—\Œã‚©‚ç‚Ý‚½×–Ef|. `GŽ÷C‘ –{”ŽsCã–V•qŽqC‘å‰ÍŒ´‘C‰º“c—²•vCVˆä³•viŽY•wjC‘å–ì‰pŽ¡C”\¨•x²ŽqCo‘º—TŽqi—ÕŒŸj: ‘æ30‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï (89.06.16), “Œ‹žC “ú–{—Õ°×–EŠw‰ïŽGŽC28(2): 184, l989.

1557. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Žq‹{“à–ŒŠà‚̃XƒeƒƒCƒhƒzƒ‹ƒ‚ƒ“Š´Žó«‚Æ‚»‚Ìì—p‹@˜|×–E”|—{‚ƃzƒ‹ƒ‚ƒ“Œ¤‹†|. `GŽ÷C`˜aŽqiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC‰º“c—²•vC‘ –{”ŽsiŽY•wj: ‘æ62‰ñ“ú–{‘gD”|—{Šw‰ï‘å‰ï (89.06.29), ‰¡•lC ‘gD”|—{Œ¤‹†C8(1): 50, l989.

1558. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Effects of Estradiol, Hydroxytamoxifen and Growth Factors on Proliferation of Human Endometrial Adenocarcinoma Cells in Culture. ˆÀ¼Œ·iŽY•wjCHolinka, C.F.iƒ}ƒEƒ“ƒgƒTƒCƒiƒC‘åjC`GŽ÷iŽY•wjCMurphy, L.J.iƒ}ƒjƒgƒo‘åjC‘ –{”ŽsiŽY•wjCGurpide, E.iƒ}ƒEƒ“ƒgƒTƒCƒiƒC‘åj: ‘æ62‰ñ“ú–{‘gD”|—{Šw‰ï‘å‰ï (89.06.29), ‰¡•lC ‘gD”|—{Œ¤‹†C8(1): 75, l989.

1559. mŠw‰ïn iˆê”Êu‰‰j Žq‹{‘ÌŠà‚É‚¨‚¯‚é“à–Œ‘BÇ‚ÆŠeŽí—\ŒãˆöŽq‚Ì‘ŠŠÖ. ‘å‰ÍŒ´‘Cã–V•qŽqC‘ –{”ŽsC“y‰®Œ³ˆêCŠp“cV•½C’†Œ´—DlCVˆä³•viŽY•wj: ‘æ41‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï (89.04.03), ‰ªŽRC “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽC41(Suppl.): S-120, l989.

1560. mŠw‰ïn iˆê”Êu‰‰j –Ɖu×–E‰»Šw–@‚É‚æ‚éŽq‹{‘ÌŠà×–EƒXƒeƒƒCƒhƒzƒ‹ƒ‚ƒ“Žó—e‘̂ƃzƒ‹ƒ‚ƒ“‰ž“š”\‚Ì’è—Ê“I‰ðÍ. `GŽ÷C‘ –{”ŽsiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jCŒË‰êè‹`–¾C‰–’Ép”VC—é–Ø^CVˆä³•viŽY•wj: ‘æ41‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï (89.04.03), ‰ªŽRC “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽC41(Suppl.): S-245, l989.

1561. mŠw‰ïn iˆê”Êu‰‰j Žq‹{‘ÌŠà×–E‚ÌGlycogen‘ãŽÓ‚É‚¨‚æ‚Ú‚·ƒXƒeƒƒCƒhƒzƒ‹ƒ‚ƒ“‚̉e‹¿. `˜aŽqC`GŽ÷iŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC‘ –{”ŽsCVˆä³•viŽY•wj: ‘æ41‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï (89.04.03), ‰ªŽRC “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽC41(Suppl.): S-441, l989.

1562. mŠw‰ïn iˆê”Êu‰‰j ƒ„ƒOƒŒ[ƒU[Eƒoƒ‹[ƒ“–@‚É‚æ‚éŽq‹{o“àŽ¡—Âւ̎Ž‚Ý. ˜e“c–M•vCò‹M•¶C²X–Ø‹I[CçÝŽ–«Cã–V•qŽqC‘ –{”ŽsCVˆä³•viŽY•wj: ‘æ41‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï (89.04.04), ‰ªŽRC “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽC41(Suppl.): S-324, l989.

1563. mŠw‰ïn iˆê”Êu‰‰j Development of Monoclonal Antibody to Gamma Seminoprotein and its Application for Immunohistochemical Study in Prostatic Tissue. “¡–ì’Wli”åjCŒK”ö’èmi•a—jC΋´WC¬ŽÄŒ’i”åj: AUA Eighty Fourth Annual Meeting (89.05.07`11), ƒ_ƒ‰ƒX.

1564. mŠw‰ïn iˆê”Êu‰‰j The Effect of Transurethral Prostatic Resection on the Serum Gamma Seminoprotein Level. “¡–ì’WlC–؋`˜aC‘ºŽR‰ëˆêCˆÉ“¡‹ÏC¬ŽÄŒ’i”åj: AUA Eighty Fourth Annual Meeting (89.05.07`11), ƒ_ƒ‰ƒX.

1565. mŠw‰ïn iˆê”Êu‰‰j ƒk[ƒhƒ}ƒEƒXˆÚAƒqƒgŽq‹{‘ÌŠà‚̃XƒeƒƒCƒh”½‰ž«. ‰Á“¡—ÇŽ÷C‘ –{”ŽsiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC`GŽ÷CX‘òFsiŽY•wj: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ï‘‰ï (89.06.01), “Œ‹ž, “ú–{“à•ª”åŠw‰ïŽGŽ, 65(4): 243, 1989.

1566. mŠw‰ïn iˆê”Êu‰‰j Žq‹{‘ÌŠà×–E‚̃OƒŠƒR[ƒQƒ“‘ãŽÓ‚É‚¨‚¯‚éƒvƒƒQƒXƒ`ƒ“‚ÆEGF‚Ìì—p. `˜aŽqC‘ –{”ŽsC`GŽ÷iŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC‰º“c—²•viŽY•wj: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ï‘‰ï (89.06.02), “Œ‹ž, “ú–{“à•ª”åŠw‰ïŽGŽ, 65(4): 368, 1989.

1567. mŠw‰ïn iˆê”Êu‰‰j —‘‘ƒ—Þ’†tŠà‚É‚¨‚¯‚é×–E‘œ‚Ìוª—Þ‚ÆŠjŒv‘ª. “y‰®Œ³ˆêCã–V•qŽqC˜e“c–M•vC—Ñ—æŽqC‹–ØM”VC‘ –{”ŽsCVˆä³•viŽY•wj: ‘æ30‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï (89.06.15), “Œ‹žC “ú–{—Õ°×–EŠw‰ïŽGŽC28(2): 159, l989.

1568. mŠw‰ïn iˆê”Êu‰‰j ‰ŠúŽq‹{‘ÌŠà‚Ì×–E‘œ|“Á‚É‹Ø‘w”ñZŠà‚Ì×–EŠŒ©‚ɂ‚¢‚Ä|. X‘òFsC‘ –{”ŽsCã–V•qŽqC—Ñ—æŽqC‘å‰ÍŒ´‘C‰Á“¡—ÇŽ÷iŽY•wjC‘å–ì‰pŽ¡i—ÕŒŸj: ‘æ30‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï (89.06.15), “Œ‹žC “ú–{—Õ°×–EŠw‰ïŽGŽC28(2): 195, l989.

1569. mŠw‰ïn iˆê”Êu‰‰j ŠjŒv‘ª‚É‚æ‚émixed Mullerian tumor‚ÌŒŸ“¢. ò‹M•¶C‰º“c—²•vC‘ –{”ŽsC—Ñ—æŽqC˜e“c–M•viŽY•wjC‘å–ì‰pŽ¡C‘å–ì‚ß‚®‚Ýi—ÕŒŸj: ‘æ30‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï (89.06.15), “Œ‹žC “ú–{—Õ°×–EŠw‰ïŽGŽC28(2): 199, l989.

1570. mŠw‰ïn iˆê”Êu‰‰j Žq‹{“à–Œ×–Ef‹U‰A«—á‚ÌŒŸ“¢. ‘å‰ÍŒ´‘Cã–V•qŽqC‘ –{”ŽsCX‘òFsCŠp“cV•½CVˆä³•viŽY•wjC‘å–ì‰pŽ¡C¡ˆä’‰˜Ni—ÕŒŸj: ‘æ30‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï (89.06.15), “Œ‹žC “ú–{—Õ°×–EŠw‰ïŽGŽC28(2): 206, l989.

1571. mŠw‰ïn iˆê”Êu‰‰j Œz•”‘BŠà‚Ìf’fŠm’è‘O‚Ì×–E‘œ‚ÌŒŸ“¢. Šp“cV•½Cã–V•qŽqC‘ –{”ŽsCVˆä³•viŽY•wj: ‘æ30‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï (89.06.16), “Œ‹žC “ú–{—Õ°×–EŠw‰ïŽGŽC28(2): 149, l989.

1572. mŠw‰ïn iˆê”Êu‰‰j Œv‰æ–ƒŒ•ª•Ø‚É‚æ‚霔ՈʊǗ¬Ñ|•ª•ØŒo‰ß‚ɂ‚¢‚Ä|. –ì“c–FlC’F‰pŽ÷C’Jº”ŽCA–ìM…C—é–Ø^C‹gŒ´ˆêC¼“‡³”ŽC“‡“cMGCVˆä³•viŽY•wj: ‘æ77‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.06.18), “Œ‹ž.

1573. mŠw‰ïn iˆê”Êu‰‰j —‘‘ƒ–¢nŠïŒ`Žî‚Ì2—á. Šâ’JO–¾C‰º“c—²•vC‘å‰ÍŒ´‘C–ì“c–FlC•{•s“ñ’jCŽRŒû“T—˜Cã–V•qŽqC‘ –{”ŽsCVˆä³•viŽY•wj: ‘æ77‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.06.18), “Œ‹žC “ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñC(50): 60, l989.

1574. mŠw‰ïn iˆê”Êu‰‰j Žq‹{ŒzŠà‚ÌŽ¡—ìÑ. ‘ –{”ŽsCã–V•qŽqC˜e“c–M•vC‰º“c—²•vCŠp“cV•½CVˆä³•viŽY•wj: ‘æ77‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.06.18), “Œ‹žC “ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñC(50): 98, l989.

1575. mŠw‰ïn iˆê”Êu‰‰j Ä”­Žq‹{ŒzŠà‚ɑ΂·‚鉻Šw—Ö@‚ÌŒŸ“¢. Šp“cV•½Cã–V•qŽqC‘ –{”ŽsC`GŽ÷C‰º“c—²•vC’Òˆä“ÄCVˆä³•viŽY•wj: ‘æ77‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.06.18), “Œ‹žC “ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñC(50): 99`100, l989.

1576. mŠw‰ïn iˆê”Êu‰‰j 50Ζ¢–ž‚Ì‘ÌŠàŠ³ŽÒ‚Ì‘‰ÁŒXŒü‚Æ‚»‚Ì“Á’¥‚ɂ‚¢‚Ä. ‘å‰ÍŒ´‘C‘ –{”ŽsCã–V•qŽqC‰º“c—²•vCŽRŒû“T—˜CVˆä³•viŽY•wj: ‘æ77‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.06.18), “Œ‹žC “ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñC(50): 100`101, l989.

1577. mŠw‰ïn iˆê”Êu‰‰j ’Ê‹CŒŸ¸AŽq‹{—‘ŠÇ‘¢‰eŽ{s—á‚É‚¨‚¯‚é• o‹¾ŠŒ©‚ÌŒŸ“¢. Îì‰ëˆêC—é–Ø^C”Ñ–ì÷“ñC’†‹Œõ¶CVˆä³•viŽY•wjCì“à”ŽlC‹ß“¡M—²CŽO’JmC‚‹´³•qi‘å˜aŽs—§•a‰@j: ‘æ77‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.06.18), “Œ‹žC “ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñC(50): 106, l989.

1578. mŠw‰ïn iˆê”Êu‰‰j Effects of Serine and Glycine on Proliferation of Human Endometrial Adenocarcinoma Cells (Ishikawa) in Serum-free Media. “n•ÓƒCˆÀ¼Œ·iŽY•wjCHolinka, C.F.iƒ}ƒEƒ“ƒgƒTƒCƒiƒC‘åjC‘ –{”ŽsiŽY•wjCGurpide, E.iƒ}ƒEƒ“ƒgƒTƒCƒiƒC‘åj: ‘æ62‰ñ“ú–{‘gD”|—{Šw‰ï‘å‰ï (89.06.30), ‰¡•lC ‘gD”|—{Œ¤‹†C8(1): 101, l989.

1579. mŠw‰ïn iˆê”Êu‰‰j ŋߌoŒ±‚µ‚½‘Šú”­Ç‚ÌdÇ”DP’†“ÅÇ‚Ì2—á. Šâ’JO–¾C–ì“c–FlC—§‰ª˜aOC¯“c—²CA–ìM…C‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ261‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï (89.07.08), ¬“cŒ´.

1580. mŠw‰ïn iˆê”Êu‰‰j _Œo•Û‘¶äNã÷‘O—§‘B‘S“Eœp‚Ì1—á|ƒŠƒWƒXƒLƒƒƒ“‚É‚æ‚épŒã‚Ì•]‰¿|. ŠÑˆä•¶•FC‰ª–{dâXC‰i“cŠ²’ji”åjC“¡–{‹±Žmi¹˜H‰Á‘Û•a‰@jC{ŽRˆê•äi”åjCŽÖ‘ò»i•a—j: ‘æ464‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï (89.07.13), “Œ‹ž, “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 81(1): 146, 1990.

1581. mŠw‰ïn iˆê”Êu‰‰j ƒNƒƒ~ƒtƒFƒ“”r—‘ŒQ‚ÆŽ©‘R”r—‘ŒQ‚É‚¨‚¯‚é”DP‘Šú‚Ì•ê‘ÌŒŒ’†ƒzƒ‹ƒ‚ƒ“’l‚ÌŒŸ“¢. Îì‰ëˆêC•{•s“ñ’jC’†‹Œõ¶iŽY•wjCì“à”Žli‘å˜aŽs—§•a‰@jC¬“c؇Žqi‰Á”[Šâ•a‰@j: ‘æ7‰ñ“ú–{Žó¸’…°Šw‰ïŠwpu‰‰‰ï (89.07.16), •Ÿˆä.

1582. mŠw‰ïn iˆê”Êu‰‰j Žq‹{Œz•”Žîᇂɑ΂·‚郌[ƒU[—Ö@‚Æ‚»‚ÌŒã‚Ì”DP—á. ò‹M•¶C˜e“c–M•vC²X–Ø‹I[C‘ –{”ŽsC“‡“cMGiŽY•wj: ‘æ18‰ñ“ú–{•wl‰È¥•a—¥ƒRƒ‹ƒ|Šw‰ï (89.07.29), “Œ‹ž, “ú–{•wl‰È¥•a—¥ƒRƒ‹ƒ|Ž, 7(2): 207, 1989.

1583. mŠw‰ïn iˆê”Êu‰‰j Žq‹{‘ÌŠàFIGOV¥‹Œ•ª—Þ‚Ì”äŠr. ã–V•qŽqC‘å‰ÍŒ´‘C‘ –{”ŽsC`GŽ÷C‰º“c—²•vCŠp“cV•½C’Òˆä“ÄiŽY•wj: ‘æ18‰ñ“ú–{•wl‰È¥•a—¥ƒRƒ‹ƒ|Šw‰ï (89.07.29), “Œ‹ž, “ú–{•wl‰È¥•a—¥ƒRƒ‹ƒ|Ž, 7(2): 209`210, 1989.

1584. mŠw‰ïn iˆê”Êu‰‰j —‘ŠÇ«•s”D‚ɑ΂·‚éƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[‚¨‚æ‚ÑpŒã‘Šúsecond-look laparoscopy‚É‚æ‚鎡—Âɂ‚¢‚Ä. ì“à”ŽlCŽO’JmC‹ß“¡M—²C‚‹´³•qCÎì‰ëˆêC’†‹Œõ¶iŽY•wj: ‘æ12‰ñŽY•wl‰Èƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ï (89.08.03), Ž­Ž™“‡.

1585. mŠw‰ïn iˆê”Êu‰‰j • o‹¾‚ÅŠm’èf’f‚𓾂½Rokitansky-Kuster-HauserÇŒóŒQ‚Ì1—á. Îì‰ëˆêC’†‹Œõ¶iŽY•wjCì“à”Žli‘å˜aŽs—§•a‰@j: ‘æ29‰ñ“ú–{ŽY‰È•wl‰È“àŽ‹‹¾Šw‰ïŠwpu‰‰‰ï (89.08.04), Ž­Ž™“‡.

1586. mŠw‰ïn iˆê”Êu‰‰j ƒqƒXƒeƒƒtƒ@ƒCƒo[ƒXƒR[ƒv‚ð—p‚¢‚½ƒŒ[ƒU[—Ö@‚ÌŽŽ‚Ý. ˜e“c–M•vCò‹M•¶C²X–Ø‹I[CçÝŽ–«Cã–V•qŽqC‘ –{”ŽsCVˆä³•viŽY•wj: ‘æ29‰ñ“ú–{ŽY‰È•wl‰È“àŽ‹‹¾Šw‰ïŠwpu‰‰‰ï (89.08.05), Ž­Ž™“‡C ´˜^WCp.41.

1587. mŠw‰ïn iˆê”Êu‰‰j • o‹¾Ž{s—á‚É‚¨‚¯‚éŽq‹{—‘ŠÇ‘¢‰eŠŒ©‚ÌŒŸ“¢|…«¥–û«‘¢‰eÜ‚Ì”äŠr. ì“à”ŽlCŽO’JmC‹ß“¡M—²C‚‹´³•qCÎì‰ëˆêC’†‹Œõ¶C”Ñ–ì÷“ñiŽY•wj: ‘æ34‰ñ“ú–{•s”DŠw‰ïŠwpu‰‰‰ï (89.09.02), ˆ®ì, “ú–{•s”DŠw‰ïŽGŽ, 34(3): 685, 1989.

1588. mŠw‰ïn iˆê”Êu‰‰j ƒAƒ“ƒhƒƒQƒ“‰ßè«”r—‘áŠQ—á‚Ì—Õ°“IŒŸ“¢. Îì‰ëˆêCçÝŽ–«C•{•s“ñ’jC’†‹Œõ¶Cì“à”ŽlC”Ñ–ì÷“ñiŽY•wj: ‘æ34‰ñ“ú–{•s”DŠw‰ïŠwpu‰‰‰ï (89.09.03), ˆ®ì, “ú–{•s”DŠw‰ïŽGŽ, 34(3): 603, 1989.

1589. mŠw‰ïn iˆê”Êu‰‰j —‘‘ƒ–¢•ª‰»ãó×–EŽî‚Ì1—á. —§‰ª˜aOCã–V•qŽqCò‹M•¶C`GŽ÷C‘ –{”ŽsiŽY•wj: ‘æ3‰ñ“ú–{—Õ°×–EŠw‰ïŠÖ“Œ˜A‡‰ïŠwpW‰ï (89.09.09), ¼–{C ƒvƒƒOƒ‰ƒ€Cp.7`8, 1989.

1590. mŠw‰ïn iˆê”Êu‰‰j Œ´”­«äNã÷ƒAƒ~ƒƒCƒh[ƒVƒX‚Ì1—á. ‘v¬_C“à“c–LºC’†ðO—²CŒàŠ²ƒCr–ØrsC‘ˆä‘¥ºC‰¡ŽR‰p“ñC^‰ºß•vC΋´WC¬ŽÄŒ’i”åj: ‘æ465‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï (89.09.21), “Œ‹ž.

1591. mŠw‰ïn iˆê”Êu‰‰j Lysis of Adhesions at Second-look Laparoscopy Following Reconstructive Pelvic Surgery. ì“à”ŽlCŽO’JmC‹ß“¡M—²C‚‹´³•qCÎì‰ëˆêi‘å˜aŽs—§•a‰@jC”Ñ–ì÷“ñC’†‹Œõ¶iŽY•wj: World Congress of Gynecologic Endoscopy (89.09.22), Washington, D.C.

1592. mŠw‰ïn iˆê”Êu‰‰j Žq‹{Œz•”‘BˆÙŒ^×–E‚ª”F‚ß‚ç‚êf’f‚É‹ê—¶‚µ‚½1—á. ‰Í‘ºŸ{ŽqCÂŽR—ÑìC“n•Óƒ}ƒŠC–¥—Ö®Žqiì肪‚ñŒŸfƒZƒ“ƒ^[jCâ–{ˆÉ“¤”üiŽY•wjC‹g“c’å—˜iì肪‚ñƒZƒ“ƒ^[jCX‘òFsiŽY•wjC‰ª“‡OKi_ “Þ삪‚ñƒZƒ“ƒ^[jC‘ –{”ŽsiŽY•wjC“V_”ü•viˆÇ‰_“°•a‰@j: ‘æ8‰ñ“ú–{—Õ°×–EŠw‰ï_“Þ쌧Žx•”’n•û‰ï (89.09.30), ‰¡•lC ´˜^WCp.10, 1989.

1593. mŠw‰ïn iˆê”Êu‰‰j RƒÁ-seminoproteinƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì‚É‚æ‚é–Ɖu‘gD‰»Šw“IŒŸ“¢i‘æ3•ñj‘O—§‘BŠà“]ˆÚ‘ƒA‘O—§‘B‚Ì”ñ‘BŠà‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ŒüˆäLÆC“¡–ì’WlC‰F“s‹{‘ñŽ¡C’†ðO—²C‘ºŽR‰ëˆêC‹PºC‰¡ŽR‰p“ñC‰““¡’‰—YC΋´Wi”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06), “Œ‹ž.

1594. mŠw‰ïn iˆê”Êu‰‰j ESWL‚É‚æ‚é”AŠÇŒ‹Î‚ÌŽ¡—ÃA“àŽ‹‹¾Žèp•¹—pÇ—á‚ÌŒŸ“¢. ‹v•Û¯ˆêCΓc—T‘¥CrìFC^‰ºß•vC¬ŽÄŒ’i”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06), “Œ‹ž.

1595. mŠw‰ïn iˆê”Êu‰‰j Œã• –ŒŒ´”­‘ÙŽ™«Šà‚Ì1—á. –{“c’¼NCŒÃ”¨½”VCŒàŠ²ƒC¬—ÑŒ’ˆêC^‰ºß•vC΋´WC¬ŽÄŒ’i”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06), “Œ‹ž.

1596. mŠw‰ïn iˆê”Êu‰‰j ”A“¹Œ`¬pŒã‚Ì”AŽ¸‹Ö‚ɑ΂µ‚Ä”A“¹UŽq•”‚ÉlH”A“¹Š‡–ñ‹ØAMS800‚ðÝ’u‚µ‚ÄŽ¡—µ‚¦‚½1—á. “¡–ì’WlCÝŠy•q–çC{ŽRo•äC‘v¬_C‘å–x—C‰¡ŽR‰p“ñC^‰ºß•vC¬ŽÄŒ’i”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06), “Œ‹ž.

1597. mŠw‰ïn iˆê”Êu‰‰j tŠà‚Ì’·ŠúÄ”­‚ð”F‚ß‚½3—á. {ŽRˆê•äC‰ª–{dâXC‰i“cŠ²’jCŠÑˆä•¶•Fi”åjC“¡–{‹±Žmi¹˜H‰Á‘Û•a‰@jCŽÖ‘ò»CÄ–Ø–ÎŽ÷i”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06), “Œ‹ž.

1598. mŠw‰ïn iˆê”Êu‰‰j tˆÚAŒã‹‘┽‰ž‚ɑ΂·‚éOKT-3‚Ì—LŒø«‚Æ•›ì—p‚ɂ‚¢‚Ä. “ü]Œ[C‰¡“c^“ñCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06), “Œ‹ž.

1599. mŠw‰ïn iˆê”Êu‰‰j Coexistence of Hyperplasia to Endometrial Carcinoma. ã–V•qŽqC‘ –{”ŽsC‘å‰ÍŒ´‘C`GŽ÷CVˆä³•viŽY•wj: 2nd Meeting of the International Gynecologic Cancer Society (89.10.09), Toronto, Abstracts, p.220, 1989.

1600. mŠw‰ïn iˆê”Êu‰‰j Alteration of the Treatment for Early Carcinoma of the Cervix. ‘ –{”ŽsCã–V•qŽqC˜e“c–M•vC‰º“c—²•vC—Ñ—æŽqCVˆä³•viŽY•wj: 2nd Meeting of the International Gynecologic Cancer Society (89.10.09), Toronto, Abstracts, p.255, 1989.

1601. mŠw‰ïn iˆê”Êu‰‰j Œo’¼’°“I’´‰¹”g’f‘w–@‚ª—L—p‚Å‚ ‚Á‚½ƒ~ƒ…[ƒ‰[ŠÇ”X–E‚Ì1—á. ŒüˆäLÆC‘å–x—CŒàŠ²ƒC“¡–ì’WlC΋´Wi”åj: ‘æ55‰ñ“ú–{’´‰¹”gˆãŠw‰ï (89.10.19), •Ÿ‰ª.

1602. mŠw‰ïn iˆê”Êu‰‰j •ª•Ø’†‚Ìvariable decelerationoŒ»—vˆö‚ÉŠÖ‚·‚錟“¢. A–ìM…Cª–{‘‘ˆêC’Jº”ŽC–ì“c–FlC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ12‰ñŽY‰È•wl‰ÈME§˜b‰ï (89.10.20), ‘åã.

1603. mŠw‰ïn iˆê”Êu‰‰j Žq‹{Œz•”¬×–EŠà”|—{Š”(HCSC-1)‚É‚¨‚¯‚é_Œo“à•ª”åƒ}[ƒJ[‚Ì•ª”å’²ß. ‰º“c—²•vC‘ –{”ŽsC‰Á“¡—ÇŽ÷C`GŽ÷C`˜aŽqiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“j: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ïH‹GŠwp‘å‰ï (89.10.20), ŽD–y, “ú–{“à•ª”åŠw‰ïŽ, 65(9): 883, 1989.

1604. mŠw‰ïn iˆê”Êu‰‰j EDAP LT-01‚É‚æ‚é”AŠÇŒ‹Î130—á‚ÌŽ¡—ÃŒoŒ±. ‰F“s‹{‘ñŽ¡Cìã’B‰›C_è­—TC–å˜e˜abC^‰ºß•vi”åj: ‘æ41‰ñ“ú–{”å”AŠí‰ÈŠw‰ï¼“ú–{‘‰ï (89.10.20`22), ’·è.

1605. mŠw‰ïn iˆê”Êu‰‰j ‘O—§‘BŠà‚ðŠÜ‚Þd•¡ˆ««Žîᇊ³ŽÒ‚̶–½—\Œã‚ÌŒŸ“¢. ‘ò‘º³”VCó–ì—F•FC¬“c“‡–M’jC’·‘q˜a•FC‰Æ“c˜a•vC‘ºˆäŸC’†‘ºGi”åj: ‘æ41‰ñ“ú–{”å”AŠí‰ÈŠw‰ï¼“ú–{‘‰ï (89.10.20`22), ’·è, —\eW, p.47, 1989.

1606. mŠw‰ïn iˆê”Êu‰‰j tƒVƒ“ƒ`ƒOƒ‰ƒ€‚É‚¨‚¯‚é123I-OIH‚Æ131I-OIH‚Ì—Õ°“I”äŠr. ŒàŠ²ƒC“¡–ì’WlC΋´Wi”åjCΈ䟌ÈC’†‘òŒ\Ž¡CˆË“cˆêdi•új: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (89.10.21), ‘å’Ã, ŠjˆãŠw, 26: 1086, 1989.

1607. mŠw‰ïn iˆê”Êu‰‰j Effects of Oral Prostaglandin E2, Laminaria, and their Combination as the Means for Preinduction Priming in Electively Induced Labors. ¼“‡³”ŽC–ì“c–FlC‹ªˆüC ’F‰pŽ÷C‹gŒ´ˆêC“‡“cMGiŽY•wj: The 2nd World Symposium: Computers in the Care of the Mother, Fetus and Newborn (89.10.24), ‹ž“s, J. Perinat. Med., 17(Suppl.): 112, 1989.

1608. mŠw‰ïn iˆê”Êu‰‰j Žq‹{‘ÌŠà×–E‚̃OƒŠƒR[ƒQƒ“‘ãŽÓ‚ɑ΂·‚鉩‘̃zƒ‹ƒ‚ƒ“ì—p‚̉ðÍ. `˜aŽqC‘ –{”ŽsC`GŽ÷iŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC‰º“c—²•vC“n•ÓƒiŽY•wj: ‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï (89.10.24), –¼ŒÃ‰®, ‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï‹LŽ–, p.182, 1989.

1609. mŠw‰ïn iˆê”Êu‰‰j Žq‹{‘ÌŠà×–EEGFŽó—e‘̂̉ðÍ. `GŽ÷C‘ –{”ŽsC`˜aŽqiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC‰º“c—²•vCŒË‰êè‹`–¾iŽY•wj: ‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï (89.10.25), –¼ŒÃ‰®, ‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï‹LŽ–, p.190, 1989.

1610. mŠw‰ïn iˆê”Êu‰‰j “à–Œ‘BÇ‚ð‡•¹‚·‚é‘ÌŠà‚Ì‘‰ÁŒXŒü‚ɂ‚¢‚Ä. ‘å‰ÍŒ´‘C‘ –{”ŽsCã–V•qŽqC`GŽ÷CŠp“cV•½CŽRŒû“T—˜CVˆä³•viŽY•wj: ‘æ27‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (89.10.25), –¼ŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŽGŽ, 24(9°2): 1930, 1989; 25(2): 232, 1990.

1611. mŠw‰ïn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚éŽq‹{ŒzŠà‚ÌŽ¡—ìÑ. Šp“cV•½C‘ –{”ŽsCã–V•qŽqC`GŽ÷C‰º“c—²•vC—Ñ—æŽqCª–{—æŽqCVˆä³•viŽY•wj: ‘æ27‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (89.10.27), –¼ŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŽGŽ, 24(9°2): 2131, 1989; 25(2): 416, 1990.

1612. mŠw‰ïn iˆê”Êu‰‰j —‘‘ƒŠàSecond look operation‚̬Ñ. ’Òˆä“ÄCã–V•qŽqC‰º“c—²•vC˜e“c–M•vCçÝŽ–«C‘ –{”ŽsCVˆä³•viŽY•wj: ‘æ27‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (89.10.27), –¼ŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŽGŽ, 24(9°2): 2139, 1989; 25(2): 424, 1990.

1613. mŠw‰ïn iˆê”Êu‰‰j —‘‘ƒŠà‰»Šw—Ö@‚ÌŒø‰Ê”»’è‚É‚¨‚¯‚éŽîᇃ}[ƒJ[CA125‚̈Ӌ`‚ÉŠÖ‚·‚éŠî‘b“IŒŸ“¢. ”Ñ“c’q”Ži¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åjC`GŽ÷C‰º“c—²•vC‘ –{”ŽsCVˆä³•viŽY•wjC—јa•FC•l“cGi¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åj: ‘æ27‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (89.10.27), –¼ŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŽGŽ, 24(9°2): 2215, 1989; 25(2): 496, 1990.

1614. mŠw‰ïn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚éITP‡•¹”DP¥•ª•Ø‚ÌŒŸ“¢. ¯“c—²C–ì“c–FlCA–ìM…Cª–{‘‘ˆêC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ78‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.10.29), ‘å‹{.

1615. mŠw‰ïn iˆê”Êu‰‰j ³í”D•w‚Ì•ê‘ÌŒŒ‚Æä`‘ÑŒŒ‚̃wƒpƒvƒ‰ƒXƒ`ƒ“ƒeƒXƒg‚ÌŠÖŒW‹y‚уrƒ^ƒ~ƒ“K2ŒoŒû“Š—^‚̉e‹¿‚ɂ‚¢‚Ä. Šâ’JO–¾C–ì“c–FlCA–ìM…C’Jº”ŽC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ78‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.10.29), ‘å‹{.

1616. mŠw‰ïn iˆê”Êu‰‰j —‘ŠÇŠà6—á‚Ì—Õ°•a—Šw“IŒŸ“¢. ‹v“ˆ‘¥sCã–V•qŽqC‘O“c@“¿C’†Œ´—DlC‘ –{”ŽsiŽY•wj: ‘æ78‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.10.29), ‘å‹{C ƒvƒƒOƒ‰ƒ€CNo.110, 1989.

1617. mŠw‰ïn iˆê”Êu‰‰j Žq‹{ŒzŠàS”X“]ˆÚ—á‚Ì—Õ°•a—Šw“IŒŸ“¢. â–{ˆÉ“¤”üCã–V•qŽqC‰º“c—²•vC‘å‰ÍŒ´‘CŠp“cV•½CŽRŒû“T—˜C‘ –{”ŽsiŽY•wj: ‘æ78‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.10.29), ‘å‹{C ƒvƒƒOƒ‰ƒ€CNo.27, 1989.

1618. mŠw‰ïn iˆê”Êu‰‰j —‘‘ƒ—Þ’†tŠà‚Ì—Õ°•a—Šw“IŒŸ“¢. “y‰®Œ³ˆêCã–V•qŽqC`GŽ÷C’Òˆä“ÄCŠâ’JO–¾C¡ˆä‰ë•vC‹–ØM”VC‘ –{”ŽsiŽY•wj: ‘æ78‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.10.29), ‘å‹{C ƒvƒƒOƒ‰ƒ€CNo.47, 1989.

1619. mŠw‰ïn iˆê”Êu‰‰j MRI‚É‚¨‚¯‚éŽq‹{‘ÌŠà‚Ìis“x”»’è. ŽRŒû“T—˜C‘å‰ÍŒ´‘C`GŽ÷C‰º“c—²•vCã–V•qŽqC¡ˆä‰ë•vC‘ –{”ŽsiŽY•wj: ‘æ78‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.10.29), ‘å‹{C ´˜^WCNo.30, 1989.

1620. mŠw‰ïn iˆê”Êu‰‰j The Pregnancy after Laser Therapy for the Treatment of Uterine Cervical Neoplasia. ˜e“c–M•vCò‹M•¶C‘ –{”ŽsC²X–Ø‹I[C“‡“cMGiŽY•wj: 8th Congress of the International Society for Laser Medicine and Surgery (89.11.05), Taipei, Surgical and Medical Lasers, 2(2-3): 139, 1989.

1621. mŠw‰ïn iˆê”Êu‰‰j Trial of Laser Hysteroscopy. ò‹M•¶C˜e“c–M•vC²X–Ø‹I[C‘ –{”ŽsiŽY•wj: 8th Congress of the International Society for Laser Medicine and Surgery (89.11.05), Taipei, Surgical and Medical Lasers, 2(2-3): 141, 1989.

1622. mŠw‰ïn iˆê”Êu‰‰j Žq‹{“à–ŒŸ÷‰t«‘BŠà‚Ì×–EŠŒ©. —§‰ª˜aOCã–V•qŽqC`GŽ÷CçÝŽ–«C—Ñ—æŽqC‘ –{”ŽsC‰Á“¡—ÇŽ÷iŽY•wj: ‘æ28‰ñ“ú–{—Õ°×–EŠw‰ïH‹G‘å‰ï (89.11.16), ‰¡•l, “ú–{—Õ°×–EŽ, 28(5): 623, 1989.

1623. mŠw‰ïn iˆê”Êu‰‰j Žq‹{“à–Œ×–Ef‚Å„’肵“¾‚½Žq‹{“à–ŒŠÔŽ¿“÷Žî‚Ì1—á. ã•Ð•½º“ñCã–V•qŽqCŽÂŒ´—m‰îC˜e“c–M•vC’Òˆä“ÄC¡ˆä‰ë•vC‘ –{”ŽsiŽY•wj: ‘æ28‰ñ“ú–{—Õ°×–EŠw‰ïH‹G‘å‰ï (89.11.16), ‰¡•l, “ú–{—Õ°×–EŽ, 28(5): 629, 1989.

1624. mŠw‰ïn iˆê”Êu‰‰j ƒTƒCƒgƒuƒ‰ƒVÌŽæ‚É‚æ‚éŽq‹{ŒzŠÇ×–Ef. —Ñ—æŽqC‘ –{”ŽsCã–V•qŽqCò‹M•¶CŠp“cV•½CŠâ’JO–¾Câ–{ˆÉ“¤”üiŽY•wjC‘å–ì‰pŽ¡C‰¡ŽR‘åi•a‰@•a—•”j: ‘æ28‰ñ“ú–{—Õ°×–EŠw‰ïH‹G‘å‰ï (89.11.16), ‰¡•l, “ú–{—Õ°×–EŽ, 28(5): 642, 1989.

1625. mŠw‰ïn iˆê”Êu‰‰j d–ŒŠO–ƒŒ•ª•Ø‚Ì•ª•Ø—\Œã‚ÉŠÖ‚·‚錟“¢. A–ìM…C—§‰ª˜aOC–ì“c–FlC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ264‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï (89.12.16), ‰¡•l.

1626. mŠw‰ïn iˆê”Êu‰‰j ãO–ÑŠà‚Æ—‘‘ƒ—Þ’†tŠà‚ª“¯Žžd•¡‚µ‚½1—á. ²“¡—Ï–çCã–V•qŽqCŠp“cV•½C`GŽ÷Cª–{—æŽqC‰º“c—²•vC‘ –{”ŽsC“cŒû–¾iŽY•wj: ‘æ265‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï (90.01.20), ‰¡•l.

1627. mŠw‰ïn iˆê”Êu‰‰j ”DP’†Šú‚É‹}«• Ç‚Ì‚½‚ßtermination‚ðs‚Á‚½1—á. ¯“c—²C’Jº”ŽC–ì“c–FlCª–{—æŽqC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ266‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï (90.02.17), ‰¡•l.

1628. mŠw‰ïn iˆê”Êu‰‰j —‘‘ƒŠàŽ¡—ÃŒã‚Ì”DP¥oŽY—á. Šâ’JO–¾Cò‹M•¶C’Òˆä“ÄCã–V•qŽqC‘ –{”ŽsiŽY•wj: ‘æ267‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï (90.03.17), ‰¡•l.

1629. mŠw‰ïn iˆê”Êu‰‰j ¸Žq•úo‰ß’ö‚É‚¨‚¯‚é Ectoplasmic specialization ‚̕ω». ŽðˆäNOCŽR‰È³•½i‰ðj: ‘æ94‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i89.04.03), ‹{è, ‰ð–UŠwŽGŽ, 64(4): 204, 1989.

1630. mŠw‰ïn iˆê”Êu‰‰j ¸Žq•úo‹y‚Ñ×–EŽ¿ˆâŽc‚ÌŽæ‚螂݉ߒö‚É‚¨‚¯‚é Ectoplasmic specialization ‚Ì“®‘Ô. ŽðˆäNOCŽR‰È³•½i‰ðj: ‘æ22‰ñ“ú–{”­¶¶•¨Šw‰ï i89.06.22), ŽD–y, —\eW, p.75, l989.

1631. mŠw‰ïn iˆê”Êu‰‰j “€Œ‹Š„’f–@‚É‚æ‚é¸ã”ç×–EŠj‚Ì—§‘ÌŠÏŽ@. ’†–{’¼i‰ðj: ‘æ22‰ñ“ú–{”­¶¶•¨Šw‰ï i89.06.23), ŽD–y, Develop. Growth & Differ., 31(4): 416, l989.

1632. mŒ¤‹†‰ïn i“Á•Êu‰‰j Ø”—‘ŽY¥‘OŠú”j…. ¼“‡³”ŽiŽY•wj: ‰¡{‰êŽsŽY•wl‰Èˆã‰ï (89.07.12), ‰¡{‰ê.

1633. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‰»Šw—Ö@Ü‚Ì‘O—§‘B‘gD“à•ª•z‚ÌŒŸ“¢. ’r“cŽ C¼‘º´ŽuC΋´Wi”åj: ‘æ1‰ñ‘O—§‘B‰ŠƒVƒ“ƒ|ƒWƒEƒ€ (89.08.26), “Œ‹ž.

1634. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‚—îŽÒ‚É‚¨‚¯‚éŽq‹{‘Ì‚ª‚ñŒŸf‚Ì–â‘è“_G‚—îŽÒŽq‹{‚ª‚ñŒŸf‚Ì”–â‘è. ‘ –{”ŽsiŽY•wj: ‘æ20‰ñ•wl‰ÈW’cŒŸfƒVƒ“ƒ|ƒWƒEƒ€ (89.11.18), “Œ‹žC ‹L˜^WCp.10`11, 1989.

1635. mŒ¤‹†‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj ƒGƒXƒgƒƒQƒ“‚ÆŽq‹{‘ÌŠàGX”NŠú‚Ì–ò•¨—Ö@. ‘ –{”ŽsiŽY•wj: X”NŠúˆãŠwŒ¤‹†‰ï‘æ4‰ñŠwpW‰ï (89.11.26), “Œ‹žC —vŽ|WCp.3`4, 1989.

1636. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒŒ[ƒU[Ž¡—Â̌»‹µ|ƒAƒƒŠƒJ‚ÌŽ{Ý‚ÌŒ»‹µ|. ˜e“c–M•viŽY•wj: ‘Š–ÍŒ´ŽsŽY•wl‰Èˆã‰ï (89.06.21), ‘Š–ÍŒ´.

1637. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘O—§‘B”ì‘åÇpŒã‚Ì‘O—§‘BŠà‚ɂ‚¢‚Ä. ‰i“cŠ²’jC‰ª–{dâXCŠÑˆä•¶•Fi”åjC“¡–{‹±Žmi¹˜H‰Á‘Û•a‰@jC{ŽRˆê•äi”åj: ‘æ6‰ñ_“Þì‘O—§‘BŽîᇌ¤‹†‰ï (89.07.08), ‰¡•l.

1638. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘ŠúŽq‹{‘ÌŠà‚Ì×–Ef’f. ‘ –{”ŽsCX‘òFsCã–V•qŽqiŽY•wj: Œú¶È‘΂ª‚ñí—ªŒ¤‹†Ž–‹Æu‚ª‚ñ‚Ì“ñŽŸ—\–h‚ÌŒø‰Ê“I‚ÈŽÀŽ{‚É‚¨‚¯‚éŠî‘b“I‚ÈŒ¤‹†vi“V_”Çj”ljï‹c (89.07.18).

1639. mŒ¤‹†‰ïn iˆê”Êu‰‰j Žq‹{‘ÌŠàISHIKAWAŠ”‚̃k[ƒhƒ}ƒEƒXˆÚAŽîᇂɂ¨‚¯‚éƒzƒ‹ƒ‚ƒ“”½‰ž«. ‰Á“¡—ÇŽ÷C‘ –{”ŽsiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC`GŽ÷CX‘òFsC‰º“c—²•viŽY•wj: ‘æ7‰ñƒqƒg×–EŒ¤‹†‰ï‘å‰ï (89.08.29), “Œ‹ž, Human Cell, 2(3-Suppl.): 32, 1989.

1640. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ä”­—‘‘ƒŠà‚ɑ΂·‚éPE—Ö@. ŽR“c“T—˜C‰º“c—²•vCŠp“cV•½C²“¡—Ï–çCã–V•qŽqC‘ –{”ŽsiŽY•wj: ‘æ2‰ñ_“ÞìŽY•wl‰ÈŽîᇌ¤‹†‰ï (89.09.29), ‰¡•l.

1641. mŒ¤‹†‰ïn iˆê”Êu‰‰j p‘O‰»Šw—Ö@Ž{s—á‚ÌCA125, CA19-9‚Ì„ˆÚ‚Æ“Eo•W–{‚Ì•a—ŠŒ©‚ÉŠÖ‚·‚錟“¢. ’Òˆä“ÄCã–V•qŽqC`GŽ÷CŠp“cV•½C‘å‰ÍŒ´‘C‰º“c—²•vC‘ –{”ŽsiŽY•wj: “ú–{•wl‰Èˆ««Žîᇉ»Šw—Ö@Œ¤‹†‰ï‘æ2‰ñŠwpW‰ï (89.11.11), “Œ‹ž, ´˜^WCp.40, 1989.

1642. mŒ¤‹†‰ïn iˆê”Êu‰‰j •wl‰Èˆ««Žîᇂɑ΂·‚éCDDP-THP-CPA—Ö@‚Ì•›ì—p‚ÉŠÖ‚·‚錟“¢. çÝŽ–«C‰º“c—²•vC¡ˆä‰ë•vCã–V•qŽqC˜e“c–M•vC`GŽ÷C‘ –{”ŽsiŽY•wj: “ú–{•wl‰Èˆ««Žîᇉ»Šw—Ö@Œ¤‹†‰ï‘æ2‰ñŠwpW‰ï (89.11.11), “Œ‹žC ´˜^WCp.50, 1989.

1643. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ä”­‚ðŒJ‚è•Ô‚·‚àPSK“Š—^‚ðs‚¢’·Šú¶‘¶‚µ‚Ä‚¢‚éŽq‹{ŒzŠà‚Ì1—á. ŽRŒû“T—˜C‰º“c—²•vCçÝŽ–«C’Òˆä“ÄC‘ –{”ŽsiŽY•wj: ‘æ13‰ñŠàŽ¡—ç˜b‰ï (89.12.02), ‰¡•l.

1644. mŒ¤‹†‰ïn iˆê”Êu‰‰j —‘‘ƒŽîᇂÌf’f‚É‚¨‚¯‚éŽîᇃ}[ƒJ[CA72-4‚Ì—L—p«‚ɂ‚¢‚Ä. ²“¡—Ï–çC`GŽ÷C‰º“c—²•vCŠp“cV•½C—Ñ—æŽqCã–V•qŽqC‘ –{”ŽsiŽY•wj: ‘æ6‰ñŽY•wl‰ÈŽîᇃ}[ƒJ[Œ¤‹†‰ï (90.02.02), “Œ‹žC ´˜^WCp.55, 1990.

1645. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹Ø‘w”ñZ‘Ì‚ª‚ñ‚Ì‘gDŠw“I”wŒi. ‘ –{”ŽsCã–V•qŽqC‘å‰ÍŒ´‘iŽY•wj: Œú¶È‘΂ª‚ñí—ªŒ¤‹†Ž–‹Æu‚ª‚ñ‚Ì“ñŽŸ—\–h‚ÌŒø‰Ê“I‚ÈŽÀŽ{‚É‚¨‚¯‚éŠî‘b“I‚ÈŒ¤‹†vi“V_”Çj”ljï‹c (90.02.13), “Œ‹ž.

1646. mŒ¤‹†‰ïn iˆê”Êu‰‰j Significance of Elective Induction of Labor and its Problem. ¼“‡³”ŽiŽY•wj: ‘æ4‰ñ‰¡{‰êŽY•wl‰ÈŒ¤‹†‰ï (90.02.21), ‰¡{‰ê.

1647. mŒ¤‹†‰ïn iŒöŠJuÀj Žq‹{“à–Œ×–Ef. ‘ –{”ŽsiŽY•wj: ˆÇ—Ñ‘åŠw•ÛŒ’Šw•”×–EŒŸ¸Žm—{¬uÀ (89.04.28), “Œ‹ž.

1648. mŒ¤‹†‰ïn iŒöŠJuÀj Žq‹{Œz•”‘BŠà. ‘ –{”ŽsiŽY•wj: ŠàŒ¤‹†‰ï•t‘®×–EŒŸ¸Žm—{¬Š (89.05.24), “Œ‹ž.

1649. mŒ¤‹†‰ïn iŒöŠJuÀj ‘ÌŠàŒŸf‚ÌŽÀÛ. ‘ –{”ŽsiŽY•wj: _“Þ쌧‚ÀŒSŽY•wl‰Èˆã‰ï—á‰ï (89.05.30), Œú–Ø.

1650. mŒ¤‹†‰ïn iŒöŠJuÀj Žq‹{‘ÌŠà‚Ìf’fA‰uŠwAŽ¡—Âɂ‚¢‚Ä. ‘ –{”ŽsiŽY•wj: ]ŒËìŽY•wl‰ÈˆãŽt‰ïŽåÃ]“Œ¥ç—t¼ƒuƒƒbƒN‡“¯‘²ŒãŒ¤C‰ï (89.06.14), “Œ‹ž.

1651. mŒ¤‹†‰ïn iŒöŠJuÀj Žq‹{‘ÌŠà|Å‹ß‚Ì“®Œü‚Æ‚»‚Ìf’f. ‘ –{”ŽsiŽY•wj: ìèŽsŽY•wl‰Èˆã‰ï—á‰ï (89.07.15), ìè.

1652. mŒ¤‹†‰ïn iŒöŠJuÀj Žq‹{‘Ì‚ª‚ñ‚Ì×–Ef‚ɂ‚¢‚Ä. ‘ –{”ŽsiŽY•wj: “ú–{•ê«•ÛŒìˆã‹¦‰ïɪŒ§Žx•”Žq‹{ŠàŒŸfˆãŽtŒ¤C‰ï (89.08.12), ɪ.

1653. mŒ¤‹†‰ïn iŒöŠJuÀj Žèp‚ð‚µ‚È‚¢Ž¡—Ö@:@Žq‹{Œz•”‚Ì‘ŠúŠà¥‘OŠà•a•Ï‚ɑ΂·‚é•Û‘¶—Ö@. ‘ –{”ŽsiŽY•wj: _“Þ쌧‘åŠwŒöŠJuÀ (89.10.28), ‘Š–ÍŒ´, “¯u‹`—vj, p.41`43, 1989.

1654. mŒ¤‹†‰ïn iŒöŠJuÀj Žq‹{Œz•”A‘Ì•”‘BŠà‚Ì×–Ef. ‘ –{”ŽsiŽY•wj: •½¬Œ³”N“xŒú¶È‚ª‚ñ—\–h‹ZpEˆõiˆãŽtjŒ¤C‰ï (90.02.07), “Œ‹ž.

1655. mŒ¤‹†‰ïn iŒöŠJuÀj Žq‹{ŠàŒŸf. ‘ –{”ŽsiŽY•wj: “Œ‹ž“s’¬“cŽsˆãŽt‰ï (90.03.12), ’¬“c.


<<109 ‹ØœŠi>>

1656. mŒ´’˜n •ÏŒ`«ŒÒŠÖßÇ‚ÌŽ©‘RŒo‰ß‚Ì‚wüŠw“IŒ¤‹†. •Ä–{ŒõˆêCŽ…–ž·Œ›C»•ÓŠ®Ž¡CŠÖŒû¹˜aC¼ŽR—TCŽR–{^i®ŠOj: Hip Joint, 15: 39`43, 1989.

1657. mŒ´’˜n Corrosion Fatigue Properties of surgical Implants in a Living Body. X“c^Žji¶‘ÌHjCù“c’¼i“ŒH‘åjCH. HayahsiC’Ë–{s’ji®ŠOj: J. Biomed. Maters Res., 22(6): 529`540, 1988.

1658. mŒ´’˜n Chinese Enternal Fixation Treatment for Fractures of the Distal End of the Radius. “ñŒ©r˜YCŽR–{^i®ŠOj: J. Hand. Surgery, 14(6): 1028`1032, 1989.

1659. mŒ´’˜n Problems in the Management of Open Articular Fractures of the Ankle. Ž…–ž·Œ›Cù–{Œ›’jC¬—Ñ–¾³C»•ÓŠ®Ž¡C‘O“cŒ’“ñCŽO—Ö´ŽuCã“cºŒáCŽR–{^i®ŠOj: JJTOM, 37(10): 630`636, 1989.

1660. mŒ´’˜n In Vivo Corrosion Fatigue Behaviors of Surgical Implants. X“c^Žji¶‘ÌHjCH. HayashiCù“c’¼i“ŒH‘åjC’Ë–{s’ji®ŠOj: Proc. 31st. Jpn. Cong. Maters Res., p.195`199, 1988.

1661. mŒ´’˜n Evaluation of Wear Toxicity in Biomaterials with Cell Culture Method. ù“c’¼i“ŒH‘åjCT. Imaizumi CX“c^ŽjC”nŸº´Ž‘i¶‘ÌHj: Proc. 31st. Jpn. Cong. Maters Res., p.200`205, 1988.

1662. mŒ´’˜n Corrosion Fatigue Test for SUS316 Stainless Steel in Quasi-Living Body Fluid. X“c^ŽjCù“c’¼i¶‘ÌHjC–쑺ŒM: Proc. 32nd. Jpn. Cong. Maters. Res., 70`74, 1989.

1663. mŒ´’˜n Effects of FK-506 on Collagen Arthritis in Mice. ‚ŠÝŒ›“ñCŽR–{^C¼‘º–¾lCŽRèŠÞC‹à‘òC˜ÅŸºF•vCŠLŒ´MãEi®ŠOj: Transplantation Proceedings, 21(1): 1063`1065, 1989.

1664. mŒ´’˜n ŠOŒã‚ÌŽî’¯¥áu’ɂɑ΂·‚éƒtƒ‹ƒ‹ƒrƒvƒƒtƒFƒ““\•zÜ(EP-A)‚Ì—Õ°•]‰¿. –،ՋgC‰Í˜H“nC›Œ´KŽqCŽOD–M’BCŽR–{^C¬ì’¨–çi®ŠOj: ‰ŠÇC9(3): 255`262, 1989.

1665. mŒ´’˜n ŽèŠÖß•”œx‘Ñ‘¹‚Ǝ誕sˆÀ’èÇ. “ñŒ©r˜YCŽR–{^i®ŠOj: ŠÖߊO‰ÈC8(11): 1579`1584, 1989.

1666. mŒ´’˜n Multiple Pinning–@‚ð‘æˆê‘I‘ð‚Æ‚µ‚½‘å‘ÚœŒz•”“à‘¤œÜÜ‘N—á‚ÌŽ¡—Ã. ŠÖŒû¹˜aC‰Í–춒ˆC{ìŒMC’·–샓ñC–©òC¬—Ñ—ÇGCŠ}Œ´rºi®ŠOj: ŠÖߊO‰ÈC8(4): 447`455, 1989.

1667. mŒ´’˜n Œ¨Ž¾Š³‚ɑ΂·‚éMRI. ‚ŠÝŒ›“ñC‘O“cŒ’“ñCù–{Œ›’jC•Ä–{ŒõˆêC’Ë–{s’jCŽR–{^i®ŠOjC’r“crºi•új: ŠÖ“Œ®ÐŽC20(5): 441`443, 1989.

1668. mŒ´’˜n ŠÏŒŒ“IŽ¡—Âðs‚Á‚½½œœÜ‚Ì—Õ°¬Ñ. ¼‘º–¾lCù–{Œ›’jC‚ŠÝŒ›“ñC»•ÓŠ®Ž¡C‰¡ŽRˆê•FCŽR–{^i®ŠOj: ŠÖ“Œ®ÐŽC20(6): 548`552, 1989.

1669. mŒ´’˜n ‰~“›“B‚Ë‚¶‰¡Ž~‚ß–@‚ð—p‚¢‚½Condylo-cephalic Nailing‚ɂ‚¢‚Ä. ŽO—Ö´ŽuCù–{Œ›’jC–k’ÜLmC‘O“cŒ’“ñCŽ…–ž·Œ›CŽR–{^i®ŠOj: œÜC11: 116`120, 1989.

1670. mŒ´’˜n ”牺ˆø‚«Šñ‚¹|ü’÷Œ‹–@‚É‚æ‚é•GŠWœœÜ‚ÌŽ¡—Ã. Ž…–ž·Œ›Cù–{Œ›’jCŽR–{^C»•ÓŠ®Ž¡C‰¡ŽRˆê•Fi®ŠOj: œÜC11: 125`131, 1989.

1671. mŒ´’˜n žôœŒz•”œÜ‚ɑ΂·‚é‚í‚ê‚í‚ê‚ÌŽ¡—Õûj. ¬—Ñ–¾³CŽ…–ž·Œ›Cù–{Œ›’jC‚ŠÝŒ›“ñCŽR–{^C“ñŒ©r˜YC’Ë–{s’ji®ŠOj: œÜC11: 203`206, 1989.

1672. mŒ´’˜n ‰~“›Œ^‘“à“B‚ÌŠJ”­‚ɂ‚¢‚Ä. ù–{Œ›’jCŽR–{^CŽ…–ž·Œ›C¬—Ñ–¾³CŽO—Ö´ŽuC–k’ÜLmC‘O“cŒ’“ñi®ŠOj: œÜC11: 382`387, 1989.

1673. mŒ´’˜n ã˜rœŠOãè÷‰ŠiƒeƒjƒX•Ij‚ÌŠO‰È“IŽ¡—Ã. “ñŒ©r˜YC‹v•ÛŽ›‘å–çC’Ë–{s’jCŽR–{^i®ŠOj: _“ÞìŠÖߊO‰ÈŠw‰ïŽ, 4: 25`29, 1989.

1674. mŒ´’˜n Fuji Computed Radiography‚ð—p‚¢‚½•GŠÖß‘¢‰e|‘O\Žšx‘Ñ‘¹‚Ìf’f|. “ñŒ©r˜YC’Ë–{s’jC¬—Ñ–¾˜YC‘O”V‰€‘½KCŽR–{^i®ŠOj: _“Þì®ÐˆãŽC2(1): 87`89, 1989.

1675. mŒ´’˜n ‹âsœ‚ð—p‚¢‚½lHŠÖß‚ÌÄ’uŠ·. •Ä–{ŒõˆêCŽ…–ž·Œ›CŽR–{^i®ŠOj: ®Œ`ŠO‰Èi•Êû:lHŠÖß‚ÌÄŽèp¥Ä’uŠ·j, (16): 93`99, 1989.

1676. mŒ´’˜n œÜŽ¡–ü‚ð‘jŠQ‚·‚é—ÍŠw“IŽhŒƒ. “¡]—T“¹C”nŸº´Ž‘i¶‘ÌHjCŽR–{^i®ŠOjCù“c’¼i“ŒH‘åj: ®Œ`ŠO‰ÈƒoƒCƒIƒƒJƒjƒNƒX, 10: 21`25, 1988.

1677. mŒ´’˜n –jñ“B–@‚É‚æ‚é‘å‘ÚœŒz•”“à‘¤œÜ‚ÌŒŸ“¢. ¬—Ñ–¾³CŽR–{^CŽ…–ž·Œ›Cù–{Œ›’jC“ì‘òˆç—YCŠÖŒû¹˜ai®ŠOj: ®Œ`¥ÐŠQŠO‰ÈC32(7): 873`876, 1989.

1678. mŒ´’˜n ŽèŠÖß•”‚wüf’f|ŽèªœœŒ`‘Ô‚¨‚æ‚ю誕sˆÀ’èÇ‚ð’†S‚Æ‚µ‚Ä|. “ñŒ©r˜YC¬—Ñ–¾³CŽá—ÑL”VC’Ë–{s’ji®ŠOj: ®Œ`¥ÐŠQŠO‰ÈC32(8): 977`981, 1989.

1679. mŒ´’˜n œ‘eé Ç‚ɑ΂·‚éADFR—Ö@|ŠeŽíœ‰–’è—Ê–@‚É‚æ‚錟“¢. ŽR“¿‹`˜YC“‡Kˆè•vC‹v•ÛŽ›‘å–çC’Ë–{s’jC‚ŠÝŒ›“ñC—L•xŠ°i®ŠOj: ‘æ10‰ñ_“ÞìCa¥œ‘ãŽÓŒ¤‹†‰ï•ñW, p.88`94, 1989.

1680. mŒ´’˜n ãøœè÷ŠÔ—²‹NœÜ‚ɑ΂·‚éŒo”ç“IœÚ‡p. ˆÀ’BŒöC‹v•ÛŽ›‘å–çC‘OŒ´G•vC‘º“cŒ‰C“ñŒ©r˜YC’Ë–{s’jC‘O”V‰€‘½KC–x“à•x—YCŽR–{^i®ŠOj: “Œ‹ž•GŠÖߊw‰ï‰ïŽC10: 31`39, 1989.

1681. mŒ´’˜n •ÏŒ`«ŒÒŠÖßǂɑ΂·‚éƒLƒAƒŠœ”՜؂èp‚̶‘ÌHŠw‚©‚ç‚Ý‚½ŒŸ“¢. •Ä–{ŒõˆêC¼ŽR—TCŽ…–ž·Œ›CŽR–{^i®ŠOjCX“c^Žji¶‘ÌHj: “Œ“ú–{—Õ®‰ïŽC1(1): 354`357, 1989.

1682. mŒ´’˜n ŽÚ‘¤ŽèªL‹ØäFÇŒóŒQ. “ñŒ©r˜YCŽá—ÑL”VC¬—Ñ–¾³C‘å—F³FC’Ë–{s’ji®ŠOj: “Œ“ú–{—Õ®‰ïŽC1(1): 511`515, 1989.

1683. mŒ´’˜n Žèªœ”XŽî—l‰A‰e‚Ì‚wüŠw“IŒŸ“¢. ¬—Ñ–¾³C“ñŒ©r˜YC‘å–ìŽiCŽá—ÑL”VC’Ë–{s’jCŽR–{^i®ŠOj: “Œ“ú–{—Õ®‰ïŽC1: 278`281, 1989.

1684. mŒ´’˜n An Analysis of Wrist Joint Movement in the Crab-eated Monkey|With Special Emphasis on the Supporting Function and Movement Control Ability of Ligamentous Structure. “ñŒ©r˜YCŽá—ÑL”VC’Ë–{s’ji®ŠOj: “úŠÖŠOŽC8(2): 187`196, 1989.

1685. mŒ´’˜n ‹—œœÜ‚ÌŽ¡—ÃŒoŒ±. ¼ŽR—TCŽ…–ž·Œ›Cù–{Œ›’jC¬—Ñ–¾³CˆÀ’BŒöCH—t—CŽR–{^i®ŠOj: “úЉïŽC37(10): 660`663, 1989.

1686. mŒ´’˜n Anatomical and Functional Study of Wrists|Comparative Study of Crab-eating Monkey and Human. Žá—ÑL”VC“ñŒ©r˜Yi®ŠOj: “úŽè‰ïŽ, 6(1): 131`139, 1989.

1687. mŒ´’˜n Abductor Pollicis Longs Tendon Transfar for Augumentation of Index Abdunction. “ñŒ©r˜YCŽá—ÑL”VC•Ä–{Œõˆêi®ŠOjC”nŸº´Ž‘i¶‘ÌHj: “úŽè‰ïŽ, 6(3): 443`447, 1989.

1688. mŒ´’˜n Estensor Carpi Ulnaris Syndrome: A Proposal of a New Clinical Entity. “ñŒ©r˜YCŽá—ÑL”VC‘å—F³FC’Ë–{s’jCŽR–{^i®ŠOj: “úŽè‰ïŽ, 6(3): 499`504, 1989.

1689. mŒ´’˜n •ÏŒ`«•GŠÖßǂɑ΂·‚éƒsƒƒLƒVƒJƒ€“îp‚Ì‘½Ž{Ý—Õ°ŽŽŒ±¬Ñ|ŽÀ’nˆã‰Æ‚É‚æ‚é‘S‘ŽŽŒ±|. ŽR–{^i®ŠOjC‘¼142–¼: –ò—‚ÆŽ¡—ÃC17(3): 1021`1033, 1989.

1690. mŒ´’˜n •ÏŒ`«•GŠÖßǂɑ΂·‚éE-0710‚Ì—Õ°•]‰¿|‰Šú—Õ°‘æ‡U‘ŠŽŽŒ±|. ŽR–{^Cù–{Œ›’jC¬—Ñ–¾³C“y‰®“ÖC–ìŒû‘¾ˆêC‰¤‹žŽqCŽR芲—YCã“cºŒáC’J‹`•Fi®ŠOj: –ò—‚ÆŽ¡—ÃC17(4): 1643`1651, 1989.

1691. mŒ´’˜n E-0710‚Ì•ÏŒ`«•GŠÖßǂɑ΂·‚é—p—ÊŒŸ“¢ŽŽŒ±¬Ñ|‘½Ž{Ý“ñd–ÓŒŸ–@‚É‚æ‚錟“¢|. ŽR–{^C–،ՋgC‰Í˜H“nCŽO‰YK—YC‰F“cì‰pˆêC¼–{~CÎì´ˆêi®ŠOj: –ò—‚ÆŽ¡—ÃC17(4): 1653`1671, 1989.

1692. mŒ´’˜n •ÏŒ`«•GŠÖßǂɑ΂·‚éE-0710‚Ì—Õ°•]‰¿|Indomethacin‚ð‘ÎÆ–ò‚Æ‚µ‚½‘½Ž{Ý“ñd–ÓŒŸ”äŠrŽŽŒ±|. ŽR–{^C‰Í˜H“nCŽO‰YK—YC‰F“cì‰pˆêC¼–{~CÎì´ˆêi®ŠOj: –ò—‚ÆŽ¡—ÃC17(5): 2277`2301, 1989.

1693. mŒ´’˜n ˜’ÉÇAŒzŒ¨˜rÇŒóŒQ‚¨‚æ‚ÑŒ¨ŠÖߎüˆÍ‰Š‚ɑ΂·‚éRPY-001‚Ì—Õ°•]‰¿|Indomethacin‚Æ‚Ì“ñd–ÓŒŸ”äŠrŽŽŒ±|. ŽR–{^C‰Í˜H“nC¡ˆä–]CŽOD–M’BCŽR“cŸ‹vC•–Ø—ÇŽC¬ì’¨–çi®ŠOj: –ò—‚ÆŽ¡—ÃC17(7): 3347`3373, 1989.

1694. mŒ´’˜n …‰j‚É‚æ‚éƒXƒ|[ƒcáŠQ. ‚ŠÝŒ›“ñC“ñŒ©r˜YC‹v•ÛŽ›‘å–çCŽR–{^i®ŠOj: —Õ°ƒXƒ|[ƒcˆãŠw, 6: 41`43, 1989.

1695. mŒ´’˜n R¶ÜƒZƒtƒ]ƒiƒ€ƒiƒgƒŠƒEƒ€‚ð“Y‰Á‚µ‚½PMMAœƒZƒƒ“ƒg‚Ì‹­“xŽŽŒ±. X“c^Žji¶‘ÌHjC—L•xŠ°i®ŠOj: —Õ°®Œ`ŠO‰È, 24(10): 1199`1205, 1989.

1696. m’Z•ñn SUS316ƒXƒeƒ“ƒŒƒX|‚Ì”æ˜J‹““®‚É—^‚¦‚é—n‘¶y‘f‚̉e‹¿. X“c^Žji¶‘ÌHjC’Ë–{s’ji®ŠOjCù“c’¼i¶‘ÌHjC–쑺ŒM: lHŠÖߌ¤‹†‰ïŽ, 19: 84, 1989.

1697. mŒ¤‹†•ñn ®Œ`ŠO‰ÈƒoƒCƒIƒƒJƒjƒNƒXŒ¤‹†‰ï‚ÉŽQ‰Á‚µ‚Ä. X“c^Žji¶‘ÌHj: ƒoƒCƒIƒƒJƒjƒYƒ€Šw‰ïŽ, 10(2): 101`102, 1986.

1698. mŒ¤‹†•ñiŒú¶Èjn tˆÚAŒã‚Ì‘å‘Úœ“ª‰óŽ€|cyclosporin AŽg—p—á‚ÌŒŸ“¢|. ŽR–{^C¬—Ñ–¾³CŽ…–ž·Œ›Cù–{Œ›’ji®ŠOj: Œú¶È“Á’莾Š³œ‰óŽ€Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.135`137, 1989.

1699. mŒ¤‹†•ñiŒú¶Èjn tˆÚAŒã‚Ì‘å‘Úœ“ª‰óŽ€|cyclosporin A“Š—^ŒQ‚ÌŒŸ“¢|. ŽR–{^CŠÖŒû¹˜aCŽ…–ž·Œ›C¬—Ñ–¾³i®ŠOj: Œú¶È“Á’莾Š³œ‰óŽ€Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.265`268, 1989.

1700. mÇ—á•ñn —¼¿œŒ‹ß—ô—£œÜ‚Ì1—á. ”’èËWiŒ`ŠOjCŽOŒ´‹v”ÍC––‹g‹`”ŒC›Œ´½C“n•ÓŒ’ˆêC¬—Ѻi‘—§‰¡•l•a‰@j: —Õ°ƒXƒ|[ƒcˆãŠw, 6: 73`75, 1989.

1701. mÇ—á•ñn Prosthetic Replacement due to Giant-cell Tumor in the Proximal Humerus: A Case Report. ‚ŠÝŒ›“ñCŽÂŒ´Osi®ŠOj: Clin. Orthop., 247: 106`110, 1989.

1702. mÇ—á•ñn lHŒÒŠÖßÄ’uŠ·p(revision)Žžƒ\ƒPƒbƒg”j‘¹‚Ì‚Ý‚ç‚ꂽ1—á‚ɂ‚¢‚Ä. ŽR“c—F‹vC“ß{–ìG“ñC—L•xŠ°Cã“cºŒái®ŠOj: ŠÖß‚ÌŠO‰È, 16: 111`116, 1989.

1703. mÇ—á•ñn ƒuƒVƒ‰ƒ~ƒ““Š—^’†‚É–Œ«tÇ‚ð‡•¹‚µ‚½–«ŠÖ߃ŠƒEƒ}ƒ`‚Ì1—á. ŒÜ‰ê‹M’jC—L•xŠ°C‚ŠÝŒ›“ñCŽO—Ö´ŽuCrˆä‹`Fi®ŠOjC¬—Ñ–LCŠ™“cvŽõi“àj: ŠÖ“ŒƒŠƒEƒ}ƒ`, 21: 51`61, 1989.

1704. mÇ—á•ñn ‘æˆê’†Žèœœ“ª‰óŽ€‚Ì1—á. —˜ªì‰ërC“ñŒ©r˜YC¬—Ñ–¾³C–k’ÜLmi®ŠOj: ŠÖ“Œ®ÐŽ, 20(6): 521`524, 1989.

1705. mÇ—á•ñn —Lçꜜ܂ɑæ5Žw‹ü‹ØäF’f—ô‚ð‡•¹‚µ‚½1—á. •“cŒo—mC’†‘ºˆêmC“ñŒ©r˜Yi®ŠOj: ŠÖ“Œ®ÐŽ, 20: 95`97, 1989.

1706. mÇ—á•ñn Šç–ÊœœÜ‚ɑ΂·‚éƒ~ƒjƒvƒŒ[ƒg‚ÌŽg—pŒoŒ±. ÷ˆäŽ¡²iŒ`ŠOj: é‹ÊŒ§ˆãŠw‰ïŽGŽ, 24(4): 938`941, 1989.

1707. mÇ—á•ñn æùœ‘O•û“Ë‹NœÜ‚Ì2—á. ŽR“c—F‹vC¬—Ñ–¾³C–kŒ©Œ\ŽiCŽ…–ž·Œ›i®ŠOj: _“Þ쌧®Œ`ЊQŠO‰ÈˆãŠw‰ïŽ, 2(1): 63`67, 1989.

1708. mÇ—á•ñn Van der HocveÇŒóŒQ‚Ì1—á. ‰Ô“ˆ”ü“ÞŽqC‹v•ÛŽ›‘å–çC“n•Ó®CÄ“¡Æ•FC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: _“Þ쌧®Œ`ЊQŠO‰ÈˆãŠw‰ïŽ, 2(1): 94`97, 1989.

1709. mÇ—á•ñn ‰Eã˜rœ‚É”­¶‚µ‚½ Periosteal Chondroma ‚Ì1—á. ÎŒ´GˆêiŒ`ŠOjCˆÉ’n’m³ŒõCˆäŒ´¬’jCŽO“‡^ˆêiŽY‹Æˆã‘åj: ®Œ`ŠO‰È‚ÆЊQŠO‰È, 37: 1763`1766, 1989.

1710. m‘àn œ”՜܂̕ۑ¶—Ö@. »•ÓŠ®Ž¡i®ŠOj: M.B. Orthop., 12: 11`15, 1989.

1711. m‘àn lHŠÖߥ‚±‚ê‚©‚ç‚ÌlHŠÖß. X“c^Žji¶‘ÌHjCŽR–{^i®ŠOj: Pharma Medica, 7(7): 53`59, 1989.

1712. m‘àn ƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒW|‚Æ‚Ìo‡‚¢;¶‘Ì‚ÉŠw‚Ô‚±‚ê‚©‚ç‚Ì‹@ŠBHŠw. X“c^Žji¶‘ÌHj: ƒgƒ‰ƒCƒ{ƒƒW, 25(9): 25`26, 1989.

1713. m‘àn ˆã—Âɂ¨‚¯‚éƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒW. ”nŸº´Ž‘i¶‘ÌHj: ƒgƒ‰ƒCƒ{ƒƒW, 3(9): 8`11, 1989.

1714. m‘àn ŠÖ߂̃gƒ‰ƒCƒ{ƒƒW[i¶‚«‚Ä‚¢‚éŒXŽÎ‹@”\ƒVƒXƒeƒ€j. ’Ë–{s’ji®ŠOj: ƒgƒ‰ƒCƒ{ƒƒW[, 25: 12`16, 1989.

1715. m‘àn œ‚Æ”æ˜J. X“c^Žji¶‘ÌHj: ƒoƒCƒIƒƒJƒjƒYƒ€Šw‰ïŽ, 11(3): 83`88, 1987.

1716. m‘àn ŒÜ\Œ¨|•}‹`|i“ÁWjŒ¨‚Ì’É‚Ý‚Æ‹@”\áŠQ. ‚ŠÝŒ›“ñi®ŠOj: ŠÖߊO‰È, 8(10): 1477`1482, 1989.

1717. m‘àn ‘å‘Úœ“ªçˆ‚èǂɑ΂·‚霒[ŒÅ’èpi“ÁWj‘å‘Úœ“ªçˆ‚èÇ. Ž…–ž·Œ›i®ŠOj: ŠÖߊO‰È, 8(11): 1637`1644, 1989.

1718. m‘àn •ÏŒ`«ŠÖßǂɑ΂·‚é–ò•¨—Ö@. ’Ë–{s’ji®ŠOj: œ¥ŠÖߥx‘Ñ, 2(2): 191`200, 1989.

1719. m‘àn ŠÖß’É: ‰ŠúÇŒó‚̂Ƃ炦•û‚ƉŠúŽ¡—Ã. Ž…–ž·Œ›i®ŠOj: Ž¡—Ã, 71: 393`399, 1989.

1720. m‘àn –€ŽC¥–€–Õ‚Ì—§ê‚©‚ç‚Ý‚½ƒCƒ“ƒvƒ‰ƒ“ƒgÞ—¿‚̶‘Ì“K‡«•]‰¿. X“c^Žji¶‘ÌHj: ®Œ`ŠO‰È, 41(2): 222, 1990.

1721. m‘àn ƒƒ{ƒbƒg‚É‚æ‚éx‘Ñ‘¹‚Ìf’fi“ÁW/ƒXƒ||ƒc‚Æ‘O\Žšx‘Ñ‘¹j. “¡]—T“¹i¶‘ÌHj: —Õ°ƒXƒ||ƒcˆãŠw, 6(12): 1309`1314, 1989.

1722. m‘àn ”ñƒXƒeƒƒCƒhR‰ŠÇÜ‘I‘ð‚̃|ƒCƒ“ƒg (3)•ÏŒ`«ŠÖßÇ. —L•xŠ°i®ŠOj: —Õ°ˆã, 15: 1594`1596, 1989.

1723. m‘àn i“ÁWj“§ÍŠ³ŽÒ‚ÌŽèpŠÅŒìƒ}ƒjƒ…ƒAƒ‹|‚w‡V®Œ`ŠO‰È|. Ž…–ž·Œ›i®ŠOjCˆÉ“¡•¶ŽqiŠÅŒì•”j: —Õ°“§Í, 5(8): 227`247, 1989.

1724. m‘àn “Á”­«‘å‘Úœ“ª‰óŽ€‚Ìf—Ã. Ž…–ž·Œ›CŽR–{^i®ŠOj: —Õ°–Ɖu, 21: 713`725, 1989.

1725. muÀn “¯Žíœi‹âsœjˆÚA|‹âsœˆÚA‚Ì“Á’¥. Ž…–ž·Œ›i®ŠOj: ‚¢‚¸‚Ý, 36(6): 20`21, 1989.

1726. muÀn “ü–åuÀ:‚wü‚Ì“Ç‚Ý•û ‘æ3Í Œ¨¥ŒÒ. ‚ŠÝŒ›“ñCŽR–{^i®ŠOj: ƒŠƒEƒ}ƒ`‰È, 1(3): 363`374, 1989.

1727. mŠwp‘n iŽ·•Mj “ú–{‹@ŠBŠw‰ï”NŠÓ; ƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒW|, 92: 849, X“c^Žji¶‘ÌHj. •ÒW “ú–{‹@ŠBŠw‰ï•ÒC “Œ‹žC89.00.00”­s.

1728. mŠwp‘n iŽ·•Mj Advance in Biomaterials; The Corrosion Fatigue Properties of Surgical Implants in a Living Body, 8: 381`386, X“c^Žji¶‘ÌHjCH. HayashiCù“c’¼i“ŒH‘åjC’Ë–{s’ji®ŠOj. •ÒW C. de PutterCG.L. LangeCK. de GrootCA.J.C. Lee•ÒC ElsevierCAmsterdamC88.00.00”­s.

1729. mŠwp‘n iŽ·•Mj ‘“à“B‚É‚æ‚éœÜŽèpG—˜_‚ÆŽÀÛ, ŽR–{^CŽ…–ž·Œ›Cù–{Œ›’ji®ŠOj. “ì]“°, “Œ‹žC89.04.10”­s.

1730. mŠwp‘n iŽ·•Mj }à“à‰Èf’fŽ¡—ÃuÀ. 12. ƒŠƒEƒ}ƒ`«Ž¾Š³; ‚wüŠŒ©¥œ. —L•xŠ°i®ŠOj. •ÒW ˆÀ”{’BC‘¼•Ò, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹žC89.06.10”­s.

1731. mŠwp‘n iŽ·•Mj ƒŠƒEƒ}ƒ`Šw; 18. •ÏŒ`«ŠÖßÇ, p.924`951, ŽR–{^CŽ…–ž·Œ›i®ŠOj. “¯•¶‘‰@C“Œ‹ž, 89.07.00”­s.

1732. mŠwp‘n iŽ·•Mj Diclofenac (Voltaren) and Cartilage in Osteoarthritis; Prospects for Cartilage Therapy, ŽR–{^i®ŠOj. •ÒW Moskowitz, R. & Hirohata, K.•Ò, Hogrofe & Huber, Toronto, 89.00.00”­s.

1733. mŠwp‘n iŽ·•Mj œ‹âs; Ž…–ž·Œ›C¬—Ñ–¾³i®ŠOj. ŠÄC ŽR–{^i–k—¢‘åŠwjŠÄC, ƒqƒ…[ƒ}ƒ“ƒeƒBƒƒB, 90.03.24”­s.

1734. m‹³‰È‘n iŽ·•Mj _’†®Œ`ŠO‰ÈŠwi‰ü’ù‘æ21”Åj; ®Œ`ŠO‰È“If’f–@AŠÖß‚Ì\‘¢‚Æ‹@”\A“̑ãŽÓ, ŽR–{^i®ŠOj. •ÒW “VŽ™–¯˜a•Ò, “ìŽR“°C“Œ‹ž, 89.11.00”­s.

1735. m‹³‰È‘n iŽ·•Mj _’†®Œ`ŠO‰ÈŠwi‰ü’ù‘æ21”Åj; œŠÖ߂̃oƒCƒIƒƒJƒjƒNƒX, ’Ë–{s’ji®ŠOj. •ÒW “VŽ™–¯˜a•Ò, “ìŽR“°C“Œ‹ž, 89.11.00”­s.

1736. m‹³‰È‘n iŽ·•Mj _’†®Œ`ŠO‰ÈŠwi‰ü’ù‘æ21”Åj; ŠÖߎ¾Š³, —L•xŠ°i®ŠOj. •ÒW “VŽ™–¯˜a•Ò, “ìŽR“°C“Œ‹ž, 89.11.00”­s.

1737. mŠwpÜn “ú–{ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ïC‘æ1‰ñƒoƒCƒIƒ}ƒeƒŠƒAƒ‹‰ÈŠw§—ãÜu”æ˜JœÜ—\’m‚ÉŠÖ‚·‚é—ÍŠw“IŒ¤‹†v. X“c^Žji¶‘ÌHj.

1738. m‘•]n ƒoƒCƒIƒƒJƒjƒNƒX‚æ‚è‚Ý‚½®Œ`ŠO‰È. X“c^Žji¶‘ÌHj: ®Œ`ŠO‰È, 40(6): 934, 1989.

1739. mŠw‰ïn i“Á•Êu‰‰j Isoelastic Total Hip Replacement: Clinical Experiences and its Biomechanical Characteristics. Ž…–ž·Œ›CŽR–{^CKashiwagi, D.C•Ä–{Œõˆêi®ŠOjCX“c^Žji¶‘ÌHj: 33rd Annual Meeting of the Korean Orthopedic Association (89.10.19`21), Seoul, Korea.

1740. mŠw‰ïn i‹³ˆçu‰‰j The Experience of Soft-tissue Expander. “àÀ‰hŽ÷iŒ`ŠOj: ‘æ2‰ñƒCƒ‰ƒ“Œ`¬ŠO‰ÈŠw‰ï (89.05.17), ƒeƒwƒ‰ƒ“.

1741. mŠw‰ïn i‹³ˆçu‰‰j ˆ««Žîᇂ̉摜f’fi•a—Šw“IŠŒ©‚Ƃ̑Δäj 5. œ. ¼—Ñ—²i•új: ‘æ25‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Õ°‘å‰ï (89.09.29), –¼ŒÃ‰®, ‘æ25‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Õ°‘å‰ï¥–¼ŒÃ‰®¥ƒvƒƒOƒ‰ƒ€¥—\eW, p.47, 1989.

1742. mŠw‰ïn i‹³ˆçu‰‰j •ÏŒ`«ŠÖßÇ‚Ìis‚ÆŽ¡—Ã. Ž…–ž·Œ›i®ŠOj: •½¬Œ³”N“x‘啪Œ§®Œ`ŠO‰È—Õ°®Œ`ŠO‰Èˆã‰ï (89.10.07), ‘啪.

1743. mŠw‰ïn i‹³ˆçu‰‰j •ÏŒ`«ŠÖßÇ‚Ì•a‘Ô‚ÆŽ¡—Ã. ŽR–{^i®ŠOj: ‘æ1‰ñ–k‹ãBA’}–L’n‹æ®Œ`ŠO‰ÈW’k‰ï (90.03.09), –k‹ãB.

1744. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j –«ŠÖ߃ŠƒEƒ}ƒ`Œz’Å•a•Ï‚ÆŽèp—Ö@. —L•xŠ°i®ŠOj: ‘æ62‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï (89.04.14`16), ‰YˆÀC “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(2): S212, 1989.

1745. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j lHŠÖß‚ÌŽèpŽè’iA‚±‚ê‚©‚ç‚ÌlHŠÖß. Ž…–ž·Œ›i®ŠOj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (89.05.25`27), “Œ‹ž.

1746. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Implant‹à‘®Þ—¿‚Ì‘Ì“à•…H‚É‚æ‚é”æ˜J‹­“x—ò‰». X“c^Žji¶‘ÌHjC–쑺ŒMCù“c’¼i“ŒH‘åj: ‘æ11‰ñƒoƒCƒIƒƒJƒjƒYƒ€ƒVƒ“ƒ|ƒWƒEƒ€ (89.07.13`15), “y‰YC —\eW, p.185`194, 1989.

1747. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j œÜŽ¡—ÂƃƒJƒjƒJƒ‹ƒXƒgƒŒƒX•À‚Ñ‚Éœ‘eé Ç‚ÆŒz•”œÜ. X“c^Žji¶‘ÌHjCŽR–{^i®ŠOjCù“c’¼i“ŒH‘åj: ‘æ7‰ñ“ú–{œ‘ãŽÓŠw‰ï (89.07.27`29), “Œ‹žC “ú–{œ‘ãŽÓŠw‰ïŽ, 7(3): 63, 1989.

1748. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ŠŠ‰tC“îœClHŠŠ‰t‚ÌŠÏ“_‚©‚ç‚Ý‚½ŠÖß‚ÌŠŠ. ”nŸº´Ž‘i¶‘ÌHjC’Ë–{s’ji®ŠOjCù“c’¼i“ŒH‘åj: ‘æ4‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (89.09.01), “Œ‹žC “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(7): S887,@1989.

1749. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‘å‘Úœè÷•”Aè÷ã•”œÜ‚ÌŽ¡—ÃŒoŒ±. “ì‘òˆç—YCr–Ø’ˆêC¼‘º–¾lC‰¡ŠÖ~C¬—Ñ–¾³C‘å–ìŽiCŽ…–ž·Œ›CŽR–{^i®ŠOjCV“¡³‹Pi‹~–½j: ‘æ37‰ñ“ú–{ЊQˆãŠw‰ïŠwp‘å‰ï (89.10.18`19), L“‡, “úЈãŽ, 38(3): 52, 1990.

1750. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Application of Robotics to Palpation of Injury of Knee Ligaments|Devolopment of a New Method of Knee Instability Test. “¡]—T“¹C”nŸº´Ž‘i¶‘ÌHjC’Ë–{s’jCŽR–{^i®ŠOjCù“c’¼i“ŒH‘åj: 110th ASME (American Society of Mechanical Engineers) Winter Annual Meeting (89.12.10`15), San Francisco.

1751. mŠw‰ïn iƒpƒlƒ‹j ‘å‘Úœ“ªçˆ‚èÇ‚ÌŽ¡—Ã:‚Ë‚¶ŒÅ’è–@. Ž…–ž·Œ›i®ŠOjC^ŠpºŒái‘啪ˆã‘åjC–I’J«Žji‰¡•l“실ϕa‰@j: ‘æ62‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï (89.04.14`16), ‰YˆÀC “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(2): S33, 1989.

1752. mŠw‰ïn iƒpƒlƒ‹j ‚킪‘‚Ì®Œ`ŠO‰È”F’èˆã§“x‚ɂ‚¢‚Ä|Œ¤CŽ{Ý‚ÆŒ¤C•û–@‚ɂ‚¢‚Ä|. ŽR–{^i®ŠOj: ‘æ62‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï (89.04.14`16), ‰YˆÀC “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(2): S443, 1989.

1753. mŠw‰ïn iƒpƒlƒ‹j ƒƒ{ƒbƒg‚É‚æ‚éx‘Ñ‘¹‚Ìf’f. “¡]—T“¹C”nŸº´Ž‘i¶‘ÌHjC’Ë–{s’jCŽR–{^i®ŠOjCù“c’¼i“ŒH‘åj: ‘æ62‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï (89.04.15), ‰YˆÀC “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(2): S412, 1989.

1754. mŠw‰ïn iƒpƒlƒ‹j —h“®‰~ŒÊ‰^“®‚É‚æ‚è\¬‚µ‚½‹UŠÖß‚Ì‹@”\‚ÆŒ`‘Ô. “¡]—T“¹i¶‘ÌHjC’|“à“ÖŽqi¶‰»ŒnjC”nŸº´Ž‘i¶‘ÌHjCŽ…–ž·Œ›CŽR–{^i®ŠOjC’†ŽR“Oi“‡’ûìŠjCù“c’¼i“ŒH‘åj: ‘æ4‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (89.08.31`09.01), “Œ‹žC “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(7): 896, 1989.

1755. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj ‚wüŠŒ©‚É‚æ‚éRƒŠƒEƒ}ƒ`Ü‚Ì—Õ°“IˆÓ‹`. —L•xŠ°i®ŠOj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (89.05.25`27), “Œ‹ž.

1756. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj –«ŠÖ߃ŠƒEƒ}ƒ`‚É‚¨‚¯‚霉–—ʂ̕ω»i‘æ6•ñjQCT‚É‚æ‚錟“¢. —L•xŠ°CŽR“¿‹`˜YC•Ä–{ŒõˆêC“ì‘òˆç—Yi®ŠOjC÷ˆä´ŽqCŠâ”g–ÎC‘–쳈êi•új: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (89.05.25`27), “Œ‹ž.

1757. mŠw‰ïn iˆê”Êu‰‰j “–‰È‚Ås‚Á‚½“ÚA‚ɂ‚¢‚Ä. ŒÃŽR“o—²CÎŒ´GˆêC—é–Ø•q•FC‰eŽRL”üC‰–’JMKiŒ`ŠOj: “ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï, _ŒË.

1758. mŠw‰ïn iˆê”Êu‰‰j ƒCƒ“ƒvƒ‰ƒ“ƒgÞ—¿‚Ì–€–Õ“Å«C‹[Ž—¶‘̊‹«‚É‚¨‚¯‚é‹à‘®ƒCƒIƒ“‚Ì‘I‘ð“I—no. ¼‘ò“N˜NCù“c’¼i“ŒH‘åjCX“c^Žji¶‘ÌHjCˆäã—tŽqi—\–hˆãŠwŒnj: ‘æ33Šú“ú–{ŠŠŠw‰ï (88.05.12`13), “Œ‹žC —\eW, p.249`252, 1988.

1759. mŠw‰ïn iˆê”Êu‰‰j ‹[Ž—¶‘Ì“à•…HŠÂ‹«‰º‚É‚¨‚¯‚éSUSA316ƒXƒeƒ“ƒŒƒX|‚Ì”æ˜J‹­“x‚Ì‘ª’è. X“c^Žji¶‘ÌHjCù“c’¼i“ŒH‘åjC–쑺ŒM: ‘æ32‰ñÞ—¿Œ¤‹†˜A‡u‰‰‰ï (88.12.08`09), ‹ž“sC —\eW, p.115`116, 1988.

1760. mŠw‰ïn iˆê”Êu‰‰j ŽèŠÖß‚wüf’f‚ɂ‚¢‚Ä. “ñŒ©r˜YCŽá—ÑL”VC¬—Ñ–¾³C‹v•ÛŽ›‘å–çC’Ë–{s’ji®ŠOj: ‘æ3‰ñ“Œ“ú–{Žè‚ÌŠO‰ÈŠw‰ï (89.02.00), ŽRŒ`.

1761. mŠw‰ïn iˆê”Êu‰‰j “ꕶŽž‘ãl‰ºŽˆœ‚Ì’·‚³‚̶‰E·. •½–{‰Ã•i‰ðj: “ú–{‰ð–UŠw‰ï (89.04.01), ‹{èC ‰ð–UŠwŽGŽC64(4): 362, l989.

1762. mŠw‰ïn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚錨½ŠÖß’E‰P‚ÌŽ¡—ÃŒoŒ±. ‚ŠÝŒ›“ñC•Ä–{ŒõˆêC’Ë–{s’jCŽR–{^i®ŠOj: ‘æ62‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï (89.04.14`16), ‰YˆÀC “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(2): S145, 1989.

1763. mŠw‰ïn iˆê”Êu‰‰j ŠÈˆÕŒÅ’è‘•‹ï‚É‚æ‚é˜V”NŽÒ¥žôœ––’[œÜ‚ÌŽ¡—Ã. “ñŒ©r˜YC‹v•ÛŽ›‘å–çC•Ä–{ŒõˆêCŽR“¿‹`˜YC’Ë–{s’ji®ŠOj: ‘æ62‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï (89.04.14`16), ‰YˆÀC “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(2): S549, 1989.

1764. mŠw‰ïn iˆê”Êu‰‰j ãøœè÷ŠÔ—²‹NœÜ‚Ì”­ÇƒƒJƒjƒYƒ€‚Æ‚»‚ÌŽ¡—ìÑ. ‹v•ÛŽ›‘å–çC’Ë–{s’jC“ñŒ©r˜YCŽR“¿‹`˜YC•Ä–{ŒõˆêC‹ß“¡‘׈êCˆÀ’BŒöCŽO—Ö´ŽuCã“cºŒáCŽR–{^i®ŠOj: ‘æ62‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï (89.04.14`16), ‰YˆÀC “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(2): S90, 1989.

1765. mŠw‰ïn iˆê”Êu‰‰j 󑤓ª“®–¬—̈æ‚Ì”ç•Ù‚É‚æ‚éŠááÙ‹y‚Ñ•@—ƒ‚ÌÄŒš. “àÀ‰hŽ÷C÷ˆäŽ¡²C‰FˆäŒª“ñCçÝŽ½C•“cŒö—˜C”Ñ“c„C‰–’JMKiŒ`ŠOj: ‘æ32‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï (89.04.21), ‰YˆÀ, “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 9(—Õ‘): 201, l989.

1766. mŠw‰ïn iˆê”Êu‰‰j ŽÚ‘¤ŽèªL‹ØäFÇŒóŒQ. “ñŒ©r˜YCŽá—ÑL”VC‘å—F³FC’Ë–{s’jCŽR–{^i®ŠOj: ‘æ32‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ï‘‰ï (89.05.11`13), –k‹ãB.

1767. mŠw‰ïn iˆê”Êu‰‰j ƒJƒjƒNƒC‰ŽŽèŠÖß•”‚̉ð–U“IŠÏŽ@il‚Æ‚Ì”äŠr‚É‚¨‚¢‚Äj. Žá—ÑL”VC“ñŒ©r˜YC‘å—F³FC’Ë–{s’jCŽR–{^i®ŠOj: ‘æ32‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ï‘‰ï (89.05.11`13), –k‹ãB.

1768. mŠw‰ïn iˆê”Êu‰‰j ŽèŽwŠO“]‹@”\ÄŒš‚ɑ΂·‚éäFˆÚsp. “ñŒ©r˜YCŽá—ÑL”VC¬—Ñ–¾³C•Ä–{ŒõˆêC’Ë–{s’ji®ŠOj: ‘æ32‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ï‘‰ï (89.05.11`13), –k‹ãB.

1769. mŠw‰ïn iˆê”Êu‰‰j •ÏŒ`«•IŠÖßǂɑ΂·‚éžôœ’ZkpiƒrƒfƒIj. “ñŒ©r˜Yi®ŠOj: ‘æ32‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ï‘‰ï (89.05.11`13), –k‹ãB.

1770. mŠw‰ïn iˆê”Êu‰‰j Žè‚ÌŠO‰È—̈æ‚É‚¨‚¯‚é‚wüCRŽB‰e–@‚̉ž—p. •Ä–{ŒõˆêC“ñŒ©r˜YC‹v•ÛŽ›‘å–çC’Ë–{s’jC¬—Ñ–¾³i®ŠOj: ‘æ32‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ï‘‰ï (89.05.11`13), –k‹ãB.

1771. mŠw‰ïn iˆê”Êu‰‰j •ÏŒ`«ŠÖßǃ}ƒEƒX‚É‚¨‚¯‚é–Ɖu”½‰ž‚ÌŠÖ—^. ‘O“cŒ’“ñC‚ŠÝŒ›“ñC”Ñ’ËŒ’Ž™CŽRèŠÞC¼‘º–¾lCŽ…–ž·Œ›C’Ë–{s’jCŽR–{^i®ŠOj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (89.05.25`27), “Œ‹ž.

1772. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒEƒX‚̃Rƒ‰[ƒQƒ“ŠÖ߉Š‚É‹y‚Ú‚·15-deoxyspergualin‚̉e‹¿. ‚ŠÝŒ›“ñC‘O“cŒ’“ñCŽRèŠÞC¼‘º–¾lC•Ä–{ŒõˆêCŽR–{^C˜ÅŸºF•vCŠLŒ´Mhi®ŠOj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (89.05.25`27), “Œ‹ž.

1773. mŠw‰ïn iˆê”Êu‰‰j ŒŒ´ˆÚ“ü‚É‚æ‚éƒRƒ‰[ƒQƒ“ŠÖ߉Š‚ɑ΂·‚écyclosporin‚̉e‹¿|FK506‚Æ‚Ìì—p‹@˜‚Ì”äŠr‚ɂ‚¢‚Ä|. ‹{Œ´F–¾C˜ÅŸºF•vC—L“ce‰›CVˆä–]C™‰ª—mˆêC‚ŠÝŒ›“ñCŠLŒ´Mhi®ŠOj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (89.05.25`27), “Œ‹ž.

1774. mŠw‰ïn iˆê”Êu‰‰j lHŠÖß‚ÆlHœŒz‚ÌŠŠ‚Æ‚»‚̉ž—p. ’Ë–{s’jC“ñŒ©r˜YC‹v•ÛŽ›‘å–çC•Ä–{ŒõˆêCŽR“¿‹`˜Yi®ŠOj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (89.05.25`27), “Œ‹ž.

1775. mŠw‰ïn iˆê”Êu‰‰j ƒŠƒEƒ}ƒ`ŽèŠÖߊŠ–ŒØœp‚ÌŽèŠÖ߈À’è«‚É‹y‚Ú‚·‰e‹¿‚Ì‚wüŠw“IŒŸ“¢. •Ä–{ŒõˆêC—L•xŠ°C‚ŠÝŒ›“ñC“ñŒ©r˜YCŽR–{^i®ŠOj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (89.05.25`27), “Œ‹ž.

1776. mŠw‰ïn iˆê”Êu‰‰j VARAf’fŠî€‚ÌŒŸ“¢i‘æ2•ñj. ¼ŽR—TC—L•xŠ°C–x“à•x—YC“¡“c³CŽR–{^i®ŠOj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (89.05.25`27), “Œ‹ž.

1777. mŠw‰ïn iˆê”Êu‰‰j ‘½”­«“]ˆÚ‚𗈂µ‚½Œã• –ŒŒ´”­‚Æl‚¦‚ç‚ê‚éMFH‚Ì1–UŒŸ—á. ˆÉ“ŒŽüìC–x“àŒPC“ì‘òˆç—YC¬—Ñ–¾³C‘å–ìŽii®ŠOjCŠâŸºŒ[ˆêC“n•Ó´Ž¡i•a—j: ‘æ518‰ñŠÖ“Œ®ÐŒŽ—á‰ï (89.05.27), “Œ‹ž.

1778. mŠw‰ïn iˆê”Êu‰‰j 圕”åñጂ̎¡—Õûj. ÎŒ´GˆêiŒ`ŠOj: ‘æ14‰ñŠO‰È˜A‡Šw‰ï (89.06.21), ‘åã.

1779. mŠw‰ïn iˆê”Êu‰‰j —L’É«•ª—ô•GŠWœ‚ɑ΂·‚éŽèp—Ö@. ‹v•ÛŽ›‘å–çC“ñŒ©r˜YCb”ãGŽÀC“‡Kˆè•vC‘OŒ´G•vCŽO—Ö´ŽuC’Ë–{s’ji®ŠOj: ‘æ18‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (89.06.24), “Œ‹ž.

1780. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒEƒX‚̃Rƒ‰[ƒQƒ“ŠÖ߉Š‚É‹y‚Ú‚·15-deoxyspergualin‚̉e‹¿. ‚ŠÝŒ›“ñC‘O“cŒ’“ñCŽRèŠÞC¼‘º–¾lC•Ä–{ŒõˆêCŽO—Ö´ŽuCŽR–{^i®ŠOj: ‘æ18‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (89.06.24), “Œ‹ž.

1781. mŠw‰ïn iˆê”Êu‰‰j ŒÒŠÖß‚É”­¶‚µ‚½synovial chondromatosis‚Ì3—á. ŽR“c—F‹vCŽ…–ž·Œ›C¬—Ñ–¾³C‘å–ìŽiC–kŒ©Œ\ŽiCŽR–{^i®ŠOj: ‘æ18‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (89.06.24), “Œ‹ž.

1782. mŠw‰ïn iˆê”Êu‰‰j Žè‚ÌŠO‰È—̈æ‚É‚¨‚¯‚é‚wücomputed radiography (CR)‚̉ž—p. •Ä–{ŒõˆêC“ñŒ©r˜YC‹v•ÛŽ›‘å–çC’Ë–{s’jC¬—Ñ–¾³CŽR“¿‹`˜YCŽR–{^i®ŠOj: ‘æ18‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (89.06.24), “Œ‹ž.

1783. mŠw‰ïn iˆê”Êu‰‰j ’·Šú“§ÍŠ³ŽÒ‚É”­¶‚µ‚½äF’f—ô‚ÌŒŸ“¢. ¬—Ñ–¾³CŽ…–ž·Œ›CŽR–{^C“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ18‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (89.06.24), “Œ‹ž.

1784. mŠw‰ïn iˆê”Êu‰‰j ãøœ‚É”­¶‚µ‚½insufficiency fracture‚Ì1—á. –Ø‘º³“C‹v•ÛŽ›‘å–çCˆÀ’BŒöC‰Ô“ˆ”ü“ÞŽqC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ18‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (89.06.24), “Œ‹ž.

1785. mŠw‰ïn iˆê”Êu‰‰j Development of the Apparatus of the Knee Instability Test by the Use of the Arm-Robot. “¡]—T“¹C”nŸº´Ž‘i¶‘ÌHjC’Ë–{s’jC‹v•ÛŽ›‘å–çC“ñŒ©r˜YCŽR–{^i®ŠOjCù“c’¼i“ŒH‘åj: First International Congress of Knee and Orthopaedic Sports Medicine Section of Western Pacific Orthpaedic Association (WPOA) (89.07.04`06), ‰¡•lC AbstractCp.19, 1989.

1786. mŠw‰ïn iˆê”Êu‰‰j ƒXƒL[‚É‚æ‚鉺Žˆ‚ÌŠO|10”N‘O‚Æ‚Ì”äŠr|. ‹v•ÛŽ›‘å–çC’Ë–{s’jC“ñŒ©r˜YCŽO—Ö´ŽuCå‚Œ´—L’jC‹{“c—fCÄ“¡º•FC‘OŒ´G•vCˆÀ’BŒöC¬—Ñ–¾˜YC‘O”V‰€‘½KC“n•Ó®C‚ŠÝŒ›“ñCŽR–{^i®ŠOj: ‘æ15‰ñ“ú–{®Œ`ŠO‰ÈƒXƒ|[ƒcˆãŠw‰ï (89.07.07), ŽD–y.

1787. mŠw‰ïn iˆê”Êu‰‰j ƒXƒ|[ƒc‚É‚æ‚éŽèŽwáŠQ. “ñŒ©r˜YC‹v•ÛŽ›‘å–çC‚ŠÝŒ›“ñC¬—Ñ–¾³C’Ë–{s’ji®ŠOj: ‘æ15‰ñ“ú–{®Œ`ŠO‰ÈƒXƒ|[ƒcˆãŠw‰ï (89.07.07), ŽD–y.

1788. mŠw‰ïn iˆê”Êu‰‰j Ulnar inpingementÇŒóŒQ‚ð’悵‚½žôœ––’[œÜ‚ÌŽ¡—ÃŒoŒ±. m•r–FŽ÷C•Ä–{ŒõˆêC“ñŒ©r˜YC–Ø‘º³“C‹v•ÛŽ›‘å–çC’Ë–{s’ji®ŠOj: ‘æ76‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï (89.07.08), ªŠÝ.

1789. mŠw‰ïn iˆê”Êu‰‰j Š°œ‰PœÜ‚ÌŒŸ“¢. ‰¡ŠÖ~C–Ø‘º³“C“n•Ó®C“ì‘òˆç—YC¬—Ñ–¾³CŽ…–ž·Œ›CŽR–{^i®ŠOj: ‘æ76‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï (89.07.08), ªŠÝ.

1790. mŠw‰ïn iˆê”Êu‰‰j ‘å‘Úœœ“ªœÜ‚ÌŽ¡—ÃŒoŒ±. —é–Ø~C¬—Ñ–¾³C‘å–ìŽiCŽO—Ö´ŽuCŽRèŠÞCŽR–{Œ›ˆêCŽ…–ž·Œ›i®ŠOj: ‘æ76‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï (89.07.08), ªŠÝ.

1791. mŠw‰ïn iˆê”Êu‰‰j •IŠÖߌ‹Šj‚ɃTƒ‹ƒRƒCƒh[ƒVƒX—l”ç]‚𔺂Á‚½1—á. ‘å–ìŽiC¬—Ñ–¾³C”ªŠª“~•FC—L•xŠ°i®ŠOj: ‘æ13‰ñ_“Þ샊ƒEƒ}ƒ`ˆã‰ï (89.07.29), ‰¡•l.

1792. mŠw‰ïn iˆê”Êu‰‰j •ÏŒ`«ŠÖßǃ}ƒEƒXiC57BLƒ}ƒEƒXj‚¨‚æ‚у}ƒEƒX‚̃Rƒ‰[ƒQƒ“ŠÖ߉Š‚É‚¨‚¯‚é‡UŒ^ƒRƒ‰[ƒQƒ“‚ɑ΂·‚é–Ɖu”½‰ž‚ÌŠÖ—^. ‘O“cŒ’“ñC‚ŠÝŒ›“ñC”Ñ’ËŒ’Ž™CŽRèŠÞC¼‘º–¾lCŽ…–ž·Œ›C’Ë–{s’jCŽR–{^i®ŠOj: ‘æ4‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (89.08.31`09.01), “Œ‹ž, “ú®‰ïŽi´j, 63(7): 1140, 1989.

1793. mŠw‰ïn iˆê”Êu‰‰j ³íŽÒ‚¨‚æ‚Ñ•ÏŒ`«ŠÖßÇŠ³ŽÒ‚É‚¨‚¯‚錌´’†ƒPƒ‰ƒ^ƒ“—°Ž_’l. ‚ŠÝŒ›“ñC‘O“cŒ’“ñCŽ…–ž·Œ›CŽR–{^i®ŠOjCŒÜäzsMC–x“c‹±Žqi¶‰»jC‘å’J‰pŽ÷i—Õ•a—j: ‘æ4‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (89.08.31`09.01), “Œ‹ž, “ú®‰ïŽi´j, 63(7): 952, 1989.

1794. mŠw‰ïn iˆê”Êu‰‰j ƒƒ{ƒbƒg‚ð—p‚¢‚½x‘Ñ‘¹f’f‘•’u‚ÌŠJ”­. “¡]—T“¹C”nŸº´Ž‘i¶‘ÌHjC’Ë–{s’jC‹v•ÛŽ›‘å–çC“ñŒ©r˜YCŽR–{^i®ŠOjCù“c’¼i“ŒH‘åj: ‘æ4‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (89.08.31`09.01), “Œ‹žC “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(7): 1081, 1989.

1795. mŠw‰ïn iˆê”Êu‰‰j ŠÖß‘¢‰e‚É‚æ‚é‘O\Žšx‘Ñ‚Ìf’f. ‹v•ÛŽ›‘å–çCŽO—Ö´ŽuC‹{“c—fCå‚Œ´—L’jC–kŒ©Œ\ŽiC‹v•Û•×CÄ“¡º•FC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ38‰ñ“Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ï (89.09.10), ˆ®ì.

1796. mŠw‰ïn iˆê”Êu‰‰j QCT–@‚É‚æ‚éÒ’Å‘eé Ç‚¨‚æ‚Ñ–«ŠÖ߃ŠƒEƒ}ƒ`‚Ìœ‰–—ʂ̕ω»‚ɂ‚¢‚Ä. —L•xŠ°CŽR“¿‹`˜YC•Ä–{ŒõˆêC‘å–ìŽiC“ì‘òˆç—Yi®ŠOjC÷ˆä´ŽqCŠâ”g–Îi•új: ‘æ38‰ñ“Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ï (89.09.10), ˆ®ì.

1797. mŠw‰ïn iˆê”Êu‰‰j •I•”ŠÇÇŒóŒQ‚ÌŽ¡—ÂƂ»‚Ì–â‘è“_. “ñŒ©r˜YC¬—Ñ–¾³C•Ä–{ŒõˆêC‹v•ÛŽ›‘å–çCŽO—Ö´ŽuC’Ë–{s’jCŽR–{^i®ŠOj: ‘æ38‰ñ“Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ï (89.09.10), ˆ®ì.

1798. mŠw‰ïn iˆê”Êu‰‰j Charnley-MullerŒ^lHŒÒŠÖß5”NˆÈãŒo‰ß—á‚ÌŒŸ“¢. •Ä–{ŒõˆêCŽ…–ž·Œ›Cã“cºŒáC’Ë–{s’jCŽR–{^i®ŠOj: ‘æ38‰ñ“Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ï (89.09.10), ˆ®ì.

1799. mŠw‰ïn iˆê”Êu‰‰j tˆÚAŒã‚Ì‘å‘Úœ“ª‰óŽ€|cyclosporine A“Š—^ŒQ‚ÌŒŸ“¢. ŠÖŒû¹˜aCŽ…–ž·Œ›C¬—Ñ–¾³C‰¡ŽRˆê•FCŽR–{^i®ŠOjC‰¡“c˜a•FiŠOj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (89.09.11`13), “Œ‹ž.

1800. mŠw‰ïn iˆê”Êu‰‰j lHŠÖßÞ—¿‚Ì–€–Õ‚É‚¨‚¯‚镵ˆÍ‹C‚̉e‹¿. ¼‘ò“N˜NCù“c’¼i“ŒH‘åjCX“c^ŽjC”nŸº´Ž‘i¶‘ÌHj: ‘æ33‰ñÞ—¿Œ¤‹†˜A‡u‰‰‰ï (89.09.13`14), “Œ‹žC —\eW, p.157`158, 1989.

1801. mŠw‰ïn iˆê”Êu‰‰j A Controlled Study of Lymphocytophoresis for Refractory Rheumatoid Arthritis. —L•xŠ°C‘å–ìŽiCã“cºŒáC–kŒ©Œ\Žii®ŠOjC‹{‘òŽµ˜Yi“dŒ°ƒZƒ“ƒ^[j: 16th ILAR Congress of Rheumatology (89.09.17`23), ƒŠƒIƒfƒWƒƒƒlƒCƒ.

1802. mŠw‰ïn iˆê”Êu‰‰j Comparative Studies of the Effect of Cyclosporin A and FK506 on Collagen Arthritis in Mice. ‚ŠÝŒ›“ñCŽRèŠÞC¼‘º–¾lC•Ä–{ŒõˆêC‘O“cŒ’“ñCŽR–{^i®ŠOj: 16th ILAR Congress of Rheumatology (89.09.17`23), ƒŠƒIƒfƒWƒƒƒlƒCƒ.

1803. mŠw‰ïn iˆê”Êu‰‰j Multicentric Evaluation of Tiaprofenic Acid in Osteoarthritic Patients Using of OA Knee Score. ŽR–{^i®ŠOjCAoki, T.COno, K.CSugioka, Y.CKoshino, T.: 16th ILAR Congress of Rheumatology (89.09.17`23), ƒŠƒIƒfƒWƒƒƒlƒCƒ.

1804. mŠw‰ïn iˆê”Êu‰‰j Multicentric Evaluation of Periarthritis Scapulohumeralis Using Shoulder Evaluation Sheets. Yamamoto, R.CMikasa, M.COgawa, K.CMorioka, K.C‚ŠÝŒ›“ñi®ŠOjCTabata, S.: 16th ILAR Congress of Rheumatology (89.09.17`23), ƒŠƒIƒfƒWƒƒƒlƒCƒ.

1805. mŠw‰ïn iˆê”Êu‰‰j IsoelasticlHŒÒŠÖß‚ÌŽg—pŒoŒ±. •Ä–{ŒõˆêCã“cºŒáCŽ…–ž·Œ›C’Ë–{s’jCŽR–{^i®ŠOj: ‘æ73‰ñ’†•”“ú–{®Œ`ЊQŠO‰ÈŠw‰ï (89.10.12`13), ‚¼.

1806. mŠw‰ïn iˆê”Êu‰‰j •GŠÖß—ÍŠwŽŽŒ±ƒƒ{ƒbƒg‚ÌŠJ”­. “¡]—T“¹C”nŸº´Ž‘i¶‘ÌHjC–kŒ©Œ\ŽiC’Ë–{s’jCŽR–{^i®ŠOjCù“c’¼i“ŒH‘åjCrˆäLŽ¡iŽO•H“d‹Cj: ‘æ11‰ñ“ú–{MEŠw‰ïH‹G‘å‰ï (89.10.17`18), ŽD–yC ˆã—p“dŽq‚ƶ‘ÌHŠw, 27(2): 158, 1989.

1807. mŠw‰ïn iˆê”Êu‰‰j ŽèŽw‚É”­¶‚µ‚½“÷Žî‚Ì1—á. ¼X“N˜YC‘å–ìŽiC¬—Ñ–¾³CŽRèŠÞCŽR–{Œ›ˆêC“ñŒ©r˜Yi®ŠOj: ‘æ521‰ñŠÖ“Œ®Œ`ЊQˆãŠw‰ïŒŽ—á‰ï (89.10.25).

1808. mŠw‰ïn iˆê”Êu‰‰j ‹[Ž—‘̉t’†‚É‚¨‚¯‚élHŠÖßÞ—¿‚Ì–€–Õ‚É”º‚¤‹à‘®ƒCƒIƒ“‚Ì—no. ¼‘ò“N˜NCù“c’¼i“ŒH‘åjCX“c^Žji¶‘ÌHjCˆäã—tŽqi—\–hˆãŠwŒnj: ‘æ34Šú“ú–{ŠŠŠw‰ï (89.10.25`26), •xŽRC —\eW, p.507, 1989.

1809. mŠw‰ïn iˆê”Êu‰‰j Cefuzonam SodiumiƒRƒXƒ‚ƒVƒ“j‚ð“Y‰Á‚µ‚½PMMAœƒZƒƒ“ƒg‚Ì‹­“x. X“c^ŽjC”nŸº´Ž‘i¶‘ÌHjCù“c’¼i“ŒH‘åj: ‘æ11‰ñƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ï (89.10.27`28), ‹ž“sC —\eW, p.18, 1989.

1810. mŠw‰ïn iˆê”Êu‰‰j ‰¡Ž~‚߃lƒW‚ð—p‚¢‚½lHŒÒŠÖßœ“ª‚ÌV‚µ‚¢ŒÅ’è–@. ”nŸº´Ž‘C“¡]—T“¹i¶‘ÌHjCŽ…–ž·Œ›CŽR–{^i®ŠOjCù“c’¼i“ŒH‘åj: ‘æ11‰ñ“ú–{ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ï‘å‰ï (89.10.28), ‹ž“sC —\eW, p.47, 1989.

1811. mŠw‰ïn iˆê”Êu‰‰j •Ð‘¤«“Á”­«‰º‘ÚŠO”P‚Ì1—á. ‹v•Û•×C‹v•ÛŽ›‘å–çCŽO—Ö´ŽuC‹{“c—fCå‚Œ´—L’jC¼Œ³‰ë•FC¬‹{Gˆê˜YC“ñŒ©r˜YC’Ë–{s’jC‹ß“¡‘׈êi®ŠOj: ‘æ77‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï (89.11.04), ‰¡•l.

1812. mŠw‰ïn iˆê”Êu‰‰j œ”Õ‚¨‚æ‚ёΑ¤‰ºŽˆ‘½”­œÜ‚Ì1—á. “n•Ó“NÆC“ì‘òˆç—YC¬—Ñ–¾³C‘å–ìŽiC¼‘º–¾lCŽ…–ž·Œ›i®ŠOjCV“¡³‹Pi‹~–½j: ‘æ77‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï (89.11.04), ‰¡•l.

1813. mŠw‰ïn iˆê”Êu‰‰j ã˜rœŠOãè÷‰Š‚ɑ΂·‚é Boyed Žèp|p’†ŠŒ©‚ð’†S‚É|. “ñŒ©r˜YC’Ë–{s’jCŽR–{^i®ŠOj: ‘æ17‰ñ“ú–{ƒŠƒEƒ}ƒ`ŠÖߊO‰ÈŠw‰ï (89.11.10`11), ‘åã.

1814. mŠw‰ïn iˆê”Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`‚É‚¨‚¯‚霉–—Ê‚ÌQCT–@‚É‚æ‚錟“¢. —L•xŠ°C•Ä–{Œõˆêi®ŠOjC÷ˆä´ŽqCŠâ”g–Îi•új: ‘æ17‰ñ“ú–{ƒŠƒEƒ}ƒ`ŠÖߊO‰ÈŠw‰ï (89.11.10`11), ‘åã.

1815. mŠw‰ïn iˆê”Êu‰‰j ƒŠƒEƒ}ƒ`ŠÖߊŠ–ŒØœŒã‚ÌŽèŠÖ߈À’諂ɑ΂·‚é‰e‹¿‚Ì‚wüŠw“IŒŸ“¢. •Ä–{ŒõˆêC“ñŒ©r˜YC’Ë–{s’jC—L•xŠ°C‚ŠÝŒ›“ñCŽR–{^i®ŠOj: ‘æ17‰ñ“ú–{ƒŠƒEƒ}ƒ`ŠÖߊO‰ÈŠw‰ï (89.11.10`11), ‘åã.

1816. mŠw‰ïn iˆê”Êu‰‰j Banked Bone Grafting: Clinical Study on Allograft in Corporation. Ž…–ž·Œ›CŽR–{^C‘å–ìŽiC‰¡ŽRˆê•FCã“cºŒái®ŠOj: 1st Meeting of Asia-Pacific Assoc. of Surgical Tissue Banking (89.11.16), Bangkok, Thailand.

1817. mŠw‰ïn iˆê”Êu‰‰j Massive Osteoarticular Allograft in Treatment for Malignant or Aggressive Bone Tumors. ‘å–ìŽiCŽ…–ž·Œ›CŽR–{^i®ŠOj: 1st Meeting of Asia-Pacific Assoc. of Surgical Tissue Banking (89.11.16), Bangkok, Thailand.

1818. mŠw‰ïn iˆê”Êu‰‰j Cold Preservation of Rat Limb in Euro-Collin's Solution with CoQ10 Pretreatment. ‰¡ŽRˆê•FCŽ…–ž·Œ›CŽR–{^C‚ŠÝŒ›“ñCã“cºŒái®ŠOj: 1st Meeting of Asia-Pacific Assoc. of Surgical Tissue Banking (89.11.16), Bangkok, Thailand.

1819. mŠw‰ïn iˆê”Êu‰‰j ¶çG”^ávÇ‚É”º‚Á‚½•a“I’ÁœœÜ‚Ì1—á. ‹´–{˜a“TC‚ŠÝŒ›“ñC‘å–ìŽiC“ß{–ìG“ñCŽRèŠÞi®ŠOj: ‘æ19‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (89.11.18), “Œ‹ž.

1820. mŠw‰ïn iˆê”Êu‰‰j œ“àŽ‰–bŽî‚Ì3—á. ŽR–{Œ›ˆêC—é–Ø~CŽRèŠÞC‘å–ìŽiC¬—Ñ–¾³CŽ…–ž·Œ›CŽR–{^i®ŠOj: ‘æ19‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (89.11.18), “Œ‹ž.

1821. mŠw‰ïn iˆê”Êu‰‰j —LçêœçêœÜ5—á‚ÌŽ¡—ÃŒoŒ±. “n•Ó®C“ì‘òˆç—YCr–Ø’ˆêC¬—Ñ–¾³C“ñŒ©r˜YCŽR–{^i®ŠOj: ‘æ19‰ñ“ú–{ƒŠƒEƒ}ƒ`ŠÖߊO‰ÈŠw‰ï (89.11.18), “Œ‹ž.

1822. mŠw‰ïn iˆê”Êu‰‰j ƒKƒ“ƒOƒŠƒIƒ“‚É‚æ‚éž™‰º‹Ø–ƒáƒ‚Ì1—á. ŽÂŒ´OsC‚ŠÝŒ›“ñC“ì‘òˆç—YC¬—Ñ–¾³C¼‘º–¾lCrˆä‹`FCŽRŒû—Ǭi®ŠOj: ‘æ522‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŒŽ—á‰ï (89.12.16).

1823. mŠw‰ïn iˆê”Êu‰‰j ‰ºŠ{œœÜ‚ɑ΂·‚éƒ~ƒjƒvƒŒ[ƒg‚ÌŽg—pŒoŒ±. ÷ˆäŽ¡²iŒ`ŠOj: é‹ÊŒ§ˆãŠw‰ï (90.01.21), ‰Y˜a.

1824. mŠw‰ïn iˆê”Êu‰‰j •GŠÖßSk‚𔺂Á‚½Kashin-Beck•a‚Ì1—á. å‚Œ´—L’jC‹v•ÛŽ›‘å–çC“‡Kˆè•vCb”ãGŽÀC‹v•Û•×C¬‹{Gˆê˜YC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ523‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŒŽ—á‰ï (90.01.27), “Œ‹ž.

1825. mŠw‰ïn iˆê”Êu‰‰j —¼‘¤½œ‰“ˆÊ’[Øœp‚ðŽ{s‚µ‚½¶çG”^ávÇ«ŠÖßÇ‚Ì1—á. –q–ìk•¶C‚ŠÝŒ›“ñC‘å–ìŽiC“ì‘òˆç—YCã“cºŒáC‹àˆä“¿²CŽ…–ž·Œ›i®ŠOj: ‘æ523‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŒŽ—á‰ï (90.01.27), “Œ‹ž.

1826. mŠw‰ïn iˆê”Êu‰‰j ‘å‘Úœ‰“ˆÊ•”œ“î‚ÌŽîᇊ‚ɜ܂𶂶‚½2—á. •½“c‰ë—TC‘å–ìŽiC¡–ì~C‹´–{˜a“TCŽ…–ž·Œ›i®ŠOj: ‘æ524‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŒŽ—á‰ï (90.02.24), “Œ‹ž.

1827. mŠw‰ïn iˆê”Êu‰‰j Žè‚Ì‚ˆ³’“ü‘¹‚Ì1—á. ŒIŒ´–«C¬—Ñ–¾³C‰¡ŠÖ~C“ñŒ©r˜Yi®ŠOj: ‘æ78‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï (90.03.03), ‰¡•l.

1828. mŠw‰ïn iˆê”Êu‰‰j ŠÏŒŒ“IŽ¡—Âðs‚Á‚½½œ‹UŠÖß‚ÌŽ¡—ÃŒoŒ±. ¼‘º–¾lC“ì‘òˆç—YCŽRŒû—ǬCr–Ø’ˆêC‚ŠÝŒ›“ñCŽ…–ž·Œ›CŽR–{^Cù–{Œ›’ji®ŠOj: ‘æ78‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï (90.03.03), ‰¡•l.

1829. mŠw‰ïn iŒöŠJuÀj ¶‘̂ƃgƒ‰ƒCƒ{ƒƒW. ”nŸº´Ž‘i¶‘ÌHj: ‘æ67Šú“ú–{‹@ŠBŠw‰ï’Ê푉ïu‰‰‰ï¥æ’[‹ZpƒtƒI|ƒ‰ƒ€ (90.03.31), “Œ‹ž, Ž‘—¿W, Vol. D, p.221`223, 1990.

1830. mŒ¤‹†‰ïn i“Á•Êu‰‰j —â“€•Û‘¶“¯ŽíœˆÚAiœ‹âsj‚ɂ‚¢‚Ä. ŽR–{^i®ŠOj: _“ÞìƒIƒXƒeƒ“Œ¤‹†u‰‰‰ï (90.03.01).

1831. mŒ¤‹†‰ïn i‹³ˆçu‰‰j œÜŽ¡—Âɋy‚Ú‚·—ÍŠw“IˆöŽq‚Ìì—p. ”nŸº´Ž‘i¶‘ÌHj: ‘æ15‰ñœÜŒ¤‹†‰ï (89.07.16), ‰ªŽRC —\eWCp.133, 1989.

1832. mŒ¤‹†‰ïn i‹³ˆçu‰‰j •ÏŒ`«ŠÖßÇ‚Ì•a‘Ô‚ÆŽ¡—Ã. ŽR–{^i®ŠOj: ŒF–{ƒŠƒEƒ}ƒ`ŠÖߎ¾Š³Œ¤‹†‰ï (89.10.07), ŒF–{.

1833. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ‘“à“B‚É‚æ‚éœÜŽ¡—ÂÌH•v. Ž…–ž·Œ›i®ŠOj: ŒF–{œÜŒ¤‹†‰ï (89.10.14), ŒF–{.

1834. mŒ¤‹†‰ïn i‹³ˆçu‰‰j œŽ¾Š³‚Ɖ摜f’f. ¼—Ñ—²i•új: •½¬Œ³”N“x_“Þ쌧f—ÕúŽËü‹ZpuK‰ï (89.10.15), ‰¡•l.

1835. mŒ¤‹†‰ïn i‹³ˆçu‰‰j RA‚ÌŠO‰È“I—Ö@. —L•xŠ°i®ŠOj: “ú–{ƒŠƒEƒ}ƒ`à’c_“Þì’n‹æƒŠƒEƒ}ƒ`‹³ˆçŒ¤C‰ï (89.11.05), ‰¡•l.

1836. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ‘“à“B‚̌Œè—Í‚Æ‚»‚Ì‘Îô. ŽR–{^i®ŠOj: ‘æ2‰ñ–¼ŒÃ‰®Žs‘完`ŠO‰È“¯–å‰ï (89.12.09), –¼ŒÃ‰®.

1837. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j —ÍŠw“IŽhŒƒ‚É‚æ‚éŠÖß‚ÌŒ`¬. ’†ŽR“Oi“‡’ûìŠjCù“c’¼i“ŒH‘åjC“¡]—T“¹C”nŸº´Ž‘i¶‘ÌHjCŽR–{^i®ŠOjC’|“à“ÖŽqi¶‰»Œnj: ‘æ9‰ñƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWƒVƒ“ƒ|ƒWƒEƒ€ (89.03.11), “Œ‹žC —\eW, p.3, 1989.

1838. mŒ¤‹†‰ïn iˆê”Êu‰‰j SUS316ƒXƒeƒ“ƒŒƒX|‚Ì”æ˜J‹““®‚É—^‚¦‚é—n‘¶Ž_‘f‚̉e‹¿. X“c^Žji¶‘ÌHjC’Ë–{s’ji®ŠOjCù“c’¼i“ŒH‘åjC–쑺ŒM: ‘æ19‰ñlHŠÖߌ¤‹†‰ï (89.02.03`04), “Œ‹žC —\eW, p.68, 1989.

1839. mŒ¤‹†‰ïn iˆê”Êu‰‰j lHŠÖßÞ—¿‚Ì–€–ÕŽŽŒ±. ”nŸº´Ž‘CX“c^Žji¶‘ÌHjCŽR–{^i®ŠOjCù“c’¼C‘O‘ò”Œ•Fi“ŒH‘åj: ‘æ9‰ñƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWƒVƒ“ƒ|ƒWƒEƒ€ (89.03.11), “Œ‹ž.

1840. mŒ¤‹†‰ïn iˆê”Êu‰‰j •G‚Ìosteochondral fracture‚ÌŽ¡—ÃŒoŒ±. ‹v•ÛŽ›‘å–çC’Ë–{s’jC“ñŒ©r˜YCb”ãGŽÀC‘OŒ´G•vC“n•Ó®CˆÀ’BŒöCŽO—Ö´ŽuC¬—Ñ–¾˜YC‘O”V‰€‘½KCŽR–{^i®ŠOj: ‘æ15‰ñ“ú–{œÜŒ¤‹†‰ï (89.07.14`15), ‰ªŽR, œÜ, 11: 1989.

1841. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‰~“›“B‚Ë‚¶‰¡Ž~‚ß–@‚ð—p‚¢‚½‘å‘Úœ“]Žq•”œÜ‚ÌŽ¡—Ã. “ì‘òˆç—YCŽRèŠÞC¼‘º–¾lCŽO—Ö´ŽuC¬—Ñ–¾³C‘å–ìŽiCŽ…–ž·Œ›CŽR–{^i®ŠOj: ‘æ15‰ñ“ú–{œÜŒ¤‹†‰ï (89.07.14`15), ‰ªŽR, œÜ, 11: 1989.

1842. mŒ¤‹†‰ïn iˆê”Êu‰‰j d“x‘å‘ÚœŠJ•úœÜ‚Ì1—á. Ž…–ž·Œ›i®ŠOj: ‘æ15‰ñ“ú–{œÜŒ¤‹†‰ï (89.07.14`15), ‰ªŽR, œÜ, 11: 1989.

1843. mŒ¤‹†‰ïn iˆê”Êu‰‰j “¯‘¤ã˜rœA‘O˜rœœÜ(floating elbow)‚ÌŒŸ“¢. ¬—Ñ–¾³C“ì‘òˆç—YC‰¡ŽRˆê•FCŽ…–ž·Œ›C’Ë–{s’jCŽR–{^Cù–{Œ›’ji®ŠOj: ‘æ15‰ñ“ú–{œÜŒ¤‹†‰ï (89.07.14`15), ‰ªŽR, œÜ, 11: 1989.

1844. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œ¨ŠÖߎ¾Š³‚ɑ΂·‚é’´‰¹”gŒŸ¸–@|äF”Â’f—ô‚ð’†S‚Æ‚µ‚Ä|. ‚ŠÝŒ›“ñC‘O“cŒ’“ñCŽR–{^i®ŠOjC‰L–ì˜a‘¥CHŽR‚¢‚í‚«i‘Š–ÍH‘åj: ‘æ1‰ñ“ú–{®Œ`ŠO‰È’´‰¹”gŒ¤‹†‰ï (89.07.29), ‘åã.

1845. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒŠƒEƒ}ƒ`ŽèŠÖߊŠ–ŒØœp‚ÌŒŸ“¢. •Ä–{ŒõˆêC“ñŒ©r˜YC’Ë–{s’jC—L•xŠ°C‚ŠÝŒ›“ñCŽR–{^i®ŠOj: ‘æ18‰ñ“Œ“ú–{ƒŠƒEƒ}ƒ`‚ÌŠO‰ÈŒ¤‹†‰ï (89.08.05), H“c.

1846. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒ\ƒPƒbƒg‚É–â‘è‚Ì‚ ‚Á‚½lHŒÒŠÖßÄ’uŠ·pŽ{s‚Ì2—á. ã“cºŒáC—L•xŠ°CŠÖŒû¹˜aCŽR“c—F‹vi®ŠOj: ‘æ18‰ñ“Œ“ú–{ƒŠƒEƒ}ƒ`‚ÌŠO‰ÈŒ¤‹†‰ï (89.08.05), H“c.

1847. mŒ¤‹†‰ïn iˆê”Êu‰‰j •GŠW‘å‘ÚŠÖߓʂ̌Ÿ“¢‚Æ•GŠWœœØ‚èp. ‹v•ÛŽ›‘å–çi®ŠOj: ‘æ4‰ñŠÖ߃tƒH[ƒ‰ƒ€ (89.08.30), “Œ‹ž.

1848. mŒ¤‹†‰ïn iˆê”Êu‰‰j •G—ÍŠwŽŽŒ±ƒƒ{ƒbƒg‚ÌŽŽì. “¡]—T“¹C”nŸº´Ž‘i¶‘ÌHjC’Ë–{s’jCŽR–{^i®ŠOjCù“c’¼i“ŒH‘åj: ‘æ16‰ñ®Œ`ŠO‰ÈƒoƒCƒIƒƒJƒjƒNƒXŒ¤‹†‰ï (89.09.02), “Œ‹ž.

1849. mŒ¤‹†‰ïn iˆê”Êu‰‰j —h“®‰~ŒÊ‰^“®‚É‚æ‚è\¬‚µ‚½‹UŠÖß‚Ì–€ŽC‹““®. “¡]—T“¹C”nŸº´Ž‘i¶‘ÌHjCŽ…–ž·Œ›CŽR–{^i®ŠOjCù“c’¼i“ŒH‘åj: ‘æ16‰ñ®Œ`ŠO‰ÈƒoƒCƒIƒƒJƒjƒNƒXŒ¤‹†‰ï (89.09.02), “Œ‹ž.

1850. mŒ¤‹†‰ïn iˆê”Êu‰‰j œŽîᇂɑ΂·‚铯Ží•Û‘¶œˆÚA; osterochondral ‚¨‚æ‚Ñsegmental graft‚ÌŒoŒ±. ‘å–ìŽiCŽ…–ž·Œ›CŽR–{^Cã“cºŒáC¬—Ñ–¾³C»•ÓŠ®Ž¡C’Ë–{s’ji®ŠOj: ‘æ8‰ñœ¥ŠÖߥ“î•”‘gDˆÚAŒ¤‹†‰ï (89.09.14`15), “Œ‹ž.

1851. mŒ¤‹†‰ïn iˆê”Êu‰‰j RatŒãŽˆ‚ð—p‚¢‚½•¡‡‘gD‚Ì•Û‘¶‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†|’Pƒ—â‹p•Û‘¶‚ÌŒÀŠE‚ÆRŽ_‰»Ü‚Ì—LŒø«‚ɂ‚¢‚Ä|. ‰¡ŽRˆê•FCŽ…–ž·Œ›C‚ŠÝŒ›“ñCŽR–{^i®ŠOj: ‘æ8‰ñœ¥ŠÖߥ“î•”‘gDˆÚAŒ¤‹†‰ï (89.09.14`15), “Œ‹ž.

1852. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œ‹»—U”­«ŠÖ߉Š¥CPPD’¾’…Ç. –Ø“c–FŽ÷CŠâŸºŒ[ˆêi•a—j: _“Þì•a—ˆã‰ï (89.09.28), ‰¡•l.

1853. mŒ¤‹†‰ïn iˆê”Êu‰‰j •ÏŒ`«•GŠÖßǂɑ΂·‚éäCœ•”•ªØœp‚ÌŽŽ‚Ý. “ñŒ©r˜YC’Ë–{s’jC‹v•ÛŽ›‘å–çCŽO—Ö´ŽuC–kŒ©Œ\ŽiCˆÀ’BŒöC‹{“c—fCå‚Œ´—L’jC“n•Ó®i®ŠOjC”nŸº´Ž‘CX“c^ŽjC“¡]—T“¹i¶‘ÌHj: ‘æ9‰ñ_“ÞìŠÖߊO‰ÈŒ¤‹†‰ï (89.09.30), ‰¡•l.

1854. mŒ¤‹†‰ïn iˆê”Êu‰‰j Power-lifting‚É‚æ‚趂¶‚½Clay Shoveller's Fracture‚Ì1—á. ‹v•ÛŽ›‘å–çi®ŠOj: ‘æ11‰ñ“Œ“ú–{ƒXƒ|[ƒcˆãŠwŒ¤‹†‰ï (89.10.01), “Œ‹ž.

1855. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒWƒ‡ƒMƒ“ƒO‚É‚æ‚éáŠQi‘æ‚P•ñj. ‚ŠÝŒ›“ñi®ŠOj: ‘æ11‰ñ“Œ“ú–{ƒXƒ|[ƒcˆãŠwŒ¤‹†‰ï (89.10.01), “Œ‹ž.

1856. mŒ¤‹†‰ïn iˆê”Êu‰‰j ˆŸ’E‰P«ŒÒŠÖßǂɑ΂·‚é‘å‘ÚœŠO”½‹ü‹ÈœØ‚èp‚Ì‚wüŠw“IŒŸ“¢. •Ä–{ŒõˆêCŽ…–ž·Œ›Cã“cºŒáC’Ë–{s’jCŽR–{^Cù–{Œ›’ji®ŠOj: ‘æ16‰ñ“ú–{ŒÒŠÖߌ¤‹†‰ï (89.11.23`24), •Ÿ‰ª.

1857. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘å‘ÚœŒz‰óŽ€‚ɑ΂·‚éŽxŽœ’ŒˆÚAp‚ÌŽ¡—ÃŒoŒ±. ¬—Ñ–¾³CŽR–{^CŽ…–ž·Œ›C“ì‘òˆç—YC—é–Ø~Cù–{Œ›’ji®ŠOj: ‘æ16‰ñ“ú–{ŒÒŠÖߌ¤‹†‰ï (89.11.23`24), •Ÿ‰ª.

1858. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒÜ\Œ¨‚É‚¨‚¯‚éMRIŠŒ©. ‚ŠÝŒ›“ñC‘O“cŒ’“ñC•Ä–{ŒõˆêC‰Ô“ˆ”ü“ÞŽqC¼‘º–¾lCŽ…–ž·Œ›C’Ë–{s’jCŽR–{^i®ŠOjC’r“crºi•új: ‘æ16‰ñ“ú–{Œ¨ŠÖߌ¤‹†‰ï (89.11.23`24), •Ÿ‰ª.

1859. mŒ¤‹†‰ïn iˆê”Êu‰‰j lHŠÖß‚ÌŠŠ‚Æ‚»‚̉ž—p. ’Ë–{s’ji®ŠOj: ‘Š–ÍŒ´ŽsˆãŽt‰ïŠO‰È®Œ`ŠO‰Èˆã‰ï (89.12.02), ‘Š–ÍŒ´.

1860. mŒ¤‹†‰ïn iˆê”Êu‰‰j “]ˆÚ«œŽîᇂª‹^‚í‚ꂽ’pœ”æ˜JœÜ‚Ì1—á. ŒIŒ´–«CŠÖŒû¹˜aCr–Ø’ˆêCŽR“¿‹`˜YC“ì‘òˆç—YC¬—Ñ–¾³CŽ…–ž·Œ›i®ŠOj: ‘æ11‰ñ_“ÞìCa¥œ‘ãŽÓŒ¤‹†‰ï (90.01.13), ‰¡•l.

1861. mŒ¤‹†‰ïn iˆê”Êu‰‰j —¼‘¤•GœëŠ³—á‚ɑ΂·‚é‘SlH•GŠÖß’uŠ·p‚É‚æ‚é‘Ήž. ’Ë–{s’jC‹v•ÛŽ›‘å–çC–kŒ©Œ\ŽiC“ñŒ©r˜YC•Ä–{ŒõˆêCŽO—Ö´Žui®ŠOj: ‘æ20‰ñlHŠÖߌ¤‹†‰ï (90.02.02`03), ‹ž“s.

1862. mŒ¤‹†‰ïn iˆê”Êu‰‰j MullerŒ^lHŒÒŠÖß5”NˆÈãŒo‰ß—á‚Ì‚wüŠw“IŒŸ“¢. •Ä–{ŒõˆêCŽ…–ž·Œ›C’Ë–{s’jCŽR–{^Cù–{Œ›’ji®ŠOj: ‘æ20‰ñlHŠÖߌ¤‹†‰ï (90.02.02`03), ‹ž“s.

1863. mŒ¤‹†‰ïn iˆê”Êu‰‰j R¶ÜCefuzonam sodium (Cosmosin)‚ð“Y‰Á‚µ‚½PMMAœƒZƒƒ“ƒg‚Ì‹­“xŽŽŒ±. X“c^Žji¶‘ÌHjC—L•xŠ°i®ŠOj: ‘æ20‰ñlHŠÖߌ¤‹†‰ï (90.02.02`03), ‹ž“s, —\eW, p.67, 1990.

1864. mŒ¤‹†‰ïn iˆê”Êu‰‰j lHŠÖßÞ—¿‚Ì‹[Ž—‘Ì“à‰t’†‚Å‚Ì–€–Õ. ¼‘ò“N˜NCù“c’¼i“ŒH‘åjCX“c^ŽjC”nŸº´Ž‘i¶‘ÌHj: ‘æ20‰ñlHŠÖߌ¤‹†‰ï (90.02.02`03), ‹ž“s, —\eW, p.68, 1990.

1865. mŒ¤‹†‰ïn iˆê”Êu‰‰j ã˜rœŠO¥“àè÷‰Š‚ɑ΂·‚éŠO‰È“I—Ö@. “ñŒ©r˜YC•Ä–{ŒõˆêC’Ë–{s’jC¬—Ñ–¾³CŽR–{^i®ŠOj: ‘æ2‰ñ“ú–{•IŠÖߌ¤‹†‰ï (90.02.10), “Œ‹ž.

1866. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‚©‚©‚¦‚ ‚°ƒXƒgƒŒƒXŽB‰e‚É‚æ‚éACL‘¹‚ÌŒŸ“¢. –kŒ©Œ\ŽiC‹v•ÛŽ›‘å–çCŽO—Ö´ŽuC‹g–ìŽõ˜YC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ11‰ñ“Œ‹ž•GŠÖߌ¤‹†‰ï (90.02.17), “Œ‹ž.

1867. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒL[ƒ“ƒxƒbƒN•a‚ɑ΂·‚éstrut bone graft‚ÌŽŽ‚Ý. “ñŒ©r˜YC¬—Ñ–¾³C•Ä–{ŒõˆêCŽá—ÑL”VC‹v•ÛŽ›‘å–çCŽO—Ö´ŽuC’Ë–{s’jCŽR–{^i®ŠOj: ‘æ4‰ñ“Œ“ú–{Žè‚ÌŠO‰ÈŒ¤‹†‰ï (90.02.17), “Œ‹ž.

1868. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‰¼œ‰„’·–@‚É‚æ‚é•êŽwÄŒš‚Ì1—á. ¬—Ñ–¾³C“ñŒ©r˜YC“n•ÓX‹vi®ŠOj: ‘æ4‰ñ“Œ“ú–{Žè‚ÌŠO‰ÈŒ¤‹†‰ï (90.02.17), “Œ‹ž.

1869. mŒ¤‹†‰ïn iˆê”Êu‰‰j •GŠÖß…Žî‚ð‰”­Çó‚Æ‚µ‚½ˆ««•F“÷Žî‚Ì1—á. ¼X“N˜YC‘å–ìŽiCŽRèŠÞC—é–Ø~C—L•xŠ°i®ŠOj: ‘æ15‰ñ_“Þ샊ƒEƒ}ƒ`ˆã‰ï (90.02.24), ‰¡•l.

1870. mŒ¤‹†‰ïn iˆê”Êu‰‰j lHŠÖß “®•”Þ‚Ì“K«•]‰¿C“Á‚É‹à‘®ƒCƒIƒ“—no‚É‹y‚Ú‚·ƒAƒ‹ƒuƒ~ƒ“‚̉e‹¿‚ɂ‚¢‚Ä. X“c^Žji¶‘ÌHjCˆäã—tŽqi—\–hˆãŠwŒnjC”nŸº´Ž‘i¶‘ÌHjC¼‘ò“N˜NCù“c’¼i“ŒH‘åj: ‘æ10‰ñƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWƒVƒ“ƒ|ƒWƒEƒ€ (90.03.03), “Œ‹ž, —\eW, p.1, 1990.

1871. mŒ¤‹†‰ïn iˆê”Êu‰‰j Vargas•Ï–@‚É‚æ‚錨½ŠÖß’E‰P‚ÌŽ¡—ÃŒoŒ±. r–Ø’ˆêC‚ŠÝŒ›“ñC•Ä–{ŒõˆêC“ì‘òˆç—YC‘O“cŒ’“ñCŽ…–ž·Œ›C’Ë–{s’ji®ŠOj: ‘æ10‰ñ_“ÞìŠÖߊO‰ÈŒ¤‹†‰ï (90.03.31), ‰¡•l.

1872. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒÒŠÖߎèp‚É‚¨‚¯‚釕¹Ç. •Ä–{ŒõˆêC’†‘ºˆêmCŽ…–ž·Œ›C’Ë–{s’jC—L•xŠ°CŽR–{^i®ŠOj: ‘æ10‰ñ_“ÞìŠÖߊO‰ÈŒ¤‹†‰ï (90.03.31), ‰¡•l.

1873. mŒ¤‹†‰ïn iˆê”Êu‰‰j •GŠWœ’E‰P‚É”º‚¤osteochondral fracture‚Ì—L–³. ‹v•ÛŽ›‘å–çCå‚Œ´—L’jC–kŒ©Œ\ŽiC‹{“c—fC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ10‰ñ_“ÞìŠÖߊO‰ÈŒ¤‹†‰ï (90.03.31), ‰¡•l.

1874. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘å‘Ú’¼‹Ø‚̃Aƒ~ƒƒCƒh[ƒVƒX‚É‚æ‚éŒÒŠÖßáŠQ‚𗈂µ‚½‚P“§Í—á. “n•ÓX‹vCŽ…–ž·Œ›CŽR–{Œ›ˆêC•“cŒo—mC¬—Ñ–¾³i®ŠOjC÷ˆäŒ’Ž¡: ‘æ10‰ñ_“ÞìŠÖߊO‰ÈŒ¤‹†‰ï (90.03.31), ‰¡•l.

1875. m“Á‹–n “ú–{CœƒZƒƒ“ƒg—p•â•‹ï. X“c^Žji¶‘ÌHjC‘å‘òF–¾CçH˜a‹viƒeƒ‹ƒ‚j.

1876. mŠw‰ï‰ï“ªi‰ï’·jn “ú–{®Œ`ŠO‰ÈŠw‰ïiŽÐ’c–@lj:‘æ4‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ïi89.08.31`09.01j. ŽR–{^i®ŠOj.


<<110 Š´ŠoŠí‚Ɣ畆>>

1877. mŒ´’˜n Requirement of Serum Factors for Wound Closure of Embryonic Skin in vitro. Kistler, A.C’–Œ´ß”V‰îiŒ`ŠOj: Ann. Plast. Surg., 23: 479`487, 1989.

1878. mŒ´’˜n lŠÔƒhƒbƒNŽófŽÒ‚Ì”N—î•Êƒ‰¹’®—Í. ‰ª–{–qlCÝŠy“N–çC–àŽRˆÀOC•½ŽR•ûrCΈä–L‘¾iŽ¨•@j: Audiology Japan.

1879. mŒ´’˜n Regulation of Mammalian Melanogenesis by Tyrosinase Inhibition. ‹TŽRFˆê˜Yi”çjCJimenez, M.CMuller J.CIshida, Y.CHeavy, V.J.(NIH): Differentiation, 42(12): 28`36, 1989.

1880. mŒ´’˜n Comparative Ultrastructural Study of Rabbit Muller Cells in Vitro and Situ. Žá‘q‰ë“oiŠájC Wallace S. Foulds (Univ. of Glasgow): Eye, 2(12): 664`669, 1988.

1881. mŒ´’˜n Senile Erythroderma with Serum Hyper IgE. óˆär–íC–x“à•ÛGi”çj: Intern. J. Dermatol., 28(4): 255`258, 1989.

1882. mŒ´’˜n Bilateral Slowly Progressive Big Blind Spot Syndrome. Žá‘q‰ë“oCŒÃ–ì‹v”üŽqiŠáj: J. Clin. Neuro-Ophtalmol., 9(3): 141`143, 1989.

1883. mŒ´’˜n A Monoclonal Antibody, SKH1, Reacts with 40Kd Sweat Gland-associated Antigen. —é–Ø—T‰îC‹´–{Œ’C‰Á“¡ˆê˜YC¼‰ª´C‰q“¡ŒõC¼ŽR–Εvi”çjC_è•Ûi–¼Žs‘åj: J. Cutan. Pathol., 16: 66`71, 1989.

1884. mŒ´’˜n Tumoral Calcinosis in Scleroderma. •ÐŽRˆê˜NC“Œˆê‹ICŒüˆäGŽ÷C¼‰ª´C¼ŽR–Εvi”çj: J. Dermatol., 16(1): 82`85, 1989.

1885. mŒ´’˜n Drug-induced Chronic Pigmented Purpura. ¼‰ª´C•ÐŽRˆê˜NC‘‘òŠ²’jC‰¡ŠÖ”Ž—YCŽR–Εvi”çj: J. Dermatol., 16(3): 220`222, 1989.

1886. mŒ´’˜n A Case of Sclerosing Lymphangitis of the Lip. ˆî‘ºŒ\ˆêC—é–Ø—T‰îC¼‰ª´C¼ŽR–Εvi”çj: J. Dermatol., 17(2): 127`129, 1990.

1887. mŒ´’˜n Poikiloderma-like Lesion on the Neck in Atopic Dermatitis. ŒüˆäGŽ÷C¼‰ª´C㑺m•vC•ÐŽRˆê˜NC¼ŽR–Εvi”çj: J. Dermatol., 17(2): 85`91, 1990.

1888. mŒ´’˜n Deposition of the Membrane Attack Complex of Complement in Pemphigus Vulgaris and Pemphigus Foliaceus Skin. ì–¼½ŽiCGeoghegan, W.D.CJordon, R.E.C¼ŽR–Εvi”çj: J. Invest. Derm., 92: 588`592, 1989.

1889. mŒ´’˜n Herpes Simplex Virus 1 Infection Upregulates Stress Protein Expression in Cultured Retinal Neurons. Peter G.E. Kennedy (Univ. of Glasgow), Žá‘q‰ë“oiŠájCWallace S. FouldsC Geoffrey B. Clements (Univ. of Glasgow): J. Neurol. Neurosurg. Psychiatr., 53: 72`75, 1990.

1890. mŒ´’˜n A Case of Phenobarbital-induced Optic Neuropathy. –{ŠÔŒ[ŽOCŽá‘q‰ë“oCÎì“NiŠáj: Neuro-ophthalmology, 9(6): 357`360, 1989.

1891. mŒ´’˜n A Quasistatic Study of Pupil and Accommodation After-Effects Following Near Vision. “y‰®–M•FC‰LŽ”ˆê•FCÎì“NiŠáj: Ophtalmic & Physiological Optics, 9(4): 385`391, 1989.

1892. mŒ´’˜n “÷‰èŽî—l‘gD‘œ‚ð’悵‚½‹u]«”~“Å]. “”I‹BC㑺‰ëŽqC“”I^—CÄ“¡—²ŽOi”çj: STDC16: 10`13, 1989.

1893. mŒ´’˜n 10¹ŒŽ—î‚©‚ç13¹ŒŽ—î˜V‰»‘£iƒ}ƒEƒX…»‘̂̉Á—ω». ¼–{_”VC‰F‰ê–ÎŽOC‹{“cŠ²•vCÎì“NiŠáj: ‚ ‚½‚炵‚¢Šá‰È, 6(12): 1851`1853, 1989.

1894. mŒ´’˜n Œã“V«‚É”­Ç‚µ‚½‚ÆŽv‚í‚ê‚éDuaneÇŒóŒQ‚Ì1—á. ŠÖ’JŽ¡‹vC‹ß“¡‰À•vCŒü–ì˜a—YiŠáj: ‚ ‚½‚炵‚¢Šá‰È, 6(6): 885`888, 1989.

1895. mŒ´’˜n ƒuƒ‰ƒ“ƒnƒƒ‰EƒJƒ^ƒ‰[ƒŠƒXŒ‹–Œ‰Š|¬Ž™‚¨‚æ‚јVl‚É‚¨‚¯‚錋–Œ‰Š‚ÌŒ´ˆö‚Æ‚µ‚Ä. â–{‘¥•qiŠáj: ‚ ‚½‚炵‚¢Šá‰È, 6(7): 1067`1069, 1989.

1896. mŒ´’˜n –k—¢‘åŠw•a‰@Šá‰È‚É‚¨‚¯‚éŽãŽ‹Š³ŽÒ‚ÌŒŸ“¢. ’m–쇎qC–x”ÍŽqCˆÉ“¡‰ëŽqCŠÝ“cç•äŽqC–ؔÉC‰LŽ”ˆê•FCÎì“NiŠáj: Šá‰È—Õ°ˆã•ñ, 84(2): 243`247, 1990.

1897. mŒ´’˜n “ï’®‚𔺂Á‚½‘å“®–¬‰ŠÇŒóŒQ11Ç—á‚ÌŒŸ“¢. ˆî–ØŸ‰pCÝŠy“N–çC‰ª–{–qlC“¿‘Œú“ñC“¡–ì–¾lCΈä–L‘¾CŠ™“c—˜•FiŽ¨•@j: Ž¨•@ˆôA‰È—Õ°C82(4): 537, 1989.

1898. mŒ´’˜n ¶–[”S‰tŽî‚É‚æ‚鶖ԖŒ’†S“®–¬•ÂÇÇ‚Ì1—á. ‹g“cŠ°iŠájCFŠ™·ˆêC“c•Ó“™i“s—§_Œo•a‰@j: _ŒoŠá‰È, 5(3): 319`325, 1988.

1899. mŒ´’˜n Šá‹…UṂ̎¡—Ãi‘æ1•ñjjŽ¡—Ö@. ¬‘òŽ¡•viŠáj: _ŒoŠá‰È, 6(2): 207`216, 1989.

1900. mŒ´’˜n Šáâ|ŠO‚ɇ•¹‚µ‚½“àŠá‹Ø–ƒáƒ‚Ì—Õ°Œo‰ß. ‰œ‰pOCŒü–ì˜a—YCÎì“NC’·’JìKŽqCŠÝ“cç•äŽqiŠáj: _ŒoŠá‰È, 6(4): 422`429, 1989.

1901. mŒ´’˜n ”畆ŒŒŠÇ‰Š‚Ì—Õ°“IŒ¤‹†i‘æ4•ÒjAnaphylactoid Purpura‚̖ƉuŠw“I”wŒi. ‰Á“¡ˆê˜YCóˆär–íC‘‘òŠ²’jCÄ“¡—²ŽOCì–¼½Žii”çjC‘¾“c”ü’ÃŽqi—ÕŒŸj: ¼“ú–{”畆‰ÈC51(5): 927`932, 1989.

1902. mŒ´’˜n ƒrƒtƒHƒiƒ][ƒ‹iƒ}ƒCƒRƒXƒ|[ƒ‹‰tj‚É‚æ‚éŠpŽ¿‘BŒ^‘«”’á‚ɑ΂·‚é—Õ°Œø‰Ê‚ÌŒŸ“¢|10%”A‘f“îpiƒEƒŒƒp[ƒ‹j•¹—pŒQ‚Æ‚Ì”äŠrŒŸ“¢‚ð‰Á‚¦‚Ä|. “cÀO”VC’†‘ºŒ’ˆêCŠâè‰ëC¼ŽR–Εvi”çj: ¼“ú–{”畆‰ÈC51(6): 1207`1210, 1989.

1903. mŒ´’˜n SLE, PSSŠ³ŽÒŒŒŸ÷’†‘æ‡[ˆöŽqAƒÀ°ƒgƒƒ“ƒ{ƒOƒƒuƒŠƒ“‚Ì‘ª’èˆÓ‹`. —é–Ø—T‰îC‘‘òŠ²’jC¼ŽR–Εvi”çj: ¼“ú–{”畆‰ÈC51: 268`271, 1989.

1904. mŒ´’˜n ‘gD”|—{–@‚ð—p‚¢‚½l‚¨‚æ‚Ñ“®•¨hair bulb-dermal papilla cell‚̶•¨Šw“I“Á’¥‚̉ðÍ. Ÿ‰ªŒ›¶C’|èLˆê˜YC‰q“¡ŒõC–x“à•ÛGCˆî‘ºŒ\ˆêi”çj: “ú–{ƒŠƒfƒBƒAƒIƒŠƒŠ[‹¦‰ï63”N“x”N•ñCp.71`73, 1989.

1905. mŒ´’˜n ³í‘ÎŒõ”½‰ž‚̉Á—î‚É‚æ‚é•Ï‰»;@VŒ^‘oŠá«ÔŠOü“dŽq“µEŒv(C2515)‚ð—p‚¢‚½ŒŸ“¢. ’·’JìKŽqCÎì“NiŠáj: “ú–{Šá‰ÈŠw‰ïŽGŽ, 93(10): 955`961, 1989.

1906. mŒ´’˜n ƒlƒRŠá—Ö‹Ø_ŒoŽx”z‚ÌŒ`‘ÔŠw“IŒ¤‹†|‚»‚̉^“®ƒjƒ…[ƒƒ“AŽx”z—L‘_Œo‚¨‚æ‚Ñ‹ØüˆÛ|. â–{‘¥•qCŒü–ì˜a—YC‰F‰ê–ÎŽOiŠáj: “ú–{Šá‰ÈŠw‰ïŽGŽ, 93(10): 969`977, 1989.

1907. mŒ´’˜n ƒ^ƒoƒR‹i‰Œ‚ÌŽ‹Šo“Å«. ‰œ‰pOC•Ÿ“‡ˆêÆC²ŒÃ”ŽPC“ï”g—´lCŽá‘q‰ë“oiŠáj: “ú–{Šá‰ÈŠw‰ïŽGŽ, 93(5): 617`624, 1989.

1908. mŒ´’˜n çtçsŠJŽUƒXƒeƒbƒv‰ž“š‚ÌŽw”ŠÖ”‹ßŽ—‚É‚æ‚é‰ðÍ. ŽR“c“OlC‰LŽ”ˆê•FCÎì“NiŠáj: “ú–{Šá‰ÈŠw‰ïŽGŽ, 93(8): 859`864, 1989.

1909. mŒ´’˜n ƒAƒgƒs[«”畆‰ŠŠ³ŽÒ‚̃_ƒj“\•zŽŽŒ±A•a—‘gDŠw“IŒŸ“¢. ˆÉ“¡“ÄCŒüˆäGŽ÷C¼‰ª´i”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC100(1): 63`69, 1990.

1910. mŒ´’˜n ¬lŒ^ƒAƒgƒs[«”畆‰Š‚Ì׋ۃƒNƒ`ƒ“’ŽË‚É‚æ‚鎡—Ãi‡Tj|—Õ°“IŒŸ“¢|. ŒüˆäGŽ÷C¼‰ª´C㑺m•vCˆÉ“¡“ÄC–ìŒûr•FC“¡–{iC¼ŽR–ΕvCHŽR–Îi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC100(3): 425`432, 1990.

1911. mŒ´’˜n ¬lŒ^ƒAƒgƒs[«”畆‰Š‚Ì׋ۃƒNƒ`ƒ“’ŽË‚É‚æ‚鎡—Ãi‡Uj|ì—p‹@˜|. ŒüˆäGŽ÷C¼‰ª´C–ìŒûr•FC“¡–{iC¼ŽR–ΕvCHŽR–Îi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC100(3): 433`439, 1990.

1912. mŒ´’˜n ”A’`”’—z«‚ðŽ¦‚µ‚½‘Sg«‹­”çÇ‚Ì—Õ°“IŒŸ“¢. ‹ß“¡Ž •vC“”I^—CŽ›–{”ÍŽqC•ÐŽRˆê˜NCVˆätŽ}C¼‰ª´C¼ŽR–Εvi”çjC“¡ˆäˆêŽjC¬—Ñ–Li“àj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(10): 1105`1110, 1989.

1913. mŒ´’˜n ˆ««•FŽî×–E•À‚Ñ‚É‘gD’†‚̃Á-glutamyl transferase‚Ì“Á«‚ɂ‚¢‚Ä. •Ä–{N‘ C‹ß“¡Ž •vC¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(11): 1139`1144, 1989.

1914. mŒ´’˜n ˆ««ŒŒŠÇ“à”ç×–EŽî‚ɑ΂·‚éƒCƒ“ƒ^[ƒƒCƒLƒ“2‹Ç’—Ö@‚ÌŒŸ“¢. ‘‘òŠ²’jC‘åìŽiCˆî‘ºŒ\ˆêC“Œˆê‹ICóˆär–íC–x“à•ÛGC¼‰ª´C¼ŽR–ΕvC‰Á“¡’m’‰i”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(12): 1459`1466, 1989.

1915. mŒ´’˜n ”|—{ƒqƒg–Ñ“û“ª×–E‚É‚¨‚¯‚éƒAƒ“ƒhƒƒWƒFƒ“Œ‹‡’`”’‚Ì‹ÇÝ‚Ædihydrotestosterone‚̉e‹¿‚ÌŒŸ“¢. Ÿ‰ªŒ›¶Cˆî‘ºŒ\ˆêC¼‰ª´C¼ŽR–Εvi”çjC¬ì’‰•¶ià–a‰»Ï•iŒ¤‹†Šj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(5): 529`536, 1989.

1916. mŒ´’˜n ‘Sg«g”Á«àÁá‡(SLE)‚É‚¨‚¯‚éRƒJƒ‹ƒWƒIƒŠƒsƒ“R‘Ì‚ÌoŒ»•p“x‚Æ—Õ°ÇóA—Õ°ŒŸ¸¬Ñ‚Æ‚ÌŠÖ˜A«. ‰¹ŽR˜aéC•ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(5): 537`541, 1989.

1917. mŒ´’˜n …áv«—Þ“Vávጅáv‰t’†‚Ìleukotriene (LT)B4‚¨‚æ‚ÑÞLTC4. ì–¼½ŽiC¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(6): 659`664, 1989.

1918. mŒ´’˜n qí«“Vávጔ畆‚É‚¨‚¯‚é•â‘Ìmembrane attack complex‚ÌŒ`¬. ì–¼½ŽiC¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(7): 833`836, 1989.

1919. mŒ´’˜n ”畆¬•ª‚ð”FŽ¯‚·‚éƒqƒgŒ^ƒ‚ƒmƒNƒƒi[ƒ‹Ž©ŒÈR‘Ì‚Ìì». ‰q“¡ŒõC’Ë–{G‘¾˜YC¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(7): 853`860, 1989.

1920. mŒ´’˜n ”畆^‹ÛÇ‚É‚¨‚¯‚é–Ɖu‘gD‰»Šw“IŒŸ“¢. “cÀO”VCŠâè‰ëC¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(9): 1007`1020, 1989.

1921. mŒ´’˜n …‹â‚É‚æ‚é‘Sg«ÚG”畆‰Š||Œo”ç‹zŽû‚Å‚àÄ”­‚·‚éI óˆär–íC’|èLˆê˜YC–ìŒûr•FC•ÐŽRˆê˜NC¼‰ª´i”çj: ”畆C31(‘6): 221`224, 1989.

1922. mŒ´’˜n ŒûO¥Œûo”S–Œ•a•Ï. ¼ŽR–Εvi”çj: ”畆‰È‚Ì—Õ°C31(8): 1161`1166, 1989.

1923. mŒ´’˜n Subacute Cutaneous Lupus Erythematosus (SCLE). “”I‹BCŽ›–{”ÍŽqCÄ“¡—²ŽOi”çj: ”畆‰È‚Ì—Õ°C31: 1261`1265, 1989.

1924. mŒ´’˜n ‹}«ˆê‰ß«ƒŠƒ“ƒp•‚Žî‚Ì1—á. “”I‹BC㑺‰ëŽqCÄ“¡—²ŽOi”çj: ”畆‰È‚Ì—Õ°C31: 657`660, 1989.

1925. mŒ´’˜n ––½_ŒoÇó‚𔺂Á‚½systemic lupus erythematosus. “”I‹BC‹TŽRFˆê˜YC‰q“¡Œõi”çj: ”畆•af—ÃC11: 681`684, 1989.

1926. mŒ´’˜n Variation in Degree of Auricular Flare for the Analysis of Protrusion of Ears in a Random Japanese Population. ’r“c•qŽqi‰ðj: –k—¢ˆãŠw, 19(2): 276`280, 1989.

1927. mŒ´’˜n Quantity of Phalangeal Hairs in a Random Japanese Population. ’r“c•qŽqi‰ðj: –k—¢ˆãŠw, 19(3): 321`326, 1989.

1928. mŒ´’˜n ”|—{”畆ˆÚA‚ÌŠî‘b“IŒ¤‹†|‡WŒ^ƒRƒ‰[ƒQƒ“‚Ì•\”ç×–EƒRƒƒj[Œ`¬‚Ö‚ÌŒø‰Ê‚ɂ‚¢‚Ä|. ‘å’J’˱”VCŒÃŽR“o—²C’–Œ´ß”V‰îiŒ`ŠOj: –k—¢ˆãŠw, 20(2): 121`131, 1990.

1929. mŒ´’˜n ŽÎŽ‹EŽãŽ‹EŠáU‚Ì‚½‚ß‚ÌŽ‹”\ŒP—û. ¬—уŽqCŒü–ì˜a—YC¼Œ´ŒbŽqC¬‘òŽ¡•viŠáj: —Šw—Ö@, 6(5): 327`334, 1989.

1930. mŒ´’˜n ŽwŠÖß‹­’¼‚𔺂Á‚½ƒAƒuƒ~œŒÅ’…Ç. ‹àŽqŒ÷C•½ŽR•ûrC‰ª–{–qlCÝŠy“N–çiŽ¨•@j: —Õ°Ž¨‰ÈC16(1): 74`78, 1989.

1931. mŒ´’˜n ’†Ž¨ƒRƒŒƒXƒeƒŠƒ““÷‰èŽîÇ‚Ì—Õ°“IŒŸ“¢. ˆî–ØŸ‰pCÝŠy“N–çC‰ª–{–qlC²–씣iŽ¨•@j: —Õ°Ž¨‰ÈC16(3): 6`13, 1989.

1932. mŒ´’˜n ”畆ŒŒŠÇ‰Š‚ÌŒŒŠÇáŠQ‚Æ•â‘Ì. ì–¼½Žii”çj: —Õ°”畆‰ÈC43(6): 538`542, 1989.

1933. mŒ´’˜n Etretinate‚Ì“à•ž‚ª‘tŒø‚µ‚½Genodermatose‚Æ‚µ‚Ä‚ÌAcanthosis Nigricans. “”I‹BC㑺‰ëŽqCÄ“¡—²ŽOC‘ºm•vi”çj: —Õ°”畆‰ÈC43: 39`42, 1989.

1934. mŒ´’˜n ”畆•a•Ï‚Ìf’fŽè‹Z. •ÐŽRˆê˜NCŽ›–{”ÍŽqC¼‰ª´C¼ŽR–Εvi”çj: —Õ°–ƉuC21(Suppl.14): 301`309, 1989.

1935. m’Z•ñn A Trichilemmoma Cell Line Congenevate Interleukin-l-alpha. ¼‰ª´C•ÐŽRˆê˜NC‰q“¡Œõi”çjC ‘D“n’‰’ji—Õ•a—j: Dermatologica, 179(Suppl. 1): 135`136, 1989.

1936. m’Z•ñn The 1988 Japanese Neuro-ophthalmology Society Meeting. Žá‘q‰ë“oiŠáj: J. Clin. Neuro-Ophthalmol., 9(3): 211`213, 1989.

1937. m’Z•ñn u‘Ñóáv]v•a‘Ô‚ÆŽ¡—à (5)Šá‰È—̈æ‚É‚à‘½Ê‚È•a‘œ. Œü–ì˜a—YiŠáj: Modern Medicine, 19(2): 34`39, 1990.

1938. m’Z•ñn “úŒoƒƒfƒBƒNƒCƒY(7)Šá‰È. Žá‘q‰ë“oiŠáj: Nikkei Medical, (1989.5.10): 29`30, 1989.

1939. m’Z•ñn Oral Florid Papillomatosis‚ÌŽ¡—Ã;@CO2ƒŒ[ƒU[‚ÆEtretinate‚Ì•¹—p—Ö@. ˆÉ“¡“Äi”çj: ˆãŠw‚Ì‚ ‚ä‚Ý, 150(12): 785, 1989.

1940. m’Z•ñn Šw‰ïˆóÛ‹L:@‘æ42‰ñ“ú–{—Õ°Šá‰ÈŠw‰ïˆê”Êu‰‰u_ŒoŠá‰ÈvƒZƒbƒVƒ‡ƒ“128`138. Œü–ì˜a—YC–ؔÉiŠáj: Šá‰È, 31(3): 371`374, 1989.

1941. m’Z•ñn ’¼ü‰Á‘¬“x•‰‰×‚Ì—Õ°ŒŸ¸‰ž—p. “¿‘Œú“ñC“¡–ì–¾liŽ¨•@j: ‘æ2‰ñ‰F’ˆˆãŠwƒVƒ“ƒ|ƒWƒEƒ€MERSSŒ¤‹†‰ï; ’¼ü‰Á‘¬“x‚ɑ΂·‚é‘O’ëŠí‚Ì–ðŠ„Cp.82`90, 1989.

1942. m’Z•ñn Vogt-¬–ö°Œ´“c•a. “”I‹BC㑺‰ëŽqCŽ›–{”ÍŽqC“”I^—CÄ“¡—²ŽOi”çj: ”畆‰È‚Ì—Õ°, 31: 1685`1686, 1989.

1943. m’Z•ñn ”|—{”畆. ‰–’JMKCŒÃŽR“o—²iŒ`ŠOj: —Šw—Ö@ƒWƒƒ[ƒiƒ‹, 23(7): 491, 1989.

1944. m’Z•ñn Bilateral Big Blind Spot Syndrome‚Ì1—á. ŒÃ–ì‹v”üŽqCŽá‘q‰ë“oC‹{“cŠ²•viŠájC“’“cŒ“ŽŸi‰¡•lŽs‘åj: —Õ°Šá‰È, 43(7): 1130`1131, 1989.

1945. mŒ¤‹†•ñn l¶’·Šú–Ñ“û“ª×–E‚̶•¨Šw“I“Á’¥‚̉ðÍ‚ÆlH”畆‚Ìì». Ÿ‰ªŒ›¶C’|èLˆê˜YC‰q“¡ŒõCˆî‘ºŒ\ˆê˜Yi”çj: º˜a63,64”N“x‰ÈŠwŒ¤‹†”ï•â•‰ïiˆê”ÊŒ¤‹†‚bjŒ¤‹†¬‰Ê•ñ‘, 1989.

1946. mŒ¤‹†•ñn Candida albicans‚É‚æ‚é“àˆö«^‹Û«Šá“à‰Š‚ÌŽ¡—Ã;ƒAƒ“ƒzƒeƒŠƒVƒ“‚aŒ‹–Œ‰º’ŽË‚Ì—LŒø«. –Ø‘º^–çC“¡ˆä‰ë˜NCŒü–ì˜a—YiŠáj: —Õ°Šá‰È, 43(12): 1825`1831, 1989.

1947. mŒ¤‹†•ñn Ò‘¬”]•Ï«Ç‚É‚¨‚¯‚铵EáŠQ‚ɑ΂·‚錟“¢|•›ŒðŠ´_ŒoŒn‚ɂ‚¢‚Ä|. ‹g“cŠ°iŠáj: —Õ°Œ¤‹†•ñ‘, º˜a62”N“x, 1987.

1948. mŒ¤‹†•ñiŒú¶Èjn ‰uŠw•ª‰È‰ï•ñ. ÝŠy“N–çiŽ¨•@j: ‹}«‚“x“ï’®’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†‹ÆÑ•ñ‘C(63): 23`24, 1989.

1949. mŒ¤‹†•ñiŒú¶Èjn “Ë”­«“ï’®’®—͌Œ莞‚̃Aƒ“ƒP|ƒg’²¸‚ɂ‚¢‚Ä. ÝŠy“N–çCŒÃ‘òTˆêC‰ª–{–qlC•½ŽR•ûriŽ¨•@j: ‹}«‚“x“ï’®’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†‹ÆÑ•ñ‘C(63): 115`116, 1989.

1950. mŒ¤‹†•ñiŒú¶Èjn ŠOƒŠƒ“ƒpá‘‚É‚¨‚¯‚é•Û‘¶“IŽ¡—ÃÇ—á‚ÆŽèpŽ¡—ÃÇ—á‚ÌŒŸ“¢. ÝŠy“N–çC‹àŽqŒ÷C‰ª–{–qlC”ª–؈ê‹LC“¿‘Œú“ñC²–씣C“¡–ì–¾lCŒÃ‘òTˆêiŽ¨•@j: ‹}«‚“x“ï’®’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†‹ÆÑ•ñ‘C(63): 141`142, 1989.

1951. mŒ¤‹†•ñiŒú¶Èjn ”½•œ«•½táŠQ‚Ì’®—Í•ª•z. ÝŠy“N–çC•½ŽR•ûrC‹àŽqŒ÷C‰ª–{–qliŽ¨•@j: ‹}«‚“x“ï’®’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†‹ÆÑ•ñ‘C(63): 165`167, 1989.

1952. mŒ¤‹†•ñiŒú¶Èjn “Á”­«—¼‘¤«Š´‰¹“ï’®‚̈æ’l㌟¸. ÝŠy“N–çC•½ŽR•ûrC‰ª–{–qlCŒÃ‘òTˆêiŽ¨•@j: ‹}«‚“x“ï’®’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†‹ÆÑ•ñ‘C(63): 169`171, 1989.

1953. mŒ¤‹†•ñiŒú¶Èjn Š´‰¹“ï’®‚Ì–ò•¨Ž¡—Â̌»ó, ÝŠy“N–çC‰ª–{–qlC‹àŽqŒ÷C•½ŽR•ûrCˆî–ØŸ‰piŽ¨•@j: ‹}«‚“x“ï’®’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†‹ÆÑ•ñ‘C(63): 193`194, 1989.

1954. mŒ¤‹†•ñiŒú¶Èjn qí«“Vávጂ¨‚æ‚Ñ—Ž—tó“Vávጔ畆‚É‚¨‚¯‚é•â‘Ìmembrane attack complex‚ÌŒ`¬. ì–¼½Žii”çj: Œú¶È“Á’莾Š³Šó­“«Ž¾Š³’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.153`158, 1989.

1955. mŒ¤‹†•ñiŒú¶Èjn …áv«—Þ“Vávጅáv‰t’†‚Ìleukotriene (LT)B4 ‚¨‚æ‚Ñ LTC4. ì–¼½Žii”çj: Œú¶È“Á’莾Š³Šó­“«Ž¾Š³’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.215`220, 1989.

1956. mŒ¤‹†•ñiŒú¶Èjn ‘Sg«‹­”çÇ‚É‚¨‚¯‚éRƒJƒ‹ƒWƒIƒŠƒsƒ“R‘Ì‚ÌoŒ»•p“x‚Æ—Õ°Çó‚Æ‚ÌŠÖ˜A«. ¼ŽR–ΕvC•ÐŽRˆê˜NC‹ß“¡Ž •vCŽ›–{”ÍŽqC‰q“¡ŒõC¼‰ª´CVˆätŽ}i”çj: Œú¶È“Á’莾Š³‹­”çÇ’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.87`90, 1989.

1957. mŒ¤‹†•ñiŒú¶Èjn ”A’`”’—z«‚ðŽ¦‚µ‚½‘Sg«‹­”çÇ‚Ì—Õ°“IŒŸ“¢. ¼ŽR–ΕvC•ÐŽRˆê˜NC¼‰ª´C‰q“¡ŒõCŽ›–{”ÍŽqC‹ß“¡Ž •vCVˆätŽ}i”çj: Œú¶È“Á’莾Š³‹­”çÇ’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.163`169, 1989.

1958. mÇ—á•ñn ƒAƒgƒs[«”畆‰Š‚Ì׋ۃƒNƒ`ƒ“—Ö@|¬lŒ^ 2Ç—á‚ÌŽ¡—ÃŒoŒ±|. ŒüˆäGŽ÷C¼‰ª´C–ìŒûr•Fi”çj: ƒAƒŒƒ‹ƒM[‚Ì—Õ°, 9(11): 740`742, 1989.

1959. mÇ—á•ñn ‹ÇŠ”ç•Ù‚É‚æ‚é‘¢ä`p. ‘厜–í—T”VC’†‘ºŒ³MCˆÀ•x‹`“NiŒ`ŠOj: Œ`¬ŠO‰È, 32(4): 357`361, 1989.

1960. mÇ—á•ñn Axial Frontal Flap ‚ÌŒoŒ±. ‘厜–í—T”VC’†‘ºŒ³MCˆÀ•x‹`“NiŒ`ŠOj: Œ`¬ŠO‰È, 32(8): 853`857, 1989.

1961. mÇ—á•ñn ˆê‘¤«“®Šá_Œo•s‘S–ƒáƒ‚𔺂Á‚½‹}«‘½”­«ª_ŒoÇiƒMƒ‰ƒ“EƒoƒŒ[ÇŒóŒQj‚Ì1—á. ‹g“cŠ°iŠájC²“¡Œ’ˆêC“c•Ó“™i“s—§_Œo•a‰@j: _ŒoŠá‰È, 5(4): 450`459, 1988.

1962. mÇ—á•ñn œƒJƒŠƒGƒX’¼ã”畆‚ɶ‚¶‚½—Þ“÷Žî—lŒ‹ŠjŒ‹ß. —é–Ø—T‰îC“cÀG”Vi”çj: ¼“ú–{”畆‰È, 52: 31`35, 1990.

1963. mÇ—á•ñn ƒ€ƒ`ƒ“’¾’…‚𔺂Á‚½üó‘Ûá‚̬l—á. ‘¾“cK‘¥C㑺m•vC¼–{KŽqC‰Í‘ºrŒõi”çj: ”畆‰È‚Ì—Õ°, 31(10): 1430`1431, 1989.

1964. mÇ—á•ñn ƒIƒLƒTƒgƒ~ƒhiƒZƒ‹ƒeƒNƒgj‚É‚æ‚é–ò]. ì–¼½Žii”çj: ”畆‰È‚Ì—Õ°, 31(10): 1436`1437, 1989.

1965. mÇ—á•ñn SLE‚Æ‘½”­«‹Ø‰Š‚Ì Overlap Syndrome. ‹{–{G–¾CÄ“¡‚·‚Ýi•½’Ë‹¤Ï•a‰@jCŽá—Ñ–õ‹vi“àjC’†“ˆOi‰¡•lŽs‘åj: ”畆‰È‚Ì—Õ°, 31(4): 485`489, 1989.

1966. mÇ—á•ñn qí«Š£á‚ɇ•¹‚µ‚½’É•—‚Ì1—á||Š£áŠ³ŽÒ‚É”º‚¤‚”AŽ_ŒŒÇ‚Æ’É•—‚ÌŠÖŒW‚ɂ‚¢‚Ä||. Žíˆä—Ç“ñC“Œˆê‹IC•ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çj: ”畆‰È‚Ì—Õ°, 31(9): 1231`1236, 1989.

1967. mÇ—á•ñn ‹›—Øá—lg”çÇ‚ðŽv‚킹‚½ˆŸ‰”Œ‡–RÇ. ‘¾“cK‘¥C“Œˆê‹IC•ÐŽRˆê˜NCŒüˆäGŽ÷C¼‰ª´C¼ŽR–Εvi”çj: ”畆‰È‚Ì—Õ°, 31(9): 1257`1260, 1989.

1968. mÇ—á•ñn Ž‘±‡–°—Ö@‚ª‘tŒø‚µ‚½MunchhausenÇŒóŒQ‚Ì1—á. Šâè‰ëC’Ë–{G‘¾˜Yi”çjC’ç–M•FC™ŽRˆêi¸j: ”畆‰È‚Ì—Õ°, 31(9): 1281`1285, 1989.

1969. mÇ—á•ñn …‹â‚É‚æ‚é‘Sg«ÚG”畆‰Š. óˆär–íC–ìŒûr•FC•ÐŽRˆê˜Ni”çj: ”畆•af—Ã, 11(11): 966`969, 1989.

1970. mÇ—á•ñn ”畆ƒNƒŠƒvƒgƒRƒbƒNƒXÇ. Šâè‰ëC“cÀO”Vi”çjC‹v•ÄŒõi•a—jCˆ¢•””ü’mŽqi—ÕŒŸjC•ìºC‘å‹v•Û[li“àj: ”畆•af—Ã, 11: 605`608, 1989.

1971. mÇ—á•ñn Mondor•a. —é–Ø—T‰îi”çj: ”畆•af—Ã, 11: 875`878, 1989.

1972. mÇ—á•ñn Œ‹ß«g”Á—l”ç]‚ð’悵‚½SjogrenÇŒóŒQ. ‘¾“cK‘¥C•ÐŽRˆê˜NC¼‰ª´i”çj: ”畆•af—Ã, 12(1): 41`44, 1990.

1973. mÇ—á•ñn ŠÔŽ¿«t‰Š‚𔺂Á‚½SjogrenÇŒóŒQ. •‹{”ü‰ÀŽqC•ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çj: ”畆•af—Ã, 12(1): 57`60, 1990.

1974. mÇ—á•ñn IgAtÇA‚ƒÁƒOƒƒuƒŠƒ“ŒŒÇ«Ž‡”Á‚𔺂Á‚½SjogrenÇŒóŒQ. –ìŒûr•FC‰¡ŠÖ”Ž—YC•ÐŽRˆê˜Ni”çj: ”畆•af—Ã, 12(1): 61`64, 1990.

1975. mÇ—á•ñn Sclerodermatomyositis, toxoplasmaR‘Ì‚’l‚𔺂Á‚½SjogrenÇŒóŒQ. “”I^—C‹ß“¡Ž •vC•ÐŽRˆê˜Ni”çj: ”畆•af—Ã, 12(1): 65`68, 1990.

1976. mÇ—á•ñn SjogrenÇŒóŒQ—lÇó‚ð’悵‚½AIDS. ‘åìŽiC‰¹ŽR˜aéC‰q“¡ŒõC•ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çjCŠ™“cvŽõi“àj: ”畆•af—Ã, 12(1): 69`72, 1990.

1977. mÇ—á•ñn ƒXƒM‰Ô•²ÇŠ³ŽÒ‚É‚Ý‚ç‚ꂽŽ¼]«•Ï‰». óˆär–íC‰¡ŠÖ”Ž—YC•ÐŽRˆê˜NC¼‰ª´i”çj: ”畆•af—Ã, 12(3): 231`234, 1990.

1978. mÇ—á•ñn ŠÂóg”Á‚ðŽå‘i‚Æ‚µ‚½SjogrenÇŒóŒQ. ‰q“¡ŒõC•ÐŽRˆê˜NCŽ›–{”ÍŽqCˆî‘ºŒ\ˆêi”çj: ”畆•af—Ã, 12: 33`36, 1990.

1979. mÇ—á•ñn ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚É”º‚¤Œ‹ß«g”Á—l”ç]‚Ì1—á. ‘¾“cK‘¥C•ÐŽRˆê˜NC¼‰ª´i”çj: —Õ°”畆‰È, 43(11): 1115`1118, 1989.

1980. mÇ—á•ñn ¸_ÇóA–Ôó•ê”ÁAŒŒ¬”ÂŒ¸­‚ð”F‚ß‚½¬Ž™’jŽq‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚Ì1—á. ‰¹ŽR˜aéC•ÐŽRˆê˜NCã’Ë^—C‹ß“¡Ž •vCì–¼½ŽiC¼‰ª´C¼ŽR–Εvi”çj: —Õ°”畆‰È, 43(5): 445`448, 1989.

1981. m—Õ°Ž¡Œ±n ƒAƒgƒs[«”畆‰Š‚ɑ΂·‚é‹g‘Ž_|Ž_ƒvƒŒƒhƒjƒ]ƒƒ“ƒ[ƒVƒ‡ƒ“‚ÌŽg—pŒoŒ±. ŒüˆäGŽ÷C¼ŽR–Εvi”çj: Prog. Med., 9(4): 1393`1398, 1989.

1982. m—Õ°Ž¡Œ±n ‘Ñóáv]‚ɑ΂·‚éƒCƒ_ƒƒ“ùiƒtƒƒNƒ^ƒtƒFƒjƒ“j‚Ì—Õ°•]‰¿. •ÄŒ³N‘ C’†‘ºŒšˆêi”çj: f—ÂÆV–ò, 26(7): 208`212, 1989.

1983. m—Õ°Ž¡Œ±n VDTÇŒóŒQ‚É‚¨‚¯‚钲ߋ@”\áŠQ‚ƃIƒtƒ^3L‚Ì—Õ°Œø‰Ê‚ɂ‚¢‚Ä. Žá‘q‰ë“oCŠÝ“cç•äŽqCÎì“NiŠáj: f—ÂÆV–ò, 26(9): 1645`1653, 1989.

1984. m—Õ°Ž¡Œ±n ¬lŒ^ƒAƒgƒs[«”畆‰Š‚ɑ΂·‚éRƒAƒŒƒ‹ƒM[Ü‚Ì—L—p«‚ÌŒŸ“¢|ƒXƒeƒƒCƒhŠO—pÜ’P“ƂƃIƒLƒTƒgƒ~ƒh•¹—p‚Ì”äŠrŽŽŒ±|. ŒüˆäGŽ÷i”çjC¬lŒ^ƒAƒgƒs[«”畆‰ŠŒ¤‹†‰ï: ¼“ú–{”畆‰È, 51(5): 995`1002, 1989.

1985. m—Õ°Ž¡Œ±n TV-02“îp‚ÌŠp‰»Ç‚ɑ΂·‚é—Õ°¬Ñ. •ÐŽRˆê˜Ni”çjCTV-02“îpŒ¤‹†‰ï: ¼“ú–{”畆‰È, 51(6): 1182`1189, 1989.

1986. m—Õ°Ž¡Œ±n TV-02“îp‚ÌŽŠ“K»Ü”Z“xݒ莎Œ±. ‰q“¡ŒõC¼ŽR–ΕvC㑺m•vi”çjCTV-01“îpŒ¤‹†‰ï: ¼“ú–{”畆‰È, 51: 310`316, 1989.

1987. m—Õ°Ž¡Œ±n Š£áŠ³ŽÒ‚ɑ΂·‚éTV-02“îpˆÀ‘S«Šm”FŽŽŒ±. ‰q“¡ŒõC¼ŽR–ΕvC㑺m•vC•ÐŽRˆê˜Ni”çjCTV-02“îpŒ¤‹†‰ï: ¼“ú–{”畆‰È, 51: 317`324, 1989.

1988. m—Õ°Ž¡Œ±n Žè¥‘«”’á‚ɑ΂·‚éFK-936‚Ì—Õ°•]‰¿|Well-controlled Comparative Study‚É‚æ‚é1% Clotrimazole»Ü‚Æ‚Ì”äŠrŒŸ“¢|. ¼ŽR–ΕvC“cÀO”VC’†‘ºŒ’ˆêCŠâè‰ëi”çjCFK-936‹¤“¯Œ¤‹†”Ç: –ò—‚ÆŽ¡—Ã, 17(12): 247`256, 1989.

1989. m‘àn The Clinical Picture and Treatment of Tinnitus. ÝŠy“N–çiŽ¨•@j: Asian Medical Journal, 133(1): 21`26, 1990.

1990. m‘àn AdieÇŒóŒQ. Œü–ì˜a—YCŽí–{N”ViŠáj: Clinical Neuroscience, 7(7): 730`732, 1989.

1991. m‘àn ”]Š²áŠQ‚Ì_ŒoŠá‰È“If’f. Œü–ì˜a—YiŠáj: Equilibrium Research, 47(1): 27`30, 1988.

1992. m‘àn ”畆Ž¾Š³‚ÌŒûo”S–Œ’×á‡. ‰q“¡Œõi”çj: JOHNS, 5(7): 38`43, 1989.

1993. m‘àn ÚG”畆‰Š. ŒüˆäGŽ÷i”çj: Medicament News, 1258: 2`4, 1989.

1994. m‘àn “µEˆÙí‚Ìf‚©‚½. ’Ò‘ò‰F•FCŒü–ì˜a—YiŠáj: Modern Physician, 9(9): 1159`1161, 1989.

1995. m‘àn “ÁW|Šá‚ÆŽY‹Æ‰q¶|“Á‚ÉVDTì‹Æ. Îì“NiŠáj: Ophthalmology Update, 4(4): 2`12, 1989.

1996. m‘àn ƒAƒgƒs[«”畆‰Š‚Ì—Õ°‚Æ‚»‚ÌŽÀ‘Ô. ¼‰ª´i”çj: ƒAƒŒƒ‹ƒM[‚Ì—Õ°, 10(118): 24`27, 1990.

1997. m‘àn ¬lŒ^ƒAƒgƒs[«”畆‰Š‚ÌŽ¡—Âɑ΂·‚éŒoŒûƒAƒŒƒ‹ƒM[Ü‚Ì—L—p«. ŒüˆäGŽ÷i”çj: ƒAƒŒƒ‹ƒM[‚Ì—Õ°, 9(14): 1048, 1989.

1998. m‘àn ƒAƒ~ƒƒCƒh[ƒVƒX. ŒüˆäGŽ÷i”çj: ƒNƒŠƒjƒJ, 16(8): 55`59, 1989.

1999. m‘àn ׋ۃƒNƒ`ƒ“—Ö@. ŒüˆäGŽ÷i”çj: ƒ}ƒ‹ƒz”畆‰ÈƒZƒ~ƒi[, 79: 16`18, 1989.

2000. m‘àn ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚̔畆Çó. •ÐŽRˆê˜NC¼ŽR–Εvi”çj: ˆãŠw‚Ì‚ ‚ä‚Ý, 150(11): 709`712, 1989.

2001. m‘àn Šá‰È‚ÌŠî‘b: ‘²ŒãŒ¤Cˆã‚Ì‚½‚ß‚É.@‡Z._ŒoŠá‰È‚ÌŠî‘b.@(2)Šá‹Ø‚Ì\‘¢‚Æ‹@”\. Žá‘q‰ë“oC‰ª–ì’q•¶iŠáj: Šá‰È, 31(11): 1255`1263, 1989.

2002. m‘àn “ÁW: æ“V«Šá‹…‰^“®ˆÙí; DuaneÇŒóŒQ. –ؔÉCŒü–ì˜a—YiŠáj: Šá‰È, 31(5): 523`530, 1989.

2003. m‘àn Šá‹…‰^“®‚Æ”­’B|‚»‚ÌŠî‘b‚Æ—Õ°|. ŠÖ’JŽ¡‹vCŒü–ì˜a—YiŠáj: Šá‰ÈMook, 38: 179`189, 1989.

2004. m‘àn VDTì‹Æ‚ÆŠá”æ˜J. Îì“NC–ؔÉiŠáj: Šá‰ÈMook, 39: 94`104, 1989.

2005. m‘àn ŠOŠá‹Ø‚̃tƒB[ƒhƒoƒbƒN(Proprioception). Œü–ì˜a—Y,Vˆä“cF—TiŠáj: Šá‰ÈMook, 41: 229`241, 1989.

2006. m‘àn å@–ƒ]. ¼‰ª´i”çj: Œ»‘ãˆã—Ã, 21(4): 65`68, 1989.

2007. m‘àn ”畆•a•Ï‚̬—§‹@˜. ¼‰ª´i”çj: ÅVˆãŠw, 45(2): 249`252, 1990.

2008. m‘àn ŒÛŽºŒ`¬p‚Ì—ðŽj. ÝŠy“N–çiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È MOOK, (14): 1`8, 1989.

2009. m‘àn ŒÛ–Œ–ü’…ǂɑ΂·‚éŒÛŽºŒ`¬p. ÝŠy“N–çiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È MOOK, (14): 85`89, 1989.

2010. m‘àn Œûo“à‰ŠÇ|…ávÇiqí«“VáváŒA—Þ“VáváŒA‚»‚Ì‘¼j|. ì–¼½Žii”çj: Ž¨•@—Õ°, 82(11): 1523`1526, 1989.

2011. m‘àn ׋ۃƒNƒ`ƒ“’ŽË‚É‚æ‚鎡—Ã. ŒüˆäGŽ÷i”çj: ¬Ž™“à‰È, 22(5): 27`30, 1990.

2012. m‘àn Šá‹…‰^“®Œn‚ɉe‹¿‚·‚é_Œo–ò•¨. ‹g“cŠ°iŠáj: _ŒoŠá‰È, 4(4): 385`398, 1987.

2013. m‘àn “à•ª”å«Šá‹…‰^“®áŠQ; “à•ª”å«Šá‹Øƒ~ƒIƒpƒ`[. Œü–ì˜a—YiŠáj: _ŒoŠá‰È, 6(2): 167`178, 1989.

2014. m‘àn Šá‰ÈŒŸ¸. ‹g“cŠ°iŠáj: ‘Ž‡—Õ°, 35(4): 691`693, 1986.

2015. m‘àn Ž¨–‚̗հ. ÝŠy“N–çiŽ¨•@j: “ú–{ˆãŽt‰ïŽGŽ, 101(5): 783`786, 1989.

2016. m‘àn ”DP«áy]. ¼‰ª´i”çj: “ú–{ˆãŽ–V•ñ, (3420): 25`28, 1989.

2017. m‘àn ×–E‚̃XƒgƒŒƒX‰ž“š‚ÆŠá. Žá‘q‰ë“oiŠáj: “ú–{Šá‰ÈŠw‰ïŽGŽ, 93(5): 511`523, 1989.

2018. m‘àn _ŒoŠá‰È‚©‚ç‚Ý‚½ŽÎŽ‹|•aˆö‚ÆŽ¡—Ö@‚É’–Ú‚µ‚Ä. Œü–ì˜a—YiŠáj: “ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï•ñ, 26(3): 3`17, 1989.

2019. m‘àn –ƉuŽó—e‘Ì‚Æ‚µ‚Ä‚Ì•\”ç. ‰¡ŠÖ”Ž—YC•ÐŽRˆê˜NC¼‰ª´i”çj: ”畆•af—Ã, 11(11): 935`945, 1989.

2020. m‘àn –Ñ“û“ª|–Ñ‚Ì”­¶A¬’·‚É‚¨‚¯‚é–ðŠ„|. Ÿ‰ªŒ›¶i”çj: ”畆•af—Ã, 11(12): 1020`1025, 1989.

2021. m‘àn ¡“ú‚̘b‘èFŽ‹_Œo‰Š‚ÌŽ¡—Ã. Žá‘q‰ë“oiŠáj: —Õ°Šá‰È, 43(11): 1733`1737, 1989.

2022. m‘àn ƒŠƒEƒ}ƒ`‰Èf—Ã}ƒjƒ…ƒAƒ‹E”畆•a•Ï. ‰q“¡ŒõC¼ŽR–Εvi”çj: —Õ°–Ɖu, 21(Suppl. 14): 200`209, 1989.

2023. muÀn ‚܂΂½‚«‚ÌŽ©“®’²ß‚Ì‚µ‚­‚Ý‚Í‚Ç‚¤‚È‚Á‚Ä‚¢‚é‚Ì‚©. Vˆä“cF—TCŒü–ì˜a—YiŠáj: Clinical Neuroscience, 7(5): 115, 1989.

2024. muÀn Ž‹—ÍáŠQAŠá‹Ø–ƒáƒ‚ð‚ß‚®‚Á‚Ä. —¢‹g‰c“ñ˜Yi‘—§¸__ŒoƒZƒ“ƒ^[jCŒü–ì˜a—YiŠájC“c‘ã–M—Yi–k‘åjCŽÄè_i‘—§¸__ŒoƒZƒ“ƒ^[j: Clinical Neuroscience, 8(2): 208`222, 1990.

2025. muÀn ”­]. ¼‰ª´i”çj: Mebio, 6(6): 119`124, 1989.

2026. muÀn –Ú‚Å‚Ý‚éƒgƒŒ[ƒjƒ“ƒOi”畆‹Ø‰Šj. ŒüˆäGŽ÷i”çjC‹ß“¡Œ[•¶i“àjC¯ŽiiˆêiMB‘åjCˆÀ“¡³KiŒF–{‘åjCŸ–ÚãEi‹ž“s•{—§ˆã‘åj: Medicina, 26(13): 2610`2616, 1989.

2027. muÀn –Ú‚Å‚Ý‚éƒgƒŒ[ƒjƒ“ƒOi‘Sg«ƒAƒ~ƒƒCƒh[ƒVƒXj. ŒüˆäGŽ÷i”çjC—ˆ¶“NC—é–؉hˆêiVŠƒ‘åjCŸ–ÚãEi‹ž“s•{—§ˆã‘åjCˆÀ“¡³KiŒF–{‘åj: Medicina, 27(1): 158`163, 1990.

2028. muÀn –Ú‚Å‚Ý‚éƒgƒŒ[ƒjƒ“ƒOiPeutz-Jeghers Syndromej. ŒüˆäGŽ÷i”çjCÔ”öM–¾C‹ß“¡—͉¤ŽŠi‹à‘ò‘åjC¯ŽiiˆêiMB‘åjCŸ–ÚãEi‹ž“s•{—§ˆã‘åj: Medicina, 27(2): 296`301, 1990.

2029. muÀn ’®—Í‘œ‚Æ”N—î•Ê•½‹Ï’l. ‰ª–{–qliŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È Mook, (12): 11`18, 1989.

2030. muÀn ƒ}ƒCƒRƒvƒ‰ƒYƒ}Š´õÇ‚É”º‚¤”畆Çó. ‰q“¡Œõi”çj: “ú–{ˆãŽt‰ïŽGŽ, 102: ss65`68, 1989.

2031. muÀn •¡Ž‹‚ɑ΂·‚é–âf‚ÆŠÈ•Ö‚ÈfŽ@–@. Œü–ì˜a—YiŠáj: “ú–{ˆãŽ–V•ñ, (3413): 130`131, 1989.

2032. muÀn Ž‹_Œo‰ŠiÇj‚Ìf’f‚ÆŽ¡—Ã. ’†”ö—YŽOi‹ß‹E‘åjCŠ`²•ÄŽŸiç—t‘åjC‰Í‡ˆêdiŽœŒbˆã‘åjCŽO‘ºŽ¡i•ºŒÉˆã‘åjCŽá‘q‰ë“oiŠáj: “ú–{Šá‰È‹I—v, 40(4): 587`595, 1989.

2033. muÀn ”畆‚̃AƒŒƒ‹ƒM[AƒAƒŒƒ‹ƒM[«ÚG”畆‰Š‚ƃAƒgƒs[«”畆‰Š‚ÌŽ¼]”½‰ž. ¼‰ª´i”çj: ”畆‚Æ”ü—e, 21(1): 25`30, 1989.

2034. muÀn ƒAƒgƒs[«”畆‰Š‚Ì–â‘è“_. ¼‰ª´i”çjC‹{–{³Œõi“Œ‹ž“sj: ”畆•af—Ã, 11(3): 257`265, 1989.

2035. muÀn ¬lŒ^ƒAƒgƒs[«”畆‰Š‚Í׋ۃƒNƒ`ƒ“Ž¡—Ö@‚Å‚©‚È‚è‰ü‘P‚Å‚«‚é. ŒüˆäGŽ÷i”çj: •é‚炵‚ÆŒ’N, 44(11): 36`37, 1989.

2036. mŠwp‘n i•ÒWEŽ·•Mj VDTˆãŠwƒ}ƒjƒ…ƒAƒ‹; VDT‚ÆŠá, p.26`28; Šá‚ÆŽ©—¥_Œo, p.40`41; ‹ßŽ‹”½‰ž‚Æ‚»‚Ì’†•, p.54`55; œŠO‚·‚ׂ«Ç—á, p.95`96, Îì“NiŠáj. •ÒW Îì“Ni–k—¢‘åEŠáj•Ò, ‘S“ú–{•a‰@o”ʼnï, “Œ‹ž, 89.09.15 ”­s.

2037. mŠwp‘n iŽ·•Mj VDTˆãŠwƒ}ƒjƒ…ƒAƒ‹; A. Šá‚̉ð–U, p.35`39, Œü–ì˜a—YiŠáj. •ÒW Îì“Ni–k—¢‘åEŠáj•Ò, ‘S“ú–{•a‰@o”ʼnï, “Œ‹ž, 89.09.15 ”­s.

2038. mŠwp‘n iŽ·•Mj VDTˆãŠwƒ}ƒjƒ…ƒAƒ‹; I. ’²ß, p.56`58; P. ‹üÜ:, p.75`76, ‰LŽ”ˆê•FiŠáj. •ÒW Îì“Ni–k—¢‘åEŠáj•Ò, ‘S“ú–{•a‰@o”ʼnï, “Œ‹ž, 89.09.15 ”­s.

2039. mŠwp‘n iŽ·•Mj VDTˆãŠwƒ}ƒjƒ…ƒAƒ‹; I°J. çtçs|Å‹ß‚Ìl‚¦•û‚¨‚æ‚Ñ‘ª’è–@, p.59`61; ‡U°C. Šá’É‚Æ“ª’É‚Ì— ‚É‚ ‚鎾Š³, p.86`88, Žá‘q‰ë“oiŠáj. •ÒW Îì“Ni–k—¢‘åEŠáj•Ò, ‘S“ú–{•a‰@o”ʼnï, “Œ‹ž, 89.09.15 ”­s.

2040. mŠwp‘n iŽ·•Mj VDTˆãŠwƒ}ƒjƒ…ƒAƒ‹; O. Ž‹‹@”\ˆÙí‚Æ‘SgÇó, p.73`74; R. VDT‚Æ”N—î, p.79, –ؔÉiŠáj. •ÒW Îì“Ni–k—¢‘åEŠáj•Ò, ‘S“ú–{•a‰@o”ʼnï, “Œ‹ž, 89.09.15 ”­s.

2041. mŠwp‘n iŽ·•Mj –Ô–¬—–ŒŽ¾Š³‚Ì—Õ°•a—; ƒVƒ“ƒi[’†“ÅEƒNƒƒƒLƒ“–Ô–ŒÇ, p.140`143, Œü–ì˜a—YiŠáj. •ÒW ’––“–Ði‹ã‘åj‘¼C•Ò, ˆãŠw‘‰@, “Œ‹ž, 89.00.00 ”­s.

2042. mŠwp‘n iŽ·•Mj Œ»‘ã”畆‰ÈŠw‘åŒn; •\”çˆÚA, p.37`46, ŒÃŽR“o—²iŒ`ŠOj. ’†ŽR‘“X, 89.00.00”­s.

2043. mŠwp‘n iŽ·•Mj ƒAƒŒƒ‹ƒM[«”畆Ž¾Š³; ÚGƒAƒŒƒ‹ƒM[‚ƇTŒ^”½‰ž‚ÌŽ¼]”½‰ž, ¼‰ª´i”çj. •ÒW ‹g“c•F‘¾˜Yi’·è‘åj•ÒC ‹¦˜aŠé‰æ’ÊM, “Œ‹ž, 89.09.30”­s.

2044. m‹³‰È‘n iŽ·•Mj ŽY‹Æ“à‰ÈŠw|_ŒoE‹ØŒn; Ž‹ŠoáŠQ, p.356`359, Œü–ì˜a—YiŠáj. •ÒW ‘c•ƒ]ˆí˜YC‘¼•Ò, ˆãŽ•–òo”Å, “Œ‹ž, 89.00.00 ”­s.

2045. m‹³‰È‘n iŽ·•Mj Aesthetic Breast Surgery; Aesthetic Breast Surgery in Orientals, ‘å’|®”VC‰–’JMKiŒ`ŠOj. •ÒW Nicholas Georgiade (Duke Univ.) •Ò, Williams & Wilkins, Baltimore, 89.00.00 ”­s.

2046. m‹³‰È‘n iŽ·•Mj ”畆Ž¾Š³ÅV‚ÌŽ¡—Ã'89°'90; …ávÇ, p.115`116, ì–¼½Žii”çj. •ÒW ¼ŽR–Εvi–k—¢‘åjC‘¼•ÒC “ì]“°, “Œ‹ž, 89.00.00”­s.

2047. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ÒWj ˜V”NŽÒ‚ÆŽ¨•@ˆôA‰È¥Ž¨•@ˆôA‰È“ªŒz•”ŠO‰È Mook No.12, •ÒW ÝŠy“N–çi–k—¢‘åj•ÒC ‹àŒ´o”Å, 89.04.00”­s.

2048. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ÒWj ƒI|ƒWƒIƒƒW|(2), —Õ°Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È‘S‘‚S‚a4b,1989, •ÒW ÝŠy“N–çi–k—¢‘åj•ÒC ‹àŒ´o”Å, 89.10.20”­s.

2049. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj Ž¨•@ˆôA‰Èf—à Questions & Answers ‘æ11†; “ªˆÊC“ªˆÊ•ÏŠ·ŠáU‚Ìf’f“IˆÓ‹`C11: 351‚Ì2`351‚Ì5, “¿‘Œú“ñiŽ¨•@j. ˜Z–@o”Å, –¼ŒÃ‰®, 89.04.19”­s.

2050. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj A Color Atlas of Dermato-Immunohistocytology; Sweat Gland, p.28`29; Desmosome, p.40`41, ‰q“¡Œõi”çj. •ÒW Hiroaki Uekiiìèˆã‘åjCHideo YaoitaiŽ©Ž¡ˆã‘åjC Wolfe Medical Publications, Ltd., London, England, 89.00.00”­s.

2051. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn iŽ·•Mj ƒXƒeƒƒCƒhÜ‚Ì‘I‚Ñ•û‚ÆŽg‚¢•û; ”畆‰È—̈æ‚ł̃XƒeƒƒCƒh—Ö@, ¼‰ª´i”çj. •ÒW –î–ìŽO˜Yi•xŽRˆã‰È–ò‰È‘åj•ÒC “ì]“°, “Œ‹ž, 90.01.10”­s.

2052. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn iŽ·•Mj ”畆ŠO—pÜ‚Ì‘I‚Ñ•û‚ÆŽg‚¢•ûC ¼‰ª´i”çj. “ì]“°, “Œ‹ž, 89.03.01”­s.

2053. mŠw‰ïn i“Á•Êu‰‰j A Comparison of Eye Strain in VDU Operators and Hard Copy Workers-|An Objective Determination by Means of Near Triad Response. Îì“NiŠáj: XII Congress of Asia Pacific Academy of Ophthalmology (89.06.01), Seoul.

2054. mŠw‰ïn i“Á•Êu‰‰j Ž¨•@ˆôA‰È—̈æ‚ÌŽå‘i‚ÆD‘i. ÝŠy“N–çiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ïŽ­Ž™“‡’n•û•”‰ï (89.12.17), Ž­Ž™“‡.

2055. mŠw‰ïn i‹³ˆçu‰‰j ƒ}ƒ‰ƒbƒZƒ`ƒAŠ´õǂɂ‚¢‚Ä. ŒüˆäGŽ÷i”çj: _“Þ쌧”畆‰Èˆã‰ï‘æ70‰ñ—á‰ï i89.12.02j, ‰¡•l.

2056. mŠw‰ïn i‹³ˆçu‰‰j ƒXƒeƒƒCƒhŠO—pÜ’P“ƂƃZƒ‹ƒeƒNƒg•¹—p‚Ì”äŠrŽŽŒ±¬Ñ. ŒüˆäGŽ÷i”çj: _“Þ쌧”畆‰Èˆã‰ï‘æ71‰ñ—á‰ï i90.02.25j, Š™‘q.

2057. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Šá‹…‰^“®áŠQ‚Æ‚»‚̈Ӌ`:@“úíf—Âɂ¨‚¯‚éf’fŽè‹ZGŒ©—Ž‚Æ‚³‚ꂪ‚¿‚ÈŠá‹…‰^“®ŠŒ©. ‹g“cŠ°iŠáj: ‘æ93‰ñ“ú–{Šá‰ÈŠw‰ï (89.05.13), ‹ž“s.

2058. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Šá‹…‰^“®áŠQ‚Æ‚»‚̈Ӌ`:@…•½Šá‹…‰^“®Œn‚Ì_Œo‹@\GPPRFÇŒóEMLFÇŒó‚ɂ‚¢‚Ä. Œü–ì˜a—YiŠáj: ‘æ93‰ñ“ú–{Šá‰ÈŠw‰ï (89.05.13), ‹ž“s.

2059. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ê–Ž•—Þ”’“àá‚̬‘÷”­Ç—lŽ®‚©‚ç‚Ý‚½…»‘Ì\’z‚ɂ‚¢‚Ä. ‰F‰ê–ÎŽOiŠáj: ‘æ28‰ñ“ú–{”’“àáŠw‰ï (89.06.24), ‹ž“s.

2060. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‘˜_F_ŒoŠá‰È‚©‚ç‚Ý‚½ŽÎŽ‹|•aˆö‚ÆŽ¡—Ö@‚É’–Ú‚µ‚Ä|. Œü–ì˜a—YiŠáj: ‘æ6‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ïuK‰ï (89.06.25), ‘åã.

2061. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Še˜_F’²ßEçtçs‚ÆŽÎŽ‹. ŠÖ’JŽ¡‹viŠáj: ‘æ6‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ïuK‰ï (89.06.25), ‘åã.

2062. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Šá‹…‰^“®ˆÙí‚Ì—Õ°G‹Ø–³—ÍÇAŠáâ|‹Ø‰ŠAæ“VˆÙí. Œü–ì˜a—YiŠáj: ‘æ27‰ñ–k“ú–{Šá‰ÈŠw‰ï (89.07.15), ŽD–y.

2063. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j •½t‹@”\áŠQ‚̃ŠƒnƒrƒŠƒe|ƒVƒ‡ƒ“. “¡–ì–¾liŽ¨•@j: ‘æ69‰ñ_“Þì’n•û•”‰ï (89.09.30), ‘Š–ÍŒ´.

2064. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j 3.–Ô–Œ‚É‚¨‚¯‚é_Œo“`’B•¨Ž¿,(4)”|—{×–E‚ð—p‚¢‚½‰ðÍ. Žá‘q‰ë“oiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.20), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.

2065. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒjƒ…[ƒƒ“‚ƃOƒŠƒA‚Ì‘ŠŒÝì—p‚ƶ—Šˆ«•¨Ž¿||–Ô–Œ‚Ì‘nŽ¡–ü‹@\‚ð‘z’肵‚Ä||. Žá‘q‰ë“oiŠáj: ‘æ7‰ñ‘ۊጤ‹†‰ï‹c“ú–{•”‰ï (89.12.10), ‘åã.

2066. mŠw‰ïn iƒpƒlƒ‹j —L‹@—ÓÜ’†“ł̈ÙíŠá‹…‰^“®”­¶‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†|GABAƒjƒ…[ƒƒ“‚̖Ɖu‘gDŠw“IŒ¤‹†|. Îì“NC¬“ˆ—ÇGCŠÖ’JŽ¡‹vC‘ìd•viŠájC’[ì•×iŠâŽèˆã‘åj: ‘æ93‰ñ“ú–{Šá‰ÈŠw‰ï (89.05.11), ‹ž“s.

2067. mŠw‰ïn iƒpƒlƒ‹j ‘½”­«d‰»Ç‚É‚¨‚¯‚銦—âŽhŒƒ‚Ì‘¼Šo“I•]‰¿. ’Ò‘ò‰F•FCŠâØ”ü—˜C–ؔÉCÎì“NiŠáj: ‘æ93‰ñ“ú–{Šá‰ÈŠw‰ï (89.05.11), ‹ž“s.

2068. mŠw‰ïn iƒpƒlƒ‹j —‘‰©—l‰©”Á•Ï«‚¨‚æ‚Ñ–Í—lƒWƒXƒgƒƒtƒB[‚𗼊á‚ɒ悵‚½1—á. ‰ª–ì’q•¶C•Ÿ“c•q‰ëC‹{“cŠ²•vCÎì“NiŠáj: ‘æ55‰ñ’†•”Šá‰ÈŠw‰ï (89.09.09), “¿“‡.

2069. mŠw‰ïn iƒpƒlƒ‹j æ“V«—Γàá‚ð‡•¹‚µ‚½’†SŠj•a floppy infant ‚Ì1—á. ’†ŽR’q•FiŠájCÎì”ü˜aŽqCŽs£—mŽqi‘Š–Í–ì•a‰@jCŽí“c–F˜YiŠájC“‡ŠÑˆèC¡ˆäƒDiŽ™j: ‘æ43‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (89.10.14), –¼ŒÃ‰®.

2070. mŠw‰ïn iƒpƒlƒ‹j Pattern VEPŒŸ¸‚É‚¨‚¯‚é“d‹ÉˆÊ’u‚ÌŒŸ“¢. “n•Ó”ü’qŽqC‹g–{gŽqi—ÕŒŸjC’m–쇎qCŽá‘q‰ë“oiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.22), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.

2071. mŠw‰ïn iƒpƒlƒ‹j ŒuŒõŠá’ê‘¢‰e‚ňÙí‚Ì‚Ý‚ç‚ꂽŽ‹Œð³•”‹ß–Tè‹’«•a•Ï. ’†‘ò³”ŽCŽá‘q‰ë“oC‰ª–ì’q•¶CÎì“NiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.22), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.

2072. mŠw‰ïn iƒpƒlƒ‹j ŋߌoŒ±‚µ‚½Šç–Ê‚Ì”’á‚ɂ‚¢‚Ä. ‘¾“cK‘¥C“cÀO•¶i”çj: ‘æ33‰ñ“ú–{ˆã^‹ÛŠw‰ï‘‰ï i00.00.00j, ‰«“ê.

2073. mŠw‰ïn iƒpƒlƒ‹j Ž©ŒÈ–Ɖu«—nŒŒ«•nŒŒŠ³ŽÒ‚É”­Ç‚µ‚½”畆ƒNƒŠƒvƒgƒRƒbƒNƒXÇ. ‹ß“¡Ž •vC‘¾“cK‘¥CŠâè‰ëC“”I^—C“cÀO”VC¼ŽR–Εvi”çjCˆ¢•””ü’qŽqC‚–Øç’ßi—ÕŒŸj: ‘æ33‰ñ“ú–{ˆã^‹ÛŠw‰ï‘‰ï i89.09.22j, ‰«“ê.

2074. mŠw‰ïn iƒpƒlƒ‹j Biological Characteristics of Gamma Glutamyl Transferase in Malignant Melanoma. ‹ß“¡Ž •vC•ÄŒ³N‘ C‰q“¡ŒõC¼ŽR–Εvi”çj: 2nd International Conference on Melanoma i89.10.16`19j, Venice, Italy.

2075. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Morphological Demonstration of Ocular Muscle Proprioception in the Human Extraocular Muscles. Œü–ì˜a—YiŠáj: International Workshop on Proprioception of the Ocular Muscles 1986 (00.00.00), Acta Ehime University Press, 19`26, 1989.

2076. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Influence of Body Temperature Change on Optic Neuritis. Žá‘q‰ë“oiŠáj: Association for Eye Research 30th Meeting & Ecofs Meeting (89.10.06), ƒtƒ‰ƒ“ƒX.

2077. mŠw‰ïn iˆê”Êu‰‰j V‚µ‚¢ŠÈˆÕŒ^ƒCƒŠƒXƒR[ƒ_[. Îì‹ÏC’Ò‘ò‰F•FC’·’JìKŽqCÎì“NiŠájC‘å˜a“c—²i‹~–½j: ‘æ4‰ñŠá‰ÈMEŠw‰ï (89.04.15), “Œ‹ž.

2078. mŠw‰ïn iˆê”Êu‰‰j “µE‚̉Á—î•Ï‰»‚ÉŠÖ‚·‚錤‹†|“µE–ÊÏA‘ÎŒõ”½‰ž‚Ì•ªÍŒ‹‰Ê|. ’·’JìKŽqCÎì“NiŠájCŒÑ“c’¼ri•l¼ƒzƒgƒjƒNƒXj: ‘æ4‰ñŠá‰ÈMEŠw‰ï (89.04.15), “Œ‹ž.

2079. mŠw‰ïn iˆê”Êu‰‰j ’܉ºŠOœŽî‚ɂ‚¢‚Ä. ŒÃŽR“o—²C‰FˆäŒª“ñCçÝŽ½C“àÀ‰hŽ÷C‰–’JMKiŒ`ŠOjC¬—Ѻi‘—§‰¡•l•a‰@j: ‘æ32‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï (89.04.21), ‰YˆÀ.

2080. mŠw‰ïn iˆê”Êu‰‰j F‘f•WŽ¯–@‚©‚ç‚Ý‚½ƒ}ƒEƒXŠáŠO«”’“àá‚Ì”­¶‹@˜. ‰F‰ê–ÎŽOC–œÂi’†‘ˆã‰È‘åjC¼–{_”VCÎì“NiŠáj: ‘æ93‰ñ“ú–{Šá‰ÈŠw‰ï (89.05.11), ‹ž“s.

2081. mŠw‰ïn iˆê”Êu‰‰j ”|—{ƒ~ƒ…[ƒ‰[×–E‚ɑ΂·‚éD,L-2-Aminoadipic acid ‚ÌCa2+ƒCƒIƒ“‚ð‰î‚µ‚½‰e‹¿‚ɂ‚¢‚Ä. Žá‘q‰ë“oiŠájCŽR–{¸iŠÅŒìŠw•”j: ‘æ93‰ñ“ú–{Šá‰ÈŠw‰ï (89.05.11), ‹ž“s.

2082. mŠw‰ïn iˆê”Êu‰‰j ˆÙíŠá‹…‰^“®‚ÆŠáU‚ÌǗጟ“¢|Opsoclonus‚ɂ‚¢‚Ä|. ‹g”ö’mC”ª–؈ê‹LC•½ŽR•ûrC¼‰ª–¾—TC“¡–ì–¾lCŒÜ“‡ˆê‹gC“¿‘Œú“ñiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‘‰ï (89.05.11), ‘åãC “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñC92(10): 1730, 1989.

2083. mŠw‰ïn iˆê”Êu‰‰j ƒlƒR‚’¼‰^“®‹Ø‚Ì“®Šá_ŒoŠj‚É‚¨‚¯‚é’†•‹ÇÝ|double labeling–@‚É‚æ‚錤‹†|. ‹ß“¡‰À•vCŠÖ’JŽ¡‹vC¬“ˆ—ÇGCÎì“NiŠáj: ‘æ93‰ñ“ú–{Šá‰ÈŠw‰ï (89.05.12), ‹ž“s.

2084. mŠw‰ïn iˆê”Êu‰‰j ƒlƒR‹y‚уTƒ‹‚É‚¨‚¯‚é’†”]‚©‚ç–Ñ—l‘Ì‚ÉŽŠ‚é’¼ÚüˆÛ˜A—. –Ø‘º^–çCVˆä“cF—TCŒü–ì˜a—YCÎì“NiŠáj: ‘æ93‰ñ“ú–{Šá‰ÈŠw‰ï (89.05.12), ‹ž“s.

2085. mŠw‰ïn iˆê”Êu‰‰j Šp–Œã”ç•\–Ê’E‰H«‚Ì—Õ°•]‰¿. ´…Œhˆê˜YiŠáj: ’†‰Ø–¯‘Šá‰ÈŠw‰ï‘æ25‰ñŠwpu‰‰‰ï (89.05.29), ‘ä“ì.

2086. mŠw‰ïn iˆê”Êu‰‰j Divergence Palsy--MRI Analysis. ¼–{_”VCÎì“NiŠáj: XII Congress of Asia Pacific Academy of Ophthalmology (89.06.01), Seoul.

2087. mŠw‰ïn iˆê”Êu‰‰j ƒGƒA[ƒKƒ“ŠáŠO‚Ì8—á. –]ŒŽˆêCŽá‘q‰ë“oC“©ŽRG•viŠáj: ‘æ6‰ñŠÖ“ŒŠá‰ÈŠw‰ï (89.06.11), “Œ‹ž.

2088. mŠw‰ïn iˆê”Êu‰‰j “ª•”ŠOŒã‚̈ê‰ß«•ûŒüŒð‘ã«ŠáUÇ—á. ’·À‰p–¾C“¿‘Œú“ñC‹g”ö’mC“¡–ì–¾lCŒÜ“‡ˆê‹giŽ¨•@j: ‘æ68‰ñ_“Þì’n•û•”‰ï (89.06.17), ¬“cŒ´.

2089. mŠw‰ïn iˆê”Êu‰‰j |‘¤–À˜H”j‰óŒã‚Ì—Õ°Œo‰ß|dS“®—h‚©‚ç‚Ý‚Ä. ¯–ìŒ÷C“¿‘Œú“ñC‹g”ö’mC“¡–ì–¾lC¼‰ª–¾—TC”ª–؈ê‹LiŽ¨•@j: ‘æ68‰ñ_“Þì’n•û•”‰ï (89.06.17), ¬“cŒ´.

2090. mŠw‰ïn iˆê”Êu‰‰j ˜V‰»‘£iƒ}ƒEƒX…»‘Ì‚Ì“ÁˆÙ‚ȉÁ—ω». ¼–{_”VC‰F‰ê–ÎŽOC‹{“cŠ²•vCÎì“NiŠájC•À–Ø–ž•vCŽR‰º‚©‚È‚Ö: ‘æ28‰ñ“ú–{”’“àáŠw‰ï (89.06.24), ‹ž“s.

2091. mŠw‰ïn iˆê”Êu‰‰j Novel Saccade‚Ì—U”­–@‚Ǝ㎋‚ւ̉ž—p. ‚‹´–MŽqC–]ŒŽˆêCŽR“c“OlC¬—уŽqCVˆä“cF—TCÎì“NiŠáj: ‘æ45‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï (89.06.24), ‘åã.

2092. mŠw‰ïn iˆê”Êu‰‰j ‘ÙŽeŠú‘nŽ¡–ü‚É‚¨‚¯‚é‘gD‚Ì‘nŽûk”\. ’–Œ´ß”V‰îiŒ`ŠOjC–{—Ñ—R”üŽqi¶‰»Œnj: “ú–{”­¶¶•¨Šw‰ï‘æ22‰ñ‘å‰ï (89.06.24), ŽD–y, —vŽ|W, p.155, 1989.

2093. mŠw‰ïn iˆê”Êu‰‰j ö•šŠáU‚Ì‹óŠÔŽü”g”“Á«‚ɂ‚¢‚Ä. ’·’JìKŽqCŠÖ’JŽ¡‹vC¬“ˆ—ÇGC¬’¬—SŽqCÎì“NiŠáj: ‘æ59‰ñ‹ãBŠá‰ÈŠw‰ï (89.07.01), “ß”e.

2094. mŠw‰ïn iˆê”Êu‰‰j Œã“V«‚É”­Ç‚µ‚½‚ÆŽv‚í‚ê‚éDuaneÇŒóŒQ‚Ì1—á. ŠÖ’JŽ¡‹vC‹ß“¡‰À•vCŒü–ì˜a—YiŠáj: ‘æ59‰ñ‹ãBŠá‰ÈŠw‰ï (89.07.01), “ß”e.

2095. mŠw‰ïn iˆê”Êu‰‰j _Œo‘©‚ÌáŠQ‚É‚æ‚é—¼ãŽÎ‹Ø–ƒáƒ. ŠâØ”ü—˜C‹g“cŠ°iŠáj: ‘æ59‰ñ‹ãBŠá‰ÈŠw‰ï (89.07.01), “ß”e.

2096. mŠw‰ïn iˆê”Êu‰‰j ‰–‘fŒn•Y”’Ü’†“Å‚É‚æ‚郉ƒbƒgŽ‹_Œo‚ւ̉e‹¿. •Ÿ“‡ˆêÆC‰œ‰pOiŠáj: ‘æ27‰ñ–k“ú–{Šá‰ÈŠw‰ï (89.07.14), ŽD–y.

2097. mŠw‰ïn iˆê”Êu‰‰j ƒXƒeƒƒCƒh‹Ç’‚Æ•úŽËü—Ö@‚ðŽŽ‚Ý‚½V¶Ž™Šáâ|“à‹‘å–Ñ׌ŒŠÇŽî. Îì‹ÏCŽá‘q‰ë“oCÎì“NiŠáj: ‘æ27‰ñ–k“ú–{Šá‰ÈŠw‰ï (89.07.15), ŽD–y.

2098. mŠw‰ïn iˆê”Êu‰‰j Primary Culture of Keratinocytes on Substrate Coated with Basement Membrane Components. ŒÃŽR“o—²C’–Œ´ß”V‰îC‰–’JMKiŒ`ŠOj: The 5th Congress of the Asian Pacific Reconstructive Surgery (89.09.08), Istanbul, Turkey.

2099. mŠw‰ïn iˆê”Êu‰‰j Œ‡–R«Ž‹_ŒoÇ‚Æ‘‰t’†ƒrƒ^ƒ~ƒ“‚a12. ‰œ‰pOC•Ÿ“‡ˆêÆC¼–{_”VC‹{“cŠ²•vCÎì“NiŠáj: ‘æ55‰ñ’†•”Šá‰ÈŠw‰ï (89.09.09), “¿“‡.

2100. mŠw‰ïn iˆê”Êu‰‰j ‘O’ë_Œo‰Š‚ÌÇó‚ð’悵‚½ƒ‰ƒ€ƒ[ƒCƒnƒ“ƒgÇŒóŒQ‚̈ê—á. –ìŒû_’jCˆäŒû–F–¾C‹g”ö’mC“¿‘Œú“ñiŽ¨•@j: ‘æ69‰ñ_“Þì’n•û•”‰ï (89.09.30), ‘Š–ÍŒ´.

2101. mŠw‰ïn iˆê”Êu‰‰j Direct Effect of DL-2-Amino Adipic Acid Mediated by Cakiumion on Cultured Muler Cells. Žá‘q‰ë“oiŠájCŽR–{¸iŠÅŒìŠw•”j: Association for Eye Research 30th Meeting & Ecofs Meeting (89.10.04), ƒtƒ‰ƒ“ƒX.

2102. mŠw‰ïn iˆê”Êu‰‰j ö•šŠáU‚̃Rƒ“ƒgƒ‰ƒXƒgŠ´“x“Á«‚ɂ‚¢‚Ä||æ“VŠáU‚Æ‚Ì”äŠr. ’·’JìKŽqCŠÖ’JŽ¡‹vC¬’¬—SŽqCÎì“NiŠáj: ‘æ43‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (89.10.14), –¼ŒÃ‰®.

2103. mŠw‰ïn iˆê”Êu‰‰j Šá‹Ø–³—ÍÇ‚Ì‘SgˆÚs—á‚Ì•ªÍ. ‰ª–ì’q•¶C’†‘ò³”ŽCŒü–ì˜a—YCÎì“NiŠáj: ‘æ43‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (89.10.14), –¼ŒÃ‰®.

2104. mŠw‰ïn iˆê”Êu‰‰j ‹}Œƒ‚È”]zŠÂ•s‘S‚É‚æ‚Á‚ÄoŒ»‚·‚éˆÙíŠá‹…‰^“®‚ɂ‚¢‚Ä. Îì‹ÏC’Ò‘ò‰F•FCŒü–ì˜a—YiŠájCŒÜ\—’•Û’jiŽD–yˆã‘åjCŠå’J˜a”Ni“àj: ‘æ43‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (89.10.14), –¼ŒÃ‰®.

2105. mŠw‰ïn iˆê”Êu‰‰j Sˆö«“àŽÎŽ‹f’f‚É‚¨‚¯‚éƒAƒ‚ƒoƒ‹ƒrƒ^[ƒ‹“_“HÃ’‚̉ž—p. ‰œ‰pOiŠájC“àŠC—²C›àV~C’†‘ºŒjŽqCàV‚Ó‚ÝŽqC–ìç²—R”üŽqCà_‘º”üŒbŽqi‘åãˆã‘åj: ‘æ43‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (89.10.14), –¼ŒÃ‰®.

2106. mŠw‰ïn iˆê”Êu‰‰j ¬l‚ÌŽ‹_Œo“û“ª‰Š‚Ì—Õ°“I“Á’¥. ‰ª–ì’q•¶CŽá‘q‰ë“oC’†‘ò³”ŽCÎì“NiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.20), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.

2107. mŠw‰ïn iˆê”Êu‰‰j “Á”­«Ž‹_Œo‰Š‚ÌŽ©‘RŒo‰ß‚ƃpƒ‹ƒX—Ö@‚ɂ‚¢‚Ä. Žá‘q‰ë“oC‰ª–ì’q•¶CŽR“c“OliŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.20), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.

2108. mŠw‰ïn iˆê”Êu‰‰j Tubringen flicker Test‚ð—p‚¢‚½•s“¯Ž‹ŽãŽ‹‚ÆŽ‹_ŒoŽ¾Š³‚ÌŽ‹‹@”\•]‰¿‚ÌŽŽ‚Ý. ¬—уŽqCŽá‘q‰ë“oCÎì“NiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.20), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.

2109. mŠw‰ïn iˆê”Êu‰‰j ƒTƒ‹ãŠááÙ‹“‹Ø‚ÌŽx”zˆŸŠj‚ɂ‚¢‚Ä. ŠÖ’JŽ¡‹vC¬“ˆ—ÇGCŒü–ì˜a—YiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.20), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.

2110. mŠw‰ïn iˆê”Êu‰‰j “œ”A•aŠ³ŽÒ‚É‚¨‚¯‚é‘ÎŒõ”½‰ž‚ɂ‚¢‚Ä||“Á‚É“œ”A•a«–Ô–ŒÇ‚Ì‚È‚¢ŽÒ||. ’·’JìKŽqC—ѳ—YCÎì“NiŠáj: ‘æ42‰ñ“ú–{Ž©—¥_ŒoŠw‰ï (89.10.21), “Œ‹ž.

2111. mŠw‰ïn iˆê”Êu‰‰j Œã“ª—t”’Ž¿•a•Ï‚Å‹¤’Ê‚µ‚½Ž‹ŠoŠá‹…‰^“®ŒnáŠQ‚ðŽ¦‚µ‚½¬Ž™‚Ì2Ç—á. ¼–q–¾”üC“¡ˆä‰ë˜NCŽá‘q‰ë“oCÎì“NiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.21), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.

2112. mŠw‰ïn iˆê”Êu‰‰j ˆê‘¤‚Ì“®Šá_ŒoEŠO“]_ŒoáŠQ‚𗈂µ‚½”]Š²•a•Ï‚Ì1—á. ‹g“cŠ°iŠájC´…r•vC—ÑG–¾i“s—§_Œo•a‰@j: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.21), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.

2113. mŠw‰ïn iˆê”Êu‰‰j ŠeŽíŽ¾Š³‚É‚¨‚¯‚钲߂̀ÓI“Á«‹L˜^‚Æ“®“I“Á«‹L˜^. Œ´’¼lC“©ŽRG•vCŠÝ“cç•äŽqCÎì“NiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.22), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.

2114. mŠw‰ïn iˆê”Êu‰‰j ö•šŠáU‚ÌŠÉ™‘Š‘¬“x. ¼Œ´ŒbŽqC–x”ÍŽqC‚‹´–MŽqCŒ´’¼lCŽR“c“OlCÎì“NiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.22), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.

2115. mŠw‰ïn iˆê”Êu‰‰j ߌ㫃zƒ‹ƒlƒ‹ÇŒóŒQ‚Ì2—á. ŠâØ”ü—˜iŠájC’߉ªˆê‰pi•{’†•a‰@jC‹g“cŠ°iŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.22), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.

2116. mŠw‰ïn iˆê”Êu‰‰j ‘½”­«d‰»Ç‚É‚¨‚¯‚éflicker VECP||Ž‹_Œo‰Š‚Æ‚Ì”äŠr||. ‹g–{gŽqC“n•Ó”ü’qŽqi—ÕŒŸjC’m–쇎qC¬—уŽqCŽá‘q‰ë“oiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.22), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.

2117. mŠw‰ïn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚鎨¬œŠïŒ`‚ÌŒŸ“¢iŠOŽ¨“¹CŒÛ–Œ³í—á‚ð’†S‚Éj. ’†ŽR–¾mC•½ŽR•ûrCŒÃ‘òTˆêC‰ª–{–qlCÝŠy“N–çiŽ¨•@j: ‘æ17‰ñ“ú–{—Õ°Ž¨‰ÈŠw‰ï‘‰ï (89.10.27), “Œ‹žC —Õ°Ž¨‰È, 16(2): 106, 1989.

2118. mŠw‰ïn iˆê”Êu‰‰j ƒRƒŒƒXƒeƒŠƒ““÷‰èŽî‚Æ“÷‰è‚ð‚Æ‚à‚È‚¤–«’†Ž¨‰Š‚Ì”äŠrŒŸ“¢. ²–씣Cˆî–ØŸ‰pC‰ª–{–qlCÝŠy“N–çiŽ¨•@j: ‘æ17‰ñ“ú–{—Õ°Ž¨‰ÈŠw‰ï‘‰ï (89.10.27), “Œ‹žC —Õ°Ž¨‰È, 16(2): 35, 1989.

2119. mŠw‰ïn iˆê”Êu‰‰j ‡•¹•aŒ^‚ðŽ‚½‚È‚¢’†Ž¨ƒRƒŒƒXƒeƒŠƒ““÷‰èŽîÇ‚Ì’®—Í‘œ‚©‚ç‚ÌŒŸ“¢. ˆî–ØŸ‰pCÝŠy“N–çC‰ª–{–qlC²–씣iŽ¨•@j: ‘æ17‰ñ“ú–{—Õ°Ž¨‰ÈŠw‰ï‘‰ï (89.10.27), “Œ‹žC —Õ°Ž¨‰È, 16(2): 36, 1989.

2120. mŠw‰ïn iˆê”Êu‰‰j æ“V«•\”ç…ávÇ2—á‚Ì—Õ°“IŒŸ“¢. ‘º¼GŽ÷CˆäŒ…^—R”üC•—’£KŽiC‰Í‘º½ŽŸCŠÖª“OC–ì“n³•FCŠ—Œ´FC¬ŒûO‹BC”ª‘ãŒö•viŽ™jC‘¾“cK‹KC‰Í–ì–MŽqC‰q“¡Œõi”çjCŽR–{OŽqC²“¡—Y “ñiŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï (89.10.28), ‘å‹{.

2121. mŠw‰ïn iˆê”Êu‰‰j Œ´ˆö•s–¾‚ÌŠ´‰¹«“ï’®‚ƘVl«“ï’®. ‰ª–{–qlCÝŠy“N–çCŒÃ‘òTˆêC•½ŽR•ûriŽ¨•@j: “ú–{ƒI|ƒWƒIƒƒW|Šw‰ï (89.11.15), ˆ¤’mC

2122. mŠw‰ïn iˆê”Êu‰‰j “ú–{lœ“±è‡’l‚Ì“™‰¿ƒtƒH|ƒXƒŒƒxƒ‹|ISO7566‚ւ̔ᔻ. ’|“à‹`•viŽ¨•@jC•Ä“c•qi¶•¨•¨—Œnj: “ú–{ƒI|ƒWƒIƒƒW|Šw‰ï (89.11.15), ˆ¤’m.

2123. mŠw‰ïn iˆê”Êu‰‰j “Á”­«—¼‘¤«Š´‰¹“ï’®i“Á“ïj‚̈æ’l㌟¸i‘æ2•ñj. •½ŽR•ûrCŒÃ‘òTˆêC‰ª–{–qlCÝŠy“N–çiŽ¨•@j: “ú–{ƒI|ƒWƒIƒƒW|Šw‰ï (89.11.15), ˆ¤’m.

2124. mŠw‰ïn iˆê”Êu‰‰j •ûŒüŒð‘ã«ãŒü«“ªˆÊŠáUÇ—á‚ÌŒŸ“¢. ’·À‰p–¾C‹g”ö’mC“¡–ì–¾lC“¿‘Œú“ñiŽ¨•@j: “ú–{•½t_Œo‰ÈŠw‰ï (89.11.23), “Þ—Ç.

2125. mŠw‰ïn iˆê”Êu‰‰j ”½•œ‚·‚é‚ß‚Ü‚¢Ç—á‚Ì’·ŠúŠÏŽ@—á‚ɂ‚¢‚Ä. •½ŽR•ûrC‹g”ö’mC“¡–ì–¾lC“¿‘Œú“ñCŒÜ“‡ˆê‹gC”ª–؈ê‹LiŽ¨•@j: “ú–{•½t_Œo‰ÈŠw‰ï (89.11.23), “Þ—Ç.

2126. mŠw‰ïn iˆê”Êu‰‰j ³Œ·”g’¼ü‰Á‘¬“xŽhŒƒ‚É‚æ‚鎨Ίí‹@”\ŒŸ¸–@CBPPNÇ—á‚ÌŒŸ“¢. “¡–ì–¾lC¯–ìŒ÷CV“cŒ’‘¾˜YC¼ŽRkˆê˜YC¼‰ª–¾—TC•½ŽR•ûrC’·À‰p–¾C‹g”ö’mC“¿‘Œú“ñiŽ¨•@j: “ú–{•½t_Œo‰ÈŠw‰ï (89.11.23), “Þ—Ç.

2127. mŠw‰ïn iˆê”Êu‰‰j ƒŠƒnƒrƒŠƒe|ƒVƒ‡ƒ“‚É‚æ‚èÇóŒy‰õ‚ð‚Ý‚½ƒXƒgƒŒƒvƒgƒ}ƒCƒVƒ“’†“Å‚É‚æ‚é‚ß‚Ü‚¢‚Ì1—á. ¼‰ª–¾—TC“¿‘Œú“ñC“¡–ì–¾lC‹g”ö’mC¯–ìŒ÷iŽ¨•@j: “ú–{•½t_Œo‰ÈŠw‰ï (89.11.24), “Þ—Ç.

2128. mŠw‰ïn iˆê”Êu‰‰j Ocular MyoclonusÇ—á‚Ì_ŒoŽ¨‰ÈŠw“IŒŸ“¢. ‹g”ö’mC¼‰ª–¾—TCV“cŒ’‘¾˜YC¯–ìŒ÷C•½ŽR•ûrC’†ŽR–¾mC“¡–ì–¾lCŒÜ“‡ˆê‹gC“¿‘Œú“ñiŽ¨•@j: “ú–{•½t_Œo‰ÈŠw‰ï (89.11.25), “Þ—Ç.

2129. mŠw‰ïn iˆê”Êu‰‰j ¿ˆÊdS“®—h‚É‚æ‚镽táŠQ‚̉ðÍ. “àŽR–õi–k—¢Œ¤‹†ŠjCˆ¢•”—EŸi—ÕŒŸjC“¿‘Œú“ñiŽ¨•@j: “ú–{•½t_Œo‰ÈŠw‰ï (89.11.25), “Þ—Ç.

2130. mŠw‰ïn iˆê”Êu‰‰j A New Type of Corneal Endothelial Dystrophy. ´…Œhˆê˜YC—ѳ—YCÎì“NiŠáj: ‘æ30‰ñ’†‰Ø–¯‘Šá‰ÈŠw‰ï (89.11.25), ‘ä–k.

2131. mŠw‰ïn iˆê”Êu‰‰j ‹ßŒ©”½‰žáz¹‚Ì2Ç—á. ˆÉ“¡K]CÎì‹ÏC¼–{_”VCŒü–ì˜a—YCÎì“NiŠájC²“¡Šìˆê˜Yi¸j: ‘æ30‰ñ“ú–{Ž‹”\‹¸³Šw‰ï (89.11.26), “Œ‹ž.

2132. mŠw‰ïn iˆê”Êu‰‰j —L‹@—ÓÜ’†“ł̈ÙíŠá‹…‰^“®”­¶‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†||GABAƒjƒ…[ƒƒ“‚̖Ɖu‘gDŠw“IŒ¤‹†||. ¬“ˆ—ÇGCÎì“NCŠÖ’JŽ¡‹vC‘ìd•viŠájC’[ì•×iŠâŽèˆã‘åj: ‘æ7‰ñ‘ۊጤ‹†‰ï‹c“ú–{•”‰ï (89.12.09), ‘åã.

2133. mŠw‰ïn iˆê”Êu‰‰j ‹}«Š´‰¹“ï’®‚ð‰”­Çó‚Æ‚µ‚½–îóÖ¬“´ŒŒðÇ‚Ì1—á. Ä“¡‘åC•½ŽR•ûrC’†ŽR–¾mC’·À‰p–¾C‹g”ö’mC‰ª–{–qlC“¡–ì–¾lC“¿‘Œú“ñiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ70‰ñŽ¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŠwpu‰‰‰ï (89.12.16), ‰¡•l.

2134. mŠw‰ïn iˆê”Êu‰‰j Ž¨‚ÌŠïŒ`‚ð‚Æ‚à‚È‚¤‘¤Œzá‘‚Ì1—á. ‰iˆä_–¤CV“cŒ’‘¾˜YC‰ª–{–qlCÝŠy“N–çiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ70‰ñŽ¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŠwpu‰‰‰ï (89.12.16), ‰¡•l.

2135. mŠw‰ïn iˆê”Êu‰‰j Degloving injury ‚É‚¨‚¯‚épŽ®‚Ì‘I‘ð. ÎŒ´GˆêC‹àˆäN–¤CˆÀ•x‹`“NCˆÉ“¡³ŽkiŒ`ŠOj: “ú–{Žè‚ÌŠO‰ÈŠw‰ï (89.95.00), –k‹ãB.

2136. mŠw‰ïn iˆê”Êu‰‰j Šp–ŒŽ‰–b’¾’…ǂ̬ˆö‚Æ‚»‚Ì–hŽ~‘Îô. ´…Œhˆê˜YCŒü–ì˜a—YCˆ¢‘]ŽqiŠáj: ‘æ14‰ñŠp–ŒƒJƒ“ƒtƒ@ƒŒƒ“ƒX (90.02.01), ‰YˆÀ.

2137. mŠw‰ïn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚éãüLÇŽèpŒã‚ÌŠ³ŽÒ‚ɑ΂·‚éƒAƒ“ƒP[ƒg’²¸‚ɂ‚¢‚Ä. ŽÄ“c—T’Bi’©“ú‘åŠwjC‚‹´Œ³iŒ`ŠOj: ‘æ15‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï“ŒŠC’n•û‰ï (90.02.24), –¼ŒÃ‰®, ´˜^W, p.4, 1990.

2138. mŠw‰ïn iˆê”Êu‰‰j Cholinergic Involvement of Behcet's Disease|Regression of Ocular Attack by Systemic Use of Atropine Nitrate. ‰ºì•Ó˜alC•Ÿ“c•q‰ëiŠáj: XXVI International Congress of Ophthalmology (90.03.23), ƒVƒ“ƒKƒ|[ƒ‹.

2139. mŠw‰ïn iˆê”Êu‰‰j Ž™“¶‰¹º‚ÌŠî–{Žü”g”. ŒÓ˜A¶iŽ¨•@j: “ú–{A“ª‰ÈŠw‰ï (90.03.24), “Œ‹ž.

2140. mŠw‰ïn iˆê”Êu‰‰j Angioimmuinoblastic Lymphadenopathy (AILD)—l‚s×–EƒŠƒ“ƒpŽî‚Ì1—á. Šâè‰ëC‰q“¡ŒõC’|èLˆê˜YC¼‰ª´i”çjC“¡–ì—R”üC•ìºi“àj: ‘æ263‰ñ“ú–{”畆‰ÈŠw‰ï•Ÿ‰ª’n•û‰ï i89.03.00j, •Ÿ‰ª.

2141. mŠw‰ïn iˆê”Êu‰‰j ƒAƒgƒs[«”畆‰Š‚Ì׋ۃƒNƒ`ƒ“—Ö@. ŒüˆäGŽ÷C–ìŒûr•FC‰¡ŠÖ”Ž—YCŸ‰ªŒ›¶i”çjCדc‚Ì‚¼‚ÝC—`…—²iŽ™j: ‘æ656‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i89.04.15j, “¡‘ò.

2142. mŠw‰ïn iˆê”Êu‰‰j Growth Hormone Neurosecretory Dysfunction (GHND) ‚É‚æ‚é¬lÇ‚É‚Ý‚ç‚ꂽ•F•\”çŽî. ‰H‹àdŠìC‰¡ŠÖ”Ž—YCŸ‰ªŒ›¶i”çjCדc‚Ì‚¼‚ÝC—`…—²iŽ™j: ‘æ656‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i89.04.15j, “¡‘ò.

2143. mŠw‰ïn iˆê”Êu‰‰j ”’á‹Û«–ÑጂÌ1—á. “”I^—CŠÖª“ÖŽqC㑺m•vi”çjCˆ¢•””ü’mŽqi—ÕŒŸj: ‘æ656‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i89.04.15j, “¡‘ò.

2144. mŠw‰ïn iˆê”Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`‚Ì•êe‚æ‚趂܂ꂽV¶Ž™ƒGƒŠƒeƒ}ƒg[ƒfƒX. ‰q“¡ŒõC•ÐŽRˆê˜Ni”çjC¬ŒûO‹BiŽ™j: ‘æ656‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i89.04.15j, “¡‘ò.

2145. mŠw‰ïn iˆê”Êu‰‰j ”|—{”畆‚ÌŠî‘b“IŒ¤‹†; ‰‘ã”|—{‚É‚¨‚¯‚é•\”ç×–E‚ÌL“W‘B. ŒÃŽR“o—²C’–Œ´ß”V‰îC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ32‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠwpW‰ï i89.04.20j, ‰YˆÀ.

2146. mŠw‰ïn iˆê”Êu‰‰j ‘ÙŽeŠú‘nŽ¡–ü 2. in vitro ƒ‚ƒfƒ‹‚Å‚Ý‚ç‚ê‚é‘gD‚Ì”½‰ž«‚Ì‘Ù—î“I•Ï“®. ’–Œ´ß”V‰îC’·”öŒb—ŽqC‰F’Öؗ´ˆêC‰–’JMKiŒ`ŠOjC–{—Ñ—R”üŽqi¶‰»Œnj: ‘æ32‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠwpW‰ï i89.04.20j, ‰YˆÀ, ´˜^W, p.208, 1989.

2147. mŠw‰ïn iˆê”Êu‰‰j Trichilerumoma Cell Line can Synthesize Interleukin 1 alpha. ¼‰ª´i”çjC‘D“n’‰’ji—Õ•a—jC‰q“¡ŒõC•ÐŽRˆê˜Ni”çjCSato, Y.: Tricontinental Meeting of ESDR, JSID and SID i89.04.29j, Washington, D.C., USA.

2148. mŠw‰ïn iˆê”Êu‰‰j Phenotypic Heterogeneity of JB/MS Murine Melanoma Cells, and Purification and Characterization of a Melangenil Inhibitor. ‹TŽRFˆê˜Yi”çjCLaw, L.W.CTanaka, S.CHeaving, V.J. (NIH): American Association for Cancer Research and Japanese Cancer Association Joint Meeting i89.05.00j, Hawaii, USA, J. Cell Physiol., 137: 35`44, 1988.

2149. mŠw‰ïn iˆê”Êu‰‰j ”DP«áy]‚Æ‚»‚Ì—ÞÇi34—á‚ÌWŒvj. ‰Í–ì–MŽqC•ÄŒ³N‘ C‰q“¡ŒõC¼‰ª´C¼ŽR–Εvi”çj: ‘æ88‰ñ“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï i89.05.11j, ‹à‘ò.

2150. mŠw‰ïn iˆê”Êu‰‰j ‘gDŠw“I‚É•\”ç•Ï‰»‚𔺂¤Œ´ˆö•s–¾‚ÌF‘f’¾’…Ç|‚Æ‚­‚É pigmentatio macularis multiplex idiopathica ‚ɂ‚¢‚Ä|. •ÄŒ³N‘ C‰Í–ì–MŽqC¼ŽR–Εvi”çj: ‘æ88‰ñ“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï i89.05.11j, ‹à‘ò, “ú–{”畆‰ÈŠw‰ïŽGŽ, 99(13), 1989.

2151. mŠw‰ïn iˆê”Êu‰‰j UVB‚É‚æ‚è—U”­‚³‚ꂽ“VáváŒA—Þ“Vávጕa•Ï‚É‚¨‚¯‚é•â‘Ì‚Ì–ðŠ„. ì–¼½ŽiC¼ŽR–Εvi”çj: ‘æ88‰ñ“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï i89.05.11j, ‹à‘ò, “ú–{”畆‰ÈŠw‰ïŽGŽ, 99(13): 298A, 1989.

2152. mŠw‰ïn iˆê”Êu‰‰j ‹¹‘BŽî‚ð‡•¹‚µ‚½G•½‘Ûá‚Ì2—á. •‹{”ü‰ÀŽqC’¾‘—YCŠâè‰ëC“”I‹BCŒüˆäGŽ÷C‹àŠÛ“NŽRi”çjCX“c—TlC•½ˆäŽO˜Yi‹¹ŠOj: ‘æ88‰ñ“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï i89.05.12j, ‹à‘ò.

2153. mŠw‰ïn iˆê”Êu‰‰j Mycoplasma‚É‚æ‚éZo«g”Á. ‰¡ŠÖ”Ž—YCóˆär–íC‰q“¡Œõi”çjC‘åι–çC“L–ØGC•½Î‘iŽ™j: “ú–{¬Ž™”畆‰ÈŠw‰ï i89.06.11j, “Œ‹ž.

2154. mŠw‰ïn iˆê”Êu‰‰j ‰ÆŒn“à‚É”­Ç‚µ‚½ƒEƒ‹ƒV”畆‰Š‚Ì4—á. ‰¡ŠÖ”Ž—YC‰q“¡ŒõC•ÐŽRˆê˜Ni”çj: “ú–{”畆‰ÈŠw‰ï‘æ657‰ñ“Œ‹ž’n•û‰ï i89.06.17j, ìè.

2155. mŠw‰ïn iˆê”Êu‰‰j MunchhausenÇŒóŒQ‚Ì1—á. –ìŒûr•FC‰¡ŠÖ”Ž—YC‰q“¡ŒõC•ÐŽRˆê˜Ni”çjCŽRéˆê˜Yi¸j: “ú–{”畆‰ÈŠw‰ï‘æ657‰ñ“Œ‹ž’n•û‰ï i89.06.17j, ìè.

2156. mŠw‰ïn iˆê”Êu‰‰j ‰A•”áu’ÉÇ‚Ì1—á. ‰¹ŽR˜aéC‚–ìWC•ÐŽRˆê˜NC¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ï‘æ657‰ñ“Œ‹ž’n•û‰ï i89.06.17j, ìè.

2157. mŠw‰ïn iˆê”Êu‰‰j ‰AŒsŒ‹Šj]‚Ì1—á. ‘¾“cK‘¥C‚–ìWC‰¡ŠÖ”Ž—YC•ÐŽRˆê˜NC‰q“¡ŒõC¼‰ª´i”çjCˆî–ìM•viÀŠÔŽsj: “ú–{”畆‰ÈŠw‰ï‘æ657‰ñ“Œ‹ž’n•û‰ï i89.06.17j, ìè.

2158. mŠw‰ïn iˆê”Êu‰‰j Lipodystrophic Centrifugaris Abdominalis Zenfantilis. Ÿ‰ªŒ›¶C¼‰ª´C¼ŽR–Εvi”çj: 5th International Congress of Pediatric Dermatology i89.07.11`15j, Milan.

2159. mŠw‰ïn iˆê”Êu‰‰j A Case of Congenital Syphilis. ì–¼½ŽiC‚–ìWC¼ŽR–Εvi”çj: 5th International Congress of Pediatric Dermatology i89.07.13j, Milan.

2160. mŠw‰ïn iˆê”Êu‰‰j ˆ««•FŽî×–E‚̃ƒ‰ƒjƒ“F‘fŽY¶”\‚ÆMSH receptor‚Ì‘ŠŠÖŠÖŒW‚ɂ‚¢‚Ä. ‹TŽRFˆê˜Yi”çjCHearing, V.J. (NIH): “ú–{”畆‰ÈŠw‰ï‘æ658‰ñ“Œ‹ž’n•û‰ï i89.07.15j, “Œ‹ž.

2161. mŠw‰ïn iˆê”Êu‰‰j •\”ç‚É‚¨‚¯‚éEpidermal Growth Factor Receptor (EGF-R)‚Ì‹ÇÝ. ‹ß“¡Ž •vC•ÄŒ³N‘ i”çj: “ú–{”畆‰ÈŠw‰ï‘æ658‰ñ“Œ‹ž’n•û‰ï i89.07.15j, “Œ‹ž.

2162. mŠw‰ïn iˆê”Êu‰‰j ŠeŽí”|—{ã”çŒnŽîá‡×–E‚ÌHLA-DRRŒ´‚Ì”­Œ»‚ɑ΂·‚égamma-interferon‚ƃrƒ^ƒ~ƒ“D3‚ÌŒø‰Ê. “”I‹BCŸ‰ªŒ›¶C‰q“¡Œõi”çj: “ú–{”畆‰ÈŠw‰ï‘æ658‰ñ“Œ‹ž’n•û‰ï i89.07.15j, “Œ‹ž.

2163. mŠw‰ïn iˆê”Êu‰‰j ƒzƒ‹ƒ}ƒŠƒ“ŒÅ’è•W–{‚ɑ΂µ‚Ä”½‰ž«‚ð—L‚·‚éRƒPƒ‰ƒ`ƒ“ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì컂̎Ž‚Ý. ‰Á“¡ˆê˜Yi”çjC‹´–{Œ’iƒEƒGƒCƒ“ƒXƒe[ƒg‘åŠwj: “ú–{”畆‰ÈŠw‰ï‘æ658‰ñ“Œ‹ž’n•û‰ï i89.07.15j, “Œ‹ž.

2164. mŠw‰ïn iˆê”Êu‰‰j ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚ÆMCTD‡•¹—á‚É‚Ý‚ç‚ꂽ“ÁˆÙ‚Ȕ畆Çó. óˆär–íC•ÐŽRˆê˜Ni”çj: ‘æ53‰ñ“ú–{”畆‰ÈŠw‰ï“Œ“ú–{Šwp‘å‰ï i89.09.10j, ’}”g.

2165. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™‚Ì‚s×–EŒn”畆ƒŠƒ“ƒz[ƒ}. Šâè‰ëCóˆär–íCŸ‰ªŒ›¶C’|èLˆê˜Yi”çjC“‡–{—R‹IŽqC”ª‘ãŒö•viŽ™jC‘D“n’‰’ji—Õ•a—j: ‘æ53‰ñ“ú–{”畆‰ÈŠw‰ï“Œ“ú–{Šwp‘å‰ï i89.09.10j, ’}”g.

2166. mŠw‰ïn iˆê”Êu‰‰j ”Má­•”‚É”­¶‚µ‚½Verrucas carcinoma‚Ì1—á. ó’J‰ë•¶CŠâè‰ëC‘¾“cK‘¥Cóˆär–íC•ÐŽRˆê˜NC¼‰ª´i”çjCät“n’‰’ji—Õ•a—j: “ú–{”畆‰ÈŠw‰ï‘æ659‰ñ“Œ‹ž’n•û‰ï i89.10.21j, ‰¡•l.

2167. mŠw‰ïn iˆê”Êu‰‰j HPVRŒ´—z«‚ðŽ¦‚µ‚½‘«’ê•\”ç”XŽî‚Ì2—á. ŽR“ckŽŸiŠÖ“Œ˜JЕa‰@jCŒüˆäGŽ÷C•xàV‘¸‹VC•ÄŒ³N‘ i”çj: “ú–{”畆‰ÈŠw‰ï‘æ659‰ñ“Œ‹ž’n•û‰ï i89.10.21j, ‰¡•l.

2168. mŠw‰ïn iˆê”Êu‰‰j Sweet•a‚Æl‚¦‚ç‚ꂽ1—á. ’ËŒ´“NÆCŠâè‰ëC•ÐŽRˆê˜NC¼‰ª´i”çj: “ú–{”畆‰ÈŠw‰ï‘æ659‰ñ“Œ‹ž’n•û‰ï i89.10.21j, ‰¡•l.

2169. mŠw‰ïn iˆê”Êu‰‰j ”S–Œ‘Ûá‚Ì1—á|ŒŒ´amylase’l‚ªŽ¡—ÃŒo‰ß‚É‘ŠŠÖ‚µ‚½SjogrenÇŒóŒQ•¹”­—á|. Žíˆä—Ç“ñC‘¾“cK‘¥CŠâè‰ëC•ÐŽRˆê˜NCŒüˆäGŽ÷i”çj: “ú–{”畆‰ÈŠw‰ï‘æ659‰ñ“Œ‹ž’n•û‰ï i89.10.21j, ‰¡•l.

2170. mŠw‰ïn iˆê”Êu‰‰j ”Ó”­«”畆ƒ|ƒ‹ƒtƒBƒŠƒ“Ç‚Ì2—á. ‰¹ŽR˜aéC•ÐŽRˆê˜NCì–¼½ŽiC¼‰ª´C¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ï’†•”Žx•”‘‰ïŠwp‘å‰ï i89.10.21`22j, ‘åã.

2171. mŠw‰ïn iˆê”Êu‰‰j Suppression of Gamma-interferon Induced HLA-DR Antigen Expression on Keratinocyte Cell Lines by 1.25(OH)2 Vitamin D3. “”I‹BCŸ‰ªŒ›¶C‰q“¡ŒõC¼‰ª´C¼ŽR–Εvi”çj: 2nd Clinically Oriented Research Symposium i89.11.10j, ‹ž“s.

2172. mŠw‰ïn iˆê”Êu‰‰j Interferon Modulate the Expression of Hormone Receptors on the Surface of Murine Melanoma Cells. ‹TŽRFˆê˜Yi”çjCHeaviy, V.J. (NIH): 2nd Clinically Oriented Research Symposium i89.11.10j, ‹ž“s, J. Clin. Invest., 83: 213`221, 1989.

2173. mŠw‰ïn iˆê”Êu‰‰j ƒAƒgƒs[«”畆‰Š‚Æ’E–Ñ. –ìŒûr•FCŸ‰ªŒ›¶C‰¹ŽR˜aéC¼‰ª´C¼ŽR–Εvi”çj: ‘æ14‰ñ“ú–{Œ¤‹†”畆‰ÈŠw‰ï‘‰ï i89.11.11j, ‹ž“s.

2174. mŠw‰ïn iˆê”Êu‰‰j ‘B«“VávጂÌ1—á. ì–¼½ŽiC㑺m•vi”çj: “ú–{”畆‰ÈŠw‰ï‘æ660‰ñ“Œ‹ž’n•û‰ï i89.11.18j, ‰¡•l.

2175. mŠw‰ïn iˆê”Êu‰‰j qí«“Vávጂæ‚èg”Á«“VávጂֈÚs‚ÌŒ©‚ç‚ꂽ1—á. ‚‹´¸ŽiC‰¹ŽR˜aéCŠâè‰ëC•ÐŽRˆê˜NCì–¼½Žii”çj: “ú–{”畆‰ÈŠw‰ï‘æ660‰ñ“Œ‹ž’n•û‰ï i89.11.18j, ‰¡•l.

2176. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g—Ö@‚ª‘tŒø‚µ‚½postthrombotic syndrome. ó’J‰ë•¶CŠâè‰ëC—é–Ø—T‰îC•ÐŽRˆê˜NC¼‰ª´i”çj: “ú–{”畆‰ÈŠw‰ï‘æ660‰ñ“Œ‹ž’n•û‰ï i89.11.18j, ‰¡•l.

2177. mŠw‰ïn iˆê”Êu‰‰j äSŠà‚Ì1—á. óˆäŽõŽqC‘¾“cK‘¥CŠâè‰ëCŽíˆä—Ç“ñC•ÐŽRˆê˜Ni”çj: “ú–{”畆‰ÈŠw‰ï‘æ660‰ñ“Œ‹ž’n•û‰ï i89.11.18j, ‰¡•l.

2178. mŠw‰ïn iˆê”Êu‰‰j ¶Ž¨‘O•”‚É‚Ý‚ç‚ꂽmixed tumor‚Ì1—á. ŽR“ckŽŸCŒüˆäGŽ÷C•xàV‘¸‹VC—é–Ø—T‰îi”çj: “ú–{”畆‰ÈŠw‰ï‘æ660‰ñ“Œ‹žŒ¤‹†’n•û‰ï i89.11.18j, ‰¡•l.

2179. mŠw‰ïn iˆê”Êu‰‰j Ž•“÷Žî’¯‚æ‚èf’f‚³‚ꂽ‹}«œ‘’P‹…«”’ŒŒ•a‚Ì1—á. –îŒûŒúC‰¹ŽR˜aéCŠâè‰ëCóˆär–íC•ÐŽRˆê˜NC¼ŽR–Εvi”çjC‰–’J–ÎCŽR‰º‚¦‚èŽqi“àj: “ú–{”畆‰ÈŠw‰ï‘æ660‰ñ“Œ‹ž’n•û‰ï i89.11.18j, ‰¡•l.

2180. mŠw‰ïn iˆê”Êu‰‰j F‘f«áy]|–k—¢‘å‰ß‹Ž10”NŠÔ‚Ì“Œv“IŠÏŽ@|. “¡“c—T‰îCŸ‰ªŒ›¶CŠâè‰ëC•ÐŽRˆê˜Ni”çj: “ú–{”畆‰ÈŠw‰ï‘æ660‰ñ“Œ‹ž’n•û‰ï i89.11.18j, ‰¡•l.

2181. mŠw‰ïn iˆê”Êu‰‰j ƒŠƒxƒh•a•Ï‚Ì’ÇÕ’²¸. —é–Ø—T‰îC‰¹ŽR˜aéCóˆär–íC‰Á“¡ˆê˜YC•ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ï‘æ660‰ñ“Œ‹ž’n•û‰ï i89.11.18j, ‰¡•l.

2182. mŠw‰ïn iˆê”Êu‰‰j The Effects of Differentiation on the Tumorgenic and Metastatic Phenotype of Murine Melanoma Cells. ‹TŽRFˆê˜Yi”çjCHearing, V.J. (NIH): “ú–{”畆‰ÈŠw‰ï‘æ660‰ñ“Œ‹ž’n•û‰ï i89.11.18j, ‰¡•l, Differentiation, 42(12): 28`30, 1989.

2183. mŠw‰ïn iˆê”Êu‰‰j ³íl‚Ì‚’¼Ž‹‰^“®«ŠáU‚ɂ‚¢‚Ä. ˆ¢•”—EŸC²‹´–M•FC‰LŽ”~Žqi—ÕŒŸjCŽO•x“N˜YC’·’JìˆêŽqi“àjC“¡–ì–¾lC“¿‘Œú“ñiŽ¨j: ‘æ48‰ñ“ú–{•½t_Œo‰ÈŠw‰ï‘‰ï i89.11.23), “Þ—Ç.

2184. mŠw‰ïn iˆê”Êu‰‰j Õ“®«Šá‹…‰^“®‰ðÍ‚Ö‚ÌV‚µ‚¢ŽŽ‚Ý. ŽO•x“N˜YC’·’JìˆêŽqCŒÃ˜a‹vKi“àjC“¿‘Œú“ñiŽ¨jCˆ¢•”—EŸi—ÕŒŸj: ‘æ48‰ñ“ú–{•½t_Œo‰ÈŠw‰ï‘‰ï i89.11.23), “Þ—Ç.

2185. mŠw‰ïn iˆê”Êu‰‰j F‘f«áy]|–k—¢‘åŠw‰ß‹Ž10”NŠÔ‚Ì“Œv“IŠÏŽ@|. “¡“c—T‰îCŠâè‰ëCŸ‰ªŒ›¶i”çj: “ú–{”畆‰ÈŠw‰ï‘æ271‰ñ•Ÿ‰ª’n•û‰ï i89.11.23j, •Ÿ‰ª.

2186. mŠw‰ïn iˆê”Êu‰‰j Opsoclonus—lŠá‹…‰^“®A’ZŠúŒð‘ã«ŠáU‚ð’悵‚½1—á. f‘ò’BŽuCŒ˘aŽqC’·’JìˆêŽqCŒÃ˜a‹vKi“àjCˆ¢•”—EŸi—ÕŒŸjC“¡–ì–¾lC“¿‘Œú“ñiŽ¨j: ‘æ48‰ñ“ú–{•½t_Œo‰ÈŠw‰ï‘‰ï i89.11.25), “Þ—Ç.

2187. mŠw‰ïn iˆê”Êu‰‰j Interleukin 1 alpha and 6 Expression in Psoriatic Skin. ‘¾“cK‘¥C¼‰ª´i”çjC‘D“n’‰’ji—Õ•a—jC¼ŽR–Εvi”çj: The 6th Japan-Korea Joint Meeting of Dermatology i89.11.5`6j, “Œ‹ž.

2188. mŠw‰ïn iˆê”Êu‰‰j A Case of Livedo with Ulceration Associated with Multiple Cereberal Infarctions and Elevated Anti-cardiolipin Antibody. ‰¹ŽR˜aéC•ÐŽRˆê˜NC—é–Ø—T‰îC¼‰ª´C¼ŽR–Εvi”çj: The 6th Japan-Korea Joint Meeting of Dermatology i89.11.5`6j, “Œ‹ž.

2189. mŠw‰ïn iˆê”Êu‰‰j ¬lŒ^ƒAƒgƒs[«”畆‰Š‚É‚¨‚¯‚é׋ۂ̖ðŠ„. –ìŒûr•Fi”çj: _“Þ쌧”畆‰Èˆã‰ï‘æ70‰ñ—á‰ï i89.12.02j, ‰¡•l.

2190. mŠw‰ïn iˆê”Êu‰‰j Š£á•\”ç‚É‚¨‚¯‚éIL-1‚¨‚æ‚Ñ6ƒƒbƒZƒ“ƒWƒƒ[RNA”­Œ»‚ÌŒŸ“¢. ‘¾“cK‘¥C¼‰ª´C¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ï‘æ661‰ñ“Œ‹ž’n•û‰ï i89.12.16j, “Œ‹ž.

2191. mŠw‰ïn iˆê”Êu‰‰j ”畆׬ŒŒŠÇ‰Š‚Ì—Õ°‘gDŠw“IŒŸ“¢. óˆär–íC‰Á“¡ˆê˜YCì–¼½ŽiC—é–Ø—T‰îi”çj: “ú–{”畆‰ÈŠw‰ï‘æ661‰ñ“Œ‹ž’n•û‰ï i89.12.16j, “Œ‹ž.

2192. mŠw‰ïn iˆê”Êu‰‰j “÷‰èŽî«‰ŠÇ‚É‚¨‚¯‚éNK×–E‚Ì–ðŠ„. ‹´–{–¾•Fi”çjCEpstein, W.L.(¶ØÌ«ÙƱ‘åj: “ú–{”畆‰ÈŠw‰ï‘æ661‰ñ“Œ‹ž’n•û‰ï i89.12.16j, “Œ‹ž.

2193. mŠw‰ïn iˆê”Êu‰‰j ˆ««•FŽî‚ÌŽo–…—á. “¡“c—T‰îCŠâè‰ëC•ÐŽRˆê˜NC•ÄŒ³N‘ i”çjC¼X“N˜NC‘å–ìŽii®ŠOjCÎì~iŠOj: “ú–{”畆‰ÈŠw‰ï‘æ662‰ñ“Œ‹ž’n•û‰ï i90.01.20j, ‰¡•l.

2194. mŠw‰ïn iˆê”Êu‰‰j Tribenoside (Hemocuron R)‚É‚æ‚é–ò]‚Ì2—á. –ìŒûr•FC’ËŒ´“NÆCóˆär–íC•ÐŽRˆê˜Ni”çj: “ú–{”畆‰ÈŠw‰ï‘æ662‰ñ“Œ‹ž’n•û‰ï i90.01.20j, ‰¡•l.

2195. mŠw‰ïn iˆê”Êu‰‰j œ‘«ƒvƒƒgƒ|ƒ‹ƒtƒBƒŠƒ“Ç. ’؈äL”üC•ÄŒ³N‘ Cóˆär–íi”çjCìè‚¢‚ÂÝiŠáj: “ú–{”畆‰ÈŠw‰ï‘æ662‰ñ“Œ‹ž’n•û‰ï i90.01.20j, ‰¡•l.

2196. mŠw‰ïn iˆê”Êu‰‰j qí«˜TáŒ. óˆär–íC•ÄŒ³N‘ CŸ‰ªŒ›¶C‘ºˆä³Œ³i”çj: “ú–{”畆‰ÈŠw‰ï‘æ662‰ñ“Œ‹ž’n•û‰ï i90.01.20j, ‰¡•l.

2197. mŠw‰ïn iˆê”Êu‰‰j ”牺ŽîáŽ‚ð‰”­‚Æ‚µŒ´”­‘ƒ‚ª”x‚Æl‚¦‚ç‚ꂽ“]ˆÚŠà‚Ì2—á. –îŒûŒúC‹ß“¡Ž •vCŠâè‰ëC•ÐŽRˆê˜Ni”çjC‰ºì‰ë•¶i“ŒŽÅ—ÑŠÔ•a‰@j: “ú–{”畆‰ÈŠw‰ï‘æ662‰ñ“Œ‹ž’n•û‰ï i90.01.20j, ‰¡•l.

2198. mŠw‰ïn iˆê”Êu‰‰j Cowden•a (multiple hamartoma syndrome). ‚–ìWC“”I‹BC•ÄŒ³N‘ i”çjC–ØìŽOŽl˜YiŠOj: “ú–{”畆‰ÈŠw‰ï‘æ662‰ñ“Œ‹ž’n•û‰ï i90.01.20j, ‰¡•l.

2199. mŠw‰ïn iˆê”Êu‰‰j TEN‚Ì1—á. ‹TŽRFˆê˜Yi”çjC”ö—§Žé”üC–؉º³Žqi‰Í–k•a‰@j: “ú–{”畆‰ÈŠw‰ï‘æ662‰ñ“Œ‹ž’n•û‰ï i90.01.20j, ‰¡•l.

2200. mŠw‰ïn iˆê”Êu‰‰j ”畆׬ŒŒŠÇ‰Š‚Ì—Õ°“IŒŸ“¢|“Á‚ɬl—á‚Ì“Á’¥‚ɂ‚¢‚Ä|. óˆär–íC‰¡ŠÖ”Ž—YC—é–Ø—T‰îC‰Á“¡ˆê˜YCì–¼½ŽiC‘‘òŠ²’ji”çj: ‘æ13‰ñ”畆–¬ŠÇ§˜b‰ï i90.01.25j, ‘q•~.

2201. mŠw‰ïn iˆê”Êu‰‰j ƒŠƒxƒh•a•Ï‚É‚¨‚¯‚é—Õ°A‘gD‘œA”]“àŒŒŠÇ•a•ÏARƒJƒ‹ƒWƒIƒŠƒsƒ“R‘Ì‚ÌŠÖ˜A«‚ɂ‚¢‚Ä. —é–Ø—T‰îC‰¹ŽR˜aéC•ÐŽRˆê˜NC¼ŽR–Εvi”çj: ‘æ13‰ñ”畆–¬ŠÇ§˜b‰ï i90.01.25j, ‘q•~.

2202. mŠw‰ïn iˆê”Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒ‚É”F‚ß‚ç‚ꂽ”畆’×ᇂ̌Ÿ“¢. Žíˆä—Ç“ñCóˆär–íC•ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çj: ‘æ13‰ñ”畆–¬ŠÇ§˜b‰ï i90.01.25j, ‘q•~.

2203. mŠw‰ïn iˆê”Êu‰‰j Žè¶g”ÁAlivedo‚ð”F‚ßARƒŠƒ“Ž‰Ž¿R‘Ì—z«‚Ì’jŽqäPŒ´•a‚Ì2—á. ‰¹ŽR˜aéC•ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çj: ‘æ37‰ñ“ú–{”畆‰ÈŠw‰ïɪ’n•û‰ï i90.02.04j, •l¼.

2204. mŠw‰ïn iˆê”Êu‰‰j ŽhÂŽÒ‚É‚Ý‚ç‚ꂽ“úŒõ]. óˆär–íC•ÐŽRˆê˜NC¼‰ª´i”çj: ‘æ37‰ñ“ú–{”畆‰ÈŠw‰ïɪ’n•û‰ï i90.02.04j, •l¼.

2205. mŠw‰ïn iˆê”Êu‰‰j ƒNƒƒ‚ƒVƒR[ƒVƒX‚Ì1—á||ƒCƒgƒ‰ƒRƒiƒ][ƒ‹Žg—p—á||. óˆäŽõŽqCŠâè‰ëC“cÀO”VC¼ŽR–Εvi”çjC‚–Øç’ßCˆ¢•””ü’mŽqi—ÕŒŸj: ‘æ27‰ñ_“Þìˆã^‹Û§˜b‰ï i90.02.10j, ‰¡•l.

2206. mŠw‰ïn iˆê”Êu‰‰j Staphylococcal Botryomycosis‚Ì1—á. ’؈äL”üCŠâè‰ëC“cÀO”VC•ÐŽRˆê˜NC¼ŽR–Εvi”çjC‹v•ÄŒõC‰œ•½‰ë•Fi•a—j: ‘æ27‰ñ_“Þìˆã^‹Û§˜b‰ï i90.02.10j, ‰¡•l.

2207. mŠw‰ïn iˆê”Êu‰‰j Cat-scratch Disease. ’؈äL”üC‰q“¡ŒõC¼‰ª´i”çjC‚‹{t’ji—ÕŒŸj: “ú–{”畆‰ÈŠw‰ï‘æ663‰ñ‡“¯—Õ°“Œ‹ž’n•û‰ï i90.02.17j, “Œ‹ž.

2208. mŠw‰ïn iˆê”Êu‰‰j ”ñ’èŒ^g”Á‚É‚æ‚è”xŠà‚ð”­Œ©‚µ‚½1—á. ó’J‰ë•¶C’ËŒ´“NÆCŽíˆä—Ç“ñC‰Á“¡ˆê˜Yi”çj: “ú–{”畆‰ÈŠw‰ï‘æ272‰ñ•Ÿ‰ª’n•û‰ï i90.03.11j, •Ÿ‰ª.

2209. mŠw‰ïn iˆê”Êu‰‰j ƒo[ƒWƒƒ[•aA‹­”çÇASLE‚̃ŒƒCƒm[Çó‚ɑ΂·‚éÉŽ_ƒCƒ\ƒ\ƒ‹ƒrƒhƒe[ƒvÜ‚ÌŽ¡—ÃŒø‰Ê‚ɂ‚¢‚Ä. ‚‹´¸ŽiC‰¹ŽR˜aéC‹ß“¡Ž •vC‰Á“¡ˆê˜Yi”çj: “ú–{”畆‰ÈŠw‰ï‘æ272‰ñ•Ÿ‰ª’n•û‰ï i90.03.11j, •Ÿ‰ª.

2210. mŠw‰ïn iˆê”Êu‰‰j “û—cŽ™ƒAƒgƒs[«”畆‰Š‚Ì’ÇÕ’²¸. –ìŒûr•FCŒüˆäGŽ÷C¼‰ª´C¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ï‘æ664‰ñ“Œ‹ž’n•û‰ï i90.03.17j, “Œ‹ž.

2211. mŠw‰ïn iˆê”Êu‰‰j ^”ç”÷¬ŒŒŠÇ“à”ç×–E(DMEC)‚ÌcAMP‚É‚æ‚é×–E‘BŒø‰Ê‚ÌŒŸ“¢. ‘‘òŠ²’jC‘åìŽiCóˆär–íC¼‰ª´C¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ï‘æ664‰ñ“Œ‹ž’n•û‰ï i90.03.17j, “Œ‹ž.

2212. mŠw‰ïn iˆê”Êu‰‰j RƒAƒ~ƒƒCƒhƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì‚Ìì»A‹y‚Ñ‚»‚Ì‘gD‰»Šw“IŒŸ“¢. ‰Á“¡ˆê˜YC‰q“¡ŒõC‹´–{–¾•FCŒüˆäGŽ÷i”çj: “ú–{”畆‰ÈŠw‰ï‘æ664‰ñ“Œ‹ž’n•û‰ï i90.03.17j, “Œ‹ž.

2213. mŠw‰ïn iˆê”Êu‰‰j Pathogenesis of Blackfoot Disease--Effects of Trivalent Arsenic on Cultured Human Umbilical Vein Endothelial Cells---. ’‘dCóˆär–íC“”I‹BC—é–Ø—T‰îC¼‰ª´C¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ï‘æ664‰ñ“Œ‹ž’n•û‰ï i90.03.17j, “Œ‹ž.

2214. mŒ¤‹†‰ïn i“Á•Êu‰‰j ŠáˆÊ‚Æ‚­‚Éu‚’¼Šá‹…‰^“®v‚̈Ùí‚ð’†S‚É. Îì“NiŠáj: ‘æ640‰ñ“Œ‹ž“sŠá‰ÈW’k‰ï (89.04.28), “Œ‹ž.

2215. mŒ¤‹†‰ïn i“Á•Êu‰‰j “µEE’²ßAŋ߂̘b‘è. Îì“NiŠáj: ‘æ74‰ñŽRŒûŒ§Šá‰Èˆã‰ïH‹G‘‰ïŽRŒûŒ§Šá‰ÈW’k‰ï (89.11.05), ¬ŒS.

2216. mŒ¤‹†‰ïn i“Á•Êu‰‰j VDT‚ÆŠáA‚Æ‚­‚ɋߌ©”½‰ž‚Æ‚ÌŠÖŒW. Îì“NiŠáj: ŽOdŒ§Šá‰Èˆã‰ïuK‰ï (90.01.15), ŽOd.

2217. mŒ¤‹†‰ïn i“Á•Êu‰‰j ƒeƒNƒmƒXƒgƒŒƒXŠáÇ. Îì“NiŠáj: ç—tŒ§Šá‰Èˆã‰ïŠwpu‰‰‰ï (90.01.21), ç—t.

2218. mŒ¤‹†‰ïn i“Á•Êu‰‰j ƒeƒNƒmƒXƒgƒŒƒXŠáÇ. Îì“NiŠáj: é‹ÊŒ§Šá‰Èˆã‰ï‹³ˆçu‰‰ (90.01.28), ‘å‹{.

2219. mŒ¤‹†‰ïn i“Á•Êu‰‰j ‚æ‚­‚Ý‚ç‚ê‚éŽq‚Ç‚à‚̊ᎾŠ³. Œü–ì˜a—YiŠáj: ‘æ76‰ñ—Õ°¬Ž™ˆãŠw§˜b‰ï (90.02.25).

2220. mŒ¤‹†‰ïn i“Á•Êu‰‰j ƒRƒ“ƒsƒ…[ƒ^[Žž‘ã‚ÌŠw“¶‚Ì–Ú‚ÌŒ’N. Îì“NiŠáj: “Œ‹ž“sŠá‰Èˆã‰ïŠwZ•ÛŒ’Šwpu‰‰‰ï (90.03.08), “Œ‹ž.

2221. mŒ¤‹†‰ïn i“Á•Êu‰‰j Ž‹_ŒoŽ¾Š³‚Æ“û“ªŠŒ©. Žá‘q‰ë“oiŠáj: –h‰qˆã‘åŠá‰ÈŠwpW‰ï (90.03.14), é‹Ê.

2222. mŒ¤‹†‰ïn i“Á•Êu‰‰j VDTì‹Æ‚É”º‚¤áŠQ‚ɂ‚¢‚Ä. Îì“NiŠáj: •½¬Œ³”N“x_“Þ쌧ˆãŽtŽY‹Æˆã•”‰ïŒ¤C‰ï (90.03.29), ‰¡•l.

2223. mŒ¤‹†‰ïn i“Á•Êu‰‰j Clinical Ecology‚ÆŠá‰È. Îì“NiŠáj: ‘æ13‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (90.03.29), ‘Š–ÍŒ´.

2224. mŒ¤‹†‰ïn i“Á•Êu‰‰j ƒtƒFƒjƒgƒCƒ“‚Ì–ò]. “”I‹BCóˆär–íC’|èLˆê˜YC¼‰ª´C¼ŽR–Εvi”çj: ‘æ14‰ñ–ƉuƒZƒ~ƒi[ i90.01.27j, “Œ‹ž.

2225. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ŠJ‹Æˆã‚É•K—v‚ÈŠá‰ÈŠw‚Ì’mŽ¯|‚—ŽÐ‰ï‚ðŒ}‚¦‚Ä|. Œü–ì˜a—YiŠáj: ‘å˜a—Õ°ˆãŠw’k˜b‰ï‘æ217‰ñŒ¤C‰ï (89.04.12), ‘å˜a.

2226. mŒ¤‹†‰ïn i‹³ˆçu‰‰j “úíŒoŒ±‚·‚éŠááÙ‚Ì‹@”\ˆÙíA‚»‚ÌŠî‘b‚Æ—Õ°. Œü–ì˜a—YiŠáj: ‘æ11‰ñ_“Þ쌧Šá‰È—Õ°’k˜b‰ï (89.07.23), ìè.

2227. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ŠááÙ‰^“®‚ÌŠî‘b‚Æ—Õ°. Œü–ì˜a—YiŠáj: ‘æ1‰ñ‰¡•lŽs‘å_ŒoƒZƒ~ƒi[ (89.09.22), ‰¡•l.

2228. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ‹»–¡‚ ‚éŠá‹…‰^“®ˆÙí‚ð’Ê‚µ‚Ä. Œü–ì˜a—YiŠáj: ‘æ1‰ñMB‘åŠw–k—¢‘åŠwŒðŠ·Œ¤‹†‰ï (89.10.28), ¼–{.

2229. mŒ¤‹†‰ïn i‹³ˆçu‰‰j “Ë‘R•¡Ž‹‚𗈂·Ž¾Š³‚Ìf’f‚ÆŽ¡—Ã. Îì“NiŠáj: ‘æ19‰ñŠá‰È‹³ˆçƒ[ƒ~ƒi[ƒ‹ (89.12.09), ‘åã.

2230. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ’²ß‚ÌV‚µ‚¢ŒŸ¸–@. ‰LŽ”ˆê•FiŠáj: ‘æ13‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (90.03.29), ‘Š–ÍŒ´.

2231. mŒ¤‹†‰ïn i‹³ˆçu‰‰j “dŽqŒ°”÷‹¾‚Ì•a—f’f‚ւ̃Aƒvƒ[ƒ`||”畆Žîᇂɂ‚¢‚Ä. ‰q“¡Œõi”çj: “ú–{“dŽqŒ°”÷‹¾Šw‰ïŠwp•”‰ï•½¬Œ³”N“xŠwpW‰ï i90.03.24j, “Œ‹ž.

2232. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Contact Desmatitis and Aging. ¼‰ª´i”çj: International Conference on Skin Aging i89.06.17j, “Œ‹ž.

2233. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Immunologic Role of Dermis. ¼‰ª´i”çj: Symposium on Immunodermatology i89.09.12j, Seoul.

2234. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ”畆‚̉ŠÇ‚̃ƒfƒBƒG[ƒ^[. ¼‰ª´i”çj: ‘æ2‰ñ”畆–ò•¨¶—ŠwŒ¤‹†‰ï i89.10.07j, “Œ‹ž.

2235. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œ‹–Œ‰ºpseudolymphoma‚Ì1—á. ”óŒû—T•FC²ŒÃ”ŽPC‘ìd•vC–ؔÉiŠáj: _“ÞìW’k‰ï (86.07.26).

2236. mŒ¤‹†‰ïn iˆê”Êu‰‰j –¬—–ŒŒŒŠÇŽî‚̉摜f’f‚ɂ‚¢‚Ä. –]ŒŽˆêCŽá‘q‰ë“oiŠáj: ‘æ11‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (89.04.06), ‰¡•l.

2237. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”ìŒú«‘–Œ‰Š‚É‚ÄŽ‹—ÍáŠQ‚ð‹N‚±‚µ‚½‚ÆŽv‚í‚ꂽ1—á. ‹ß“¡‰À•vCŠÖ’JŽ¡‹viŠájC²“¡³KióŠÔ‘‡•a‰@j: ‘æ11‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (89.04.06), ‰¡•l.

2238. mŒ¤‹†‰ïn iˆê”Êu‰‰j FisherÇŒóŒQ‚Ì’²ßáŠQ‚ɂ‚¢‚Ä. Œ´’¼lC“©ŽRG•vCÎì“NiŠáj: ‘æ42‰ñ_“Þ쌧Šá‰ÈW’k‰ï (89.05.28), ‰¡•l.

2239. mŒ¤‹†‰ïn iˆê”Êu‰‰j –³‹Û«‘–Œ‰ŠA‚¤‚ÁŒŒ“û“ª‚ðŽ¦‚µ‚½ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á. ¡“c–LCŽá‘q‰ë“oiŠáj: ‘æ42‰ñ_“Þ쌧Šá‰ÈW’k‰ï (89.05.28), ‰¡•l.

2240. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ž‘±«‚Ìâ‘ΓµE‹­’¼‚ð‚«‚½‚µ‚½1Ç—á. Œ´’¼lCŽá‘q‰ë“oCŒü–ì˜a—YiŠáj: ‘æ16‰ñ_ŒoŠá‰È•×‹­‰ï (89.06.14), “Œ‹ž.

2241. mŒ¤‹†‰ïn iˆê”Êu‰‰j Myotonic dystrophy‚ÌŠá’ê•a•Ï. ’Ò‘ò‰F•FC’m–쇎qC¼Œ´ŒbŽqiŠáj: ‘æ43‰ñ_“Þ쌧Šá‰ÈW’k‰ï (89.07.08), ‰¡•l.

2242. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ž©‘RŠ°‰ð‚µ‚½‹×–E«“®–¬‰Š‚É‚æ‚鎋_ŒoÇ. Žs•Ó‹`ÍCŽá‘q‰ë“oCÎì“NiŠáj: ‘æ43‰ñ_“Þ쌧Šá‰ÈW’k‰ï (89.07.08), ‰¡•l.

2243. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œ´ˆö•s–¾‚ÌŠ´‰¹“ï’®‚Ì”N—î•Ê’®—Í. ‰ª–{–qlCÝŠy“N–çCŒÃ‘òTˆêC•½ŽR•ûriŽ¨•@j: Œú¶È“Á’莾Š³‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ1‰ï‘‰ï (89.08.12), “Œ‹ž.

2244. mŒ¤‹†‰ïn iˆê”Êu‰‰j “Á“ï‚̈æ’lã’®—ÍŒŸ¸i‘æ3•ñj. •½ŽR•ûrCÝŠy“N–çC‰ª–{–qlCŒÃ‘òTˆêiŽ¨•@j: Œú¶È“Á’莾Š³‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ1‰ï‘‰ï (89.08.12), “Œ‹ž.

2245. mŒ¤‹†‰ïn iˆê”Êu‰‰j Šáâ|ƒRƒŒƒXƒeƒŠƒ““÷‰èŽî‚Ì1Ç—á. ’†‘ò³”ŽCŽá‘q‰ë“oCÎì“NiŠájCŠâŸºŒ[ˆêi•a—j: ‘æ24‰ñŠá‰È—Õ°•a—‘gDŒ¤‹†‰ï (89.09.08).

2246. mŒ¤‹†‰ïn iˆê”Êu‰‰j X-Yƒgƒ‰ƒbƒJ[‚ð—p‚¢‚½ŒÅŽ‹”÷“®‚Ì‘ª’è. Ä“¡—²C–ؔÉCÎì“NC¼–q–¾”üiŠáj: ‘æ7‰ñVDTŒ¤‹†‰ï (89.10.13), –¼ŒÃ‰®.

2247. mŒ¤‹†‰ïn iˆê”Êu‰‰j VDTì‹Æ‚ð’†S‚Æ‚·‚éŠá¸”æ˜JŠ³ŽÒ‚ÌŽ©—¥_ŒoáŠQ‚ɂ‚¢‚Ä||“_ŠáƒeƒXƒg‚É‚æ‚铵E‚©‚ç‚̃Aƒvƒ[ƒ`. ¡“c–LC¬“ˆ—ÇGC–ؔÉCÎì“NCŠÝ“cç•äŽqCˆÉ“¡K]iŠáj: ‘æ7‰ñVDTŒ¤‹†‰ï (89.10.13), –¼ŒÃ‰®.

2248. mŒ¤‹†‰ïn iˆê”Êu‰‰j Congenital Eyelid Retraction ‚Ì2—á. ”óŒû—T•FCŒü–ì˜a—YiŠáj: ‘æ18‰ñ“È–ØW’k‰ï (89.11.10), “È–Ø.

2249. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ž©“®–D‡Ší(Staple)‚Æ‘nŽ¡–ü. ŽR“c’¼lC“àÀ‰hŽ÷CÎŒ´GˆêC¼‘q’m”VC‰–’JMKiŒ`ŠOj: ‘nŽ¡–üŒ¤‹†‰ï (89.12.02), ‹v—¯•Ä.

2250. mŒ¤‹†‰ïn iˆê”Êu‰‰j äNã÷Šà‚ÌŠáâ|“à“]ˆÚ‚ð‚«‚½‚µ‚½1—á. Žs•Ó‹`ÍC“©ŽRG•vC”µ–ì’·•¶iŠáj: ‘æ4‰ñŠáâ|Ž¾Š³ƒVƒ“ƒ|ƒWƒEƒ€ (89.12.03).

2251. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’±Œ`œ“´”S‰t”XŽî‚Æ‘OŒð’Ê“®–¬áŽ‚ð‡•¹‚µ‚½1—á. ”µ–ì’·•¶C“©ŽRG•vCŽs•Ó‹`ÍiŠáj: ‘æ4‰ñŠáâ|Ž¾Š³ƒVƒ“ƒ|ƒWƒEƒ€ (89.12.03).

2252. mŒ¤‹†‰ïn iˆê”Êu‰‰j VDTì‹Æ‚ð’†S‚Æ‚·‚éŠá¸”æ˜JŠ³ŽÒ‚ÌŽ©—¥_ŒoáŠQ‚ɂ‚¢‚Ä||“_ŠáƒeƒXƒg‚É‚æ‚铵E‚©‚ç‚̃Aƒvƒ[ƒ`||. –ؔÉC¬“ˆ—ÇGCÎì“NCŠÝ“cç•äŽqCˆÉ“¡K]iŠáj: “ú–{ŽY‹Æ‰q¶Šw‰ïVDTì‹ÆŒ¤‹†‰ï‘æ8‰ñŒ¤‹†‰ï (89.12.06), “Œ‹ž.

2253. mŒ¤‹†‰ïn iˆê”Êu‰‰j Epstein-Barr Virus‚É‚æ‚é‚ÆŽv‚í‚ê‚éNeuro-retinitis‚Ì1—á. ”–ØLÆCŽs•Ó‹`ÍCŽá‘q‰ë“oiŠáj: ‘æ12‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (89.12.21), ‘Š–ÍŒ´.

2254. mŒ¤‹†‰ïn iˆê”Êu‰‰j –Ɖu—}§Ü’·Šú“Š—^Œã‚É”­Ç‚µ‚½ƒTƒCƒgƒƒKƒƒEƒCƒ‹ƒX–Ô–ŒÇ‚Ì1—á. “¡“c“NCÎì‹ÏCŽá‘q‰ë“oiŠáj: ‘æ12‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (89.12.21), ‘Š–ÍŒ´.

2255. mŒ¤‹†‰ïn iˆê”Êu‰‰j Š®‘S’E‰P…»‘Ì‚ðÉŽq‘ÌŽèp‚É‚æ‚蜋Ž‚µ‚½1—á. “¡ˆä‰ë˜NC•Ÿ“c•q‰ëiŠáj: ‘æ12‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (89.12.21), ‘Š–ÍŒ´.

2256. mŒ¤‹†‰ïn iˆê”Êu‰‰j çtçsŠá‹…‰^“®‚̃Gƒ‰[ƒVƒOƒiƒ‹. ŽR“c“OlC‰LŽ”ˆê•FiŠáj: 1990”N“~ŠúŽ‹ŠoŒ¤‹†‰ï (90.00.00), Vision, 2(1): 18, 1990.

2257. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒqƒg‚ÌŠOŠá‹Ø‹Ø–aŽ‚ÌŒ`‘ÔŠw“IŒ¤‹†|(2)•a“I󋵂ɂ¨‚¯‚é‹Ø–aŽ‚̕ω». Œü–ì˜a—YCVˆä“cF—TC–Ø‘º^–çiŠáj: Šá‹ØŽ©ŒÈŽó—eŠí‚ÌŠî‘b“I‚¨‚æ‚Ñ—Õ°“I‰ž—p‚ÌŒ¤‹†; ‘‡Œ¤‹†A”ljï‹c (90.01.13), ¼ŽR.

2258. mŒ¤‹†‰ïn iˆê”Êu‰‰j –îóÖ¬“´ŒŒðÇ‚Ì1—á. Ä“¡‘åCÝŠy“N–çC‰ª–{–qlC•½ŽR•ûrC“¿‘Œú“ñC“¡–ì–¾liŽ¨•@j: Œú¶È“Á’莾Š³‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ2‰ñ‘‰ï (90.02.03), “Œ‹ž.

2259. mŒ¤‹†‰ïn iˆê”Êu‰‰j “Ë”­«“ï’®ŒŒ‰tŒŸ¸ŠŒ©‚ÌŒŸ“¢i‘æ‚P•ñj. ‰ª–{–qlCÝŠy“N–çCŒÃ‘òTˆêC•½ŽR•ûriŽ¨•@j: Œú¶È“Á’莾Š³‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ2‰ñ‘‰ï (90.02.03), “Œ‹ž.

2260. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒXƒeƒƒCƒhŽ‘±“Š—^Š´‰¹“ï’®‚ÌŒŸ“¢. ŒÃ‘òTˆêCÝŠy“N–çC‰ª–{–qlC•½ŽR•ûriŽ¨•@j: Œú¶È“Á’莾Š³‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ2‰ñ‘‰ï (90.02.03), “Œ‹ž.

2261. mŒ¤‹†‰ïn iˆê”Êu‰‰j “Ë”­«Š´‰¹“ï’®‚ÌŒŸ“¢|Žá”NŒ^‚ƬlŒ^‚ɂ‚¢‚Ä. •½ŽR•ûrCÝŠy“N–çC‰ª–{–qlCŒÃ‘òTˆêiŽ¨•@j: Œú¶È“Á’莾Š³‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ2‰ñ‘‰ï (90.02.03), “Œ‹ž.

2262. mŒ¤‹†‰ïn iˆê”Êu‰‰j Oculo-kinetic Perimetry—ΓàኳŽÒ‚ɑ΂·‚鎋–쌟¸. “©ŽRG•vCŽá‘q‰ë“oiŠáj: ‘æ7‰ñ_“Þ쌧—Γàá’k˜b‰ï (90.02.17).

2263. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’†SŠj•afloppy infant‚ɇ•¹‚µ‚½æ“V«—Γàá‚ÌŽ¡—Âɂ‚¢‚Ä. ’†ŽR’q•FCŽí“c–F˜YiŠáj: ‘æ7‰ñ_“Þ쌧—Γàá’k˜b‰ï (90.02.17).

2264. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹•ŒŒ«‚©’E‘«‚©ŠÓ•Ê‚É–À‚Á‚½Ä”­«Ž‹_ŒoÇ. ìè‚¢‚ÂÝC¡“c–LCŽá‘q‰ë“oiŠáj: ‘æ45‰ñ_“Þ쌧Šá‰ÈW’k‰ï (90.02.18), ‰¡•l.

2265. mŒ¤‹†‰ïn iˆê”Êu‰‰j _ŒoŠá‰ÈŠw“I‚ÉÇŒó‚ðŽ¦‚µ‚½¬Ž™‚ÌMCTD‹^‚¢—á. ª–{“OiŠáj: ‘æ18‰ñ_ŒoŠá‰È•×‹­‰ï (90.03.07), “Œ‹ž.

2266. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ž‹_Œo‰Š‚Æ‚µ‚Ä’·ŠúŠÔŽ¡—³‚ê‚Ä‚¢‚½ˆÆã•”‘–ŒŽî. ”µ–ì’·•¶CVˆä“cF—TiŠáj: ‘æ13‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (90.03.29), ‘Š–ÍŒ´.

2267. mŒ¤‹†‰ïn iˆê”Êu‰‰j 7”NŠÔ‚É6‰ñ‚ÌŽ‹—͒ቺ‚𗈂µ‚½‘½”­«d‰»Ç‚Ì1—á. ‹g‰i½ŽqC‰ª–ì’q•¶C’m–쇎qC¼Œ´ŒbŽqC–ؔÉiŠáj: ‘æ13‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (90.03.29), ‘Š–ÍŒ´.

2268. mŒ¤‹†‰ïn iˆê”Êu‰‰j óŠÔ‘‡•a‰@Šá‰ÈŽóf‚É‚Ý‚ç‚ꂽ‰æ‘œf’f—z«—á. ‘ìd•vC‹ß“¡‰À•viŠájC‰Í“à‰ëÍióŠÔ‘‡•a‰@j: ‘æ13‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (90.03.29), ‘Š–ÍŒ´.

2269. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒAƒgƒs[«”畆‰Š‚Ì׋ۃƒNƒ`ƒ“—Ö@. ŒüˆäGŽ÷C–ìŒûr•FC¼‰ª´C¼ŽR–Εvi”çj: ‘æ1‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Õ°W‰ï i89.04.14j, “Œ‹ž.

2270. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹ÈÜüó‹›—Øá‚ÌeŽq—á. ‰¹ŽR˜aéC¼‰ª´i”çj: ‘æ4‰ñŠp‰»ÇŒ¤‹†‰ï i89.06.03j, “Œ‹ž.

2271. mŒ¤‹†‰ïn iˆê”Êu‰‰j Pleomorphic Lymphomatoid Papulosis (PLP). Šâè‰ëCóˆär–íC’|èLˆê˜Yi”çjC‘D“n’‰’ji—Õ•a—j: ‘æ8‰ñ”畆‚̃Šƒ“ƒtƒH[ƒ}Œ¤‹†‰ï i89.07.00j, •Ÿ‰ª, ”畆ƒŠƒ“ƒtƒH[ƒ}, IX, 1990.

2272. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒXƒM‰Ô•²ÇŠ³ŽÒ‚É‚Ý‚ç‚ꂽŽ¼]«•a•Ï‚ÌŒŸ“¢. óˆär–íC‰¡ŠÖ”Ž—YC•ÐŽRˆê˜NC¼‰ª´i”çj: ‘æ19‰ñRŒ´Œ¤‹†‰ï i89.07.01j, ’ÃŽs.

2273. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒAƒŒƒrƒAƒ`ƒ“‚Ì–ò]. “”I‹BC’|èLˆê˜YC¼‰ª´C¼ŽR–Εvi”çj: ‘æ19‰ñRŒ´Œ¤‹†‰ï i89.07.01j, ’ÃŽs.

2274. mŒ¤‹†‰ïn iˆê”Êu‰‰j MCTD‚Ì—Õ°Œo‰ß‚ÌŒŸ“¢i“–‰È‚ÅŒoŒ±‚µ‚½15—á‚ɂ‚¢‚Äj. ‹ß“¡Ž •vC‘¾“cK‘¥C“”I^—CŽ›–{”ÍŽqC•ÐŽRˆê˜NC‰q“¡ŒõC㑺m•vCVˆätŽ}C¼‰ª´C¼ŽR–Εvi”çj: Œú¶È“Á’莾Š³‹­”çÇ’²¸Œ¤‹†”Ç•½¬Œ³”N“xƒZƒ~ƒi[ i89.08.26j, ŒS㔪”¦CŠò•Œ.

2275. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹­”çÇ‚ÌŽ¡—Âƌo‰ß|“–‰È‚Å‚ÌŒoŒ±—ái“Á‚ɃXƒeƒƒCƒhŽ¡—ÂɊւµ‚Äj|. ‹ß“¡Ž •vC‘¾“cK‘¥C“”I^—CŽ›–{”ÍŽqC•ÐŽRˆê˜NCVˆätŽ}C‰q“¡ŒõC㑺m•vC¼‰ª´C¼ŽR–Εvi”çj: ‘æ4‰ñäPŒ´•aŒ¤‹†‰ï i90.01.26j, ‘q•~.

2276. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒyÇŒ^SLE‚̔畆Çó‚ɂ‚¢‚Ä‚Ì—Õ°“IŒŸ“¢|subacute LE vs subacute cutaneous LE|. ‰q“¡ŒõC‹ß“¡Ž •vC²X–Ø–MŽqC“”I^—CŽ›–{”ÍŽqCVˆätŽ}C•ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çj: ‘æ4‰ñäPŒ´•aŒ¤‹†‰ï i90.01.26j, ‘q•~.

2277. mŒ¤‹†‰ïn iˆê”Êu‰‰j •\”ç×–EŠj‚ɖƉuƒOƒƒuƒŠƒ“‚Ì’¾’…‚ð”F‚ß‚½MCTD. ‹ß“¡Ž •vC•ÐŽRˆê˜NC‰q“¡ŒõC¼‰ª´C¼ŽR–Εvi”çj: Œú¶È“Á’莾Š³‹­”çÇ’²¸Œ¤‹†”Ç•½¬2”N“x”ljï‹c i90.01.31j, “Œ‹ž.

2278. mŒ¤‹†‰ïn iˆê”Êu‰‰j “Vávጂ̑ˆ«ˆöŽq‚Æ‚µ‚Ä‚ÌŽ‡ŠOü. ì–¼½ŽiC‚‹´¸ŽiCŠâè‰ëC•ÐŽRˆê˜Ni”çj: Œú¶È“Á’莾Š³‹H­“«Ž¾Š³’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ2‰ñ‘‰ï i90.02.10j, ‹ž“s.

2279. mŒ¤‹†‰ïn iŒöŠJuÀj ‘Ì•½t‚ÌŒŸ¸. “¿‘Œú“ñiŽ¨•@j: ‘æ19‰ñ“ú–{•½t_Œo‰ÈŠw‰ï•½t‹@”\‹ZpuK‰ï (89.07.27), ìè.


<<111 ‚»‚Ì‘¼>>

2280. mÇ—á•ñn ˜Vl«“ï’®‚Ì“Á’¥. ‰ª–{–qliŽ¨•@j: JOHNS, 5(12): 1723`1727, 1989.

2281. mÇ—á•ñn Œûo¥ã’×ᇕa•Ï‚ÌŠÓ•Êf’f. ‚‹´œAbiŽ¨•@j: JOHNS, 5(7): 947`951, 1989.

2282. mÇ—á•ñn “Á”­«—¼‘¤«Š´‰¹“ï’®. ‰ª–{–qlC•½ŽR•ûriŽ¨•@j: JOHNS, 6(1): 75`78, 1990.

2283. m—Õ°Ž¡Œ±n ƒqƒgŒûŠWG“‚É‚¨‚¯‚é•a—‘gDŠw“IŒ¤‹†|“Á‚É”N—î•Ï‰»‚ɂ‚¢‚Ä|. Œ´“cGˆêiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñ, 92: 1049`1064, 1989.

2284. m‘àn —ÞŽ—•a•Ï‚Æ‚ÌŠÓ•Ê‚Ì—v“_. ‚‹´œAbiŽ¨•@j: JOHNS, 6(2): 153`157, 1990.

2285. m‘àn Œ`¬ŠO‰È—̈æ‚É‚¨‚¯‚é Prostaglandin E1 ‚ÌŽg—pŒoŒ±. ’†‘ºŒ³MCˆÀ•x‹`“NC“àÀ‰hŽ÷C‰–’JMKiŒ`ŠOj: Œ»‘ãˆã—Ã, 32: 694`699, 1990.

2286. mŠw‰ïn iƒpƒlƒ‹j Œûo“à–ŒŒ´”­adenoid squamous cell carcinoma‚Ì1—á. –Ø“c–FŽ÷i“àjCŠâŸºŒ[ˆêi•a—jC‹{‘òŽµ˜Yi“dŒ°ƒZƒ“ƒ^[jC‹T’J“OC‰œ•½‰ë•Fi•a—j: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.29), •Ÿ‰ª.

2287. mŠw‰ïn iˆê”Êu‰‰j š‹‰º‚É‚¨‚¯‚é㜉^“®‚Ì”N—î•Ï‰»i‘æ3•ñj. ‹àŽqŒ÷CΈä–L‘¾CŒ´“cGˆêCŒÃì_ŽOC‚‹´œAbCÝŠy“N–çiŽ¨•@jCV”ü¬“ñi“Œ‘åj: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‘‰ï (89.05.12), ‘åãC “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñC92(10): 1613, 1989.

2288. mŠw‰ïn iˆê”Êu‰‰j d“Ä‚ÈŒo‰ß‚ð‚½‚Ç‚Á‚½Œz•”Š´õǂɂ‚¢‚Ä. ˆäŒû–F–¾C’†ŽR–¾mC’·À‰p–¾CŒÃì_ŽOC‚‹´œAbiŽ¨•@j: ‘æ68‰ñ_“Þì’n•û•”‰ï (89.06.17), ¬“cŒ´.

2289. mŠw‰ïn iˆê”Êu‰‰j [Œz•”Š´õÇ. ˆäŒû–F–¾C’†ŽR–¾mCŒÃì_ŽOC‚‹´œAbCΈä–L‘¾iŽ¨•@j: ŒûoEˆô“ª‰ÈŠw‰ï (89.09.01), ‘åã, ŒûoEˆô“ª‰È, 2(1): 19, 1989.

2290. mŠw‰ïn iˆê”Êu‰‰j Œûo‚Ì”S‰t”X–E‚Ì—Õ°“IŒŸ“¢. ‚‹´œAbC“¿‘Œú“ñCÝŠy“N–çiŽ¨•@j: ŒûoEˆô“ª‰ÈŠw‰ï (89.09.01), ‘åã, ŒûoEˆô“ª‰È, 2(1): 32, 1989.

2291. mŠw‰ïn iˆê”Êu‰‰j •›ˆô“ªŠÔŒ„_ŒoâŽî‚ÌŒŸ“¢. ¼‰ª–¾—TC‚‹´œAbCŒ´“cGˆêCˆî–ØŸ‰pC•½ŽR•ûriŽ¨•@j: ŒûoEˆô“ª‰ÈŠw‰ï (89.09.01), ‘åã, ŒûoEˆô“ª‰È, 2(1): 48, 1989.

2292. mŠw‰ïn iˆê”Êu‰‰j ƒqƒgã‚Ì•a—‘gDŠw“IŒ¤‹†i”S–Œã”ç‚Ì”N—î•Ï‰»‚ð’†S‚Éj. ’†ŽR–¾mC”ª”ö˜a—YC‚‹´œAbCÝŠy“N–çCŒ´“cGˆêiŽ¨•@j: ŒûoEˆô“ª‰ÈŠw‰ï (89.09.01), ‘åã, ŒûoEˆô“ª‰È, 2(1): 55, 1989.

2293. mŠw‰ïn iˆê”Êu‰‰j 㪳’†•”‚É‚¨‚¯‚é‘B‘gD‚Ì•a—‘gDŠw“IŒ¤‹†. Š™“c—˜•FCŒ´“cGˆêC”ª”ö˜a—YC‚‹´œAbCÝŠy“N–çiŽ¨•@j: ŒûoEˆô“ª‰ÈŠw‰ï (89.09.01), ‘åã, ŒûoEˆô“ª‰È, 2(1): 56, 1989.

2294. mŠw‰ïn iˆê”Êu‰‰j Two Cases of Congenital Stapes Fixation with Sympha Langism. ‹àŽqŒ÷C‰ª–{˜NŽqCÝŠy“N–çiŽ¨•@j: 14th World Congres of Otorhinolaryngology Head and Neck Surgery (89.09.12), Madrid, 14th World Congres of Otorhinolaryngology Head and Neck Surgery, Abstracts, p.133.

2295. mŠw‰ïn iˆê”Êu‰‰j ãˆô“ªŠïŒ`Žî‚̈ê—á. ¼ŽRkˆê˜YC•½ŽR•ûrC’†‘º—vC‹àŽqŒ÷CŒÃ‘òTˆêC‰ª–{–qliŽ¨•@j: ‘æ69‰ñ_“Þì’n•û•”‰ï (89.09.30), ‘Š–ÍŒ´.

2296. mŠw‰ïn iˆê”Êu‰‰j Œûo”S–Œ•a•Ï‚ð’悵‚½–ò]‚̈êÇ—á. ”n‰z’q_CΈä–L‘¾C²–씣iŽ¨•@j: ‘æ69‰ñ_“Þì’n•û•”‰ï (89.09.30), ‘Š–ÍŒ´.

2297. mŠw‰ïn iˆê”Êu‰‰j SEPŒŸ¸‚É‚¨‚¯‚éŽü”g”“Á«. ’†‘º–LŽqC‹g–{gŽqi—ÕŒŸjC‘å’J‰pŽ÷i—Õ•a—j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 133, 1989.

2298. mŠw‰ïn iˆê”Êu‰‰j Cinefluorographic Analysis of Dysphagia. ŒÃì_ŽOCΈä–L‘¾CÝŠy“N–çC‹àŽqŒ÷iŽ¨•@j: ‘æ6‰ñ¢ŠE‹CŠÇH“¹‰ÈŠw‰ï (89.10.17), “Œ‹žC ‘æ6‰ñ¢ŠE‹CŠÇH“¹‰ÈŠw‰ï—\eW, p.70.

2299. mŠw‰ïn iˆê”Êu‰‰j Movement Pattern of the Hyoid Lione in the Swallowing and It's Aging. ‹àŽqŒ÷CΈä–L‘¾CŒÃì_ŽOCÝŠy“N–çCV”ü¬“ñiŽ¨•@j: ‘æ6‰ñ¢ŠE‹CŠÇH“¹‰ÈŠw‰ï (89.10.17), “Œ‹žC ‘æ6‰ñ¢ŠE‹CŠÇH“¹‰ÈŠw‰ï—\eW, p.72.

2300. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™‹}«â¿œ“´‰Š‚ÌŒŸ“¢. ¼‰ª–¾—Ti‰¡•lÔ\Žš•a‰@jCÝŠy“N–çC”ª”ö˜a—YiŽ¨•@j: “ú–{•@‰ÈŠw‰ï (89.10.20), ” ª.

2301. mŠw‰ïn iˆê”Êu‰‰j ƒqƒg•@’†Šu‚Ì‘gDŠw“IŒ¤‹†i‘æ2•ñj. ˆî–ØŸ‰pC”ª”ö˜a—YC‚‹´œAbCÝŠy“N–çiŽ¨•@j: “ú–{•@‰ÈŠw‰ï (89.10.20), ” ª.

2302. mŠw‰ïn iˆê”Êu‰‰j ‘å‹C‚̊‹«•Ï‰» 2.•@o’Ê‹C“x|‰·“x‚É‚æ‚é‰e‹¿i‘æ2•ñj|. ²–씣CΈä–L‘¾CV“cŒ[ŽŸ˜YC“¡–ì–¾lC¼’[TˆêiŽ¨•@j: “ú–{•@‰ÈŠw‰ï (89.10.21), ” ª.

2303. mŠw‰ïn iˆê”Êu‰‰j ƒnƒ“ƒgÇŒóŒQ‚Ì’®—ÍáŠQ‚ɂ‚¢‚Ä. ŒÃ‘òTˆêC•½ŽR•ûrC‰ª–{–qlCÝŠy“N–çiŽ¨•@j: “ú–{ƒI|ƒWƒIƒƒW|Šw‰ï (89.11.15), ˆ¤’m.

2304. mŠw‰ïn iˆê”Êu‰‰j ‚ß‚Ü‚¢‚Å”­•a‚µ‚½Creutzfeldt-Jakob•a‚Ì‚P—á. “¿‘Œú“ñC“¡–ì–¾lC‹g”ö’miŽ¨•@jC•Ä“c•qi¶•¨•¨—Œnj: “ú–{•½t_Œo‰ÈŠw‰ï (89.11.23), “Þ—Ç.

2305. mŠw‰ïn iˆê”Êu‰‰j A“ªBŠJ‚É‚æ‚é“û—cŽ™‚Ì‹C“¹‹·ó‚ÌŽ¡—Ã. –ö‘CŽÄè½C¬ìŽ“ñiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ71‰ñŽ¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŠwpu‰‰‰ï (90.03.03), “¡‘ò.

2306. mŠw‰ïn iˆê”Êu‰‰j Ž¨‰º‘BŽî’¯‚©‚çŽn‚Ü‚Á‚ÄL”Í‚ÈŒz•”‰óŽ€‚𗈂µ‚½1Ç—á. Š™“c—˜•FC“c‘ã’¼Ž÷C‰Í‡ƒˆê˜YiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ71‰ñŽ¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŠwpu‰‰‰ï (90.03.03), “¡‘ò.

2307. mŠw‰ïn iˆê”Êu‰‰j —¼‘¤“û–[‚É“¯Žž«‚É”­¶‚µ‚½”ñZ«“ûŠÇŠà‚Ì1—á. ²“¡ˆêŠìC’|’†°KC]“ª´“¿C•Ð“c‰Ä–çC‘êK‹ÏC¼ŽR•Û”äŒÃC–ØìŽOŽl˜YCˆäŒ´ŒúC¼ˆäŒ’CŠ“cç”ü”TCΓc˜a•viŠOjC‘åê³–¤iŠÅŒìŠw•”jC”äŠé ”\Ž÷iŠOjCŠâŸºŒ[ˆêi•a—j: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï i89.09.30), ‘Š–ÍŒ´, –k—¢ˆãŠw, 19(6): 642, 1989.

2308. mŒ¤‹†‰ïn i‹³ˆçu‰‰j Œz•”Žî’°‚ÆŽ¨•@ˆôA‰È|“úí—Õ°‚Å‚æ‚­‚Ý‚éæ“V«¥‰ŠÇ«”X–E«Ž¾Š³‚ɂ‚¢‚Ä|. ‚‹´œAbiŽ¨•@j: ‘æ3‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ïê–åˆãuK‰ï (89.11.19), –¼ŒÃ‰®, ‘æ3‰ñ“úŽ¨•@ê–åˆãuK‰ïŽ,@1989.

2309. mŒ¤‹†‰ïn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é“ûŠàŠÌ“]ˆÚ—á‚ÌŒŸ“¢. ’|’†°KCΓc˜a•viŠOjC‘åê³–¤iŠÅŒìŠw•”jC”äŠé”\Ž÷iŠOj: ‘æ50‰ñ“ûŠàŒ¤‹†‰ï i89.07.00), ŽD–y.

2310. mŒ¤‹†‰ïn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚鋹œÓƒŠƒ“ƒpß“]ˆÚ—z«—á‚ÌŒŸ“¢. ’|’†°KCΓc˜a•viŠOjC‘åê³–¤iŠÅŒìŠw•”jC”äŠé”\Ž÷CE“cÍiŠOj: ‘æ51‰ñ“ûŠàŒ¤‹†‰ï i90.02.00), ‘åã.

2311. mŒ¤‹†‰ïn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é•a—“ÁŽêŒ^“ûŠàÇ—á‚ÌŒŸ“¢. ’|’†°KCΓc˜a•viŠOjC‘åê³–¤iŠÅŒìŠw•”jC”äŠé”\Ž÷CE“cÍiŠOj: _“Þì“û‘Bbó‘BŒ¤‹†‰ï i90.03.00), ‰¡•l.


<<201 Š´õÇEŠñ¶’Ž>>

2312. mŒ´’˜n Studies on Effects of Paromomycin Sulphate, Bithionol, Mebendazole and Flubendazole in the Treatment of Mice Infected with Plerocercoids of Diphyllobothrium erinaei. –qƒC –ö‘ò\Žl’jiŠñj: Jpn. J. Trop. Med. Hyg., 17(3): 237`241, 1989.

2313. mŒ´’˜n —Žq”A“¹äNã÷‰ŠÇ—á‚ɑ΂·‚é7432-S‚Ì—p–@¥—p—Ê‚ÌŒŸ“¢. L£’‹»C‘呺´—²C‹g‰ª‘ôCŒF–{‰x–¾iŽD–yˆã‰È‘åjC‰¡ŽR‰p“ñi”åjC¼‘º¹Gi–kŒ©Ô\Žš•a‰@jC–{ŠÔº—YCŽO‘¶iˆ®ìÔ\Žš•a‰@jC‹{–{TˆêC “c‹{‚GC‚’ËŒcŽŸi»ìŽs—§•a‰@jC–سŽ¡CÄ“¡½ˆêC“ì•”–¾–¯i‹ú˜HÔ\Žš•a‰@jC–å–ì‰ë•vC‰ªŽRŒåi¬’M–k¶•a‰@jC‰Á“¡CŽ¢C’O“c‹ÏiŽOŽ÷‰ï•a ‰@jC“‡‘ººŒáC“c’‡‹I–¾CŽðˆä–ÎiŽD–y’üM•a‰@jC–Ø‘º•¶GCˆäì‹ÓŽsi—¤ãŽ©‰q‘àŽD–y’n‹æ•a‰@jC—ÑŒªŽ¡C‹{”ö‘¥bi‹ä’mˆÀŒú¶•a‰@jC]‰Ä’©¼CŠâ ‘ò»•Fi‰¤Žq‘‡•a‰@j: “ú–{‰»Šw—Ö@Šw‰ïŽ, 37(11°s1): 351`374, l989.

2314. mŒ´’˜n Possible Role of Streptococcus pyogenes in Mucocutaneous Lymph Node Syndrome ‡[. Immunological Tolerance to S. pyogenes-associated Antigens Seems Essential to Induction of MCLS. ‘å‘òLFi”÷jCŽR‰Y¸C’r˜eM’¼iŠÅŒìŠw•”jC”ª‘ãŒö•viŽ™jCHŽR•‹vi”÷j: Acta Paediatr. Jpn., 31(4): 462`468, 1989.

2315. mŒ´’˜n Possible Role of Streptococcus Pyogenes in Mucocutaneous Lymph Node Syndrome ‡\. Quantitation by ELISA of Streptococcal Pyrogenic Exotoxin in the Serum of MCLS Patients. ‰Í‡^‹|i—\–hˆãŠwŒnjC‘å‘òLFi”÷jCŽR‰Y¸C’r˜eM’¼iŠÅŒìŠw•”jC”ª‘ãŒö•vC•½Î‘iŽ™jCWatanabe M.i–kŒ¤jCHŽR•‹vi”÷j: Acta Paediatr. Jpn., 31(5): 529`536, 1989.

2316. mŒ´’˜n Comparative Efficacy of Flubendazole and Mebendazole on Encysted Larvae of Trichinella spiralis (USA strain) in the Diaphragm of Mice and Rats. –qƒC–ö‘ò\Žl’jiŠñj: J. Helminthol., 62(1): 35`39, 1988.

2317. mŒ´’˜n Chemotherapeutic Effects of Praziquantel, Niclosamide, Mebendazole and Bithionol on Larvae and Adults of Hymenolepis nana in Mice. –qƒC –ö‘ò\Žl’jiŠñj: Jpn. J. Parasitology, 38(4): 236`239, 1989.

2318. mŒ´’˜n Š´õǂɑ΂·‚郊ƒ|ƒ\|ƒ€••“üR¶Ü‚ÌŽ¡—ÃŒø‰Ê@3) ŽÀŒ±“I[Ý«ƒJƒ“ƒWƒ_Ç‚É‚¨‚¯‚郊ƒ|ƒ\|ƒ€••“üƒAƒ€ƒzƒeƒŠƒVƒ“B‚ÌŽ¡—ÃŒø‰Ê‚ÌŒŸ“¢. ùŒ´•Žui”÷j: Š´õÇŠwŽGŽ, 63(12): 1301`1307, 1990.

2319. mŒ´’˜n “à‘Ÿ^‹ÛÇ‚Ì”­Ç•a—‚ÉŠÖ‚·‚錤‹†|ˆÕŠ´õŽw”‚Ì—L—p«‚ɑ΂·‚é•]‰¿(1)|. –]ŒŽ^‹|C‘º£¨’ÃŽqC’©’·•¶–íi–òÜ•”jCÎìçŒbŽqC‹v•ÄŒõC‰œ•½‰ë•Fi•a—j: ^‹Û‚Æ^‹ÛÇC30(3): 160`172, 1989.

2320. mŒ´’˜n ƒXƒ|ƒƒgƒŠƒR|ƒVƒX‚Ì”­Ç•a—‚ÉŠÖ‚·‚錤‹†. ‚£FŽqCã–쌫ˆêi’}”g‘åjC‹v•ÄŒõi•a—j: “Œ‹ž—Žqˆã‰È‘åŠwŽGŽ, 59(8): 891`897, 1989.

2321. mŒ´’˜n •²––’ŽËÜ‚ÌŠeŽí—n‰ð–@‚É‚¨‚¯‚é”÷¶•¨‰˜õ‚ÌŽÀŒ±“IŒ¤‹†. Ύ˳‰pC“‡“cŽœ•Fi–òÜ•”j: •a‰@–òŠwC15(5): 359`364, 1989.

2322. mŒ´’˜n Ž‡ŠOüÆŽË‚É‚æ‚é—¬…‚Ö‚ÌŽE‹ÛŒø‰Ê‚Æ‚»‚ÌŽ‘±«‚ɂ‚¢‚Ä‚ÌŒ¤‹†. Ύ˳‰pi–òÜ•”jCHŽR•‹vi”÷j: –k—¢ˆãŠwC19(2): 235`245, 1989.

2323. m’Z•ñn ‚킪‘‚Ì“à‘Ÿ^‹ÛÇ‚Ì•a—Šw“IŒ¤‹†. ‰œ•½‰ë•Fi•a—j: •a‘Ô¶—, 8(1): 946`948, 1989.

2324. mÇ—á•ñn ‰E㉺Žˆ•s‘S–ƒáƒ‚ðŒ_‹@‚É”­Œ©‚³‚ꂽ‹‘å”]”^ᇂ̂P—á. ˆÀ•ÛŒ«ˆêCˆäŒ…^—R”üC‘åι–çCŠ`À—R•FCŒÃ“¡G—mCV’J®‹vCãp—z‘¾˜YiŽ™j: ‘Š–ÍŒ´ŽsˆãŽt‰ï•ñC302(1): 30`32, 1990.

2325. mÇ—á•ñn ŒuŒõR‘Ì•â‘Ì–@‹y‚Ñy‘fR‘ÌABC–@‚Åf’f‚µ“¾‚½ˆÝ”~“Å‚Ì2—á. ˆÉ“¡‹ÏC^‹ÊŽõ”ü¶C“¡ˆä•ÛŽ¡C¼–{ˆÌ’jC›’m–çC‰ª“c–LŽŸi“àjCŒÜŒŽ—–Îi‰º“s‰ê‘‡•a‰@jC•Ÿ“‡”ÍŽqi“¯ˆ¤‹L”O•a‰@j: “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 31(10): 2665`2669, 1989.

2326. m‘àn “à‘Ÿ^‹ÛÇ‚ÌŒ»‹µ‚Æ‘Îô|Šª“ªŒ¾. ‰œ•½‰ë•Fi•a—j: Progress in Medicine, 9(10): 2559`2560, 1989.

2327. m‘àn “à‘Ÿ^‹Ûǂɑ΂·‚éˆÕŠ´õ«‚Ì•]‰¿–@|–{Ç‚Ì‘Šúf’f‚ÉŽ‘‚·‚邽‚ß‚É|. ‹v•ÄŒõi•a—jC–]ŒŽ^‹|i–òÜj: Progress in Medicine, 9(10): 2581`2588, 1989.

2328. m‘àn “à‘Ÿ^‹Ûǂ̧‹š‚ÉŠÖ‚í‚é”–â‘è. ‹v•ÄŒõi•a—j: ƒ}ƒCƒRƒgƒLƒVƒ“, 29: 1`4, 1989.

2329. m‘àn ”畆‚ÉŠñ¶‚·‚éŠñ¶’ŽÇ‚ÌÅ‹ß‚Ì“®Œü. ˆÉ“¡—mˆêiŠñj: ˆãŠw‚Ì•à‚ÝC151(2): 91`94, 1989.

2330. m‘àn ŋߘb‘è‚ÌŠ´õ«•aŒ´”÷¶•¨|^‹Û. ‰œ•½‰ë•Fi•a—j: ŒŸ¸‚Æ‹Zp, 17(6): 559`562, 1989.

2331. m‘àn Š´õÇ‚Ì•a—Šw“IŒŸ¸–@. ‹v•ÄŒõC”©ŽRŒbŽqi•a—j: ŒŸ¸‚Æ‹Zp, 17(6): 706`711, 1989.

2332. m‘àn ”D•w‚¨‚æ‚ÑV¶Ž™‚ÌGBSŠ´õÇ‚Æ‚»‚Ì‘Îô. –åˆäL‹ÅCmŽu“c”ŽŽiiŽ™j: ŽY•wl‰È‚ÌŽÀÛC38(8): 1135`1139, 1989.

2333. m‘àn •êŽqŠ´õ‚Ìŋ߂̘b‘è| BŒQ—n˜A‹Û| –åˆäL‹ÅiŽ™jC•Û‰È´i“Œ‹ž—Žqˆã‘åj: ŽüŽYŠúˆãŠwC19(11): 1549`1553, 1989.

2334. m‘àn BŒQ—n˜A‹ÛŠ´õÇ‚ÌŒ»ó|‘æ2‰ñ‘S‘ƒAƒ“ƒP|ƒg’²¸Œ‹‰Ê|. •Û‰È´C—é–Ø—tŽqC“s‚à‚ÆŽqCŠC–ìŽõ”üi“Œ‹ž—Žqˆã‘åjC–åˆäL‹ÅCmŽu“c”ŽŽiiŽ™j: ¬Ž™‰È—Õ°C42(6): 1251`1255, 1989.

2335. m‘àn ^‹Û|•a—‚Ì—§ê‚©‚ç. ‰œ•½‰ë•FC‹v•ÄŒõi•a—j: ’_‚ÆäX, 10(7): 1089`1096, 1989.

2336. m‘àn ƒlƒp|ƒ‹‰¤‘‚ÌŠ´õÇ|Š´õÇŠî‘b’²¸’c‚Ì•ñ‚æ‚è|. ˆÉ“¡—mˆêiŠñj: ”M‘ÑC22: 83`88, 1989.

2337. m‘àn ƒRƒbƒz‚ÌPostulates‚Æìè•a‚ÌAŒQ—n˜A‹ÛŠ´õÇà ‡T) Germ Theory‚Ì•Ï‘J. ŽR‰Y¸iŠÅŒìŠw•”jCHŽR•‹vi”÷j: –k—¢ˆãŠw, 20(1): 1`5, 1990.

2338. m‘àn ƒRƒbƒz‚ÌPostulates‚Æìè•a‚ÌAŒQ—n˜A‹ÛŠ´õÇà ‡U)ìè•a‚ÍAŒQ—n˜A‹Û‚É‚æ‚銴õÇ‚Æl‚¦‚½‚¢. ŽR‰Y¸iŠÅŒìŠw•”jCHŽR•‹vi”÷j: –k—¢ˆãŠw, 20(1): 6`12, 1990.

2339. m‘àn [Ý«^‹ÛŠ´õÇ‚Ìf’f;@ŒŒ´Šw“If’f–@‚ÌŒ»ó. ‹v•ÄŒõCÎìçŒbŽqi•a—jCˆ¢•””ü’mŽqi—ÕŒŸj: —Õ°ˆã, 15(5): 552`555, 1989.

2340. muÀn Š´õ–hŽ~‚Æ‚»‚Ì—\–h‡@‹Nˆö”÷¶•¨‚¨‚æ‚ÑŠ´õŒo˜H. ¼“c—zi—Õ•a—j: NICUC3(3): 5`11, 1990.

2341. muÀn ^‹ÛŠ´õÇ‚Ìf’f‚ÆŽ¡—ÃiÅ‹ß‚ÌŽ‹“_‚æ‚èj. ‹v•ÄŒõi•a—jC´…Šì”ª˜Yi“Œ‹ž—Žqˆã‘åj: Today's Therapy '89, 13(3): 79`87, 1989.

2342. mŠwp‘n iŽ·•Mj Aspergillosis |ƒAƒXƒyƒ‹ƒMƒ‹ƒXÇ‚Æ‚»‚ÌŽü•Ó; ŽÀŒ±“I”xƒAƒXƒyƒ‹ƒMƒ‹ƒXÇ, p.38`45, ‹v•ÄŒõi•a—j. •ÒW ’r–{G—Yi‡‘åj•Ò, ‹¦˜aŠé‰æ’ÊM, “Œ‹ž, 89.11.30”­s.

2343. mŠwp‘n iŽ·•Mj Aspergillosis |ƒAƒXƒyƒ‹ƒMƒ‹ƒXÇ‚Æ‚»‚ÌŽü•Ó; “à‘ŸƒAƒXƒyƒ‹ƒMƒ‹ƒXÇ‚Ì”‘Š, p.78`82, ‰œ•½‰ë•FC‹v•ÄŒõi•a—j. •ÒW ’r–{G—Yi‡‘åj•Ò, ‹¦˜aŠé‰æ’ÊM, “Œ‹ž, 89.11.30”­s.

2344. mŠwp‘n iŽ·•Mj bˆãŠ´õ•aŠw; f’fCp.47`53C ›–ìN‘¥i–ƒ•z‘åjC“ŒŒ´–«i–kŒ¤jCŒ´“c—Ǻiƒtƒ@ƒCƒU|»–òjC‘å‘òLFi”÷jCŒ´Œ³éCŠÝ쳄i–ƒ•z‘åjC“n•Ó’‰’ji“Œ”_‘åjC“cŒû–MŽji”_… Èj. •ÒW ›–ìN‘¥i–ƒ•z‘åj•ÒC Œ[–¾o”Å, “Œ‹ž, 89.10.01”­s.

2345. m‹³‰È‘n iŽ·•Mj S—Óà‰ÈŠw; ‘ŸŠí•ÊŠ´õÇ, p.1098`1116, ”è’õ•vC”Ñ‘–í¶i“àj. •ÒW ˆ¢•”—TC‰–ì—Dˆê•Ò, ‹àŒ´o”Å, “Œ‹ž, 89.01.25”­s.

2346. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ƒ}ƒ‹ƒz”畆‰ÈƒZƒ~ƒi| No. 78; “ú–{‚Å‹ß”N’–Ú‚³‚ê‚é”畆‰È—̈æ‚ÌŠñ¶’ŽÇ, 78: 16`20, ˆÉ“¡—mˆêiŠñj. •ÒW ‹¦˜aŠé‰æ, ‘åã, 89.04.30.”­s.

2347. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj [Ý«^‹ÛÇ‚Ìf’f‚ÆŽ¡—Ã; ‰uŠw|–UŒŸ—á‚æ‚è|, p.1`16, ‰œ•½‰ë•Fi•a—j. •ÒW ã“c‘×iŽœŒbˆã‘åjC´…Šì”ª˜Yi“Œ‹ž—Žqˆã‘åj•Ò, ƒƒfƒBƒJƒ‹ƒWƒƒ|ƒiƒ‹ŽÐ, “Œ‹ž, 89.11.00”­s.

2348. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj [Ý«^‹ÛÇ‚Ìf’f‚ÆŽ¡—Ã; f’f|f’f‚̎臂ƌŒ´f’f|, p.25`38, ‹v•ÄŒõi•a—j. •ÒW ã“c‘×iŽœŒbˆã‘åjC´…Šì”ª˜Yi“Œ‹ž—Žqˆã‘åj•Ò, ƒƒfƒCƒJƒ‹ƒWƒƒ|ƒiƒ‹ŽÐ, “Œ‹ž, 89.11.00”­s.

2349. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn i•ÒWCŠÄCCŽ·•Mj ”÷¶•¨ŠwŽ«“T; ìã³–çi•ª¶j. •ÒW “ú–{”÷¶•¨Šw‹¦‰ï•ÒC ŠÄC ìã³–çi–k—¢‘åjC‘¼ŠÄCC ‹Z•ñ“°o”ÅŽÐ, 89.08.23”­s.

2350. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn iŽ·•Mj ”÷¶•¨ŠwŽ«“T; •úü‹ÛÇ,‘¼20€–Ú, ‰œ•½‰ë•Fi•a—j. •ÒW “ú–{”÷¶•¨Šw‰ï•ÒC ‹Z•ñ“°o”Å, “Œ‹ž, 89.08.00”­s.

2351. mŠw‰ïn iˆê”Êu‰‰j ‚ç‚¢‹Û‚̃}ƒEƒX‚̃}ƒNƒƒtƒ@|ƒW‚É‚¨‚¯‚é“®‘Ԃɂ‚¢‚Ä. ‘å‘òLFCHŽR•‹vi”÷jC¼‰ª³“Ti‘—§‘½–€Œ¤j: “ú–{‚ç‚¢Šw‰ï (89.04.00), ŒÃìC “ú–{‚ç‚¢Šw‰ïŽGŽC58(1): 51, 1989.

2352. mŠw‰ïn iˆê”Êu‰‰j Že‹ŒŒ´“Y‰Á‹y‚Ñ–³“Y‰Á”|—{‰t‚ɉ—‚¯‚é Dipetalonema viteae ¬’Ž‚̈ێ‚ÉŠÖ‚·‚錤‹†. –qƒC–ö‘ò\Žl’jiŠñjCPaul P. Weinstein iƒm|ƒgƒ‹ƒ_ƒ€‘åj: ‘æ58‰ñ“ú–{Šñ¶’ŽŠw‰ï‘å‰ï (89.04.03), “Œ‹žC Šñ¶’ŽŠwŽGŽC38(‘): 44,l989.

2353. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒ“ƒ\ƒ“ZŒŒ‹z’ŽŠ´õƒ}ƒEƒX‚ɑ΂·‚éHHH‚ÌŽ¡—ÃŒø‰Ê‹y‚ÑŽ¡—ÃŒã‚ÌELISAR‘̉¿‚Ì•Ï“®. “mŒRCˆÉ“¡—mˆêiŠñjC’·“c–[Žqi—\–hˆãŠwŒnj: ‘æ58‰ñ“ú–{Šñ¶’ŽŠw‰ï‘å‰ï (89.04.04), “Œ‹žC Šñ¶’ŽŠwŽGŽC38(‘): 93,l989.

2354. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒ“ƒ\ƒ“—ô“ªð’ŽƒvƒŒƒƒZƒ‹ƒRƒCƒh‚Ì’`”’•ª‰ðy‘f|Šˆ«•”ˆÊ‚ÌŒŸõ. ’†‘ºŒ’iŠñjC•–¾Žqi—\–hˆãŠwŒnjC–ö‘ò\Žl’jiŠñj: ‘æ58‰ñ“ú–{Šñ¶’ŽŠw‰ï‘å‰ï (89.04.04), “Œ‹žC Šñ¶’ŽŠwŽGŽC38(•â): 86,l989.

2355. mŠw‰ïn iˆê”Êu‰‰j •²––’ŽËÜ‚ÌŠeŽí—n‰ð–@iƒLƒbƒg»•i‚ðŠÜ‚Þj‚É‚¨‚¯‚é”÷¶•¨‰˜õ‚ÌŽÀŒ±“IŒ¤‹†i‘æ2•ñj“Á‚É’ŽËŠí‚̈Ⴂ‚ɂ‚¢‚Ä. Ύ˳‰pC“‡“cŽœ•FC‘¾“c‹v”üŽqC‰¡“cœÄˆêC‘哇”ü˜aŽqC‹àŽqCŽqC¬—Ñç—mŽqi–òÜ•”j: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.05), –¼ŒÃ‰®.

2356. mŠw‰ïn iˆê”Êu‰‰j AMPH‚Ì‘å—ÊŒoŒû“Š—^Œã‚Ì—¬ŒŒ’†ƒJƒ“ƒWƒ_RŒ´‚ÌÁ’·|“Š—^–@‚ÌÝ’è‚ÉŽ‘‚·‚邽‚ß‚É|. ÎìçŒbŽqC‹v•ÄŒõC‰œ•½‰ë•Fi•a—j: ‘æ63‰ñ“ú–{Š´õÇŠw‰ï‘‰ï (89.04.19), ·‰ªC Š´õÇŠwŽGŽC(—Õ‘): 85, 1989.

2357. mŠw‰ïn iˆê”Êu‰‰j “à‘Ÿ^‹ÛÇ‚Ì”­Ç•a—‚ÉŠÖ‚·‚錤‹†|”’ŒŒ•aŠ³ŽÒ‚É‚¨‚¯‚éˆÕŠ´õ«”»•ÊŽ®|. –]ŒŽ^‹|C‘º£¨’ÃŽqC’©’·•¶–íi–òÜ•”jC‹v•ÄŒõC‰œ•½‰ë•Fi•a—j: ‘æ63‰ñ“ú–{Š´õÇŠw‰ï‘‰ï (89.04.20), ·‰ªC Š´õÇŠwŽGŽ, 63(8): 958`959,1989.

2358. mŠw‰ïn iˆê”Êu‰‰j ”A—R—ˆ‚̗Δ^‹Û‚ÉŠÖ‚·‚錟“¢. ¼‘º´ŽuC{ŽRˆê•äC‰¡ŽR‰p“ñC’r“cŽ Cˆî—tŒbŽqC΋´Wi”åjC•½“c‘×—Çi—ÕŒŸj: ‘æ37‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (89.05.19), “Œ‹ž.

2359. mŠw‰ïn iˆê”Êu‰‰j ŒƒÇ‚ÈŒo‰ß‚ð‚Æ‚Á‚½–ƒ]‡•¹”DP‚Ì1—á. ¯“c—²C–ì“c–FlCA–ìM…C‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ260‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï (89.05.20), ‰¡•l.

2360. mŠw‰ïn iˆê”Êu‰‰j dÇŠ³ŽÒ‚É‚¨‚¯‚éƒQƒ“ƒ^ƒ}ƒCƒVƒ“‚Ì“Š—^–@‚ÌŒŸ“¢. ’†‘º‹±ŽqC‹ß“¡—¯”üŽqi–òÜ•”jC¬—Ñ–¾–Fi“àjC’©’·•¶–íi–òÜ•”jC‘å˜a“c—²i‹~–½j: ‘æ16‰ñ“ú–{W’†Ž¡—Êw‰ï (89.06.07`10), ˆ®ì.

2361. mŠw‰ïn iˆê”Êu‰‰j Recent status of group B streptococcus infection in Japan. •Û‰È´C—é–Ø—tŽqCKobayashi, M.CŠC–ìŽõ”üi“Œ—ˆã‘åjC–åˆäL‹ÅiŽ™j: 19th International Congress of Pediatrics (89.07.25), Paris, 19th ICP abstract, p.200, 1989.

2362. mŠw‰ïn iˆê”Êu‰‰j Cryptococcus neoformans ‚ÌŒŒ´Œ^•Ê‚ÉŠÖ‚·‚錟“¢. ÎìçŒbŽqi—ÕŒŸjC’†“ˆ”ü‹IC‹v•ÄŒõC‰œ•½‰ë•Fi•a—jCˆ¢•””ü’mŽqi—ÕŒŸj: ‘æ33‰ñ“ú–{ˆã^‹ÛŠw‰ï‘‰ï (89.09.22), ‰«“ê, ´˜^WCp.101, 1989.

2363. mŠw‰ïn iˆê”Êu‰‰j Œ¢ƒNƒŠƒvƒgƒRƒbƒNƒXÇ‚É‚¨‚¯‚錌´’†‚ÌRŒ´‰¿‚Ì„ˆÚ. â–{‹žŽqC‘¼iH–òƒZƒ“ƒ^|jC‹v•ÄŒõi•a—j: ‘æ33‰ñ“ú–{ˆã^‹ÛŠw‰ï‘‰ï (89.09.22), ‰«“ê, ´˜^WCp.89, 1989.

2364. mŠw‰ïn iˆê”Êu‰‰j “à‘Ÿ^‹ÛÇ‚Ì”­Ç•a—‚ÉŠÖ‚·‚錤‹†|”’ŒŒ•aŠ³ŽÒ‚É‚¨‚¯‚éˆÕŠ´õ«”»•ÊŽ®‚Ì•]‰¿i‘æ2•ñj|. –]ŒŽ^‹|C‘º£¨’ÃŽqC’©’·•¶–íi–òÜ•”jCÎìçŒbŽqC‹v•ÄŒõC‰œ•½‰ë•Fi•a—j: ‘æ33‰ñ“ú–{ˆã^‹ÛŠw‰ï‘‰ï (89.09.22`23), ‰«“êC ´˜^W, p.75, 1989.

2365. mŠw‰ïn iˆê”Êu‰‰j ˆ««Žîᇂɂ¨‚¯‚郿2 Macroglobulin‚Ì•s‹Ïˆê«‚Æ‚»‚ÌŽY¶‚ÉŠÖ‚·‚錟“¢. ‚èŒõ‹Ii—Õ•a—jCŽsìŒbŽqC‘åŠÑ—TŽqi‘‡—Õ°ŒnjC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 74, 1989.

2366. mŠw‰ïn iˆê”Êu‰‰j ìè•a‚Æ‹Û‘ÌŠO“Å‘f:Œ´ˆö‚ɘA‚È‚éƒzƒXƒtƒ@ƒ`ƒaƒ‹¥ƒCƒmƒVƒg|ƒ‹CƒzƒXƒzƒŠƒp|ƒ[C(PLC),IgMƒvƒƒeƒA|ƒ[Šˆ«RŒ´‘¼‚ÌŒ¤‹†“WŠJ‚ɂ‚¢‚Ä. ‘å’Ép“ñiŽ™jC–{ŠÔDC¬—Ñ–M•FC“¡‘ò—Ï•FCŒõ‰ª’m‘«C¯–ì‰x˜Y: ‘æ62‰ñ“ú–{׋ۊw‰ïŠÖ“Œ’n•ûŽx•”‘‰ï (89.10.13), …ã, “ú–{׋ۊw‰ïŽGŽ, 45(2): 600, 1990.

2367. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒ“ƒ\ƒ“—ô“ªð’ŽƒvƒŒƒƒZƒ‹ƒRƒCƒh‚ÌŽ_«pH—̈æ‚É‚¨‚¯‚鎩ŒÈ•”•ª—Z‰ðŒ»Û ’†‘ºŒ’iŠñjC•–¾Žqi—\–hˆãŠwŒnjC–ö‘ò\Žl’jiŠñj: ‘æ59‰ñ“ú–{Šñ¶’ŽŠw‰ï“Œ“ú–{‘å‰ï (89.10.25), “Œ‹ž, u‰‰—vŽ|, p.28, 1989.

2368. mŠw‰ïn iˆê”Êu‰‰j ƒpƒLƒXƒ^ƒ“‰ñ‹³‹¤˜a‘‚É‚¨‚¯‚銴õÇ‚ÌŒ»‹µ. ˆÉ“¡—mˆêiŠñjC‘]“cŒ¤“ñCŽs콈êC–Ø‘º´ŽŸi‰¡•lŽs‘åjC•½–ì˜ii’é‹ž‘åj: ‘æ48‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (89.10.26), ’}”g, “ú–{ŒöO‰q¶Šw‰ïŽ, 36(10): 284, l989.

2369. mŠw‰ïn iˆê”Êu‰‰j ’°‰Š‹ÛŠ´õ‚É‚æ‚Á‚Ä—U“±‚³‚ê‚é• oZo×–E‚Ì”«ó‚̉ðÍ. ùŒ´•ŽuC’†—¢˜a”üC‹Ê“àGˆêi”÷jC’r˜eM’¼CŽR‰Y¸iŠÅŒìŠw•”jC‘å‘òLFCHŽR•‹vi”÷j: ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ï (89.11.14), ŽD–yC “ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^C19: 484, 1989.

2370. mŠw‰ïn iˆê”Êu‰‰j Dipetalonema viteae ¬’Ž‚Ì’·Šú‚ɂ킽‚鎎Œ±ŠÇ“àˆÛŽ‚ÉŠÖ‚·‚錤‹†. –qƒiŠñj: ‘æ31‰ñ“ú–{”M‘шãŠw‰ï‘‰ï (89.11.18), –¼ŒÃ‰®, “ú–{”M‘шãŠw‰ïŽGŽ, 17(‘): 43, l989.

2371. mŠw‰ïn iˆê”Êu‰‰j ƒpƒLƒXƒ^ƒ“‰ñ‹³‹¤˜a‘‚ÌŠñ¶’ŽÇ. ˆÉ“¡—mˆêiŠñjC‘]“cŒ¤“ñCŽs콈êC–Ø‘º´ŽŸi‰¡•lŽs‘åjC•½–ì˜ii’é‹ž‘åj: ‘æ31‰ñ“ú–{”M‘шãŠw‰ï‘‰ï (89.11.19), –¼ŒÃ‰®, “ú–{”M‘шãŠw‰ïŽGŽ, 17(‘): 86, l989.

2372. mŠw‰ïn iˆê”Êu‰‰j ƒ\ƒPƒCƒwƒ‹ƒjƒAªŽ¡pŒã‚É”­¶‚µ‚½äNã÷ŽüˆÍ‰ŠÇ«“÷‰èŽî‚Ì1—á. ´…rŽŸC‘ò‘º³”VC¬“c“‡–M’jC’†‘ºGi”åj: ‘æ35‰ñ–h‰q‰q¶Šw‰ï (90.02.07`08), “Œ‹ž.

2373. mŠw‰ïn iˆê”Êu‰‰j Ý‘îlHŒÄ‹zŠí—Ö@‚ł̌ċzŠí‰ñ˜H‚Ì׋ۉ˜õ‚ÌŒŸ“¢. Ύ˳‰pi–òÜ•”jCŽO‰YNŽ¡i—ÕŒŸjC‰Z¶LˆêiMEƒZƒ“ƒ^[jC‚“ˆ‰Á‘ãŽqC‰““¡MŽqiŠÅŒì•”jC“c‹{^Žqi‘‡‘Š’kjC–Ø“¡‹žŽqiŠÅŒì•”jCדc –«CÄ“¡–L˜ai“àjC”·—EŽŠi—ÕŒŸjC“àŽRKMi—Õ•a—jC“‡“cŽœ•Fi–òÜ•”jC“n•Ó•qi–ƒj: ‘æ5‰ñ“ú–{ŠÂ‹«Š´õŠw‰ï (90.02.09), “Œ‹ž.

2374. mŠw‰ïn iˆê”Êu‰‰j ìè•aŠ³ŽÒ‚É‚¨‚¯‚éR‘ÌŽY¶”\‚̈Ùí‚Æ–{•a‚ÌAŒQ—n˜A‹ÛŠ´õÇà. HŽR•‹vC‘å‘òLFC‹v•Û“cFˆêi”÷jCŽR‰Y¸iŠÅŒìŠw•”j: ‘æ63‰ñ“ú–{׋ۊw‰ï‘‰ï (90.03.27), “¿“‡C “ú–{׋ۊwŽGŽC45(1): 167, 1990.

2375. mŠw‰ïn iˆê”Êu‰‰j ƒVƒNƒƒXƒ|ƒŠƒ“A‚Ì’°‰Š‹ÛŠ´õÇ‚É‹y‚Ú‚·Œø‰Ê‚ÌŒŸ“¢. ’†—¢˜a”üCùŒ´•ŽuC‹Ê“àGˆêi”÷jC’r˜eM’¼CŽR‰Y¸iŠÅŒìŠw•”jC‘å‘òLFCHŽR•‹vi”÷j: ‘æ63‰ñ“ú–{׋ۊw‰ï‘‰ï (90.03.28), “¿“‡C “ú–{׋ۊwŽGŽC45(1): 318, 1990.

2376. mŠw‰ïn iˆê”Êu‰‰j ŽÀŒ±“IƒTƒ‹ƒ‚ƒlƒ‰Ç‚ÌŒ¤‹†CŠ´Žó«Œn‚Æ’ïR«Œnƒ}ƒEƒX‚Ì”äŠr‚ɂ‚¢‚Ä. ‘å‘òLFi”÷jC¬ŽR“à—mŽqi—\–hˆãŠwŒnjCùŒ´•ŽuCHŽR•‹vi”÷j: ‘æ63‰ñ“ú–{׋ۊw‰ï‘‰ï (90.03.28), “¿“‡C “ú–{׋ۊwŽGŽC45(1): 319, 1990.

2377. mŠw‰ïn iˆê”Êu‰‰j dÇ”sŒŒÇŠ³Ž™‚Å‚Ì Vancomycin ‚ÌŽg—pŒoŒ±iŒŒ’†”Z“xƒ‚ƒjƒ^ƒŠƒ“ƒO‚Ì•K—v«‚ɂ‚¢‚Äj. ŠÖª“OCŠ—Œ´FC–åˆäL‹ÅC¬ŒûO‹BC”ª‘ãŒö•viŽ™jC¼“c—zi—Õ•a—jC‹gŽR—F“ñi–òŠw•”jC‚‹´‰Á‘ãŽqi—ÕŒŸjC‹ß“¡—¯”üŽqC–]ŒŽ^‹|i–òÜj: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï i89.07.04), ‘å‹{.

2378. mŠw‰ïn iˆê”Êu‰‰j ìè•aŽ™‚æ‚è“ÁˆÙ“I‚É•ª—£‚³‚ꂽƒ¿—nŒŒ«×‹Û‚ÌŽå‚Æ‚µ‚Ķ‰»Šw“I«ó‚ɂ‚¢‚Ä. ‘å’Ép“ñiŽ™jC²“¡ŽOçŽqC¯–ì‰x˜YC‘ê‘ò‹àŽŸ˜YC“¡‘ò—Ï•FCŒõ‰ª’m‘«C¡‘º–ÎsC¶“c–Î: ‘æ63‰ñ“ú–{׋ۊw‰ï‘‰ï i90.03.29), “¿“‡, “ú–{׋ۊw‰ïŽGŽ, 45(1): 463, 1990.

2379. mŒ¤‹†‰ïn i“Á•Êu‰‰j ‘gD“àŠñ¶^‹Û‚Ì aging ‚ɂ‚¢‚Ä. ‰œ•½‰ë•Fi•a—j: ‘æ3‰ñç—t^‹ÛŠ´õÇŒ¤‹†‰ï (88.07.16), ç—t, ‘æ3‰ñç—t^‹ÛŠ´õÇŒ¤‹†‰ï‹L˜^W, p.47`56, 1989.

2380. mŒ¤‹†‰ïn i“Á•Êu‰‰j [Ý«^‹ÛÇ‚ÌŒ»ó|‚»‚Ìf’f‚ÆŽ¡—Ã|. ‹v•ÄŒõi•a—j: ‘啪ˆãŽt‰ï (89.07.26), ‘啪.

2381. mŒ¤‹†‰ïn i“Á•Êu‰‰j “à‘Ÿ^‹ÛÇ‚Ì‘gDf’f. ‰œ•½‰ë•Fi•a—j: ‘æ27‰ñ_“Þìˆã^‹Û’k˜b‰ï (90.02.10), ‰¡•l.

2382. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ”D•w‚̃EƒCƒ‹ƒXŠ´õ. “‡“cMGiŽY•wj: ‘æ2‰ñŽÀ’nˆã‰Æ‚Æ•ŽY•w‚Ì‚½‚ß‚ÌŽüŽYŠúƒZƒ~ƒi[ (89.07.30), ŽD–y.

2383. mŒ¤‹†‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj RŒ´ŒŸoŒn‚É‚¨‚¯‚郉ƒeƒbƒNƒX‹ÃW”½‰ž. ‹v•ÄŒõi•a—j: ‘æ10‰ñŠÖ“Œ’n•û^‹Û§˜b‰ï (89.06.03), “Œ‹ž.

2384. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‰E㉺Žˆ•s‘S–ƒáƒ‚ðŒ_‹@‚É”­Œ©‚³‚ꂽ‹‘å”]”^ᇂ̂P—á. ˆÀ•ÛŒ«ˆêCˆäŒ…^—R”üC‘åι–çCŠ`À—R•FCŒÃ“¡G—mCV’J®‹vCãp—z‘¾˜YiŽ™j: ‘æ129‰ñ‘Š–ÍŒ´Žs¬Ž™‰Èˆã‰ïŒŽ—᧘b‰ï (89.00.00), ‘Š–ÍŒ´.

2385. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹É¬–¢nŽ™‚É‚¨‚¯‚éƒNƒ‰ƒ~ƒWƒAƒgƒ‰ƒRƒ}ƒ`ƒXR‘Ì‚ÌŒŸ“¢. –åˆäL‹ÅCÄ“¡KˆêiŽ™jC¼“c—zCâ“Œ—R‹Ii—Õ•a—jC‚‹{t’ji—ÕŒŸj: ‘æ7‰ñƒNƒ‰ƒ~ƒWƒAŒ¤‹†‰ï (89.04.18), ·‰ª, —Õ°‚ƃEƒCƒ‹ƒX, 17(32): 366, l989.

2386. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒ‰ƒ€ƒ[ƒCƒnƒ“ƒgÇŒóŒQ‚Ì’®—Í‘œ. ŒÃ‘òTˆêCÝŠy“N–çC‰ª–{–qlC•½ŽR•ûriŽ¨•@j: Œú¶È“Á’莾Š³‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ1‰ï‘‰ï (89.08.12), “Œ‹ž.

2387. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”A—R—ˆƒOƒ‰ƒ€—z«•s’èž…‹Û‚ɂ‚¢‚Ä. ¼‘º´ŽuC’r“cŽ C΋´WCˆî—tŒbŽqi”åjC‘å‘òLFi”÷j: _“Þ슴õÇŒ¤‹†‰ï (89.09.09), ‰¡•l.

2388. mŒ¤‹†‰ïn iˆê”Êu‰‰j ìè•aŠ³ŽÒ‚ÅŠÏŽ@‚³‚ê‚éˆÙí‚ÈR‘ÌŽY«”\‚̬ˆö‚ð’T‚é. HŽR•‹vC‘å‘òLFi”÷jC”ª‘ãŒö•viŽ™j: ‘æ9‰ñ“ú–{ìè•aŒ¤‹†‰ï (89.10.27), ‰F“s‹{.

2389. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”A—R—ˆ‚ÌCitrobacter‘®‚ɂ‚¢‚Ä. ¼‘º´ŽuC’r“cŽ Cˆî—tŒbŽqC΋´Wi”åjC•½“c‘×—Çi—ÕŒŸjC‘å‘òLFi”÷j: ‘æ27‰ñ_“Þ쌧Š´õÇŒ¤‹†‰ï (90.02.03), ‰¡•l.

2390. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”’ŒŒ•aŠ³ŽÒ‚É‚¨‚¯‚éˆÕŠ´õ«”»•ÊŽ®‚Ì—L—p«‚ÉŠÖ‚·‚錤‹†. M‰ª”ü»ŽqC–]ŒŽ^‹|C‰Á‰ê’J”£C‘º£¨’ÃŽqC’©’·•¶–íi–òÜ•”jC“¿O‰p¶C‰–’J–ÎC“¡–ì—R”üCŒÃ’J—²CŽR‰º‚¦‚èŽqi“àjCÎìçŒbŽqC‹v•ÄŒõC‰œ•½‰ë •Fi•a—j: ‘æ27‰ñ_“Þ쌧Š´õÇŒ¤‹†‰ï (90.02.10). ‰¡•l.

2391. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒ}ƒ“ƒ\ƒ“ZŒŒ‹z’ŽŠ´õƒ}ƒEƒX‚ð—p‚¢‚½ hybridoma ‚ÌŒ`¬ó‹µ. ˆÉ“¡—mˆêiŠñjC’·“c–[Žqi—\–hˆãŠwŒnjC–ö‘ò\Žl’jiŠñj: “ú•ÄˆãŠwŠñ¶’Ž•”‰ï (90.02.24), “Œ‹ž.

2392. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŽŽŒ±ŠÇ“à”|—{‚É‚æ‚èƒ~ƒNƒƒtƒBƒ‰ƒŠƒAŽY¶”\‚̒ቺ‚µ‚½ Dipetalonema viteae ¬’Ž‚̃XƒiƒlƒYƒ~‚ւ̈ÚA‚É‚æ‚é‰ñ•œ. –qƒC–ö‘ò\Žl’jiŠñjCPaul P. Weinstein iƒm|ƒgƒ‹ƒ_ƒ€‘åj: “ú•ÄˆãŠwŠñ¶’Ž•”‰ï (90.02.24), “Œ‹ž.

2393. mŒ¤‹†‰ïn iŒöŠJuÀj ƒlƒp|ƒ‹‰¤‘‚ÌŠ´õÇ‚ÌŒ»ó. ˆÉ“¡—mˆêiŠñj: ‘æ2‰ñŒú¶ÈˆÏ‘õŒ¤C‰ï (89.07.27), “Œ‹ž.


<<202 V¶•¨>>

2394. mŒ´’˜n Cessation of Autonomous Proliferation of Mouse lymphoma EL4 by Fusion with a T Cell line. ‹v•Û“cFˆêi”÷jC‰Á“¡GŽ÷iŽÀ’†Œ¤j: Int. J. CancerC45(3): 540`545, 1990.

2395. mŒ´’˜n Use of Nude Mice in Experimental Neutron Caputure Therapy With 10B-BPA. Norikazu Tamaokii“ŒŠC‘åjCMasato Uedai_ŒË‘åjC‹Ê“àGˆêi”÷jCKumiko Yamamotoi“ŒŠC‘åjCYutaka Mishimai_ŒË‘åj: Pigment Cell Research, 2: 343`344, 1989.

2396. mŒ´’˜n Šà‚̉摜f’f‚É‚¨‚¯‚éV‚µ‚¢“WŠJ; –ƉuŠjˆãŠwŒŸ¸|RI•WŽ¯ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì (96.5, ZME-018) ‚É‚æ‚鈫«•FŽî‚̃Cƒ[ƒWƒ“ƒO‚ð’†S‚É|. Έ䟌Èi•újC¼ŽR–Εvi”çjC¬ŽR“c“ú‹gŠÛiŠàŒ¤jC‰““¡Œ[Œái‹ž‘åj: Šà‚Ɖ»Šw—Ö@, 16(4): 1194`1203, 1989.

2397. mŒ´’˜n CastlemanƒŠƒ“ƒpŽî‚Ì‘gDŠw“IŒŸ“¢. ’·À‰p–¾iŽ¨•@jC£ì²‹vi‰ðjC¼ŽRkˆê˜YC‹g”ö’mC‰ª–{–qliŽ¨•@jCŽR‰È³•½i‰ðjC‚‹´œAbiŽ¨•@j: Ž¨•@ˆôA‰È—Õ°C82(12): 1757`1765, 1989.

2398. mŒ´’˜n –k—¢‘åŠw•a‰@‚É‚¨‚¯‚铪Œz•”‚ª‚ñ‚Ì“Œv“IŠÏŽ@@‘æ1•ñ@13”NŠÔ‚Ì‚ª‚ñ‚ÌŽÀ‘Ô’²¸‚æ‚è. ‚‹´œAbC‰ª–{–qlC”ª”ö˜a—YiŽ¨•@jC‹T’J“Oi•a—j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰ÈC61(12): 1107`1111, 1989.

2399. mŒ´’˜n ˆ««Žîᇂɔº‚¤ƒ¿2 Macroglonbulin‚Ì•s‹Ïˆê«‚Æ‚»‚ÌŽY¶‚ÉŠÖ‚·‚錤‹†. ‚èŒõ‹IC‘å’J‰pŽ÷i—Õ•a—j: ¶•¨•¨—‰»Šw, 33(4): 87`94, 1989.

2400. mŒ´’˜n ‚—î‚ÌŠàŠ³ŽÒ‚ɑ΂·‚鎡—ÃŽwj|•Û‘¶Ž¡—Â̈ӎ¯|. ‚‹´œAbiŽ¨•@j: “ªŒz•”Žîá‡, 15(1): 6`10, 1988.

2401. mŒ´’˜n bó‘BŽîᇂ̗հ“IŒŸ“¢|—×Ú‘ŸŠí‚ÉZ‚µ‚½ˆ««Žîᇂð’†S‚É|. ’†ŽR–¾mCˆî–ØŸ‰pCŒ´“cGˆêCŒÃì_ŽOC”ª”ö˜a—YC‰ª–{–qlC‚‹´œAbiŽ¨•@j: “ú‹CH‰ï•ñC40(5): 431`437, 1989.

2402. mÇ—á•ñn Œ´”­«‘O“ª“´Šà‚Ì2Ç—á. Š™“c—˜•FC‚‹´œAbC‰ª–{–qlC”ª”ö˜a—YCˆî–ØŸ‰pC’†ŽR–¾liŽ¨•@j: Ž¨•@ˆôA‰È—Õ°, 82(9): 1259`1264, 1989.

2403. m‘àn ˜Vl‚̈««Žîá‡;Ž¡—Â̒ˆÓ‚ƎЉ‹A. ‚‹´œAbiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È MOOK, 12: 293`300, 1989.

2404. m‘àn Šà«áu’É¥Žèp—Ö@‚Ì“K‰ž‚ÆŒÀŠE. ‚‹´œAbiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È, 61(10): 819`821, 1989.

2405. m‘àn ˆ««ƒŠƒ“ƒpŽî‚ɑ΂·‚駊àÜ‚Ì‘I‘ð. ”ª”ö˜a—YC‰ª–{–qlC‚‹´œAbiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È, 62(3): 197`201, 1990.

2406. m‘àn ˆ««Žîá‡f’f‚Ìi•à; ŠjˆãŠwŒŸ¸–@. Έ䟌Èi•új: —Õ°¬l•a, 19(11): 1857`1864, 1989.

2407. m–|–ón iŽ·•Mj ƒKƒ“ˆâ“`Žq‚̉ð–¾; ƒEƒCƒ‹ƒX‚É‚æ‚é”­ƒKƒ“iR. ƒ_ƒ‹ƒxƒRj, p.6`17, ‘ –{”ŽsiŽY•wj. •ÒW ”¨’†³ˆêi‹ž‘åj•Ò, “úŒoƒTƒCƒGƒ“ƒX, “Œ‹ž, 89.06.23 ”­s.

2408. mŠw‰ïn iƒpƒlƒ‹j ˆÝŒ´”­ Immature teratoma ‚Ì1“ûŽ™—á. Œ´^lC‰Í‘º½ŽŸCŽl‘q³”ŽC^“º‘¾˜YC“‡–{—R‹IŽqiŽ™jCΓc˜a•viŠOjCŠâŸºŒ[ˆêi•a—j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (89.05.20), VŠƒ.

2409. mŠw‰ïn iƒpƒlƒ‹j ‹}‘¬‚È‘‘å‚ð‚Ý‚½‰EŒ¨ŠÖß•”Žîá‡. V’Ã’J^li“àjCŠâŸºŒ[ˆêC‹T’J“Oi•a—j: “ú–{®Œ`ŠO‰ÈŠw‰ïœ¥“î•”ŽîᇊwpW‰ï (89.07.22), •Ÿ‰ª, “ú®‰ïŽ, 53(6): S841, 1989.

2410. mŠw‰ïn iˆê”Êu‰‰j Ò‘Lipoma‚Ì‚P“ûŽ™—á. ¯–ì–r•vC²“¡‰ë•FCŒ´^lCŽl‘q³”ŽC“‡–{—R‹IŽqiŽ™j: ‘æl78‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þì’n•û‰ï (89.04.15), ‰¡•l.

2411. mŠw‰ïn iˆê”Êu‰‰j Acid Soluble Glycoproteins in Malignancies. ‘å’J‰pŽ÷i—Õ•a—jC¬o’©’ji–k—¢ƒ‰ƒ{j: ‘æ13‰ñ‘Û—Õ°•a—Šw‰ï (89.05.19), ƒtƒ|ƒŒƒ“ƒX.

2412. mŠw‰ïn iˆê”Êu‰‰j ŠÌ×–EŠà‚¨‚æ‚Ñ‚»‚Ì—ÞŽ—•a•Ï‚̉摜‰ðÍ“IŒv‘ª“IŒ¤‹†. –{‹´ˆèŽqC‚ˆä’qŽqC‹àŽq‘C‘å•”½C‰œ•½‰ë•Fi•a—j: ‘æ25‰ñŠÌ‘ŸŠw‰ï (89.06.01), ‹à‘ò, ŠÌ‘Ÿ, 30(Suppl.): 87, 1989.

2413. mŠw‰ïn iˆê”Êu‰‰j V‚µ‚¢“ûƒKƒ“Žîᇃ}|ƒJ|:ƒ€ƒ`ƒ“—l“œ’`”’‚Ì—Õ°“IˆÓ‹`‚ɂ‚¢‚Ä. “àŽRKMC“n•Ó—Ç•FC‚èŒõ‹IC‘å’J‰pŽ÷i—Õ•a—jCˆêŽç‰À‘ãŽqC•xŠ~˜a”üC{“¡–F³iƒuƒŠƒXƒgƒ‹j: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï (89.09.30), ‘Š–ÍŒ´C –k—¢ˆãŠw, 19(6): 642, 1989.

2414. mŠw‰ïn iˆê”Êu‰‰j V‚µ‚¢“ûŠàŽîᇃ}|ƒJ|Cƒ€ƒ`ƒ“—l“œ’`”’(CA M26, CA M29) ‚Ì—Õ°“I—L—p«‚ɂ‚¢‚Ä. “àŽRKMC“n•Ó—Ç•FC‚èŒõ‹IC‘å’J‰pŽ÷i—Õ•a—jC–{ŠÔÕvC‰v“c’å•Fi“Œ‹ž’üM•a‰@jC“n•”™PC•“c”Ž”Vi]“Œ•a‰@jCˆêŽç‰À‘ãŽqC•xŠ~˜a”üC{“¡–F ³iƒuƒŠƒXƒgƒ‹j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 296, 1989.

2415. mŠw‰ïn iˆê”Êu‰‰j “ûŠà‘gDDNA‚É‚¨‚¯‚éŠàˆâ“`Žq‘•‚ÉŠÖ‚·‚錟“¢. –î—R‰ÀC’·’JìºC“c‘ò—TŒõC–Ø•½FŽ¡i–k—¢ƒ‰ƒ{jCät“n’‰’jC‘å’J‰pŽ÷i—Õ•a—jC’|’†°KCΓc˜a•vC‘åê³–¤iŠOj: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 69, 1989.

2416. mŠw‰ïn iˆê”Êu‰‰j ŠÌ×–EŠà‹y‚Ñ‚»‚Ì—ÞŽ—•a•Ï‚̉摜‰ðÍ‚É‚æ‚é‘gDŒv‘ª“IŒ¤‹† (2). –{‹´ˆèŽqC‚ˆä’qŽqC‹àŽq‘C“n•Ó´Ž¡C‘å•”½C‰œ•½‰ë•Fi•a—j: ‘æ24‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (89.10.21), ’·–ì, ŠÌ‘Ÿ 30(Suppl.2): 113, 1989.

2417. mŠw‰ïn iˆê”Êu‰‰j Superoxide Dismutase—lŠˆ«‚ð’æ‚·‚éƒNƒŒƒXƒ`ƒ“‚Ì•ªŽq\‘¢‹y‚ÑSOD—lŠˆ«‚ð‚µ‚ß‚·BRM‚ɂ‚¢‚Ä. ’†‘º‘‰qC’†“‡—mˆêi•ª¶j: ‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï (89.10.23), –¼ŒÃ‰® C —\eW, p.2091, 1989.

2418. mŠw‰ïn iˆê”Êu‰‰j ˆ««ƒŠƒ“ƒpŽî‚É‚¨‚¯‚éT×–ERŒ´Žó—e‘Ì”­Œ»‚ÌŒŸ“¢. Š}ˆäŒ‰i•a—jC˜a“c’m‰vi—Õ•a—jC¬–ì‰ë•vi•ª¶jC‹T’J“Oi•a—j: ‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï (89.10.24), –¼ŒÃ‰®, “ú–{ŠàŠw‰ï‘‰ï‹LŽ–, p.329, 1989.

2419. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒEƒXƒŠƒ“ƒpŽî‚ÆRŒ´ˆË‘¶«T×–EŠ”‚Æ‚Ì×–E—Z‡‚É‚æ‚éŽîᇑB‚Ì’âŽ~. ‹v•Û“cFˆêi”÷jC‰Á“¡GŽ÷iŽÀ’†Œ¤j: ‘æ48‰ñ“ú–{ŠàŠw‰ï (89.10.24), –¼ŒÃ‰®C “ú–{ŠàŠw‰ï‘‰ï‹LŽ–C48: 112, 1989.

2420. mŠw‰ïn iˆê”Êu‰‰j Glomus Jugulare Tumors in Japan. “¿‘Œú“ñC“¡–ì–¾liŽ¨•@j: ‡T. Symposium fur Scull Base Surgery (89.10.25), Berlin, ‡T. Symposium fur Scull Base Surgery Abastracts, 1989.

2421. mŠw‰ïn iˆê”Êu‰‰j ˆ««Žîᇂɂ¨‚¯‚é•›bó‘Bƒzƒ‹ƒ‚ƒ“ŠÖ˜A’`”’(PTHrP)ˆâ“`Žq”­Œ». ˜a“c’m‰vi—Õ•a—jCŽsìŒbŽqi‘‡—Õ°ŒnjCät“n’‰’jC‘å’J‰pŽ÷i—Õ•a—jCŠ}ˆäŒ‰i•a—j: ‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï (89.10.25), –¼ŒÃ‰®C ‘‰ï‹LŽ–, p.253, 1989.

2422. mŠw‰ïn iˆê”Êu‰‰j •›tœ‘Ž‰–bŽî‚Ì1—á. {ŽRo•äC“à“c–LºC–{“c’¼NCŒàŠ²ƒC‘v¬_CÝŠy•q–çCŒÃ”¨½”VC‰¡ŽR‰p“ñC‰““¡’‰—YC΋´WC¬ŽÄŒ’i”åj: ‘æ466‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï (89.12.07), “Œ‹ž.

2423. mŠw‰ïn iˆê”Êu‰‰j ˆÝŠà‚ð‡•¹‚µ‚½äNã÷Šà‚Ì1—á. ÝŠy•q–çCŒÃ”¨½”VCŒàŠ²ƒC“ü]Œ[C“à“c–LºC΋´WC¬ŽÄŒ’i”åj: ‘æ1‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï (90.02.17), ‰¡•l.

2424. mŠw‰ïn iˆê”Êu‰‰j Œûo“à‚É”­¶‚µ‚½Verrcous Carcinoma‚Ì2Ç—á. ’·À‰p–¾C¬–ì—YˆêC”ª”ö˜a—YC‰ª–{–qlC‚‹´œAbiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ71‰ñŽ¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŠwpu‰‰‰ï (90.03.03), “¡‘ò.

2425. mŠw‰ïn iˆê”Êu‰‰j ‹H‚È㪕”ŽîáŽ|œ‘gD«‚Ì1—á|. ‰iˆä_ŒÈC‹àŽqŒ÷C‚‹´œAbiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ71‰ñŽ¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŠwpu‰‰‰ï (90.03.03), “¡‘ò.

2426. mŠw‰ïn iˆê”Êu‰‰j A“ªŠà‚Ì•úŽËü‰»Šw—Ö@“¯Žž•¹—p‚̬Ñ. ‚‹´œAbC”ª”ö˜a—YC‰ª–{–qliŽ¨•@j: “ú–{A“ª‰ÈŠw‰ï (90.03.23), “Œ‹ž.

2427. mŠw‰ïn iˆê”Êu‰‰j A“ª”’F•a•Ï‚Ì—Õ°‘œ‹y‚Ñ‘gDŠw“IŒŸ“¢. ‹àŽqŒ÷CŒÃì_ŽOC‚‹´œAbiŽ¨•@j: “ú–{A“ª‰ÈŠw‰ï (90.03.23), “Œ‹ž.

2428. mŠw‰ïn iˆê”Êu‰‰j ŒûoG•½ã”çŠà×–E‚ɑ΂·‚郂ƒmƒNƒ|ƒiƒ‹R‘Ì‚Ìì» i‡Uj–Ɖu“dŒ°‚É‚æ‚éŠÏŽ@. ªŠÝ–¾Gi“Œ‹žˆãŽ•‘åjC‘¼C£ì²‹vi‰ðj: ‘æ31‰ñŽ•‰ÈŠî‘bˆãŠw‰ï i89.09.01), “¿“‡C Ž•‰ÈŠî‘bˆãŠw‰ïŽGŽC3l(•â): 68, l989.

2429. mŠw‰ïn iˆê”Êu‰‰j Von Rocklinghausen •a‚ɇ•¹‚µ‚½ã‰º•”ŽîᇂÌ1—á. –쑺ƒŽqCŠâèŒ\ŽqC‘º¼GŽ÷C–xŒû‘דTC“‡–{—R‹IŽqiŽ™jC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ181‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þì’n•û‰ï i89.11.18j, ‰¡•l.

2430. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ò’ÅŠÇ“àŽ‰–bŽî‚Ì1—á. Žl‘q³”ŽC¯–ì–r•vCŒ´^lC“‡–{—R‹IŽqC”ª‘ãŒö•viŽ™jCí”ՉÈêC‹kŽ ‘i”]ŠOjC–x’rdŽ¡i•új: ‘æ22‰ñ“ú–{¬Ž™•úŽËüŒ¤‹†‰ï (89.05.11), ‰z’JC “ú–{¬Ž™•úŽËüŒ¤‹†‰ïŽGŽ, 5(2): 56`57, 1989.

2431. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠÌ×–EŠà‚̉摜‰ðÍ‚É‚æ‚é×–EŒv‘ª“IŒ¤‹†|“Á‚ÉŠO‰ÈØœ—á‚Æ–UŒŸ—á‚É‚¨‚¯‚é·‚ÌŒŸ“¢. –{‹´ˆèŽqC‚ˆä’qŽqC‹àŽq‘C‘å•”½C‰œ•½‰ë•Fi•a—j: ‘æ25‰ñ“ú–{ŠÌŠàŒ¤‹†‰ï (89.05.31), ‹à‘ò.

2432. mŒ¤‹†‰ïn iˆê”Êu‰‰j Diethylstilbesterol Phosphate‚É‹Nˆö‚·‚é‚Æl‚¦‚ç‚ꂽ‰©át‚𔺂¤ŠÌ‹@”\áŠQ‚ð’悵‚½‘O—§‘BŠàstage D2‚Ì1—á. ŒüˆäLÆC“¡–ì’WlCÝŠy•q–çCŒàŠ²ƒC’†ðO—²C‰¡ŽR‰p“ñC‰““¡’‰—YC΋´WC¬ŽÄŒ’i”åj: ‘æ6‰ñ_“Þì‘O—§‘BŽîᇌ¤‹†‰ï (89.07.08), ‰¡•l.

2433. mŒ¤‹†‰ïn iˆê”Êu‰‰j Šî’ê–ŒŒ`¬‚ð”F‚ß‚½ƒqƒg‘å’°Šà—R—ˆ×–EŠ”‚ÌŽ÷—§ ’†‰p’ji•a—jCŽR‰º˜a–çC“n•Óˆê]i“Œ•a‰@•a—•”j: ‘æ7‰ñƒqƒg×–EŒ¤‹†‰ï (89.08.29), “Œ‹ž.

2434. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒqƒg‘å’°Šà—R—ˆ×–EŠ”‚ÌŽ÷—§‚Æ«ó. ŽR‰º˜a–çi“Œ•a‰@•a—jC’†‰p’ji•a—jC“n•Óˆê]i“Œ•a‰@•a—j: ‘æ7‰ñƒqƒg×–EŒ¤‹†‰ï‘å‰ï (89.08.29), “Œ‹ž, Human Cell, 2(3): 41, 1989.

2435. mŒ¤‹†‰ïn iˆê”Êu‰‰j ˆÝ”Õ“à‰¡–ä‹Ø“÷Žî‚Ì1’jŽ™—á. Œ´^lC^“º‘¾˜YC”Ñ‚Šì‹v—YiŽ™jC‘º“cWˆê˜Yi•újC¡ˆä’‰˜Ni•a‰@•a—jC‘å•”½i•a—j: ‘æ23‰ñ“ú–{¬Ž™•úŽËüŒ¤‹†‰ï (89.09.27), –¼ŒÃ‰®.

2436. mŒ¤‹†‰ïn iˆê”Êu‰‰j Žîᇃ}|ƒJ|EPFKƒeƒXƒgE‚Æ’S‚ª‚ñ¶‘Ì‘¤‚Ì“œ‘ãŽÓ•Ï’²‚Æ‚Ì‹¤’Ê—vˆöEHydrogenn Ionic Stress (HIS)E‚ɂ‚¢‚Ä. ’†‘º‘‰qi•ª¶jC–쌳‚¯‚¢Žqi¶•¨‰»ŠwŒnjC’†“‡—mˆêi•ª¶j: ‘æ9‰ñŽîᇃ}|ƒJ|Œ¤‹†‰ï (89.10.22), –¼ŒÃ‰® C —\eW, p.B24, 1989.

2437. mŒ¤‹†‰ïn iˆê”Êu‰‰j “÷Šá“IŒŒ”A‚ðŒ_‹@‚É”­Œ©‚³‚ꂽ Renal cell carcinoma ‚Ì‚P’jŽ™—á. ‘º¼GŽ÷Cדc‚Ì‚¼‚ÝC“‡–{—R‹IŽqiŽ™jCΓc˜a•viŠOjC–x’rdŽ¡i•újCŠâŸºŒ[ˆêi•a—j: ‘æ5‰ñ“ú–{¬Ž™‚ª‚ñŒ¤‹†‰ï i89.11.28j, “Œ‹žC —\eW, p.70, 1989.


<<203 ‰ŠÇEƒAƒŒƒ‹ƒM[E–ƉuEäPŒ´•a>>

2438. mŒ´’˜n Anticardiolipin Antibody in Henoch-Schoenlein Purpura and Related Vascular Disorders. •ÐŽRˆê˜NC‘‘òŠ²’jC¼‰ª´C¼ŽR–Εvi”çj: Arch. Dermatol. Res., 281: 296`298, 1989.

2439. mŒ´’˜n Evidence for the Involvement of a Plasma Kallikrein-Kinin System in the Immediate Hypotension Produced by Endotoxin in Anaesthetized Rats. Ž­ŽæMC”n“ˆ³—²CR. Odoi-Adomei–ò—jCN. Sunaharai‘å“ú–{»–òjC“à“c‘×Oi’†ŠO»–òj: Br. J. Pharmacol., 98: 1383`1391, 1989.

2440. mŒ´’˜n Relative Strength of the Mitogenic and Interleukin-2-production-inducing Activities of Staphylococcal Exotoxins Presumed to be Causative Exotoxin of Toxic Shock Syndrome: Toxic Shock Syndrome Toxin-1 and Enterotoxins A, B and C to Murine and Human T Cells. Uchiyama, T.CKamagata, K.i“Œ‹ž—Žqˆã‘åjCYan, X-J.CKawachi, A.CFujikawa, H.CIgarashi, H.C‘å‹v•Û[li“àj: Clin. exp. Immunol., 75: 239`244, 1989.

2441. mŒ´’˜n Modulation of Plasma Exudation by PGE2 and That of Leukocyte Migration by LTB4 in Inflammatory Models. Ž­ŽæMCŒ´“c–FÆCã–ìWŒ›C”n“ˆ³—²C¬“c—²Ž¡C쑺“¹Žqi–ò—j: Dermatologica, 179(Suppl.): 60`63, 1989.

2442. mŒ´’˜n Activation of Human T Cells by Toxic Shock Syndrome Toxin-1: The Toxin-Binding Structures Expressed on Human Lymphoid Cells Acting as Accessory Cells are HLA Class ‡U Molecules. “àŽR’|•FC¡¼Œ’ˆêCÄ“¡T“ñCr–¾”ü“ÞŽqCŠÞ¬Œ†C“¡ì_CŒÜ\—’‰p•vi“Œ—ˆã‘åjC‰Á“¡GlC¬”¦•¶–íC”–Ø“oiˆÚA–ƉujC’–Žq‰pri“ŒŠC‘åj: Eur. J. Immunol., 19: 1803`1809, 1989.

2443. mŒ´’˜n Development of CD4+CD8+ Cells in Athymic Nude Mice. ‹Ê“àGˆêi”÷jCNorikazu TamaokiCSonoko Habui“ŒŠC‘åj: Immune-Deficient Animals in Experimental Medicine, 6: 102`106, 1989.

2444. mŒ´’˜n Two Distinct Subtypes of the HLA-DRW12 Haplotypes in the Japanese Population Detected by Nucleotide Sequence Analysis and Oligonucleotide Genotyping. ˆ¢•”Í•vi–kŒ¤jCˆÉ“Œˆê˜YC‘å‹v•Û‚Ý‚Ç‚èi—\–hˆãŠwŒnjC‹àŽq„‹vCˆÉ“¡IˆêC‰Á“¡GlC”–Ø“oC¬”¦•¶–íiˆÚA–Ɖuj: ImmunogeneticsC30: 422`426, 1989.

2445. mŒ´’˜n Neonatal Lupus Erythematosus with a High Anticardiolipin Antibody Titer. •ÐŽRˆê˜NC‹ß“¡Ž •vCì–¼½ŽiC¼‰ª´C¼ŽR–Εvi”çj: J. Am. Acad. Derm., 21(3): 490`492, 1989.

2446. mŒ´’˜n Annular Erythema Associated with Primary Sjogren Syndrome: Analysis of T Cell Subsets in Cutaneous Infiltrates. •ÐŽRˆê˜NCóˆär–íC¼‰ª´C¼ŽR–Εvi”çj: J. Am. Acad. Derm., 21(6): 1218`1221, 1989.

2447. mŒ´’˜n Dietary Maline Lipids Suppress Murine Autoimmune Disease. Robinson, D.R.(Massachusetts General Hospital)CŠÚ–샶i“àjCKnoell, C.COlesiak, W.CXu, L.CHirai, A.CGuo, M.CColvin, R.B.(Massachusetts General Hospital): J. Intern. Med., 225(Suppl.): 211`216, 1989.

2448. mŒ´’˜n Lipid Mediators of Inflammatory and Immune Reactions. Robinson, D.R.(Massachusetts General Hospital)CŠÙ–샶i“àjCPatel, B.CHirai, A.(Massachusetts General Hospital): J. Parenter. Enteral. Nutr., 12(Suppl. 6): 37S`42S, 1988.

2449. mŒ´’˜n Production and Characterization of A Human Monclonal Antibody Recognizing A New Antigen Expressed on Some Lymphoid Cells. ’r˜eM’¼iŠÅŒìŠw•”jC‹Ê“àGˆêi”÷jCŽR‰Y¸iŠÅŒìŠw•”jC‚‹´œAbiŽ¨•@jC’–Žq‰pri“ŒŠC‘åj: Jpn. J. Cancer Res., 81: 153`160, 1990.

2450. mŒ´’˜n Low Responsiveness of Lymphocytes from Normal Individuals against the Stimulation with Pokeweed Mitogen. ät“n’‰’jCâ“Œ—R‹IC‘å’J‰pŽ÷i—Õ•a—j: Kitasato Arch. Exp. Med., 62(2-3): 133, 1989.

2451. mŒ´’˜n Dietary Maline Lipids after the Course of Autoimmune Disease. Robinson, D.R.(Massachusetts General Hospital)CŠÚ–샶i“àjCPatel, B.CHirai, A.(Massachusetts General Hospital): Prog. Clin. Biol. Res., 282: 295`303, 1988.

2452. mŒ´’˜n Oligonucleotide-Genotyping as a Method of Detecting the HLA-DR2 (DRW15)-DW2, -DR2 (DRW15)-DW12, -DR4-DW15, and -DR4-DgKT2h Haplotypes in the Japanese Population. ¬”¦•¶–íiˆÚA–ƉujCˆÉ“Œˆê˜Yi—\–hˆãŠwŒnjC‹àŽq„‹viˆÚA–ƉujC‘å‹v•Û‚Ý‚Ç‚èi—\–hˆãŠwŒnjCA.L.IshimotoiˆÚA–ƉujCˆ¢•”Í•v i–kŒ¤jC”–Ø“oiˆÚA–Ɖuj: Tissue AntigensC33: 550`558, 1989.

2453. mŒ´’˜n Immunosuppressive Mode of Action of Deoxyspergualin in Mice, as Compared with Cyclosporine A and Mizoribine. ‘å‹v•Û[li“àjC^è‹`•FiŽÀ“®ŒnjCŠ™“cvŽõC²“¡’¼”VCˆäãŒcˆêC”~’J’¼Ž÷i“àj: Transpl. Proc., 21: 1085`1087, 1989.

2454. mŒ´’˜n ƒCƒk‚Ì‘gD“K‡«RŒ´‚Æt“¯ŽíˆÚA‚ÉŠÖ‚·‚錤‹†|Microlymphocytotoxicity Test ‚É‚æ‚éDLA‰ðÍ|. ¡ˆä‹M”üŽqC‰Æ“c˜a•vCó–ì—F•FC‚”ö‰ë–çC¬“c“‡–M’jC“¡‰ªr•vC‘ºˆäŸC’†‘ºGC¬—ÑŒ«Cˆ¢“¡‚Ý‚âŽqi–h‰qˆã‘åjC“n•”_“ñiˆÚA–ƉujC‘å‹v•Û‚Ý‚Ç ‚èi—\–hˆãŠwŒnj: ˆÚAC24(4): 376`380, 1989.

2455. mŒ´’˜n Clq Solid-Phase EIA ‚ð—p‚¢‚½Circulating Immune Complex (CIC) ‚Ì‘ª’è‚ÉŠÖ‚·‚é—Õ°“I—L—p«‚ÌŒŸ“¢|Šî‘b“IŒŸ“¢C‚È‚ç‚Ñ‚É•a‘Ô‚É‚¨‚¯‚é•Ï“®. ”«‘º˜a’jC–F“cvi—ÕŒŸjC‘å’J‰pŽ÷C‚èŒõ‹Ii—Õ•a—j: Šî‘b‚Æ—Õ°, 23(4): 5629`5638, 1989.

2456. mŒ´’˜n Œz•”ƒŠƒ“ƒpߌ‹Šj‚Ì—Õ°“Œv“IŒŸ“¢. ’†ŽR–¾mC”ª”ö˜a—YC‰ª–{–qlC‚‹´œAbiŽ¨•@j: Ž¨•@ˆôA‰È—Õ°C82(6): 871, 1989.

2457. mŒ´’˜n Yeast glucan“Š—^‚É‚æ‚郉ƒbƒg”牺‘gD‚¨‚æ‚уŠƒ“ƒpß“à“÷‰èŽîŒ`¬‚ÉŠÖ‚·‚é‘gDŠw“I‚È‚ç‚Ñ‚É“dŽqŒ°”÷‹¾“IŒ¤‹†. Šâè‰ëi”çj: H“cˆãŠwC16(2): 415`439, 1989.

2458. mŒ´’˜n Sjogren ÇŒóŒQ‚̔畆Çó‚Æ‚»‚Ì—Õ°“IŒŸ“¢. •ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(6): 717`723, 1989.

2459. mŒ´’˜n ƒ‰ƒeƒbƒNƒX‹ÃW–@‚É‚æ‚錌´ƒŠƒEƒ}ƒ`ˆöŽq‘ª’è‚ÌŠî‘b“IŒŸ“¢|COBAS MIRA‚ւ̉ž—p|. ÷ˆäŒc‘¢C”·—EŽŠi—ÕŒŸjC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—j: “ú–{—Õ°ŒŸ¸Ž©“®‰»Šw‰ï‰ïŽ, 13(6): 741`745, 1988.

2460. mŒ´’˜n äPŒ´•a‚É‚¨‚¯‚éRƒrƒƒ“ƒ`ƒ“R‘ÌARƒTƒCƒgƒPƒ‰ƒ`ƒ“R‘Ì‚Æ‚»‚Ì—Õ°“IˆÓ‹`. —é–Ø‹M”ŽC‹ß“¡Œ[•¶C”è’õ•vi“àj: “ú–{—Õ°–ƉuŠw‰ï‰ïŽ, 12: 184`191, 1989.

2461. mŒ´’˜n ”DP¥oŽY‚Ì‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚É‹y‚Ú‚·‰e‹¿. –k‘º–’mŽqC‰ª“cƒC‹ß“¡Œ[•¶C”è’õ•vi“àj: “ú–{—Õ°–ƉuŠw‰ï‰ïŽ, 12: 302`310, 1989.

2462. mŒ´’˜n ¬‡«Œ‹‡‘gD•a‚É‚¨‚¯‚é”xüˆÛÇ‚ÆR×–EœŠiR‘Ì. —é–Ø‹M”ŽC‹ß“¡Œ[•¶C”è’õ•vi“àj: “ú–{—Õ°–ƉuŠw‰ï‰ïŽ, 12: 623`629, 1989.

2463. mŒ´’˜n Piroxicam‚É‚æ‚éŒÅ’è–ò]:ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚ÌŒo‰ß’†‚ɶ‚¶Subacute cutaneous lupus erythematosus (SCCE) —l‚Ì‘œ‚ð’悵‚½Ç—á. •ÐŽRˆê˜NC’|èLˆê˜YC¼‰ª´C¼ŽR–Εvi”çj: ”畆C31(‘6): 21`24, 1989.

2464. mŒ´’˜n ƒƒCƒRƒgƒŠƒGƒ“‚̃‰ƒWƒIƒCƒ€ƒmƒAƒbƒZƒC–WŠQ•¨Ž¿‚ÌŠÈ•Ö‚Èœ‹Ž–@‚ÌŒŸ“¢‚Æ‚»‚̶‘ÌŽŽ—¿‚ւ̉ž—p. ã–ìWŒ›i–ò—jC²X–ØK“ñi“àjCŽ­ŽæMi–ò—j: –k—¢ˆãŠw, 19(3): 327`335, 1989.

2465. mŒ´’˜n –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒ”A’†‚̃Cƒ“ƒ^[ƒƒCƒLƒ“1(IL-1)•À‚Ñ‚ÉIL-1—}§Šˆ«. ‘O“c’å‘¥CÔ¯“§C”è’õ•vi“àj: –k—¢ˆãŠw, 19: 246`253, 1989.

2466. mŒ´’˜n ¬Ž™‹CŠÇŽxšb‘§Š³ŽÒ‚Ì––½ŒŒƒŠƒ“ƒp‹…‚É‚¨‚¯‚éFc‚ƃŒƒZƒvƒ^|‚ÌŒŸ“¢|Flow Cytometry, “ñdŒuŒõõF–@‚É‚æ‚é‰ðÍ. â“Œ—R‹ICät“n’‰’jC‘å’J‰pŽ÷i—Õ•a—j: —Õ°•a—, 37(4): 397`400, 1989.

2467. m’Z•ñn A Site of Action of Dexamethasone on Leukocyte Extravasation in Microcirculation. Ž­ŽæMC¬“c—²Ž¡i–ò—jC‰iˆäˆê¬i–ƒj: Agents and Actions, 29(1/2): 24`26, 1990.

2468. m’Z•ñn A Significant Role of Plasma Kallikrein-Kinin System in Plasma Exudation of Rat Carrageenin-Induced Pleurisy. Ž­ŽæMC”n“ˆ³—²CŒ´“c–FÆCã–ìWŒ›i–ò—j: Kinins, V(Part A): 137`144, 1989.

2469. m’Z•ñn Mechanism of Bradykinin-Induced Nociceptive Response. Ž­ŽæMCS. YongC”n“ˆ³—²Cã–ìWŒ›i–ò—j: Kinins, V(Part A): 255`259, 1989.

2470. m’Z•ñn Degradation of Hageman Factor by Chymotrypsin-Like Protease Released from Rat Mast Cells during Degranulation. ”n“ˆ³—²i–ò—jC’J‹`•Fi®ŠOjCŽ­ŽæMi–ò—j: Kinins, V(Part A): 487`492, 1989.

2471. m’Z•ñn Inhibition Mechanism of Dexamethasone in Leukocyte Extravasation in Hamster Cheek Pouch. ¬“c—²Ž¡CŽ­ŽæMi–ò—j: Microcirculation Annual 1989, p.27`28, 1989.

2472. mŒ¤‹†•ñn ‹­”çÇ‚É‚¨‚¯‚é‘«‚wüŠŒ©‚Ì—Õ°“IˆÓ‹`. ”è’õ•vCã“cŠ°”VCÔ¯“§i“àj: º˜a63”N“x“ÁŽêŽ¾•ai“ï•aj‚ÉŠÖ‚·‚錤‹†•ñ‘, p.76`82, 1989.

2473. mŒ¤‹†•ñi•¶•”Èjn •a‘Ô‚É‚¨‚¯‚郃CƒRƒgƒŠƒGƒ“—Þ‚Ì–ðŠ„‚Æ5°ƒŠƒ|ƒLƒVƒQƒi|ƒ[‘jŠQ–ò‚ÌŽ¡—Âւ̉ž—p. Ž­ŽæMCŒ´“c–FÆC“à“c‘×OCã–ìWŒ›C”n“ˆ³—²C¬“c—²Ž¡C쑺“¹ŽqC¼ŽR˜a’ji–ò—j: º˜a61`63”N“x•¶•”ȉȊwŒ¤‹†”ï•â•‹àiˆê”Ê(B)jŒ¤‹†•ñ‘, p.1`31, 1989.

2474. mŒ¤‹†•ñi•¶•”Èjn ”÷¬zŠÂ‚©‚ç‚Ý‚½‘ŸŠízŠÂ‘½Œ`Šj”’ŒŒ‹…‚ÌŒŒŠÇŠO—V‘–‹@˜‹y‚Ñ”S–ŒáŠQ. Ž­ŽæMi–ò—j: º˜a63”N“x•¶•”ȉȊwŒ¤‹†”ï“Á’茤‹†uŒŒŠÇ‘ãŽÓvuŒŒŠÇ‚Ì×–E¶•¨Šw“I•ªŽq¶•¨Šw“I•À‚Ñ‚É‘ãŽÓŠw“IŒ¤‹†v, p.307`309, 1989.

2475. mŒ¤‹†•ñi•¶•”Èjn NSAID‚Ìì—p‹@˜. Ž­ŽæMi–ò—j: º˜a63”N“x•¶•”ȉȊwŒ¤‹†”ï“Á’茤‹†˜a•¶˜_•¶W‡UuŒŒŠÇ‚Ì×–E¶•¨Šw“IC•ªŽq¶•¨Šw“I‚È‚ç‚Ñ‚É‘ãŽÓŠw“IŒ¤‹†v, p.158`166, 1989.

2476. mŒ¤‹†•ñi•¶•”Èjn ‰ŠÇƒ‚ƒfƒ‹‚É‚¨‚¯‚郃fƒCƒG|ƒ^|‚ÌŽžŠÔŒo‰ß‚ƶ‘ÌŒ°”÷‹¾‚É‚æ‚鑽Œ`Šj”’ŒŒ‹…ŒŒŠÇŠO—V‘–‚̉ðÍ. Ž­ŽæMCŒ´“c–FÆCã–ìWŒ›C¬“c—²Ž¡C”n“ˆ³—²C쑺“¹Žqi–ò—j: •¶•”ȉȊwŒ¤‹†”(B)º˜a63”N“xŒ¤‹†•ñ‘C×–EC•ªŽqƒŒƒxƒ‹‚Ì‹@\‚ðŠî‘b‚É‚µ‚½Mediator‚̉ŠÇƒ‚ƒfƒ‹‚É‚¨‚¯‚鑇“I‰ðÍ |Mediator‚ÌŽžŠÔŒo‰ß‚Æ‘ŠŒÝì—p‚̉ðÍ, p.10`13, 1989.

2477. mŒ¤‹†•ñiŒú¶Èjn ‹­”çÇ‚É‚¨‚¯‚é”xüˆÛÇ‚Ì—Õ°“IŒ¤‹†1: —Õ°‘œ‚ÆŒŸ¸¬Ñ. ‹ß“¡Œ[•¶C‚•i®ÆC—é–Ø‹M”ŽC”è’õ•vi“àj: Œú¶È“Á’莾Š³‹­”çÇ’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.133`136, 1989.

2478. mŒ¤‹†•ñiŒú¶Èjn ‹­”çÇ‚É‚¨‚¯‚é”xüˆÛÇ‚Ì—Õ°“IŒ¤‹†2: ”xüˆÛÇ‚Ì„ˆÚ. ‹ß“¡Œ[•¶C‚•i®ÆC—é–Ø‹M”ŽC”è’õ•vi“àj: Œú¶È“Á’莾Š³‹­”çÇ’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.137`141, 1989.

2479. mŒ¤‹†•ñiŒú¶Èjn MCTD‚Ì—Õ°Œo‰ß‚ÌŒŸ“¢i“–‰È‚ÅŒoŒ±‚µ‚½15—á‚ɂ‚¢‚Äj. ‹ß“¡Ž •vC‘¾“cK‘¥C“”I^—CŽ›–{”ÍŽqC•ÐŽRˆê˜NC‰q“¡ŒõC㑺m•vCVˆätŽ}C¼‰ª´C¼ŽR–Εvi”çj: Œú¶È“Á’莾Š³‹­”çÇ’²¸Œ¤‹†”Ç•½¬Œ³”N“xŒ¤‹†•ñ‘, 1989.

2480. mÇ—á•ñn Boop‚ªæs‚µ‚½–«ŠÖ߃ŠƒEƒ}ƒ`‚Ì1—á. –쑺³¢C—Ñ”ü’ÃŽ}CÎìÍC—é–ØŒúC–î“ߣM—YC‰ª“cƒC”è’õ•vi“àj: ŠÖ“ŒƒŠƒEƒ}ƒ`|‹»–¡‚ ‚éÇ—á‚Æ‚»‚Ì–â‘è“_, ‘æ22W, p.183`190, 1989.

2481. mÇ—á•ñn ‹¹–Œ‰Š‚ð‡•¹‚µ‚½SLE‚Ì1—á. ‰ª“cƒi“àj: ‘Š–ÍŒ´ŽsˆãŽt‰ï•ñ, 289: 1`4, 1989.

2482. mÇ—á•ñn ƒXƒŠƒ“ƒ_ƒbƒN‚É‚æ‚è—U”­‚³‚ꂽ–³‹Û«‘–Œ‰Š‚Ì1—á. “à“cŒ›Cã“cŠ°”VC‹ß“¡Œ[•¶C”è’õ•vi“àj: “ú–{—Õ°–ƉuŠw‰ï‰ïŽ, 12: 178`183, 1989.

2483. mÇ—á•ñn “Á”­«–å–¬ˆ³˜´iÇ‚ð‡•¹‚µ‚½‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚Ì1—á. —é–ØŒúC‚•i®ÆC‰ª“cƒC‹ß“¡Œ[•¶i“àjC‘å•”½i•a—jC”è’õ•vi“àj: “ú–{—Õ°–ƉuŠw‰ï‰ïŽ, 12: 668`674, 1989.

2484. m—Õ°Ž¡Œ±n ‘Sg«‹­”çÇ‚¨‚æ‚Ñ—Þ‰Ž¾Š³‚É”º‚¤ã•”Á‰»ŠÇÇó‚ɑ΂·‚éƒtƒ@ƒ‚ƒ`ƒWƒ“iƒKƒXƒ^[j‚ÌŽ¡—ÃŒø‰Ê‚ÌŒŸ“¢. •ÐŽRˆê˜NC“”I^—CŽ›–{”ÍŽqCVˆätŽ}C‰q“¡ŒõC¼‰ª´C¼ŽR–Εvi”çj: Prog. Med., 9: 1380`1385, 1989.

2485. m‘àn –Ɖu‚ÌŠî‘b,HLARŒ´‚Ì–ðŠ„. ”–Ø“oiˆÚA–Ɖuj: Clinical Neuroscience, 7(2): 133`137, 1989.

2486. m‘àn V‚µ‚¢Ž¡—Öò¥Ž¡—Ö@|Methotrexate. ã“cŠ°”VCÔ¯“§C”è’õ•vi“àj: Medical Practice, 6: 1109`1111, 1989.

2487. m‘àn ³‚µ‚¢Ž¡—Öò‚ÌŽg‚¢•û‚ÌŽÀÛ|”ñƒXƒeƒƒCƒhR‰ŠÇÜ. ”è’õ•vi“àj: Medical Practice, 6: 1123`1126, 1989.

2488. m‘àn ƒAƒŒƒ‹ƒM|«Ž¾Š³‚Ì•a‘Ô; ‰ŠÇ”½‰ž‚ƃAƒŒƒ‹ƒM|. ã–ìWŒ›CŽ­ŽæMi–ò—j: Modern Physician, 9(10): 1321`1323, 1989.

2489. m‘àn äPŒ´•a‚Ì”xüˆÛÇ‚Æ‚»‚ÌŽ¡—Ã. ‰ª“cƒCŠÔ’†‹v”üC”è’õ•vi“àj: ƒJƒŒƒ“ƒgƒeƒ‰ƒs[, 7: 715`720, 1989.

2490. m‘àn CRESTÇŒóŒQ. ‹ß“¡Œ[•¶i“àj: ƒŠƒEƒ}ƒ`‰È, 1: 643`650, 1989.

2491. m‘àn PM/DM‚É‚¨‚¯‚é—Õ°ŒŸ¸‚͂ǂ̂悤‚ȃVƒXƒeƒ€‚Å‚·‚·‚ß‚ç‚ê‚é‚©A•a‘œ‚Æ‚ÌŠÖŒW‚Í. ‰ª“cƒC”è’õ•vi“àj: ƒŠƒEƒ}ƒ`‰È, 2: 329`333, 1989.

2492. m‘àn •aŠú¥•a‘Ô‚©‚ç‚Ý‚½–òÜ‚Ì‘I‘ð‚Æ“Š—^–@; ‘½”­«‹Ø‰Š. ’·’JìˆêŽqi“àjC”W’†ªÆi‘—§¸__ŒoƒZƒ“ƒ^[j: ˆãŠw‚Æ–òŠw, 22(5): 1155`1159, 1989.

2493. m‘àn Chemotactic Factor. ã–ìWŒ›CŽ­ŽæMi–ò—j: ˆãŠw‚Ì‚ ‚ä‚Ý, 150(1): 4, 1989.

2494. m‘àn ”÷¬zŠÂ‚É‚¨‚¯‚錌ŠÇ“à”ç×–E‚Ì–ðŠ„|ŒŒŠÇ“§‰ß«˜´i‚Æ‘½Œ`Šj”’ŒŒ‹…ŒŒŠÇŠO—V‘–|. Ž­ŽæMC¬“c—²Ž¡i–ò—jC‰iˆäˆê¬i–ƒj: ‰ŠÇ, 9(2): 79`83, 1989.

2495. m‘àn ƒƒCƒRƒgƒŠƒGƒ“‚Ì”wŒã‚É‚ ‚é‚à‚Ì. Ž­ŽæMi–ò—j: Œ»‘ãˆã—Ã, 21(10): 3004, 1989.

2496. m‘àn ŒŒŠÇ‰ŠAŽ¡—Ö@‚Ìi•à|“à‰È‚Ì—§ê‚©‚ç. ”è’õ•vC‰ª“cƒi“àj: Œ»‘ãˆã—Ã, 21: 3287`3289, 1989.

2497. m‘àn ƒeƒmƒLƒVƒJƒ€. •ŸˆäŒõ•¶C×–ìF˜YC”è’õ•vi“àj: Œ»‘ãˆã—Ã, 22: 298`301, 1989.

2498. m‘àn i˜˜_j–«ŠÖ߃ŠƒEƒ}ƒ`‚É‘Šúf’f¥‘ŠúŽ¡—Â͂ ‚蓾‚é‚©. ”è’õ•vi“àj: ÅVˆãŠw, 44: 1773`1774, 1989.

2499. m‘àn ƒŠƒEƒ}ƒ`«‘½”­‹Ø’É. ‹ß“¡Œ[•¶i“àj: ÅVˆãŠw, 44: 1861`1866, 1989.

2500. m‘àn RAŽ¡—ÂÌi•à‚Æ–â‘è“_|–Ɖu—}§Ü. Ô¯“§Cã“cŠ°”VC”è’õ•vi“àj: ÅVˆãŠw, 44: 1918`1923, 1989.

2501. m‘àn äPŒ´•a|i•à‚Æ–â‘è“_: Žå—v‚È‘ŸŠí•a•Ï. ‰ª“cƒi“àj: ÅVˆãŠw, 45(2): 283`287, 1990.

2502. m‘àn äPŒ´•a|i•à‚Æ–â‘è“_: Žü•ÓŽ¾Š³; RƒŠƒ“Ž‰Ž¿R‘ÌÇŒóŒQ. ‰ª“cƒi“àj: ÅVˆãŠw, 45(2): 351`356, 1990.

2503. m‘àn äPŒ´•a|i•à‚Æ–â‘è“_; ˜˜_. ”è’õ•vi“àj: ÅVˆãŠw, 45: 217, 1990.

2504. m‘àn ƒ‹[ƒvƒX• –Œ‰Š. ‹ß“¡Œ[•¶C¼¬“c^C”è’õ•vi“àj: ÅVˆãŠw, 45: 288`292, 1990.

2505. m‘àn ŽO³_ŒoáŠQ. •ŸˆäŒõ•¶C”è’õ•vi“àj: ÅVˆãŠw, 45: 301`306, 1990.

2506. m‘àn äPŒ´•a‚ƈ««Žîá‡. ‚•i®ÆC”è’õ•vi“àj: ÅVˆãŠw, 45: 313`317, 1990.

2507. m‘àn •aŒ^f’f‚̉”\«‚Æ‚»‚Ì—Õ°“IˆÓ‹`|‹­”çÇ. ”è’õ•vC‹ß“¡Œ[•¶C•Û‰È”Ž“oC‚•i®Æi“àj: ÅVˆãŠw, 45: 326`333, 1990.

2508. m‘àn äPŒ´•a—̈æ‚Ì“®Œü. ”è’õ•vC‹ß“¡Œ[•¶C‰ª“cƒi“àj: Ž¡—Ã, 72: 101`107, 1989.

2509. m‘àn Šà«áu’É|Á‰Š’Á’ÉÜ. ‰ª“cƒC”è’õ•vi“àj: Ž¨A“ªŒz, 61: 841`844, 1989.

2510. m‘àn ‰ºb‰î‰»ŠwÜŽèp. ”ª”ö˜a—YiŽ¨•@j: Ž¨•@ˆôA‰Èf—à Question & Answers, (12): 619‚Ì2`619‚Ì5, 1990.

2511. m‘àn ƒZƒ‹ƒtƒgƒŒƒ‰ƒ“ƒX‚É‚¨‚¯‚鋹‘BŠîŽ¿×–E‚Ì–ðŠ„. ‹Ê“àGˆêi”÷j: ŽÀŒ±ˆãŠw, 17(12): 1404`1407, 1989.

2512. m‘àn •s–O˜aŽ‰–bŽ_‚ƶ‘Ì‚Ì’²ß‹@”\|‰ŠÇ‚â–ƉuŒn‚̧Œä‚̉”\«‚à|. Ž­ŽæMi–ò—j: H‚̉Ȋw, (138): 47`57, 1989.

2513. m‘àn –òÜ”M. ”è’õ•vi“àj: f—ÃŽè’ , 105: 16, 1989.

2514. m‘àn ˆâ“`Žq‘•–@‚Æ”z—ñ“ÁˆÙ“IƒIƒŠƒSƒkƒNƒŒƒIƒ`ƒh‚ð—p‚¢‚½HLAˆâ“`Žq‚Ì‘½Œ^«‚̉ðÍ. ¬”¦•¶–íC”–Ø“oiˆÚA–Ɖuj: ’`”’Ž¿¥ŠjŽ_¥y‘f, 34(15): 1989`2002, 1989.

2515. m‘àn ƒ”ƒBƒWƒ…ƒAƒ‹f’f|–«ŠÖ߃ŠƒEƒ}ƒ`‚Ì‘Šúf’f. ‰ª“cƒi“àj: “úŒoƒƒaƒJƒ‹, 1: 64`68, 1989.

2516. m‘àn RAƒeƒXƒg¥RAHAƒeƒXƒg‚Ì“Ç‚Ý•û. ”è’õ•vi“àj: “ú–{ˆãŽ–V•ñ, (3391): 176, 1989.

2517. m‘àn ‰ºb‰î‰»ŠwÜŽèp|ƒgƒŠƒNƒ|ƒ‹|Ž_‚̉ž—p|. ”ª”ö˜a—YCÝŠy“N–çiŽ¨•@j: “ú–{ˆãŽ–V•ñ, (3394): 15`18, 1989.

2518. m‘àn Šw‰ï‹L|ƒŠƒEƒ}ƒ`Šw‰ï. ”è’õ•vi“àj: “ú–{ˆãŽ–V•ñ, (3412): 47`48, 1989.

2519. m‘àn ’PŠÖß’É‚Æ–«ŠÖ߃ŠƒEƒ}ƒ`. ”è’õ•vi“àj: “ú–{ˆãŽ–V•ñ, (3416): 137`138, 1989.

2520. m‘àn —Õ°u‹`|‹­”çÇ. ”è’õ•vC‚•i®Æi“àj: “ú–{ˆãŽ–V•ñƒWƒ…ƒjƒA”Å, 290: 3`6, 1990.

2521. m‘àn ƒŒƒZƒvƒ^|‚Æ‚µ‚Ä‚ÌMHC•ªŽq ”–Ø“oiˆÚA–Ɖuj: “ú–{—Õ°, 47(‘): 694`704, 1989.

2522. m‘àn –«ŠÖ߃ŠƒEƒ}ƒ`‚É‚¨‚¯‚é–ò•¨—Ö@‚ÌÅ‹ß‚Ì“®Œü. ”è’õ•vC‰ª“cƒCÔ¯“§Cã“cŠ°”VC•ŸˆäŒõ•¶i“àj: “ú–{—Õ°–ƉuŠw‰ï‰ïŽ, 12: 349`361, 1990.

2523. m‘àn SjogrenÇŒóŒQ‚Ì–â‘è“_. •ÐŽRˆê˜Ni”çj: ”畆•af—Ã, 12(1): 24`32, 1990.

2524. m‘àn ƒfƒ†ƒAƒ‹ƒCƒ“ƒqƒrƒ^|. Ž­ŽæMi–ò—j: —Õ°ˆã, 15(9): 1613`1615, 1989.

2525. m‘àn ‰ŠÇ‚ƃTƒCƒgƒJƒCƒ“. Ô¯“§CL“c˜a‰iC”è’õ•vi“àj: —Õ°ˆã, 15: 1730`1732, 1989.

2526. m‘àn ”ñƒXƒeƒƒCƒhR‰ŠÇ–ò‚Ìì—p‹@˜|Å‹ß‚Ì—‰ð‚Æ–â‘è“_|. ”è’õ•vi“àj: —Õ°ˆã, 15: 6`10, 1989.

2527. m‘àn iÀ’k‰ïj”ñƒXƒeƒƒCƒhR‰ŠÇ–ò‚ÌŽg‚¢•û. “ŒžŠ‹BiŒc‘åjC“ŒˆÐi¹ƒ}ƒŠ‘åjC”è’õ•vi“àjCŒÜ\—’ŽO’Ã’ji“s—§—{ˆç‰@j: —Õ°ˆã, 15: 93`107, 1989.

2528. m‘àn RƒŠƒEƒ}ƒ`–ò. ‰ª“cƒC”è’õ•vi“àj: —Õ°ˆã, 16: 8`11, 1990.

2529. m‘àn «—ˆCtˆÚA‚ł̶’…—¦100“‚͉”\‚©|–ƉuŠw“I—§ê‚©‚ç|. ”–Ø“oiˆÚA–Ɖuj: —Õ°“§Í, 5(4): 475`480, 1989.

2530. m‘àn ‘Sg«‹­”çÇ‚Ìf—Ã. ”è’õ•vC–쑺³¢CŠÖŽRØ•äi“àj: —Õ°–Ɖu, 21(14): 571`578, 1989.

2531. m‘àn IL-1ƒÀ—R—ˆ‚̃|ƒŠƒyƒvƒ`ƒh‚Ìì—p. Ô¯“§C‘O“c’å‘¥C”è’õ•vi“àj: —Õ°–Ɖu, 21: 1619`1625, 1989.

2532. m‘àn TNF‚ƉŠÇ. Ô¯“§C‰““¡•½mC”è’õ•vi“àj: —Õ°–Ɖu, 21: 620`632, 1989.

2533. muÀn –Ú‚Å‚Ý‚éƒgƒŒ[ƒjƒ“ƒO. ‹ß“¡Œ[•¶i“àj: Medicina, 26: 2256`2261, 1989.

2534. muÀn –Ú‚Å‚Ý‚éƒgƒŒ[ƒjƒ“ƒO. ‹ß“¡Œ[•¶i“àj: Medicina, 26: 2425`2428, 1989.

2535. muÀn ‚±‚ꂾ‚¯‚Í’m‚Á‚Ä‚¨‚«‚½‚¢ŒŸ¸‚̃|ƒCƒ“ƒg‘æ4WC–ƉuŒŒ´ŒŸ¸¥CRPiC”½‰ž«ƒ^ƒ“ƒpƒNj. ¼“c—zi—Õ•a—j: MedicinaC26(‘10): 1750`1752, 1989.

2536. muÀn –ƉuƒOƒƒuƒŠƒ“‚Æ‚»‚̈ÙíÇ. ‘å’J‰pŽ÷i—Õ•a—j: ŒŒ´”½‰ž‚Ì‚ ‚ä‚ÝC10(5): 87`95, 1989.

2537. muÀn –ò]‚É‚¨‚¯‚é–ƉuŠw. ‰¡ŠÖ”Ž—YC•ÐŽRˆê˜NC¼‰ª´i”çj: “ú”狦ƒWƒƒ[ƒiƒ‹, 12(1): 13`18, 1989.

2538. muÀn …ávÇ‚É‚¨‚¯‚é–ƉuŠw. ‰¡ŠÖ”Ž—YC•ÐŽRˆê˜NC¼‰ª´i”çj: “ú”狦ƒWƒƒ[ƒiƒ‹, 12(2): 16`20, 1989.

2539. muÀn RClqR‘Ì. ‘å’J‰pŽ÷i—Õ•a—j: “ú–{—Õ°C601(‘): 485`486, 1990.

2540. muÀn CRP,SAP. ‘å’J‰pŽ÷i—Õ•a—j: —Õ°ˆãC15(‘): 1140`1144, 1989.

2541. mŠwp‘n iŽ·•Mj ƒŠƒEƒ}ƒ`Šw; ‡U.‰ŠÇC2.’ᕪŽqChemical MediatorC1)ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“ŒQ‚̶‡¬‚ƉŠÇ‚É‚¨‚¯‚é–ðŠ„Cp.139`151C Ž­ŽæMi–ò—j. “¯•¶‘‰@, 89.07.00”­s.

2542. mŠwp‘n iŽ·•Mj ¡“ú‚̈•û; äPŒ´•aA‚»‚Ì‘¼‚Ì‘SgŽ¾Š³AƒŠƒEƒ}ƒ`«‘½”­‹Ø’ÉÇ‚È‚Ç, p.526`531, ‹ß“¡Œ[•¶i“àj. •ÒW “ì]“°, “Œ‹ž, 90.00.00”­s.

2543. mŠwp‘n iŽ·•Mj ƒŠƒEƒ}ƒ`¥äPŒ´•a‚̖Ɖu—Ö@|Å‹ß‚Ìi•à|; ”ñƒXƒeƒƒCƒhR‰ŠÇÜ, p.117`127, ”è’õ•vi“àj. •ÒW ‰–ì—DˆêC •Ò, ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, “Œ‹ž, 89.06.10”­s.

2544. mŠwp‘n iŽ·•Mj –«ŠÖ߃ŠƒEƒ}ƒ`; Š³ŽÒ‚ւ̃Aƒvƒ[ƒ`, p.5`12, ”è’õ•vi“àj. •ÒW …“‡—T•Ò, “ì]“°, “Œ‹ž, 89.09.15”­s.

2545. mŠwp‘n iŽ·•Mj }à:“à‰Èf’fŽ¡—ÃuÀ 12. ƒŠƒEƒ}ƒ`«Ž¾Š³; ‹­”çÇ, p.150`155, ‹ß“¡Œ[•¶i“àj. •ÒW ŒFŒ´—YˆêC‘¼•Ò, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 89.00.00”­s.

2546. mŠwp‘n iŽ·•Mj –ƉuAƒAƒŒƒ‹ƒM[AƒŠƒEƒ}ƒ`•aŠw; ‹­”çÇA‘½”­«‹Ø‰Š¥”畆‹Ø‰Š, p.161`183, ‹ß“¡Œ[•¶i“àj. •ÒW ”è’õ•vCŽë–쯌á•Ò, ˆãŠw‘‰@, “Œ‹ž, 89.00.00”­s.

2547. mŠwp‘n iŽ·•Mj ƒŠƒEƒ}ƒ`AäPŒ´•a‚̖Ɖu—Ö@|Å‹ß‚Ìi•à; ‘Sg«‹­”çÇ, p.204`210, ‹ß“¡Œ[•¶i“àj. •ÒW ‰–ì—DˆêC•Ò, ˆãŠwƒWƒƒ[ƒiƒ‹ŽÐ, “Œ‹ž, 89.00.00”­s.

2548. mŠwp‘n iŽ·•Mj ƒŠƒEƒ}ƒ`Šw; ‘Sg«is«‹­”çÇ, p.651`657, ‹ß“¡Œ[•¶i“àj. •ÒW ‰–ì—DˆêC•Ò, “¯•¶‘‰@, “Œ‹ž, 89.00.00”­s.

2549. mŠwp‘n iŽ·•Mj ƒvƒ‹ƒ~ƒGˆãŠwŠe˜_A“à‰ÈAŠO‰ÈA¬Ž™‰ÈA‡[.ƒAƒŒƒ‹ƒM[«Ž¾Š³AäPŒ´•aA–Ɖu•a; ‹­”çÇA”畆‹Ø‰ŠA‘½”­«‹Ø‰Š, p.42`48, ‹ß“¡Œ[•¶i“àj. •ÒW …“‡—TC•Ò, ˆãŽ•–òo”Å, “Œ‹ž, 89.00.00”­s.

2550. mŠwp‘n iŽ·•Mj Common Disease Series –«ŠÖ߃ŠƒEƒ}ƒ`; –ò•¨—Ö@|–Ɖu—}§Ü, p.140`143, ‰ª“cƒi“àj. •ÒW …“‡—TC•Ò, “ì]“°, “Œ‹ž, 89.00.00”­s.

2551. mŠwp‘n iŽ·•Mj VŠO‰ÈŠw‘ÌŒn12; ‘ŸŠíˆÚA|ˆÚA–Ɖu‚ÌŠî‘bCp.33`80C ”–Ø“oiˆÚA–Ɖuj. ’†ŽR‘“X, “Œ‹ž, 89.06.30”­s.

2552. mŠwp‘n iŽ·•Mj Immunobiology of HLA; DR4 Recognized by PLT ClonesC‡U: 210`211C ‹àŽq„‹viˆÚA–ƉujC‘å‹v•Û‚Ý‚Ç‚èi—\–hˆãŠwŒnjCˆÉ“¡IˆêC”–Ø“oiˆÚA–Ɖuj. •ÒW B.Dupont•ÒC Springer Verlag, N.Y., 89.00.00”­s.

2553. m‹³‰È‘n iŽ·•Mj –Ɖu¥ƒAƒŒƒ‹ƒM[¥ƒŠƒEƒ}ƒ`•aŠw; ”è’õ•vi“àjCŽë–쯌á. ˆãŠw‘‰@, “Œ‹ž, 89.04.01”­s.

2554. m‹³‰È‘n iŽ·•Mj ƒTƒNƒZƒXˆãŽt‘‰ÆŽŽŒ±—Õ°ŽÀ’n–â‘èW; äPŒ´•a, ‰ª“cƒi“àj. •ÒW ²“¡“oŽu˜YC•Ò, “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 89.00.00”­s.

2555. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj }à:“à‰Èf’fŽ¡—ÃuÀ 12. ƒŠƒEƒ}ƒ`«Ž¾Š³; ŒŸ¸‚©‚ç‚Ý‚½f’f‚Ìi‚ß•û|Á‰»ŠÇ‚wüŠŒ©, p.236`241; ƒŠƒEƒ}ƒ`¥äPŒ´•a‚ÌŠˆ“®«‚Ì‚«‚ß•û‚ÆŽ¡—Ã, p.264`267, ”è’õ•vi“àj. •ÒW ŒFŒ´—YˆêC‘¼•Ò, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 89.06.10”­s.

2556. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj }à:“à‰Èf’fŽ¡—ÃuÀ 12. ƒŠƒEƒ}ƒ`«Ž¾Š³; ƒŒƒCƒm[Œ»Û, ‰ª“cƒi“àj. •ÒW ˆÀ”{’B•Ò, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 89.09.00”­s.

2557. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj; ‘½”­«‹Ø‰Š, p.549`550, ‰ª“cƒi“àj. •ÒW “ú–쌴d–¾C‘¼•Ò, ˆãŠw‘‰@, “Œ‹ž, 90.01.00”­s.

2558. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj; –«ŠÖ߃ŠƒEƒ}ƒ`, p.554`556;@is«‘Sg«d‰»Çi‹­”çÇj, p.557`558, ‹ß“¡Œ[•¶i“àj. •ÒW “ú–쌴d–¾C‘¼•Ò, ˆãŠw‘‰@, “Œ‹ž, 90.01.00”­s.

2559. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ‘½Ü•¹—p—Ö@‚Ì’ˆÓ“_; –«ŠÖ߃ŠƒEƒ}ƒ`, p.153`160, ”è’õ•vi“àj. •ÒW ´…’¼—e•Ò, ƒVƒNƒX, “Œ‹ž, 89.09.25”­s.

2560. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj VŽå—v’¥Œó‚©‚ç‚Ý‚½ŒŸ¸‚Ìi‚ß•û; ƒŒƒCƒm[Œ»Û, ‰ª“cƒC”è’õ•vi“àj. •ÒW ¼“cdŽOC•Ò, V‹»ˆãŠwo”ÅŽÐ, “Œ‹ž, 90.01.10”­s.

2561. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj –«ŠÖ߃ŠƒEƒ}ƒ`‚Æ’·Šú—Ö@|‚æ‚è—Ç‚«Quality of Life‚Ì‚½‚ß‚É|; •›ì—p‘Îô|ƒŠƒXƒN¥ƒxƒlƒtƒBƒbƒg‚Ì—§ê‚©‚ç|, p.96`103, ‹ß“¡Œ[•¶C”è’õ•vi“àj. •ÒW –{ŠÔŒõ•vC•Ò, ƒƒfƒBƒJƒ‹ƒrƒ…[ŽÐ, ‘åã, 90.02.01”­s.

2562. mŠw‰ïn i“Á•Êu‰‰j Purification and Characterization of a Murine Melanoma Derived Inhibitory Factor of Tyrosinase. ‹TŽRFˆê˜Yi”çjCTanaka, S.CHearing, V.J. (NIH): Tricontinental Meeting of ESDR, JSID and SID i89.04.26j, Washington, D.C., USA, J. Investigative Dermatology, 92: 455, 1989.

2563. mŠw‰ïn i“Á•Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`(RA)Š³ŽÒŠŠ–Œ×–E‚ÌIL-6ŽY¶—U“±‚Ì‹@˜. ‰““¡•½mCÔ¯“§Cã“cŠ°”VC”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.

2564. mŠw‰ïn i‹³ˆçu‰‰j ƒL[ƒm[ƒgƒŒƒNƒ`ƒƒ[: DMARDs, ‚»‚Ì–â‘è“_. ”è’õ•vi“àj: ‘æ1‰ñ’†•”ƒŠƒEƒ}ƒ`Šw‰ï i89.11.04).

2565. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ”ñR‘Ì«‚̉t«’ïRˆöŽq. ìã³–çi•ª¶j: ‘æ16‰ñ“ú–{׋ۊw‰ïŠÖŒWŽx•”‘‰ï (89.06.03), “Œ‹žC “ú–{׋ۊwŽGŽC44(5): 739`740, 1989.

2566. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‰ŠÇ”½‰ž‚Æ—Õ°ŒŸ¸(2)C-”½‰ž«’`”’(CRP). ¼“c—zi—Õ•a—j: ‘æ1‰ñ“ú–{—Õ°•a—Šw‰ïŠÖ“ŒbM‰zŽx•”‘‰ï (89.10.28), VŠƒ.

2567. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒƒCƒRƒgƒŠƒGƒ“‚̂Ђ«‚¨‚±‚·•a‘Ô‚Æ‚»‚̧Œä. Ž­ŽæMC¬“c—²Ž¡Cã–ìWŒ›C¼ŽR˜a’ji–ò—j: ‘æ63‰ñ“ú–{–ò—Šw‰ï‘‰ï (90.03.25-28), “Œ‹žC Jpn. J. Pharmacol., 52(suppl.): 44, 1990.

2568. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‘Šú‚É‰ðŒˆ‚·‚ׂ«•a•Ï‚Ì”­Ç‹@˜‚ÆŽ¡—Ã:‹­”çÇ•a•Ï. ‹ß“¡Œ[•¶i“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.

2569. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j A Novel Drug Delivery System for the Treatment of Rheumatic Diseases, Lipo-PGE1 for the Treatment of Peripheral Vascular Diseases. ”è’õ•vi“àj: XVIIth ILAR Congress of Rheumatology i89.09.17-23), Rio de Janeiro, Brazil.

2570. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Systemic Scleroderma, Clinical Subsets. ”è’õ•vC‹ß“¡Œ[•¶C‚•i®Æi“àj: XVIIth ILAR Congress of Rheumatology i89.09.17-23), Rio de Janeiro, Brazil.

2571. mŠw‰ïn iƒpƒlƒ‹j CD4+CD8+ Thymocytes Can Develop into CD4+CD8- and CD4-CD8+ Cells. ‹Ê“àGˆêCNorikazu TamaokiCSonoka Habui“ŒŠC‘åj: 7th International Congress of Immunology (89.08.04), Berlin (West), Abstracts, 7: 197, 1989.

2572. mŠw‰ïn iƒpƒlƒ‹j BCG-stimulated Lymphocytes Induce Microvascular Endothelial Cell Injury by LAK Activity. óˆär–íC‘àVŠ²’jC¼‰ª´C¼ŽR–Εvi”çj: 2nd International Dermatology Symposium i89.10.11j, Berlin, West Germany.

2573. mŠw‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj ‘½Œ`Šj”’ŒŒ‹…ŒŒŠÇŠO—V‘–‚̈ê˜A‚̉ߒö‚̉ðÍ. ¬“c—²Ž¡CŽ­ŽæMi–ò—j: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï (89.07.20-21), “Œ‹žC —\eW, p.156, 1989.

2574. mŠw‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj ‹¹‘B“ÁˆÙ“IŽ©ŒÈ”FŽ¯ƒNƒ|ƒ“‚Ì‘I‘ð“Iœ‹Ž‚ÉŠÖ‚·‚錤‹†|VƒÀ6—z«×–E‚ðŽw•W‚Æ‚µ‚Ä|. ‹Ê“àGˆêC²“¡Œ’lCŠ_¶‰€Žqi“ŒŠC‘åj: ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ï (89.11.15), ŽD–y, “ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 19: 111, 1989.

2575. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj (1)ƒ‹[ƒvƒXt‰Š|”­Ç‹@˜‚ÆŽ¡—Ã|; (5)ƒ‹[ƒvƒXt‰Š‚ÌŽ¡—ÂÌi•àuƒ~ƒ]ƒŠƒrƒ“—Ö@v. ‹ß“¡Œ[•¶i“àjC–{ŠÔŒõ•vC‰¡’£—´ˆêC”è’õ•vi“àjC‹´–{”ŽŽjCHŒŽ³Žj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.

2576. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj (2)–Ɖu’²ßÜ‚Ìì—p“_‚Æ“Š—^–@u’á—p—ÊMTX‚¨‚æ‚Ñcyclophosphamide‚Ìì—p‹@\‚ÌŒŸ“¢v. Ô¯“§Cã“cŠ°”VC”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.

2577. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj (2)–Ɖu’²ßÜ‚Ìì—p“_‚Æ“Š—^–@u–Ɖu’²ßÜ‚ÌŠÔŸ[“Š—^–@v. ”è’õ•vC‰ª“cƒi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.

2578. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj (5)R‰ŠÇ¥RƒŠƒEƒ}ƒ`–ò‚ÌŽ¡—Èâ“`ŠwuRƒŠƒEƒ}ƒ`–òi(ARD)‚ÌŒø‰Ê‚¨‚æ‚Ñ•›ì—p‚ÆHLARŒ´‚Æ‚ÌŠÖŒWv. ‰ª“cƒC—é–ؒ唎i“àjC‰œ“c‚Ý‚³‚ði—\–hˆãŠwŒnjC‘å’J•¶—Yi‘ŸˆÚjC”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.

2579. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj (11)äPŒ´•aŒ¤‹†‚É‚¨‚¯‚éƒoƒCƒIƒeƒNƒmƒƒW[‚̉ž—pu‰ŠÇ«ƒTƒCƒgƒJƒCƒ“(IL-1, TNF)‚Ìì—p‚Æ‚»‚̃ŒƒZƒvƒ^[‚Ì”­Œ»’²ß‹@˜v. Ô¯“§C‰““¡•½mC”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.

2580. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj (13)RƒŠƒEƒ}ƒ`Ü‚Ì—Õ°•]‰¿|V‚µ‚¢–â‘è“_‚ɂ‚¢‚Ä|, 8)’xŒø«RƒŠƒEƒ}ƒ`–ò•]‰¿‚Ì«—ˆ,@ˆË—Š”­Œ¾(1)u•]‰¿€–Úv. ‰ª“cƒC”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.

2581. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj (15)RƒŠƒEƒ}ƒ`ÜuTNF‚É‚æ‚éD’†‹…Šˆ«Ž_‘fŽY¶—U“±‚É‹y‚Ú‚·RƒŠƒEƒ}ƒ`–ò‚̉e‹¿v. ã“cŠ°”VCÔ¯“§C”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.

2582. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Profiles of Anti-nuclear Antibodies in Scleroderma Sepctrum Disorders. ‹ß“¡Œ[•¶C‚•i®ÆC”è’õ•vi“àj: International Workshop on the Molecular and Cell Biology of Autoantibodies and Autoimmunity i89.07.00).

2583. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj –Ɖu’²ß–òu–Ɖu’²ß–ò‚ÌŠÔŒ‡“Š—^–@v. ‰ª“cƒC”è’õ•vi“àj: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï i89.07.20, 21), “Œ‹ž.

2584. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Pathogenesis of Systemic Sclerosis: Effects of Cytokines on the Proliferation of Skin Fibroblast from Scleroderma Patients and Normal Controls. ‹ß“¡Œ[•¶C‚•i®ÆC”è’õ•vi“àj: XVIIth ILAR Congress of Rheumatology i89.09.17-23), Rio de Janeiro, Brazil.

2585. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Pathogenesis of Systemic Sclerosis: Detection of Autoantibody to l7-kD Centromeric Antigen Using Immunoblotting in the Scleroderma Spectrum. ‚•i®ÆC‹ß“¡Œ[•¶C”è’õ•vi“àj: XVIIth ILAR Congress of Rheumatology i89.09.17-23), Rio de Janeiro, Brazil.

2586. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Immunosuppressor Therapy of Lupus Nephritis: Clinical Efficacy of a New Immunosuppressive Agent, Mizoribine, on Lupus Nephritis-long Term Trial. ‹ß“¡Œ[•¶i“àjC–{ŠÔŒõ•vC‰¡’£—´ˆêC”è’õ•vi“àjC‹´–{”ŽŽjCHŒŽ³Žj: XVIIth ILAR Congress of Rheumatology i89.09.17-23), Riode Janeiro, Bradil.

2587. mŠw‰ïn iˆê”Êu‰‰j ”DPˆÛŽ‚ÉŠÖ—^‚·‚éHLA–Ɖu—Ö@‚Ìì—p‹@˜. “c’†’‰•vCŽü‹X‹»C“V–ìMlC‘q“‡•x‘ãC’ñ‹I•vCˆÉ“¡Ž¡‰pi‘—§‘å‘ •a‰@jCˆÉ“¡IˆêC”–Ø“oiˆÚA–Ɖuj: ‘æ41‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï (89.04.02), ‰ªŽR.

2588. mŠw‰ïn iˆê”Êu‰‰j ŠeŽíƒXƒM‰Ô•²RŒ´‰t—͉¿‚ÌŒŸ“¢|SBPŠÜ—ʂƔ畆”½‰žè‡’l. “¡–ì–¾liŽ¨•@jCˆÀŽ}_C‘O“c—T“ñC‘ì“N•vC’·’Jì^‹IC“cŠŒ›Ž¡CHŽRˆê’jCM‘¾—²•vi‘—§‘Š–ÍŒ´•a‰@j: ‘æ1‰ñ“ú–{ƒAƒŒƒ‹ƒM|Šw‰ït‹G—Õ°W‰ï (89.04.14), “Œ‹žC ƒAƒŒƒ‹ƒM|C38(2): 212, 1989.

2589. mŠw‰ïn iˆê”Êu‰‰j COBAS MIRA ‚É‚æ‚錌´•â‘̉¿‘ª’è‚ÌŒŸ“¢. ‹Iì‹v”üŽqC÷ˆäŒc‘¢C”·—EŽŠi—ÕŒŸjCät“n’‰’jC“àŽRKMi—Õ•a—j: ‘æ38‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï (89.04.29), ŒSŽRC ‰q¶ŒŸ¸C38(3): 471, 1989.

2590. mŠw‰ïn iˆê”Êu‰‰j Effects of PAF on Leukocyte Migration and Microvessels. Ž­ŽæMC”n“ˆ³—²C¬“c—²Ž¡i–ò—jC‰iˆäˆê¬i–ƒjC‚Œ´ŽO’qŽqi¶•¨‰»ŠwŒnj: Third International Conference on Platelet-Activating Factor and Structurally Related Alkyl Ether Lipid (89.05.08-12), Tokyo.

2591. mŠw‰ïn iˆê”Êu‰‰j Action of Dexamethasone on Leukocyte Extravasation in Microcirculation. Ž­ŽæMC¬“c—²Ž¡i–ò—j: 11th European Workshop on Inflammation (89.05.18-19), Copenhagen, DenmarkC Agents and ActionsC29(1/2): 24`26, 1990.

2592. mŠw‰ïn iˆê”Êu‰‰j ŽüŽYŠú‚É‚¨‚¯‚錌´IgE’l‚Ì‘ª’è|’á”Z“xIgE’l‘ª’è–@‚É‚æ‚錟“¢|. â“Œ—R‹IC¼“c—zCät“n’‰’jC‘å’J‰pŽ÷i—Õ•a—jCŠ—Œ´FC¬ŒûO‹BC–åˆäL‹ÅiŽ™j: ‘æ25‰ñ“ú–{V¶Ž™Šw‰ï‘‰ï (89.07.03), “Œ‹žC ´˜^W, p.125, 1989.

2593. mŠw‰ïn iˆê”Êu‰‰j ŒŒŸ÷‚É‚æ‚éƒuƒ‰ƒWƒLƒjƒ“•ª‰ðŒo˜H‚ÌŽí·. “‡çŽqi¶•¨‰»ŠwŒnjC”n“ˆ³—²CŽ­ŽæMi–ò—j: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï (89.07.20-21), “Œ‹žC —\eW, p.127, 1989.

2594. mŠw‰ïn iˆê”Êu‰‰j ‘½Œ`Šj”’ŒŒ‹…ŒŒŠÇŠO—V‘–‚É‚¨‚¯‚銈«Ž_‘f‚âƒvƒƒeƒA|ƒ[‚ÌŠÖ—^. ¬“c—²Ž¡CŒ´“c–FÆCŽ­ŽæMi–ò—j: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï (89.07.20-21), “Œ‹žC —\eW, p.157, 1989.

2595. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒgƒJƒIƒŠƒ“‹¹–Œ‰Š‚É‚¨‚¯‚é“ñ‘Š«‚ÌŒŒŸ÷ƒLƒjƒ“—V—£‚Ì‹@˜. ”n“ˆ³—²i–ò—jC–x—mŽOiƒVƒIƒmƒM»–òjC‚Œ´ŽO’qŽqi¶•¨‰»ŠwŒnjC쑺“¹Žq CŽ­ŽæMi–ò—j: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï (89.07.20-21), “Œ‹žC —\eW, p.182, 1989.

2596. mŠw‰ïn iˆê”Êu‰‰j Host-Parasite Relationship in Murine Salmonellosis. ‘å‘òLFCHŽR•‹vi”÷j: 7th International Congress of Immunology (89.08.01), Berlin (West).

2597. mŠw‰ïn iˆê”Êu‰‰j Spontaneous, Trasferable, and Degenerative Polyarthritis in Male NZB/KN Mice. ’†‘º‘‰qi•ª¶jC”è’õ•vi“àjCã“cŠ°”Vi‰qjC‚ŠÝŒ›“ñC’Ë–{s’ji®ŠOjC”¯N—YiŽÀ“®j: 7th International Congress of Immunology (89.08.02), Berlin (West).

2598. mŠw‰ïn iˆê”Êu‰‰j DNA‰ðÍ‚É‚æ‚Á‚ÄŒŸo‚³‚ꂽ“ú–{l‚É‚¨‚¯‚é“ñ‚‚ÌDRW12ƒTƒuƒ^ƒCƒv‚ɂ‚¢‚Ä. ˆÉ“Œˆê˜YC¬”¦•¶–íC‹àŽq„‹viˆÚA–ƉujC‘å‹v•Û‚Ý‚Ç‚èi—\–hˆãŠwŒnjCˆ¢•”Í•vi–kŒ¤jC”–Ø“oiˆÚA–Ɖuj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (89.09.11), “Œ‹ž, ˆÚA, 24(—Õ‘): 182, 1989.

2599. mŠw‰ïn iˆê”Êu‰‰j ƒCƒktˆÚA‚É‚¨‚¯‚ép‘OƒŠƒ“ƒp‘gDÆŽËDonorœ‘×–EˆÚ“ü‹y‚ÑFK506•¹—p‚É‚æ‚éDonor“ÁˆÙ“I–Ɖu—}§‚̉ðÍ. “n•”_“ñC‹|í‹žŽqC”–Ø“oiˆÚA–ƉujC²“¡ŒõŽjiŠOjC‰€“c˜a•Fi‹¹ŠOj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (89.09.11), “Œ‹ž, ˆÚA, 24(—Õ‘): 322, 1989.

2600. mŠw‰ïn iˆê”Êu‰‰j Clinical Application of Trichloroacetic Acid to Allergic Rhinitis. ”ª”ö˜a—YC‚‹´œAbCÝŠy“N–çiŽ¨•@j: 14th World Congres of Otorhinolaryngology Head and Neck Surgery (89.09.14), Madrid, 14th World Congres of Otorhinolaryngology Head and Neck Surgery, Abstracts, p.218, 1989.

2601. mŠw‰ïn iˆê”Êu‰‰j ˆÚA•Ð‚Æ‚µ‚Ä‚Ì‘ÙŽ™|‘Ù¶ˆÛŽ‚ÉŠÖ‚·‚éRƒCƒfƒCƒIƒ^ƒCƒvR‘Ì‚Ì–ðŠ„. ˆÉ“¡IˆêC”–Ø“oiˆÚA–Ɖuj: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï (89.09.30), ‘Š–ÍŒ´, –k—¢ˆãŠw, 19(6): 644, 1989.

2602. mŠw‰ïn iˆê”Êu‰‰j SLEŠ³ŽÒ‚É‚¨‚¯‚éCR1‚ƖƉu•¡‡‘Ì‚ÌŠÖ˜A«. ”«‘º˜a’ji—ÕŒŸjC‘å’J‰pŽ÷i—Õ•a—j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 170, 1989.

2603. mŠw‰ïn iˆê”Êu‰‰j ‰ºb‰î‰»ŠwÜŽèp|Ž¡—ÃŒø‰Ê‚ÌŒŸ“¢|. ˆäŒû–F–¾CV“cŒ’‘¾˜YC”ª”ö˜a—YC‚‹´œAbCÝŠy“N–çiŽ¨•@j: “ú–{•@‰ÈŠw‰ï (89.10.20), ” ª.

2604. mŠw‰ïn iˆê”Êu‰‰j ƒAƒ¬‡ƒŠƒ“ƒp‹…”|—{”½‰ž‚É‚¨‚¯‚éT×–EƒTƒuƒZƒbƒg‚Ì•Ï“®. ‰Á“¡GliˆÚA–ƉujCŠÖŒûŽˆêiŽœŒbˆã‘åjC‰º“c—EŽ¡iƒuƒŠƒXƒgƒ‹jC”–Ø“oiˆÚA–Ɖuj: ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ï (89.11.14), ŽD–yC ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 19: 147, 1989.

2605. mŠw‰ïn iˆê”Êu‰‰j Toxic Shock Syndrome Toxin-1‚̓AƒNƒZƒTƒŠ|×–E‚ÌHLAƒNƒ‰ƒX‡U•ªŽq‚ÉŒ‹‡‚µ‚ÄT×–E‚ðŠˆ«‰»‚·‚é. ¡¼Œ’ˆêC“àŽR’|•FC•H–¾”ü“ÞŽqCÄ“¡T“ñCŠÞ¬Œ†C“¡ì_CŒÜ\—’‰p•vi“Œ—ˆã‘åjC‰Á“¡GlC¬”¦•¶–íC”–Ø“oiˆÚA–ƉujC’–Žq‰pri“ŒŠC‘åj: ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ï (89.11.14), ŽD–yC ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 19: 324, 1989.

2606. mŠw‰ïn iˆê”Êu‰‰j HLA-DRgJX6": DNA‰ðÍ‚Å–¾‚ç‚©‚É‚³‚ꂽ“ú–{lDRgƒuƒ‰ƒ“ƒNhŒ^‚̈ê‚‚ɂ‚¢‚Ä. ¬”¦•¶–íiˆÚA–ƉujCˆ¢•”Í•vi–kŒ¤jC‘å‹v•Û‚Ý‚Ç‚èCˆÉ“Œˆê˜YC‰œ“c‚Ý‚³‚ði—\–hˆãŠwŒnjC‘å’J•¶—YC‹àŽq„‹vC”–Ø“oiˆÚA–Ɖuj: ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ï (89.11.14), ŽD–yC ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 19: 440, 1989.

2607. mŠw‰ïn iˆê”Êu‰‰j Fractionated Lymphoid Irradiation (FLI)‘Oˆ’uƒCƒk‚ªŠl“¾‚·‚étˆÚA•Ð–Ɖu•s‰ž“š«‚ÉŠÖ‚í‚étDonor‚©‚ç‚Ìœ‘×–EˆÚ“ü‚Ì–ðŠ„. “n•”_“ñiˆÚA–ƉujC‹|í‹žŽqi—\–hˆãŠwŒnjC”–Ø“oiˆÚA–Ɖuj: ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ï (89.11.14), ŽD–yC ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 19: 448, 1989.

2608. mŠw‰ïn iˆê”Êu‰‰j ”½•œ—¬ŽY‚É‚¨‚¯‚éHLA-DRRŒ´•p“x‚̉ðÍ. ˆÉ“¡IˆêiˆÚA–ƉujC“c’†’‰•vC’ç‹I•vi‘—§‘å‘ •a‰@jC”–Ø“oiˆÚA–Ɖuj: ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ï (89.11.14), ŽD–yC ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 19: 500, 1989.

2609. mŠw‰ïn iˆê”Êu‰‰j ”½•œ—¬ŽY‚ɑ΂·‚é–Ɖu—Ö@‚Ìì—p‹@˜|RHLAR‘Ì‚Ìd—v«‚ɂ‚¢‚Ä|. “c’†’‰•vC’ç‹I•vC‘q“‡•x‘ãCˆÉ“¡Ž¡‰pi‘—§‘å‘ •a‰@jCˆÉ“¡IˆêC”–Ø“oiˆÚA–Ɖuj: ‘æ4‰ñ“ú–{ˆãŠw¶B–ƉuŠw‰ï (89.11.30), –¼ŒÃ‰®.

2610. mŠw‰ïn iˆê”Êu‰‰j •@o”|—{‚É‚æ‚éV¶Ž™Žº‚Ì´Œ‰“x‚̃‚ƒjƒ^ƒŠƒ“ƒO‚ÉŠÖ‚·‚錟“¢. b‰êŠ°ŽqC²“¡—T”üC“ü]‹ÅŽqiŠÅŒì•”jC–L“ciŽqiŠÅŒìŠw•”jC¼“c—zi—Õ•a—j: ‘æ3‰ñ_“Þì•ê«‰q¶Šw‰ï (90.02.03), ‰¡•l.

2611. mŠw‰ïn iˆê”Êu‰‰j 67GaƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚ÅŽw“E‚µ“¾‚½‹ØƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á. ¼Šª”ŽCΈ䟌ÈC’†‘òŒ\Ž¡C›MˆêC“cŠŽŒÈC¼ŽR³ŒáC¬—Ñ–ÎŽ÷CˆË“cˆêdC¼—Ñ—²i•új: ‘æ32‰ñ“ú–{ŠjˆãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (90.03.10), “Œ‹ž.

2612. mŠw‰ïn iˆê”Êu‰‰j Con A ŽhŒƒŠ”‰»T×–E(CEM)•\–Êã‚ÌCD57(Leu7)‚¨‚æ‚ÑCD11b(Mo-1)‚Æ‚»‚Ì‹@”\. ’r˜eM’¼iŠÅŒìŠw•”jC‹Ê“àGˆêi”÷jC¼è‹MŽqCŽR‰Y¸iŠÅŒìŠw•”jC’–Žq‰pri“ŒŠC‘åj: ‘æ63‰ñ“ú–{׋ۊw‰ï‘‰ï (90.03.27), “¿“‡, “ú–{׋ۊwŽGŽ, 45(1): 233, 1990.

2613. mŠw‰ïn iˆê”Êu‰‰j Phenotypic Heterogeneity of JB/MS Murine Melanoma Cells: Purification and Characterization of a Melanogenic Inhibitor. ‹TŽRFˆê˜Yi”çjCLaw, L.W.CTanaka, S.CHearing, V.J. (NIH): Panamerican Society for Pigment Cell Research i89.04.00j, Bethesda, USA, Pigment Cell Research, 2: 449, 1989.

2614. mŠw‰ïn iˆê”Êu‰‰j Neutrophil-mediated Detachment of Dermal Microvascular Endothelial Cells. ‘‘òŠ²’jCóˆär–íC‘åìŽiC¼‰ª´C¼ŽR–Εvi”çj: Tricontinental Meeting of ESDR, JSID and SID i89.04.26j, Washington, D.C., USA.

2615. mŠw‰ïn iˆê”Êu‰‰j Regulation of Epidermal Cell Growth by Mast Cell Derived Mediators in Atopic Dermatitis. •ÐŽRˆê˜NC‰¡ŠÖ”Ž•vCì–¼½ŽiC¼‰ª´C¼ŽR–Εvi”çj: Tricontinental Meeting of ESDR, JSID and SID i89.04.26j, Washington, D.C., USA.

2616. mŠw‰ïn iˆê”Êu‰‰j ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚É‚¨‚¯‚éŒûO¶ŒŸ‚Ì—Õ°“IˆÓ‹`. •ÐŽRˆê˜NCŽ›–{”ÍŽqCVˆätŽ}C‰q“¡ŒõC¼‰ª´C¼ŽR–Εvi”çj: ‘æ88‰ñ“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï i89.05.11j, ‹à‘ò.

2617. mŠw‰ïn iˆê”Êu‰‰j Œ‹ß«g”Á‚ª‘OŒi‚É—§‚Á‚½ˆ««ƒŠƒ“ƒpŽî‚Ì1—á. L“c˜a‰iC—é–Ø‹M”ŽC—é–ØŒúC‹ß“¡Œ[•¶C”è’õ•vC“cè‹`ºi“àj: ‘æ382‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i89.05.13), “Œ‹ž.

2618. mŠw‰ïn iˆê”Êu‰‰j ‹¹•”‚wü㑽”­‚·‚éŽîáŽó‰A‰e‚ª”F‚ß‚ç‚ꂽ‰óás«”^”çÇ‚ð‡•¹‚µ‚½–«ŠÖ߃ŠƒEƒ}ƒ`‚Ì1—á. —é–ؒ唎C‘å–ì‹v”üC¬—Ñ–M–FC”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.

2619. mŠw‰ïn iˆê”Êu‰‰j SLE‚Ì”x•a•Ï‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢. ŠÔ’†‹v”üC‰ª“cƒCŠÖŽRØ•äC”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.

2620. mŠw‰ïn iˆê”Êu‰‰j PSS, PM-DM, MCTD‚É‚¨‚¯‚é”DP‚Æ‚»‚ÌŒ‹‰Ê. —Ñ”ü’ÃŽ}C‹ß“¡Œ[•¶C–k‘º–’mŽqC”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.

2621. mŠw‰ïn iˆê”Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`‚É‚¨‚¯‚émethotrexate (MTX)•GŠÖßo“à’“ü—Ö@‚ÌŒŸ“¢. ã“cŠ°”VC•ŸˆäŒõ•¶CÎìÍCÔ¯“§C”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.

2622. mŠw‰ïn iˆê”Êu‰‰j ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX(SLE)‚Ì’†•_ŒoáŠQ(CNS)‚ÉŠÖ‚·‚é—Õ°“I¥–ƉuŠw“IŒŸ“¢. ÎìÍC‰ª“cƒC–쑺³¢C”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.

2623. mŠw‰ïn iˆê”Êu‰‰j ‹­”çÇ‚É‚¨‚¯‚é”xüˆÛÇ‚Ì„ˆÚ. ‚•i®ÆCL“c˜a‰iC‹ß“¡Œ[•¶C”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.

2624. mŠw‰ïn iˆê”Êu‰‰j “º‚ÌüˆÛ‰è×–E‚É‹y‚Ú‚·‰e‹¿. ‰““¡•½mCÔ¯“§C”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.

2625. mŠw‰ïn iˆê”Êu‰‰j ƒXƒeƒƒCƒhƒ~ƒIƒpƒ`[‚ÌProspective study. —é–ØŒúC—é–Ø‹M”ŽC‰ª“cƒC”è’õ•vi“àj: ‘æ17‰ñ“ú–{—Õ°–ƉuŠw‰ï‘‰ï i89.06.07°09), L“‡.

2626. mŠw‰ïn iˆê”Êu‰‰j SLEˆÈŠO‚ÌäPŒ´•a‚É‚¨‚¯‚é–³‹Û«œ‰óŽ€Ç(AN)‚Ì—Õ°“IŒŸ“¢. •äâ–ÎC‰ª“cƒC—é–Ø‹M”ŽC‹ß“¡Œ[•¶C”è’õ•vi“àj: ‘æ17‰ñ“ú–{—Õ°–ƉuŠw‰ï‘‰ï i89.06.07°09), L“‡.

2627. mŠw‰ïn iˆê”Êu‰‰j RƒZƒ“ƒgƒƒƒAR‘̖̂Ɖuƒvƒƒbƒg–@‚É‚æ‚錟o. ‚•i®ÆC‹ß“¡Œ[•¶C”è’õ•vi“àj: ‘æ17‰ñ“ú–{—Õ°–ƉuŠw‰ï‘‰ï i89.06.07°09), L“‡.

2628. mŠw‰ïn iˆê”Êu‰‰j Myasthenia gravis ‚ɑ΂µ‚Ä‹¹‘B‚Ì•úŽËüŽ¡—ÃŒãSLE”­Ç‚µ‚½1—á. ¼¬“c^CF쳋MC”è’õ•vi“àjC‘¼: ‘æ383‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i89.06.10),

2629. mŠw‰ïn iˆê”Êu‰‰j ‹­”çÇ’P‹…—R—ˆƒTƒCƒgƒJƒCƒ“‚ÆüˆÛ‰è×–E‚Ì‘B. ‹ß“¡Œ[•¶C‚•i®ÆC”è’õ•vi“àj: ‘æ21‰ñ“ú–{Œ‹‡‘gDŠw‰ï‘‰ï i89.07.10), “Œ‹ž.

2630. mŠw‰ïn iˆê”Êu‰‰j ŒŒŠÇ“à”ç×–E‚ÌTNFŽó—e‘Ì‚ÆIL-6ŽY¶. ‰““¡•½mCÔ¯“§C”è’õ•vi“àj: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï i89.07.20, 21), “Œ‹ž.

2631. mŠw‰ïn iˆê”Êu‰‰j TNF‚É‚æ‚éD’†‹…Šˆ«‰»‚É‹y‚Ú‚·RƒŠƒEƒ}ƒ`–ò‚̉e‹¿. ã“cŠ°”VCÔ¯“§C”è’õ•vi“àj: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï i89.07.20, 21), “Œ‹ž.

2632. mŠw‰ïn iˆê”Êu‰‰j œ‰è×–EŠ”‚É‚¨‚¯‚éIL-1ƒŒƒZƒvƒ^[‚Ì”­Œ»’²ß. ŽOã—RCÔ¯“§C”è’õ•vi“àj: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï i89.07.20, 21), “Œ‹ž.

2633. mŠw‰ïn iˆê”Êu‰‰j RAŠ³ŽÒŠŠ–Œ×–E‚ÌIL-6ŽY¶’²ß‹@˜‚ÌŒŸ“¢. …’J—fŽqCÔ¯“§C”è’õ•vi“àj: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï i89.07.20, 21), “Œ‹ž.

2634. mŠw‰ïn iˆê”Êu‰‰j Cyclic-AMP Up-regulate the Expression of the Receptors for Both Interleukin l and Tumor Necrosis Factor. Ô¯“§Cã“cŠ°”VC‰““¡•½mC”è’õ•vi“àj: 7th International Congress of Immunology i89.07.30-08.05), Berlin.

2635. mŠw‰ïn iˆê”Êu‰‰j Effects of Interleukin l (IL-1) and Tumor Necrosis Factor (TNF) on Human Vascular Endotherial Cells (EC). ‰““¡•½mCÔ¯“§C”è’õ•vi“àj: 7th International Congress of Immunology i89.07.30-08.05), Berlin.

2636. mŠw‰ïn iˆê”Êu‰‰j Induction of Interleukin-6/BSF2 Production of Osteoblast like Cell by Interleukin 1 and Tumor Necrosis Factor. ã“cŠ°”VCÔ¯“§C”è’õ•vi“àj: 7th International Congress of Immunology i89.07.30-08.05), Berlin.

2637. mŠw‰ïn iˆê”Êu‰‰j ƒTƒCƒgƒJƒCƒ“‚ÌŒŒŠÇ“à”ç×–E‹@”\‚É‹y‚Ú‚·‰e‹¿. ‰““¡•½mCÔ¯“§C”è’õ•vi“àj: ‘æ11‰ñ_“Þ쌧–Ɖu§˜b‰ï i89.09.02).

2638. mŠw‰ïn iˆê”Êu‰‰j ŠJ• ‚µ‚½ŠÌ¶ŒŸ‚ň««ƒŠƒ“ƒpŽî‚̇•¹‚ðØ–¾‚µ“¾‚½SLE‚Ì1—á. ‘å–ì‹v”üC’†ˆä‹v—YC—é–ؒ唎C–k‘º–’mŽqC‹gˆäº•vC‹k“c‹P—YC‚‹´—B˜YC”è’õ•vi“àj: ‘æ385‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i89.09.09), “Œ‹ž.

2639. mŠw‰ïn iˆê”Êu‰‰j ƒwƒ‹ƒyƒX”]‰Š‚ª‹^‚í‚ꂽCNSƒ‹[ƒvƒX‚Ì1—á. ‰¡ŠÖ”Ž—YC‰¹ŽR˜aéC•ÐŽRˆê˜NC‰q“¡ŒõC¼‰ª´C¼ŽR–ΕvCVˆätŽ}i”çj: ‘æ53‰ñ“ú–{”畆‰ÈŠw‰ï“Œ“ú–{Šwp‘å‰ï i89.09.10j, ’}”g.

2640. mŠw‰ïn iˆê”Êu‰‰j Clinical Efficacy of a New Immunosuppressive Agent: HE-69 (Mizoribine), on Lupus Nephritis. –{ŠÔŒõ•vCHŒŽ³ŽjC‰¡’£—´ˆêC‹´–{”ŽŽjC”è’õ•vC‹ß“¡Œ[•¶C“üŒðºˆê˜Y: XVIIth ILAR Congress of Rheumatology i89.09.17-23), Rio de Janeiro, Brazil.

2641. mŠw‰ïn iˆê”Êu‰‰j Studies on a Mechanism of Action and Clinical Usefulness of Lobenzarit Disodium (CCA) in Rheumatoid Arthritis. Ichikawa, Y.C”è’õ•vi“àjCTorikai, K.CKatagiri, K.CTakano, T.CHomma, M.: XVIIth ILAR Congress of Rheumatology i89.09.17-23), Rio de Janeiro, Brazil.

2642. mŠw‰ïn iˆê”Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒŠŠ–Œ×–E‚ÌIL-6ŽY¶‚É‹y‚Ú‚·IL-1, TNF‚È‚ç‚тɃÁ-INF‚Ìì—p. Ô¯“§C‰““¡•½mCã“cŠ°”VC”è’õ•vi“àj: ‘æ385‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ï‘‰ï i89.09.28).

2643. mŠw‰ïn iˆê”Êu‰‰j CNS-SLE‚É‚¨‚¯‚éNeurofilamentR‘Ì‚Ì—Õ°“IˆÓ‹`. ‰ª“cƒCÎìÍC”è’õ•vi“àj: ‘æ385‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ï‘‰ï i89.09.28).

2644. mŠw‰ïn iˆê”Êu‰‰j ƒjƒ…[ƒ‚ƒVƒXƒeƒBƒX¥ƒJƒŠƒj”x‰Š‚ð‡•¹‚µ‚½äPŒ´•a. ‰ª“cƒCL“c˜a‰iC”è’õ•vi“àj: ‘æ17‰ñ“à‰ÈŠw‚Ì“W–] i89.10.14°15).

2645. mŠw‰ïn iˆê”Êu‰‰j Monoclonal R DNP IgE R‘Ì‚É‚æ‚鎼]•a•Ï‚Ì—U“±‚Æ‚»‚̧Œä. •ÐŽRˆê˜NCŽíˆä—Ç“ñC‰¡ŠÖ”Ž—YC¼‰ª´i”çj: ‘æ19‰ñ“ú–{–ƉuŠw‰ï i89.11.00j, ŽD–y.

2646. mŠw‰ïn iˆê”Êu‰‰j •ª‰»—U“±ˆöŽq‚É‚æ‚éHL-60×–E‚ÌTNFƒŒƒZƒvƒ^[”­Œ»—U“±. Ô¯“§C‰““¡•½mCã“cŠ°”VC”è’õ•vi“àj: ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ï¥ŠwpW‰ï i89.11.14°16).

2647. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒEƒXˆ««•FŽî—R—ˆ‚̃`ƒƒWƒi[ƒ[—}§ˆöŽq‚Ì«Ž¿‚Ƹ». ‹TŽRFˆê˜Yi”çjC“c’†CŽiCHearing, V.J. (NIH): ‘æ5‰ñ“ú–{F‘f×–EŠw‰ï i89.12.00j, •Ÿ‰ª.

2648. mŠw‰ïn iˆê”Êu‰‰j ƒŠƒ“ƒp߶ŒŸ‚Ńwƒ}ƒgƒLƒVƒŠƒ“‘Ì‚ðØ–¾‚µA’˜–¾‚ÈŒŒ¬”‘‰Á‚𔺂Á‚½SLE‚Ì1—á. •äâ–ÎC‹g“cTCÎìÍC‰ª“cƒC”è’õ•vC“cè‹`ºi“àj: ‘æ388‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i89.12.09).

2649. mŠw‰ïn iˆê”Êu‰‰j JRA‚ÌŒo‰ß’†‚ÉSLE‚Ì”­Ç‚ðŒ©‚½1—á. ŠÖŽRØ•äCÎìÍC—é–ØŒúCÔ¯“§C‰ª“cƒC‹ß“¡Œ[•¶C”è’õ•vi“àj: ‘æ15‰ñ_“Þ샊ƒEƒ}ƒ`ˆã‰ï i90.02.24), ‰¡•l.

2650. mŠw‰ïn iˆê”Êu‰‰j Basedow•aA‹¹•”‘å“®–¬áŽ‚ð‡•¹‚µ‚½¶çG”^áv«œŠÖ߉Š‚Ì1—á. ¼¬“c^CXì‘CÎìr”VCs–؈ø^²CÄ“¡‹`—YC”è’õ•vi“àj: ‘æ390‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i90.03.10), ŽR—œ.

2651. mŠw‰ïn iˆê”Êu‰‰j Zinc Enhances the Interleukin-1 Activity Produced by Epidermal Cells in Culture. ŸŠ“약C‘¾“cK‘¥C•ÐŽRˆê˜NC‰q“¡ŒõC¼‰ª´C¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ï‘æ664‰ñ“Œ‹ž’n•û‰ï i90.03.17j, “Œ‹ž.

2652. mŠw‰ïn iˆê”Êu‰‰j ÚG‰ß•qÇ‚ð—U“±‚·‚éRŒ´“ÁˆÙ“Iƒwƒ‹ƒp[‚s×–EŠ”‚ÌŽ÷—§‚Æ‚»‚ÌŠˆ«‰»‹@\‚̉ðÍ. ‰¡ŠÖ”Ž—YC•ÐŽRˆê˜NC¼‰ª´i”çj: “ú–{”畆‰ÈŠw‰ï‘æ664‰ñ“Œ‹ž’n•û‰ï i90.03.17j, “Œ‹ž.

2653. mŠw‰ïn iŒöŠJuÀj Š³ŽÒ‚ƉƑ°‚Ì‚½‚ß‚ÌŒöŠJu‰‰uŒ»Ý‚ÌŽ¡—Â̖â‘è“_v. ”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.

2654. mŒ¤‹†‰ïn iˆê”Êu‰‰j PCR-SSO–@‚É‚æ‚éHLA-DRƒQƒmƒ€ƒ^ƒCƒsƒ“ƒO. ¬”¦•¶–íCˆÉ“Œˆê˜YiˆÚA–ƉujCˆÀ•”Í•vi–kŒ¤jC‹àŽq„‹viˆÚA–ƉujC‘å‹v•Û‚Ý‚Ç‚èi—\–hˆãŠwŒnjC”–Ø“oiˆÚA–Ɖuj: ‘æ33‰ñ‘gD“K‡Œ¤‹†‰ï (89.09.10), “Œ‹ž.

2655. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹}«‰ŠÇ‚É‚¨‚¯‚錌ŠÇ“§‰ß«˜´i. Ž­ŽæMi–ò—j: ‘æ2‰ñtŽ¾Š³Ž¡—ÖòŠJ”­‚ÉŠÖ‚·‚é’}”gƒtƒH|ƒ‰ƒ€ (90.03.09), ’}”g.

2656. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒ}ƒEƒX‚É‚¨‚¯‚éIgE mediated skin reaction‚ÌŒŸ“¢. •ÐŽRˆê˜NC¼‰ª´i”çj: ‘æ9‰ñ–Ɖu‚ƃAƒŒƒ‹ƒM[‚Ì‚ ‚ä‚Ý i89.05.20j, ‘åã.

2657. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹­”çÇ‚É‚¨‚¯‚é‘«‚wüŠŒ©‚Ì—Õ°“IˆÓ‹`. ”è’õ•vCã“cŠ°”Vi“àj: •½¬Œ³”N“x“Œ‹ž“s“ÁŽêŽ¾•ai“ï•ajŒ¤‹†ŒŸ“¢‰ï i89.06.03), “Œ‹ž.

2658. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒ^ƒoƒR‚É‚æ‚éå@–ƒ]‚Ì1—á. ‰¡ŠÖ”Ž—YCóˆär–íC•ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çj: ‘æ19‰ñRŒ´Œ¤‹†‰ï i89.07.01j, ’ÃŽs.

2659. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹‘åäBŽî‚𔺂¤PH‡•¹PSS‚Ì1—á. –쑺³¢CÎìÍC•äâ–ÎCÔ¯“§C‰ª“cƒC‹ß“¡Œ[•¶C”è’õ•vi“àj: ‘æ30‰ñŠÖ“ŒƒŠƒEƒ}ƒ`Œ¤‹†‰ï i89.12.09).

2660. mŒ¤‹†‰ïn iˆê”Êu‰‰j äPŒ´•aŠeŽ¾Š³‚É‚¨‚¯‚é–³‹Û«œ‰óŽ€Ç‚̊댯ˆöŽq‚Ì”äŠrŒŸ“¢. •äâ–ÎC‰ª“cƒC”è’õ•vi“àj: Œú¶È“Á’莾Š³A“Á”­«‘å‘Úœ“ª‰óŽ€Ç’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ2‰ñ”ljï‹c i90.01.25°26).

2661. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠÂóg”Á‚ð’悵‚½ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚Ì—Õ°“IŒŸ“¢. •ÐŽRˆê˜NCŽ›–{”ÍŽqCVˆätŽ}C¼‰ª´C¼ŽR–Εvi”çj: ‘æ4‰ñäPŒ´•aŒ¤‹†‰ï i90.01.26j, ‘q•~.

2662. mŒ¤‹†‰ïn iˆê”Êu‰‰j RnRNPR‘Ì—z«Š³ŽÒ‚Ì—Õ°Œo‰ß. ‹ß“¡Œ[•¶C‚•i®ÆC”è’õ•vi“àj: Œú¶È“Á’莾Š³A¬‡«Œ‹‡‘gD•a(MCTD)’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ2‰ñ‘‰ï i90.01.29).

2663. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹­”çÇ‚É‚¨‚¯‚é––½_ŒoáŠQ. ‚•i®ÆC‹ß“¡Œ[•¶C”è’õ•vi“àj: Œú¶È“Á’莾Š³A‹­”çÇ’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ2‰ñ”ljï‹c i90.01.31°02.01).

2664. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”ñtÇSLE‚ɑ΂·‚éCyclophosphamide (CY)—Ö@‚ÌŒø‰Ê. ‰ª“cƒCÎìÍC•äâ–ÎC”è’õ•vi“àj: Œú¶È“Á’莾Š³AŽ©ŒÈ–ƉuŽ¾Š³’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ2‰ñ‘‰ï i90.02.02°03), “Œ‹ž.


<<204 ¬’·E”­ˆçE‰h—{>>

2665. mŒ´’˜n ”ñ“ÁˆÙ«‘½”­«¬’°’×á‡Ç‚ɑ΂·‚éÝ‘îŒo’°¬•ª‰h—{—Ö@‚ÌŽÀÛ. Žðˆä—RC”È–ö•S‡ŽqC’|“à”üŒbŽqiŠÅŒì•”jC’|‹g—R‰ÁŽuCŸ–””º‰hi“àjC¬ìK—YC“‡“cŽœ•Fi–òÜ•”j: JJPEN, 11(7): 893`895, 1989.

2666. mŒ´’˜n ––ŠúŠàŠ³ŽÒ‚ɑ΂·‚éÝ‘îÖ¬‰h—{‚ÉŠÖ‚·‚錟“¢. ã–쑈ê˜YC‘å’J„³C“Œ”ŽC’[ŽR䎟C—é–س“¹C²X–͖ؔ¾C‰Á“¡NsC“ˆ”ömCŽOd–슰ŠìC匴÷C‘åê³–¤C”äŠé”\Ž÷iŠOjC¬ìK—YC“‡“cŽœ•F i–òÜ•”jCŠp“c‡ŽqiŠÅŒì•”j: –k—¢ˆãŠw, 19(6): 612`616, 1989.

2667. m’Z•ñn ƒVƒ“ƒ|ƒWƒEƒ€‡T‚Ì‚Ü‚Æ‚ß|¬Ž™•½t‹@”\‚Ì”­’B‚ÆŒP—û|. “¿‘Œú“ñiŽ¨•@j: ¬Ž™Ž¨•@ˆôA‰ÈC10(1): 8`9, 1989.

2668. mÇ—á•ñn •Øo‚̃^ƒCƒ~ƒ“ƒO‚É‹ê—¶‚µ‚½dÇ”DP’†“ÅÇAITP‡•¹‚Ì”DP’†ŠúIUGR‚Ì1—á. ’F‰pŽ÷CŒË‰êè‹`–¾C–ì“c–FlCª–{‘‘ˆêC“cŠ‹`WC‹gŒ´ˆêC¼“‡³”ŽC“‡“cMGCVˆä³•viŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 26(1): 21`28, 1989.

2669. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj Medical Topics Series 2 —Õ°‰h—{'89; ‚—îŽÒ‚É‚¨‚¯‚é‰h—{—Ö@Cp.121`131C ²“¡“oŽu˜Yi¶—jC”’‘é‘’jiˆã—pî•ñj. •ÒW ã“c®•Fi‘åã‘åj•ÒC ƒƒfƒCƒJƒ‹ƒrƒ…|ŽÐ, ‘åã, 89.11.30”­s.

2670. mŠw‰ïn iˆê”Êu‰‰j “dŽqŽ«“TƒVƒXƒeƒ€iQRSj‚ð—p‚¢‚½‰h—{Žw“±ƒVƒXƒeƒ€. ”’‘é‘’jC’|“ດŽC’r“cŒ›ºC‹{Œ´‰p•viˆã—pî•ñjC²“¡“oŽu˜Yi¶—jC¼“cÝŒ«iƒAƒLƒ‰ƒbƒNƒXj: ‘æ28‰ñ“ú–{MEŠw‰ï‘å‰ï (89.05.23), ‘åãC ˆã—p“dŽq‚ƶ‘ÌHŠwC27(“Á•Ê): 127, 1989.

2671. mŠw‰ïn iˆê”Êu‰‰j ƒpƒ\ƒRƒ“‚É‚æ‚éHŽ–—Ö@‰î•ƒVƒXƒeƒ€. ”’‘é‘’jC‹{Œ´‰p•vC’|“ດŽC’ß“c—z˜aC’r“cŒ›ºiˆã—pî•ñjC²“¡“oŽu˜Yi¶—j: ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï (90.02.03), “Œ‹ž, ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï˜_•¶W, p.841`842, 1990.


<<205 ‘ÙŽ™EV¶Ž™Eæ“VˆÙíEŠïŒ`>>

2672. mŒ´’˜n •ª•ØŽž‚̈Ùí‘ÙŽ™S””}. ¼“‡³”ŽiŽY•wj: ŽY•wl‰È‚ÌŽÀÛ, 38(7): 1023`1029, 1989.

2673. mŒ´’˜n NST‚¨‚æ‚Ñ‘ÙŽ™ŽhŒƒ‚É‚æ‚éfetal distress‚Ì—\’m. ¼“‡³”ŽCª–{‘‘ˆêiŽY•wj: ŽY•wl‰È‚ÌŽÀÛ, 39(1): 13`17, 1990.

2674. mŒ´’˜n ‘ŽY‚ƕꎙŠ´õ. “‡“cMGC’F‰pŽ÷C–ì“c–FliŽY•wj: ŽüŽYŠúˆãŠw, 19(11): 1587`1592, 1989.

2675. mŒ´’˜n SFD‚ÌdÇ“x‚É‚æ‚éV¶Ž™‚Ì“K‰ž‚ÆŠÇ—. ¬ŒûO‹BCŠ—Œ´FC‚“cŽj’jC–ì“n³•FCmŽu“c”ŽŽiiŽ™j: ŽüŽYŠúŠw‰ïŽGŽ, 7: 136`147, 1989.

2676. mŒ´’˜n ‘ŽY’áo¶‘ÌdŽ™‚ÌRDS”­Ç‚ÉŠÖ‚·‚éŽY‰È—vˆö‚ÆŽ™‚Ì—\Œã‚ɂ‚¢‚Ä. A–ìM…C’F‰pŽ÷C’Jº”ŽC–ì“c–FlC‹gŒ´ˆêC¼“‡³”ŽC“‡“cMGCVˆä³•viŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 26(1): 16`20, 1989.

2677. mŒ´’˜n “–‰@‚É‚¨‚¯‚éæ“V«…“—Ç‚Ì—Õ°“IŒŸ“¢. —§‰ª˜aOC¯“c—²CA–ìM…C–ì“c–FlC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 26(2): 52`56, 1990.

2678. mŒ´’˜n Color Doppler –@‚¨‚æ‚Ñ Pulsed Doppler –@‚É‚æ‚éo¶‘Šú‚̬nŽ™‚¨‚æ‚Ñ–¢nŽ™‚Ì“®–¬ŠÇ‚ð‰î‚·‚é’Z—ŒŒ—¬‚Ì•ªÍ. ¬ŒûO‹BCŠ—Œ´FC‚“cŽj’jC•½Î‘C”ª‘ãŒö•viŽ™j: “ú–{V¶Ž™Šw‰ïŽGŽ, 25(2): 323`329, 1989.

2679. m’Z•ñn –¢nŽ™•ª•Ø‚ƒ鉤؊J;‚»‚Ì¡“ú“I’茩. Vˆä³•vC¼“‡³”ŽiŽY•wj: ˆãŠw‚Ì‚ ‚ä‚Ý, 149(2): 99, 1989.

2680. mÇ—á•ñn ‘gDŠw“I‚Ɉ««‚Æl‚¦‚ç‚ꂽ¬Ž™non-functioning pheochromocytoma‚Ì1—á. Γc˜a•vC¬ŽÅÍ„C–ÈŠÑ•¶•vCˆ¢‘]OˆêiŠOjC“‡–{—R‹IŽqCדc‚Ì‚¼‚ÝiŽ™jC‘å•”½i•a—j: ¬Ž™ŠO‰È, 21(11): 1205`1209, 1989.

2681. mÇ—á•ñn •ª—£Žèp‚ÌŒoŒ±—áFˆê•û‚ªŽ€–S‚µ‚½‹¹• Œ‹‡‘Ì‚¨‚æ‚Ñ“ñ“ª“ñŽˆŽl˜rŒ‹‡‘Ì‚ÌŒoŒ±. ’†ðr•vC‹k“s_•½i“Œ‘åjCHŽR—miŽ­Ž™“‡‘åjCΓc˜a•viŠOjC‘¼: ¬Ž™ŠO‰È, 21(5): 515`522, 1989.

2682. mÇ—á•ñn æ“V«Œz•”á‘E:V¶Ž™—á‚ɂ‚¢‚Ä|‘¤Œz”X–E‚Ì2V¶Ž™—á|. Γc˜a•vCˆ¢‘]OˆêCŠÔ’†½iŠOj: ¬Ž™ŠO‰È, 21(7): 791`796, 1989.

2683. mÇ—á•ñn —r…‰ß‘½¥‘ÙŽ™…Žî‚ð‚«‚½‚µ‚½‘Ù”ÕŒŒŠÇŽí‚Ì1—á. –ì“c–FlC’F‰pŽ÷C’†Œ´—DlC¼“‡³”ŽC“‡“cMGCVˆä³•viŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 26(1): 51`54, 1989.

2684. mÇ—á•ñn ŒƒÇ‚ÈŒo‰ß‚ð‚Æ‚Á‚½–ƒ]‡•¹”DP‚Ì1—á. ¯“c—²C–ì“c–FlCA–ìM…C‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 26(2): 42`46, 1990.

2685. mÇ—á•ñn MNŽ®ŒŒ‰tŒ^•s“K‡‚É‚æ‚é‚ÆŽv‚í‚ꂽV¶Ž™—nŒŒ«Ž¾Š³‚Ì1Ç—á. –ì“c–FlC’F‰pŽ÷CA–ìM…C¼“‡³”ŽC“‡“cMGiŽY•wjC¬ŒûO‹BiŽ™jC¼“c—zi—Õ•a—j: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 26(2): 57`60, 1990.

2686. m—Õ°Ž¡Œ±n ŒûŠW”S–Œ•Ù–@‚ÌpŒãŒ¾Œê¬Ñ. —é–ØŒbŽqC‰ª–{˜NŽqCŒ´—R‹IiŽ¨•@jC’·’Jì˜aŽqiz–KÔ\Žš•a‰@jCV”ü¬“ñiŽ¨•@jC’¹Ž”ŸsC‰–’JMKiŒ`ŠOjCãÎOi‹ß‘åj: “ú–{ŒûŠW—ôŠw‰ïŽGŽ, 14(1): 123`131, 1989.

2687. m‘àn V¶Ž™“à‰ÈŽ¾Š³‚É‚¨‚¯‚é ECMO ‚̉ž—p. ¬ŒûO‹BiŽ™j: ˆãŠw‚Ì‚ ‚ä‚Ý, 150(8): 523`526, 1989.

2688. m‘àn ‚킪‹³Žº‚É‚¨‚¯‚é‘ÙŽ™ŠÇ—. Vˆä³•vC‹gŒ´ˆêCª–{‘‘ˆêC“cŠ‹`WiŽY•wjC‘O“c“OiŠÅŒìŠw•”j: ŽY•wl‰ÈŽ¡—Ã, 58(5): 574`577, 1989.

2689. m‘àn Persistent Fetal Circulation (PFC) |Œ´ˆöCf’fCŽ¡—Ã|. ¬ŒûO‹BiŽ™j: ¬Ž™‰È, 30(10): 1131`1145, 1989.

2690. m‘àn zŠÂŠÇ—. ¬ŒûO‹BiŽ™j: ¬Ž™ŠÅŒì, 12(10): 1286`1296, 1989.

2691. muÀn ƒxƒr|‚Ì‚½‚ß‚ÌV¥‚­‚·‚èuÀ|“®–¬ŠÇ•Â½–ò|. ¬ŒûO‹BiŽ™j: NICU, (4): 66`72, 1990.

2692. muÀn “®–¬ŠÇŠJ‘¶Ç‚Ì•a‘Ô¶—. ¬ŒûO‹BiŽ™j: NICU, 2(10): 30`38, 1989.

2693. muÀn ‘ÙŽ™‰¼Ž€‚Ìf’f‚ÆŽ¡—Ã. ¼“‡³”ŽiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ, 41(7): N°116`119, 1989.

2694. mŠwp‘n iŽ·•Mj ƒvƒ‹ƒ~ƒGŽY•wl‰ÈŠe˜_; V¶Ž™‰¼Ž€CV¶Ž™‚̌ċzŠíŽ¾Š³CV¶Ž™‚ÌS‘Ÿ¥ŒŒŠÇŽ¾Š³C•ª•Ø‘¹, p.265`278, “‡“cMGC’F‰pŽ÷iŽY•wj. •ÒW H’J´i“Œ‹žˆã‘åj•Ò, ˆãŽ•–òo”Å, “Œ‹ž, 89.11.10 ”­s.

2695. m‹³‰È‘n iŽ·•Mj NICUƒ}ƒjƒ…ƒAƒ‹; ’´‰¹”g’f‘wŒŸ¸|2.S, p.280`286, ¬ŒûO‹BiŽ™j. •ÒW V¶Ž™ˆã—ØA—‰ï•ÒC ‹àŒ´o”Å, “Œ‹ž, 89.05.15”­s.

2696. m‹³‰È‘n iŽ·•Mj V¶Ž™‚Ìf—ÂƌŸ¸; 8. ’´‰¹”g, b. S‘Ÿ, p.357`366, ¬ŒûO‹BiŽ™j. •ÒW ¬ì—Y”V—ºC‘½“c—TCmŽu“c”ŽŽiC •ÒC “Œ‹žˆãŠwŽÐ, “Œ‹ž, 89.10.30”­s.

2697. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj NICUƒ}ƒjƒ…ƒAƒ‹; Žå—v’¥Œó‚ɑ΂·‚éf’fŠw“IƒAƒvƒ|ƒ`‚ÆŠÇ—|šM“ûáŠQCšq“fC• •”–c–žCp.73`80, –åˆäL‹ÅiŽ™j. •ÒW V¶Ž™ˆã—ØA—‰ï•ÒC ‹àŒ´o”Å, “Œ‹ž, 89.05.15”­s.

2698. mŠw‰ïn i‹³ˆçu‰‰j Ô‚¿‚á‚ñ‚É“d˜b‚µ‚Ă݂悤. “‡“cMGiŽY•wj: ‘æ3‰ñ_“Þ쌧•ê«‰q¶Šw‰ï (90.02.03), ‰¡•l.

2699. mŠw‰ïn i‹³ˆçu‰‰j V¶Ž™‚Ì“K‰ž¶—|zŠÂ‚Ì“K‰ž|. ¬ŒûO‹BiŽ™j: ‘æ25‰ñ“ú–{V¶Ž™Šw‰ï‘‰ï i89.07.02), “Œ‹ž.

2700. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ŽüŽYŠú‚É‚¨‚¯‚é–¢nŽ™”]áŠQ‚Ì—\–h|Intrapartum‚©‚ç|. ’F‰pŽ÷iŽY•wj: ‘æ25‰ñ“ú–{V¶Ž™Šw‰ï‘‰ï (89.07.04), “Œ‹žC ƒvƒƒOƒ‰ƒ€Cp.102`103, 1989.

2701. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j gŽüŽYŠú‚Ì–ƒŒhƒnƒCƒŠƒXƒNŽ™‚Ì‘Îô. ¬ŒûO‹BC–ì“n³•FiŽ™j: ŠÖ“ŒbM‰z–ƒŒŠw‰ï (89.10.07), “Œ‹ž.

2702. mŠw‰ïn iƒpƒlƒ‹j o¶‘Of’f‚Å‘˜‹ö‚µ‚½ƒ^|ƒi|ÇŒóŒQ‚Ì‚P—á. –î•”“TŽqCät“n’‰’jC˜a“c’m‰vi—Õ•a—jCŽsìŒbŽqi‘‡—Õ°ŒnjCät“n•üŽqC‘å–쓹Žqi—ÕŒŸjC‹gŒ´‹žŽqC¼M»C‘O“c“OiŽY•wjC‘å’J‰pŽ÷i—Õ•a —j: ‘æ35‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (88.10.20), ŽRŒû.

2703. mŠw‰ïn iƒpƒlƒ‹j ”]ŽºŽüˆÍ«”’Ž¿“(PVL)‚É‚¨‚¯‚鎥‹C‹¤–‰摜f’f‚Ì—L—p«‚ÌŒŸ“¢. –쑺ƒŽqiŽ™j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (89.05.19), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(3): 245, 1989.

2704. mŠw‰ïn iƒpƒlƒ‹j –³“ª–³S‘Ì‚Ì2–UŒŸ—á. ‚ˆä’qŽqC‘å•”½C‰œ•½‰ë•Fi•a—j: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.29), •Ÿ‰ª, “ú–{•a—Šw‰ï‰ïŽ, 79(1): 131, 1990.

2705. mŠw‰ïn iˆê”Êu‰‰j HPLC‚É‚æ‚é”A’†—tŽ_ŠÖ˜AƒvƒeƒŠƒWƒ“—U“±‘Ì•ªÍ‚ÌŒŸ“¢‚Æ‚»‚Ì—Õ°“IˆÓ‹`. “àŽRKMC“n•Ó—Ç•FC‘å’J‰pŽ÷i—Õ•a—jC‘O“c’‰LC÷ˆäŒc‘¢C”·—EŽŠi—ÕŒŸj: ‘æ35‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (88.10.20), ŽRŒû, —Õ°•a—, 36(•â): 96, 1988.

2706. mŠw‰ïn iˆê”Êu‰‰j ƒVƒoƒ„ƒM‘ÙŽe‚É‚¨‚¯‚éŒo•êbŽ_‘f“Š—^‚Ì‘ÙŽeŒŒ‰tƒKƒX“®‘Ԃւ̉e‹¿. ‹gŒ´ˆêCŒ¹“c’C—YCA–ìM…C’F‰pŽ÷C¼“‡³”ŽC“‡“cMGCVˆä³•viŽY•wj: ‘æ41‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï (89.04.03), ‰ªŽRD

2707. mŠw‰ïn iˆê”Êu‰‰j ”DPŠeT‚É‚¨‚¯‚é‘ÙŽ™•t‘®•¨‚ÌŒŸ“¢‹y‚Ñ‘ÙŽ™‚Æ‚ÌŠÖŒW‚ɂ‚¢‚Ä. ¯“c—²C–ì“c–FlC—§‰ª˜aOCA–ìM…CóˆämŽiC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGCVˆä³•viŽY•wj: ‘æ77‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.06.18), “Œ‹ž.

2708. mŠw‰ïn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é…“—ÇÇ—á‚Ì—Õ°“IŒŸ“¢. —§‰ª˜aOC¯“c—²CA–ìM…C–ì“c–FlCª–{‘‘ˆêC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGCVˆä³•viŽY•wj: ‘æ77‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.06.18), “Œ‹ž.

2709. mŠw‰ïn iˆê”Êu‰‰j •ª•ØŽž‚Ì•ê‘Ì‚Ö‚ÌŽ_‘f“Š—^‚ªä`‘ÑŒŒ‚ÌŒŒ‰tƒKƒX“®‘Ô‚Ö—^‚¦‚é‰e‹¿. ‹gŒ´ˆêC¯“c—²CŠâ’JO–¾C‹ªˆüCª–{‘‘ˆêC¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ25‰ñ“ú–{V¶Ž™Šw‰ï‘‰ï (89.07.04), “Œ‹ž.

2710. mŠw‰ïn iˆê”Êu‰‰j Œã• –ŒŒ´”­‘ÙŽ™«Šà‚Ì1—á. ŒàŠ²ƒCŒÃ”¨½”VC–{“c’¼NC“¡–ì’WlC^‰ºß•vC΋´WC¬ŽÄŒ’i”åj: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï (89.09.30), ‘Š–ÍŒ´.

2711. mŠw‰ïn iˆê”Êu‰‰j ‘ÙŽeŠú‘nŽ¡–ü; ŠÔ[D×–E‚Ì«Ž¿. –{—Ñ—R”üŽqi¶‰»ŒnjC’–Œ´ß”V‰îiŒ`ŠOj: “ú–{“®•¨Šw‰ï‘æ60‰ñ‘å‰ï (89.10.04), ‹ž“s, Zoological Science, 6(6): 1201, 1989.

2712. mŠw‰ïn iˆê”Êu‰‰j The Change of Atrial Natriuretic Peptide during Graded Fetal Hypoxia. ‹gŒ´ˆêCA–ìM…Cª–{‘‘ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: The 2nd World Symposium: Computers in the Care of the Mother, Fetus and Newborn (89.10.24), ‹ž“s.

2713. mŠw‰ïn iˆê”Êu‰‰j Ø”—‘ŽY”D•w‚©‚ço¶‚µ‚½Ž™‚Ì’·Šú—\Œã‚ɂ‚¢‚Ä. ’Jº”ŽCA–ìM…C–ì“c–FlC—§‰ª˜aOC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ78‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.10.29), ‘å‹{.

2714. mŠw‰ïn iˆê”Êu‰‰j ŒûŠW—ôƒ`|ƒ€ƒAƒvƒ|ƒ`‚ÆŒ¾ŒêŠÇ—. —é–ØŒbŽqC‰ª–{˜NŽqCŒ´—R‹IiŽ¨•@jCV”ü¬“ñi“Œ‘åjC’¹Ž”ŸsiŒ`ŠOj: “ú–{‰¹ºŒ¾ŒêˆãŠw‰ï (89.11.11), ˆ¤’mC ‘æ34‰ñ“ú–{‰¹ºŒ¾ŒêˆãŠw‰ï‘‡Šwpu‰‰‰ï—\eW, p.126, 1989.

2715. mŠw‰ïn iˆê”Êu‰‰j –j”S–Œ‹Ø•Ù–@‚É‚æ‚éŒûŠWŒ`¬p‚ÌpŒã•]‰¿‚¨‚æ‚ÑpŽ®‚̉ü—ǂɂ‚¢‚Ä. ’†–kMºC‘O“c‰Ø˜Yi_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[jC‘厜–í—T”VC‰F’Öؗ´ˆêiŒ`ŠOjC‘Oì“ñ˜Yi‰¡•lŽs‘åj: ‘æ32‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i89.04.21), ‰YˆÀ.

2716. mŠw‰ïn iˆê”Êu‰‰j Ž²Œã«‘½æäÇ‚ÌpŒã•]‰¿. ‰FˆäŒª“ñCˆÉ“¡³ŽkC”’èËWCŽÄ“c—T’BC‰–’JMKiŒ`ŠOj: ‘æ32‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i89.04.21), ‰YˆÀ, “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 9(—Õ‘): 268, 1989.

2717. mŠw‰ïn iˆê”Êu‰‰j ¶Œã24ŽžŠÔˆÈ“à‚É”­Ç‚µ‚½V¶Ž™‰¡Šu–Œƒwƒ‹ƒjƒA—á‚ÌŒŸ“¢|Ž€–S—á‚ð’†S‚Æ‚µ‚Ä|. Γc˜a•vC‘å‹{“Œ¶Cˆ¢‘]OˆêiŠOjC¬ŒûO‹BCŠÖª“OCŠ—Œ´FiŽ™j: ‘æ26‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï i89.06.08), ç—t, “ú–{¬Ž™ŠO‰ÈŠw‰ïŽ, 25(3): 473, 1989.

2718. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒgãó×–EÄW‡‘Ì‚©‚ç–Ñ•ï‚ðŒ`¬‚³‚¹‚鎎‚Ý. “n•Ó^—ŽqC’·”öŒb—ŽqC’–Œ´ß”V‰îiŒ`ŠOj: “ú–{“®•¨Šw‰ï‘æ60‰ñ‘å‰ï i89.10.04), ‹ž“s, Zoological Science, 6(6): 1201, 1989.

2719. mŠw‰ïn iˆê”Êu‰‰j ƒT|ƒtƒ@ƒNƒ^ƒ“ƒg–³Œø—á‚Ì—Õ°‘œ. ¬ŒûO‹BC–ì“n³•FCŠ—Œ´FC’†‘ºP•äCÄ“¡KˆêC–åˆäL‹ÅC”ª‘ãŒö•viŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï i89.10.27), ‘å‹{.

2720. mŠw‰ïn iˆê”Êu‰‰j dÇ”sŒŒÇŠ³Ž™‚Å‚Ì Vancomycin ‚ÌŽg—pŒoŒ±iŒŒ’†”Z“xƒ‚ƒjƒ^ƒŠƒ“ƒO‚Ì•K—v«‚ɂ‚¢‚Äj. ŠÖª“OCŠ—Œ´FC–åˆäL‹ÅC¬ŒûO‹BC”ª‘ãŒö•viŽ™jC¼“c—zi—Õ•a—jC‹gŽR—F“ñi–òŠw•”jC‚‹´‰Á‘ãŽqi—ÕŒŸjC‹ß“¡—¯”üŽqC–]ŒŽ^‹|i–òÜj: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï i89.10.27), ‘å‹{.

2721. mŠw‰ïn iˆê”Êu‰‰j ’´–¢nŽ™ SFD ‚Ì—Õ°ŒŸ“¢. Š—Œ´FC¬ŒûO‹BC–åˆäL‹ÅCÄ“¡KˆêC’†‘ºP•äC»‰ŸÂC–ì“n³•FiŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï i89.10.27), ‘å‹{.

2722. mŠw‰ïn iˆê”Êu‰‰j ”XŽîó‘Ù•Ö«• –Œ‰Š‚Ì5—á‚É‚¨‚¯‚é•a‘Ô¥ŠÇ—‚ɂ‚¢‚Ä. ã–ìM–íC¬ŒûO‹BC’†‘ºP•äC–åˆäL‹ÅCŠ—Œ´FC–ì“n³•FCˆÀ•ÛŒ«ˆêCŠ`À—R•FC”ª‘ãŒö•viŽ™jCΓc˜a•viŠOj: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï i89.10.28), ‘å‹{.

2723. mŠw‰ïn iˆê”Êu‰‰j ‹‘å‚È Nasopharyngeal teratoma ‚Ì1Ç—á. ‘åι–çC–ì“n³•FC’†‘ºP•äC¬ŒûO‹BC”ª‘ãŒö•viŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï i89.10.28), ‘å‹{.

2724. mŠw‰ïn iˆê”Êu‰‰j “®–¬ŠÇ“àŒŒ—¬”gŒ`•ªÍ‚Ì—Õ°“IˆÓ‹`. ¬ŒûO‹BCŠ—Œ´FCÄ“¡KˆêC’†‘ºP•äC•½Î‘C”ª‘ãŒö•viŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï i89.10.28), ‘å‹{.

2725. mŠw‰ïn iˆê”Êu‰‰j Ò’ÅŠïŒ`‚𔺂¤’¼’°ãè–åd•¡Ç‚Ì1—á. Γc˜a•vC–x—²CŒÃ“cˆê“¿iŠOjCŠâŸºŒ[ˆêi•a—j: ‘æ24‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i89.11.11), ‘O‹´.

2726. mŒ¤‹†‰ïn i“Á•Êu‰‰j ŽüŽYŠú‚Ìŋ߂̃gƒsƒbƒNƒX. ¼“‡³”ŽiŽY•wj: •ŸˆäŽsŽY•wl‰Èˆã‰ï (89.06.30), •Ÿˆä.

2727. mŒ¤‹†‰ïn i“Á•Êu‰‰j ‘ÙŽ™‰¼Ž€‚ÌŠÇ—. ¼“‡³”ŽiŽY•wj: “ú–{•ê«•ÛŒìˆã‹¦‰ïå‘äŽOƒuƒƒbƒNŠwpu‰‰‰ï (89.08.25), å‘ä.

2728. mŒ¤‹†‰ïn i“Á•Êu‰‰j ŽüŽYŠúˆãŠw‚ÌÅ‹ß‚Ìi•à. “‡“cMGiŽY•wj: ‘æ4‰ñH“cŒ§ŽüŽYŠú¥V¶Ž™ˆã—ÃŒ¤‹†‰ï‘‰ï (89.10.14), H“c.

2729. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j NST‚ÌV‚µ‚¢f’f¥ƒNƒ‰ƒX•ª—Þ. “‡“cMGiŽY•wj: ‘æ2‰ñŽÀ’nˆã‰Æ‚Æ•ŽY•w‚Ì‚½‚ß‚ÌŽüŽYŠúƒZƒ~ƒi[ (89.07.29), ŽD–y.

2730. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œv‰æ•ª•Ø‚É‚¨‚¯‚镪•Ø‘O’´‰¹”gŒŸ¸‚̈Ӌ`. A–ìM…Cª–{‘‘ˆêC‹ªˆüC–ì“c–FlC’Jº”ŽC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: •ª•ØŠÇ—Œ¤‹†‰ï (89.07.02), “Œ‹ž.

2731. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘ÙŽ™‰¼Ž€‚ÌŠÇ—. ¼“‡³”ŽiŽY•wj: ”’‹‰¶ˆã‰È‘åŠwŠwpŒð—¬–K–â’cu‰‰‰ï (89.08.14), ’·tŽs.

2732. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒƒÇ‚ÈŒo‰ß‚ð‚Æ‚Á‚½–ƒ]‡•¹”DP. ¯“c—²C–ì“c–FlC’Jº”ŽCA–ìM…C‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ296‰ñŽl…‰ï (89.09.20), “Œ‹ž.

2733. mŒ¤‹†‰ïn iˆê”Êu‰‰j NST, CST‚Æ‘Ù“àŽ¡—Ã. ¼“‡³”ŽiŽY•wj: ‘Š–ÍŒ´ŽsŽY•wl‰Èˆã‰ï (89.09.20), ‘Š–ÍŒ´, ‘Š–ÍŒ´ŽsˆãŽt‰ï•ñ, (299): 14`15, 1989.

2734. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŽY•wl‰È‚É‚¨‚¯‚éŋ߂̃gƒsƒbƒNƒXiŽå‚Æ‚µ‚Ä”DP’†°•ª•ØŽž‚Ì‘ÙŽ™‰¼Ž€‚ÌŠÇ—‚ɂ‚¢‚Äj. ¼“‡³”ŽiŽY•wj: ‚À¥ŠC˜V–¼ŽY•wl‰Èˆã‰ï (89.11.28), Œú–Ø.

2735. m‚»‚Ì‘¼iŒ¤‹†‰ï‰ï’·jn ‘æ6‰ñ“ú–{“ñ•ªÒ’ÅŒ¤‹†‰ï‰ï’·, 1989.7.1, –î“cŒ«ŽOi”]ŠOj.


<<206 “à•ª”åE‘ãŽÓ>>

2736. mŒ´’˜n Sensitive Assay of Cytochrome P450SCC Activity by High-Performance Lquid Chromatography. ›–ìKŽqCX“‡’¼•FiŠÅŒìŠw•”jC’r“c•ä‚C–x]Ž •vi¶‰»j: Anal. Biochem., 182: 327`333, 1989.

2737. mŒ´’˜n Amino Acid Sequence and Relative Biological Activity of Eel Atrial Natriuretic Peptide. ’|ˆä˘Yi¶—jC‚‹´–¾‹`i•ª¶jC“n•Ó‘ìŽiCK. NakajimaCS. Sakakibaraiƒyƒvƒ`ƒhŒ¤j: Biochem. Biophys. Res. Commun., 164(1): 537`543, 1989.

2738. mŒ´’˜n Usefulness of Anaerobic Threshold in Estimating Intensity of Exercise for Diabetics. ‰Í˜HWˆêC“¡“c–F–MC–‹`’‰i“àjC”’‘é‘’ji¶—jC‹v•Û”Žºi–òŠw•”j: Diabetes Res. Clin. Prac., 6: 303`309, 1989.

2739. mŒ´’˜n Relationship between Age-adjusted Heart Rate and Anaerobic Threshold in Estimating Exercise Intensity in Diabetics. “¡“c–F–MC‰Í˜HWˆêC‹àXWC“Iê´˜aC–‹`’‰i“àjC’|“ດŽiˆãîjCΈäŒö“¹i“àj: Diabetes Res. Clin. Prac., 8: 60`74, 1990.

2740. mŒ´’˜n Brain Natriuretic Peptide-Like Immunoreactivity Is Present in Human Plasma. •xŠ~˜a”üi–k—¢ƒ‰ƒ{jC•½“cŒ‹Šìi“Œ‹žˆãŽ•‘åjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC’|ˆä˘Yi¶—jCìã³–çi•ª¶jCŠÛ–Ε¶ºi“Œ‹žˆãŽ•‘åj: FEBS Letters, 250(2): 235`237, 1989.

2741. mŒ´’˜n ”|—{‚É‚æ‚éƒqƒgbó‘B×–E‹@”\‚ÌŒ¤‹†|bó‘BŠà×–E‚Ìî•ñŽó—e“`’B‹@\‚̈Ùí|. ˆ¢•”D•¶i“àj: Human Cell, 2(3): 238`245, 1989.

2742. mŒ´’˜n Epidermal Growth Factor (EGF) Receptors in Plasma Membranes of Normal and Diseased Human Thyroid Glands. ‹àXWCˆ¢•”D•¶C–‹`’‰i“àjCY. ManabeCˆÉ“¡š •FiˆÉ“¡•a‰@j: J. Clin. Endocrinol. Metab., 68(5): 899`903, 1989.

2743. mŒ´’˜n The Role of ras Oncogene Product p21 in Human Thyroid Tissue. ˆ¢•”D•¶C‹àXWC–‹`’‰i“àj: Kitasato Arch. Exp. Med., 62(1): 72`74, 1989.

2744. mŒ´’˜n ƒoƒZƒhƒE•aŠáÇ‚É‚¨‚¯‚éRŠá‹ØR‘Ì‚Ì“ÁˆÙ«‚Æ‚»‚ÌRŒ´‚ÌŒŸ“¢. ˆ¢•”D•¶C–ìX‘º–í¶C‚“cˆê‘¾˜YC‹àXWC–‹`’‰i“àjCˆäã—mˆêCˆÉ“¡š •FiˆÉ“¡•a‰@j: Modern Physician, 9(11): 1586`1590, 1989.

2745. mŒ´’˜n Burst forming unit erythroid (BFU-E) ‘ª’èŒn‚É‚¨‚¯‚é×–E‘BŽhŒƒŒø‰Ê‚æ‚è‚Ý‚½gGrowth without GH" Ç—á‚Ìg’·”­ˆç‘£i‚Ì‹@˜|’Pƒ«”ì–ž‚Æ‚Ì”äŠrŒŸ“¢|. ‘åŽR‹XGC›šà†‹ÊC‰¡“csŽjC—`…—²iŽ™j: ƒzƒ‹ƒ‚ƒ“‚Æ—Õ°C37(6): 471`475, 1989.

2746. mŒ´’˜n ƒqƒgbó‘B×–E‚É‚¨‚¯‚郉ƒX‚ª‚ñˆâ“`Žq‚Ì”­Œ»‚ƈâ“`ŽqŽY•¨p21‚Ì‹@”\‚ÉŠÖ‚·‚錤‹†. ˆ¢•”D•¶C‹àXWC–‹`’‰i“àjCˆÉ“¡š •FiˆÉ“¡•a‰@j: ƒzƒ‹ƒ‚ƒ“‚Æ—Õ°iH‹G‘Š§j, 37: 121`128, 1989.

2747. mŒ´’˜n ƒ}ƒXƒXƒNƒŠ|ƒjƒ“ƒO‚Å”­Œ©‚³‚ꂽæ“V«bó‘B‹@”\’ቺNJ³Ž™‚É‚¨‚¯‚é¸__ŒoŠw“I—\Œã‘S‘’²¸¬Ñ. ’†“‡”Ž“¿C²“¡_ˆêC’–ŒÒO–¾iç—t‘åjC¼‰YM•vi–k‘åjC‰ª’ëMˆêi‘åŠÙŽs—§‘‡•a‰@jCŒÜ\—’—Ti“Œ–k‘åjC‰¡ŽRV‹giŽRŒ`‘åjC‰ª•”ˆê˜YiŽ©Ž¡ˆã ‘åjCŽRŒûCˆêié‹ÊŒ§—§¬Ž™ˆã—ÃZƒ“ƒ^|jC“y‰®—Ti“s—§´£¬Ž™•a‰@jC‘º“cŒõ”Íi“Œ‹ž—Žqˆã‘åjC‘åŽR‹XGiŽ™jCX“N•vi‘—§—×{Š“Œ¼–{•a ‰@jCΕ˜a³i•xŽRŒ§—§’†‰›•a‰@jC²“¡•Ûi‹à‘ò‘åjCÄ“¡‹vŽqi–¼ŒÃ‰®Žs‘åjC‘å–î‹IºiŽ ‰êˆã‘åjC•Sˆä‹œi‹ž‘åjC‹g‰ªÍi“ޗLjã‘åjC¬¼˜aF i‘åãˆã‘åjC‚‹´—˜˜ai_ŒË‘åjC‹½ŽiŽŒÈi•ºŒÉŒ§—§‚±‚Ç‚à•a‰@jC¼”ü˜aiL“‡Ô\ŽšEŒ´”š•a‰@jC’–•û”ŽŽqi•Ÿ‰ª‘åjC–ì“c³‹IiŽY‹Æˆã‘åjCsŽÀ ¬“¿i‹v—¯•Ä‘åjCŠŒ´^li‘啪Œ§—§•a‰@jC¼ŽR@˜ZiŒF–{‘åjC¬–쯌áiŽ­Ž™“‡‘åj: “ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(9): 2011`2016, 1989.

2748. mŒ´’˜n “œ”A•a«‰óásÄ”­—á‚Ì—Õ°“I“Á’¥‚È‚ç‚Ñ‚ÉÄ”­ŠëŒ¯ˆöŽq. –‹`’‰C‹àXWC“¡“c–F–MC“Iê´˜aC‰Í˜HWˆêCŽç‰®’B”üCâ–{—mŽqC–ìX‘º–í¶C‘å˜a“c—¢i“àj: –k—¢ˆãŠw, 19(5): 510`517, 1989.

2749. mŒ´’˜n “œ”A•a‚É‚¨‚¯‚é”A’†ƒAƒ‹ƒuƒ~ƒ“”rŸ•; timed overnight urine‚É‚æ‚錟“¢. –‹`’‰CŽç‰®’B”üC‰Í˜HWˆêC“Iê´˜aC“¡“c–F–MC‹àXWCˆ¢•”D•¶C‚“cˆê‘¾˜YC–ìX‘º–í¶C‘å˜a“c—¢C•½ˆä–@”Ži“àj: –k—¢ˆãŠw, 19(6): 575`582, 1989.

2750. mŒ´’˜n ŠeŽí•‰‰×ŽŽŒ±‚É‚¨‚¯‚éRRŠÔŠu‚ÌŽ©“®Œv‘ªƒVƒXƒeƒ€‚Ìì¬. ’|“ດŽC’r“cŒ›ºiˆã—pî•ñjC“¡“c–F–Mi“àjC“c’†ŠÚ–¾”Ži¶•¨•¨—Œnj: –k—¢ˆãŠw, 19: 336`339, 1989.

2751. mŒ´’˜n ƒCƒ“ƒXƒŠƒm[ƒ}6—á‚ÌäXB×–E‹@”\‚È‚ç‚Ñ‚É‹ÇÝf’f. â–{—mŽqC‚“cˆê‘¾˜YC–Ø“cŒõLCŽç‰®’B”üC‰Í˜HWˆêC‹àXWC“Iê´˜aCˆ¢•”D•¶C“¡“c–F–MC–‹`’‰i“àj: –k—¢ˆãŠw, 20(1): 74`82, 1990.

2752. mŒ´’˜n ƒqƒgbó‘BŠà‚Ì‘B‚ƃzƒ‹ƒ‚ƒ“‚É‚æ‚é‚»‚̧Œä|Šàˆâ“`Žq‚Ì”­Œ»‚Æî•ñŽó—e“`’B‹@\‚̈Ùí‚ɂ‚¢‚Ä|. ˆ¢•”D•¶i“àj: —Õ°¬l•a, 19(10): 1787`1788, 1989.

2753. mŒ´’˜n ˆ««Žîᇂɔº‚¤‚ƒJƒ‹ƒVƒEƒ€ŒŒÇ‚ðŽä‹N‚·‚é•›bó‘Bƒzƒ‹ƒ‚ƒ“ŠÖ˜A’`”’(Parathyroid Hormone Related Protein; PTHrP); V‚µ‚¢ƒzƒ‹ƒ‚ƒ“«Žîᇃ}|ƒJ|‚Æ‚µ‚Ä‚ÌPTHrP‚ÌŒŸ“¢. ˜a“c’m‰vC‘å’J‰pŽ÷i—Õ•a—j: —Õ°•a—, 38(3): 288`293, 1990.

2754. m’Z•ñn ’·ŠúŠÔ‚ɂ킽‚霑ãŽÓˆÙí‚É‚¨‚¯‚霔玿‚Ìœ‰–—Ê‘ª’è‚Ì—L—p«. ÷ˆä´ŽqC¼—Ñ—²i•újC—L•xŠ°i®ŠOjCŠâ”g–Îi•újCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjC‘–쳈êi•új: “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 50(1): 81`83, 1990.

2755. m’Z•ñn ŠeŽí“à•ª”åŽîᇂɂ¨‚¯‚é–Ɖu‘gD‰»Šw“IŒŸ“¢|ECG,NEM‚ð’†S‚Æ‚µ‚Ä|. ²”Œ”ü“ÞŽqCŽsì‚‚íi•a‰@•a—jCŠâŸºŒ[ˆêC‰œ•½‰ë•Fi•a—j: •a—‹Zp, (39): 10`12, 1989.

2756. mŒ¤‹†•ñi•¶•”Èjn Žîᇃ}|ƒJ|‚Æ‚µ‚Ä‚Ì•›bó‘Bƒzƒ‹ƒ‚ƒ“—l’`”’(PTH-LP)‚ÌŠî‘b“IC—Õ°“IŒŸ“¢. ˜a“c’m‰vi—Õ•a—j: •¶•”ȧ—㌤‹†(A)Œ¤‹†•ñ‘, 1989.

2757. mÇ—á•ñn 3”NˆÈã‚ɂ킽‚èGH”ñˆË‘¶«‚Ì—ÇD‚Èg’·‘‰Ái8.8 cm/”Nj‚ðŽ¦‚µ‚Ä‚¢‚é“Á”­«‰º‚‘Ì‹@”\’ቺǂÌ6Î’jŽ™—á. ‰¡“csŽjC‘åŽR‹XGC›šà†‹ÊC—`…—²iŽ™j: ƒzƒ‹ƒ‚ƒ“‚Æ—Õ°i“à•ª”å‹»–¡‚ ‚éÇ—áC‘æ13Wj,(‘): 49`51, 1989.

2758. mÇ—á•ñn An Autopsy Case of Erythropoietic Protoporphyria with Liver Cirrhosis. ’†‰p’jC£ìŒªˆêC–{‹§C‰ªTˆê˜YC‰œ•½‰ë•Fi•a—j: –k—¢ˆãŠw, 19(4): 445`451, 1989.

2759. m—Õ°Ž¡Œ±n ƒyƒvƒVƒmƒQƒ“RIAƒLƒbƒg‚Ì—Õ°‰ž—p. ‰ª”ŽCŽO–؈ê³i“Œ‘åjCŽODH”ni•l¼ˆã—ÃZƒ“jC‰ª•”Ž¡–íi“àjC•ž•”Mi‹à‘ò‘åjCìˆäŒ[Žsi‹ž•{ˆã‘åjC’†‘òŽO˜Yi–¼ŒÃ‰®‘åjC‹{è•Ûi–k‘åjC ’J“àºiŽD–yˆã‘åjCÎXÍi“Œ–k‘åjC²X–ØNliŒQ‘åjC•Ÿ•x‹v”Vi’}”g‘åjC¼”ö—Ti“ú‘åjCΈ䟌Èi•újC‹àŽq‰h‘ i•l¼ˆã‘åjC—L‹gŠ°iˆ¤’m ‚ª‚ñƒZƒ“jCX‰ê–{Ki‹ž‘åjCX•’åi‘åã‘åjCX“c—¤Žiiìèˆã‘åjCŠÝ–{^–çiL“‡‘åjC•l–{Œ¤iˆ¤•Q‘åjC™’¬Œ\‘ i‹ã‘åjC‘å]ŒcŽ¡iŽY‹Æˆã ‘åj: —Õ°¬l•a, 19(4): 531`537, 1989.

2760. m‘àn “œ”A•a‚̃}ƒl[ƒWƒƒ“ƒg; ƒtƒ@[ƒXƒgƒ`ƒ‡ƒCƒX‚Ì~ˆ³–ò. –‹`’‰C‹àXWi“àj: Chronic Disease, (1): 119`121, 1990.

2761. m‘àn “ÁW; ŒoŒûÜ‚Ì–ò—¥—p–@¥•ž–ò¥Žw“±ABGÜ‚Ì“K‰ž‚Æ—p–@ã‚Ì—¯ˆÓ“_. “¡“c–F–MCŽç‰®’B”üC–‹`’‰i“àj: Practice, 6: 388`391, 1989.

2762. m‘àn ‘ŠútÇitǃAƒ‹ƒuƒ~ƒ“”AŠúj‚Ì–ò•¨—Ö@. –‹`’‰C“Iê´˜ai“àj: Ž¡—Ã, 71: 111`116, 1989.

2763. m‘àn ¬lÇ. —`…—²iŽ™j: ¬Ž™‰Èf—à 1989‘Š§†¢¬Ž™‚ÌŽ¡—ÃŽwj '89£,@52: 541`544, 1989.

2764. m‘àn IDDM‚É‚¨‚¯‚éƒCƒ“ƒXƒŠƒ“—Ö@|ƒCƒ“ƒXƒŠƒ“»Ü‚ÌŽí—Þ‚Æ‘I‘ð–@|. ‰¡“csŽjiŽ™j: ¬Ž™“à‰È,@22(2): 223`228, 1990.

2765. m‘àn “œ”A•a; ‡•¹Ç‚Æ‚»‚Ì‘Îô. ‰ª”ŽCÔÀˆÀ•vC‹TŽR˜aŽqC–‹`’‰i“àjC¼‰ªŒ’•½: “à‰È, 64: 87`104, 1989.

2766. m‘àn ƒCƒ“ƒXƒŠƒ“; ‚Æ‚­‚É–«t•s‘Só‘Ô‚É‚¨‚¯‚éäXB×–E‹@”\‚ƃCƒ“ƒXƒŠƒ“’ïR«‚Ì‹@˜‚ɂ‚¢‚Ä. –‹`’‰C“¡“c–F–MCŽç‰®’B”üi“àj: —Õ°“§Í, 5: 171`177, 1989.

2767. mŠwp‘n iŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj 1989; ‹}«¥ˆŸ‹}«bó‘B‰Š, ˆ¢•”D•¶i“àj. •ÒW ˆîŠ_‹`–¾C‘¼•Ò, ˆãŠw‘‰@, “Œ‹ž, 89.02.15 ”­s.

2768. mŠwp‘n iŽ·•Mj ‘æ23‰ñ“œ”A•aŠw‚Ìi•àA“œ”A•a‚̗×{Žw“± 1989; “œ”A•aŠ³ŽÒA“ÁŽêŠÇ—‚Ì–â‘è“_;tÇŠ³ŽÒ‚ÌŠÇ—, p.113`119, –‹`’‰C“Iê´˜ai“àj. •ÒW “ú–{“œ”A•aŠw‰ï•Ò, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 89.00.00 ”­s.

2769. mŠwp‘n iŽ·•Mj Endocrinology of Birds|Molecular to Behavioral; Hormonal Regulation of Water and Sodium Intake in Birds,@p.171`183, ’|ˆä˘Yi¶—jCHideshi Kobayashii‘S–òH‹Æj. •ÒW Masaru Wadai“Œ‹žˆãŽ•‘åjCSusumu Ishiii‘‘åjCC.G. Scanes (Ruters Univ.)•ÒC Japan Scientific Societies Press, “Œ‹ž, 90.01.00”­s.

2770. m‚»‚Ì‘¼‚Ì’˜‘n i•ÒWj Proceedings of the Japan Society for Comparative Endocrinology, •ÒW •½–ì“N–çi“Œ‘åjC’|ˆä˘Yi–k—¢‘åj•ÒC “ú–{”äŠr“à•ª”åŠw‰ï, “Œ‹ž, 89.12.00”­s.

2771. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj “à•¶”åƒP|ƒXƒXƒ^ƒfƒB|48—á‚ÌPO Œ¤C@‘æ2”Å; “û–[Žî‘储‚æ‚Ñ«ŠíoŒŒ‚ð’悵‚½2Î7‚©ŒŽ‚Ì—Ž™Cp.34`38, —`…—²iŽ™j. •ÒW ´…’¼—ei’é‹ž‘åjC”Ñ–ìŽj˜Yiº˜a‘åj•ÒC ˆãŠw‘‰@, “Œ‹ž, 89.05.01”­s.

2772. mŽ‹’®Šoo”Å•¨n iŽ·•Mj ˆãŠw¶‚Ì‚½‚߂̬Ž™‰ÈŠwŽÊ^W; ‘ãŽÓC“à•ª”厾Š³Cp.31`40, ‘åŽR‹XGiŽ™j. •ÒW óˆä—˜•vi“Œ‹ž—Žqˆã‘åjCÔâ“Oié‹Êˆã‘åj•ÒC ’†ŠOˆãŠwŽÐ, “Œ‹ž, 89.04.01”­s.

2773. mŠw‰ïn i“Á•Êu‰‰j ˆ««Žîᇂɔº‚¤‚ƒJƒ‹ƒVƒEƒ€ŒŒÇ‚ðŽä‹N‚·‚é•›bó‘Bƒzƒ‹ƒ‚ƒ“ŠÖ˜A’`”’(Parathyroid Hormone Related Protein; PTHrP); V‚µ‚¢ƒzƒ‹ƒ‚ƒ“«Žîᇃ}|ƒJ|‚Æ‚µ‚Ä‚ÌPTHrP‚ÌŒŸ“¢. ˜a“c’m‰vi—Õ•a—j: ‘æ1‰ñ“ú–{—Õ°•a—Šw‰ïŠÖ“ŒbM‰zŽx•”‘‰ï (89.10.28), VŠƒ.

2774. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒqƒgbó‘B‰‘ã”|—{Œn‚É‚æ‚é×–Eî•ñŽó—e“`’B‹@\‚ÌŒ¤‹†. ˆ¢•”D•¶C‹àXWC–‹`’‰i“àjC‹T’J“Oi•a—j: ‘æ62‰ñ“ú–{‘gD”|—{Šw‰ï‘å‰ï (89.06.29), _“Þì.

2775. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ”ñ‹@”\«“à•ª”åŽîá‡Fbó‘B”ñ‹@”\«‘BŽî‚̶‰»Šw“I“Á«. ˆ¢•”D•¶C‹àXWC–‹`’‰i“àjC‹T’J“Oi•a—jC”öèC•CˆÉ“¡š •FiˆÉ“¡•a‰@j: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ïH‹GŠwp‘‰ï (89.10.21), ŽD–y, “ú–{“à•ª”åŠw‰ïŽGŽ, 65(9): 859, l989.

2776. mŠw‰ïn iƒpƒlƒ‹j Intestinal Movement Video-Solarbattery-Computerized. ‘ëàV’¼’èi¶—jC‰Á“¡NsiŠOjC‘åŠÑMi¶—j: 31st International Congress of Physiological Sciences (89.07.14), Helsinki, Finland, Proc. Intna. Union of Physiol. Sci. 17, p.502`503, 1989.

2777. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj “œ”A•a«tÇ”­ÇˆöŽq‚Æ‚µ‚Ä‚ÌS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh‚ɂ‚¢‚Ä. “Iê´˜aCâ–{—mŽqCŽç‰®’B”üC‰Í˜HWˆêC“¡“c–F–MC–‹`’‰i“àj: ‘æ32‰ñ“ú–{“œ”A•aŠw‰ï‘‰ï (89.04.22), ‹à‘ò.

2778. mŠw‰ïn iˆê”Êu‰‰j œ”½‰žŒ^‚ð’悵‚½‹U«•›bó‘B‹@”\’ቺÇType Ib‚Ì1—á. ˆ¢•”D•¶Câ–{—mŽqCŽç‰®’B”üC‹àXWC‰Í˜HWˆêC“Iê´˜aC‚“cˆê‘¾˜YC“¡“c–F–MC–‹`’‰i“àj: ‘æ10‰ñ_“ÞìCa¥œ‘ãŽÓŒ¤‹†‰ï (89.01.28), _“Þì.

2779. mŠw‰ïn iˆê”Êu‰‰j ƒEƒiƒM‚ÌS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒzƒ‹ƒ‚ƒ“(ANP)—l•¨Ž¿. ’|ˆä˘Yi¶—jCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“ŒˆãŽ•‘åj: ‘æ66‰ñ“ú–{¶—Šw‰ï‘å‰ï (89.04.06), ‰ªŽRC Jpn. J. Physiol., 39(Suppl.): 689, 1989.

2780. mŠw‰ïn iˆê”Êu‰‰j Anaerobic Threshold (AT)‚©‚ç‚Ý‚½“œ”A•aŠ³ŽÒ‚̌ċz‹@”\. ‰Í˜HWˆêC“¡“c–F–MC’J–{‹ž”üCâ–{—mŽqCŽç‰®’B”üC“Iê´˜aC–‹`’‰i“àjC”’‘é‘’ji¶—j: ‘æ32‰ñ“ú–{“œ”A•aŠw‰ï‘‰ï (89.04.21), ‹à‘ò, “œ”A•a, 34(Suppl. 1): 164, l989.

2781. mŠw‰ïn iˆê”Êu‰‰j “œ”A•aŽ¡—Â̂½‚ß‚ÌŽŠ“K‰^“®‹­“x‚ÌŒˆ’è–@|Anaerobic Threshold‚É‚¨‚¯‚éS””‚Æ”N—î•ÊS””‚Ì”äŠr|. “¡“c–F–MC‰Í˜HWˆêC’J–{‹ž”üCâ–{—mŽqCŽç‰®’B”üC“Iê´˜aC–‹`’‰i“àjC‰““¡‹±ŽqC”’‘é‘’ji¶—j: ‘æ32‰ñ“ú–{“œ”A•aŠw‰ï‘‰ï (89.04.21), ‹à‘ò, “œ”A•a, 34(Suppl. 1): 164, l989.

2782. mŠw‰ïn iˆê”Êu‰‰j ”A’†ƒAƒ‹ƒuƒ~ƒ“”rŸ•—¦‚Ì•Ï“®ŒW”‚¨‚æ‚Ñ”÷—ʃAƒ‹ƒuƒ~ƒ“”A‚ɉe‹¿‚·‚éˆöŽq‚ɂ‚¢‚Ä. Žç‰®’B”üCâ–{—mŽqC‰Í˜HWˆêC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ32‰ñ“ú–{“œ”A•aŠw‰ï‘‰ï (89.04.22), ‹à‘ò.

2783. mŠw‰ïn iˆê”Êu‰‰j Biologically and Immunologically Active Atrial Natriuretic Peptide (ANP) in the Eel Heart. ’|ˆä˘Yi¶—jCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{j: 11th International Symposium on Comparative Endocrinology (89.05.16), Malaga, Spain, Abstracts, p.255, 1989.

2784. mŠw‰ïn iˆê”Êu‰‰j ‰Æ‘°«‚ƒRƒŒƒXƒeƒ|ƒ‹ŒŒÇ(FH)‚̃XƒNƒŠ|ƒjƒ“ƒO|‘æ3•ñCä`‘ÑŒŒCƒKƒXƒŠ|ŒŒC‘ƒRƒŒƒXƒeƒ|ƒ‹‚’l—á‚ÌŒo‰ß‹y‚ÑFH—á‚Æ‚Ì”äŠr|. –xŒû‘דTC•½Î‘C–åˆäL‹ÅCÄ“¡KˆêC”ª‘ãŒö•viŽ™jC¼“c—zi—Õ•a—jC¬o’©’ji–k—¢ƒ‰ƒ{j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.18), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽC93: 517, 1989.

2785. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™“œ”A•a‚É‚¨‚¯‚éy‘f‘ª’è–@‚É‚æ‚錌’† l,5 Anhydroglucitol (AG) ‘ª’è‚Ì—Õ°“I—L—p«‚ɂ‚¢‚Ä. ‘åŽR‹XGC‰¡“csŽjC›šà†‹ÊC—`…—²iŽ™jC–÷“ೕFi“ú–{‰»–òj: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.19), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(3): 579, 1989.

2786. mŠw‰ïn iˆê”Êu‰‰j Effect of anaesthesia on endocrine metabolic response to lower abdominal surgery. “c’†—ºC‘ºã‰ëŽqC–쌩ŽREi–ƒj: ‘æ9‰ñ¢ŠE–ƒŒŠw‰ï (89.05.22`28), U.S.A..

2787. mŠw‰ïn iˆê”Êu‰‰j ¬’·ƒzƒ‹ƒ‚ƒ“—Ö@’†‚̃^|ƒi|ÇŒóŒQ(TS)‚É‚¨‚¯‚é–ƉuŠw“IŒŸ“¢. ‰¡“csŽjC—`…—²C‘åŽR‹XGCŽÄŽRŒ[ŽqC›šà†‹ÊiŽ™j: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ï‘‰ï (89.06.01), “Œ‹žC “ú–{“à•ª”åŠw‰ïŽGŽC65(4): 304, 1989.

2788. mŠw‰ïn iˆê”Êu‰‰j ƒoƒZƒhƒE•abó‘B‚É‚¨‚¯‚é—}§«G’`”’‚̕ω»‚Æ‚»‚Ì‹@˜‚ɂ‚¢‚Ä. ˆ¢•”D•¶Câ–{—mŽqC‹àXWC‚“cˆê‘¾˜YC–‹`’‰i“àjC”öèC•CˆÉ“¡š •FiˆÉ“¡•a‰@j: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï (89.06.03), “Œ‹ž, “ú–{“à•ª”åŠw‰ïŽGŽ, 65(4): 380, l989.

2789. mŠw‰ïn iˆê”Êu‰‰j —cŽáƒ‰ƒbƒg‚ÌŽ‹°‰º•”CäXCÁ‰»ŠÇ‚É‚¨‚¯‚éGrowth Hormone Releasing Hormone-Like Immunoreactivity (GHRH-LI)‚Ì•ª•z‚Æ‚»‚Ì“ú—î‚É‚æ‚é•Ï‰». ‘åŽR‹XGCŽÄŽRŒ[ŽqC—`…—²iŽ™j: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ï (89.06.03), “Œ‹žC “ú–{“à•ª”åŠw‰ïŽGŽC65(4): 433, 1989.

2790. mŠw‰ïn iˆê”Êu‰‰j Comparison of Heart Rate at Anaerobic Threshold (AT) with Age-adjusted Heart Rate for Evaluating Optimal Exercise Intensity in Diabetics. “¡“c–F–MC‰Í˜HWˆêCŽç‰®’B”üC“Iê´˜ai“àjC”’‘é‘’ji¶—jC–‹`’‰i“àj: American Diabetes Association, 49th Meeting (89.06.03-06), Detoroit, Diabetes Program, 38(Suppl. 2): 156A, 1989.

2791. mŠw‰ïn iˆê”Êu‰‰j ƒqƒgŒŒ’†Endothelin‚̃‰ƒWƒIƒCƒ€ƒmƒAƒbƒZƒC. ˆÀ“¡Œ¤ŽiC•xŠ~˜a”üi–k—¢ƒ‰ƒ{jC’|ˆä˘Yi¶—jCìã³–çi•ª¶jC]Xr–¾CŽµ—¢^‹`C•½“cŒ‹ŠìCŠÛ–Ε¶ºi“ŒˆãŽ•‘åj: ‘æ26‰ñ“ú–{—Õ°‘ãŽÓŠw‰ï‘‰ï (89.06.09), ‘åã, Proceedings, 26: 122`123, 1989.

2792. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒWƒIƒCƒ€ƒmƒAƒbƒZƒC(RIA)‚É‚æ‚éBrain Natriuretic Peptide(BNP)‚Ì‘ª’è. •xŠ~˜a”üCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC’|ˆä˘Yi¶—jCìã³–çi•ª¶jC]Xr–¾CŽµ—¢^‹`C•½“cŒ‹ŠìCŠÛ–Ε¶ºi“ŒˆãŽ•‘åj: ‘æ26‰ñ“ú–{—Õ°‘ãŽÓŠw‰ï‘‰ï (89.06.09), ‘åã, Proceedings, 26: 228`229, 1989.

2793. mŠw‰ïn iˆê”Êu‰‰j ‰©FƒuƒhƒE‹…‹Û”sŒŒÇA‘–Œ‰Š‚ÅŽ€–S‚µ‚½“œ”A•a‚Ì1Ç—á. ‰Í˜HWˆêC’J–{‹ž”üCŽç‰®’B”üC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ383‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.06.10), “Œ‹ž.

2794. mŠw‰ïn iˆê”Êu‰‰j The Development of Pancreatic and Gastrointestinal Growth Hormone Releasing Hormone-Like Immunoreactivity (GHRH-LI) in Neonatal Rats. ‘åŽR‹XGC—`…—²CŽÄŽRŒ[ŽqiŽ™j: ‘æ71‰ñƒAƒƒŠƒJ“à•ª”åŠw‰ï (71th Annual Meeting of the Endocrine Society) (89.06.21), Seattle, U.S.A., Abstracts, p.106, 1989.

2795. mŠw‰ïn iˆê”Êu‰‰j ƒqƒgbó‘B”|—{×–E‚É‚¨‚¯‚éATPŽhŒƒŽž‚Ì×–E“àƒJƒ‹ƒVƒEƒ€”Z“x‚̕ω». ‹àXWCˆ¢•”D•¶C–‹`’‰i“àj: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï (89.09.30), ‘Š–ÍŒ´.

2796. mŠw‰ïn iˆê”Êu‰‰j ƒEƒiƒM‚ÌS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒzƒ‹ƒ‚ƒ“‚̶•¨Šˆ«. ’|ˆä˘Yi¶—jC¼“c‘•ci¶•¨•¨—ŒnjC‚‹´–¾‹`i•ª¶j: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï (89.09.30), ‘Š–ÍŒ´C –k—¢ˆãŠw, 19(6): 645, 1989.

2797. mŠw‰ïn iˆê”Êu‰‰j ƒEƒiƒMS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh(ANP)‚̈ꎟ\‘¢‚Æ‚»‚̔䊈«. ’|ˆä˘Yi¶—jC‚‹´–¾‹`i•ª¶jC“n•Ó‘ìŽiiƒyƒvƒ`ƒhŒ¤j: ‘æ60‰ñ“ú–{“®•¨Šw‰ï‘å‰ï (89.10.06), ‹ž“sC Zoological Science, 6(6): 1186, 1989.

2798. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒg”­î‘OŠú‚Ì LH, PRL•ª”å‚É‹y‚Ú‚·ƒEƒŒƒ^ƒ“–ƒŒ‚̉e‹¿‚ɂ‚¢‚Ä. ŒÃŠÚêˆêiŽÀ“®j: “ú–{“à•ª”åŠw‰ï (89.10.20), ŽD–yC “ú–{“à•ª”åŠw‰ïŽGŽC65(9): 88l, l989.

2799. mŠw‰ïn iˆê”Êu‰‰j 17,20-desmolaseŒ‡‘¹ÇPartial defect (type 1)‚Æl‚¦‚ç‚ê‚é9Î’jŽ™—á. ‘åŽR‹XGC—`…—²CŽÄŽRŒ[ŽqC›šà†‹ÊC‰¡“csŽjiŽ™j: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ïH‹G‘å‰ï (89.10.21), ŽD–y, “ú–{“à•ª”åŠw‰ïŽGŽ, 65(9): 979, 1989.

2800. mŠw‰ïn iˆê”Êu‰‰j Familial Isolated Growth Hormone Deficiency (IGHD) Type 3 without Any Immunodeficiency in Two Male Siblings. ‘åŽR‹XGC—`…—²CŽÄŽRŒ[ŽqC›šà†‹ÊC‰¡“csŽjiŽ™j: Third Joint Meeting of the European Society for Pediatric Endocrinology and Lawson Wilkins Pediatric Endocrinology Society (89.10.30), Jerusalem, Hormone Research, 31(Suppl.1): 30, 1989.

2801. mŠw‰ïn iˆê”Êu‰‰j Ontogeny of Growth Hormone Releasing Hormone-Like Immunoreactivity (GHRH-LI) in the Hypothalamus, Pancreas and Gastrointestinal Tract in Rat. ‘åŽR‹XGC—`…—²CŽÄŽRŒ[ŽqiŽ™j: Third Joint Meeting of the European Society for Pediatric Endocrinology and Lawson Wilkins Pediatric Endocrinology Society (89.11.01), Jerusalem, Hormone Research, 31(Suppl.1): 19, 1989.

2802. mŠw‰ïn iˆê”Êu‰‰j ƒVƒgƒNƒƒ€P-450SCC‚É‚æ‚é3-one-4-enƒXƒeƒƒCƒh‚Ì‘ãŽÓ‚Æ”½‰ž’†ŠÔ‘Ì‚Ì•ª—£. ›–ìKŽqCX“‡’¼•FiŠÅŒìŠw•”jC–x]Ž •vi¶‰»j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.03), ‹ž“s, ¶‰»Šw, 61(9): 853, 1989.

2803. mŠw‰ïn iˆê”Êu‰‰j ’†«”TŽŠŽ_«‚Ì“™“d“_‚ð‚à‚•›t”玿P-450SCC‚Ì•ªŽq‘½—l‘Ì‚Ì’²»‚Æ«Ž¿. –x]Ž •vC“n•Ó“”ü”Ti¶‰»jC‘]ª—R”üŽqi¶‰»ŒnjC›–ìKŽqiŠÅŒìŠw•”j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.03), ‹ž“s, ¶‰»Šw, 61(9): 853, 1989.

2804. mŠw‰ïn iˆê”Êu‰‰j ƒXƒeƒƒCƒhŽY¶×–E‚Ìy‘f‘gD‰»Šw“IõF‚ÆŽY¶ƒXƒeƒƒCƒh—Ê‚Æ‚ÌŠÖŒW. ’r“c•ä‚C–x]Ž •vi¶‰»j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.04), ‹ž“s, ¶‰»Šw, 61(9): 1043, 1989.

2805. mŠw‰ïn iˆê”Êu‰‰j IDDMtÇ‚É‚¨‚¯‚éS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh(ANP)‚ɂ‚¢‚Ä. “Iê´˜aC‘å˜a“c—¢C–ìX‘º–í¶CŽç‰®’B”üC‰Í˜HWˆêC“¡“c–F–MC–‹`’‰i“àj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï‘‰ï (89.11.09), •l¼.

2806. mŠw‰ïn iˆê”Êu‰‰j “œ”A•a‚É‚¨‚¯‚é”÷—ʃAƒ‹ƒuƒ~ƒ“”A‚ÌŒo‰ß‚ɂ‚¢‚Ä. Žç‰®’B”üC‘å˜a“c—¢C–ìX‘º–í¶C‰Í˜HWˆêC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï‘‰ï (89.11.09), •l¼.

2807. mŠw‰ïn iˆê”Êu‰‰j 17,20-desmolase•”•ªŒ‡‘¹Ç(Zachmann Type 1)‚Æl‚¦‚ç‚ê‚é9Î’jŽ™—á. ‘åŽR‹XGCŽÄŽRŒ[ŽqC›šà†‹ÊC‰¡“csŽjC—`…—²iŽ™j: ‘æ23‰ñ“ú–{¬Ž™“à•ª”åŠw‰ï (89.11.10), b•{, ´˜^W, p.45, 1989.

2808. mŠw‰ïn iˆê”Êu‰‰j V¶Ž™ƒ‰ƒbƒg‚ÌÁ‰»ŠÇ‚É‚¨‚¯‚éSomatostatinˆâ“`Žq”­Œ»‚ɂ‚¢‚Ä. ŽÄŽRŒ[ŽqC‘åŽR‹XGC›šà†‹ÊC—`…—²iŽ™j: ‘æ23‰ñ“ú–{¬Ž™“à•ª”åŠw‰ï (89.11.10), b•{, —\eW, p.96, 1989.

2809. mŠw‰ïn iˆê”Êu‰‰j ƒEƒiƒM‚Ì”]‚É‘¶Ý‚·‚éS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh—l•¨Ž¿. ’|ˆä˘Yi¶—jC¼“c‘•ci¶•¨•¨—ŒnjC‚‹´–¾‹`i•ª¶jCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{j: ‘æ14‰ñ“ú–{”äŠr“à•ª”åŠw‰ï‘å‰ï (89.11.18), ’·èC Proc. Jpn. Soc. Comp. Endocrinol., 4: 16,1989.

2810. mŠw‰ïn iˆê”Êu‰‰j Radioimmunoassay‚É‚æ‚éBNP—l–ƉuŠˆ«‚Ì‘ª’è. •xŠ~˜a”üCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC’|ˆä˘Yi¶—jCìã³–çi•ª¶jCŠÛ–Ε¶ºi“Œ‹žˆãŽ•‘åj: “ú–{“à•ª”åŠw‰ï‘‰ï (89.11.21), “Œ‹žC “ú–{“à•ª”åŠw‰ïŽGŽ, 65(9): 903, 1989.

2811. mŠw‰ïn iˆê”Êu‰‰j ”A’†Endothelin‚Ì‘¶Ý. ˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC’|ˆä˘Yi¶—jCìã³–çi•ª¶jC•½“cŒ‹Šì—YCŠÛ–Ε¶ºi“Œ‹žˆãŽ•‘åj: “ú–{“à•ª”åŠw‰ï‘‰ï (89.11.21), “Œ‹žC “ú–{“à•ª”åŠw‰ïŽGŽ, 65(9): 908, 1989.

2812. mŠw‰ïn iˆê”Êu‰‰j ƒqƒg³í‚¨‚æ‚ÑŠàbó‘B”|—{×–E‚É‚¨‚¯‚éATPŽhŒƒŽž‚Ì×–E“àƒJƒ‹ƒVƒEƒ€”Z“x‚̕ω». ‹àXWCˆ¢•”D•¶C–‹`’‰i“àjC”öèC•CˆÉ“¡š •FiˆÉ“¡•a‰@j: ‘æ32‰ñ“ú–{“à•ª”åŠw‰ïbó‘B•ª‰È‰ï (89.11.25), ŒQ”n, “ú–{“à•ª”åŠw‰ïŽGŽ, 65(9): 1058, 1989.

2813. mŠw‰ïn iˆê”Êu‰‰j ƒzƒ‹ƒ‚ƒ“ŽY¶bó‘BŽîᇂ̶‰»Šw“I“Á«. ˆ¢•”D•¶C‹àXWC‚“cˆê‘¾˜YC–‹`’‰i“àjC”öèC•CˆÉ“¡š •FiˆÉ“¡•a‰@j: ‘æ32‰ñ“ú–{“à•ª”åŠw‰ïbó‘B•ª‰È‰ï (89.11.25), ŒQ”n, “ú–{“à•ª”åŠw‰ïŽGŽ, 65(9): 1079, 1989.

2814. mŠw‰ïn iˆê”Êu‰‰j WernerÇŒóŒQ‚ɇ•¹‚µ‚½NIDDM‚Ì1—á. ‹àXWC•½ˆä–@”ŽC‘å˜a“c—¢C–ìX‘º–í¶C‰Í˜HWˆêC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ27‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (90.01.27), “Œ‹ž.

2815. mŠw‰ïn iˆê”Êu‰‰j ‰Šú“œ”A•a«tǂɑ΂·‚éACE‘jŠQÜ‚ÌŒø‰Ê. “Iê´˜aC•½ˆä–@”ŽC‘å˜a“c—¢C–ìX‘º–í¶CŽç‰®’B”üC‰Í˜HWˆêC‹àXWC“¡“c–F–MC–‹`’‰i“àj: ‘æ27‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (90.01.27), “Œ‹ž.

2816. mŠw‰ïn iˆê”Êu‰‰j æ“V«’_“¹•Â½Ç‚ÆŠÓ•Ê¢“ï‚Å‚ ‚Á‚½‘J‰„‰©át‚𔺂Á‚½æ“V«Œ´”­«•›t”玿‹@”\’ቺǂÌ1—á. Š`À—R•FC‰¡“csŽjC–ì“n³•FC¬ŒûO‹BC—`…—²iŽ™j: ‘æ182‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï (90.02.17), ‰¡•l.

2817. mŠw‰ïn iˆê”Êu‰‰j ˆ««Žîᇂɔº‚¤‚ƒJƒ‹ƒVƒEƒ€ŒŒÇ‚ðŽä‹N‚·‚é•›bó‘Bƒzƒ‹ƒ‚ƒ“ŠÖ˜A’`”’(PTHrP)‚ÌŒŸ“¢i‘æ2•ñj. ŽsìŒbŽqi‘‡—Õ°ŒnjC˜a“c’m‰vC¼“c—zC‘å’J‰pŽ÷i—Õ•a—j: ‘æ16‰ñ—Õ°‰»ŠwŒŸ¸‚ÉŠÖ‚·‚é“~ŠúƒZƒ~ƒi| (90.03.06), ŠâŽè.

2818. mŒ¤‹†‰ïn iˆê”Êu‰‰j “œ”A•a‚É‚¨‚¯‚é”A’†”÷—ʃAƒ‹ƒuƒ~ƒ“‘ª’è‚Ì—Õ°“IˆÓ‹`. Žç‰®’B”üC‘å˜a“c—¢C–ìX‘º–í¶C‰Í˜HWˆêC‹àXWC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ6‰ñ_“Þì“œ”A•aŒ¤‹†‰ï (89.07.08), ‰¡•l.

2819. mŒ¤‹†‰ïn iˆê”Êu‰‰j œ‘ãŽÓˆÙí‚Ì•]‰¿. ÷ˆä´Žqi•új: ‘æ151‰ñ“Œ‹žˆãŠw•¨—Œ¤‹†‰ïƒZƒ~ƒi[ (89.09.11), “Œ‹ž.

2820. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”玿œœ‰–’è—Ê‚Ìd—v«. ÷ˆä´ŽqCŠâ”g–ÎC¼—Ñ—²C‘–쳈êi•újC—L•xŠ°i®ŠOjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: ‘æ8‰ñœ‚Æœ‘ãŽÓŒ¤‹†‰ï (89.10.07), ‘åã.

2821. mŒ¤‹†‰ïn iˆê”Êu‰‰j bó‘BŽîᇂ̓Á«‚ÉŠÖ‚·‚é–Ɖu‘gDŠw“IŒŸ“¢. ˆ¢•”D•¶C‹àXWC–‹`’‰i“àjCŒY•”“ŒŽ¡iŠOjC‹T’J“Oi•a—jC”öèC•CˆÉ“¡š •FiˆÉ“¡•a‰@j: ‘æ6‰ñbó‘B•a‘Ô¶—Œ¤‹†‰ï (89.12.02), “Œ‹ž.

2822. mŒ¤‹†‰ïn iˆê”Êu‰‰j “œ”A•a«×¬ŒŒŠÇǂɑ΂·‚é”DP‚̉e‹¿i‘æ4•ñj. ‘å˜a“c—¢CŽç‰®’B”üC‰Í˜HWˆêC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ5‰ñ“œ”A•a‚Æ”DP‚ÉŠÖ‚·‚錤‹†‰ï (89.12.02), “Œ‹ž.

2823. mŒ¤‹†‰ïn iˆê”Êu‰‰j “ª•”ŠOŒãA’ጌ“œ‚ðŒ_‹@‚É”­Œ©‚³‚ꂽ”ĉº‚‘Ì‹@”\’ቺǂÌ1—á. –ìX‘º–í¶C•½ˆä–@”ŽCŽç‰®’B”üC‰Í˜HWˆêC‹àXWCˆ¢•”D•¶C‚“cˆê‘¾˜YC“¡“c–F–MC–‹`’‰i“àj: ‘æ17‰ñ“à•ª”å‘ãŽÓŒ¤‹†‰ï (89.12.09), “Œ‹ž.

2824. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒŒ’†C”A’†Endothelin—l–ƉuŠˆ«•¨Ž¿‚ɂ‚¢‚Ä. ˆÀ•”‹žŽqCˆÀ“¡Œ¤ŽiC•xŠ~˜a”üC{“¡–F³i–k—¢ƒ‰ƒ{jC’|ˆä˘Yi¶—jCìã³–çi•ª¶jC]Xr–¾CŽµ—¢^‹`C•½“cŒ‹ŠìCŠÛ–Ε¶ºi“ŒˆãŽ•‘åj: ‘æ17‰ñ“à•ª”å‘ãŽÓŒ¤‹†‰ï (89.12.09), “Œ‹žC ´˜^W, p.55`57, 1989.

2825. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒEƒiƒMANP‹y‚ÑBNP‚Ì\‘¢‚Æ‚»‚̔䊈«. ’|ˆä˘Yi¶—jC‚‹´–¾‹`i•ª¶jC“n•Ó‘ìŽiiƒyƒvƒ`ƒhŒ¤j: ‘æ5‰ñANPŒ¤‹†‰ï (90.02.16), ‘åã.

2826. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒEƒiƒM‚̃iƒgƒŠƒEƒ€—˜”Aƒzƒ‹ƒ‚ƒ“ƒtƒ@ƒ~ƒŠ|. ’|ˆä˘Yi¶—jC‚‹´–¾‹`i•ª¶j: ‘æ3‰ñANPŒ¤‹†‰ï (90.02.23), ‘Š–ÍŒ´C –k—¢ˆãŠw, 20(2): 184, 1990.

2827. mŒ¤‹†‰ïn iˆê”Êu‰‰j Brain Natriuretic Peptide (BNP) ‚̃uƒ^S‘Ÿ‚É‚¨‚¯‚鑶ݗlŽ®. •xŠ~˜a”üi–k—¢ƒ‰ƒ{jC’|ˆä˘Yi¶—jCìã³–çi•ª¶j: ‘æ3‰ñANPŒ¤‹†‰ï (90.02.23), ‘Š–ÍŒ´C –k—¢ˆãŠw, 20(2): 185, 1990.


<<207 ˜V‰»>>

2828. mŒ´’˜n ˜Vl‚Ìš‹‰º. ŒÃì_ŽOiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È MookC12: 145`150, 1989.

2829. m‘àn ˜Vl‚Æ•›•@o‰Š. ”ª”ö˜a—YiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È MOOK, 12: 258`264, 1989.


<<208 ŠOE’†“ÅEŽ–ŒÌ>>

2830. mŒ´’˜n Injuries from Falls in Patients with Mental Disorders. Žá—ÑL”Vi®ŠOjCV“¡³‹PC‘å˜a“c—²i‹~–½j: J. Jpn. Surg. Trauma, 3: 290`294, 1989.

2831. mŒ´’˜n Subacute Toxicity of (-)15-deoxyspergualin in BALB/c Mice. I. Hematological Study. ‘å‹v•Û[li“àjC^è‹`•FiŽÀ“®ŒnjCˆäãŒcˆêi“àjCŒ´—ŒbŽqC•½”ü–çŽqi‘‡—Õ°ŒnjCŠ™“cvŽõi“àjCZhang, H.i•a—j: J. Toxicol. Sci., 14: 237`245, 1989.

2832. mŒ´’˜n Subacute Toxicity of (-)15-deoxyspergualin in BALB/c Mice. ‡U. Histological Study. Zhang, H.i•a—jC ˆäãŒcˆêi“àjC^è‹`•FiŽÀ“®ŒnjCŒ´—ŒbŽqi‘‡—Õ°ŒnjCŠ™“cvŽõC‘å‹v•Û[li“àj: J. Toxicol. Sci., 14: 247`255, 1989.

2833. mŒ´’˜n äB‘¹‚Ì•Û‘¶“IŽ¡—Âɂ¨‚¯‚éTranscatheter Arterial Embolization‚Ì–ðŠ„. –x’rdŽ¡C‘Oì˜a•FCó—˜–õC¡ˆäPC™–{Ÿ•FCV“¡³‹PC‘å˜a“c—²i‹~–½j: “ú–{ŠOŒ¤‹†‰ïŽ, 3(3): 276`281, 1989.

2834. m’Z•ñn A Study of the Concentration of Mannitol for the Treatment of Raised ICP. “c’†¹‘ãC‹gŽR—F“ñi–òŠw•”jC‹ß“¡—¯”üŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC‘å˜a“c—²i‹~–½jC‚–ØGi‘å˜aŽs—§•a‰@j: Intracranial Pressure, 7(1): 469`473, 1989.

2835. mÇ—á•ñn ‹­—̓lƒIƒ~ƒmƒtƒ@[ƒQƒ“‚b‚É‚æ‚éƒAƒiƒtƒBƒ‰ƒLƒV[ƒVƒ‡ƒbƒN‚Ì1—á. ”’싳li¸jC“c•Ó‘C‘Š”nˆêˆåC–Ø“cŒõLC“¡–ìé”VC¡ˆäPC¼ŽR´ŒhC–kˆä‘¥•vC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽ, 10(2): 246`248, 1989.

2836. mÇ—á•ñn ŠO«¬’°úE‚̬Ž™—á7—á‚ÌŒŸ“¢. “¡–ìé”VC‘Oì˜a•FC™–{Ÿ•FC–x’rdŽ¡C¡ˆäPC‘å˜a“c—²i‹~–½j: • •”‹~‹}f—ÂÌi•à, 9(5): 801`804, 1989.

2837. m‘àn œ”՜܌ã‚̘’É¥¿œ_Œo’É‚Ì•a‘Ô‚ÆŽ¡—Ö@. V“¡³‹Pi‹~–½jCŽ…–ž·Œ›i®ŠOj: Monthly Book, Orthopaedics, 15: 97`106, 1989.

2838. m‘àn ‹¹•”ŠO‚Æ‚»‚̑Ήž. ‘Oì˜a•Fi‹~–½j: ‹~‹}ˆãŠw, 13(10): 1511`1516, 1989.

2839. m‘àn ŠO«ŠÌ”j—ô. ‘Oì˜a•FC™–{Ÿ•Fi‹~–½j: Žèp, 43(6): 763`771, 1989.

2840. m‘àn ‘½”­ŠO. ¡ˆäPC‘Oì˜a•Fi‹~–½j: f’f‚ÆŽ¡—Ã, 77(10): 2741`2745, 1989.

2841. mŠwp‘n iŽ·•Mj Œ»‘ã•a—Šw‘åŒn; ƒGƒ`ƒ‹ƒAƒ‹ƒR|ƒ‹, 10(C): 59`69, ‰œ•½‰ë•Fi•a—j. •ÒW ”Ñ“‡@ˆêi–¼‘åjCÎì‰h¢iŽœ‘åjC‰eŽRŒ\ŽOiŒc‘åjC“‡•ô“O˜YCX˜ji“Œ‘åj•ÒC ’†ŽR‘“X, “Œ‹ž, 89.09.30”­s.

2842. mŠwp‘n iŽ·•Mj ‹~‹}ˆã—ÂɕK—v‚ȉ摜f’f; ˆãŒ´«‡•¹Ç|‘å“®–¬ƒoƒ‹[ƒ“ƒpƒ“ƒsƒ“ƒOAƒy[ƒXƒ[ƒJ[“d‹É, 3: p.270`271, |ƒAƒ“ƒMƒICIntervention’†‚ÌŽ–ŒÌ, 3: p.272`273, ‘–쳈êi•új. •ÒW ™–{Š¤iã‘åj•Ò, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ,“Œ‹ž, 89.05.20 ”­s.

2843. m‹³‰È‘n iŽ·•Mj }àA‹~‹}ˆãŠwuÀ:ŠO‹~‹}; ŠÌŠO, 5: 180`185; äBŠO, 5: 186`191, ‘Oì˜a•Fi‹~–½j. •ÒW ™–{iã‘åj•Ò, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 89.06.10”­s.

2844. m‹³‰È‘n iŽ·•Mj ŠO‰ÈŠw; Šç–Ê‘¹Cp.679`683, ‰©‹àˆäN–¤iŒ`ŠOjC‘Oì˜a•Fi‹~–½j. •ÒW X¹‘¢C‹ÊŒF³‰xC¬àV˜aŒbC™’¬Œ\‘ •ÒC ‚Ö‚é‚·o”Å, “Œ‹ž, 89.04.01”­s.

2845. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ƒTƒNƒZƒXˆãŽt‘‰ÆŽŽŒ±—Õ°ŽÀ’n–â‘èW; ‘æ81‰ñE–â‘è, Šùo–â‘è‘æ81‰ñE-1, ŠÖ˜A–â‘è‘æ81‰ñE-1, p.200`201, ‰©‹àˆäN–¤iŒ`ŠOj. ŠÄC ²“¡“oŽu˜Yi–k—¢‘åjŠÄC, “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 89.11.15”­s.

2846. mŠw‰ïn iƒpƒlƒ‹j The Recent Advances in Chest Trauma Management. ‘Oì˜a•Fi‹~–½j: The 5th World Congress on Intensive & Critical Care Medicine (89.09.07), ‹ž“s.

2847. mŠw‰ïn iƒpƒlƒ‹j Heart Stroke, ˆ««‚‘̉·ÇAˆ««ÇŒóŒQ‚É‚¨‚¯‚鎡—Ö@‚Ì‘I‘ð. L£—²ˆêC’ç–M•FC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.07), “Œ‹ž.

2848. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj ŠO«ŠÌAäBAäX‘¹‚Ìf’f‚ÆŽ¡—Ã. ‘Oì˜a•Fi‹~–½j: ‘æ34‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (89.07.14), ‹v—¯•Ä.

2849. mŠw‰ïn iˆê”Êu‰‰j ‚“x‚Ì“î•”‘gD‘¹‚𔺂¤ŠJ•ú«œ”՜܂̌Ÿ“¢. V“¡³‹PC‘Oì˜a•FC¡ˆäPC‘å˜a“c—²i‹~–½jC“ì‘òˆç—Yi®ŠOj: ‘æ37‰ñ“ú–{ЊQˆãŠw‰ï‘‰ï (89.10.18), L“‡, “úЈãŽ, 38(3): 113, 1990.

2850. mŠw‰ïn iˆê”Êu‰‰j ‹}«’†“ʼnŠúŽ¡—Â̖â‘è“_‚ÆV‚µ‚¢ŽŽ‚Ý. ŽR“cr•Fi‹~–½jCŽá—Ñ–õ‹vi“àjC’ç–M•FC“c•Ó‘CL£—²ˆêC•½“cŒõ”Ži‹~–½jC‹ß“¡—¯”üŽqi–òÜ•”jC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.06), “Œ‹ž.

2851. mŠw‰ïn iˆê”Êu‰‰j ”ÄŒŒ‹…Œ¸­ACentral Pontine Myelinolysis (CPM) ‚̇•¹‚ª‹^‚í‚ꂽƒWƒNƒƒbƒg’†“Å‚Ì1Ç—á. –ذ•Fi®ŠOjCŽá—Ñ–õ‹vC“c•Ó‘C–kˆä‘¥•vC•½“cŒõ”Ži“àjC’†‘º‹±Žqi–òÜ•”jCŽRéˆê˜YC¼ŽR’¼‹vC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.06), “Œ‹ž.

2852. mŠw‰ïn iˆê”Êu‰‰j ŽlŽˆ“Ý“IŽå—vŒŒŠÇ‘¹‚ÌŒŸ“¢. V“¡³‹PC‘Oì˜a•FC™–{Ÿ•FC¡ˆäPC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.07), “Œ‹ž.

2853. mŠw‰ïn iˆê”Êu‰‰j ”M‚É‚æ‚鎀–SÇ—á‚ÌŒŸ“¢. ‰FˆäŒª“ñC‰F’Öؗ´ˆêC•“cŒ[C–،Ҋ®miŒ`ŠOjC‘Oì˜a•Fi‹~–½jC‰©‹àˆäN–¤C‰–’JMKiŒ`ŠOj: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.07), “Œ‹žC ‹~‹}ˆãŠwCp.806, 1989.

2854. mŠw‰ïn iˆê”Êu‰‰j Œz‘‘¹‚É‚¨‚¯‚é—\Œã”»’èˆöŽq‚ÌŒŸ“¢. ŽRè‹`‹éC‚–ì½i”]ŠOjC‰““¡¹FC–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ28‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (90.02.17), “Œ‹ž.

2855. mŠw‰ïn iˆê”Êu‰‰j ‘½”­ŠOŽ¡—Ã’†‚ÉŒoŒ±‚µ‚½Wernicke”]Ç‚Ì1—á. •“cŒ[iŒ`ŠOjC–kŒ´F—YC–،Ҋ®mC‰FˆäŒª“ñC’ç–M•FCŽá—Ñ–õ‹vC‘Š”nˆêˆåC‰F’Öؗ´ˆêC‘å˜a“c—²i‹~–½j: ‘æ28‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (90.02.17), “Œ‹ž.

2856. mŒ¤‹†‰ïn iˆê”Êu‰‰j dÇ“ª•”ŠO‚𔺂¤‘½”­ŠO‚ÌŠÇ—ã‚Ì–â‘è. –kŒ´F—YCó—˜–õC‚–ì—²–¾C•½“cŒõ”ŽC‘å˜a“c—²i‹~–½j: ‘æ3‰ñ“ú–{ŠOŒ¤‹†‰ï (89.06.01), ŽD–y.

2857. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠÌŠO‚Ì•Û‘¶“IŽ¡—Â̌ÀŠE. ¡ˆäPCó—˜–õC™–{Ÿ•FCV“¡³‹PC–x’rdŽ¡C‘•ª–ΔŽC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ3‰ñ“ú–{ŠOŒ¤‹†‰ï (89.06.01), ŽD–y.

2858. mŒ¤‹†‰ïn iˆê”Êu‰‰j •Û‘¶“IŽ¡—Âðs‚Á‚½ŠO«ŠÌ“àŒŒŽî‚Ì—\Œã‚ÉŠÖ‚·‚錟“¢. ¡ˆäPCó—˜–õC™–{Ÿ•FCV“¡³‹PC–x’rdŽ¡C‘•ª–ΔŽC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ3‰ñ“ú–{ŠOŒ¤‹†‰ï (89.06.01), ŽD–y.

2859. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘½”­ŠOŒã‚Ì‘½‘ŸŠí•s‘S|”­Ç‚ÉŠÖ‚·‚éˆöŽq‚ÌŒŸ“¢|. ™–{Ÿ•FCó—˜–õC¼ŽR’¼‹vCV“¡³‹PC‘å˜a“c—²i‹~–½j: ‘æ3‰ñ“ú–{ŠOŒ¤‹†‰ï (89.06.01), ŽD–y.

2860. mŒ¤‹†‰ïn iˆê”Êu‰‰j ¸_Ž¾Š³‚𔺂Á‚½’Ä—ŽŠO‚ÌŒŸ“¢. Žá—ÑL”Vi®ŠOjCV“¡³‹PC’ç–M•FC‘Oì˜a•FC‘å˜a“c—²i‹~–½jC‹àˆä“¿²C‘å–ìŽii®ŠOj: ‘æ3‰ñ“ú–{ŠOŒ¤‹†‰ï (89.06.01), ŽD–y.

2861. mŒ¤‹†‰ïn iˆê”Êu‰‰j äB‘¹‚Ì•Û‘¶“IŽ¡—Âɂ¨‚¯‚éTAE‚Ì–ðŠ„. –x’rdŽ¡C‘Oì˜a•FCó—˜–õC¡ˆäPC™–{Ÿ•FCV“¡³‹PC‘å˜a“c—²i‹~–½j: ‘æ3‰ñ“ú–{ŠOŒ¤‹†‰ï (89.06.01), ŽD–y, “ú–{ŠOŒ¤‹†‰ïŽ, 3(1): 83, 1989.

2862. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠJ•ú«œ”՜܂̌Ÿ“¢. V“¡³‹PC‘Oì˜a•FC™–{Ÿ•FC‘å˜a“c—²i‹~–½jCŽá—ÑL”VC“ì‘òˆç—Yi®ŠOj: ‘æ3‰ñ“ú–{ŠOŒ¤‹†‰ï (89.06.02), ŽD–y.

2863. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠOŠ³ŽÒ‚É‚¨‚¯‚éƒEƒŠƒiƒXƒ^ƒ`ƒ“‚Ì“Š—^‚̈Ӌ`. ó—˜–õC‘Oì˜a•FC¡ˆäPC™–{Ÿ•FCV“¡³‹PC‘å˜a“c—²i‹~–½j: ‘æ3‰ñ“ú–{ŠOŒ¤‹†‰ï (89.06.02), ŽD–y.

2864. mŒ¤‹†‰ïn iˆê”Êu‰‰j œÜ‚ɇ•¹‚µ‚½•Gâ|“®–¬‘¹‚ÌŒŸ“¢. V“¡³‹PC¡ˆäPC‘Oì˜a•Fi‹~–½j: ‘æ3‰ñLimb Salvage Œ¤‹†‰ï (89.07.07), ˆ®ì.

2865. mŒ¤‹†‰ïn iˆê”Êu‰‰j œÜ‚ɇ•¹‚µ‚½‰ºŽˆŽåŠ²“®–¬‘¹‚Ìf’fAŽ¡—Ãã‚Ì–â‘è“_. V“¡³‹PC‘Oì˜a•FC™–{Ÿ•FC¡ˆäPC‘å˜a“c—²i‹~–½jC‘å–ìŽiCŽá—ÑL”Vi®ŠOj: ‘æ15‰ñ“ú–{œÜŒ¤‹†‰ï (89.07.14), ‰ªŽR.

2866. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŽOŽŸ‹~‹}ˆã—ÃŽ{Ý‚É‚¨‚¯‚é‹}«’†“Å‚ÌŒŸ“¢|î•ñ’ñ‹Ÿ‚Ì—§ê‚©‚ç|. ‹ß“¡—¯”üŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jCL£—²ˆêC‘å˜a“c—²i‹~–½jC¼ì—²i—Õ•a—j: ‘æ11‰ñ“ú–{’†“ÅŒ¤‹†‰ï (89.07.21), ‘åã.

2867. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’YŽ_…‘fƒiƒgƒŠƒEƒ€“Š—^‚É‚æ‚èCˆêŽž“I‚ÉÇó‚ÌŒy‰õ‚ð‚Ý‚½‚ªC‚»‚ÌŒã”x…Žî‚É‚æ‚莀–S‚µ‚½Aspirin’†“Å‚Ì‚P’jŽ™—á. דc‚Ì‚¼‚ÝiŽ™jC“¡–ìé”VCŽá—Ñ–õ‹vC¡ˆäPCV“¡³‹PC™–{Ÿ•FC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ11‰ñ“ú–{’†“ÅŒ¤‹†‰ï (89.07.26), ‘åã, ´˜^W, p.34, 1989.

2868. mŒ¤‹†‰ïn iˆê”Êu‰‰j ¬Ž™• •”“Ý“IŠO‚̉摜f’f. ¬—Ñ–ÎŽ÷C–x’rdŽ¡C¼Šª”ŽC¼ŽR³ŒáC’J“c—ˆê˜YC‰¡ŽR‹v˜NC¼—Ñ—²i•új: “ú–{¬Ž™•úŽËüŒ¤‹†‰ï (89.09.27), –¼ŒÃ‰®, “ú–{¬Ž™•úŽËüŒ¤‹†‰ï´˜^W, p.26, 1989.

2869. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒÀŽÕ’f܉ߗʕž—p‚É‚æ‚èˆê‰ß«‚Ì“´–[ƒuƒƒbƒN‚ð‚Ý‚½–«t•s‘SA’჌ƒjƒ“’áƒAƒ‹ƒhƒXƒeƒƒ“Ç‚Ì1—á. ŠÖŽRØ•äi“àjC¼ŽR’¼‹vC’†_Œ¹ˆêCŽá—Ñ–õ‹vC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ4‰ñ“ú–{’†“ÅŒ¤‹†‰ï“Œ“ú–{•”‰ï (90.01.20), “Œ‹ž.

2870. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒAƒZƒ^ƒP‘®ƒNƒƒgƒ}ƒ„ƒ_ƒP’†“Å‚Ì2Ç—á. “c’†•üŽqC•½“cŒõ”ŽC’ç–M•Fi‹~–½jC‹ß“¡—¯”üŽqi–òÜ•”jCŽá—Ñ–õ‹vC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ4‰ñ“ú–{’†“ÅŒ¤‹†‰ï“Œ“ú–{•”‰ï (90.01.20), “Œ‹ž.


<<209 ˆê”ÊÇŒóŒQ>>

2871. mŒ´’˜n G“ŽüˆÍ”^ᇂ̗հ“IŒŸ“¢. ¼‰ª–¾—TCÝŠy“N–çC”ª”ö˜a—YCŒ´“cGˆêC”ª–؈ê‹LCˆî–ØŸ‰piŽ¨•@j: “ú–{G“Œ¤‹†‰ï‰ïŽC28: 162`168, 1989.

2872. mÇ—á•ñn GVHD‚Ì1—á. ŽR–{Œ›ˆêi®ŠOjC™–{Ÿ•FCL£—²ˆêC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽ, 10(1): 286`287, 1989.

2873. m‹³‰È‘n iŽ·•Mj ŠO‰ÈŠw; ‹}«• Ç, p.590`598, ”äŠé”\Ž÷C’Ë–{GliŠOj. •ÒW X¹‘¢i“Œ–k‘åjC‘¼•Ò, ‚Ö‚é‚·o”Å, “Œ‹ž, 89.04.01”­s.

2874. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰ÈMook, No.12.˜V”NŽÒ‚ÆŽ¨•@ˆôA‰È; ˜Vl‚Ì‘O’ë‹@”\C‹@”\ŒŸ¸¬ÑC”N—î‚Ƴí’lCp.56`64C “¿‘Œú“ñiŽ¨•@j. •ÒW –쑺‹±–çi“Œ‘åjC–{¯Œµi‹ž‘åjCÝŠy“N–çi–k—¢‘åj•ÒC ‹àŒ´o”Å, “Œ‹ž, 89.04.01”­s.

2875. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ˜V”N•af—à Questions & Answers ‘æ11†; “®—h•aiæ‚蕨Œ‚¢jC11: 1557‚Ì6`1557‚Ì7, “¿‘Œú“ñiŽ¨•@j. •ÒW ‰i–ìˆòC‘¼•ÒC ˜Z–@o”Å, –¼ŒÃ‰®, 89.04.00”­s.

2876. mŠw‰ïn iˆê”Êu‰‰j Pseudoflutter-Like Oscillation. “¿‘Œú“ñC‹g”ö’miŽ¨•@j: ‡W. Symposium fur Neuro-Otologie. (89.10.27), Berlin.

2877. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ŠJ‹Æˆã‚É•K—v‚ÈŽ¨•@ˆôA‰ÈŠw‚Ì’mŽ¯|‚—ŽÐ‰ï‚ðŒ}‚¦‚Ä. “¿‘Œú“ñiŽ¨•@j: ‘æ218‰ñ‘å˜a—Õ°ˆãŠw’k˜b‰ïŒ¤C‰ï (89.05.24), ‘å˜a, 1989.

2878. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‚ß‚Ü‚¢Ž¾Š³‚Ìf’f‚Ì‚¨‚Æ‚µ‚ ‚È. “¿‘Œú“ñiŽ¨•@j: ‘æ33‰ñ‘Š•Ž¨ƒr‰ÈŒ¤‹†‰ï (89.07.15), ‘Š–ÍŒ´.

2879. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŽY‰È“IDIC‚ÆŠO‰È“IDIC. ¡ˆäPC‘Oì˜a•Fi‹~–½j: ‘æ4‰ñ‹~–½‹~‹}ˆã—ÃŒ¤‹†‰ï (89.10.21), “Œ‹ž.


<<210 ˆê”ÊŽ¡—Êw‹y‚Ñ–òŒøi–ƒŒ‚ðŠÜ‚Þj>>

2880. mŒ´’˜n Chronopharmacokinetic Study of Valproic Acid in Man; Comparison of Oral and Rectal Administration. ‹gŽR—F“ñi–òŠw•”jC’†–ìdsC¬ì’¨–çiˆ¤•Q‘åj: J. Clin. Pharmacol., 29(11): 1048`1052, 1989.

2881. mŒ´’˜n Œ`ó‹L‰¯‡‹à‚Ì•â‘•‹ï‚ւ̉ž—p. ‘O“c^Ž¡i“àj: ‹à‘®, p.22`26, 1990.

2882. mŒ´’˜n –³’É•ª•Ø‚ÌŒ»ó. ¼“‡³”ŽCVˆä³•viŽY•wj: ŽY•wl‰ÈŽ¡—Ã, 58(6): 637`641, 1989.

2883. mŒ´’˜n ‘O’ê_Œo‰Š|f’f‚Ì—v“_‚Æ•—]ƒEƒBƒ‹ƒXŠ´õ‚Æ‚ÌŠÖ˜A«‚ɂ‚¢‚Ä|. “¡–ì–¾lC“¿‘Œú“ñC‰ª–{–qlC’|“à‹`•vC”ª–؈ê‹LCŒÜ“‡ˆê‹gC‰®‹XWCŒ´“cGˆêCŒÃ‘òTˆêiŽ¨•@jCˆÉ•Û´ŽqCó–ì˜a]C‰LŽ”~ŽqC—é–Ø~ŽqC‚‹{t’j i—ÕŒŸj: Ž¨•@ˆôA‰ÈE“ªŒz•”ŠO‰ÈC61(3): 173`179, 1989.

2884. mŒ´’˜n ‚ß‚Ü‚¢•½táŠQ‚̃ŠƒnƒrƒŠƒe|ƒVƒ‡ƒ“. “¿‘Œú“ñiŽ¨•@j: Ž¨•@ˆôA‰ÈE“ªŒz•”ŠO‰ÈC61(4): 257`264, 1989.

2885. mŒ´’˜n ‘åŠw•a‰@‚É‚¨‚¯‚é”D•wŒŸf‚̃‹ƒ`ƒ“ŒŸ¸. “‡“cMGiŽY•wj: ŽüŽYŠúˆãŠw, 20(1): 25`29, 1990.

2886. mŒ´’˜n ƒoƒ‹ƒvƒŽ_ƒiƒgƒŠƒEƒ€¿Ü‚Ì–òÜŠw“IŒ¤‹†. ’†‘º‹±Žqi–òÜ•”jC‹gŽR—F“ñi–òŠw•”jC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”j: •a‰@–òŠwC15(3): 175`180, 1989.

2887. mŒ´’˜n dÇ”DP’†“ÅÇ‚É‚¨‚¯‚é’鉤؊J–ƒŒ–@‚ÌŒŸ“¢. ’Jº”ŽC–ì“c–FlC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGCVˆä³•viŽY•wjC’|’†’qºC“c’†—ºi–ƒj: •ª•Ø‚Æ–ƒŒ, (65°66): 25`32, 1989.

2888. mŒ´’˜n Methotrexate“îp‚̈À’è«‚¨‚æ‚у‰ƒbƒg‚É‚¨‚¯‚éŒo”ç‹zŽû. Ύ˳‰pC”ö’¹Ÿ–çi–òÜ•”jC‹gŽR—F“ñi–òŠw•”jC•½ŽR•ŽiC’©’·•¶–íi–òÜjC¼ŽR–Εvi”çj: –k—¢ˆãŠwC19(6): 604`611, 1989.

2889. m’Z•ñn Phase 1 StudyŽÀŽ{ã‚Ì”–â‘è. ŽÄ“c‹v—Yi“àj: ƒtƒ@ƒ‹ƒ}ƒVƒA, 24: 28`29, 1988.

2890. mŒ¤‹†•ñi•¶•”Èjn Ž¨«‚ß‚Ü‚¢‚ɑ΂·‚锽•œ“àŽ¨ŽhŒƒŽ¡—ÃŒø‰Ê‚ÌŠî‘b“IŒ¤‹†. “¿‘Œú“ñiŽ¨•@j: º˜a63”N“x‰ÈŠwŒ¤‹†”ï•â•‹àiˆê”ÊŒ¤‹†‚bjŒ¤‹†•ñ‘Cp.1`24, 1989.

2891. mŒ¤‹†•ñiŒú¶Èjn –ò•¨“®‘ÔŽŽŒ±ƒKƒCƒhƒ‰ƒCƒ“iˆÄj. ˆ¾’Ñ‘Žii“Œ‹ž–ò‰È‘åjCŽO‰YŽõ’jiŽ™jC‘¼: –ò•¨“®‘ÔŽŽŒ±i‹zŽû¥•ª•z¥‘ãŽÓ¥”rŸ•j‚ÉŠÖ‚·‚éƒKƒCƒhƒ‰ƒCƒ“Œ¤‹†”Ç•ñ‘C1989.

2892. mÇ—á•ñn ‡U“x”M‘n‚ɑ΂·‚郊ƒ]ƒ`[ƒ€“îp‚Ì—Õ°Œø‰Ê. ìãd•FC’Ë“c’å•vi‹à‘òˆã‘åjC“ï”g—YÆC–ì“cD‹éi’·è‘åjC‰¬–ì—mˆêCŒF’JŒ›•vi¹ƒ}ƒŠƒAƒ“ƒiˆã‘åjC‰–’JMKC‰FˆäŒª“ñiŒ`ŠOjCˆäãW•¶CXŒû —²•Fiìèˆã‘åj: “ú–{”MŠw‰ï‰ïŽ, 15(2): 109`117, 1989.

2893. m—Õ°Ž¡Œ±n ƒoƒNƒXƒ^[ƒCƒ“ƒtƒ…[ƒU[‚É‚æ‚é5Fu‚¨‚æ‚уŒƒyƒ^ƒ“‚ÌŽ‘±“Š—^. ‘å’J„³C”äŠé”\Ž÷iŠOjC“‡“cŽœ•Fi–òÜ•”j: Jpn. J. Parenter. Enter. Nutr., 11(4): 425`432, 1989.

2894. m—Õ°Ž¡Œ±n ”M‘n‚ɑ΂·‚郊ƒ]ƒ`[ƒ€“îp‚Ì—Õ°Œø‰Ê. ìãd•FC’Ë“c’å•vi‹à‘òˆã‘åjC“ï”g—YÆC–ì“cD‹éi’·è‘åjC‰¬–ì—mˆêCŒF’JŒ›•vi¹ƒ}ƒŠƒAƒ“ƒiˆã‘åjC‰–’JMKC‰FˆäŒª“ñiŒ`ŠOjCXŒû—²•Fiìè ˆã‘åj: ÅVˆãŠw, 44: 1962`1964, 1989.

2895. m—Õ°Ž¡Œ±n ƒ‹[ƒvƒXt‰Š‚ɑ΂·‚éƒ~ƒ]ƒŠƒrƒ“‚Ì—Õ°•]‰¿(1)|ƒvƒ‰ƒZƒ{‚ð‘ÎÆ‚Æ‚µ‚½‘½Ž{Ý’P–ÓŒŸ”äŠrŽŽŒ±|. –{ŠÔŒõ•vCHŒŽ³•vC‰¡’£—´ˆêC‹´–{”ŽŽjC”è’õ•vC‹ß“¡Œ[•¶i“àjC“üŒðºˆê˜Y: —Õ°ˆã–ò, 5: 795`824, 1989.

2896. m—Õ°Ž¡Œ±n ƒ‹[ƒvƒXt‰Š‚ɑ΂·‚éƒ~ƒ]ƒŠƒrƒ“‚Ì—Õ°•]‰¿(2)|’P–ÓŒŸ”äŠrŽŽŒ±‚©‚ç‚ÌŒp‘±“Š—^|. –{ŠÔŒõ•vC‹ß“¡Œ[•¶i“àjCHŒŽ³•vC‰¡’£—´ˆêC‹´–{”ŽŽjC”è’õ•vi“àjC“üŒðºˆê˜Y: —Õ°ˆã–ò, 5: 825`835, 1989.

2897. m—Õ°Ž¡Œ±n Second Interium Report of the Nation-Wide Collaborative Study on the Long-term Effects of Bromocriptine in the Treatment of Parkinsonian Patients. Nakanishi, T.i’}”g‘åjCIwata, M.i“Œ‘åjCGoto, I.i‹ã‘åjCKanazawa, I.i’}”g‘åjCŒÃ˜a‹vKi“àjCMannen, T.i“Œ‘åjCMizuno, Y.i‡“V“°‘åjCNishitani, H.: —Õ°ˆã–ò, 5: 825`835, 1989.

2898. m‘àn —Õ°HŠw‹ZŽm‚Ì‹Æ–±”͈͂Ǝ󂯓ü‚ê. “n•Ó•qi–ƒj: Clinical Engineering, 1(1): 44`48, 1990.

2899. m‘àn lHŒÄ‹zŠí‚ÌW’†ŠÇ—‚Æ•ÛŽç“_ŒŸ. L£–«C“íé¢iMEƒZƒ“ƒ^[j: Clinical Engineering, 1(1): 57`61, 1990.

2900. m‘àn lHŒÄ‹z—Ö@‚͂ǂ̂悤‚È󋵂ŕK—v‚©. “n•Ó•qi–ƒj: Clinical Engineering, 1(2): 94`98, 1990.

2901. m‘àn ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“‘ãŽÓ‚ÌŠî‘b’mŽ¯‚Æ—Õ°ŒŸ¸‚ւ̉ž—p. Ž­ŽæMi–ò—j: Laboratory and Clinical Practice, 7(2): 29`40, 1989.

2902. m‘àn Œü¸_–ò‚Ì—LŒø‚ÈŽg‚¢•û‚Æ‚»‚ÌŒoÏ«|‚Æ‚­‚ÉR•sˆÀ–ò‚ɂ‚¢‚Ä|. ŽO‰Y’å‘¥i¸j: Prog. Med., 10(2): 269`274, 1990.

2903. m‘àn ŽèpŽº‚É‚¨‚¯‚éЊQ‘Îô‡AŽèpŽº‚É‚¨‚¯‚éÝ”õ¥‹@Ší‚̈À‘S‘Îô. “n•Ó•qi–ƒj: ƒIƒyƒi[ƒVƒ“ƒO, 4(8): 17`22, 1989.

2904. m‘àn ‚¨‚Ú‚¦‚Ä‚¨‚±‚¤IME‹@Ší(1). “n•Ó•qi–ƒjC”Ñ“‡Œõ—YC’r“cŒõŠìCˆî–Ñ”ŽC‘åL˜a–¾C²“¡³Œ›C–쑺’q”VC–{‘½—²C¬—ÑŠ]C”’ˆä“ÖŽjiMEƒZƒ“ƒ^[j: ƒNƒŠƒjƒJƒ‹ƒXƒ^ƒfƒB, 10(11“Á): 1`16, 1989.

2905. m‘àn ‚¨‚Ú‚¦‚Ä‚¨‚±‚¤IME‹@Ší(2). “n•Ó•qi–ƒjC’r“cŒõŠìC“íé¢C¼ì‰·C–쑺’q”VCL£–«C‰Z¶Lˆê C–kŒ´Œ[iMEƒZƒ“ƒ^[j: ƒNƒŠƒjƒJƒ‹ƒXƒ^ƒfƒB, 10(12)“Á•Ê•t˜^: 1`16, 1989.

2906. m‘àn ME ‹@Ší‚Ì’†‰›ŠÇ—. “n•Ó•qi–ƒj: ˆã‰ÈŠíŠBŠw, 60(3): 116`120, 1990.

2907. m‘àn ‡–°–ò‚Ì—Õ°•]‰¿ƒKƒCƒhƒ‰ƒCƒ“‚ɂ‚¢‚Ä. ŽO‰Y’å‘¥i¸j: ˆã–ò•iŒ¤‹†, 21(1): 1`5, 1990.

2908. m‘àn ‚à‚Á‚Æ’m‚肽‚¢ME‹@Ší (3)lHŒÄ‹zŠí Part l €”õ‚©‚ç‘•’…‚Ü‚Å. ‰Z¶LˆêCŽR“c’JߎqC–ìŒû‰À‘ãŽqC“n•Ó•qi–ƒj: ŒŽŠ§ƒi|ƒVƒ“ƒO, 9(8): 894`899, 1989.

2909. m‘àn ‚à‚Á‚Æ’m‚肽‚¢ME‹@Ší‡ClHŒÄ‹zŠí Part 2 ‘•’…’†‚ÌŠÇ—‚ƃPƒA. ‰Z¶LˆêCŽR“c’JߎqC–ìŒû‰À‘ãŽqC“n•Ó•qi–ƒj: ŒŽŠ§ƒi|ƒVƒ“ƒO, 9(9): 1032`1037, 1989.

2910. m‘àn ŒŸ¸ƒtƒ@ƒCƒ‹ Œõ“dŽ®–¬”gŒŸ¸. “•ûLˆêi—ÕŒŸjC“n•Ó•qi–ƒj: ŒŸ¸‚Æ‹Zp, 17(13): 1624`1625, 1989.

2911. m‘àn Ý‘îlHŒÄ‹z—Ö@. “n•Ó•qi–ƒj: Œ»‘ãˆã—Ã, 22(3): 807`814, 1990.

2912. m‘àn —Õ°HŠw‹ZŽm|‚»‚Ì‹Æ–±‚Æ¡Œã‚ÌŠú‘Ò|. “n•Ó•qi–ƒj: _“ÞìˆãŠw‰ïŽGŽ, 17(1): 14`19, 1990.

2913. m‘àn ”DP’†“ÅÇ|ƒˆŒ^|. “‡“cMGiŽY•wj: t‚Æ“§Í, 1989”N—ÕŽž‘Š§†utŽ¾Š³‚Ì–ò•¨—Ö@v: 195`196, 1989.

2914. m‘àn ˆã—ÃŽ{Ý‚É‚¨‚¯‚é—Õ°HŠw•”–å‚Ìd—v«. “n•Ó•qi–ƒj: ‘ÌŠOzŠÂ‹Zp, 15(2): 14`19, 1989.

2915. m‘àn ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“|‚»‚̶‘Ì“à‚É‚¨‚¯‚éˆÊ’u‚¯‚Æ‘S‘Ì‘œ. Ž­ŽæMi–ò—j: “ú–{–ò—ŠwŽGŽ, 94: 159`171, 1989.

2916. m‘àn Ö°’ÁÃÜAR‚Ä‚ñ‚©‚ñÜ. ŽO‰Y’å‘¥i¸jC’|“எqi–òÜ•”j: —Õ°‚Æ–ò•¨Ž¡—Ãi‘Š§†j, 8(7): 782`789, 1989.

2917. muÀn ‚ß‚Ü‚¢‚̃ŠƒnƒrƒŠƒe|ƒVƒ‡ƒ“. “¿‘Œú“ñiŽ¨•@j: ƒJƒŒƒ“ƒgƒeƒ‰ƒs|, 7(12): 80`84, 1989.

2918. muÀn “ÁW;Ž¨•@ˆôA¥“ªŒz•”—̈æ‚Ì’É‚Ý|‚»‚Ì‹@˜‚Æ—Õ°|’É‚Ý‚ÆŠO—ˆˆ’u. ”ª”ö˜a—YCÝŠy“N–çiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È, 61(10): 953`955, 1989.

2919. muÀn ’鉤؊J. “‡“cMGC‹gŒ´ˆêiŽY•wj: ŽüŽYŠúˆãŠw, 20(3): 415`418, 1990.

2920. mÀ’k‰ïn "R’s•ð–ò"‚ÌŒ»ó‚Æ«—ˆ‚ð’T‚é. ‘å—F‰pˆêi—•—‰€jCr–،ܘYi“ŒŠC‘åjCŽO‰Y’å‘¥i¸jC´…MiŽœŒbˆã‘åj: Clinical Neuroscience, 7(11): 1226`1239, 1989.

2921. mŠwp‘n iŽ·•Mj •ÛŽçŠÇ—‚ƈÀ‘S‘Îô; –ƒŒ¥W’†Ž¡—Âƃ‚ƒjƒ^ƒŠƒ“ƒO, p.473`483, “n•Ó•qi–ƒj. •ÒW ‰œHîC’r“c˜a”VC–L‰ªGŒPC•ÒC Ž½“°o”Å,@“Œ‹žC89.10.11”­s.

2922. mŠwp‘n iŽ·•Mj ˆã—×p‹@Ší‚ÌŒ´—‚ÆŽÀÛ; B.‘ª’è—p‚l‚d‹@Ší, C.Ž¡—×p‚l‚d‹@Ší, Œn“ŠÅŒìŠwuÀ ê–å3, Šî‘bŠÅŒìŠw 3. p.251`266, “n•Ó•qi–ƒj. ˆãŠw‘‰@, “Œ‹ž, 90.01.06”­s.

2923. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj; tˆÚAŠ³ŽÒ‚̃PƒA, 32: 805`806, ‰““¡’‰—Yi”åj. •ÒW ˆîŠ_‹`–¾iç—t‘åj‘¼•Ò, ŠÄC “ú–쌴d–¾i¹˜H‰Á‘Û•a‰@j‘¼ŠÄC, ˆãŠw‘‰@, “Œ‹žC90.02.15”­s.

2924. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj; “à‰ÈŽ¾Š³‚É‚æ‚é¸_áŠQ, p.261`262, ŽO‰Y’å‘¥i¸j. •ÒW ˆîŠ_‹`–¾iç—t‘åjC‘½‰ê{K’jiŠÖ“Œ’üM•a‰@jC”öŒ`‰x˜Yi“Œ‘åj•ÒC ˆãŠw‘‰@, “Œ‹ž, 90.02.15”­s.

2925. mŽ‹’®Šo‹³Þn i•ÒWj TURP‚̃Rƒc‚ƃCƒ[ƒW(video tape), ‰¡ŽR‰p“ñC“à“c–LºC“¡–ì’WlC¬ŽÄŒ’i”åj. •ÒW ‰¡ŽR‰p“ñ •Ò, ŠÄC ¬ŽÄŒ’ŠÄCC 89.09.00”­s.

2926. mŽ‹’®Šo‹³Þn iŠÄCj ‚ß‚Ü‚¢‚̉^“®—Ö@. ŠÄC “¡–ì–¾liŽ¨•@jŠÄCC EisaiŠwpƒrƒfƒI, 90.03.00”­s.

2927. mŠw‰ïn i“Á•Êu‰‰j ˆã—Ë@Ší‚Ì•ÛŽçŠÇ—‚ɂ‚¢‚Ä|–k—¢‘åŠw•a‰@‚Å‚ÌŽÀ—á|. “n•Ó•qi–ƒj: ˆã—Ë@Ší§˜b‰ïià’c–@l ˆã—Ë@ŠíƒZƒ“ƒ^|j (89.09.25), “Œ‹ž.

2928. mŠw‰ïn i‹³ˆçu‰‰j áu’ÉŽ¡—Âɂ¨‚¯‚éŋ߂̘b‘è. “n•Ó•qi–ƒj: ‘æ27‰ñ–k—¢‘åŠwˆãŠw•”®Œ`ŠO‰ÈŒŽ—áƒJƒ“ƒtƒ@ƒŒƒ“ƒX (90.02.19), ‘Š–ÍŒ´.

2929. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‹Æ–±”͈͂Ƃ»‚Ì–â‘è“_. “n•Ó•qi–ƒj: ‘æ28‰ñ“ú–{MEŠw‰ï‘å‰ï–é‚Ì’k˜b‰ïu—Õ°HŠw‹ZŽm‚Ì”–â‘èv. (89.05.23.), ‘åã.

2930. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j –k—¢‘åŠw“Œ•a‰@‘‡‘Š’k•”–K–âˆã—ÃVƒXƒeƒ€‚ɂ‚¢‚Ä. Ä“¡–L˜ai“àjC‰““¡MŽqC–x‰z—R‹IŽqC‚“ˆ‰Á‘ãŽqCŽR–{ŒPŽqC“c‹{^ŽqiŠÅŒì•”jC’·‘òOC‰Z¶LˆêiMEƒZƒ“ƒ^[jC•ŸŽR‰Ã|i¸jC–ìŒû‹…Žqi‰h—{ ‰ÈjCΎ˳‰pi–òÜ•”jC‰Á“¡ºiˆã—ÉÈjCדc–«C‘O“c^Ž¡CŒÃ˜a‹vKi“àj: ‘æ12‰ñƒvƒ‰ƒCƒ}ƒŠ|¥ƒPƒAŠw‰ïuÝ‘îƒPƒAv. (89.06.00), ƒvƒ‰ƒCƒ}ƒŠ|¥ƒPƒA, 12: 405`410, 1989.

2931. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j —Õ°ŽÀK•a‰@‚ÌŽó“ü‘̧‹Æ–±. “n•Ó•qi–ƒj: ‘æ4‰ñ“ú–{MEŠw‰ïH‹G‘å‰ïu—Õ°HŠw‹ZŽm‚Ì—{¬‚ð‚ß‚®‚‚Äv. (89.10.17), ŽD–y, ˆã—p“dŽq‚ƶ‘ÌHŠw, 27(Suppl. 2): 24, 1989.

2932. mŠw‰ïn iƒpƒlƒ‹j Ý‘îŒÄ‹z—Ö@‚ÌŒ»ó‚Æ«—ˆ. “n•Ó•qi–ƒj: ‘æ5‰ñƒGƒ‹¥ƒGƒX¥ƒeƒBŠw‰ï‘å‰ïu¶–½ˆÛŽŠÇ—‘•’uv. (89.11.25), “Œ‹ž.

2933. mŠw‰ïn iˆê”Êu‰‰j Study of cardiac arrest associated with spinal anesthesia. ŒÜ\”¨mC“c’†—ºi–ƒj: ‘æ9‰ñ¢ŠE–ƒŒŠw‰ï (88.05.22`28), Washington D.C., U.S.A.

2934. mŠw‰ïn iˆê”Êu‰‰j Study on mechanical pressure produced by caryngscopy. “c’†—ºC‰¤“VŒ³i–ƒjC‹´–{¬Li¶‘ÌHj: ‘æ9‰ñ¢ŠE–ƒŒŠw‰ï (88.05.22`28), Washington D.C., U.S.A.

2935. mŠw‰ïn iˆê”Êu‰‰j ŠeŽíR¶Ü‚Ì’`”’Œ‹‡—¦‚ÌŒŸ“¢i‘æ1•ñj|Œ’íl‚¨‚æ‚ÑtáŠQŠ³ŽÒ‚É‚¨‚¯‚éƒZƒtƒ@ƒƒ`ƒ“‚Ì’`”’Œ‹‡—¦|. –{‹´–ÎC•ŽR­ˆêC‹´–{²ŽqC‘º£¨’ÃŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jCŒF–ì˜a•vi”åj: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.05), –¼ŒÃ‰®C u‰‰—vŽ|W11Cp.30, 1989.

2936. mŠw‰ïn iˆê”Êu‰‰j ƒoƒ‹ƒvƒŽ_‚ÌŽžŠÔ–ò•¨“®‘ÔŠw“IŒ¤‹†:ƒ}ƒEƒX‚É‚¨‚¯‚éŒoŒû‹y‚Ñ’¼’°“à“Š—^Žž‚Ì”äŠrŒŸ“¢. ‹gŽR—F“ñi–òŠw•”jC’©’·•¶–íi–òÜ•”jC’†–ìdsC¬ì’¨–çiˆ¤•Q‘åj: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.05), –¼ŒÃ‰®C u‰‰—vŽ|W11Cp.42, 1989.

2937. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™–«t•s‘SŠ³ŽÒ‚ÌtˆÚAp‚Ì–ƒŒŠÇ—. ‘ºã‰ëŽqC–쌩ŽRECŒÜ–¡—ŒbC÷–{çŒbŽqC”’ˆä³rC‰ª“c¹•½C“n•Ó•qC“c’†—ºi–ƒj: ‘æ36‰ñ“ú–{–ƒŒŠw‰ï‘‰ï (89.04.13), ŽRŒû, –ƒŒ, 38(9,Suppl.): S223, 1989.

2938. mŠw‰ïn iˆê”Êu‰‰j ˆã—ÃKƒX‚̈À‘S|ˆã—ÃKƒXˆÀ‘S¥ŠÇ—ˆÏˆõ‰ï‚ÌÝ—§‚Æ‚»‚Ì–â‘è“_. “n•Ó•qi–ƒj: ‘æ36‰ñ“ú–{–ƒŒŠw‰ï‘‰ï¤ (89.04.14), ŽRŒû, –ƒŒ, 38(9,Suppl.): S.393, 1989.

2939. mŠw‰ïn iˆê”Êu‰‰j Žw’è”­Œ¾|’ጌˆ³–ƒŒ‚Í—L—p‚©. “n•Ó•qi–ƒj: ‘æ36‰ñ“ú–{–ƒŒŠw‰ï‘‰ï (89.04.15), ŽRŒû.

2940. mŠw‰ïn iˆê”Êu‰‰j Pharmacokinetics of Amphotericin B|Analysis of Its Elimination Process|. ‘º£¨’ÃŽqC–]ŒŽ^‹|C•ŽR­ˆêC–ؘHŒbi–òÜ•”jC‹gŽR—F“ñi–òŠw•”jC’©’·•¶–íi–òÜ•”jC‹v•ÄŒõi•a—j: Pan Pacific ‡X (89.05.07`11), ƒ\ƒEƒ‹C Abstract, p.324, 1989.

2941. mŠw‰ïn iˆê”Êu‰‰j ƒAƒ€ƒzƒeƒŠƒVƒ“B‚Ì‘Ì“à“®‘Ô|Žå‚É”rŸ•‚ɂ‚¢‚Ä|. –ؘHŒbC‘º£¨’ÃŽqC•ŽR­ˆêC–]ŒŽ^‹|C’©’·•¶–íi–òÜ•”jC‹gŽR—F“ñi–òŠw•”jC‹v•ÄŒõi•a—j: ‘æ4‰ñ–ò•¨ƒ‚ƒjƒ^ƒŠƒ“ƒO‘S‘Œð—¬‰ïC‘æ6‰ñ“ú–{TDMŠwpW‰ï (89.05.12`13), “Œ‹žC TDMŒ¤‹†, 6(1): 33`37, 1989.

2942. mŠw‰ïn iˆê”Êu‰‰j Chronopharmacokinetic Study of Valproic Acid in Man: Comparison of Oral and Rectal Administration. ‹gŽR—F“ñi–òŠw•”jC’©’·•¶–íi–òÜ•”jC’†–ìdsC¬ì’¨–çiˆ¤•Q‘åj: ‡W World Conference on Clinical Pharmacology & Therapeutics (89.07.25), ¼ƒhƒCƒc, Eur. J. Clin. Pharmacol., 36(Suppl.): A178, 1989.

2943. mŠw‰ïn iˆê”Êu‰‰j ƒAƒ€ƒzƒeƒŠƒVƒ“B‚Ì‘å—Ê“à•ž‚É‚¨‚¯‚é‘Ì“à“®‘Ô. ‘º£¨’ÃŽqC–]ŒŽ^‹|C•ŽR­ˆêC–ؘHŒbC’©’·•¶–íi–òÜ•”jC‹gŽR—F“ñi–òŠw•”jC‹v•ÄŒõC‰œ•½‰ë•Fi•a—j: ‘æ33‰ñ“ú–{ˆã^‹ÛŠw‰ï‘‰ï (89.09.22`23), ‰«“êC ´˜^W, p.130, 1989.

2944. mŠw‰ïn iˆê”Êu‰‰j ƒoƒ‹ƒvƒŽ_–ò•¨“®‘Ô‚É‹y‚Ú‚·“Š—^‚̃^ƒCƒ~ƒ“ƒO:ŒoŒû‹y‚Ñ’¼’°“à“Š—^‚É‚¨‚¯‚éHŽ–ðŒ‚̉e‹¿. ‹gŽR—F“ñi–òŠw•”jC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC”ª‘ãŒö•viŽ™j: “ú–{–òÜŠw‰ï‘æ5”N‰ï (89.09.28), “Œ‹žC u‰‰—vŽ|W, p.138`139, 1989.

2945. mŠw‰ïn iˆê”Êu‰‰j ‚—îŽÒ‚É‚¨‚¯‚éTriazolam˜A—pŽž‚ÌŒŒ’†”Z“x‚ÉŠÖ‚·‚錤‹†. Ž›“c‹vŽqi“Œ‹ž•‘ –ì•a‰@jC_’ëdMiŒc‘åjC¼ì—²i—Õ•a—j: ‘‡•a‰@¸_ˆãŠw‰ï (89.10.00).

2946. mŠw‰ïn iˆê”Êu‰‰j TURP‚̃Rƒc‚ƃCƒ[ƒW. ‰¡ŽR‰p“ñC“à“c–LºC“¡–ì’WlC¬ŽÄŒ’i”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06), “Œ‹ž.

2947. mŠw‰ïn iˆê”Êu‰‰j ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ò•¨‚̃‰ƒWƒIƒŠƒZƒvƒ^|ƒAƒbƒZƒC:¸_‰È‚¨‚æ‚Ñ‹~‹}ƒZƒ“ƒ^|Š³ŽÒ‚ւ̉ž—p. ¼ì—²C‘å’J‰pŽ÷i—Õ•a—jCìŒû‹Bi¸jC‹ß“¡—¯”üŽqi–òÜ•”j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.06), ‹ž“sC —Õ°•a—, 37(•â): 193, 1989.

2948. mŠw‰ïn iˆê”Êu‰‰j ŠàI––Šúáu’ÉŠÇ—‚É‚¨‚¯‚é intrapleural block ‚ÌŒoŒ±. “ü‘qOŽqC–쌩ŽREC’|’†’qºC“I–씎C“n•Ó•qC“c’†—ºi–ƒj: ‘æ29‰ñ“ú–{–ƒŒŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (89.10.07), “Œ‹ž.

2949. mŠw‰ïn iˆê”Êu‰‰j Gentamicint“Å«‚É‹y‚Ú‚·“Š—^Žž‚̉e‹¿. ‹gŽR—F“ñi–òŠw•”jC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC’†–ìdsiˆ¤•Q‘åj: ‘æ81‰ñ“ú–{–ò—Šw‰ïŠÖ“Œ•”‰ï (89.10.14), “Œ‹žC “ú–{–ò—Šw‰ïŽ, 94(6): 106, 1989.

2950. mŠw‰ïn iˆê”Êu‰‰j PGE1‚ð—p‚¢‚½dÇ”DP’†“ÅÇ‚Ì’éØ–ƒŒŠÇ—. —§‰ª˜aOCA–ìM…C¯“c—²C–ì“c–FlC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wjC–쌩ŽREC“c’†—ºi–ƒj: ‘æ78‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.10.29), ‘å‹{.

2951. mŠw‰ïn iˆê”Êu‰‰j Intra-pleural block‚É‚æ‚éáu’ÉŠÇ—‚ÌŒ¤‹†. “ü‘qOŽqC“I–씎C–쌩ŽREC“n•Ó•qC“c’†—ºCŒÜ\”¨mi–ƒj: ‘æ9‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï (89.11.02) “Œ‹žC “ú–{—Õ°–ƒŒŠw‰ïŽ, 9(6): 157, 1989.

2952. mŠw‰ïn iˆê”Êu‰‰j •a‰@“d‹CÝ”õ‚̈À‘S«‚ð‚ß‚´‚µ‚Ä. “n•Ó•qi–ƒjC•y“c³”üC–kŒ©‰À–[i•a‰@j: ‘æ18‰ñ“ú–{“d‹CÝ”õŠw‰ï (89.11.09) “Œ‹žC •a‰@Ý”õ, 32(2): 171`172, 1990.

2953. mŠw‰ïn iˆê”Êu‰‰j R¶•¨Ž¿•¹—p—Ö@‚ÌŽžŠÔ–ò—Šw“IŒ¤‹†. ‹gŽR—F“ñi–òŠw•”jC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC’†–ìdsiˆ¤•Q‘åj: ‘æ33‰ñ“ú–{–òŠw‰ïŠÖ“ŒŽx•”‘å‰ï (89.11.11), “Œ‹žC u‰‰—vŽ|W, p.55, 1989.

2954. mŠw‰ïn iˆê”Êu‰‰j ƒoƒ‹ƒvƒŽ_‚ÌŽžŠÔ–ò•¨“®‘ÔŠw“IŒ¤‹†;ƒ}ƒEƒX‹y‚уqƒg‚É‚¨‚¯‚éŒoŒû‹y‚Ñ’¼’°“à“Š—^‚Ì”äŠrŒŸ“¢. ‹gŽR—F“ñi–òŠw•”jC’©’·•¶–íi–òÜ•”jC’†–ìdsC‘åŒË–ÎOC¬ì’¨–çiˆ¤•Q‘åj: ‘æ10‰ñ“ú–{—Õ°–ò—Šw‰ï (89.11.15), “Œ‹žC —Õ°–ò—, 21(1): 69`70, 1990.

2955. mŠw‰ïn iˆê”Êu‰‰j ŠÅŒì‚É‚¨‚¯‚éVASŽg—p‚É‚æ‚é’É‚Ý‚Ì•]‰¿. ‰ªèŽõ”üŽqC–x—ÇŽqiŠÅŒìŠw•”jC“n•Ó•qi–ƒjC¬“‡‹±ŽqCŒÃ¯•y”üŽqiŠÅŒìŠw•”j: ‘æ11‰ñ“ú–{áu’ÉŠw‰ï (89.12.02), ‘åã.

2956. mŠw‰ïn iˆê”Êu‰‰j ãŠ{ŠàŽ¡—Âɂ¨‚¯‚é•úŽËüƎ˂̈Ӌ`. ‚‹´œAbiŽ¨•@jC¼—Ñ—²i•új: “ú–{•úŽËüŽîᇊw‰ï (90.01.14), “Œ‹ž, “ú–{•úŽËüŽîᇊw‰ïŽJastro—\eWC1989.

2957. mŠw‰ïn iˆê”Êu‰‰j ‹}«ˆê‘¤«‘O’ëáŠQ‚̉^“®—Ö@. VˆäŠî—mC’·À‰p–¾C’†ŽR–¾mC–ìŒû_’jCV“cŒ’‘¾˜YC¯–ìŒ÷C“¡–ì–¾lC‹g”ö’mC“¿‘Œú“ñiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ71‰ñŽ¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŠwpu‰‰‰ï (90.03.03), “¡‘ò.

2958. mŠw‰ïn iˆê”Êu‰‰j Ý‘î—×{‚Ì‚½‚ß‚Ì‹CŠÇ‹zˆøƒJƒe|ƒeƒ‹|ŠÈˆÕÁ“Å¥•Û‘¶—eŠí‚ÌŽŽì‚Æ‚»‚̉ž—p|. דc–«i“àjC‰Z¶LˆêiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒj: ‘æ64‰ñ“ú–{ˆã‰ÈŠíŠBŠw‰ï‘å‰ï (90.05.28), ‘åã, ˆã‰ÈŠíŠBŠw, 59(Suppl.): 59`60, 1990.

2959. mŠw‰ïn iˆê”Êu‰‰j ME‹@Šíƒgƒ‰ƒuƒ‹ƒ}ƒjƒ…ƒAƒ‹‚̃pƒ\ƒRƒ“—˜—p. ”’ˆä“ÖŽjC¬—ÑŠ]Cˆ¾–ìŠwC‰Z¶LˆêiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒjCˆî–Ñ”ŽC’r“cŒõŠìCL£–«Crˆä•¶•viMEƒZƒ“ƒ^[j: ‘æ64‰ñ“ú–{ˆã‰ÈŠíŠBŠw‰ï‘å‰ï (90.05.28), ‘åã, ˆã‰ÈŠíŠBŠw, 59(Suppl.): 77`78, 1990.

2960. mŠw‰ïn iˆê”Êu‰‰j “dŒ¹Ý”õ‚̈À‘S«. ”Ñ“‡Œõ—YC¼ì‰·C“íé¢C‘åL˜a–¾Cˆî–Ñ”ŽCL£–«C–{‘½—²C’r“cŒõŠìC–쑺’q”VC²“¡³Œ›C–kŒ´Œ[C‰¡aŽŒÈiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒj: ‘æ64‰ñ“ú–{ˆã‰ÈŠíŠBŠw‰ï‘å‰ï (90.05.28), ‘åã, ˆã‰ÈŠíŠBŠw, 59(Suppl.): 81`82, 1990.

2961. mŠw‰ïn iˆê”Êu‰‰j —Õ°HŠw‹ZŽm‚Ì’a¶|—Õ°‚ÌŒ»ê‚Å‚Ì–ðŠ„‚Æ–â‘è“_|. “n•Ó•qi–ƒj: ‘æ68‰ñ–k—¢ˆãŠw‰ï—á‰ï (90.05.30), ‘Š–ÍŒ´, –k—¢ˆãŠw, 21: 1990.

2962. mŠw‰ïn iˆê”Êu‰‰j zŠÂáŠQ‚ð”F‚ß‚¸‚É‘ãŽÓ«ƒAƒVƒh|ƒVƒX‚ð’悵‚½3Ç—á. rì^”VCŒÜ–¡—ŒbC÷–{çŒbŽqC•lè‚—TC‰ª“c¹•½C–쌩ŽREC“n•Ó•qi–ƒj: ‘æ28‰ñ“ú–{–ƒŒŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i88.09.09j, “Œ‹ž.

2963. mŠw‰ïn iˆê”Êu‰‰j p’†AT‡V»Ü‚ÌŽg—pŒoŒ±. ›’J˜a]CóˆäŽ}C’|’†’qºCŒÜ\”¨mC‘ºã‰ëŽqC–쌩ŽREi–ƒj: ‘æ28‰ñ“ú–{–ƒŒŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i88.09.09j, “Œ‹ž.

2964. mŠw‰ïn iˆê”Êu‰‰j ŽvtŠúŠ³ŽÒ‚ÌÒ’Å–ƒŒŽ€‚ÌŒŸ“¢. “c’†—ºCóˆäŽ}CJin, H.Y.CŒÜ\”¨mC–쌩ŽREi–ƒj: ‘æ7‰ñ“ú–{‘h¶ˆãŠw‰ï i88.09.23`24j, ‰ªŽR.

2965. mŠw‰ïn iˆê”Êu‰‰j Circulatory responses to epidural blockade of treated and untreated hypertensive patients. Jin, H.Y.C“c’†—ºi–ƒj: ‘æ14‰ñ–k—¢ˆãŠw‰ï‘‰ï i88.10.01j, ‘Š–ÍŒ´.

2966. mŠw‰ïn iˆê”Êu‰‰j ŽüpŠú‚É‚¨‚¯‚éPGE 1‚ÌŒŒŠÇŠg’£—Ö@–ò‚Æ‚µ‚Ă̈Ӌ`. –쌩ŽREC“c’†—ºi–ƒj: ‘æ36‰ñ“ú–{–ƒŒŠw‰ï‘‰ï i89.04.13`15j, ŽRŒû.

2967. mŠw‰ïn iˆê”Êu‰‰j • •”‘å“®–¬áŽŽèp‚É‚¨‚¯‚éPhentolamine•¹—pd–ŒŠO–ƒŒ–@‚ÌzŠÂ“®‘Ô‚É—^‚¦‚éŒø‰Ê. –쌩ŽREC‘ºã‰ëŽqCŒÜ\”¨mC’|’†’qºC•lè‚—TC¬‘òÍŽqC“I–씎C–î“c_CVˆä³NC“¡Œ´ŒjŽqC“c’†—ºi–ƒj: ‘æ36‰ñ“ú–{–ƒŒŠw‰ï‘‰ï i89.04.13`15j, ŽRŒû, –ƒŒ, 38(9,Suppl.): S271, 1989.

2968. mŒ¤‹†‰ïn i“Á•Êu‰‰j ƒgƒ‰ƒ“ƒLƒ‰ƒCƒU[‚ÌŽg‚¢•û. ŽO‰Y’å‘¥i¸j: ‘æ108‰ñ‘å‹ÈŽsˆãŽt‰ïW’k‰ï (88.10.07), ‘å‹È.

2969. mŒ¤‹†‰ïn i“Á•Êu‰‰j •ª•ØŠJŽnŽž‚̃`ƒFƒbƒN¥ƒ|ƒCƒ“ƒg. “‡“cMGiŽY•wj: “Œ–kŽüŽYŠúƒZƒ~ƒi[ (89.07.08), å‘ä.

2970. mŒ¤‹†‰ïn i“Á•Êu‰‰j ”AŽ¸‹Ö‚ÌŽèp|Gittes•Ï–@‚É‚æ‚éäNã÷Œz•”’Ý‚èã‚°p. ‰¡ŽR‰p“ñi”åj: ƒZƒ~ƒi[u”AŽ¸‹Ö‚ÌŽèpv (90.02.17), ‹ž“s.

2971. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ƒ†|ƒUƒTƒCƒh‚©‚猩‚½ƒƒ“ƒeƒiƒ“ƒXƒT|ƒrƒX‚Ì‚ ‚è•û. ‰Z¶LˆêiMEƒZƒ“ƒ^[j: iŠ”jƒAƒgƒ€‘æ11‰ñƒƒ“ƒeƒiƒ“ƒXuK‰ï (89.08.30), ‰Y˜a.

2972. mŒ¤‹†‰ïn i‹³ˆçu‰‰j TURP. ‰¡ŽR‰p“ñi”åj: ‘æ5‰ñ”å”AŠí‰ÈŽèpŽè‹ZŠÖ“Œ’n‹æŒ¤‹†‰ï (89.09.09), “Œ‹ž.

2973. mŒ¤‹†‰ïn i‹³ˆçu‰‰j TURP‚ÌŽèpŽè‹Z‚ɂ‚¢‚Ä. ‰¡ŽR‰p“ñi”åj: ’†‘ŽR¼ÈEndourologyƒZƒ~ƒi[ (89.11.02`04), ’†‘¥ŽR¼ÈA‘¾Œ´Žs.

2974. mŒ¤‹†‰ïn i‹³ˆçu‰‰j –ƒŒ‰È—̈æ‚̈À‘S«‚ð‚ß‚´‚µ‚Ä. “n•Ó•qi–ƒj: ‰¡•lŽs—§‘åŠwˆãŠw•”–ƒŒ‰ÈƒZƒ~ƒi|. (89.12.02), ‰¡•l.

2975. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j —Õ°ŒŸ¸‚ÌŽè‡. ‚‹´œAbiŽ¨•@j: ‘æ33‰ñ‘Š•Ž¨ƒr‰ÈŒ¤‹†‰ï (89.07.15), ‘Š–ÍŒ´.

2976. mŒ¤‹†‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj —¼‘¤–À˜H‹@”\‚“x’ቺ—á‚̃ŠƒnƒrƒŠƒe|ƒVƒ‡ƒ“. ¼‰ª–¾—TC“¡–ì–¾lC“¿‘Œú“ñiŽ¨•@j: ‘æ2‰ñ•½tŒP—ûŠî€‰»ˆÄ컂̂½‚߂̃|ƒNƒVƒ‡ƒbƒv (89.08.19), L“‡, Equilibrium Res., 49(1): 160`167, 1990.

2977. mŒ¤‹†‰ïn iˆê”Êu‰‰j Foxic megacolon‚ð’悵‚½’×ᇫ‘å’°‰Š2Ç—á‚Ì–ƒŒŒoŒ±. ¬‘òÍŽqC–쌩ŽREC•lè‚—TCŒÜ–¡—ŒbC‘ºã‰ëŽqC“n•Ó•qi–ƒjC‚‹´r‹BC‘å’J„³iŠOj: ‘æ11‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï (88.00.00), å‘ä.

2978. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒ†|ƒU‚©‚猩‚½ƒeƒŒƒ|ƒ^—˜—p‚ÌŒ»ó‚Æ–â‘è“_. L£–«iMEƒZƒ“ƒ^[j: —Õ°MEˆÀ‘SŒ¤‹†‰ï (89.04.15), “Œ‹ž.

2979. mŒ¤‹†‰ïn iˆê”Êu‰‰j •a‰@ME•”–å‚ð‚Ç‚¤ì‚é‚©–k—¢‘åŠw•a‰@‚Ìê‡. “n•Ó•qi–ƒj: “ú–{MEŠw‰ïê–å•ÊŒ¤‹†‰ï —Õ°MEˆÀ‘SŒ¤‹†‰ï (89.05.26), ‘åã.

2980. mŒ¤‹†‰ïn iˆê”Êu‰‰j PGE1‚ð—p‚¢‚½dÇ”DP’†“ÅÇ‚Ì’éØ–ƒŒŠÇ—. —§‰ª˜aOCA–ìM…C¯“c—²CŠâ’JO–¾C–ì“c–FlCª–{‘‘ˆêC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ78‰ñ–³’É•ª•ØŒ¤‹†‰ï (89.06.24), “Œ‹ž.

2981. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹ó‹C‰Áˆ³Ž¡—Ã’†A‹ó‹Cˆ³k‹@‚ªŒÌႵ‹Ù‹}ŽÕ’f‘•’u‚ªì“®‚µ‚½1—á. –{‘½—²C’r“cŒõŠìC¼ì‰·iMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒjCV“¡³‹PC‘å˜a“c—²i‹~–½j: “ú–{‚‹Cˆ³ŠÂ‹«ˆãŠw‰ï‘æ‚P‰ñ‹Zp•”‰ïŒ¤‹†”­•\‰ï (89.11.10), •ÄŽq.

2982. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒŒ‰t‰Á‰·Ší‚̈Ùí”­”M. L£–«iMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒj: “ú–{MEŠw‰ïê–å•ÊŒ¤‹†‰ï¥—Õ°MEˆÀ‘SŒ¤‹†‰ï (90.02.17), “Œ‹ž.

2983. mŒ¤‹†‰ïn iˆê”Êu‰‰j Clinical Studies of Synthetic Wound Dressing with Drug Delivery Capacity. ‰FˆäŒª“ñC‰F’Öؗ´ˆêiŒ`ŠOjC‘Oì˜a•Fi‹~–½jC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ4‰ñƒ}ƒEƒC”M‰ï‹c (90.02.19), ƒnƒƒC, Abstract, p.46, 1989.

2984. mŒ¤‹†‰ïn iŒöŠJuÀj ‚ß‚Ü‚¢Š³ŽÒ‚Ìf—ÂƊŌì‚̃|ƒCƒ“ƒg. “¿‘Œú“ñiŽ¨•@j: ‘æ14‰ñŽ¨•@ˆôA‰ÈƒZƒ~ƒi|EŽ¨•@ˆôA‰ÈŠÅŒì‚̃|ƒCƒ“ƒgiƒvƒ‰ƒ“ƒi|j”­•\”NŒŽ“ú(89.09.09), “Œ‹ž, ƒƒfƒCƒJo”Å:‘æ14‰ñŽ¨•@ˆôA‰ÈƒZƒ~ƒi|,p.13`19, 1989.

2985. mŒ¤‹†‰ïn iŒöŠJuÀj ”D•wfŽ@‚Å‚ÌV‚µ‚¢ƒ`ƒFƒbƒN¥ƒ|ƒCƒ“ƒg1989”N”Å. “‡“cMGiŽY•wj: ÅVŽüŽYŠúˆãŠwƒZƒ~ƒi[u‰f‚©‚番•Ø‚Ü‚Åv‚»‚Ì11 (89.07.22`23), “Œ‹ž.


<<211 ‚»‚Ì‘¼>>

2986. mŒ´’˜n •¡‡”|—{”畆‚Ìì». ‘å’|®”VC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 10(3): 165`180, 1990.

2987. m’Z•ñn ‹³Žº‚¾‚æ‚è|–k—¢‘åŠwˆãŠw•””å”AŠí‰È|. ‰¡ŽR‰p“ñi”åj: —Õ°”å”AŠí‰È, 43: 914Cl989.

2988. m‘àn ‹~–½‹~‹}‚ÌŽÀÛA‹~‹}ŒŸ¸‚Æ‚»‚Ì•]‰¿|‹Ù‹}’´‰¹”gŒŸ¸|. ‘å‹{“Œ¶iŠOjC‘•ª–ΔŽi“àjC‹g“c@‹IiŠOj: f’f‚ÆŽ¡—Ã, 77(10): 2386`2390, 1989.

2989. muÀn ˜b‘è‚ÌŒŸ¸–@|lŠÔƒhƒbƒN|. ‘å’J‰pŽ÷i—Õ•a—j: ‘‡—Õ°C38(‘): 1652`1653, 1989.

2990. mŠwp‘n iŽ·•Mj lH‘ŸŠí‚ÌŒ»ó; lH”畆, 7: 16`22, •–ö”\Œõi¶‘ÌHj. Þ—¿‹Zp‹¦‰ïC89.04.00”­s.

2991. mŠwp‘n iŽ·•Mj ¶‘Ì¥ˆã—pƒGƒ‰ƒXƒgƒ}|; lH”畆, p.394`400, •–ö”\Œõi¶‘ÌHj. “ú–{ƒSƒ€‹¦‰ïC89.06.05”­s.

2992. mŠwp‘n iŽ·•Mj •a‘Ô¶—; R‹ÛÜ™•ú«‘n”핢܂̊J”­, 8: 589`594, •–ö”\Œõi¶‘ÌHj. ‰iˆä‘“XC89.07.01”­s.

2993. mŠwp‘n iŽ·•Mj ‚•ªŽq‚ƈã—Ã; lH”畆, p.320`349, •–ö”\Œõi¶‘ÌHj. ŽO“co”ʼnïC89.08.10”­s.

2994. mŠwp‘n iŽ·•Mj —Õ°ŽGŽ¥ŠO‰È; V‚µ‚¢lH”畆, 51: 929`935, •–ö”\Œõi¶‘ÌHj. “ì]“°C89.09.01”­s.

2995. mŠwp‘n iŽ·•Mj ‚•ªŽqV‘fÞ•Ö——; Œ`¬—pÞ—¿, p.318`322, •–ö”\Œõi¶‘ÌHj. •ÒW ‚•ªŽqŠw‰ï•Ò, ŠÛ‘PC89.09.20”­s.

2996. mŠwp‘n iŽ·•Mj ‘@ˆÛ‚ÆH‹Æ; ˆã—×pƒfƒBƒXƒ||ƒUƒuƒ‹•sD•z‚Ì“®Œü, 45: 394`397, •–ö”\Œõi¶‘ÌHj. ‘@ˆÛŠw‰ïC89.09.00”­s.

2997. mŠwp‘n iŽ·•Mj 89ÅV‹Zp100‘I¥ƒgƒŠƒK|; ׋ۂ̑B‚ð—}‚¦‚é‘n”í•¢Þ, p.96`97, •–ö”\Œõi¶‘ÌHj. “úŠ§H‹ÆV•·ŽÐC89.00.00”­s.

2998. mŠwp‘n iŽ·•Mj ŠO‰Èf—Ã; V‚µ‚¢‘n”í•¢Þ‚Æ”|—{”畆, 31: 1315`1326, •–ö”\Œõi¶‘ÌHj. f’f‚ÆŽ¡—ÃŽÐC89.09.00”­s.

2999. mŠwp‘n iŽ·•Mj VDTˆãŠwƒ}ƒjƒ…ƒAƒ‹; ŽY•wl‰È‚É‚¨‚¯‚é–â‘è“_, p.93`94, Vˆä³•vCÎì‰ëˆêiŽY•wj. •ÒW Îì“Ni–k—¢‘åj•Ò, ‘S“ú–{•a‰@o”ʼnï, “Œ‹ž, 89.09.15 ”­s.

3000. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj ƒTƒNƒZƒXˆãŽt‘‰ÆŽŽŒ±—Õ°ŽÀ’n–â‘èW; ª–{EiŠOj. ŠÄC ²“¡“oŽu˜Yi–k—¢‘åjŠÄC, “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 89.11.15”­s.

3001. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj –òÜ‚É‚æ‚é•›ì—p‚Æ’†“Å; ’®ŠíÇóCp.132`141, “¿‘Œú“ñiŽ¨•@j. •ÒW ´…’¼—ei’é‹ž‘åj•ÒC ƒ~ƒNƒX, “Œ‹ž, 89.07.25”­s.

3002. m‚»‚Ì‘¼‚Ì’˜‘i–â‘èWjn iŽ·•Mj ƒTƒNƒZƒXˆãŽt‘‰ÆŽŽŒ±—Õ°ŽÀ’n–â‘èWC “n•Ó“oiŽ™j. “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 89.11.15”­s.

3003. m‚»‚Ì‘¼‚Ì’˜‘i–â‘èWjn iŽ·•Mj ƒTƒNƒZƒXˆãŽt‘‰ÆŽŽŒ±—Õ°ŽÀ’n–â‘èWC ”Ñ‚Šì‹v—YiŽ™j. ŠÄC ²“¡“oŽu˜Yi–k—¢‘åjŠÄCC “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 89.11.15”­s.

3004. m–|–ón iŽ·•Mj ƒm|ƒxƒ‹Üu‰‰, 5)¶—Šw¥ˆãŠw; ŒÄ‹z‚ÌŽ_‘f“`’By‘f (O.H.ƒ|ƒ‹ƒuƒ‹ƒN), 5: 39`59, –x]Ž •vi¶‰»j. •ÒW ìŠì“cˆ¤˜Yiç—t‘åjC“n•ÓŠiC’Ë“c—TŽOiŒc‰ž‘åj•ÒC u’kŽÐ, “Œ‹ž, 85.06.10”­s.

3005. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒRƒ‰|ƒQƒ“‚ðƒ}ƒgƒŠƒbƒNƒX‚Æ‚µ‚½•¡‡”|—{•\”ç‚Ìì». •–ö”\Œõi¶‘ÌHjC‘å’|®”VC’†–kMºC‰–’JMKiŒ`ŠOj: ‘æ18‰ñˆã—p‚•ªŽqƒVƒ“ƒ|ƒWƒEƒ€ (89.06.05), “Œ‹ž.

3006. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Development of Synthetic Dressing with Drug Delivery Capacity. •–ö”\Œõi¶‘ÌHj: ‘@ˆÛŠw‰ï‹{èŠî‹à‘ÛƒVƒ“ƒ|ƒWƒEƒ€ (89.06.28), “Œ‹žC —\eW, p.A27`A34, 1989.

3007. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒwƒpƒŠƒ“™•ú«–ü’…–hŽ~–Œ‚ÉŠÖ‚·‚錤‹†. ìˆä’‰’qC‹{“cô’ji‚Œ¤jC–ìˆêF‘×°i‰ªŽR‘åjC•–ö”\Œõi¶‘ÌHj: ‘æ6‰ñ¶‘Ì‘@ˆÛ‚ƶˆãŠwÞ—¿‚ÉŠÖ‚·‚éƒVƒ“ƒ|ƒWƒEƒ€ (89.06.29), “Œ‹žC —\eW, p.A50, 1989.

3008. mŠw‰ïn iˆê”Êu‰‰j •¡‡”|—{”畆‚Ìì¬: Šî‘b“IŒŸ“¢. •–ö”\Œõi¶‘ÌHjC‘å’|®”VC‰–’JMKiŒ`ŠOj: ‘æ15‰ñ“ú–{”MŠw‰ï (89.05.19), O‘OC u‰‰´˜^, p.81, 1989.

3009. mŠw‰ïn iˆê”Êu‰‰j Composite Skin Substitute Composed of Cultured Keatinocytes and Fibroblasts Combined with Collagen Matrix. ‘å’|®”VC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: The 5th Congress of the Asian Pacific Reconstructive Surgery (89.09.08), Istanbul, Turkey.

3010. mŠw‰ïn iˆê”Êu‰‰j ­”NƒTƒbƒJ|‘IŽè‚Ì‘‡“I‘Ì—Í•]‰¿i‘æ1•ñjŒ`‘ÔŠw“I•]‰¿‚Æ—LŽ_‘f&–³Ž_‘f«ƒpƒ|‚Ì•]‰¿. “n•Ó“oC’†“ˆ‰p•FCŽl‘q³”ŽC–¥‰YŽ‘¥C”~Œ´ŽÀCV‘º•¶’jC–åˆäL‹ÅiŽ™jC‚ŠÝŒ›“ñi®ŠOj: ‘æ44‰ñ“ú–{‘̗͈ãŠw‰ï (89.09.27), ŽD–y, ‘̗͉Ȋw, 38(6): 582, 1989.

3011. mŠw‰ïn iˆê”Êu‰‰j ƒqƒgüˆÛ‰è×–E‚ƃqƒg•\”ç×–E‚ð‘g‚Ýž‚ñ‚¾•¡‡”|—{”畆. •–ö”\Œõi¶‘ÌHjC‘å’|®”VC’†–kMºC‰–’JMKiŒ`ŠOj: ‘æ38‰ñ‚•ªŽq“¢˜_‰ï (89.10.04), •Ÿˆä.

3012. mŠw‰ïn iˆê”Êu‰‰j ”ŽíŽ¾Š³‚É‚¨‚¯‚郿2 Macroglobulin‚ÌŒ¸­‚Æ‚»‚̈Ӌ`‚̂‚¢‚Ä. ‚“ˆ—˜Ž}ŽqiŽOˆä‹L”O•a‰@jC‘å’J‰pŽ÷i—Õ•a—j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 73, 1989.

3013. mŠw‰ïn iˆê”Êu‰‰j •¡‡”|—{”畆‚Ì컂ƕ]‰¿. •–ö”\Œõi¶‘ÌHjC‘å’|®”VC‰–’JMKiŒ`ŠOj: ‘æ11‰ñ“ú–{ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ï (89.10.27), ‹ž“s.

3014. mŒ¤‹†‰ïn i“Á•Êu‰‰j Computed Radiography‚Ì—Õ°‰ž—p. ‘–쳈êi•új: —Õ°‰æ‘œf’f§˜b‰ï (89.06.07), ‘O‹´C —Õ°‰æ‘œf’f§˜b‰ï‹L˜^WC2: l989.

3015. mŒ¤‹†‰ïn iˆê”Êu‰‰j •¡‡”|—{”畆‚ÌŠJ”­. ‘å’|®”VC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: “ú’†Œ`¬ŠO‰ÈŒð—¬ŠwpW‰ï (89.11.21), ’·è.

3016. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒRƒ‰[ƒQƒ“‚ðƒ}ƒgƒŠƒbƒNƒX‚Æ‚µ‚½•¡‡”|—{”畆. ‘å’|®”VC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ19‰ñ‘nŽ¡–üŒ¤‹†‰ï (89.12.02), ‹v—¯•Ä.

3017. mŒ¤‹†‰ïn iˆê”Êu‰‰j ­”NƒTƒbƒJ|‘IŽè‚Ì‘‡“I‘Ì—Í•]‰¿i‘æ‚P•ñj—LŽ_‘f«•–³Ž_‘f«ƒpƒ|‚Ì•]‰¿. –åˆäL‹ÅC“n•Ó“oC’†“ˆ‰p•FC”~Œ´ŽÀC–¥‰YŽ‘¥CŽl‘q³”ŽCV‘º•¶’jiŽ™jC‚ŠÝŒ›“ñi®ŠOj: ‘æ10‰ñƒTƒbƒJ|ˆã‰ÈŠwŒ¤‹†‰ï (90.02.11), “Œ‹ž, ´˜^W, p.44, 1990.


<<301 ¶•¨•¨—Šw>>

3018. mŒ´’˜n Reconstitution of Human Fetal Hemoglobin From Isolated ƒ¿ and ƒÁ Chains. ¬¼NŽqC—é–Øt’ji¶•¨•¨—‰»j: Biochemistry International, 19(3): 469`476, 1989.

3019. mŠwp‘n iŽ·•Mj ˆâ“`; ŠT“úƒŠƒYƒ€”­Œ»‚Ìê‚Æ•ªŽq, 43: 7`11, ’·’J쌚Ž¡i¶—j. ։ؖ[, “Œ‹ž, 89.12.01”­s.

3020. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒ]ƒEƒŠƒ€ƒV‚Ìs“®‚ÌŠT“úƒŠƒYƒ€‚Æd—Íê. ’·’J쌚Ž¡i¶—jC“c’†ŠÚ–¾”Ži¶•¨•¨—Œnj: ‘æ3‰ñ“ú–{‰F’ˆ¶•¨‰ÈŠw‰ï‘å‰ï (89.09.23), “Œ‹ž, u‰‰—vŽ|W, p.11, 1989.

3021. mŠw‰ïn iƒpƒlƒ‹j Circadian Locomotor Activity in an Isolated Cell of Paramecium. ’·’J쌚Ž¡i¶—jC“c’†ŠÚ–¾”ŽCÎìœAi¶•¨•¨—Œnj: 5th Gordon Conference (89.07.27). Plymouth, U.S.A.

3022. mŠw‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj Circadian Locomotor Activity in an Isolated Cell of Paramecium. ’·’J쌚Ž¡i¶—jC“c’†ŠÚ–¾”ŽCÎìœAi¶•¨•¨—Œnj: 19th Internat. Conference Soc. Chronobiology (89.07.25).

3023. mŠw‰ïn iˆê”Êu‰‰j Š^• •”ã”ç×–EŠÔ˜A—‚ɑ΂·‚éd’YŽ_ƒCƒIƒ“‚̉e‹¿. •Ð‘q—²i¶—jC¼“c‘•ci¶•¨•¨—Œnj: ‘æ66‰ñ“ú–{¶—Šw‰ï‘å‰ï (89.04.06), ‰ªŽRC Jpn. J. Physiol., 39(Suppl.): s50,1989.

3024. mŠw‰ïn iˆê”Êu‰‰j ƒAƒ‹ƒR[ƒ‹’E…‘fy‘f‚ɑ΂·‚鎇ŠOüƎ˂̉e‹¿. ‘¾“cŒ°¬C¼—Ñ—²i•újC‘]ª—R”üŽqC‚ŽR‹v”üŽqi¶•¨‰»ŠwŒnj: ‘æ48‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï¥¶•¨•”‰ï‘å‰ï (89.04.07), _ŒËC “ú–{ˆãŠw•úŽËüŠw‰ï¶•¨•”‰ïŽC2(1): 69`71, l989.

3025. mŠw‰ïn iˆê”Êu‰‰j Emission of Light from Eggs during Early Cleavage. ‘åŠÑMi¶—jC—´è³Žmi¶•¨j: “ú–{”­¶¶•¨Šw‰ï (89.06.00), –kŠC“¹C Develop. Growth & Differ., 31: 415, 1989.

3026. mŠw‰ïn iˆê”Êu‰‰j •úŽËüƎ˂ɑ΂·‚郉ƒbƒg”畆”½‰ž‚Ì•úŽËüŠ´Žó«‚ɂ‚¢‚Ä. ‘¾“cŒ°¬C¼—Ñ—²i•újC‘]ª—R”üŽqi¶•¨‰»ŠwŒnjC’†ŽR–ÎMiŽÀ“®Œnj: “ú–{•úŽËü‰e‹¿Šw‰ï‘æ32‰ñ‘å‰ï (89.09.30), –k‹ãB, u‰‰—vŽ|W, p.270, 1989.

3027. mŠw‰ïn iˆê”Êu‰‰j ƒ~ƒIƒOƒƒrƒ“‚ÌFolding‚ÉŠÖ‚·‚錤‹†. ç—t‚©‚¨‚èi“Œ‹ž—‘åjC¬¼NŽqi¶•¨•¨—‰»jC–ØŒ´—TiŽ©Ž¡ˆã‘åj: “ú–{¶•¨•¨—Šw‰ï (89.10.07), “Œ‹žC ¶•¨•¨—, 29(Suppl.): S198, 1989.

3028. mŠw‰ïn iˆê”Êu‰‰j ƒ]ƒEƒŠƒ€ƒV‚Ìs“®ˆÙ튔‚ÌŠT“úƒŠƒYƒ€. ’·’J쌚Ž¡i¶—jC“c’†ŠÚ–¾”Ži¶•¨•¨—Œnj: ‘æ27‰ñ“ú–{¶•¨•¨—Šw‰ï”N‰ï (89.10.07). “Œ‹ž, ¶•¨•¨—, 29(9): s254, 1989.

3029. mŠw‰ïn iˆê”Êu‰‰j ‘ÙŽ™ƒwƒ‚ƒOƒƒrƒ“‚ÌÅ\¬‘¬“x. ¬¼NŽqC—é–Øt’ji¶•¨•¨—‰»j: “ú–{¶‰»Šw‰ï (89.11.05), ‹ž“sC ¶‰»Šw, 61(9): 1145, 1989.

3030. mŠw‰ïn iˆê”Êu‰‰j ƒAƒNƒ`ƒoƒuƒ‹Œ³‘f•ªÍ–@‚É‚æ‚éƒJƒ‹ƒVƒEƒ€ÛŽæ‚Ì‘ª’è. ‘¾“cŒ°¬i•új: “ú–{ˆãŠw•úŽËüŠw‰ï‘æ58‰ñ•¨—•”‰ï‘å‰ï (89.11.12), ˆÉ•Û, “ú–{ˆãŠw•úŽËü•¨—•”‰ïŽ, 9(3): 214, 1989.

3031. mŠw‰ïn iˆê”Êu‰‰j ”÷¬ŠÇ‚ð”j‰ó‚µ‚½FL×–E‚É‚¨‚¯‚éƒgƒ‰ƒ“ƒXƒtƒFƒŠƒ“ƒŠƒTƒCƒNƒŠƒ“ƒO‚ÌŒo˜H. ä—§–çi‹ž‘åjCŽR‰È³•½i‰ðjC‘å¼rˆêi‹ž‘åj: ‘æ42‰ñ“ú–{×–E¶•¨Šw‰ï i89.10.25j, ‹ž“sC Cell Structure and Function, 14(6): 993, 1989.

3032. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‘O’ë_ŒoŽhŒƒŽž‚̈݉^“®‚Ɖ„‘šq“f’†•‚ɂ‚¢‚Ä. “¿‘Œú“ñC¯–ìŒ÷C“¡–ì–¾liŽ¨•@jC•Ä“c•qi¶•¨•¨—Œnj: •¶•”ȉȊwŒ¤‹†‘‰ï A;‚ß‚Ü‚¢‚ÆŽ©—¥_Œo”ÇŒ¤‹†‰ï (90.02.11), ‘åã.

3033. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒg“ûŠà‚ɑ΂·‚éSFƒTƒCƒNƒƒgƒƒ“—zŽqü‚ÌÆŽË‚Æ‚»‚ÌŒø‰Ê. ‘¾“cŒ°¬i•új: •½¬Œ³”N“x“Œ‹ž‘åŠwŒ´ŽqŠjŒ¤‹†ŠƒTƒCƒNƒƒgƒƒ“Œ¤‹†‰ï (89.07.20), “c–³.


<<302 ¶•¨‰»Šw>>

3034. mŒ´’˜n Types of Oligosaccharide Sulphation, Depending on Mucus Glycoprotein Source, Corpus or Antral, in Rat Stomach. ŒÜäzsMC–x“c‹±Žqi¶‰»j: Biochem. J., 264(3): 805`812, 1989.

3035. mŒ´’˜n Structure and Significance of N-Linked Sugar Unit of Human Serum Amyloid P Component. •lèG–¾i¶•¨j: Biochim. Biophys. Acta, 1037: 435`438, 1990.

3036. mŒ´’˜n Calcium-Dependent Polymerization of Human Serum Amyloid P Component is Inhibited by Heparin and Dextran Sulfate. •lèG–¾i¶•¨j: Biochim. Biophys. Acta, 998: 231`235, 1989.

3037. mŒ´’˜n Studies on the Molecular Structure of Spinach Ferredoxin ‡T. Comparison of Two Molecular Species of Ferredoxin. D. Ohmorii‡‘åjC˜@Œ©‰p¢i¶•¨•¨—‰»jCF. Yamakurai‡‘åjCM. MurakamiC K. FujisawaC Y. TaneokaC T. Ymamurai“Œ‹ž—‘åj: Biochim. Biophys. Acta., 996: 166`172, 1989.

3038. mŒ´’˜n Studies on the Molecular Structure of Spinach Ferredoxin ‡U. Effects of Urea and Sodium Chloride. ˜@Œ©‰p¢i¶•¨•¨—‰»jCD. Ohmorii‡‘åj: Biochim. Biophys. Acta., 996: 173`180, 1989.

3039. mŒ´’˜n Plasma Profiles of the N-Terminal Peptide of Proopiomelanocortin in the Rainbow Trout with Reference to Stress. ‚‹´–¾‹`i•ª¶jCOgasawara Tsuyoshii“Œ‘åjCì“à_Žii…ŽYŠw•”jCHirano Tetsuyai“Œ‘åj: Gen. Comp. Endocrinol.C77(1): 98`106, 1990.

3040. mŒ´’˜n The Pathway of Ghitamine Oxidation in MC-29 Hepatoma Mitochondria. T. Matsunoi—\Œ¤jC—é–Øt’ji¶•¨•¨—‰»jCK. Nittai’é‹ž‘åjCT. AokiCK. IriyamaiŽœŒbˆã‘åj: Jikeikai Med. J., 36: 241`249, 1989.

3041. mŒ´’˜n Heat Production During Early Developmental stages of the Frog. ‘ëàV’¼’èi¶—jC—´è³Žmi¶•¨jC‘åŠÑMi¶—j: Journal of Thermal Biology, 1989.

3042. mŒ´’˜n Changes in Lipid Composition in the Tail of Rana Catesbeiana Larvae during Metamorphosis. —´è³Žmi¶•¨jC‘åŠÑMi¶—j: Zoological Science, 1990.

3043. m’Z•ñn Biological Response Modifiers Such as Organo-Germanium Compounds and Krestin (PS-K) Express the Activity as the Ion Radical Scavenger. ’†‘º‘‰qC’†“‡—mˆêi•ª¶j: Medical, Biochemical and Chemical Aspects of Free Radicals, p.519`522, 1989.

3044. m‘àn R‘Ìy‘f. —é–Øt’ji¶•¨•¨—‰»j: ƒoƒCƒIƒTƒCƒGƒ“ƒX‚ƃCƒ“ƒ_ƒXƒgƒŠ|, 47(5): 43`46, 1989.

3045. m‘àn “®•¨×–E‚̃^ƒ“ƒpƒNŽ¿‡¬‚Ì–|–óŠJŽnƒŒƒxƒ‹‚Å‚Ì’²ß. —é–Øt’ji¶•¨•¨—‰»j: ƒoƒCƒIƒTƒCƒGƒ“ƒX‚ƃCƒ“ƒ_ƒXƒgƒŠ|, 47(8): 11`18, 1989.

3046. m‘àn RaRF|•â‘̬•ªC1‚ÉŽ—‚½ŒŒ´ƒŒƒNƒ`ƒ“. ìã³–çi•ª¶j: ¶‰»Šw, 61(6): 482`486, 1989.

3047. m‘àn ƒAƒ~ƒƒCƒhP¬•ª‚ɂ‚¢‚Ä. •lèG–¾i¶•¨j: ¶‰»Šw, 62(1): 45`49, 1990.

3048. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn iŽ·•Mj ‰»Šw‘厫“T; –x]Ž •vi¶‰»j. •ÒW ‘å–Ø“¹‘¥C‘å‘ò—˜ºC“c’†Œ³Ž¡C猴Gº@•Ò, “Œ‹ž‰»Šw“¯l, “Œ‹ž, 89.10.20”­s.

3049. mŠw‰ïn iˆê”Êu‰‰j Lipid Composition in the Tadpole Tail of Rana Catesbeiana During Metamorphosis. —´è³Žmi¶•¨j: Zoological Society of Japan (88.10.10), Zoological ScienceC5(6): 1248, 1988.

3050. mŠw‰ïn iˆê”Êu‰‰j Emission of Light from Frog Eggs during Early Cleavage. —´è³Žmi¶•¨jC‘åŠÑMi¶—j: The Japanese Society of Developmental Biologists (89.06.22-24), ŽD–yC Development, Growth & DifferentiationC31(4): 415, 1989.

3051. mŠw‰ïn iˆê”Êu‰‰j Characterization of Galactosyl Ceramide and Constituent Glycerophspholipid Fatty Acids during Early Development of the Japanese Pond Frog, Rana Nigromaculata. —´è³Žmi¶•¨j: 11th International Congress of the International Society of Developmental Biologists. Satellite Meeting-early Amphibian Development. (89.08.18-20), The Netherlands (Utrecht)C —\eWCp.30, 1989.

3052. mŠw‰ïn iˆê”Êu‰‰j New Type of Endo-Glycosidase, Endo-ƒ¿-N-Acetylgalactosaminidase S from Streptomyces sp. OH-11242 Culture Medium. Šâ£m—ECΈäˆèŽqC–x“c‹±Žqi¶‰»jC“c’†–F•C‘呺’qi–k—¢Œ¤‹†Šj: 10th International Symposium on Glycoconjugates (89.09.10), Jerusalem, Israel, Proceedings, p.314, 1989.

3053. mŠw‰ïn iˆê”Êu‰‰j Sulfation of Oligosaccharides on Mucus Glycoproteins in Rat Stomach. ŒÜäzsMC–x“c‹±Žqi¶‰»j: 10th International Symposium on Glycoconjugates (89.09.11), Jerusalem, Israel, Proceedings, p.244, 1989.

3054. mŠw‰ïn iˆê”Êu‰‰j Mucus Glycoproteins in the Cardiac, Fundic and Pyloric Gland Regions of Pig Stomach. ¬Œ´ii¶‰»jCÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»j: 10th International Symposium on Glycoconjugates (89.09.13), Jerusalem, Israel, Proceedings, p.164, 1989.

3055. mŠw‰ïn iˆê”Êu‰‰j ”DPƒ‰ƒbƒg‚̃Aƒ‹ƒR|ƒ‹ÛŽæ‚ªŽeƒ‰ƒbƒg‚É‹y‚Ú‚·‰e‹¿|‚»‚̶‰»Šw“IŒ¤‹†i‡Uj2',3'-ŠÂóƒkƒNƒŒƒIƒ`ƒh-3'ƒzƒXƒtƒHƒWƒGƒXƒeƒ‰|ƒ[‚ÌmRNA‚ɂ‚¢ ‚Ä. ¬“ˆ‹vŽqi¶‰»jC–k“‡—Œbi¶•¨‰»ŠwŒnjCŒIŒ´³iVŠƒ‘åjC’†‘º˜a¶i¶‰»jC‚‹´N•viVŠƒ‘åjC‹Êˆä—mˆêi¶‰»j: ‘æ32‰ñ“ú–{_Œo‰»Šw‰ï‘å‰ï (89.09.27), ŽD–y, _Œo‰»Šw, 28: 108`109, 1989.

3056. mŠw‰ïn iˆê”Êu‰‰j Phenol”ä‘÷–@‚É‚æ‚é—r…’†ŠE–ÊŠˆ«•¨Ž¿‚Ì‘ª’è‚Æ—r…’†ƒŠƒ“Ž‰Ž¿‚Ì‘ŠŒÝŠÖŒW‚ɂ‚¢‚Ä. –ì“c–FlCA–ìM…C’Jº”ŽC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wjCÎŒ´˜a•FC–x“c‹±Žqi¶‰»j: ‘æ25‰ñ“ú–{ŠE–ÊŠw‰ï (89.10.07), H“c.

3057. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒgŠÌ‘Ÿ‚ÆS‹Ø‚̃~ƒgƒRƒ“ƒhƒŠƒAŒÄ‹z”\‚É‹y‚Ú‚·ƒAƒ‹ƒJƒŠ‹à‘®‚¨‚æ‚уAƒ‹ƒJƒŠ“y‹à‘®‚̉e‹¿. “n•Ó“”ü”Ti¶‰»jC‘]ª—R”üŽqi¶‰»ŒnjC–x]Ž •vi¶‰»j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.03), ‹ž“s, ¶‰»Šw, 61(9): 856, 1989.

3058. mŠw‰ïn iˆê”Êu‰‰j ƒGƒC”]‚̃Kƒ“ƒOƒŠƒIƒVƒh. ’†‘º˜a¶C‹Êˆä—mˆêi¶‰»j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.03), ‹ž“s, ¶‰»Šw, 61(9): 886, 1989.

3059. mŠw‰ïn iˆê”Êu‰‰j ƒQƒ‹ƒ‰ß‚Æ”–‘wƒNƒƒ}ƒgƒOƒ‰ƒtƒB|‚Ì‘g‡‚¹‚É‚æ‚éO-ƒOƒŠƒRƒVƒhŒ^“œ½‚Ì•ªÍ. ŒÜäzsMC–x“c‹±Žqi¶‰»j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.04), ‹ž“s, ¶‰»Šw, 61(9): 1024, 1989.

3060. mŠw‰ïn iˆê”Êu‰‰j PA‰»”½‰ž‚É‚¨‚¯‚éPA‰»“œ—U“±‘Ì‚©‚ç2-AP‚Ì‘I‘ð“Iœ‹Ž. Šâ£m—ECΈäˆèŽqi¶‰»jC‰Y“c’ËMŽqi¶‰»ŒnjC–x“c‹±Žqi¶‰»j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.04), ‹ž“s, ¶‰»Šw, 61(9): 1024, 1989.

3061. mŠw‰ïn iˆê”Êu‰‰j ƒ€ƒ`ƒ“—R—ˆOH-11242Š””|’nƒIƒŠƒS“œ‚ÌPA‰»—U“±‘Ì‚Ì•ªÍ. ‰Y“c’ËMŽqi¶‰»ŒnjCŠâ£m—ECΈäˆèŽqC–x“c‹±Žqi¶‰»j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.04), ‹ž“s, ¶‰»Šw, 61(9): 1024, 1989.

3062. mŠw‰ïn iˆê”Êu‰‰j ƒ€ƒ`ƒ“‚ð—Bˆê‚Ì’Y‘fŒ¹‚Æ‚·‚éOH-11242Š””|—{‰t’†‚ÉŽY¶‚³‚ê‚éV l-ƒGƒ“ƒhŒ^y‘f|‘æ2•ñ|. ΈäˆèŽqCŠâ£m—Ei¶‰»jC‰Y“c’ËMŽqi¶‰»ŒnjC–x“c‹±Žqi¶‰»jC“c’†–F•C‘呺’qi–k—¢Œ¤‹†Šj: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.04), ‹ž“s, ¶‰»Šw, 61(9): 1024, 1989.

3063. mŠw‰ïn iˆê”Êu‰‰j PC12×–E‚Ì•ª‰»‚ƃKƒ‰ƒNƒg|ƒX“]ˆÚy‘fŠˆ«‚ɂ‚¢‚Ä. –k“‡—Œbi¶‰»ŒnjC¬“ˆ‹vŽqC‹Êˆä—mˆêi¶‰»j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.05), ‹ž“s, ¶‰»Šw, 61(9): 1157, 1989.

3064. mŠw‰ïn iˆê”Êu‰‰j Advanced Glycation End Products (AGE)‚̶¬‘jŠQ(‡T) Lens Crystallin ‚ð—p‚¢‚½in vitro Cataractƒ‚ƒfƒ‹‚Ì쬂Ɣ½‰ž‚Ì‘jŠQ. ’†‘º‘‰qi•ª¶jC–쌳‚¯‚¢Žqi¶‰»Œnj: ‘æ62‰ñ“ú–{¶‰»Šw‰ï (89.11.05), ‹ž“s C —\eW, 3PD615, 1989.

3065. mŠw‰ïn iˆê”Êu‰‰j Advanced Glycation End Products (AGE)‚̶¬‘jŠQ(‡U)Ž_‰Â—n«ƒEƒVƒRƒ‰|ƒQƒ“‚©‚ç‚ÌAGEŒ`¬‚Æ‚»‚Ì‘jŠQ. –쌳‚¯‚¢Žqi¶‰»ŒnjC’†‘º‘‰qi•ª¶j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï (89.11.05), ‹ž“s C —\eW, 3PD616, 1989.

3066. mŠw‰ïn iˆê”Êu‰‰j –|–óŠJŽnˆöŽqeIF-2‚ÌN-ƒGƒ`ƒ‹ƒ}ƒŒƒCƒ~ƒh”½‰ž«SHŠî‚ɂ‚¢‚Ä. —é–Øt’ji¶•¨•¨—‰»jCŒüŽRŒb’ÃŽqi¶‰»ŒnjC‹Tˆä—²Ki¶•¨•¨—‰»Œ¤C¶j : “ú–{”_Œ|‰»Šw‰ï1990”N“x‘å‰ï (90.03.31), •Ÿ‰ªC “ú–{”_Œ|‰»Šw‰ïŽ, 64(3): 315`315, 1990.


<<303 ˆâ“`Šw>>

3067. mŠw‰ïn iˆê”Êu‰‰j –EóŠï‘Ù‚É‚¨‚¯‚éHLAˆâ“`ŽqŒ^‚ÌŒŸõ:in vitro ˆâ“`Žq‘•–@‚̉ž—p. –î•”“TŽqi—Õ•a—jC¬”¦•¶–íCˆÉ“Œˆê˜YCˆÉ“¡IˆêiˆÚA–ƉujCät“n’‰’ji—Õ•a—jC‘å–쓹Žqi—ÕŒŸjC‘O“c“OiŠÅŒìŠw•”jC‘å’J‰pŽ÷i—Õ•a—j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 70, 1989.


<<304 •ªŽq¶•¨Šw>>

3068. mŒ´’˜n Production of Salivary Type ƒ¿-Amylase in Human Lung Cancer. Yusuke NakamuraCNaohiro TomitaCTakahiro NishidaCMitsuru EmiCAkira HoriiCMichio OgawaCTakesada Morii‘åã‘åjCGoro Kasakii“s—§‹îž•a‰@jCTetsuro OkabeCMichio FujisawaCNakaaki Ohsawai“Œ‘åjC‹T’J“Oi•a—jCKenichi Matsubara i‘åã‘åj: Gene, 77: 107`112, 1989.

3069. mŒ´’˜n Structures of Two Genes Coding for Melanin-Concentrating Hormone of Chum Salmon. ‚ŽR‹g‰ii•ª¶jC˜a“c’m‰vi—Õ•a—jCì“à_Žii…ŽYŠw•”jC¬–ì‰ë•vi•ª¶j: GeneC80: 65`73, 1989.

3070. mŒ¤‹†•ñi…ŽY’¡jn —L—p‹›—ÞŽ‹°‰º•”ƒzƒ‹ƒ‚ƒ“‚ÌDNAƒ‰ƒCƒuƒ‰ƒŠ|‚Ìì¬. ¬–ì‰ë•vi•ª¶j: º˜a63”N“x…ŽYƒoƒCƒeƒN“±“üŠî”Õ®”õŽ–‹Æ•ñ‘, p.45`48, 1989.

3071. m‘àn Detection and Elimination of Endogenous Retroviruses and Retrovirus-Like Particles in Continuous Cell Lines. ¬–ì‰ë•vi•ª¶j: Dev. Biol. Stand., 70: 69`81, 1989.

3072. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Prevention of Maillard Reaction and the Reversible Destruction of Advanced Glycation End Products (AGE) by Novel Organic Germanium Compounds and Aminoguanidine. ’†‘º‘‰qi•ª¶jC‰F‰ê–ÎŽOC‹{“cŠ²•viŠájCNorihiro Kakimoto iAsai Germanium Institutej: 4th International Symposium on the Maillard Reaction (89.09.08), Lausanne, Switzerland.

3073. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Prevention of Maillard Reaction between Crystallin and Glucose and Induction of Reversible Transparency in Turbid Lens By Organic Germanium Componds. ’†‘º‘‰qi•ª¶jC‰F‰ê–ÎŽOC‹{“cŠ²•viŠájCNorihiro Kakimoto iAsai Germanium Institutej: The Fifth Congress of the US-JAPAN Cooperative Cataract Research (89.11.13), ‹à‘ò —\eWCp.48.

3074. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒEƒX•â‘ÌŠˆ«‰»ŽE‹ÛˆöŽqRaRF•¡‡‘Ì’†‚Ìy‘f—l¬•ª‚ɂ‚¢‚Ä. ‚‹´–¾‹`C‹Gˆç‰Øi•ª¶jC‰£—m”üi¶•¨‰»ŠwŒnjCé°Œ›‹`i•ª¶jC“¡“c’õŽOi’}”g‘åjCìã³–çi•ª¶j: ‘æ26‰ñ•â‘̃Vƒ“ƒ|ƒWƒEƒ€ (89.07.16`18), ‘åã, u‰‰W, 26: 97`98, 1989.

3075. mŠw‰ïn iˆê”Êu‰‰j Functional and Structural Similarities of Ra-Reactive Factor to C1 Component of Complement. ‚‹´–¾‹`C‹v‰ºŽü²C‹Gˆç‰Øi•ª¶jC“¡“c’õŽOi’}”g‘åjC‰£—m”üi¶•¨‰»ŠwŒnjCìã³–çi•ª¶j: ‡]‡Vth International Complement Workshop (89.09.12), San Diego, U.S.A.C Complement and Inflammation, 6(5): 404, 1989.

3076. mŠw‰ïn iˆê”Êu‰‰j •â‘ÌŠˆ«‰»ŽE‹ÛˆöŽqRaRF‚ÌRa‘½“œ‘Ì”FŽ¯¬•ª. Z—F˜aOC“y‹˜aOi•ª¶jC‰£—m”üi¶•¨‰»ŠwŒnjC‚‹´–¾‹`Cìã³–çi•ª¶j: ‘æ62‰ñ“ú–{׋ۊw‰ïŠÖ“ŒŽx•”‘‰ï (89.10.13), …ã C “ú–{׋ۊwŽGŽ, 45(2): 603, 1990.

3077. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒEƒXŽE‹ÛˆöŽqRaRFƒTƒuƒRƒ“ƒ||ƒlƒ“ƒg‚Ì•ª—£. ‚‹´–¾‹`C‹Gˆç‰Øi•ª¶jC‰£—m”üi¶‰»ŒnjCé°Œ›‹`Cìã³–çi•ª¶jC“¡“c’õŽOi’}”g‘åj: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.03), ‹ž“s C ¶‰»Šw, 61(9): 882, 1989.

3078. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒEƒX•â‘ÌŠˆ«‰»ŽE‹Ûƒ^ƒ“ƒpƒNŽ¿RaRF•¡‡‘Ì’†‚ÌC4Á”«‚ð—L‚·‚鬕ª. ‚‹´–¾‹`C‹Gˆç‰Øi•ª¶jC‰£—m”üi¶‰»ŒnjC“¡“c’õŽOi’}”g‘åjCìã³–çi•ª¶j: ‘æ63‰ñ“ú–{׋ۊw‰ï‘‰ï (90.03.27), “¿“‡ C “ú–{׋ۊwŽGŽ, 45(1): 159, 1990.

3079. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹›—Þ‚ÌŽ‹°‰º•”ƒzƒ‹ƒ‚ƒ“‚̈â“`Žq\‘¢. ¬–ì‰ë•vi•ª¶j: “Œ‘åŠC—mŒ¤ƒVƒ“ƒ|ƒWƒEƒ€i‹›‰î—ނ̶•¨Šw¥…ŽYŠw‚ƃoƒCƒIƒeƒNƒmƒƒW|j (89.11.25), “Œ‹žC —\eWCp.12`13, 1989.


<<305 •a‘ÔŠw>>

3080. muÀn ü—Ê•W€‘ª’è–@‚̃h[ƒYƒvƒƒbƒeƒBƒ“ƒOƒVƒXƒeƒ€‚ւ̉ž—p(1). Šâ”g–ÎC‚Œ´êŽCã‘O•ôŽqC–kŽR‹v”üC’†‘º‹`‘¥i•újC‹g’J³•vi“Œ—mƒƒfƒBƒbƒNj: “ú–{ˆãŠw•úŽËüŠw‰ï•¨—•”‰ïŽ, 9(2): 51`59, 1989.


<<306 Œ`‘ÔŠw>>

3081. m‘àn ×–E‹É«Œ`¬‚̃ƒJƒjƒYƒ€. £ì²‹vCŽR‰È³•½i‰ðj: ×–E, 21(10): 371`376, 1989.

3082. muÀn “€Œ‹€’´”–Ø‚É‚æ‚é–Ɖu‘gD‰»Šw. Ÿ–”CiŒ`‘ÔŒnjCŽR‰È³•½i‰ðj: ×–EC21(10): 30`34, 1989.

3083. mŠwp‘n iŽ·•Mj Œ»‘ã•a—Šw‘åŒn; zŠÂáŠQ|Š¥ó“®–¬‚Ì\‘¢‚Æ‹@”\|, 11A, ŒK”ö’èmC¼ŽR•Ûˆêi•a—jC”©ŽRˆê•½i¶—j. ’†ŽR‘“X, “Œ‹ž, 90.03.00”­s.

3084. m–|–ón iŽ·•Mj ƒCƒ‰ƒXƒg•a—Šw; ‘æ13Í ”å”AE¶BŠíŒnCp.631`727, ŒK”ö’èmi•a—j. •¶Œõ“°, “Œ‹ž, 89.04.20”­s.

3085. mŠw‰ïn iˆê”Êu‰‰j —Öóbó‹Ø‚Ì‘gDŠw“IŒ¤‹†|‘æ3•ñ|. Έä–L‘¾CŒ´“cGˆêCŒÃì_ŽOC”ª”ö˜a—YC‚‹´œAbCÝŠy“N–çiŽ¨•@jCV”ü¬“ñi“Œ‘åj: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‘‰ï (89.05.13), ‘åãC “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñC92(10): 1724, 1989.

3086. mŠw‰ïn iˆê”Êu‰‰j …‘f•ªŽq‹¤–Âó‘Ô‚Ì“dŽq‘ŠŠÖ. ‚–ØGˆêi•¨—j: “ú–{•¨—Šw‰ï (89.10.04), Ž­Ž™“‡C 1989”NH‚Ì•ª‰È‰ïu‰‰—\eWC‘æ4•ªû: 49, 1989.

3087. mŠw‰ïn iˆê”Êu‰‰j Bouin ŒÅ’è‰t‚Ì‘–¸Œ^“dŽqŒ°”÷‹¾‚ւ̉ž—p. ’†–{’¼i‰ðj: “ú–{“dŽqŒ°”÷‹¾Šw‰ï i89.06.01), ‘åã, J. Electron Microsc., 38(4): 303, l989.

3088. mŠw‰ïn iˆê”Êu‰‰j ¶Œã”­¶‰ß’ö‚É‚¨‚¯‚郉ƒbƒg\“ñŽw’°‚Ì Globule leucocyte ‚ÌŒ`‘Ô‚Æ•ª•z“®‘Ô. ’r“c‚â‚æ‚¢CŽR‰È³•½i‰ðj: ‘æ77‰ñ“ú–{‰ð–UŠw‰ïŠÖ“Œ’n•û‰ï i89.10.21), “Œ‹ž, —\eW, p.33, l989.

3089. mŠw‰ïn iˆê”Êu‰‰j ×–EœŠi‚Í‹É«Œ`¬‚Ì—vˆö‚ƂȂ肤‚é‚©i‡VjƒfƒXƒ‚ƒ\|ƒ€‚Ì‹É«”z’u‚Æ×–EœŠi‚ÌŠÖŒW. £ì²‹vCŽR‰È³•½i‰ðj: ‘æ42‰ñ“ú–{×–E¶•¨Šw‰ï i89.10.26), ‹ž“s, Cell Structure and Function, 14(6): 908, 1989.

3090. mŠw‰ïn iˆê”Êu‰‰j ƒwƒ~ƒfƒXƒ‚ƒ\|ƒ€‚ð“ÁˆÙ“I‚É”FŽ¯‚·‚郂ƒmƒNƒ|ƒiƒ‹R‘Ì‚Ìì». ªŠÝ–¾Gi“Œ‹žˆãŽ•‘åjC‘¼C£ì²‹vi‰ðj: ‘æ42‰ñ“ú–{×–E¶•¨Šw‰ï i89.10.26), ‹ž“s, Cell Structure and Function, 14(6): 909, 1989.

3091. mŒ¤‹†‰ïn i‹³ˆçu‰‰j “ª•”‰æ‘œ‰ð–UŠw. ›Mˆêi•új: _“Þ쌧•úŽËü‹ZŽt‰ï‘S‘“ˆêuK‰ï (89.09.17), ‰¡•l.

3092. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ×–E‚ð“Ç‚Þ. ŽR‰È³•½i‰ðj: ‘æ38‰ñ“dŽqŒ°”÷‹¾‹ZpŒ¤‹†‰ï i89.12.02), “Œ‹ž.


<<307 ŽÐ‰ïˆãŠw>>

3093. mŒ´’˜n ‘ŸŠí“Eo‚É‚¨‚¯‚鳑ø‚Ì‚ ‚è•û. ‰SFˆêiˆãŠwŒ´˜_j: Clin. Neurosci., 17(12): 92`95, 1989.

3094. mŒ´’˜n In the Matter of John Storar; Soper v. Storar; Eichner v. Dillon, 420 N.E. 2d 64 (N.Y.1981) |Ž¡—Ñł¿Ø‚è‚Ì—v¿‚ɑ΂µƒjƒ…|¥ƒˆ|ƒNB‚ªŽ–ˆÄ‚à–@—‚àŒ‹˜_‚àˆÙ‚È‚é“ñ‚‚̔»Œˆ‚ð‘g‚݇‚킹‚Ä”­•\‚µ‚½Ž–—á. ‰SFˆêiˆãŠwŒ´˜_j: ƒAƒƒŠƒJ–@C1989(2): 438`445, 1989.

3095. mŒ´’˜n In the Matter of Claire C. Conroy, 486A. 2d 1209 (N.J. 1983) |Sg‚Ì•a‚ªd“Ä‚Å—]–½‚àŒÀ‚ç‚ê‚Ä‚¢‚éQ‚½‚«‚è‚̃i|ƒVƒ“ƒO. ƒz|ƒ€ÝZŠ³ŽÒ‚©‚ç•@o‰h—{‚Ì‚½‚߂̃`ƒ…|ƒu‚ðŽæ‚èŠO‚µ‚¤‚é‚©. ‰SFˆêiˆãŠwŒ´˜_j: ƒAƒƒŠƒJ–@C1989(2): 445`452, 1989.

3096. mŒ´’˜n ‰Æ‘°‚ƈã—Ãi‚PjŒÂ‚ÌĶŽY‚ÆŽí‚ÌĶŽY. ‰SFˆêiˆãŠwŒ´˜_j: ƒP|ƒXŒ¤‹†, 222: 33`52, 1990.

3097. mŒ´’˜n u—Ï—ˆÏˆõ‰ïvl¥‚P. ‰SFˆêiˆãŠwŒ´˜_j: –@—¥Žž•ñ, 61(5): 139`144, 1989.

3098. mŒ´’˜n u—Ï—ˆÏˆõ‰ïvl¥‚Q. ‰SFˆêiˆãŠwŒ´˜_j: –@—¥Žž•ñ, 61(6): 154`159, 1989.

3099. mŒ¤‹†•ñn ‚¶‚ñ”xXüf’f‚ÌŒv—ʉ»‚ÉŠÖ‚·‚é’²¸Œ¤‹†. ‘ŠàVDŽ¡i‰qjC”ÑÀ•i•úŽËüˆãŠw‘‡Œ¤‹†ŠjC‰Á“¡‹v–Li•xŽmŽÊ^ƒtƒBƒ‹ƒ€jC¬”¨G•¶i“Œ‹ž”_H‘åjCÄ“¡éÆi“Œ“ú–{—·‹q“S“¹’†‰›•ÛŒ’ŠÇ—ŠjC Žu“cŽõ•viŒ]”x˜JЕa‰@jC‚“‡‹vi“Œ‹ž“sŽO‘é•ÛŒ’ŠjC‚“c™¦i‰qjC‚–ì³—Yi•xŽmŽÊ^ƒtƒBƒ‹ƒ€jCŠÙ³’mi’†‰›˜J“­ÐŠQ–hŽ~‹¦‰ïjCŠÚ–ì”V’ji•úŽË üˆãŠw‘‡Œ¤‹†ŠjCç—t•Û”Vi‘S“ú–{˜J“­•ŸŽƒ‹¦‰ïjC’¹˜eƒˆê˜Yi–¼ŒÃ‰®‘åjC–ì•Ó’n“ĘYi¹˜H‰Á‘Û•a‰@jC•Ÿ‹vŒ’“ñ˜Yi•úŽËüˆãŠw‘‡Œ¤‹†ŠjC× “c—Ti•úŽËü‰e‹¿Œ¤‹†ŠjC¼–{“Oi•úŽËüˆãŠw‘‡Œ¤‹†Šj: ‚¶‚ñ”xXüf’f‚ÌŒv—ʉ»‚ÉŠÖ‚·‚é’²¸Œ¤‹†•ñ‘, p.1`69, 1989.

3100. mŒ¤‹†•ñn ƒhƒ‰ƒCƒNƒŠ|ƒjƒ“ƒOŒã‚̈ߕžŽc—¯Î–ûŒn—nÜ”Z“x. ‚“c™¦C‘ŠàVDŽ¡C‹´–{‹Nˆê˜YC•x‰i‰qC’F—mi‰qjC–å˜e•”ŽC¡ˆäDiŠÅŒìŠw•”jC’†‘ºŒ«iˆã—ÎЉïŠwj: ƒNƒŠ|ƒjƒ“ƒO‚ÆŒöO‰q¶‚ÉŠÖ‚·‚錤‹†•ñ‘Cp.34`40, 1989.

3101. mŒ¤‹†•ñn Œ’N•ÛŽ‘iŠˆ“®‚ÉŠÖ‚·‚é’²¸Œ¤‹†. ‚“c™¦i‰qjC’†‘ºŒ«iˆã—ÎЉïŠwj: Eˆæ‚É‚¨‚¯‚é•ÛŒ’Ž–‹Æ‚ÉŠÖ‚·‚錤‹†Cp.8`23, 1989.

3102. mŒ¤‹†•ñiŠÂ‹«’¡jn ”÷¬ƒAƒXƒxƒXƒg‚Ì‹z“ü‚É‚æ‚鶑̉e‹¿’²¸Œ¤‹†. —`dŽ¡iŽY‹ÆˆãŠw‘‡Œ¤‹†ŠjC–ìè˜j‰Ei“ú–{ƒoƒCƒIƒAƒbƒZƒCŒ¤‹†ƒZƒ“ƒ^|jC‚“c™¦i‰qjC_ŽRé•FiŽY‹ÆˆãŠw‘‡Œ¤‹†ŠjC¬¼iliƒwƒ‹ƒXjC’J‘¾ ”ü—YiŽÄ“c‰ÈŠwŠíŠBH‹Æj: u”÷¬ƒAƒXƒxƒXƒg‚Ì‹z“ü‚É‚æ‚鶑̉e‹¿’²¸Œ¤‹†vŒ‹‰Ê•ñ‘Cp.1`109, 1989.

3103. mŒ¤‹†•ñi˜J“­Èjn ƒeƒNƒmƒXƒgƒŒƒX‚ÉŠÖ‚·‚é’²¸Œ¤‹†ÅI•ñ‘. ‘哇³Œõiˆã—Ãî•ñƒVƒXƒeƒ€ŠJ”­ƒZƒ“ƒ^|jC‘ŠàVDŽ¡i‰qjC“àŽRŒ[Žii•xŽm’ÊjCì‡i“Œ‹ž—Žqˆã‘åjC_‘ã‰ë°iŽY‹Æˆã‰È‘åjCŒIŒ´‰ë’¼iŒÕƒm–å•a ‰@jC¬“‡_iIBMjC¬•õO‹vi“ŒˆŸ”R—¿H‹ÆjC²X–ØŽž—YiŠÖ“Œ˜JЕa‰@jCŠFì—m“ñiNTTjCŽR–{@•½i˜J“­ÈŽY‹ÆˆãŠw‘‡Œ¤‹†Šj: ƒeƒNƒmƒXƒgƒŒƒX‚ÉŠÖ‚·‚é’²¸Œ¤‹†ÅI•ñ‘, 1990.

3104. mŒ¤‹†•ñi˜J“­Èjn ‚”N—î˜J“­ŽÒ‚Ì–«Ž¾Š³‘Îô‚ð”z—¶‚µ‚½E‹Æƒ‚ƒfƒ‹‚̉ü—Ç’²¸Œ¤‹†•ñ‘. ŽR–{@•½iŽY‹ÆˆãŠw‘‡Œ¤‹†ŠjC‘ŠàVDŽ¡i‰qjC²“¡‹Óˆêi“ú–{|ŠÇjC“c’†–ÎiV“ú“SjC’†‘ºŒ’ˆêi–h‰qˆã‘åjC—ÑŠì’jiŒc‘åjCXì—˜•FiŽO•H“d ‹@jC”ªã‹œŽiiº˜a‘åjC’†ŠÙr•vCŒ´’J—²ŽjiŽY‹ÆˆãŠw‘‡Œ¤‹†ŠjC‘«—§M”VC¬ŠCGŽ¡C²“¡‘¥‰pC‹g•x•ÛŒbi‰ü—Ç’²¸Œ¤‹†•”j: ‚”N—î˜J“­ŽÒ‚Ì–«Ž¾Š³‘Îô‚ð”z—¶‚µ‚½E‹Æƒ‚ƒfƒ‹‚̉ü—Ç’²¸Œ¤‹†•ñ‘C1989.

3105. mŒ¤‹†•ñi˜J“­Èjn •²‚¶‚ñ‚΂­˜Iì‹ÆŽÒ‚̖ƉuˆÙí‚ÉŠÖ‚·‚é—Õ°Œ¤‹†. ‚“c™¦C‘ŠàVDŽ¡i‰qj: •²‚¶‚ñ‚΂­˜Iì‹ÆŽÒ‚̖ƉuˆÙí‚ÉŠÖ‚·‚é—Õ°Œ¤‹†•ñ‘Cp.1`30, 1989.

3106. mŒ¤‹†•ñi˜J“­Èjn Ò‘‘¹ŽÒ‚ÌŽ¾•a”­¶—vˆö‚̉ðÍ|Ò‘‘¹ŽÒ‚Ì«Ši‚Æ—…Š³Ž¾•a‚Æ‚ÌŠÖŒW|. ‚“c™¦i‰qjC–å˜e•”ŽiŠÅŒìŠw•”jC‘ŠàVDŽ¡i‰qjC¡ˆäDiŠÅŒìŠw•”j: ¢Ò‘‘¹ŽÒ‚ÌŽ¾•a”­¶—vˆö‚̉ðÍ£Œ¤‹†•ñ‘Cp.1`24, 1989.

3107. m‘àn Health for Today's Youth, Hope for Tomorrow's World|Educate for Health. â㳓¹C‰Í¼‹IºiŽ™j: World Health Forum, 10(2): 158`159, 1989.

3108. m‘àn ‰^“®•‰‰×‚Æ”æ˜J. ‘ŠàVDŽ¡i‰qj: ‚©‚炾‚̉Ȋw, 148: 43`46, 1989.

3109. m‘àn ƒnƒCƒeƒNŽY‹Æ˜J“­ŽÒ‚ÌŒ’N‚ÆŽ¾•a. ‘ŠàVDŽ¡C’F—mC‚“c™¦i‰qj: ƒqƒ…|ƒ}ƒ“ƒTƒCƒGƒ“ƒX, 2(2): 23`29, 1989.

3110. m‘àn •a‰@iˆã—ÃŒ»êj‚É‚¨‚¯‚éì‹ÆŠÂ‹«ŠÇ—. ‚“c™¦i‰qjC–å˜e•”ŽiŠÅŒìŠw•”j: ˆÀ‘SHŠw, 29(1): 2`11, 1990.

3111. m‘àn ’†‚”N—î˜J“­ŽÒ‚̶—‹@”\‚ƘJ“­ÐŠQ|•½t‹@”\¥Ž‹Šo”½‰žŽžŠÔ‚ÌŒŸ“¢. ‚“c™¦C‹´–{‹Nˆê˜Yi‰qj: ˆãŠw‚Ì‚ ‚ä‚Ý, 149(13): 934, 1989.

3112. m‘àn ”¼“±‘Ìì‹ÆŽÒ‚É‚¨‚¯‚éƒq‘f‚̶•¨Šw“Iƒ‚ƒjƒ^ƒŠƒ“ƒO|”AC–Ñ”¯CŒŒ‰t‚ð—p‚¢‚½ƒ‚ƒjƒ^ƒŠƒ“ƒO|. ‘ŠàVDŽ¡C‚“c™¦i‰qj: ˆãŠw‚Ì‚ ‚ä‚Ý, 151(20): 113, 1989.

3113. m‘àn ƒAƒXƒxƒXƒg‚É‚æ‚錒N‰e‹¿‚Æ‚»‚Ì“Å«. ‘ŠàVDŽ¡i‰qj: ŒöŠQ‚Æ‘Îô, 25(10): 979`983, 1989.

3114. m‘àn •p‰ñŒ‡‹Î. ‘ŠàVDŽ¡C‚“c™¦i‰qj: Sgˆã—Ã, 1(8): 1158`1163, 1989.

3115. m‘àn ŽY‹Æ•ÛŒ’‚ð’S‚¤lX|V‚µ‚¢Œ’N‘ª’è‚ÆTHPiƒg|ƒ^ƒ‹¥ƒwƒ‹ƒX¥ƒvƒƒ‚|ƒVƒ‡ƒ“ƒvƒ‰ƒ“j|. ‚“c™¦i‰qjC’†‘ºŒ«iˆã—ÎЉïŠwj: •ÛŒ’‚̉Ȋw, 31(6): 389`393, 1989.

3116. m‘àn Eê‚Å‚ÌŒ’Nf’f. ‘ŠàVDŽ¡C‚“c™¦i‰qj: •êŽq•ÛŒ’î•ñ, (19): 86`91, 1989.

3117. muÀn Šª“ªŒ¾|ˆã—ÃŽÒ‘¤‚Ì–ž‘«‚ÆŠ³ŽÒ‘¤‚Ì–ž‘«. ‘O“c^Ž¡i“àj: ‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“, 17(9): 649, 1989.

3118. mŠwp‘n iŽ·•Mj ‚±‚ê‚©‚ç‚ÌŒ’NŠÇ—; –{Ž‚ÌŠ§s‚É‚ ‚½‚Á‚Ä|Œ’NŠÇ—‚̉Ȋw“I•]‰¿‚ÌŽ‹“_‚æ‚è|, p.2`4, ‚“c™¦i‰qj. •ÒW ‘S‘˜J“­‰q¶’c‘̘A‡‰ï•ÒC ‘S‘˜J“­‰q¶’c‘̘A‡‰ï, “Œ‹ž, 89.11.30”­s.

3119. mŠwp‘n iŽ·•Mj ‚±‚ê‚©‚ç‚ÌŒ’NŠÇ—; æ’[ŽY‹Æ‚É‚¨‚¯‚錒NŠÇ—‚̉ۑè, ‘ŠàVDŽ¡i‰qj. •ÒW ŠÙ³’m•ÒC ‘S‘˜J“­‰q¶’c‘̘A‡‰ï, “Œ‹ž, 89.11.30”­s.

3120. mŠwp‘n iŽ·•Mj VDTˆãŠwƒ}ƒjƒ…ƒAƒ‹; VDTì‹Æ‚É”º‚¤Ž©ŠoÇó‚ÆŠá‚ÉŠÖ‚·‚é‘i‚¦‚ª‘½‚¢——R, p.18`22, ‘ŠàVDŽ¡i‰qj. •ÒW Îì“Ni–k—¢‘åj•ÒC ‘S“ú–{•a‰@o”ʼnï, “Œ‹ž, 89.09.15”­s.

3121. mŠwp‘n iŽ·•Mj VŠO‰ÈŠw‘åŒn (12)‘ŸŠíˆÚA;@ ‘ŸŠíˆÚA‚Æ–@—¥,@p.17`31C ‰SFˆêiˆãŠwŒ´˜_j. •ÒW oŒŽN•vC‘¼, ŠÄC –Ø–{½“ñC˜a“c’B—Y ŠÄC, ’†ŽR‘“X, “Œ‹ž, 89.06.30”­s.

3122. mŠwp‘n iŽ·•Mj ”]Ž€‚ðŠw‚Ô,@ ‰SFˆêiˆãŠwŒ´˜_j. “ú–{•]˜_ŽÐ, “Œ‹ž, 89.06.20”­s.

3123. mŠwp‘n iŽ·•Mj —Õ°ˆã‚Ì‚½‚ß‚Ì–@ˆãŠw; –@ˆãŠw“ü–å|–@ˆãŠw‚Æ‚Í|Cp.1`4C ‘D”ö’‰Fi–@ˆãj. ’©‘q‘“X, “Œ‹ž, 89.04.20 ”­s.

3124. mŠwp‘n iŽ·•Mj —Õ°ˆã‚Ì‚½‚ß‚Ì–@ˆãŠw; ŒŒ‰tŒ^‚¨‚æ‚ÑeŽqŠÓ•Ê, p.117`127CŒÂlŽ¯•Ê‚¨‚æ‚Ñ•¨‘Ìi­ÕjŒŸ¸, p.129`138C ¬’J~ˆêi–@ˆãj. ’©‘q‘“X, “Œ‹ž, 89.04.20 ”­s.

3125. mŠwp‘n iŽ·•Mj ˆãŠw¶‚Ì‚½‚ß‚ÌŠî‘bˆãŠw–â‘èÚ‰ð, Series 9 –@ˆãŠw(‰ü’ù‘æ2”Å); ‡U. ŒŸŽr¥ŒŸˆÄ‚Æ–@ˆã‰ð–UCp.17`21C‡W. Ž€‘ÌŒ»ÛCp.33`40, ‘D”ö’‰Fi–@ˆãj. •ÒW àVŒû²Žqi“Œ—ˆã‘åj•ÒC ˆãŠw‹³ˆço”ÅŽÐ, “Œ‹ž, 90.02.28 ”­s.

3126. mŠwp‘n iŽ·•Mj ˆãŠw¶‚Ì‚½‚ß‚ÌŠî‘bˆãŠw–â‘èÚ‰ð, Series 9 –@ˆãŠw(‰ü’ù‘æ2”Å); ‡]‡W. ŒŒ‰tŒ^, p.152`165, ‡]‡X. •s“K‡—AŒŒ¥V¶Ž™—nŒŒ«Ž¾Š³, p.175`187, ‡]‡Y. eŽqŠÓ•Ê, p.189`203C ¬’J~ˆêi–@ˆãj. •ÒW àVŒû²Žqi“Œ—ˆã‘åj•ÒC ˆãŠw‹³ˆço”ÅŽÐ, “Œ‹ž, 90.02.28 ”­s.

3127. m‹³‰È‘n iŽ·•Mj ÅVˆãŠw’mŽ¯‚Ì®—|ƒvƒ‹ƒ~ƒGŒöO‰q¶Še˜_; ì‹ÆŠÂ‹«ŠÇ—Cì‹ÆŠÇ—‚¨‚æ‚ÑŒ’NŠÇ—Cp.154`160C ‚“c™¦i‰qjC–å˜e•”ŽiŠÅŒìŠw•”j. •ÒW â–{OiŽOd‘åjC˜a“cUi“Œ‘åj•ÒC ˆãŽ•–òo”Å, “Œ‹ž, 89.07.20”­s.

3128. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ÒWj ‰ü’ùì‹ÆŠÂ‹«‘ª’èQ&A, •ÒW —`dŽ¡i˜J“­ÈŽY‹ÆˆãŠw‘‡Œ¤‹†ŠjC‚“c™¦i–k—¢‘奉qjCÀ–ì—YŽuiÀ–ì˜J“­ˆÀ‘S‰q¶ƒRƒ“ƒTƒ‹ƒ^ƒ“ƒgjC¬’rT–çi_“Þ쌧—\–hˆãŠw‹¦‰ïjC¬¼il i–k—¢¥ƒwƒ‹ƒX¥ƒTƒCƒGƒ“ƒXjC‘åŠÖeC˜I–Ø•Ûi˜J“­ÈŠÂ‹«‰ü‘PŽºjC“c’†’C—Yi“ú–{ì‹ÆŠÂ‹«‘ª’苦‰ïj•ÒC “ú–{ì‹ÆŠÂ‹«‘ª’苦‰ï, “Œ‹ž, 89.06.25”­s.

3129. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ÒW¥Ž·•Mj V”Å¥ŽY‹Æˆã‚ÌE–± Q & A, •ÒW ‚“c™¦i‰qjC”~‘ò•×i“ú–{—\–hˆãŠw‹¦‰ïjC—`dŽ¡iŽY‹ÆˆãŠw‘‡Œ¤‹†ŠjC“c’†–Îi‘S‘˜J“­‰q¶’c‘̘A‡‰ïjC‘¼•ÒC ŽY‹ÆˆãŠwU‹»à’c, “Œ‹ž, 89.06.00”­s.

3130. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj “O’ꕪ͊Ǘ‰h—{Žm‘‰ÆŽŽŒ±–â‘èW; Œ’NŠÇ—Cp.245`256C ‘ŠàVDŽ¡i‰qj. •ÒW ‘ŠàVDŽ¡i–k—¢‘åjC‘¼•ÒC ˆãŽ•–òo”Å, “Œ‹ž, 89.04.00”­s.

3131. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj ƒAƒXƒxƒXƒg‚É’§‚ÞŽOŠÇ—; ƒAƒXƒxƒXƒgì‹ÆŽÒ‚ÌŒ’NŠÇ—, p.158`173, ‘ŠàVDŽ¡i‰qj. •ÒW “‡³Œá•ÒC ’†‰›˜J“­ÐŠQ–hŽ~‹¦‰ï, “Œ‹ž, 89.04.28”­s.

3132. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj ‚¹‚«‘‘¹‚Ì•û‚ÌŒ’NŠÇ—‚Ì‚µ‚¨‚èCp.1`45, ‚“c™¦i‰qjC‹{èˆê‹»i_“Þ쌧‘‡ƒŠƒnƒZƒ“ƒ^|jCòŽR’†ŽOi“ŒŠC‘åjC’†ìˆê•Fi’}”g‘åj. ˜JДN‹à•ŸŽƒ‹¦‰ï, “Œ‹ž, 89.10.20”­s.

3133. m‚»‚Ì‘¼i•¶Œ£Ð‰îjn ƒ}ƒCƒNƒƒGƒŒƒNƒgƒƒjƒNƒXŽY‹Æ. ‘ŠàVDŽ¡i‰qj: ˆÀ‘S‰q¶ƒRƒ“ƒTƒ‹ƒ^ƒ“ƒg, 9: 79`80, 1989.

3134. m‚»‚Ì‘¼i˜_’djn ’†‚”N‚ÌŒ’N‚ƃXƒ||ƒc; Eê‚ÍŒ’N‚Ì”­MŠî’n‚Å‚ ‚é. ‚“c™¦i‰qj: ‚Ý‚ñ‚Ȃ̃Xƒ||ƒc, 11(9): 4, 1989.

3135. mŠw‰ïn i‹³ˆçu‰‰j ŽY‹Æˆã‚ÆЊQˆãŠw. ‚“c™¦i‰qj: ‘æ37‰ñ“ú–{ЊQˆãŠw‰ïŠwp‘å‰ï (89.10.18), L“‡, “ú–{ЊQˆãŠw‰ïŽ, (—Õ‘): 39, 1989.

3136. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‘O—Õ°¥—Õ°¥ŽÐ‰ï–Ê‚©‚猩‚½V–ò‚Ì–â‘è“_|—Õ°•]‰¿‚ÌŠÏ“_‚©‚ç|. ”è’õ•vi“àj: ‘æ63‰ñ“ú–{–ò—Šw‰ï‘‰ï i90.03.25°28), “Œ‹ž.

3137. mŠw‰ïn iƒpƒlƒ‹j ŠÂ‹«ˆãŠw‚Æ”xŽ¥ŠE‘ª’è. ‘ŠàVDŽ¡C‚“c™¦i‰qjC¬’J½i“Œ‹ž“d‹@‘åj: ‘æ4‰ñ“ú–{¶‘ÌŽ¥‹CŠw‰ï‘å‰ï (89.06.02), “¿“‡.

3138. mŠw‰ïn iˆê”Êu‰‰j ¸_‰È‚Ƃ̃`[ƒ€ƒAƒvƒ[ƒ`‚ɂ‚¢‚Ä. ŒÃŽR“o—²C‰eŽRL”üC—é–Ø•q•FC•“cŒ[C‰–’JMKiŒ`ŠOj: ‘æ32‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (89.04.20), ‰YˆÀ.

3139. mŠw‰ïn iˆê”Êu‰‰j Eˆæ‚Å‚Ì’èŠúŒ’Nf’f‚ÌŒ‹‰Ê‚©‚ç‚Ý‚½ŒŒˆ³‚ÆŒŒ´Ca,Mg,P‚ÌŠÖŒW. —é–Ø_ˆêC¬“cŒ›ˆêC’Å–¼•x‘ iŠÖ“Œ˜JЕa‰@jC‚“c™¦i‰qj: ‘æ62‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (89.04.28), ÂXC Šw‰ïu‰‰—vŽ|WCp.61, 1989.

3140. mŠw‰ïn iˆê”Êu‰‰j ‰^“®ƒXƒgƒŒƒX‚ɑ΂·‚ézŠÂŠíŒn”½‰žCŒŒ’†ƒJƒeƒR|ƒ‹ƒAƒ~ƒ““®‘Ô. ‹´–{‹Nˆê˜YC‚“c™¦C‘ŠàVDŽ¡C•x‰i‰qC’F—mi‰qjCˆäã—tŽqC¡–ì—mŽÀi—\–hˆãŠwŒnjC’†‘ºŒ«iˆã—ÎЉïŠwj: ‘æ62‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (89.04.28), ÂXC Šw‰ïu‰‰—vŽ|WCp.86, 1989.

3141. mŠw‰ïn iˆê”Êu‰‰j Eê‚É‚¨‚¯‚é“ñ‚‚̗}‚¤‚ÂŽÚ“x‚Ì”äŠrŒŸ“¢. ’|“à‚Ђë‚ÝC’J“c‹v”üŽqiƒwƒ‹ƒXjC‚“c™¦C‘ŠàVDŽ¡i‰qjC™‰Y—R”üŽqC–‹I”ü‘ãi—\–hˆãŠwŒnj: ‘æ62‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (89.04.30), ÂXC Šw‰ïu‰‰—vŽ|WCp.204, 1989.

3142. mŠw‰ïn iˆê”Êu‰‰j ƒgƒ‹ƒGƒ“¥ƒLƒVƒŒƒ“‚΂­˜IŽÒ‚̶•¨Šw“Iƒ‚ƒjƒ^ƒŠƒ“ƒOƒf|ƒ^‚ÌŠˆ—p‚ɂ‚¢‚Ä. ¬¼r—YC‘åX‹`•¶C—é–Ø”ü’q‘ãC¬¼iliƒwƒ‹ƒXjC‚“c™¦i‰qj: ‘æ62‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (89.04.30), ÂXC Šw‰ïu‰‰—vŽ|WCp.289, 1989.

3143. mŠw‰ïn iˆê”Êu‰‰j Ò‘‘¹ŽÒ‚ÌŒ’Nó‘Ԃɉe‹¿‚·‚éˆöŽq‚̉ðÍ. ¡ˆäDC–å˜e•”ŽiŠÅŒìŠw•”jC‚“c™¦C‘ŠàVDŽ¡i‰qjC’†‘ºŒ«iˆã—ÎЉïŠwjC‹´–{‹Nˆê˜YC•x‰i‰qC’F—mi‰qj: ‘æ59‰ñ“ú–{‰q¶Šw‰ï‘‰ï (89.05.03), H“cC “ú–{‰q¶Šw‰ïŽC44(1): 171, 1989.

3144. mŠw‰ïn iˆê”Êu‰‰j ‰”ì‹ÆŽÒ‚ÌT×–EƒTƒuƒZƒbƒg. ‘ŠàVDŽ¡C‚“c™¦C‘O“cŒúŽuC‹´–{‹Nˆê˜YCŒIŒ´–«C•x‰i‰qC’F—mi‰qj: ‘æ59‰ñ“ú–{‰q¶Šw‰ï‘‰ï (89.05.03), H“cC “ú–{‰q¶Šw‰ïŽC44(1): 208, 1989.

3145. mŠw‰ïn iˆê”Êu‰‰j ‰^“®ƒXƒgƒŒƒX‚ÆT×–EƒTƒuƒZƒbƒg. ‹´–{‹Nˆê˜YC‚“c™¦C‘ŠàVDŽ¡C•x‰i‰qC’F—mi‰qjC’†‘ºŒ«iˆã—ÎЉïŠwj: ‘æ59‰ñ“ú–{‰q¶Šw‰ï‘‰ï (89.05.03), H“cC “ú–{‰q¶Šw‰ïŽC44(1): 291, 1989.

3146. mŠw‰ïn iˆê”Êu‰‰j •²‚¶‚ñì‹Æ•ÊŒ’fŒ‹‰Ê‚ÌŒŸ“¢. •x‰i‰qC‚“c™¦C‘ŠàVDŽ¡C‹´–{‹Nˆê˜YC’F—mi‰qj: ‘æ59‰ñ“ú–{‰q¶Šw‰ï‘‰ï (89.05.04), H“cC “ú–{‰q¶Šw‰ïŽC44(1): 554, 1989.

3147. mŠw‰ïn iˆê”Êu‰‰j Ž€ŒãŒo‰ßŽžŠÔ„’è‚ÉŠÖ‚·‚éÄŒŸ“¢i‘æ‡[•ñj|Ž€”Á—̈æ‚É‚Ý‚ç‚ê‚é”畆ˆìŒŒ“_‚̈Ӌ`‚ɂ‚¢‚Ä|. ŒÃì—FC‘D”ö’‰Fi–@ˆãj: ‘æ73ŽŸ“ú–{–@ˆãŠw‰ï‘‰ï (89.05.12), ‰ªŽRC “ú–@ˆãŽC43(•â) : 145, 1989.

3148. mŠw‰ïn iˆê”Êu‰‰j ’‚‘§‹@\‚É‚¨‚¯‚éƒnƒvƒgƒOƒƒrƒ“‚Ì–ðŠ„‚ÉŠÖ‚·‚錤‹†i‡Tj. ’†“cLŽqCàVŒû²Žqi“Œ—ˆã‘åjC¬’J~ˆêC‘D”ö’‰Fi–@ˆãjCŽR‰ºƒPƒTŽqCHŽRŸ‘¥i“Œ—ˆã‘åj: ‘æ73ŽŸ“ú–{–@ˆãŠw‰ï‘‰ï (89.05.12), ‰ªŽRC “ú–@ˆãŽC43(•â): 130, 1989.

3149. mŠw‰ïn iˆê”Êu‰‰j •â‘ÌŒn‚Ì–@ˆãŠw“IŒ¤‹†|’‚‘§Žž‚É‚¨‚¯‚éC3‚Ì•Ï“®|. ’†‘º–ΊîCàVŒû²Žqi“Œ—ˆã‘åjC¬’J~ˆêi–@ˆãjC’†ŽR–ÎMiŽÀ“®ŒnjC‘D”ö’‰Fi–@ˆãj: ‘æ73ŽŸ“ú–{–@ˆãŠw‰ï‘‰ï (89.05.12), ‰ªŽRC “ú–@ˆãŽC43(•â): 166, 1989.

3150. mŠw‰ïn iˆê”Êu‰‰j ”]ŒŒ—¬“®‘Ô‚©‚ç‚Ý‚½’‚‘§Ž€‚ÌÄŒŸ“¢i‡Wj|ŽÀŒ±“I‹}‘¬“MŽ€Žž‚ɂ‚¢‚Ä|. ¬’J~ˆêi–@ˆãjCàVŒû²Žqi“Œ—ˆã‘åjC‘D”ö’‰Fi–@ˆãjC’†ŽR–ÎMiŽÀ“®ŒnjC’†“cLŽqi“Œ—ˆã‘åj: ‘æ73ŽŸ“ú–{–@ˆãŠw‰ï‘‰ï (89.05.12), ‰ªŽRC “ú–@ˆãŽC43(•â): 170, 1989.

3151. mŠw‰ïn iˆê”Êu‰‰j Å‹ß17”NŠÔ‚ÌŒŸˆÄ—á‚Ì“Œv“IŠÏŽ@. ™]G–¾C‘D”ö’‰FC¬’J~ˆêCŒÃì—FCŒIŒ´•¶’ji–@ˆãjCàVŒû²Žqi“Œ—ˆã‘åjCŒIŒ´Ž—RiŒc‘åj: ‘æ73ŽŸ“ú–{–@ˆãŠw‰ï‘‰ï (89.05.12), ‰ªŽRC “ú–@ˆãŽC43(•â): 280, 1989.

3152. mŠw‰ïn iˆê”Êu‰‰j ŒŸˆÄ¥‰ð–U—á‚É‚¨‚¯‚é’†“ÅŽ€‚ÌŒ»‹µ. àVŒû²ŽqCŽR‰ºƒPƒTŽqi“Œ—ˆã‘åjC‘D”ö’‰FC¬’J~ˆêCŒÃì—FC™]G–¾CŒIŒ´•¶’ji–@ˆãj: ‘æ58‰ñ“ú–{–@ˆãŠw‰ïŠÖ“Œ’n•û‰ï (89.10.07), “Œ‹ž.

3153. mŠw‰ïn iˆê”Êu‰‰j –@ˆã–UŒŸŽž‚É‚¨‚¯‚é‘ŸŠíd—Ê‚Ì“Œv“IŠÏŽ@(‘æ1•ñ). ™]G–¾C¬’J~ˆêCŒÃì—FCŒIŒ´•¶’jC‘D”ö’‰Fi–@ˆãjCàVŒû²Žqi“Œ—ˆã‘åj: ‘æ58‰ñ“ú–{–@ˆãŠw‰ïŠÖ“Œ’n•û‰ï (89.10.07), “Œ‹ž.

3154. mŠw‰ïn iˆê”Êu‰‰j •²‚¶‚ñì‹Æ‚Æ‚¶‚ñ”xŒ’fŒ‹‰Êi‘æ2•ñj. •x‰i‰qC‚“c™¦C‘ŠàVDŽ¡C‹´–{‹Nˆê˜YC’F—mi‰qj: ‘æ37‰ñ“ú–{ЊQˆãŠw‰ïŠwp‘å‰ï (89.10.18), L“‡, “ú–{ЊQˆãŠw‰ïŽ, (—Õ‘): 77, 1989.

3155. mŠw‰ïn iˆê”Êu‰‰j ˜J“­ÐŠQˆãŠwŒ¤‹†‚ÌŽY‹ÆŽÐ‰ïŠw“IlŽ@. ’†‘ºŒ«iˆã—ÎЉïŠwjC‚“c™¦C‘ŠàVDŽ¡C‘O“cŒúŽuC‹´–{‹Nˆê˜YC•x‰i‰qC’F—mi‰qjC–å˜e•”ŽC¡ˆäDiŠÅŒìŠw•”j: ‘æ37‰ñ“ú–{ЊQˆãŠw‰ïŠwp‘å‰ï (89.10.19), L“‡, “ú–{ЊQˆãŠw‰ïŽ, (—Õ‘): 130, 1989.

3156. mŠw‰ïn iˆê”Êu‰‰j –«ŠúÒ‘‘¹ŽÒ‚ÌCMIŽ©ŠoÇó“Á«. ¡ˆäDC–å˜e•”ŽiŠÅŒìŠw•”jC•Ÿ•x˜a•vi‘—§Œö‰q‰@jC‚“c™¦C‘ŠàVDŽ¡i‰qjC’†‘ºŒ«iˆã—ÎЉïŠwjC‹´–{‹Nˆê˜YC•x‰i‰qi‰qj: ‘æ37‰ñ“ú–{ЊQˆãŠw‰ïŠwp‘å‰ï (89.10.19), L“‡, “ú–{ЊQˆãŠw‰ïŽ, (—Õ‘): 138, 1989.

3157. mŠw‰ïn iˆê”Êu‰‰j ‹~–½‹~‹}ƒZƒ“ƒ^[‚É‚¨‚¯‚é“]‰@‚ւ̃\[ƒVƒƒƒ‹ƒ[ƒN‰‡•|“Á‚ɉ“Šu’n‚Ö“]‰@‚µ‚½12Ç—á‚ÌlŽ@. Žæo~ŽqC‰Á“‡–¾iˆã—ÑŠ’kŽºjC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.07), “Œ‹ž.

3158. mŠw‰ïn iˆê”Êu‰‰j ”ü—eŠO‰È‚Æ•ÏŒ`‹°•|ǂɂ‚¢‚Ä. ŒÃŽR“o—²CçÝŽ½C‰FˆäŒª“ñC“àÀ‰hŽ÷C‰–’JMKiŒ`ŠOjCŽRéˆê˜YC΋½‰ªƒi¸j: ‘æ32‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i89.04.20), ‰YˆÀ.

3159. mŠw‰ïn iˆê”Êu‰‰j ’nˆæ‚ÌuÝ‘îˆã—ÃŒŸ“¢‰ïv‚É‚¨‚¯‚鎖—á‚ð’Ê‚µ‚Ẳۑè. ¬–ì•q–¾i‘Š–ÍŒ´ŽÐ‰ï•ŸŽƒ‹¦‹c‰ïjCÄ“¡–L˜ai“àj: ‘æ12‰ñƒvƒ‰ƒCƒ}ƒŠ[ƒPƒAŠw‰ï i89.06.25), –¼ŒÃ‰®.

3160. mŠw‰ïn iˆê”Êu‰‰j –k—¢‘åŠw“Œ•a‰@‚É‚¨‚¯‚éÝ‘îƒPƒA[ƒVƒXƒeƒ€. Ä“¡–L˜ai“àjC‰““¡MŽqiŠÅŒì•”jC–x‰z—R‹IŽqi‘‡ˆã—ÑŠ’k•”jC‚“ˆ‰Á‘ãŽqCŽR–{ŒPŽqiŠÅŒìjCדc–«i“àj: ‘æ12‰ñƒvƒ‰ƒCƒ}ƒŠ[ƒPƒAŠw‰ï i89.06.25), –¼ŒÃ‰®.

3161. mŒ¤‹†‰ïn i“Á•Êu‰‰j —Õ°‚ƈ㎖•´‘ˆ. “c’†—ºi–ƒj: ‘æ14‰ñ‘ÌŠOzŠÂŒ¤‹†‰ï (88.12.03), ‘Š–ÍŒ´.

3162. mŒ¤‹†‰ïn i“Á•Êu‰‰j Countermeasures of Kitasato University Hospital against Damaging Earth Quakes. ‘åê³–¤iŠÅŒìŠw•”jC‘å˜a“c—²i‹~–½jC–î“cˆê•vi•a‰@Ž––±jCÎŒ´ºi‹¹ŠOj: Seminario International de Planeamiento (89.08.20), Lima, Peru.

3163. mŒ¤‹†‰ïn i“Á•Êu‰‰j Role of the University Hospital in Emergency Medical System. ‘å˜a“c—²i‹~–½jC‘åê³–¤iŠÅŒìŠw•”jC–î“cˆê•vi•a‰@Ž––±jCÎŒ´ºi‹¹ŠOj: Seminario International de Planeamiento (89.08.20), Lima, Peru.

3164. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j –k—¢‘åŠw•a‰@‚Æ’nˆæˆã—Âɂ‚¢‚Ä. ‘å˜a“c—²i‹~–½j: –k—¢‘åŠw•a‰@ŠJ‰@‹L”OƒVƒ“ƒ|ƒWƒEƒ€ (89.07.19), ‘Š–ÍŒ´.

3165. mŒ¤‹†‰ïn iƒpƒlƒ‹j ––Šúˆã—ÂÌÝ‚é‚ׂ«Žp‚ð‹‚ß‚Ä. ‰SFˆêiˆãŠwŒ´˜_j: i89.10.02), “Œ‹ž, ƒWƒ…ƒŠƒXƒg, (945): 17`36, 1989.

3166. mŒ¤‹†‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj Biological Monitoring of Arsenic Exposure. ‘ŠàVDŽ¡C‚“c™¦i‰qj: United States-Japan Cooperative Seminer on Biological Monitoring”­•\”NŒŽ“ú(89.08.25), Hawai.

3167. mŒ¤‹†‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj ”¼“±‘ÌH‹Æ‚É‚¨‚¯‚é‚Бf‚̶•¨Šw“Iƒ‚ƒjƒ^ƒŠƒ“ƒO. ‘ŠàVDŽ¡C‚“c™¦C’F—mi‰qj: “ú–{‰q¶Šw‰ïƒ|ƒNƒVƒˆƒbƒv¥ƒqƒg‚É‚¨‚¯‚é—LŠQ‰»Šw•¨Ž¿‚̶•¨Šw“Iƒ‚ƒjƒ^ƒŠƒ“ƒO (89.11.25), ‘åã.

3168. mŒ¤‹†‰ïn iˆê”Êu‰‰j î•ñ’ñ‹Ÿ‚ÉŠÖ‚·‚éˆãŽt‚ÆŠ³ŽÒŠÖŒW‚ɂ‚¢‚Ä. ‰SFˆêiˆãŠwŒ´˜_j: Œú¶ÈŠ³ŽÒƒT|ƒrƒX‚ÌÝ‚è•û‚ÉŠÖ‚·‚駒k‰ï (88.04.20), “Œ‹ž, Š³ŽÒƒT|ƒrƒXƒKƒCƒhƒ‰ƒCƒ“, p.88`93, 1989.


<<308 ˆãŠwŠT˜_>>

3169. mŒ´’˜n Eà–¾‚Æ“¯ˆÓE‚ɂ‚¢‚Ä‚Ì•ñ. ‰Á“¡ˆê˜Yi¬éŠw‰€jCˆ¢•”³˜aiŽœŒbˆã‘åjCìã³–çi•ª¶jC™–{Š¤iã‘åjC—é–؉i“ñiŽO•H‰»¬jC‘\–숻Žqiì‰ÆjC’†ªçŽ}i–¯‘°ŠwU‹»‰ïjC ’†‘º—Y“ñ˜Yi–¾Ž¡‘åjC‰i£³–¤i“ú–{ˆãŽt‰ïjC–x“cŸ“ñi•ÙŒìŽmj: “ú–{ˆãŽt‰ïŽGŽC103(4): 515`528, 1990.


<<309 ŽÀŒ±“®•¨Šw>>

3170. mŒ´’˜n Prolactin Secretion and Its Response to Stress during the Estrous Cycle of the Rats. ŒÃŠÚêˆêiŽÀ“®jCˆ°Œ´‹v‘ãi‘‡—Õ°ŒnjC’†–쌒ŽiiŽÀ“®j: Exp. Anim., 38(4): 313`318, 1989.

3171. mŠw‰ïn iˆê”Êu‰‰j ƒEƒŒƒ^ƒ“–ƒŒ‚É‚æ‚郉ƒbƒg”­î‘OŠú‚̃vƒƒ‰ƒNƒ`ƒ“¥ƒT|ƒW‚Ì—}§. ŒÃŠÚêˆêiŽÀ“®jCˆ°Œ´‹v‘ãi‘‡—Õ°ŒnjC’†–쌒ŽiiŽÀ“®j: ‘æ36‰ñ“ú–{ŽÀŒ±“®•¨Šw‰ï (89.05.30), “Œ‹ž, u‰‰—vŽ|WCp.113, l989.

3172. mŠw‰ïn iˆê”Êu‰‰j ƒCƒk‚Ì”ñŠJ‹¹‰º‚É‚¨‚¯‚éŽÀŒ±“I•s®–¬ì¬‚ɂ‚¢‚Ä. ”¯N—YiŽÀ“®jC’†ŽR–ÎMCŠÛŽR–ΑPiŽÀ“®ŒnjCˆ°Œ´‹v‘ãi‘‡—Õ°ŒnjC“ޗljÀ—mi¶•¨•¨—ŒnjC˜kì_ŽiiŽÀ“®Œnj: ‘æ108‰ñ“ú–{bˆãŠw‰ï (89.10.03), ·‰ª, u‰‰—vŽ|WCp.231, l989.

3173. mŠw‰ïn iˆê”Êu‰‰j ‹U”DPƒ‰ƒbƒg‚̃vƒƒ‰ƒNƒ`ƒ“¥ƒT|ƒW‚É‹y‚Ú‚·ƒEƒŒƒ^ƒ“–ƒŒ‚̉e‹¿. ŒÃŠÚêˆêiŽÀ“®jC’†–쌒ŽiiŽÀ“®j: ‘æ108‰ñ“ú–{bˆãŠw‰ï (89.10.03), ·‰ª, u‰‰—vŽ|WCp.66, l989.

3174. mŒ¤‹†‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj ˆ««‚”Mǃ‚ƒfƒ‹ƒuƒ^‚̈笂ƬŒ^‰»‚ɂ‚¢‚Ä. ’†–쌒ŽiiŽÀ“®j: ‘æ13‰ñˆ««‚”MŒ¤‹†‰ï (89.12.10), “Œ‹ž, ´˜^WCp.5, l989.

3175. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’´‰¹”g–@‚É‚æ‚éƒlƒR‚Ì”DPf’f‚ÆŽq‹{’~”^Ç‚Ì‚P—á. ”¯N—YiŽÀ“®jC’·’Jì”ü•ÛC•½”ö‚ß‚®‚ÝiŽÀ“®ŒnjC’†–쌒ŽiiŽÀ“®j: ‘æ5‰ñbˆã‰æ‘œf’fŒ¤‹†‰ï (89.00.00), “Œ‹ž, —vŽ|WCp.9, l989.

3176. mŒ¤‹†‰ïn iˆê”Êu‰‰j ˆ««‚”MÇ•a‘Ôƒ‚ƒfƒ‹ƒuƒ^‚̬Œ^‰»‚ɂ‚¢‚Ä. ”¯N—YiŽÀ“®jC˜kì_ŽiC‚éŽçC‰º‰Í•”L¹iŽÀ“®ŒnjC’†–쌒ŽiiŽÀ“®jC–쌩ŽREC“n•Ó•qC“c’†—ºi–ƒj: ‘æ6‰ñ“ú–{Ž¾Š³ƒ‚ƒfƒ‹“®•¨Œ¤‹†‰ï‘‰ï (89.11.29), “Œ‹ž, ´˜^WCp.55, l989.


<<310 ‘ª’è–@E‹Zp˜_‚È‚Ç>>

3177. mŒ´’˜n ³Œ·”g’¼ü‰Á‘¬“xŽhŒƒ‚É‚æ‚鎨΋@”\ŒŸ¸–@|–À˜H‹@”\‚“xáŠQ—á‚ÌŽ¨Î‹@”\‚ɂ‚¢‚Ä. “¡–ì–¾lC“¿‘Œú“ñC”ª–؈ê‹LC‹g”ö’mC•½ŽR•ûrCŒÜ“‡ˆê‹giŽ¨•@jC•Ä“c•qi¶•¨•¨—Œnj: Equilibrium ResearchC48(3): 235`240, 1989.

3178. mŒ´’˜n ––½‘O’ë«‚ß‚Ü‚¢‚ɑ΂·‚郊ƒnƒrƒŠƒe|ƒVƒ‡ƒ“–@i–k—¢‘åŠw_ŒoŽ¨‰È•ûŽ®j. “¡–ì–¾lC“¿‘Œú“ñC¼‰ª–¾—TCV“cŒ’‘¾˜YC”ª–؈ê‹LC‹g”ö’mC•½ŽR•ûrC’·À‰p–¾C¯–ìŒ÷CŒÜ“‡ˆê‹gCiŽ¨•@j: Equilibrium ResearchC48(4): 325`331, 1989.

3179. mŒ´’˜n Quantitative Computed Tomographic Evaluation of Femoral Bone Mineral Content in Renal Osteodystrophy Compared with Radial Photon Absorptiometry. ÷ˆä´Žqi•újCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjCŠâ”g–Îi•újC“à“c‹v‘¥i“Œ‘åˆã‰ÈŒ¤jC¼—Ñ—²i•új: Investigative Radiology, 24(5): 375`382, 1989.

3180. mŒ´’˜n ƒJ|ƒhŒ^’mŽ¯ƒx|ƒXƒVƒXƒeƒ€‚ðŽg—p‚µ‚½“dŽq‹³‰È‘EQRS¥zŠÂ¶—ŠwE‚Ìì¬. ’|“ດŽiˆã—pî•ñjC²“¡“oŽu˜Yi¶—jC’r“cŒ›ºC‰““¡‹±Žqiˆã—pî•ñjC²“¡—ºiƒAƒLƒ‰ƒbƒNƒXj: ˆã—pî•ñŠw, 9(4): 461`467, 1989.

3181. mŒ´’˜n ‘@ˆÛóƒGƒAƒƒ]ƒ‹ƒ‚ƒjƒ^|‚É‚æ‚é‘å‹C’†ƒAƒXƒxƒXƒg‚Ì‘ª’è. ¬¼iliƒwƒ‹ƒXjC‚“c™¦i‰qj: ŒöŠQ‚Æ‘ÎôC25(10): 990`995, 1989.

3182. mŒ´’˜n “ªŒz•”Žîᇂɂ¨‚¯‚錌´’†G•½ã”çŠàŠÖ˜ARŒ´iSCCRŒ´j‚ɂ‚¢‚Ä. ’·À‰p–¾Cˆî–ØŸ‰pC”ª”ö˜a—YC‰ª–{–qlC‚‹´œAbiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰ÈC61(6): 483`487, 1989.

3183. mŒ´’˜n ŒŒ´—tŽ_Œ‹‡’`”’‚Ì•ª—£•ªÍ‚ÉŠÖ‚·‚錤‹†. “àŽRKMC‘å’J‰pŽ÷i—Õ•a—j: —Õ°•a—, 37(5): 533`536, 1989.

3184. m’Z•ñn Measurement of Des-Phe8-Arg9-Bradykinin by Enzyme-Immunoassay|A Useful Parameter of Plasma Kinin Release. ”n“ˆ³—²Cã–ìWŒ›CN. Sunaharai‘å“ú–{»–òjCŽ­ŽæMi–ò—j: Kinins, V(Part A): 331`335, 1989.

3185. m‚»‚Ì‘¼‚Ì•ñn “ú–{‘gD”|—{Šw‰ï‘æ62‰ñ‘å‰ï. ‘ –{”ŽsiŽY•wj: ‘gD”|—{, 15(11): 374`377, 1989.

3186. mÇ—á•ñn V‚µ‚¢ˆã—×pƒeƒŒƒ|ƒ^ƒVƒXƒeƒ€|‚»‚ÌŠT—v‚Æ¡Œã‚Ì–â‘è“_|. “n•Ó•qi–ƒjCL£–«iMEƒZƒ“ƒ^[j: ˆã‰ÈŠíŠBŠw, 59(6): 296`301, 1989.

3187. mÇ—á•ñn CE¢ŠEŒ©•·˜^A‚±‚ê‚©‚ç‚ÌCE‚Ì‚½‚ß‚ÉA“ú–{‚Ì•a‰@CE•”–å‡A–k—¢‘åŠw•a‰@MEƒZƒ“ƒ^|. “n•Ó•qi–ƒj: ŒŽŠ§Vˆã—Ã, 16(4): 122`123, 1989.

3188. m—Õ°Ž¡Œ±n Ž¨•@ˆôA‰È—̈æ‚̔畆‚ÌÁ“Å–@. ‰ª–{–qliŽ¨•@j: JOHNS, 5(8): 1165`1169, 1989.

3189. m—Õ°Ž¡Œ±n ƒqƒg’¼—§ŽždS“®—h‚Ì‘½•Ï—ʉðÍi‘æ1•ñj|dS“®—h‚©‚ç‚Ý‚½”N—î•Ï‰»|. ”ª–؈ê‹LiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñ, 92(6): 899`908, 1989.

3190. m—Õ°Ž¡Œ±n ƒqƒg’¼—§ŽždS“®—h‚Ì‘½•Ï—ʉðÍi‘æ2•ñj|dS“®—h‚̃pƒ^|ƒ“”FŽ¯|. ”ª–؈ê‹LiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñ, 92(6): 909`922, 1989.

3191. m‘àn ‰æ‘œf’f|MRI|. ¼Šª”ŽC–x’rdŽ¡i‹~–½jC›Mˆêi•újC‘Oì˜a•Fi‹~–½j: Emergency Nursing, 2(4): 300`306, 1989.

3192. m‘àn ƒgƒƒ“ƒ{ƒLƒTƒ“B2‚Æ6°ƒPƒg°ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“F1ƒ¿‚̈À’è‘ãŽÓ•¨. Ž­ŽæMi–ò—j: Œ»‘ãˆã—Ã, 21(11): 3250`3253, 1989.

3193. m‘àn ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“‚Í‚¢‚©‚É‘ª‚é‚ׂ«‚©. Ž­ŽæMi–ò—j: Œ»‘ãˆã—Ã, 21(11): 3259, 1989.

3194. m‘àn 90”N‘ãˆã—Ë@Ší‚Í‚±‚ꂾF‹@Ší•ÛŽçŠÇ—‘̧‚ÌŠm—§. “n•Ó•qi–ƒj: Vˆã—Ã, 17(2): 28`29, 1990.

3195. m‘àn ‘å“®–¬‚É‚¨‚¯‚éŽ_«ƒ€ƒR‘½“œ—Þ‚ÌõF–@‚ÌŒŸ“¢. ‘å‹´‚ä‚©‚èCˆÉ“¡®ŽqC‹ß–ì´”üCŽsì‚‚íi•a‰@•a—jCV’Ã’J^li“àjCŒK”ö’èmC‰œ•½‰ë•Fi•a—j: •a—‹Zp, (40): 12`13, 1989.

3196. m‘àn V‚µ‚¢ˆã—×pƒeƒŒƒ|ƒ^ƒVƒXƒeƒ€‚ɂ‚¢‚Ä. “n•Ó•qi–ƒj: –ƒŒ, 38(7): 954`959, 1989.

3197. muÀn C”½‰ž«ƒ^ƒ“ƒpƒN(CRP)|–Ñ׊ǒ¾~–@‚ƃ‰ƒeƒbƒNƒX–Ɖu‹ÃW”ä‘÷–@|. ¼“c—zC‘å’J‰pŽ÷i—Õ•a—j: Med. Technol., 17(9): 961`966, 1989.

3198. muÀn SPECT‘•’u‚̉ñ“]Ž²‚¸‚ꂨ‚æ‚уCƒ[ƒWƒTƒCƒY•Ï“®‚ÉŠÖ‚·‚é“ú펎Œ±. ‹v“c‹Óˆêi‹à‘ò‘åjC—L…¸iç—t‘åjCΈ䟌Èi•újC‰ª–ì^Ž¡i—Œ¤jC¬ŽR“c“ú‹gŠÛiŠàŒ¤jCì㌛ŽiiŽœŒbˆã‘åjC²X–ØNliŒQ‘åjC—é–Ø–L i“ŒŠC‘åjC“yŠí‰®‘ìŽui‘—§“Œ“ñ•a‰@jC¼ìˆêi“Œ‘åjC¼•½³“¹i‹à‘ò‘åjC¼–{“Oi•úˆãŒ¤jCŒüˆäF•vi‹ž“s‹Z’Z‘åjC–ûˆäMtiç—tŒ§‚ª‚ñƒZ ƒ“j: Radioisotopes, 39(2): 53`59, 1990.

3199. mŠwp‘n iŽ·•Mj S“d}ƒRƒ“ƒsƒ…|ƒ^f’f; ƒ~ƒjƒRƒ“‰@“àƒVƒXƒeƒ€Cp.64`78C ‹{Œ´‰p•viˆã—pî•ñj. •ÒW ‰ª“‡ŒõŽ¡i“¡“cŠw‰€j•ÒC ’†ŽR‘“X, “Œ‹ž, 89.12.20”­s.

3200. mŠwp‘n iŽ·•Mj ‘gD×–E‰»Šw‚Ì‹Zp|×–E–Œ; 5'-nucleotidase, p. 222`227, ŽR‰È³•½i‰ðj. •ÒW ¬ì˜a˜Ni‹ž‘åjC’†ªˆê•äi’·è‘åj•Ò, ’©‘q‘“X, “Œ‹ž, 89.11.25 ”­s.

3201. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ì‹ÆŠÂ‹«•]‰¿‚Ì‹ï‘Ì“Ii‚ß•û|‘ª’è‹L˜^‚̃‚ƒfƒ‹—lŽ®‚ÌŒ©•û‚̃|ƒCƒ“ƒg|C ‚“c™¦i‰qjC‘¼. •ÒW ‘S‘˜J“­‰q¶’c‘̘A‡‰ï•ÒC “ú–{ì‹ÆŠÂ‹«‘ª’苦‰ï_“ÞìŽx•”, ‰¡•l, 89.09.00”­s.

3202. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn iŽ·•Mj V¶‰»ŠwŽÀŒ±uÀ12C•ªŽq–ƉuŠw‡Ti–Ɖu×–ECƒTƒCƒgƒJƒCƒ“j; ‘æ1•” –Ɖu’S“–×–E‚Ì•ª—£CŒŸ’è–@C‘æ1Í ƒŠƒ“ƒp‹…’P—£–@C12:@9`24C ‹Ê“àGˆêi”÷j. •ÒW ‘å‘ò—˜ºi“Œ‘åjC‰œ‘ºNi‡‘åjC–î“cƒˆêi“ŒˆãŽ•‘åjC‰iˆäŽFi“Œ‘åj•ÒC “Œ‹ž‰»Šw“¯l, “Œ‹ž, 89.11.28”­s.

3203. m‚»‚Ì‘¼‚Ì’˜‘i‹Zp‘jn iŽ·•Mj õF–@‚Ì‚·‚ׂÄiŒŽŠ§Medical Technology•Êûj; PTAHõF, p.28`30; ƒVƒ…ƒ‚|ƒ‹”½‰ž¥’_`õF, p.50`53; ƒxƒ‹ƒŠƒ“ÂõF, p.98`99, ŽÂ“cGi“Œ•a‰@•a—j. ˆãŽ•–òo”Å, “Œ‹ž, 88.07.15”­s.

3204. mŽ‹’®Šo‹³Þn iŠÄCj iŽ·•Mj‚ƒJƒƒŠ|—A‰t‚Ì’²®|, “‡“cŽœ•FCΎ˳‰pC¬ìK—Yi–òÜ•”j. ŠÄC “‡“cŽœ•Fi–k—¢jŠÄCC ‹¦˜aŠé‰æ, 90.01.00”­s.

3205. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j –Ɖu‘gD‰»Šw”½‰ž‚É‚¨‚¯‚éƒ}ƒCƒNƒƒEƒF|ƒuÆŽË‚Ì•]‰¿. ŽR‰È³•½CŸ–”CCŠÖª‚ê‚¢Žqi‰ðj: ‘æ30‰ñ“ú–{‘gD×–E‰»Šw‰ï i89.10.23j, ‹ž“sC ´˜^WCp.7, 1989.

3206. mŠw‰ïn iˆê”Êu‰‰j •a—¶ŒŸ•W–{‚É‚¨‚¯‚鎉–bŠÌ‚ÌŒv‘ªŠw“IŒŸ“¢. Žs£‹I‘ã”üCˆÉ“¡—R”üŽqC“n•ÓiŽqi“Œ•a‰@•a—j: ‘æ35‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï (86.05.04), Šò•Œ, ‰q¶ŒŸ¸, 35(3): 572, 1986.

3207. mŠw‰ïn iˆê”Êu‰‰j ƒŠƒ“ƒ^ƒ“ƒOƒXƒeƒ“Ž_ƒwƒ}ƒgƒLƒVƒŠƒ“(PTAH)õF‚ÌŒŸ“¢iõF–@‚ÌŠm”F‹y‚Ñ‚»‚̉ü—Çj. ŽÂ“cGC‰¡‘ò³ŽuCŽR‰º˜a–çC“n•Óˆê]i“Œ•a‰@•a—jC’†‰p’ji•a—j: ‘æ36‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï (87.05.03), Ž­Ž™“‡, ‰q¶ŒŸ¸, 36(3): 477, 1987.

3208. mŠw‰ïn iˆê”Êu‰‰j •a—ŒŸ¸‚É‚¨‚¯‚鸓xŠÇ—‚ɂ‚¢‚Ä. ŽÂ“cGi“Œ•a‰@•a—j: ‘æ5‰ñŽ„—§ˆã‰È‘åŠw—Õ°ŒŸ¸‹ZŽt‰ïŠwpŒ¤C‰ï (88.02.28), “Œ‹ž, ´˜^W, p.33, 1988.

3209. mŠw‰ïn iˆê”Êu‰‰j ˆÝ‰©FŽî‚ÌŠeŽíõF‚É‚æ‚é•a—Šw“IŒŸ“¢. ‰¡‘ò³ŽuCŽÂ“cGCŽR‰º˜a–çC“n•Óˆê]i“Œ•a‰@•a—jC’†‰p’ji•a—j: ‘æ37‰ñ_“Þ쌧—Õ°‰q¶ŒŸ¸Šw‰ï (88.04.17), •½’Ë, _“Þ쌧—Õ°‰q¶ŒŸ¸‹ZŽt‰ïŽGŽ, 23(2): 44, 1988.

3210. mŠw‰ïn iˆê”Êu‰‰j ‘å’°ƒƒ‰ƒm|ƒVƒX‚É‚¨‚¯‚é•a—‘gDŠw“IŒŸ“¢. ŽR‰º˜a–çCŽÂ“cGC‰¡‘ò³ŽuC“n•Óˆê]i“Œ•a‰@•a—jC’†‰p’ji•a—j: ‘æ37‰ñ_“Þ쌧—Õ°‰q¶ŒŸ¸Šw‰ï (88.04.17), •½’Ë, _“Þ쌧—Õ°‰q¶ŒŸ¸‹ZŽt‰ïŽGŽ, 23(2): 46, 1988.

3211. mŠw‰ïn iˆê”Êu‰‰j ’_”XƒRƒŒƒXƒeƒ|ƒVƒX‚Ì•a—‘gDŠw“IŒŸ“¢. “n•Óˆê]CŽÂ“cGCŽR‰º˜a–çC‰¡‘ò³Žui“Œ•a‰@•a—jC’†‰p’ji•a—j: ‘æ37‰ñ_“Þ쌧—Õ°‰q¶ŒŸ¸Šw‰ï (88.04.17), •½’Ë, _“Þ쌧—Õ°‰q¶ŒŸ¸‹ZŽt‰ïŽGŽ, 23(2): 45, 1988.

3212. mŠw‰ïn iˆê”Êu‰‰j ’¼’°ƒJƒ‹ƒ`ƒmƒCƒh‚ɑ΂·‚é–Ɖu‘gDŠw“IŒŸ“¢. “n•ÓiŽqCŽÂ“cGCŽs£´”üi“Œ•a‰@•a—jC’†‰p’ji•a—j: ‘æ37‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï (88.07.16), _ŒË, ‰q¶ŒŸ¸, 37(5): 666, 1988.

3213. mŠw‰ïn iˆê”Êu‰‰j «õF‘̈Ùí‚𔺂Á‚½–³S‘Ì‚Ì‚P—á. –î•”“TŽqi—Õ•a—j: “ú–{õF‘ÌŒŸ¸Šw‰ï (88.11.00), “Œ‹ž.

3214. mŠw‰ïn iˆê”Êu‰‰j ŒoŒû’°ŠÇôò‰t‚̈À’è«‹y‚Ñ׋ۉ˜õ‚ÉŠÖ‚·‚錟“¢. ¬ìK—YC‘¾“c‹v”üŽqC“‡“cŽœ•Fi–òÜ•”jCŸ–””º‰hi“àjC”äŠé”\Ž÷iŠOj: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.05), –¼ŒÃ‰®.

3215. mŠw‰ïn iˆê”Êu‰‰j ü—Ê•W€‘ª’è–@‚̃h[ƒYƒvƒƒbƒeƒBƒ“ƒOƒVƒXƒeƒ€‚ւ̉ž—p(1). Šâ”g–ÎC‚Œ´êŽCã‘O•ôŽqC–kŽR‹v”üC’†‘º‹`‘¥i•újC‹g’J³•vi“Œ—mƒƒfƒBƒbƒNj: “ú–{ˆãŠw•úŽËüŠw‰ï‘æ57‰ñ•¨—•”‰ï‘å‰ï (89.04.07), _ŒËC “ú–{ˆãŠw•úŽËüŠw‰ïŽC49(7): 952, l989.

3216. mŠw‰ïn iˆê”Êu‰‰j ‘@ˆÛóƒGƒAƒƒ]ƒ‹ƒ‚ƒjƒ^|(FAM-1)‚É‚æ‚éƒAƒXƒxƒXƒg‚Ì‘ª’è‚ɂ‚¢‚Äi‘æ2•ñj. ¬¼iliƒwƒ‹ƒXjC‚“c™¦i‰qj: ‘æ62‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (89.04.28), ÂXC Šw‰ïu‰‰—vŽ|WCp.707, 1989.

3217. mŠw‰ïn iˆê”Êu‰‰j ŒÜŽˆ‘I‘ðŽ®Œê‰¹–¾—Ä“xŒŸ¸—pŒê•\‚ÌŒ¤‹†. ’|“à‹`•viŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‘‰ï (89.05.11), ‘åãC “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñC92(10): 1545, 1989.

3218. mŠw‰ïn iˆê”Êu‰‰j f—ÃŽx‰‡ƒVƒXƒeƒ€‚Æ‚µ‚Ä‚Ì“dŽqƒJƒ‹ƒe‚ÌŽŽ‚Ý. ’|“ດŽC”’‘é‘’jC’ß“c—z˜aC’r“cŒ›ºC‹{Œ´‰p•viˆã—pî•ñjC²“¡“oŽu˜Yi¶—jC“‡Œû’å•viŠÅŒìŠw•”jC¼“cÝŒ«iƒAƒLƒ‰ƒbƒNƒXj: ‘æ28‰ñ“ú–{MEŠw‰ï‘å‰ï (89.05.23), ‘åãC ˆã—p“dŽq‚ƶ‘ÌHŠwC27(“Á•Ê): 120, 1989.

3219. mŠw‰ïn iˆê”Êu‰‰j ˆöŽq•ªÍ‚Ì”]ŒŒŠÇáŠQŠ³ŽÒ‚Ì”]ŒŒ—¬ŠÏŽ@‚ւ̉ž—p. ’†‘òŒ\Ž¡CΈ䟌Èi•új: ‘æ28‰ñ“ú–{MEŠw‰ï (89.05.23), ‘åãC ˆã—p“dŽq‚ƶ‘ÌHŠwC27(“Á•Ê): 76, l989.

3220. mŠw‰ïn iˆê”Êu‰‰j HPLC–@‚É‚æ‚é”A’†ƒvƒeƒŠƒWƒ“—U“±‘Ì‚Ì•ªÍ‚Æ‚»‚Ì—Õ°“IˆÓ‹`. “àŽRKMC‚èŒõ‹IC“n•Ó—Ç•FC‘å’J‰pŽ÷i—Õ•a—j: ‘æ41‰ñ“ú–{ƒrƒ^ƒ~ƒ“Šw‰ï‘å‰ï (89.06.09), ŽD–yC ƒrƒ^ƒ~ƒ“, 63(4): 204, 1989.

3221. mŠw‰ïn iˆê”Êu‰‰j Quantitative CT of Distal Femur and Radial Photon Absorptiometry in the Assessment of Renal Osteodystrophy. ÷ˆä´Žqi•újCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjCŠâ”g–Îi•újC“à“c‹v‘¥i“Œ‘åˆã‰ÈŒ¤jC¼—Ñ—²i•új: 17th International Congress of Radiology (89.07.06), Paris.

3222. mŠw‰ïn iˆê”Êu‰‰j ‰^“®•‰‰×ƒeƒXƒg‚É‚¨‚¯‚éƒpƒ‹ƒXƒIƒLƒVƒ|ƒ^|‚Ì—L—p«‚ɂ‚¢‚Ä. “n•Ó“oC’†“ˆ‰p•FCŽl‘q³”ŽC–¥‰YŽ‘¥C”~Œ´ŽÀC–åˆäL‹ÅiŽ™jC‚ŠÝŒ›“ñi®ŠOŽ™j: ‘æ86‰ñ–{‘̗͈ãŠw‰ïŠÖ“Œ’n•û‰ï (89.07.08), ’}”gC ‘̗͉Ȋw, 38(5): 215, 1989.

3223. mŠw‰ïn iˆê”Êu‰‰j ˆöŽq•ªÍ‚Ì”xŒŒ—¬“®‘ÔŠÏŽ@‚ւ̉ž—p. ’†‘òŒ\Ž¡CΈ䟌ÈC¼—Ñ—²i•új: ‘æ8‰ñˆã—p‰æ‘œHŠwƒVƒ“ƒ|ƒWƒEƒ€ (89.07.21), ‘åã, Medical Imaging Technology, 7(2): 209`210, 1989.

3224. mŠw‰ïn iˆê”Êu‰‰j Difference of BC Threshold Torce Levels Between Direct and Equivalent Measurements. ’|“à‹`•viŽ¨•@j: 14th World Congres of Otorhinolaryngology Head and Neck Surgery (89.09.15), Madrid, 14th World Congres of Otorhinolaryngology Head and Neck Surgery, Abstracts, p.162.

3225. mŠw‰ïn iˆê”Êu‰‰j ‚Š´“x–Ɖu“¯’è–@‚ð—p‚¢‚½”÷—ÊM’`”’‚Ì“¯’è|“Á‚É‘½•ô«M’`”’ŒŒÇ‚ɂ‚¢‚Ä. ät“n’‰’jC‘å’J‰pŽ÷i—Õ•a—j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 173, 1989.

3226. mŠw‰ïn iˆê”Êu‰‰j ‰»Šw”­Œõ‚ð—p‚¢‚½DNAƒvƒ|ƒuƒAƒbƒZƒC‚ÌŒŸ“¢. “c‘ò—TŒõiƒuƒŠƒXƒgƒ‹jCät“n’‰’jC‘å’J‰pŽ÷i—Õ•a—j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 318, 1989.

3227. mŠw‰ïn iˆê”Êu‰‰j ƒEƒ~ƒzƒ^ƒ‹¥ƒ‹ƒVƒtƒFƒŠƒ“—U“±‘Ì‚ð—p‚¢‚½‰»Šw”­Œõ–@‚É‚æ‚éD’†‹…ƒX|ƒp|ƒIƒLƒTƒCƒh‘ª’è–@‚ÌŒŸ“¢. ¼“c—zCät“n’‰’jC‘å’J‰pŽ÷i—Õ•a—j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 335, 1989.

3228. mŠw‰ïn iˆê”Êu‰‰j ƒ‚ƒmƒNƒ|ƒiƒ‹R‘Ì‚É‚æ‚éSalnomella Typhimurium‚ÌRŒ´Œ^•Ê. ¼è‹MŽqC’r˜eM’¼CŽR‰Y¸iŠÅŒìŠw•”jC‘å‘òLFCHŽR•‹vi”÷jC‘¼: ‘æ62‰ñ“ú–{׋ۊw‰ïŠÖ“ŒŽx•”‘‰ï (89.10.13), …ã.

3229. mŠw‰ïn iˆê”Êu‰‰j 123I-IMP SPECT‚̉摜•]‰¿‚ƓljeŠŒ©i”]ŒŒŠÇáŠQ‚ɑ΂·‚é123I-IMP SPECT‚Ì—Õ°“I—LŒø“x•]‰¿‚ÉŠÖ‚·‚鋤“¯Œ¤‹†j. –ª“‡‘iç—t‘åjC‘¼8Ž{ÝCΈ䟌Èi•új: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (89.10.19`21), ‘å’Ã, ŠjˆãŠw, 26(8): 1026, 1989.

3230. mŠw‰ïn iˆê”Êu‰‰j ƒh[ƒYƒvƒƒbƒ^[‚Ì•W€‘ª’è–@‰»ƒvƒƒOƒ‰ƒ€. Šâ”g–ÎC¼—Ñ—²C‚Œ´êŽCã‘O•ôŽqi•újC‹g’J³•vi“Œ—mƒƒfƒBƒbƒNj: ‘æ2‰ñ“ú–{•úŽËüŽîᇊw‰ïŠwp‘å‰ï (89.11.07), _ŒË, “ú–{•úŽËüŽîᇊw‰ïŽ, 1(Suppl. 3): 52, 1989.

3231. mŠw‰ïn iˆê”Êu‰‰j ”Z“x•ÏŠ·ŒW”‚ð—p‚¢‚½ŒŸ’mŠÇ–@‚Ì—LŒø‚ÈŠˆ—p•û–@. –÷“c\ŽiC‘åX‹`•¶C¬¼iliƒwƒ‹ƒXjCŠâè’õC¬¼—²C‹{–{˜a•qC‚“c™¦i‰qj: “ú–{˜J“­‰q¶HŠw‰ï (89.11.17), “Œ‹ž, Šw‰ï—\eW, p.51`52, 1989.

3232. mŠw‰ïn iˆê”Êu‰‰j ƒpƒbƒVƒuƒTƒ“ƒvƒ‰|‚É‚æ‚éì‹ÆŠÂ‹«‘ª’è‚̉”\«‚ɂ‚¢‚Ä. —é–Ø”ü’q‘ãC¬¼iliƒwƒ‹ƒXjC‰|–{•Û“TCù¶–«C‹{–{˜a•qC‚“c™¦i‰qj: “ú–{˜J“­‰q¶HŠw‰ï (89.11.17), “Œ‹ž, Šw‰ï—\eW, p.53`54, 1989.

3233. mŠw‰ïn iˆê”Êu‰‰j ƒ‚ƒmƒNƒ|ƒiƒ‹R‘Ì‚Ì—Õ°ŒŸ¸‚ւ̉ž—p;–Ɖu‘gDŠw“I•û–@‚ւ̉ž—p. ŽÂ“cGi“Œ•a‰@•a—j: ‘æ7‰ñŽ„—§ˆã‰È‘åŠw—Õ°ŒŸ¸‹ZŽt‰ïŠwpŒ¤C‰ï (89.11.26), “Œ‹ž, ´˜^W, p.10`11, 1989.

3234. mŠw‰ïn iˆê”Êu‰‰j “dŽqŽ–“TƒVƒXƒeƒ€‚Ì‹@”\Šg’£|“®‰æ‘œ‚̎戵‚Æ‚»‚̉ž—p. “‡Œû’å•viŠÅŒìŠw•”jC’|“ດŽC’r“cŒ›ºC’ß“c—z˜aC‹{Œ´‰p•viˆã—pî•ñjCÎìrLi“dŽqŒvŽZ‹@ƒZƒ“ƒ^|jC²“¡—ºiƒAƒLƒ‰ƒbƒNƒXj: ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï (90.02.02), “Œ‹ž, ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï˜_•¶W, p.599`602, 1990.

3235. mŠw‰ïn iˆê”Êu‰‰j “dŽqƒJƒ‹ƒeƒVƒXƒeƒ€‚ÌŠJ”­. ’|“ດŽC’r“cŒ›ºC‹{Œ´‰p•viˆã—pî•ñjC²“¡“oŽu˜Yi¶—jC²“¡—ºiƒAƒLƒ‰ƒbƒNƒXj: ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï (90.02.03), “Œ‹ž, ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï˜_•¶W, p.865`868, 1990.

3236. mŠw‰ïn iˆê”Êu‰‰j ”]ŒŒŠÇáŠQ‚ɑ΂·‚é123I-IMP‚É‚æ‚éSPECT‚Ì—Õ°“I—LŒø“x•]‰¿‚ÉŠÖ‚·‚鋤“¯Œ¤‹†|BVC(bias to variance characteristic)‰ðÍ‚É‚æ‚éf’f‚̂΂ç‚‚«‚Ì•]‰¿. ¼–{“OC”ÑÀ•i•úˆãŒ¤jC‘¼CΈ䟌Èi•új: ‘æ32‰ñ“ú–{ŠjˆãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (90.03.10), “Œ‹ž.

3237. mŠw‰ïn iˆê”Êu‰‰j ‹¤Å“_ƒŒ|ƒU|Œ°”÷‹¾‚É‚æ‚é‘Á‰tü×–E‚ÌŠJŒû•ª”å‰ß’ö‚ÌŠÏŽ@. £ì²‹vi‰ðj: ‘æ54‰ñŒûo•aŠw‰ïŠwp‘å‰ï i89.00.00j, “Œ‹ž.

3238. mŠw‰ïn iˆê”Êu‰‰j Ý‘î—×{‚Ì‚½‚ß‚Ì‹CŠÇ‹zˆøƒJƒe[ƒeƒ‹ŠÈˆÕÁ“Å•Û‘¶—eŠí‚ÌŽŽì‚Æ‚»‚̉ž—p. דc–«i“àjC“n•Ó•qi–ƒjC‰Z¶LˆêiMEƒZƒ“ƒ^[j: ‘æ64‰ñ“ú–{ˆã‰ÈŠíŠBŠw‰ï‘å‰ï i89.05.28), ‘åã.

3239. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ž¡—×p“dŽqü‚É‚æ‚è…’†‚ɶ‚¶‚銈«Ž_‘f‚ÌŽû—Ê. Šâ”g–Îi•új: ‘æ5‰ñŽ_‘f—R—ˆƒ‰ƒWƒJƒ‹Œ¤‹†‰ï (89.05.17), ‘Š–ÍŒ´.

3240. mŒ¤‹†‰ïn iˆê”Êu‰‰j “ú–{‘gD”|—{Šw‰ï‚ðŽåµ‚Ä. ‘ –{”ŽsiŽY•wj: ‘Š–ÍŒ´ŽsŽY‰È•wl‰Èˆã‰ï7ŒŽ“x’è—áŠwp•”‰ï (89.07.12), ‘Š–ÍŒ´.

3241. mŒ¤‹†‰ïn iˆê”Êu‰‰j QCT‚É‚æ‚阒Œő̊C–ÈŽ¿‚Ìœ‰–—Ê. ÷ˆä´ŽqC¼—Ñ—²i•újC—L•xŠ°i®ŠOjC—§•½eli•új: ‘æ11‰ñ_“ÞìCa¥œ‘ãŽÓŒ¤‹†‰ï (90.01.13), ‰¡•l.

3242. mŠw‰ï‰ï“ªn “ú–{‘gD”|—{Šw‰ï‘æ62‰ñ‘å‰ï, ‘ –{”ŽsiŽY•wj:


<<311 ‚»‚Ì‘¼>>

3243. mŒ´’˜n ”Ä—pŒo’°‰h—{Ü‚Ì•¨«‚ÌŒŸ“¢|‘æ2•ñ|. ¬ìK—YC“‡“cŽœ•Fi–òÜ•”jC’|“à”üŒbŽqiŠÅŒì•”jC–ìŒû‹…Žqi‰h—{•”jCŸ–””º‰hi“àjC”äŠé”\Ž÷iŠOj: JJPEN, 11(7): 886`892, 1989.

3244. mŒ´’˜n Gastric Mucus Secretion in Portal Hypertension. ‹TŽRmˆêiŽRŒ`‘åjC‘¼C¼ŽRŒ›Žqi¶‰»ŒnjCÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»j: Journal of Gastroenterology and Hepatology, 4(Suppl. 1): 126`128, 1989.

3245. mŒ´’˜n Development and Evaluation of a Radiological Reporting System for Use with a Personal Computer. ‘º“cWˆê˜YC‘–쳈êCˆä“›—¤CHigushi, N.C‘ºŽROi•új: Medical Informatics, 14(1): 71`83, 1989.

3246. mŒ´’˜n Functional Difference in Monoamine Transmitters in the Behaviorally Abnormal Mouse Mutant (Wriggle Mouse Sagami). Koichi IshikawaCShinji ShibanokiCTaizo KuboCMiki KogureCYoshiko Imamurai“ú‘åjC‘å‘òLFi”÷jCMichio Ohmurai‘呺ŽÀ“®Œ¤jCKatsuhiko Mikoshibai‘åã‘åj: Neuroscience Letters, 103: 343`348, 1989.

3247. mŒ´’˜n Observation of Quantum Beats in Autoionizing Electron Spectra Created by Slow Na+ -Ne Collisions. A. DanjoiVŠƒ‘åjC¬’r•¶”Ži•¨—j: Phys. Rev. Lett., 62(7): 741`743, 1989.

3248. mŒ´’˜n •a‰@•a—•”‚Ì“úí‹Æ–±‚É‚¨‚¯‚éƒRƒ“ƒsƒ†|ƒ^|“±“ü‚ÆŠˆ—p‚ɂ‚¢‚Ä. ˆÉ“¡—R”üŽqC“cŠ‰xŽqCŽs£‹I‘ã”üC“n•ÓiŽqi“Œ•a‰@•a—jC’†‰p’ji•a—j: ‰q¶ŒŸ¸, 37(4): 408`414, 1988.

3249. mŒ´’˜n ‹z“ü—Ö@‚É‚¨‚¯‚郀ƒRƒ\ƒ‹ƒoƒ“‰t‚̈À’è«. ‹gŽR—F“ñi–òŠw•”jC‘º£¨’ÃŽqC’©’·•¶–íi–òÜ•”j: ŒÄ‹zC8(4): 422`425, 1989.

3250. mŒ´’˜n ’…FƒiƒCƒƒ“12‹…‚©‚ç‚Ìõ—¿—no‚Æ“ñŽ_‰»ƒ`ƒ^ƒ“‚ÌŒø‰Ê. –{“cG—²C²’|ˆÀ‹IŽqi“Œ‹ž—‰È‘åjC¼–ìVŽmi‰»jC¬Î^ƒi“Œ‹ž—‰È‘åj: Þ—¿‹Zp, 7(4): 136`142, 1989.

3251. mŒ´’˜n ƒRƒ“ƒsƒ…|ƒ^|ƒVƒ~ƒ…ƒŒ|ƒVƒ‡ƒ“‚É‚æ‚镲‘Ì‚Ì•\–ʉüŽ¿‰ß’ö‚̉ðÍ. –{“cG—²CŠ›‰º—S–çi“Œ‹ž—‰È‘åjC¼–ìVŽmi‰»jC¬Î^ƒi“Œ‹ž—‰È‘åj: Þ—¿‹Zp, 8(2): 54`60, 1990.

3252. mŒ´’˜n R‹ÛÜ™•ú«‘n”í•¢Þ‚Ì•]‰¿. ‹à‰h‹gC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 9(8): 676`686, 1989.

3253. mŒ´’˜n Biological dressing ‚Æ‚µ‚Ä‚Ì—r–Œi‘Ù¶j‚ÆŒ{—‘–Œi—‘¶j‚ɂ‚¢‚Ä. ‘O“c‰Ø˜YC’†–kMºC‘厜–í—T”ViŒ`ŠOj: “ú–{”MŠw‰ï‰ïŽ, 15(4): 234`239, 1989.

3254. mŒ´’˜n Ã’—p–ƉuƒOƒƒuƒŠƒ“»Ü’†‚ÌRHIVR‘Ì¥HIVRŒ´‚ÌŒŸ“¢. •ŽR­ˆêi–òÜ•”jC‚‹{t’ji—ÕŒŸjC‘º£¨’ÃŽqC’©’·•¶–íi–òÜ•”jC‘å’J‰pŽ÷i—Õ•a—j: •a‰@–òŠwC15(3): 167`174, 1989.

3255. mŒ´’˜n ‚‘¬‹C—¬’†ÕŒ‚–@‚É‚¨‚¯‚镲‘Ì•¨«‚ÌŒø‰Ê. –{“cG—²i“Œ‹ž—‰È‘åjC¼–ìVŽmi‰»jC¬Î^ƒi“Œ‹ž—‰È‘åj: •²‘ÌHŠw‰ïŽ, 26(9): 666`671, 1989.

3256. mŒ´’˜n Variational Patterns of Arm Folding in a Random Population of Japanese. ’r“c•qŽqi‰ðj: –k—¢ˆãŠw, 19(5): 477`482, 1989.

3257. mŒ´’˜n Mode of Hand Clasping in a Random Japanese Population. ’r“c•qŽqi‰ðj: –k—¢ˆãŠw, 19(6): 546`550, 1989.

3258. mŒ´’˜n Pattern of Hand-Clapping and its Relation to Handedness in a Random Population of Japanese. ’r“c•qŽqi‰ðj: –k—¢ˆãŠw, 20(1): 13`16, 1990.

3259. m’Z•ñn –k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@|f’fî•ñƒf[ƒ^ƒx[ƒX•a—ðŠÇ—‚ÌŒ»ó. ‘º“cWˆê˜Yi•új: Innervision, 5(4): 56`57, 1990.

3260. m’Z•ñn ƒŠƒUƒxƒ“ƒhƒ‰ƒCƒVƒƒbƒv‚Ì”z‡•Ï‰»ŽŽŒ±i‘æ1•ñj. –ؘHŒbC–쑺’mŽqC‘º£¨’ÃŽqC’©’·•¶–íi–òÜ•”jC‹gŽR—F“ñC“c’†¹‘ãi–òŠw•”j: Journal of Japanese Society of Hospital Pharmacists, 25(9): 1053`1064, 1989.

3261. m’Z•ñn ƒŠƒUƒxƒ“ƒhƒ‰ƒCƒVƒƒbƒv‚Ì”z‡•Ï‰»ŽŽŒ±i‘æ2•ñj. –ؘHŒbC–쑺’mŽqC‘º£¨’ÃŽqC’©’·•¶–íi–òÜ•”jC‹gŽR—F“ñC“c’†¹‘ãi–òŠw•”j: Journal of Japanese Society of Hospital Pharmacists, 25(10): 1213`1225, 1989.

3262. mŒ¤‹†•ñi•¶•”Èjn d“_—̈挤‹†(1) ‹¹œãœ‹Ø‚Í“Œ‹žŒê‚̉¹’²‚ÌŽÀŒ»‚É‚Ç‚¤‚©‚©‚í‚Á‚Ä‚¢‚é‚©. “‡“cƒˆêi¶—jCœA£”£i“Œ‘åj: “ú–{Œê‰¹º‚É‚¨‚¯‚é‰C—¥“I“Á’¥‚ÌŽÀ‘Ô‚Æ‚»‚Ì‹³ˆç‚ÉŠÖ‚·‚鑇“IŒ¤‹†C‘Š‡”ÇŒ¤‹†¬‰Ê’†ŠÔ•ñ‘1989¢“ú–{Œê‰¹º£Œ¤‹†•ñ, (1): 19`20, 1989.

3263. m‘àn Thrombospondin. “àŽRKMi—Õ•a—j: Laboratory and Clinical Practice, 6(1): 4`5, 1988.

3264. m‘àn V‚µ‚¢–òÜŽt‚Ì‹Æ–±‘ÌŒn;¡‚ð‹Æ–±‚Ì“]Š·Šú‚Æ”FŽ¯‚µŠ³ŽÒ‚Ì—˜‰v‚Ì‚½‚ß‚É. Ύ˳‰pi–òÜ•”j: ‚΂ñ‚Ô‚¤, (95): 110`112, 1989.

3265. m‘àn ¸__Œo‰È•a“‚Å‚Ì•ž–òŽw“±‚ðŠJŽn‚µ‚Ä. ’|“எqCΎ˳‰pC“‡“cŽœ•Fi–òÜ•”j: ƒNƒŠƒjƒJƒ‹ƒtƒ@|ƒ}ƒV|, 5(18): 10`24, 1989.

3266. m‘àn –k—¢‘åŠw“Œ•a‰@‚É‚¨‚¯‚鈕û쬎x‰‡ƒVƒXƒeƒ€. ‘Š‘ò­–¾C’†ŽR–LC“‡“cŽœ•Fi–òÜ•”j: ˆã—ÂƃRƒ“ƒsƒ…|ƒ^, 3(Suppl.1): 73`81, 1990.

3267. m‘àn CT, MRI ‚ð‘ÎÛ‚Æ‚µ‚½¬‹K–Í PACS ‚ÌŠJ”­‚Æ•]‰¿|•úŽËüf’fˆã‚©‚ç‚Ý‚½ PACS ‚ÌŒ»ó. ‘º“cWˆê˜YC›MˆêC’J“c—ˆê˜YC¼ŽR³ŒáC¼™É”ŽC’r“cr–¾C“cŠŽŒÈC÷ˆä´ŽqC’†‘òŒ\Ž¡CΈ䟌ÈC¼—Ñ—²i•új: ‰f‘œî•ñƒƒfƒBƒJƒ‹, 21(13): 617`621, 1989.

3268. m‘àn “Š–ò¥Žw“±‹L˜^쬂̎ÀÛ. –Ø‘º—˜”üi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 102`112, 1989.

3269. m‘àn ’ŽË–òŠÇ—‚ÌŽÀÛ. Œú“cKˆê˜YCΎ˳‰pi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 113`125, 1989.

3270. m‘àn •a“‚É‚¨‚¯‚éˆã–ò•iî•ñ’ñ‹Ÿ‚ÌŽÀÛ. –]ŒŽ^‹|i–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 126`131, 1989.

3271. m‘àn g100 “_‹Æ–±h‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²¸Œ‹‰Ê. ¬—Ñ‹P–¾C•ŽR­ˆêCŒú“cKˆê˜YC’¬“c[i–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 132`139, 1989.

3272. m‘àn g100 “_‹Æ–±h‚ɂ悹‚Ä[ˆãŽt, ŠÅŒì•w, Š³ŽÒ‚Ì—§ê‚©‚ç. ‹g‘º”Ž–Mi‹¹ŠOjC“Iê´˜ai“àjC‰ÔˆäŒbŽqiŠÅŒì•”jCÔ¼@¹: ŒŽŠ§–òŽ–, 31(8—Õ‘): 140`143, 1989.

3273. m‘àn ŋ߂̈ã—ʋ«‚ɂ‚¢‚Ä. ¬—Ñ‹P–¾i–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 14`17, 1989.

3274. m‘àn g100 “_‹Æ–±h‚Ì¡Œã‚̉ۑè‚Æ“W–]. “‡“cŽœ•Fi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 150`156, 1989.

3275. m‘àn TDM. ‘º£¨’ÃŽqi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 159`164, 1989.

3276. m‘àn “ÁŽê»Ü. –îŒã˜a•vi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 165`171, 1989.

3277. m‘àn ‰h—{ŠÇ—. ˆÉ“¡—msi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 172`179, 1989.

3278. m‘àn ŠO—ˆŠ³ŽÒ‚Ö‚Ì•ž–òŽw“±. ²ìŒ«ˆêi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 180`187, 1989.

3279. m‘àn Š³ŽÒ‚Ö‚ÌW’c‹³ˆç. •—ŠÔKŽOCΎ˳‰pi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 188`193, 1989.

3280. m‘àn ‚¢‚í‚ä‚ég100 “_‹Æ–±h‚Æ‚»‚̈Ӌ`. ¬—Ñ‹P–¾i–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 18`21, 1989.

3281. m‘àn ‹~–½‹~‹}ƒZƒ“ƒ^[‚Å‚Ì–òÜŽt‚Ì–ðŠ„. ‹ß“¡—¯”üŽqi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 194`200, 1989.

3282. m‘àn Ý‘îˆã—Â̌»‹µ‚Æ¡Œã. ¬ìK—Yi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 201`206, 1989.

3283. m‘àn ƒAƒƒŠƒJ—Õ°–òÜ‹Æ–±ƒCƒ“ƒTƒCƒhƒŒƒ|[ƒg. ‰Á‰ê’J”£i–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 207`211, 1989.

3284. m‘àn g100 “_‹Æ–±h‚Ì“±“ü‚É“–‚½‚Á‚Ä. ù–ì–œ—Žqi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 22`30, 1989.

3285. m‘àn g100 “_‹Æ–±hŽÀ‘H‹³ˆç‚ɂ‚¢‚Ä. ¬—Ñ‹P–¾i–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 31`34, 1989.

3286. m‘àn ˆã–ò•iî•ñŠˆ“®. •ŽR­ˆêi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 35`43, 1989.

3287. m‘àn uV‚½‚È•a‰@–òÜ‹Æ–±‚Ì“WŠJv‚Ì”­s‚ÉÛ‚µ‚Ä. ’©’·•¶–íi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 3`13, 1989.

3288. m‘àn •a“‚É‚¨‚¯‚éˆãŽt, ŠÅŒì•w‚Ì‹Æ–±‚Æ—¬‚ê. ¬—Ñ‹P–¾i–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 44`47, 1989.

3289. m‘àn ƒJƒ‹ƒe, ŒŸ¸’l‚ÌŒ©•û. ‹gŽR—F“ñi–òŠw•”jC“c’†¹‘ãi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 48`61, 1989.

3290. m‘àn •ž–òŽw“±‚ÌŠî–{. ¬—Ñ‹P–¾i–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 65`67, 1989.

3291. m‘àn –òÜ‹Æ–±‚ƃRƒ“ƒsƒ…[ƒ^. aŒûš Oi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 68`76, 1989.

3292. m‘àn Š³ŽÒî•ñ‚ÌŽûW. Ύ˳‰pi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 79`83, 1989.

3293. m‘àn •ž–òŽw“±‚ÌŽÀÛ(1)|–k—¢‘åŠw•a‰@‚Ìê‡. ²ìŒ«ˆêCù–ì–œ—ŽqC–Ø‘º—˜”üC‹´–{²ŽqC‹{“c—æŽqC‰ªè”ü‘ãŽqC–{‹´–ÎCž³‘ò—R”üi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 84`96, 1989.

3294. m‘àn •ž–òŽw“±‚ÌŽÀÛ(2)|–k—¢‘åŠw“Œ•a‰@‚Ìê‡. ’|“எqCΎ˳‰pC’†ŽR–LC‘¾“c‹v”üŽqC‘哇”ü˜aŽqC•½ŽR•Žii–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 97`101, 1989.

3295. m‘àn •a‰@–ò‹Ç‚ÆGCP; Ž¡Œ±R¸ˆÏˆõ‰ï‚ÌŒ»ó‚ð’†S‚É. ’©’·•¶–íC•ŽR­ˆêi–òÜ•”j: ŒŽŠ§–òŽ–, 32(2): 257`262, 1990.

3296. m‘àn ƒp|ƒLƒ“ƒ\ƒ“•aŠ³ŽÒ‚Ì•ž–ò’²¸‚Æ•ž–òŽw“±. ’†žŒ[ˆêCΎ˳‰pC“‡“cŽœ•Fi–òÜ•”jCŒÃ˜a‹vKi“àj: ŒŽŠ§–òŽ–C31(7): 1427`1431, 1989.

3297. m‘àn •a“Šˆ“®“WŠJ‚Ö‚ÌŒoˆÜ. Ύ˳‰pi–òÜ•”j: ç—tŒ§•a–ò‰ï•ñ, (87): 8`14, 1989.

3298. m‘àn ƒŠƒ“Ž_ƒJƒ‹ƒVƒEƒ€‚̶‘Ì’†‚É‚¨‚¯‚錋»¬’·. ¼–ìVŽmi‰»jCì–ìM”Vi”]ŠOjC‹{‘òŽµ˜Yi“dŒ°ƒZƒ“ƒ^|jC¬Î^ƒi“Œ‹ž—‰È‘åjC–î“cŒ«ŽOi”]ŠOj: “ú–{Œ‹»¬’·Šw‰ïŽ, 16(1): 91`97, 1989.

3299. m‘àn ‰@“à‚É‚¨‚¯‚é•›ì—pŽûW‘̧‚ÌŠm—§|–k—¢‘åŠw•a‰@•›ì—pŒŸ“¢ˆÏˆõ‰ï‚ÌÝ—§‚Æ‚»‚ÌŠˆ“®ó‹µ|. •ŽR­ˆêC¬—Ñ‹P–¾i–òÜ•”jC“¿‘Œú“ñiŽ¨•@jC²“¡Šìˆê˜Yi¸j: “ú–{•a‰@‰ïŽGŽ, 36(10): 1657`1661, 1989.

3300. m‘àn •ªŽq‚Ì’´—ã‹Nó‘Ô;‚»‚Ì“®“I‰ß’ö‚Æ—ÊŽqŒ‡‘¹—˜_. ’†‘ºGŽ÷i•ªŽqŒ¤jC‚–ØGˆêi•¨—j: “ú–{•¨—Šw‰ïŽ, 45(2): 87`93, 1990.

3301. m‘àn L”͈͌Œ‰t¥”A‰»ŠwŒŸ¸¥–ƉuŠw“IŒŸ¸|‚»‚Ì”’l‚ð‚Ç‚¤“Ç‚Þ‚©|i‰ºŠªj‡Y.Tumor Marker, 13.ƒlƒIƒvƒeƒŠƒ“. “àŽRKMi—Õ•a—j: “ú–{—Õ°C(601): 937`941, 1990.

3302. m‘àn ¡Œã‚Ì–òÜ‹Æ–±|iŠe˜_j’ŽË–ò¬‡‹Æ–±‚ÌŽæ‚è‘g‚Ý•û|. “‡“cŽœ•Fi–òÜ•”j: –òŽ–V•ñ, (1534): 427`431, 1989.

3303. m‘àn Ý‘îˆã—ÂƖòÜŽt. ¬ìK—Yi–òÜ•”j: –òŽ–V•ñ, (1580): 5`6, 1990.

3304. muÀn ˆã—×pˆã–ò•i‚̃o|ƒR|ƒh•\Ž¦‚Ì„i‚ɂ‚¢‚Ä|“ú–{•a‰@–òÜŽt‰ïŠOˆÏˆõ‰ï‚ÌŠˆ“®•ñ‚æ‚è|. ’©’·•¶–íC•ŽR­ˆêi–òÜ•”jC‘¼ÂŠOˆÏˆõ‰ïˆÏˆõ8–¼: Journal of Japanese Society of Hospital Pharmacists, 26(1): 108`112, 1990.

3305. muÀn ŒŒ´’`”’. ‘å’J‰pŽ÷i—Õ•a—j: MedicinaC26(‘10): 1850`1851, 1989.

3306. muÀn “d‹C‰j“®. ‘å’J‰pŽ÷i—Õ•a—j: MedicinaC26(‘10): 1852`1854, 1989.

3307. muÀn ƒ`[ƒ€ˆã—Ã. ’†“‡ß•vi¸j: ˆãŠw‚Ì‚ ‚ä‚Ý, 158(1): 74, 1989.

3308. muÀn ”\“®“I‚Ȉã–ò•iî•ñ‚Ì’ñ‹Ÿ. •ŽR­ˆêC–]ŒŽ^‹|C‘º£¨’ÃŽqC’©’·•¶–íi–òÜ•”j: ˆã–òƒWƒƒ|ƒiƒ‹, 25(10): 2317`2322, 1989.

3309. muÀn •ž–òŽw“±‚ÌŽÀÛ(4j _Œo“à‰È•a“. ‘¾“c‹v”üŽqCΎ˳‰pC’|“எqC“‡“cŽœ•Fi–òÜ•”j: ŒŽŠ§–òŽ–, 32(1): 159`161, 1990.

3310. muÀn •ž–òŽw“±‚ÌŽÀÛ(5j ®Œ`ŠO‰È•a“. ‘哇”ü˜aŽqCΎ˳‰pC’†ŽR–LC’|“எqC“‡“cŽœ•Fi–òÜ•”j: ŒŽŠ§–òŽ–, 32(2): 377`379, 1990.

3311. muÀn ˆã–ò•iî•ñ‚É‚¨‚¯‚é“dŽqŒvŽZ‹@‚̉ž—p. •ŽR­ˆêC’©’·•¶–íi–òÜ•”jC’ß“c—z˜aiˆã—pî•ñjC•Ÿ–{^—Žqi–òŠw•”jC’|“ດŽiˆã—pî•ñjC²“¡“oŽu˜Yi¶—j: ŒŽŠ§–òŽ–, 32(3): 581`589, 1990.

3312. muÀn –ò‚Ì•›ì—p‚Ì“¯’è. ’©’·•¶–íC•ŽR­ˆêi–òÜ•”j: “à‰È, 64(4): 608`612, 1989.

3313. mŠwp‘n iŽ·•Mj ŒŸ¸ŠÇ—‘˜_/—Õ°ŒŸ¸‘˜_; ÌŒŒ–@Cp.85`104C “àŽRKMi—Õ•a—jC‘O“c’‰Li—ÕŒŸj. •ÒW ˆÉ“¡‹@ˆêi“ŒŠC‘åjCŒÜ–¡–M‰piº˜a‘åj•ÒC u’kŽÐ, “Œ‹ž, 89.03.20”­s.

3314. mŠwp‘n iŽ·•Mj ’´”÷—±ŽqŠJ”­‰ž—pƒnƒ“ƒhƒuƒbƒN; “dŽqŒ°”÷‹¾‚É‚æ‚é’´”÷—±Žq‚ÌŠÏŽ@Cp.186`195C ¼–ìVŽmi‰»j. •ÒW ¬Î^ƒi“Œ‹ž—‰È‘åj•ÒC ƒTƒCƒGƒ“ƒXƒtƒH|ƒ‰ƒ€, “Œ‹ž, 89.04.05”­s.

3315. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj ƒTƒNƒZƒXˆãŽt‘‰ÆŽŽŒ±—Õ°ŽÀ’n–â‘èW; ‘–쳈êi•új. •ÒW ²“¡“oŽu˜Yi–k—¢‘åj•Ò, “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 89.11.15 ”­s.

3316. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn iŽ·•Mj ˆãŠw‘厫“Ti‘æ17”Åj; AZANõFC‘¼–ñ30€–Ú, ‰œ•½‰ë•Fi•a—j. “ìŽR“°, “Œ‹ž, 90.02.01”­s.

3317. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn iŽ·•Mj ”÷¶•¨ŠwŽ«“T; ’`”’Ž¿C’`”’Ž¿‡¬Cy‘f“™38€–ÚC —é–Øt’ji¶•¨•¨—‰»j. •ÒW “ú–{”÷¶•¨Šw‹¦‰ï•ÒC ‹Z•ñ“°o”Å, “Œ‹ž, 89.08.23”­s.

3318. m‚»‚Ì‘¼n iŽ·•Mj ƒTƒNƒZƒXˆãŽt‘‰ÆŽŽŒ±—Õ°ŽÀ’n–â‘èW; •x‰i½ˆêi‹¹ŠOj. •ÒW ²“¡“oŽu˜Yi–k—¢‘åj•ÒC “ú–{ˆãŽ–V•ñŽÐ,@“Œ‹žC89.11.15”­s.

3319. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Radiology Information and Digital Image Management Systems; Data Base Construction and Clinical Applications. ‘–쳈êi•új: 1st Nordic-Japan IMAC Symposium (89.03.29), “Œ‹ž.

3320. mŠw‰ïn iƒpƒlƒ‹j IBD (Inflammatory Bowel Disease)Š³ŽÒ‚É‚¨‚¯‚éƒvƒŒƒhƒjƒ]ƒƒ“ŒŒ’†“®‘Ô‚ÌŒŸ“¢. ‰¡“cœÄˆêC’|“எqCM‰ª”ü»ŽqCΎ˳‰pC“‡“cŽœ•Fi–òÜ•”jCŽR–{‰À³CŸ–””º‰hi“àjCÎì~C‚‹´r‹BiŠOj: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.05), –¼ŒÃ‰®.

3321. mŠw‰ïn iƒpƒlƒ‹j R‹ÛÜ™•ú«ƒ|ƒŠƒƒCƒVƒ“‘n”í•¢Þ‚Ì•]‰¿. ‹à‰h‹gCŒÃŽR“o—²C²“¡Žj˜YC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ32‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï (89.04.21), ‰YˆÀ, “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 9: 310, 1989.

3322. mŠw‰ïn iƒpƒlƒ‹j Intestinal Movement Video-Solor Battery-Microcomputerized. ‘ëàV’¼’èi¶—jC‰Á“¡NsiŠOjC‘åŠÑMi¶—j: 31st International Congress of Physiological Sciences (89.07.14), Helsinki, FinlandC Proceedings of the International Union of Physiological Sciences, (17): 502`503, 1989.

3323. mŠw‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj –Ɖu‘gD‰»ŠwõF‚ɂ‚¢‚Ä‚ÌŽÀ‘Ô’²¸¥WŒvŒ‹‰Ê•ñ. ŽÂ“cGi“Œ•a‰@•a—j: ‘æ35‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï (86.05.03), Šò•Œ, ‰q¶ŒŸ¸, 35(7): 998`1009, 1989.

3324. mŠw‰ïn iˆê”Êu‰‰j Independent Double Reading System; Application of Digital Image Management Data Base. ‘–쳈êCˆä“›–rC¼–{—æŽqC‹àˆä’Ë•¶–¾C¬—ѬŽiC‰““¡‚i•új: 75th Scientific Meeting of Radiological Society of North America”­•\”NŒŽ“ú(89.11.26), Chicago, Radiology, 173(Suppl.): 473, 1989.

3325. mŠw‰ïn iˆê”Êu‰‰j •¡”ƒI|ƒgƒoƒCŽ–ŒÌŽ€‚Ì–UŒŸ—á‚©‚ç‚Ý‚½ƒI|ƒgƒoƒC‘–s‚ÉŠÖ‚·‚éˆÀ‘S«. àVŒû²Žqi“Œ—ˆã‘åjC‘D”ö’‰FC™]G–¾i–@ˆãjCŽR‰ºƒPƒTŽqi“Œ—ˆã‘åj: “ú–{Œð’ʉȊw‹¦‹c‰ï‘‰ï “Œ‹ž, Œð’ʉȊwŒ¤‹†Ž‘—¿C‘æ30W: 104`107, 1989.

3326. mŠw‰ïn iˆê”Êu‰‰j •a‰@•a—•”‚Ì“úí‹Æ–±‚É‚¨‚¯‚éƒRƒ“ƒsƒ…|ƒ^|“±“ü‚ÆŠˆ—p‚ɂ‚¢‚Ä. ˆÉ“¡—R”üŽqC“cŠ‰xŽqCŽs£‹I‘ã”üC“n•ÓiŽqi•a‰@•a—jC’†‰p’ji•a—j: ‘æ36‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï (87.05.03), Ž­Ž™“‡, ‰q¶ŒŸ¸, 36(3): 514, 1987.

3327. mŠw‰ïn iˆê”Êu‰‰j ‘æ“ñ¬ˆÏˆõ‰ï uŠ³ŽÒ‚ւ̈ã–ò•iî•ñ’ñ‹ŸŽž‚ÌŽwjì¬v. ’©’·•¶–íi–òÜ•”jC_‘ãºCrì³–¤C‹ß“¡—R—˜ŽqC‘º“c³OC›–ì—FŽqC“¡ˆärŽuC“ì“cˆÀ‹Ii•a‰@–ò‹Ç‹¦‹c‰ïjC¬—Ñ‹P–¾i–òÜ•”jC–x”ü’qŽqCH“¡‹` –[CŽR–{M•vi•a‰@–ò‹Ç‹¦‹c‰ïj: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.04), –¼ŒÃ‰®C u‰‰—vŽ|W11Cp.2, 1989.

3328. mŠw‰ïn iˆê”Êu‰‰j ‰@“à‚É‚¨‚¯‚éˆã–ò•i•›ì—pî•ñŽûW‘̧‚ÌŠm—§. •ŽR­ˆêC‘ºãˆèŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC“¿‘Œú“ñiŽ¨•@jC²“¡Šìˆê˜Yi¸j: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.04), –¼ŒÃ‰®C “ú–{•a‰@‰ïŽGŽ, 36(10): 1657`1661, 1989.

3329. mŠw‰ïn iˆê”Êu‰‰j ICU‚É‚¨‚¯‚éAgsŒnR¶Ü‚Ì•a‘Ô•Ê“Š—^•û–@‚ÌŒŸ“¢. ’†‘º‹±ŽqC‹ß“¡—¯”üŽqC•ŽR­ˆêC‰Á‰ê’J”£C¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC‘å˜a“c—²i‹~–½j: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.05), –¼ŒÃ‰®C u‰‰—vŽ|W11Cp.31, 1989.

3330. mŠw‰ïn iˆê”Êu‰‰j ¸__Œo‰È“ü‰@Š³ŽÒ‚Ì•ž–òŽw“±‚ÌŒ»ó‚Æ–â‘è“_. •½ŽR•ŽiC’|“எqC“‡“cŽœ•Fi–òÜ•”jCŽO‰Y’å‘¥i¸j: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.06), –¼ŒÃ‰®.

3331. mŠw‰ïn iˆê”Êu‰‰j •a‰@–òÜŽtE”\‚ÌV‚½‚È‚é“WŠJ‚Æ•]‰¿. ù–ì–œ—ŽqC‰Á‰ê’J”£C–îŒã˜a•vC²ìŒ«ˆêC•ŽR­ˆêC‘º£¨’ÃŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”j: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.06), –¼ŒÃ‰®C u‰‰—vŽ|W11Cp.50, 1989.

3332. mŠw‰ïn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@î•ñƒg|ƒ^ƒ‹ƒVƒXƒeƒ€i‘æ1•ñjƒg|ƒ^ƒ‹ƒVƒXƒeƒ€‚ÌŠT—v‚Æ–ò•iƒ}ƒXƒ^|‚Ì\’z. ¬‘î³CaŒû‘OC•—ŠÔKŽOC²“¡“§C¼Œ´”£C‹´–{‚Ђë”üC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC¼‘º³–¾C´…ŽO‘¾˜YiŠé‰æŽºj: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.06), –¼ŒÃ‰®C u‰‰—vŽ|W11Cp.52, 1989.

3333. mŠw‰ïn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@î•ñƒg|ƒ^ƒ‹ƒVƒXƒeƒ€i‘æ2•ñj’ŽËƒI|ƒ_‚ðŠî–{‚É‚µ‚½’ŽË–ò‹Ÿ‹‹. Œú“cKˆê˜YC“n•ÓÛŽqC‰Á‰ê’J”£C¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC™è“¹•viŠé‰æŽºj: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.06), –¼ŒÃ‰®C u‰‰—vŽ|W11Cp.53, 1989.

3334. mŠw‰ïn iˆê”Êu‰‰j Ý‘îˆã—Âɂ¨‚¯‚é–òÜŽt‚Ì–ðŠ„i‘æ1•ñjƒCƒ“ƒXƒŠƒ“Ž©ŒÈ’ŽË‚̈À‘S«‚ÌŒŸ“¢. ‚‹´Œ«¬C²“¡“§C÷“c˜a’jC•—ŠÔKŽOC¬‘î³C¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC—§èŽOç‘ãC‚£•xŽ}iŠÅŒì•”jC‚‹{t’ji—ÕŒŸj: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.06), –¼ŒÃ‰®C u‰‰—vŽ|W11Cp.55, 1989.

3335. mŠw‰ïn iˆê”Êu‰‰j •¡‡‹ÃŒÅˆöŽq‘ª’莎–ò‚Ì•]‰¿. —]ŒÎ‹v”üŽqC‘O“c’‰LC”~“c‹v”üC”·—EŽŠi—ÕŒŸjC“àŽRKMi—Õ•a—j: ‘æ38‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï (89.04.29), ŒSŽRC ‰q¶ŒŸ¸C38(3): 393, 1989.

3336. mŠw‰ïn iˆê”Êu‰‰j —AŒŒ‹Æ–±‚É‚¨‚¯‚éƒRƒ“ƒsƒ…|ƒ^|ŠÇ—ƒVƒXƒeƒ€‚ÌŽg—pŒoŒ±. óˆäD”üC“yŽu“c^”üC‰““¡—mC”·—EŽŠi—ÕŒŸjC“àŽRKMi—Õ•a—jCŽOd–슰ŠìiŠOj: ‘æ38‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï (89.04.29), ŒSŽRC ‰q¶ŒŸ¸C38(3): 578, 1989.

3337. mŠw‰ïn iˆê”Êu‰‰j A Trial of Drug Information Service by On-line System in Kitasato University Hospital. –]ŒŽ^‹|C•ŽR­ˆêC‘º£¨’ÃŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC’ß“c—z˜aiˆã—pî•ñj: Pan Pacific ‡X (89.05.07), ƒ\ƒEƒ‹C Abstract, p.323, 1989.

3338. mŠw‰ïn iˆê”Êu‰‰j Patho-Physiology in Cancer Patients as Reflected by the PFK Test. ’†‘º‘‰qC’†“‡—mˆêi•ª¶j: 6th International Conference on Human Tumor Markers (89.05.23), “Œ‹žC Journal of Tumor Marker OncologyC4(2): 138, 1989.

3339. mŠw‰ïn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@ˆã–ò•iW‚̃Rƒ“ƒsƒ…|ƒ^‰». ’ß“c—z˜aC’r“cŒ›ºiˆã—pî•ñjC²“¡“oŽu˜Yi¶—jC’|“ດŽiˆã—pî•ñjC”–ˆäŽjŽqCÎìrLi“dŽqŒvŽZ‹@ƒZƒ“ƒ^|j: ‘æ28‰ñ“ú–{MEŠw‰ï‘å‰ï (89.05.23), ‘åãC ˆã—p“dŽq‚ƶ‘ÌHŠwC27(“Á•Ê): 144, 1989.

3340. mŠw‰ïn iˆê”Êu‰‰j ‹@”\“I\‰¹áŠQŽ™‚ÌITPA‚ɂ‚¢‚Ä. ‰ª–{˜NŽqC—é–ØŒbŽqCŒ´—R‹IiŽ¨•@j: “ú–{’®”\Œ¾ŒêŠw‰ï (89.05.28), ɪ, ‘æ15‰ñ“ú–{’®”\Œ¾ŒêŠw‰ïŠwpu‰‰‰ï—\eW, p.73, 1989.

3341. mŠw‰ïn iˆê”Êu‰‰j Dry Impact Blending Preparation and Properties of Encapsulated Powder Polymers. ¬Î^ƒC–{“cG—²i“Œ‹ž—‰È‘åjC¼–ìVŽmi‰»j: 5th International Conference on Pharmaceutical Technology (89.06.01), ƒpƒŠ, Proceedings, 5: 396`405, 1989.

3342. mŠw‰ïn iˆê”Êu‰‰j ˆã–ò•iî•ñ‚É‚¨‚¯‚é“dŽqŒvŽZ‹@‚̉ž—pi‡Uj. ‹´–{‚Ђë”üC•ŽR­ˆêC–쑺’mŽqC–]ŒŽ^‹|C‘ºãˆèŽqC¬‘î³C‘º£¨’ÃŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC’ß“c—z˜aiˆã—pî•ñjC¼‘º³–¾CŽR츈êC ´…ŽO‘¾˜YiŠé‰æŽºj: ‘æ39‰ñ“ú–{•a‰@Šw‰ï (89.06.15), ’·–ìC u‰‰W, p.452`453, 1989.

3343. mŠw‰ïn iˆê”Êu‰‰j “_“H‰tŽ©“®ƒZƒbƒeƒBƒ“ƒO‘•’u‚Ì—L—p«‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‘哇”ü˜aŽqC‘¾“c‹v”üŽqC‰¡“cœÄˆêC‹àŽqCŽqC¬—Ñç—mŽqCΎ˳‰pC“‡“cŽœ•Fi–òÜ•”j: ‘æ39‰ñ“ú–{•a‰@Šw‰ï (89.06.15), ’·–ì, u‰‰W, p.458`459, 1989.

3344. mŠw‰ïn iˆê”Êu‰‰j ŠÅŒì•w—{¬Z‚É‚¨‚¯‚éˆã–ò•iŠÖ˜A‹³ˆç‚ÌŽÀ‘Ô’²¸|–òÜŽt‚Ƃ̃`|ƒ€ˆã—Äi‚Ì•K—v«|. ‹gŽR—F“ñi–òŠw•”jC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”j: ‘æ39‰ñ“ú–{•a‰@Šw‰ï (89.06.16), ’·–ìC u‰‰W, p.612`613, 1989.

3345. mŠw‰ïn iˆê”Êu‰‰j A“ª“EoŒã‚ÌH“¹‰¹ºKn‚ÉŠÖ˜A‚·‚é—vˆö‚ɂ‚¢‚Ä. ‰ª–{˜NŽqC‚‹´œAbiŽ¨•@j: “ú–{“ªŒz•”Žîᇊw‰ï (89.07.01), ‘åã, ‘æ13‰ñ“ú–{“ªŒz•”Žîᇊw‰ïŠwpu‰‰‰ïƒvƒƒOƒ‰ƒ€—\eW, p.174, 1989.

3346. mŠw‰ïn iˆê”Êu‰‰j ’¹‚ð—p‚¢‚½”­º|’®ŠoŒn‚̶—S—Šw“IŒ¤‹†i‡Vj. ŽRèŽÌ•vi¶—j: ‘æ7‰ñ“ú–{¶—S—Šw‰ï‘å‰ï (89.07.11), –kŠC“¹C ƒvƒƒOƒ‰ƒ€, p.23, 1989.

3347. mŠw‰ïn iˆê”Êu‰‰j ‚‘¬‹C—¬’†ÕŒ‚–@‚É‚æ‚镲‘Ì‚Ì•\–ʉüŽ¿. –{“cG—²C¬Î^ƒi“Œ‹ž—‰È‘åjC¼–ìVŽmi‰»j: “ú–{‰»Šw‰ï–kŠC“¹Žx•”1989”N‰Ä‹GŒ¤‹†”­•\‰ï (89.07.22), Žº—–, u‰‰—vŽ|W, p.66, 1989.

3348. mŠw‰ïn iˆê”Êu‰‰j ’ŽËܬ‡‹Æ–±‚É‚¨‚¯‚é׋ۉ˜õ‚ÌŒŸ“¢i‘æ2•ñj. ‹àŽqCŽqC‘¾“c‹v”üŽqC‰¡“cœÄˆêC‘哇”ü˜aŽqC¬—Ñç—mŽqCΎ˳‰pC“‡“cŽœ•Fi–òÜ•”j: ŠÖ“ŒƒuƒƒbƒN‘æ19‰ñŠwp‘å‰ï (89.08.27), ŽR—œ.

3349. mŠw‰ïn iˆê”Êu‰‰j Development of Biosynthetic Bilaminar Wound Dressing Capable of Releasing an Antibacterial Drug. ‹à‰h‹gC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ5‰ñƒAƒWƒA¥‘¾•½—mŒ`¬ŠO‰ÈŠw‰ï (89.09.10), ƒCƒXƒ^ƒ“ƒu[ƒ‹, ƒgƒ‹ƒR.

3350. mŠw‰ïn iˆê”Êu‰‰j ƒWƒ‹ƒRƒjƒAƒ]ƒ‹‰üŽ¿•²‘Ì‚Ì’²». –{“cG—²i“Œ‹ž—‰È‘åjC¼–ìVŽmi‰»jC¬Î^ƒi“Œ‹ž—‰È‘åj: ‘æ42‰ñƒRƒƒCƒh‚¨‚æ‚ÑŠE–ʉ»Šw“¢˜_‰ï (89.10.14), b•{, u‰‰—vŽ|W, p.438`439, 1989.

3351. mŠw‰ïn iˆê”Êu‰‰j ‚Œ‹»«ƒŠƒ“Ž_|…‘fƒJƒ‹ƒVƒEƒ€“ñ…˜a•¨‚Ì‹…»ó¬’·. ¼–ìVŽmi‰»jC¬Î^ƒi“Œ‹ž—‰È‘åj: ‘æ42‰ñƒRƒƒCƒh‚¨‚æ‚ÑŠE–ʉ»Šw“¢˜_‰ï (89.10.14), b•{, u‰‰—vŽ|W, p.516`517, 1989.

3352. mŠw‰ïn iˆê”Êu‰‰j ‚‘¬‹C—¬’†ÕŒ‚–@‚É‚¨‚¯‚镲‘Ì‚Ì•t’…‹@\. –{“cG—²i“Œ‹ž—‰È‘åjC¼–ìVŽmi‰»jC¬Î^ƒi“Œ‹ž—‰È‘åj: ‘æ27‰ñ•²‘Ì‚ÉŠÖ‚·‚é“¢˜_‰ï (89.10.19), ç—t, u‰‰—vŽ|W, p.185`188, 1989.

3353. mŠw‰ïn iˆê”Êu‰‰j ‚‘¬‹C—¬’†ÕŒ‚–@‚É‚æ‚éƒJƒvƒZƒ‹•²‘Ì‚Ì’²». –{“cG—²i“Œ‹ž—‰È‘åjC¼–ìVŽmi‰»jC¬Î^ƒi“Œ‹ž—‰È‘åj: 1989”N“xFÞ‹¦‰ïŒ¤‹†”­•\‰ï (89.10.30), “Œ‹ž, u‰‰—vŽ|W, p.81`82, 1989.

3354. mŠw‰ïn iˆê”Êu‰‰j œ“±ƒ}ƒCƒN‚ð—p‚¢‚½H“¹”­ºŽÒ—pŠgº‘•’u‚ÌŽŽì. ¢–ØG–¾C]Œ©‹±ˆêiE‹ÆŒP—û‘åjC‰ª–{˜NŽqCŒ´—R‹IiŽ¨•@jC–xŒû—˜”VCV”ü¬“ñi“Œ‘åj: “ú–{‰¹ºŒ¾ŒêˆãŠw‰ï (89.11.11), ˆ¤’mC ‘æ34‰ñ“ú–{‰¹ºŒ¾ŒêˆãŠw‰ï‘‡Šwpu‰‰‰ï—\eW, p.129, 1989.

3355. mŠw‰ïn iˆê”Êu‰‰j ’¹‚ð—p‚¢‚½”­º|’®ŠoŒn‚̶—S—Šw“IŒ¤‹†i‡WjƒCƒ“ƒR‚ÌlŒ¾Œê‚Ì”­º‰¹º. ŽRèŽÌ•vi¶—j: ‘æ53‰ñ“ú–{S—Šw‰ï‘å‰ï (89.11.30), ’}”gC ˜_•¶W, p.491, 1989.

3356. mŠw‰ïn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@î•ñƒg|ƒ^ƒ‹ƒVƒXƒeƒ€i‘æ5•ñj|ˆ•ûƒI|ƒ_‚ÌŽÀÛ2|. ‚‹´Œ«¬C¬‘î³CaŒû‘OC•—ŠÔKŽOC²“¡“§C”ö’¹Ÿ–çC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC¼‘º³–¾CŽæˆê—EC´…ŽO‘¾˜YiŠé‰æŽºj: ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï (90.02.01`03), “Œ‹žC ˜_•¶W, p.489`492, 1990.

3357. mŠw‰ïn iˆê”Êu‰‰j 200°’†‹K–Í•a‰@‚É\’z‚µ‚½•úŽËüŒŸ¸ƒI[ƒ_ƒŠƒ“ƒOƒVƒXƒeƒ€‚ÌŒ»ó‚Æ”–â‘è. ‚¼r“¹C–ö“c’qCã–ì•×CFè‹`OC‘º‰ª¼¶C–î‹v•Ûƒ•½C‘º“cWˆê˜YCˆÀ“ŒH‘¥C•“cŒõ–¾Cù–{Œ›’ji–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@j: ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï (90.02.02), “Œ‹ž, ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï˜_•¶W, p.463`464, 1990.

3358. mŠw‰ïn iˆê”Êu‰‰j •a‰@î•ñƒVƒXƒeƒ€‚É‘g‚Ýž‚ñ‚¾•úŽËüŒŸ¸î•ñƒVƒXƒeƒ€‚ÌŠJ”­. ‘º“cWˆê˜YC–î‹v•Ûƒ•½i–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@jC‘å•”½i•a—jC•“cŒõ–¾C‘º‰ª¼¶i–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@j: ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï (90.02.02), “Œ‹ž, ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï˜_•¶W, p.467`468, 1990.

3359. mŠw‰ïn iˆê”Êu‰‰j –k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@‚É‚¨‚¯‚é•a—ðƒf[ƒ^ƒx[ƒX‚ÌŒ»ó. ‰i‹v•Û^C¼’JOŒõC‹v•Û“c–FˆêC‘º“cWˆê˜YCù–{Œ›’jC‘å•”½C•“cŒõ–¾C‰ª“c–¾”üC“àŽR–õi–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@j: ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï (90.02.03), “Œ‹ž, ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï˜_•¶W, p.637`640, 1990.

3360. mŠw‰ïn iˆê”Êu‰‰j ¸_‰È•ž–òŽw“±‚É‚¨‚¯‚é–òÜŽt‚Ì–ðŠ„|–k—¢‘åŠw“Œ•a‰@‚ÌŒoŒ±‚Æ‘S‘ƒAƒ“ƒP|ƒg’²¸‚ÌŒ‹‰Ê‚ɂ‚¢‚Ä|. ’|“எqC”ÑòŒb”üŽqCˆÉ“¡s‘ãC“‡“cŽœ•Fi–òÜ•”jC΋½‰ªƒC‘å’J‹`•vCŽO‰Y’å‘¥i¸j: ‘æ18‰ñ“ú–{¸_•a‰@‹¦‰ï¸_ˆãŠw‰ï (90.03.22). å‘ä.

3361. mŠw‰ïn iˆê”Êu‰‰j ‹¹œãœ‹Ø‚É‚æ‚é”­˜bŠJŽnŽž‚̃sƒbƒ`’²ß. “‡“cƒˆêi¶—jC–xŒû—˜”VCV”ü¬“ñCœA£”£i“Œ‘åj: ‘æ2‰ñ“ú–{A“ª‰ÈŠw‰ï (90.03.23), “Œ‹žC —\eWCp.80, 1990.

3362. mŠw‰ïn iˆê”Êu‰‰j •ê‰¹‚ª–³º‰»‚³‚ê‚é‚Æ‚«‚Ì—Öóbó‹Ø‚ÌŠˆ“®. “‡“cƒˆêi¶—jC–xŒû—˜”VCV”ü¬“ñCœA£”£i“Œ‘åj: “ú–{‰¹‹¿Šw‰ï (90.03.29), “Œ‹žC ˜_•¶W‡T, p.255`256, 1990.

3363. mŠw‰ïn iˆê”Êu‰‰j ’†‰›Žèp•”ˆã—ËZpˆõ‚Ì“úA“–’¼‹Î–±“à—e‚ɂ‚¢‚Ä. —é–ØDMC‰ª–{kˆê˜YC¼—ÑŒõC’r“cŒbŽqi’†‰›Žèp•”jCª–{EiŠOjC“c’†—ºi–ƒj: ‘æ11‰ñ“ú–{Žèp•”ˆãŠw‰ï‘‰ï i89.10.27), ŽRŒ`, “ú–{Žèp•”ˆãŠw‰ïŽ, 10(—Õ‘): 50, 1989.

3364. mŒ¤‹†‰ïn i‹³ˆçu‰‰j Å‹ß‚ÌMR‘•’u‚ÌŒ»‹µ. ›Mˆêi•új: _“Þ쌧f—ÕúŽËü‹ZpuK‰ï (89.09.10), ‰¡•l.

3365. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ˆã—Âɂ¨‚¯‚éV‚µ‚¢“¹‹ïA‰æ‘œf’f. ›Mˆêi•új: _“Þ쌧‘åŠwŒöŠJuÀ (89.10.14), ‘Š–ÍŒ´.

3366. mŒ¤‹†‰ïn iƒpƒlƒ‹j ”÷—ÊŒ³‘f»Ü‚Ì”z‡•Ï‰». “‡“cŽœ•Fi–òÜ•”j: ‘æ5‰ñ—A‰t¥”÷—ʉh—{‘fŒ¤‹†‰ï (89.07.08), “Œ‹ž.

3367. mŒ¤‹†‰ïn iˆê”Êu‰‰j –k—¢Total System. ΋´Wi”åj: ‘æ3‰ñƒwƒ‹ƒXƒGƒOƒ[ƒNƒeƒBƒuƒJƒ“ƒtƒ@ƒŒƒ“ƒX (89.08.27), ƒoƒ“ƒRƒN.

3368. mŒ¤‹†‰ïn iˆê”Êu‰‰j HPNŽ{sŠ³ŽÒ‚ɑ΂·‚é–K–âˆã—Â̕K—v«. ¬ìK—YC“‡“cŽœ•Fi–òÜ•”jCŽR–{ŒPŽqC•Ð•£Œ[ŽqiŠÅŒì•”jC‘å’J„³C”äŠé”\Ž÷iŠOj: ‘æ4‰ñÝ‘îÖ¬‰h—{iHPNjŒ¤‹†‰ï (89.09.02), ‘åã.

3369. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œz‘MRŽ²ˆÊ‘œ‚̉ð–UŠw“IŒŸ“¢: ƒXƒsƒ“ƒGƒR[–@‚ƃOƒ‰ƒWƒFƒ“ƒgƒGƒR[–@‚Ì”äŠr. ‹àˆä’Ë•¶–¾C’J“c—ˆê˜YC‰““¡‚C¬—ѬŽiC¼–{—æŽqCˆä“›–rC‘–쳈êi•új: ‘æ18‰ñ’f‘w‰f‘œŒ¤‹†‰ï (89.10.22).

3370. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒ}ƒCƒNƒƒRƒ“ƒsƒ…|ƒ^‚ð—p‚¢‚½ŠeŽíˆã—Ãî•ñ’ñ‹ŸƒVƒXƒeƒ€. ’ß“c—z˜aC‹{Œ´‰p•viˆã—pî•ñjC²“¡“oŽu˜Yi¶—jC“c’†—ºi–ƒj: ‘æ7‰ñ–ƒŒ¥W’†Ž¡—ÃRƒ“ƒsƒ…|ƒ^Œ¤‹†‰ï (89.11.18), •xŽR, ´˜^W, p.13, 1989.

3371. mŒ¤‹†‰ïn iˆê”Êu‰‰j R‹ÛÜ™•ú«“ñ‘w\‘¢‘n”í•¢Þ‚ÌŠJ”­. ‹à‰h‹gC_‘ò•qC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: “ú’†Œ`¬ŠO‰ÈŒð—¬ŠwpW‰ï (89.11.22), ’·è.

3372. mŒ¤‹†‰ïn iˆê”Êu‰‰j R‹ÛÜ™•ú«‘n”í•¢Þ‚Ì컂ƕ]‰¿. ‹à‰h‹gC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ19‰ñ‘nŽ¡–üŒ¤‹†‰ï (89.12.02), ‹v—¯•Ä.

3373. mŒ¤‹†‰ïn iˆê”Êu‰‰j Development of Biosynthetic Bilaminar Wound Dressing Capable of Releasing Antibacterial Drug. ‹à‰h‹gC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ4‰ñƒ}ƒEƒC Burn Conference (90.02.18), ƒnƒƒC, Abstract, p.28, 1989.

3374. mŒ¤‹†‰ïn iˆê”Êu‰‰j •½t‹@”\ŒŸ¸Œ‹‰Ê‚̃f|ƒ^|ƒx|ƒX‰». V“cŒ’‘¾˜YC“¿‘Œú“ñiŽ¨•@j: Ž¨•@ˆôA‰Èî•ñˆ—Œ¤‹†‰ï (90.03.17), “Œ‹ž, Ž¨•@ˆôA‰Èî•ñˆ—Œ¤‹L6‰ñ, 1990.